data_1z2e_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z2e _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.88 174.07 3.97 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.42 142.59 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.25 149.7 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 119.308 0.958 . . . . 0.0 109.189 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 138.3 42.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.842 0.857 . . . . 0.0 109.185 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.23 131.06 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.6 mt -127.94 140.08 52.21 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.785 0.834 . . . . 0.0 110.547 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -139.26 175.26 9.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.176 0.99 . . . . 0.0 111.887 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -55.36 -32.1 62.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.789 1.236 . . . . 0.0 111.142 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 143.27 9.9 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.12 57.83 2.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.094 0.958 . . . . 0.0 111.424 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 m -127.92 -20.22 3.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.0 m -134.33 -93.81 0.3 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.229 0.922 . . . . 0.0 109.052 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -55.36 -50.9 68.49 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.969 0.907 . . . . 0.0 111.518 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 p -67.58 -37.85 83.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.748 0.703 . . . . 0.0 111.501 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -60.5 -52.8 63.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.147 0.979 . . . . 0.0 110.347 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.1 mtm -59.9 -42.07 93.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.54 0.736 . . . . 0.0 111.358 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.91 -43.66 98.2 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.457 0.571 . . . . 0.0 111.329 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -55.96 -43.28 77.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.959 0.345 . . . . 0.0 110.332 171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HE2' ' A' ' 25' ' ' LYS . . . -54.5 -52.26 46.21 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.34 -0.7 . . . . 0.0 112.754 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.525 0.662 . . . . 0.0 111.275 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.69 98.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.806 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 46.1 mtmt -51.09 -41.2 59.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.238 0.926 . . . . 0.0 111.325 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -67.32 -61.97 1.65 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.329 0.393 . . . . 0.0 110.566 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -69.48 -39.15 77.85 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.3 mt -77.84 -5.37 50.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.507 0.723 . . . . 0.0 112.542 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.57 55.96 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.559 1.076 . . . . 0.0 114.006 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 58.69 8.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.427 2.291 . . . . 0.0 114.292 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.82 -3.88 7.89 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.89 -1.131 . . . . 0.0 111.093 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 8.6 m95 -132.4 121.59 23.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.9 mmpt? -67.62 97.3 0.6 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 t -80.39 139.86 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -146.93 165.23 30.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.408 1.483 . . . . 0.0 109.501 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.0 p -144.5 157.48 44.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.734 0.814 . . . . 0.0 109.624 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.89 -166.31 1.57 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.87 1.268 . . . . 0.0 109.552 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -179.46 46.18 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mt -56.14 -27.66 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.997 1.319 . . . . 0.0 111.448 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.63 171.94 13.98 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.74 1.216 . . . . 0.0 108.968 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.65 135.36 17.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -137.03 17.46 3.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.24 1.016 . . . . 0.0 109.896 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.97 167.61 25.1 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -91.31 149.79 21.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.224 0.61 . . . . 0.0 110.721 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -74.47 134.14 76.65 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.872 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.87 -34.84 57.34 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.778 2.318 . . . . 0.0 114.115 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -72.98 -32.74 65.38 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.447 -0.783 . . . . 0.0 110.297 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -44.72 91.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.37 -51.22 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -58.07 -44.49 87.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.921 0.782 . . . . 0.0 111.511 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.0 86.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.39 -37.58 77.58 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.984 0.356 . . . . 0.0 111.333 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -27.58 69.31 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.927 -1.108 . . . . 0.0 111.309 174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.35 -16.27 63.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.018 0.826 . . . . 0.0 110.769 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.27 0.55 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.908 0.883 . . . . 0.0 112.052 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.45 18.75 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.35 160.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.05 141.88 51.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.67 0.788 . . . . 0.0 109.596 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.76 -0.54 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.406 1.482 . . . . 0.0 109.826 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -58.62 -33.01 69.54 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.344 -1.473 . . . . 0.0 111.116 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -63.28 -17.75 62.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.254 1.821 . . . . 0.0 114.763 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -120.86 52.53 1.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.664 1.12 . . . . 0.0 110.569 -168.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -48.18 136.07 12.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 110.984 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -57.11 155.57 8.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -168.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -153.72 156.31 37.58 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.359 1.464 . . . . 0.0 109.395 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.55 168.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.544 1.138 . . . . 0.0 109.447 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -56.51 142.99 11.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.673 0.789 . . . . 0.0 108.935 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.61 140.88 43.15 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.513 1.125 . . . . 0.0 109.876 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.67 -30.56 61.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.066 1.346 . . . . 0.0 113.166 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -70.01 -11.12 60.65 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.278 1.031 . . . . 0.0 112.069 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.0 mt -121.06 -43.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 pp -56.93 -40.66 76.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.078 1.308 . . . . 0.0 112.341 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.2 4.84 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.901 0.881 . . . . 0.0 112.542 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -125.59 -26.42 3.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.813 1.245 . . . . 0.0 112.851 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.39 132.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.617 1.167 . . . . 0.0 109.384 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.03 -25.48 66.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.705 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.6 tp -147.77 141.97 26.14 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.672 1.189 . . . . 0.0 108.655 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.63 147.04 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.1 t -132.64 127.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -100.89 134.39 43.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.25 18.22 21.33 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.212 0.605 . . . . 0.0 109.971 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.6 p -67.98 116.04 8.18 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 170.892 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 113.357 0.483 . . . . 0.0 113.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -68.61 145.69 53.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.373 1.069 . . . . 0.0 109.57 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -130.2 158.23 74.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.095 1.758 . . . . 0.0 109.868 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 138.18 35.05 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 121.907 1.738 . . . . 0.0 109.291 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.63 -21.19 25.86 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.802 2.335 . . . . 0.0 112.306 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -67.89 -23.13 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.132 0.973 . . . . 0.0 112.083 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.98 142.21 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -170.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.05 139.24 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.984 0.914 . . . . 0.0 108.589 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -133.64 151.64 51.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.598 0.759 . . . . 0.0 110.123 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.92 159.23 34.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.781 2.033 . . . . 0.0 107.723 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -135.05 111.15 9.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -121.42 62.03 0.91 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.968 1.707 . . . . 0.0 106.847 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.37 133.4 23.81 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 121.198 -0.939 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 161.16 35.19 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.561 1.944 . . . . 0.0 106.126 169.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.23 143.2 55.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.237 0.542 . . . . 0.0 110.903 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.24 127.15 93.06 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.81 -23.73 62.23 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.176 1.251 . . . . 0.0 113.378 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.67 -14.66 63.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.334 0.97 . . . . 0.0 112.337 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -110.02 3.84 20.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.121 1.368 . . . . 0.0 111.294 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.22 61.66 0.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.406 1.882 . . . . 0.0 111.225 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -59.13 138.68 57.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.805 1.642 . . . . 0.0 110.701 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.09 -59.36 0.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.1 t -165.06 167.58 18.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.81 1.644 . . . . 0.0 107.402 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.28 -30.77 70.68 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.115 0.566 . . . . 0.0 111.283 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.63 -38.54 80.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.831 0.452 . . . . 0.0 110.379 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.27 -42.3 72.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -56.35 -52.21 65.43 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.114 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.8 t-105 -56.99 -40.34 76.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.89 0.768 . . . . 0.0 111.287 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.22 -40.98 97.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.511 0.596 . . . . 0.0 110.16 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -67.31 -29.86 69.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.634 -1.174 . . . . 0.0 113.139 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -60.55 -50.79 72.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.853 1.66 . . . . 0.0 109.813 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -65.9 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.94 0.791 . . . . 0.0 112.035 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -65.58 -51.81 56.93 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.359 0.982 . . . . 0.0 110.893 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.08 -37.9 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -54.65 -53.57 53.0 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.571 0.749 . . . . 0.0 109.581 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.06 -43.47 98.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.763 0.256 . . . . 0.0 110.963 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -40.45 91.21 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.737 -0.602 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -59.32 -50.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.02 63.79 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -59.64 -50.0 75.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.558 0.679 . . . . 0.0 110.895 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -70.32 -30.13 67.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 117.321 -1.323 . . . . 0.0 111.554 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -39.95 84.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.654 1.115 . . . . 0.0 110.104 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -56.4 -50.92 70.2 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.02 -36.17 83.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.201 0.455 . . . . 0.0 111.662 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.7 -36.63 83.57 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.357 -0.84 . . . . 0.0 111.539 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.37 -36.93 33.29 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.481 0.312 . . . . 0.0 111.173 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.4 -42.78 10.71 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.047 1.339 . . . . 0.0 111.797 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 p -115.05 -20.29 10.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.464 1.106 . . . . 0.0 111.475 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.35 82.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.939 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 119.12 1.46 . . . . 0.0 109.059 178.244 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -77.45 178.25 7.35 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.9 140.41 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -143.27 152.1 16.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.778 0.831 . . . . 0.0 109.325 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.62 136.45 29.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.095 0.958 . . . . 0.0 109.088 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.64 125.37 44.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.654 1.182 . . . . 0.0 108.261 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.3 142.41 49.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.755 1.222 . . . . 0.0 109.477 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -139.95 171.44 14.2 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.158 0.983 . . . . 0.0 111.833 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -60.04 -23.0 63.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.941 0.897 . . . . 0.0 111.795 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.96 134.88 4.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 169.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.82 55.01 1.96 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.289 1.036 . . . . 0.0 111.528 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -126.55 -16.86 5.22 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.4 m -137.88 -87.12 0.27 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.073 0.851 . . . . 0.0 109.478 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -57.99 -54.36 47.86 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.754 0.822 . . . . 0.0 111.192 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 p -67.01 -34.57 78.04 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.975 0.352 . . . . 0.0 111.238 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -62.16 -55.5 28.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.958 0.903 . . . . 0.0 109.998 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.5 mtm -58.06 -42.71 86.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.274 0.63 . . . . 0.0 111.484 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.92 97.96 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.621 0.646 . . . . 0.0 111.353 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -56.88 -41.68 78.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.933 0.333 . . . . 0.0 110.611 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.35 68.63 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.484 0.584 . . . . 0.0 112.41 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -63.53 -42.97 98.4 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.596 0.698 . . . . 0.0 111.089 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.35 99.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.564 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -52.0 -38.6 57.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.954 0.797 . . . . 0.0 111.643 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -70.51 -62.59 1.33 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.204 0.315 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -68.81 -36.87 78.75 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.427 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.2 mt -78.44 -2.11 36.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.353 0.661 . . . . 0.0 112.197 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.5 24.05 58.96 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.979 1.276 . . . . 0.0 113.961 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.14 14.32 1.97 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.031 2.132 . . . . 0.0 113.633 -172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.15 -0.86 15.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.928 1.291 . . . . 0.0 110.91 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.7 m95 -133.46 122.52 23.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.54 97.42 0.59 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.1 140.88 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -144.76 166.13 26.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.166 1.387 . . . . 0.0 109.533 174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.8 p -145.68 158.44 43.85 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.689 0.796 . . . . 0.0 109.888 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.34 -168.17 1.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.708 1.203 . . . . 0.0 110.205 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.0 179.96 46.82 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.534 -0.729 . . . . 0.0 111.325 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -56.38 -27.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.049 1.34 . . . . 0.0 111.304 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.11 168.94 21.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.915 1.286 . . . . 0.0 108.563 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.48 138.44 26.15 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.74 12.97 6.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.757 1.223 . . . . 0.0 109.826 172.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 163.77 34.43 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -170.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.53 146.21 38.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.217 0.532 . . . . 0.0 110.375 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -70.52 134.33 86.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.671 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.15 -35.62 43.11 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.657 2.238 . . . . 0.0 114.095 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.42 -27.26 63.18 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.451 -0.78 . . . . 0.0 111.011 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.9 85.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.36 -49.91 81.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -57.81 -40.24 79.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.395 0.998 . . . . 0.0 111.642 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.84 84.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.598 0.636 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.2 mmm -68.1 -35.3 77.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.423 0.556 . . . . 0.0 111.123 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -68.07 -23.72 64.98 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.669 -1.269 . . . . 0.0 111.308 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -67.13 -21.16 65.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.091 0.859 . . . . 0.0 110.398 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.59 -1.47 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.24 0.616 . . . . 0.0 112.133 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.0 33.28 15.46 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.64 159.28 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.94 144.39 49.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -128.82 3.53 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.984 1.314 . . . . 0.0 110.261 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.98 -28.66 67.87 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 111.061 171.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.49 -4.65 4.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.421 1.888 . . . . 0.0 115.192 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -138.16 49.23 1.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.425 1.466 . . . . 0.0 110.879 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 p -46.61 131.56 11.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 110.747 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -56.85 156.73 6.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.134 1.773 . . . . 0.0 115.179 -169.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -153.38 157.04 39.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.069 1.348 . . . . 0.0 109.132 171.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 164.89 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.867 0.867 . . . . 0.0 109.402 169.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.49 139.89 14.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 109.546 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.64 138.39 50.06 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.435 1.494 . . . . 0.0 109.671 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -57.56 -27.63 62.83 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.598 1.559 . . . . 0.0 113.29 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.05 -12.72 61.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.828 1.251 . . . . 0.0 112.075 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -112.73 -41.21 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.47 -58.56 4.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.836 1.198 . . . . 0.0 111.499 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.79 0.36 27.28 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -118.66 -31.75 4.76 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.984 1.314 . . . . 0.0 111.783 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 128.36 35.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 109.755 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.65 -25.41 64.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.174 0.59 . . . . 0.0 110.781 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.8 tp -145.53 141.08 27.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.44 1.096 . . . . 0.0 108.171 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.86 153.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.88 136.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -109.17 122.3 47.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.3 25.28 5.06 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.054 0.941 . . . . 0.0 109.52 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -75.42 68.34 2.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.019 2.127 . . . . 0.0 113.606 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.228 0 O-C-N 121.122 -0.987 . . . . 0.0 111.203 170.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.534 0.494 0 N-CA-C 114.011 0.735 . . . . 0.0 114.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 147.08 52.77 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.866 1.266 . . . . 0.0 111.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -133.39 159.38 72.8 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.967 2.107 . . . . 0.0 108.964 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.1 138.61 40.35 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.77 1.647 . . . . 0.0 109.429 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 -18.48 39.48 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.902 2.402 . . . . 0.0 112.129 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -64.45 -19.93 65.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.493 1.117 . . . . 0.0 112.019 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.5 t -110.99 136.66 46.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 118.937 0.79 . . . . 0.0 109.105 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -63.2 132.13 50.71 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.132 0.973 . . . . 0.0 108.746 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.99 159.55 28.11 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.598 0.759 . . . . 0.0 109.475 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -128.7 169.78 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.73 2.012 . . . . 0.0 107.188 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -136.11 122.49 20.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.61 58.6 1.3 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.86 1.664 . . . . 0.0 107.107 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.19 125.07 14.59 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.939 -1.101 . . . . 0.0 112.07 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.26 158.72 43.21 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.569 2.347 . . . . 0.0 105.806 168.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.27 149.5 48.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.198 0.523 . . . . 0.0 110.832 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.89 125.69 89.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.52 -25.11 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.378 1.385 . . . . 0.0 113.471 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.54 52.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.351 0.978 . . . . 0.0 112.115 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -114.57 3.74 14.94 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.951 1.3 . . . . 0.0 110.842 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.94 64.41 0.32 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.851 2.06 . . . . 0.0 110.308 169.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.51 139.67 56.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.495 1.518 . . . . 0.0 110.658 -171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.67 -57.59 0.21 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.64 169.43 13.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.019 1.728 . . . . 0.0 107.378 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.97 -30.5 70.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.902 -0.499 . . . . 0.0 111.349 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.75 -36.93 73.37 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.762 0.425 . . . . 0.0 110.676 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.89 -46.34 75.23 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -57.04 -48.46 78.48 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.294 0.637 . . . . 0.0 110.17 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -61.24 -37.86 84.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.5 0.72 . . . . 0.0 111.972 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.47 82.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.43 -33.26 75.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.861 0.465 . . . . 0.0 110.931 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.85 -48.57 79.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.81 0.844 . . . . 0.0 110.459 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.27 -41.49 98.5 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.474 0.579 . . . . 0.0 110.752 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -62.89 -48.61 78.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.117 0.871 . . . . 0.0 111.172 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.84 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 118.613 0.642 . . . . 0.0 109.301 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -55.23 -53.81 51.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.029 0.831 . . . . 0.0 109.235 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.07 -40.89 91.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.319 0.387 . . . . 0.0 111.236 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.91 -45.89 87.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.38 0.672 . . . . 0.0 110.428 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.1 mt -58.13 -50.14 79.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.87 51.4 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.573 0.624 . . . . 0.0 111.842 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -59.48 -48.6 81.01 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 117.751 0.776 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.87 -25.83 53.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.656 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.67 -38.54 83.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 120.057 1.299 . . . . 0.0 109.673 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.61 -50.42 73.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.43 -42.32 98.57 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 110.503 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -58.78 -33.26 70.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 120.274 -1.516 . . . . 0.0 111.854 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.56 -35.4 24.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.702 0.401 . . . . 0.0 111.958 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.31 -45.47 8.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.774 1.23 . . . . 0.0 112.034 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.7 p -113.86 -20.14 11.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 110.835 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.21 11.01 81.6 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.585 1.088 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt . . . . . 0 C--O 1.246 0.907 0 CA-C-N 118.916 1.358 . . . . 0.0 110.379 -177.384 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.71 172.9 9.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.15 142.37 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.58 151.5 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.083 0.953 . . . . 0.0 109.546 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.83 139.04 39.74 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.965 0.906 . . . . 0.0 109.321 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -122.54 128.59 50.95 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.406 1.082 . . . . 0.0 108.653 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.64 139.85 53.49 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.34 1.056 . . . . 0.0 110.015 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -139.93 175.03 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.184 1.793 . . . . 0.0 108.407 170.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -52.78 63.93 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 120.941 -1.099 . . . . 0.0 109.537 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.88 126.92 7.31 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.91 60.05 0.72 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.35 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -134.75 -20.67 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -126.49 -99.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -47.98 83.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 112.31 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.8 p -62.95 -38.41 90.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.425 0.557 . . . . 0.0 111.485 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -62.38 -55.21 30.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.193 0.997 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 49.7 mtm -55.91 -43.78 77.65 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.263 0.625 . . . . 0.0 111.316 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.3 99.34 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.362 0.665 . . . . 0.0 111.553 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.27 -41.19 79.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.918 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -49.48 78.19 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.707 0.685 . . . . 0.0 112.493 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -61.32 -46.25 91.05 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.579 0.69 . . . . 0.0 110.833 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.07 -40.78 97.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.315 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -51.31 -43.68 61.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.297 0.953 . . . . 0.0 111.006 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -71.15 -58.3 3.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 123.699 0.625 . . . . 0.0 111.206 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -64.37 -39.43 93.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.967 0.348 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.51 -2.86 54.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.178 0.991 . . . . 0.0 112.274 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.95 59.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.208 1.385 . . . . 0.0 114.629 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.56 5.8 0.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 0.0 113.97 -170.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.27 -7.55 19.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.837 -1.164 . . . . 0.0 110.343 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -128.08 121.02 28.63 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -68.92 97.86 0.89 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.01 140.69 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.35 167.06 23.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.337 1.455 . . . . 0.0 109.175 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.3 p -144.72 157.47 44.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.82 0.848 . . . . 0.0 109.692 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.9 -170.28 2.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 110.894 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.75 -177.55 42.18 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 122.052 -0.405 . . . . 0.0 113.069 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -56.48 -32.6 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.11 1.364 . . . . 0.0 109.637 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.07 169.07 19.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.867 1.667 . . . . 0.0 109.634 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.46 24.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.28 8.92 5.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.737 1.215 . . . . 0.0 110.087 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.96 165.58 25.92 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -170.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.27 150.08 25.03 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.047 0.539 . . . . 0.0 111.098 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -73.33 133.25 80.97 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.507 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.72 -36.29 61.29 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.732 2.288 . . . . 0.0 113.994 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -70.94 -32.97 70.03 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.723 -0.611 . . . . 0.0 110.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.5 90.88 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.67 -47.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -40.09 93.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.441 0.564 . . . . 0.0 111.184 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.27 99.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.626 0.771 . . . . 0.0 109.914 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.1 mmm -68.49 -38.0 80.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.23 0.468 . . . . 0.0 110.974 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -27.5 68.74 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 173.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.95 -16.77 64.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.869 0.758 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.63 1.47 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.157 0.983 . . . . 0.0 112.054 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.73 21.1 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -117.8 158.89 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.77 146.08 48.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.492 1.117 . . . . 0.0 108.506 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.27 3.31 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 110.431 170.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.06 -28.19 67.59 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 119.885 -1.76 . . . . 0.0 111.276 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.1 -5.45 4.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 115.091 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.48 50.83 1.95 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.993 1.269 . . . . 0.0 110.397 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 p -47.09 134.37 10.74 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.958 0.903 . . . . 0.0 110.724 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 m -56.79 156.23 6.81 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.033 1.733 . . . . 0.0 115.653 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -153.91 157.4 39.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.213 1.405 . . . . 0.0 109.465 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.5 169.04 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.193 . . . . 0.0 109.441 170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.38 141.76 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.39 141.4 41.73 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.475 1.11 . . . . 0.0 109.844 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 m -55.4 -30.24 60.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.088 1.355 . . . . 0.0 113.299 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.21 -13.67 62.53 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.006 0.922 . . . . 0.0 111.984 -173.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -121.06 -42.46 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.383 1.073 . . . . 0.0 108.299 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.37 -39.05 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.329 1.422 . . . . 0.0 112.118 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.5 4.87 51.8 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.792 0.837 . . . . 0.0 112.705 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -125.32 -28.8 3.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.886 1.274 . . . . 0.0 112.435 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 128.71 38.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.043 1.337 . . . . 0.0 108.983 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.77 -23.25 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.85 139.89 26.66 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.746 1.218 . . . . 0.0 108.067 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.7 146.51 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 t -135.43 129.37 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.07 129.98 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.47 23.18 11.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.627 0.771 . . . . 0.0 109.379 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -76.56 104.26 6.98 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.379 -1.451 . . . . 0.0 112.317 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.187 0 O-C-N 121.682 -0.636 . . . . 0.0 111.892 169.255 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.461 -0.425 0 N-CA-C 113.115 0.391 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.4 mmt -73.84 152.82 40.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.565 0.746 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 p -133.2 165.29 37.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.528 1.931 . . . . 0.0 109.393 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.81 155.21 68.72 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 172.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.03 -9.29 14.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.229 2.619 . . . . 0.0 114.56 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -129.77 0.04 4.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.515 1.052 . . . . 0.0 113.492 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.6 t -85.93 145.5 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.17 133.11 55.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -130.24 149.54 51.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.879 0.872 . . . . 0.0 109.003 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -132.89 169.75 16.32 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.085 1.354 . . . . 0.0 108.6 170.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -134.78 115.76 14.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 23.3 m0 -121.63 61.43 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.486 1.515 . . . . 0.0 107.243 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.82 128.84 9.86 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.172 -0.955 . . . . 0.0 112.367 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.85 159.5 44.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.177 2.191 . . . . 0.0 106.401 168.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.0 153.8 43.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.573 0.749 . . . . 0.0 110.612 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.05 125.01 73.73 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 110.124 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.51 -26.34 62.35 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.691 1.594 . . . . 0.0 113.864 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.27 -13.12 62.02 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.022 0.828 . . . . 0.0 112.264 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mtm105 -114.39 13.9 17.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.264 0.938 . . . . 0.0 111.476 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.83 67.29 0.81 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 0.0 109.975 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -58.6 138.71 56.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.793 0.837 . . . . 0.0 110.383 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.24 -60.02 0.23 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -167.32 167.48 13.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.671 1.589 . . . . 0.0 107.522 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.12 -29.21 68.46 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.093 0.557 . . . . 0.0 111.291 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.97 -39.66 75.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.964 0.506 . . . . 0.0 110.681 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.58 -44.63 86.1 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.83 -50.33 74.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.711 -0.662 . . . . 0.0 110.503 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -57.39 -40.28 77.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.242 0.928 . . . . 0.0 111.153 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.08 74.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.627 -0.671 . . . . 0.0 110.892 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.93 -34.92 64.51 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.703 -1.248 . . . . 0.0 111.26 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -58.26 -52.54 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.962 0.801 . . . . 0.0 109.881 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.81 -30.97 71.68 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.513 0.597 . . . . 0.0 112.115 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.11 -49.68 69.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.631 1.105 . . . . 0.0 111.117 173.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.4 -39.61 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.708 0.686 . . . . 0.0 109.187 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -53.04 -52.85 57.15 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.26 1.024 . . . . 0.0 109.727 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.41 -41.06 89.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.145 0.278 . . . . 0.0 111.331 -172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -64.15 -43.29 95.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.995 0.518 . . . . 0.0 110.421 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.36 -49.35 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.66 -47.35 64.52 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -59.74 -49.71 76.66 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 117.31 0.555 . . . . 0.0 110.391 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.14 69.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.312 -175.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -42.04 79.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.029 0.831 . . . . 0.0 110.069 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.07 -49.65 75.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.46 -36.35 82.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.743 -0.17 . . . . 0.0 111.237 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -61.51 -37.67 84.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.238 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.89 -37.0 41.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.451 0.3 . . . . 0.0 111.183 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.42 -48.32 6.71 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.727 1.211 . . . . 0.0 111.011 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.7 p -105.73 -20.49 13.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.749 1.22 . . . . 0.0 111.41 -169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.33 18.35 78.21 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.538 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.2 mttt . . . . . 0 C--O 1.248 1.021 0 CA-C-N 118.507 1.154 . . . . 0.0 109.51 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 175.53 2.9 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.11 142.04 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 tt -143.36 151.05 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -137.8 135.8 36.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.901 0.881 . . . . 0.0 108.795 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -117.88 137.74 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 mt -133.65 145.63 50.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.222 0.609 . . . . 0.0 111.509 -169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.02 173.51 12.39 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.504 1.122 . . . . 0.0 112.359 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.8 m -57.79 -29.65 65.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.165 1.786 . . . . 0.0 111.433 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 141.36 8.29 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -83.78 55.8 3.4 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.508 0.654 . . . . 0.0 112.087 -169.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 m -132.6 -12.05 3.06 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.7 m -131.68 -105.81 0.26 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -50.89 -47.17 60.71 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.587 1.155 . . . . 0.0 111.688 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -61.9 -42.12 98.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -69.37 -45.03 70.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.504 0.722 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.5 -43.23 99.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.978 0.511 . . . . 0.0 110.221 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.4 98.49 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.377 0.671 . . . . 0.0 111.255 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -57.37 -40.94 79.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.068 0.395 . . . . 0.0 110.075 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.86 -53.51 45.73 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.062 0.839 . . . . 0.0 111.532 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.52 -45.88 92.31 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.141 0.47 . . . . 0.0 110.686 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.39 93.83 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.316 0.646 . . . . 0.0 110.321 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -57.72 -33.58 68.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.869 0.759 . . . . 0.0 111.353 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.31 -62.28 1.45 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.16 0.437 . . . . 0.0 110.664 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -65.7 -43.06 90.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.337 0.255 . . . . 0.0 111.397 -169.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.78 -6.55 52.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.599 1.16 . . . . 0.0 112.112 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.56 51.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.972 1.272 . . . . 0.0 114.136 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t70 56.35 11.44 0.82 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.488 2.315 . . . . 0.0 114.081 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -64.89 -7.5 11.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.979 1.312 . . . . 0.0 110.484 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -126.65 118.78 25.48 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.67 98.78 0.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.08 138.77 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -140.11 166.06 25.69 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.772 1.629 . . . . 0.0 109.22 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -151.6 145.0 24.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.024 0.929 . . . . 0.0 108.711 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.39 -170.38 2.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.698 1.199 . . . . 0.0 112.02 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.06 -176.59 45.31 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.155 -0.966 . . . . 0.0 112.117 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.29 -30.38 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.862 1.265 . . . . 0.0 111.23 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.92 167.6 24.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.688 1.195 . . . . 0.0 109.193 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.82 141.9 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -132.16 1.59 3.87 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.574 1.15 . . . . 0.0 110.263 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.12 -166.25 22.81 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.04 149.85 40.97 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 110.322 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -72.0 134.2 83.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.759 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.38 -36.14 56.95 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.691 2.26 . . . . 0.0 113.895 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.46 -32.49 66.29 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.538 -0.726 . . . . 0.0 110.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.24 84.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.04 -52.04 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -58.91 -40.07 83.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.604 0.638 . . . . 0.0 111.633 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.89 94.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.512 0.596 . . . . 0.0 109.596 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.2 mmm -68.65 -36.83 79.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.28 0.491 . . . . 0.0 111.184 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.35 -25.21 67.93 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.886 -1.134 . . . . 0.0 111.524 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.32 -17.14 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.9 0.773 . . . . 0.0 110.885 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.52 -0.34 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.705 0.802 . . . . 0.0 112.108 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 31.68 13.9 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.21 159.74 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.77 145.54 51.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.96 -6.51 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.833 1.253 . . . . 0.0 110.625 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -57.59 -38.5 74.99 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.866 0.867 . . . . 0.0 110.894 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -18.59 37.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.845 1.258 . . . . 0.0 113.984 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.03 -40.73 18.01 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 119.639 1.109 . . . . 0.0 110.395 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 p 56.07 176.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.162 1.785 . . . . 0.0 111.069 -168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -128.27 153.68 46.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.79 158.52 35.39 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.045 0.938 . . . . 0.0 109.467 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.37 163.48 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.647 0.779 . . . . 0.0 108.992 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.61 149.0 5.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.771 1.228 . . . . 0.0 110.209 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.54 136.6 33.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.354 1.062 . . . . 0.0 110.113 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.86 -28.64 51.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.392 1.477 . . . . 0.0 113.161 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.25 -11.15 60.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.034 1.333 . . . . 0.0 112.188 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -114.12 -42.76 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.23 -58.42 5.07 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.206 . . . . 0.0 111.504 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -0.93 30.52 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.45 -31.54 5.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.945 1.298 . . . . 0.0 111.928 -168.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.959 1.304 . . . . 0.0 109.705 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.3 -26.24 67.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.75 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 tp -147.28 142.65 27.4 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.534 1.134 . . . . 0.0 108.669 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.41 151.38 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -140.03 128.26 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.46 136.16 37.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.9 7.74 26.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.563 0.745 . . . . 0.0 111.054 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.95 126.7 28.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.898 1.279 . . . . 0.0 110.638 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.929 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.226 170.266 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 CA--C 1.541 0.833 0 CA-C-O 121.606 0.586 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 48.3 tpp -124.73 156.35 37.79 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.71 1.604 . . . . 0.0 108.843 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p -128.43 161.17 58.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.622 1.569 . . . . 0.0 110.459 -169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.21 139.25 54.55 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.965 1.777 . . . . 0.0 109.576 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 -22.45 26.34 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.803 2.335 . . . . 0.0 112.25 -173.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -81.07 3.13 24.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.717 0.807 . . . . 0.0 112.48 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.37 134.55 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -64.39 132.05 48.96 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -123.34 159.07 29.63 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.663 0.785 . . . . 0.0 109.125 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.58 166.2 17.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.144 1.778 . . . . 0.0 107.337 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -133.56 113.17 12.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -119.9 58.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.847 1.659 . . . . 0.0 106.702 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.15 134.24 21.23 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.335 -0.853 . . . . 0.0 112.364 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.2 161.26 33.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.935 2.094 . . . . 0.0 106.118 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.71 146.95 24.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.663 1.185 . . . . 0.0 111.68 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.87 117.89 70.0 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 124.819 1.248 . . . . 0.0 108.937 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.38 -22.96 71.78 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.535 1.49 . . . . 0.0 113.628 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.41 61.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.427 1.012 . . . . 0.0 113.036 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -120.95 13.28 11.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.563 1.074 . . . . 0.0 112.094 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.22 55.65 0.21 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.306 1.842 . . . . 0.0 110.378 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.93 148.61 43.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.81 2.044 . . . . 0.0 112.201 -169.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.56 -54.05 0.34 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -166.42 166.93 16.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.106 1.763 . . . . 0.0 107.322 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.55 -29.66 69.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.177 0.591 . . . . 0.0 111.158 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.22 -37.07 74.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.896 0.479 . . . . 0.0 110.717 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.66 -47.33 69.83 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -54.54 -50.96 66.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.935 0.494 . . . . 0.0 110.086 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -58.84 -39.09 80.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.872 0.869 . . . . 0.0 112.027 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.07 86.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.496 -0.752 . . . . 0.0 110.114 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.58 -36.37 82.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.797 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.25 -47.37 83.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.411 1.005 . . . . 0.0 110.157 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -64.64 -39.18 93.24 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.645 0.657 . . . . 0.0 111.518 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -64.49 -49.09 72.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.242 0.928 . . . . 0.0 110.684 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.18 -39.2 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -54.05 -53.78 48.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.003 0.921 . . . . 0.0 109.442 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.2 -44.04 96.46 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.27 0.356 . . . . 0.0 111.29 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.12 -40.88 95.1 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.852 -0.53 . . . . 0.0 111.108 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.48 -49.68 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.18 -46.06 71.82 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -60.77 -46.95 88.48 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.465 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -72.7 -31.19 64.82 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.9 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -40.9 87.3 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.263 0.625 . . . . 0.0 110.017 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.42 -49.16 75.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.8 -43.82 98.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.095 0.474 . . . . 0.0 110.408 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.93 -33.82 69.21 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.804 -1.185 . . . . 0.0 112.334 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.43 22.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.019 0.528 . . . . 0.0 112.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -94.14 -52.39 4.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.001 1.321 . . . . 0.0 110.625 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.8 p -102.06 -14.69 17.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.344 1.457 . . . . 0.0 110.37 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.05 13.59 83.19 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.845 1.212 . . . . 0.0 112.052 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.245 0.862 0 CA-C-N 118.038 0.919 . . . . 0.0 109.572 -175.297 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--O 1.235 0.305 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.06 176.17 7.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.619 0.645 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -142.51 143.13 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.24 149.71 17.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.611 0.765 . . . . 0.0 109.151 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.49 132.78 33.78 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.959 0.904 . . . . 0.0 108.733 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -115.9 129.99 56.64 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -129.08 139.38 52.02 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.59 0.756 . . . . 0.0 109.562 -169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.7 p -150.16 -174.25 4.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.995 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -67.6 -9.46 43.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.252 1.021 . . . . 0.0 113.158 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.8 126.63 1.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.13 52.07 0.33 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.282 1.433 . . . . 0.0 113.293 -169.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 -18.63 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 m -136.3 -90.57 0.28 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.741 0.701 . . . . 0.0 109.379 -170.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -55.21 -53.2 58.98 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.748 0.819 . . . . 0.0 111.437 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.4 p -68.01 -35.73 78.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.63 -51.59 64.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.944 0.898 . . . . 0.0 110.836 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.5 mtm -60.66 -43.06 98.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.249 0.62 . . . . 0.0 110.69 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.5 97.22 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.455 0.57 . . . . 0.0 111.032 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -57.98 -41.32 82.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.695 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.34 -51.85 56.18 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.889 0.768 . . . . 0.0 111.973 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -62.9 -45.69 91.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 117.577 0.689 . . . . 0.0 110.711 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.53 99.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.235 0.614 . . . . 0.0 110.595 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -52.69 -36.29 56.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.866 0.757 . . . . 0.0 111.598 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -72.28 -62.79 1.31 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.368 0.531 . . . . 0.0 110.733 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -65.41 -41.26 93.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.521 0.328 . . . . 0.0 111.822 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.53 -5.85 53.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.819 0.848 . . . . 0.0 112.444 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.74 50.67 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.942 1.258 . . . . 0.0 114.601 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 59.21 6.24 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.211 2.205 . . . . 0.0 114.197 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.33 -7.42 18.76 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.929 -1.107 . . . . 0.0 110.358 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -130.93 121.75 25.72 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.46 97.62 1.02 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.08 134.73 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.53 168.3 20.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.24 1.416 . . . . 0.0 109.616 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -145.5 160.43 41.62 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.581 0.752 . . . . 0.0 110.12 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.51 -166.85 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.632 1.173 . . . . 0.0 109.842 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.27 -179.39 43.91 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 121.399 -0.813 . . . . 0.0 111.514 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.65 -27.65 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.349 1.46 . . . . 0.0 111.298 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -146.26 169.79 18.07 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.813 1.245 . . . . 0.0 108.405 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 136.33 18.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -136.79 26.26 3.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.716 1.206 . . . . 0.0 109.428 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.09 168.43 42.8 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.41 147.68 25.91 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.303 0.573 . . . . 0.0 110.779 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -73.97 133.74 78.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.081 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.51 -34.47 42.38 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.775 2.317 . . . . 0.0 114.438 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.23 -28.21 62.03 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.189 -0.944 . . . . 0.0 110.921 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.44 81.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.09 -49.59 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -59.92 -41.89 92.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.75 0.705 . . . . 0.0 111.592 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.78 92.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.448 0.567 . . . . 0.0 109.752 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.8 mmm -68.11 -36.22 79.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.401 0.546 . . . . 0.0 111.313 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 120.985 -1.072 . . . . 0.0 111.52 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.73 -17.54 64.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.036 0.835 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.72 -0.41 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.89 0.876 . . . . 0.0 112.167 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 32.59 13.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.3 160.83 20.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.22 145.97 52.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.2 pt -128.05 -9.93 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.811 1.644 . . . . 0.0 109.923 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.4 p -60.97 -25.84 67.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.844 1.202 . . . . 0.0 111.549 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.44 -27.39 69.08 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.431 1.493 . . . . 0.0 113.638 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -96.17 -29.24 14.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.47 1.032 . . . . 0.0 112.437 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.0 p 52.04 -173.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.882 1.673 . . . . 0.0 112.946 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -123.81 156.41 36.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.241 1.017 . . . . 0.0 111.234 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.56 157.24 35.0 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.125 0.97 . . . . 0.0 109.638 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.52 163.71 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.033 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.0 mt -56.56 146.71 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.905 1.282 . . . . 0.0 110.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.14 136.18 33.26 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.376 1.07 . . . . 0.0 110.067 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.71 -28.75 50.23 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.479 1.512 . . . . 0.0 113.188 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.61 -11.58 60.95 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.88 1.272 . . . . 0.0 112.177 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mt -114.47 -42.36 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 mt -48.52 -58.69 4.3 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.7 1.136 . . . . 0.0 111.775 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -1.12 34.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -116.14 -32.37 5.37 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.142 1.377 . . . . 0.0 111.614 -168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.53 126.77 28.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.291 1.436 . . . . 0.0 109.586 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.26 -24.55 66.6 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.22 0.608 . . . . 0.0 111.037 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.12 139.65 27.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.41 1.084 . . . . 0.0 108.554 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.88 145.26 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.32 129.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -97.55 132.7 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.34 19.13 20.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.593 1.157 . . . . 0.0 109.51 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.89 114.46 6.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 110.008 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.286 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 170.099 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 CA--C 1.533 0.462 0 N-CA-C 113.495 0.537 . . . . 0.0 113.495 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -71.25 145.83 49.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.518 1.127 . . . . 0.0 110.007 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 p -131.22 158.84 74.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.328 1.851 . . . . 0.0 110.133 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.1 136.68 38.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.228 1.952 . . . . 0.0 109.327 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.25 -23.95 20.4 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.528 2.152 . . . . 0.0 112.641 -171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -79.11 -9.59 59.6 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.214 0.606 . . . . 0.0 112.532 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.96 138.48 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -62.04 132.25 52.28 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -130.46 156.91 43.99 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.485 1.114 . . . . 0.0 109.572 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -134.44 167.86 19.98 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.241 1.817 . . . . 0.0 108.341 169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -135.86 118.15 15.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -125.34 57.66 1.31 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.377 1.871 . . . . 0.0 106.967 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.52 134.92 28.64 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.784 -1.198 . . . . 0.0 112.311 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 160.75 35.08 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.523 1.929 . . . . 0.0 106.089 169.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.71 143.83 55.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.92 126.25 92.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 -26.2 55.33 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.139 1.226 . . . . 0.0 112.921 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.48 -4.3 41.87 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.034 0.833 . . . . 0.0 112.538 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -120.43 0.44 10.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.992 1.717 . . . . 0.0 109.385 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.71 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.9 1.68 . . . . 0.0 109.192 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -58.16 123.27 15.42 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.33 -91.33 0.1 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.9 t -158.04 167.89 28.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.97 1.308 . . . . 0.0 108.023 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 -31.02 70.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.121 0.568 . . . . 0.0 111.874 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -39.48 84.3 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.64 0.376 . . . . 0.0 110.164 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.6 -38.5 70.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.72 -49.12 78.77 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 118.568 0.622 . . . . 0.0 110.186 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.23 -37.61 77.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.759 0.708 . . . . 0.0 111.207 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.65 84.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -63.32 -31.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.176 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.31 -52.06 66.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.251 1.387 . . . . 0.0 110.091 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.4 -34.63 78.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.869 0.759 . . . . 0.0 111.587 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -63.18 -52.6 61.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.836 1.198 . . . . 0.0 110.942 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.73 -37.5 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -54.32 -53.85 48.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.777 0.717 . . . . 0.0 109.409 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.34 -42.65 92.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.367 0.417 . . . . 0.0 110.58 -171.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.48 -41.1 93.67 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.959 -0.463 . . . . 0.0 111.195 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.38 -49.97 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.03 -46.57 61.29 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.589 0.631 . . . . 0.0 111.661 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.33 -48.8 80.2 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.618 0.709 . . . . 0.0 110.602 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -70.69 -30.0 66.46 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 117.297 -1.335 . . . . 0.0 111.611 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -39.82 82.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.93 1.241 . . . . 0.0 110.068 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.21 -49.41 74.18 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.445 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.67 -37.32 83.65 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.23 -35.84 35.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.496 0.318 . . . . 0.0 111.041 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.73 -42.18 10.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.513 1.125 . . . . 0.0 111.664 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.2 p -114.41 -20.81 10.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 0.0 111.817 -169.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.59 78.36 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.359 0.98 . . . . 0.0 112.836 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.245 0.853 0 CA-C-N 118.817 1.308 . . . . 0.0 109.958 -176.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -71.26 170.27 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -145.16 143.12 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -147.62 152.67 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.598 0.759 . . . . 0.0 109.526 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.49 133.03 30.32 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.805 0.842 . . . . 0.0 109.248 -173.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.89 127.81 55.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -124.1 141.54 51.97 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.623 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t -144.19 172.12 13.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.993 0.917 . . . . 0.0 110.633 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 p -59.37 -28.61 67.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.337 1.455 . . . . 0.0 110.824 169.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.5 147.98 16.87 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.8 45.72 1.02 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.853 -0.792 . . . . 0.0 111.886 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -128.12 -3.13 5.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 p -145.91 -106.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.964 1.256 . . . . 0.0 110.982 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -55.31 -36.94 66.74 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.941 0.896 . . . . 0.0 112.163 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.5 -52.72 64.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.337 1.055 . . . . 0.0 111.169 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -60.06 -50.34 74.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.501 1.121 . . . . 0.0 110.363 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.3 mtm -58.41 -44.53 89.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.92 0.488 . . . . 0.0 111.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -44.57 96.9 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.626 0.648 . . . . 0.0 111.437 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -59.57 -42.74 93.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.38 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.86 -53.1 46.75 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.852 0.739 . . . . 0.0 112.073 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -61.55 -43.8 98.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.299 0.55 . . . . 0.0 110.838 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.29 99.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 117.618 -1.182 . . . . 0.0 111.193 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -55.92 -37.58 69.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.381 1.446 . . . . 0.0 111.102 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -67.52 -56.43 9.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.285 0.493 . . . . 0.0 110.887 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -73.09 -45.59 56.34 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.068 0.147 . . . . 0.0 111.189 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.9 mt -72.15 -32.84 67.27 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.131 0.572 . . . . 0.0 111.367 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.4 176.51 51.03 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.02 -8.86 13.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.182 1.393 . . . . 0.0 111.565 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.14 -6.79 7.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 111.398 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 24.2 m95 -129.18 128.8 44.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.109 1.764 . . . . 0.0 107.02 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -76.48 88.64 3.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.54 133.72 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -141.41 167.33 22.43 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.863 1.265 . . . . 0.0 109.527 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.7 p -146.9 159.51 43.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.801 0.84 . . . . 0.0 109.093 169.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -168.04 1.96 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.911 1.284 . . . . 0.0 109.189 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.3 -175.78 43.02 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 121.427 -0.795 . . . . 0.0 111.517 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 mt -55.96 -28.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.716 1.606 . . . . 0.0 111.059 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -146.29 173.0 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.686 1.194 . . . . 0.0 109.455 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.26 18.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -139.13 10.7 2.58 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.788 0.835 . . . . 0.0 111.259 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.01 136.09 9.2 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -62.2 145.41 53.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.823 0.849 . . . . 0.0 112.686 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -72.26 133.62 83.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.685 1.194 . . . . 0.0 108.86 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.29 -34.63 41.07 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.823 2.349 . . . . 0.0 114.353 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -73.06 -29.33 62.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.751 0.705 . . . . 0.0 110.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.13 -49.3 74.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.7 -49.87 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.37 -39.88 92.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.964 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.9 96.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.713 0.688 . . . . 0.0 110.228 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.5 mmm -68.6 -36.39 78.64 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.807 -0.558 . . . . 0.0 111.28 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.712 -1.243 . . . . 0.0 111.485 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.65 -17.46 64.85 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.003 0.819 . . . . 0.0 110.935 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.57 -0.43 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.894 0.877 . . . . 0.0 112.125 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.15 32.45 14.13 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.53 159.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -127.31 146.3 50.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.25 0.65 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.182 1.393 . . . . 0.0 110.391 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -58.58 -28.74 65.84 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.285 -1.509 . . . . 0.0 111.15 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -67.42 -4.38 11.02 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.972 1.709 . . . . 0.0 115.001 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.82 49.81 2.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.577 1.535 . . . . 0.0 110.256 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 p -48.18 144.5 3.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 112.647 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -56.78 148.71 19.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.929 1.691 . . . . 0.0 113.936 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.44 153.52 31.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.281 1.433 . . . . 0.0 109.911 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.99 165.72 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.448 1.099 . . . . 0.0 109.68 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.37 145.87 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.552 1.141 . . . . 0.0 110.047 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -140.04 134.99 32.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.452 1.101 . . . . 0.0 109.872 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.0 -28.11 49.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.472 . . . . 0.0 113.168 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.12 -11.87 61.18 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.104 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -114.42 -41.54 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 mt -48.77 -57.62 6.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.035 1.288 . . . . 0.0 111.557 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.25 1.29 29.08 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -119.83 -32.14 4.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.007 1.323 . . . . 0.0 111.862 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.65 128.41 36.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.237 1.415 . . . . 0.0 109.44 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.59 -23.48 65.4 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.944 0.498 . . . . 0.0 110.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.3 tp -146.47 142.07 27.73 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.67 1.188 . . . . 0.0 107.993 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.02 152.86 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.46 129.0 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.9 134.72 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.12 3.57 30.46 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.883 0.873 . . . . 0.0 111.485 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.3 p -65.9 110.31 2.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.912 1.285 . . . . 0.0 111.688 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.191 0 C-N-CA 124.353 0.978 . . . . 0.0 111.746 169.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 120.567 0.153 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.6 mtm -79.39 156.31 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.781 0.833 . . . . 0.0 109.962 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -131.38 161.94 58.99 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.291 1.836 . . . . 0.0 110.263 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.5 140.52 52.57 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.904 1.736 . . . . 0.0 109.948 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.98 -22.01 20.14 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.917 2.412 . . . . 0.0 112.044 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -81.76 6.15 16.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.195 0.998 . . . . 0.0 112.461 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.01 140.71 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.97 136.42 57.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -128.31 156.22 43.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -124.3 164.51 19.45 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.606 . . . . 0.0 107.497 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -131.33 109.92 10.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -116.4 55.54 0.81 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.83 126.99 32.95 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.68 166.0 33.53 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.506 1.922 . . . . 0.0 106.628 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -64.24 149.76 47.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.665 0.745 . . . . 0.0 110.772 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.95 118.03 70.62 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.72 -23.13 63.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.617 1.544 . . . . 0.0 112.949 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.4 63.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.35 0.977 . . . . 0.0 112.214 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -111.27 4.79 19.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.47 1.508 . . . . 0.0 111.497 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.01 60.91 0.79 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.231 1.812 . . . . 0.0 111.55 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.16 141.67 53.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.016 1.726 . . . . 0.0 110.983 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.86 -58.41 0.23 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -165.94 167.29 16.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.033 1.733 . . . . 0.0 107.13 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.19 -30.16 70.24 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.86 -0.525 . . . . 0.0 111.416 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.912 0.485 . . . . 0.0 110.491 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.45 -43.25 67.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.323 0.649 . . . . 0.0 109.315 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.62 -48.32 75.11 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 121.85 -0.531 . . . . 0.0 110.394 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -60.76 -37.45 81.88 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.788 0.722 . . . . 0.0 111.704 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.93 77.77 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.296 -0.877 . . . . 0.0 110.5 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.211 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.35 -48.77 79.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.437 1.017 . . . . 0.0 109.3 171.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -47.61 79.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.571 1.078 . . . . 0.0 112.0 172.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -60.34 -47.91 84.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.663 0.665 . . . . 0.0 110.383 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.59 -37.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -56.02 -54.8 40.47 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.487 1.04 . . . . 0.0 108.693 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -65.9 -43.39 88.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.506 0.504 . . . . 0.0 110.436 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.04 -34.48 73.3 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.256 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -59.14 -52.22 63.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 169.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.09 -46.79 61.57 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.75 -37.29 85.95 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.603 0.702 . . . . 0.0 111.541 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -78.96 -30.85 44.78 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.371 -0.831 . . . . 0.0 111.111 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -40.1 81.22 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.86 174.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -51.29 -50.17 59.84 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.874 0.87 . . . . 0.0 109.674 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.83 -45.08 87.67 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 117.657 0.208 . . . . 0.0 110.82 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -57.32 -33.3 67.57 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.902 -1.124 . . . . 0.0 112.32 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.55 -37.88 24.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.934 0.493 . . . . 0.0 111.996 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.45 -51.71 5.28 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.444 1.097 . . . . 0.0 111.014 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.8 p -104.07 -17.15 15.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 110.722 -169.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.63 80.09 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.291 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 118.926 1.363 . . . . 0.0 108.864 175.225 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.05 170.14 8.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.48 141.57 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.85 149.71 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 119.021 0.828 . . . . 0.0 108.947 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.37 134.72 36.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.87 121.15 42.34 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.68 143.56 45.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 110.15 -169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -153.17 -176.16 5.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.477 0.711 . . . . 0.0 111.389 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 p -86.4 -0.98 57.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.159 1.384 . . . . 0.0 112.808 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.44 114.09 0.44 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.67 50.71 0.25 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.879 1.272 . . . . 0.0 114.332 -169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 m -124.88 -20.11 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 121.206 -0.934 . . . . 0.0 113.444 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.0 m -128.86 -106.08 0.3 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.042 0.837 . . . . 0.0 109.426 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -40.25 46.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.391 1.476 . . . . 0.0 113.553 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 p -65.99 -45.99 79.64 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.706 0.802 . . . . 0.0 110.911 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.56 -46.39 90.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.841 0.857 . . . . 0.0 110.049 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 mtm -59.45 -45.38 91.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.043 0.537 . . . . 0.0 111.033 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.05 95.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.449 0.568 . . . . 0.0 111.334 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 -42.96 80.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.825 0.45 . . . . 0.0 110.594 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.14 -52.19 53.94 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.297 -0.724 . . . . 0.0 112.135 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -60.03 -43.92 94.99 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.503 0.651 . . . . 0.0 110.627 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.85 98.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.307 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -55.77 -36.2 67.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.73 1.15 . . . . 0.0 111.307 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -69.44 -58.03 4.5 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.5 0.591 . . . . 0.0 110.792 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -73.08 -46.01 53.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.995 0.118 . . . . 0.0 111.106 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 87.0 mt -73.08 -36.36 66.8 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.762 0.425 . . . . 0.0 111.487 -176.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.14 173.28 43.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -169.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.33 -2.36 5.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.958 0.903 . . . . 0.0 111.666 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -58.89 -13.11 5.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 111.289 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.3 m95 -128.45 120.97 27.9 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -71.15 95.4 1.24 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.96 133.54 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -143.28 167.52 21.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.212 1.405 . . . . 0.0 109.59 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.0 p -145.0 159.64 42.62 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.768 0.827 . . . . 0.0 109.36 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.7 -170.96 2.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.652 1.181 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.02 -172.43 41.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.0 mt -57.38 -28.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.958 1.303 . . . . 0.0 110.942 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.32 166.73 29.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.627 1.171 . . . . 0.0 109.568 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.65 26.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.128 1.371 . . . . 0.0 107.773 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.13 17.46 4.11 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.093 1.357 . . . . 0.0 110.258 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 168.41 44.74 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.68 149.41 25.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.469 0.652 . . . . 0.0 111.831 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.91 138.13 57.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.299 1.439 . . . . 0.0 109.746 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.52 -28.61 70.39 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.79 1.66 . . . . 0.0 112.959 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -71.99 -33.56 68.2 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.97 92.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -57.3 -50.1 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.333 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -57.93 -44.75 87.08 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.159 0.89 . . . . 0.0 111.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.87 87.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.7 mmm -68.88 -37.86 79.32 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.157 0.183 . . . . 0.0 111.008 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -32.53 69.7 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.287 -0.883 . . . . 0.0 111.121 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.51 -11.32 60.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.343 1.057 . . . . 0.0 110.477 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -115.68 0.45 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.328 1.051 . . . . 0.0 112.031 173.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 30.76 13.09 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -120.55 160.11 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.85 145.52 51.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.31 -8.32 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.676 1.591 . . . . 0.0 110.436 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -55.97 -32.67 64.11 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.87 0.868 . . . . 0.0 111.119 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.76 -14.34 61.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.381 1.472 . . . . 0.0 114.371 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -107.69 -30.08 8.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 -169.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.0 p 51.2 -175.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.283 1.833 . . . . 0.0 113.716 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 m -119.88 155.87 31.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.68 1.192 . . . . 0.0 111.0 -170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -158.43 158.9 35.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 109.629 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.26 144.25 9.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.921 0.888 . . . . 0.0 109.466 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -136.46 140.18 42.91 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.773 1.229 . . . . 0.0 110.129 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.63 -29.91 62.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.187 1.395 . . . . 0.0 113.449 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.33 -12.28 61.48 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 111.95 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.45 -44.64 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.45 -40.59 78.79 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.1 1.318 . . . . 0.0 112.712 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -1.64 55.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -117.69 -26.35 6.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.126 1.37 . . . . 0.0 112.831 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.36 124.65 18.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.198 1.399 . . . . 0.0 110.08 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -32.43 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.247 1.419 . . . . 0.0 109.817 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.07 144.33 30.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.197 1.399 . . . . 0.0 108.106 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -117.66 153.21 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.91 138.61 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 p -113.46 131.98 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.44 21.69 16.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.809 1.244 . . . . 0.0 108.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -82.79 99.37 9.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.019 1.327 . . . . 0.0 109.718 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.498 0 C-N-CA 123.929 0.776 . . . . 0.0 111.441 169.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 110.57 -0.589 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.52 158.25 36.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 109.97 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -123.06 157.02 61.84 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.948 1.699 . . . . 0.0 109.147 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 162.17 34.13 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 121.567 1.512 . . . . 0.0 110.36 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.22 -17.66 24.23 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.949 2.433 . . . . 0.0 111.591 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -65.91 -22.63 66.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.252 1.021 . . . . 0.0 112.352 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.98 150.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.637 0.653 . . . . 0.0 111.11 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -72.6 149.56 43.85 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -132.55 156.69 46.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 111.363 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.74 162.14 26.52 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.009 2.523 . . . . 0.0 106.822 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -144.86 114.76 7.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -122.38 10.67 9.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.517 1.527 . . . . 0.0 111.49 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.7 138.22 5.32 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.938 1.256 . . . . 0.0 114.844 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 -100.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.868 1.667 . . . . 0.0 107.177 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -154.86 152.69 30.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.62 126.41 86.08 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.04 -25.58 66.24 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.34 1.36 . . . . 0.0 113.939 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.89 -13.09 62.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.346 0.975 . . . . 0.0 112.368 172.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mtm-85 -111.96 6.24 19.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.259 . . . . 0.0 111.378 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.66 60.9 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.335 1.854 . . . . 0.0 110.737 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.56 141.76 54.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.919 1.688 . . . . 0.0 111.137 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.66 -59.29 0.22 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -166.38 169.61 13.84 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 107.108 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -30.12 68.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.279 0.631 . . . . 0.0 111.292 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.84 -37.8 73.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.832 0.453 . . . . 0.0 110.766 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.64 -43.56 76.02 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -57.01 -51.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.81 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -58.06 -38.4 76.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.792 0.837 . . . . 0.0 111.903 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.69 87.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.443 -0.785 . . . . 0.0 109.863 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -63.95 -34.92 79.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.988 0.515 . . . . 0.0 111.85 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -57.76 -49.96 74.83 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.172 0.896 . . . . 0.0 109.798 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -63.91 -36.06 82.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.293 0.497 . . . . 0.0 111.76 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.52 -48.05 68.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.637 0.653 . . . . 0.0 111.014 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.09 -41.85 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -54.29 -53.61 51.38 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.02 0.928 . . . . 0.0 109.537 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.54 -42.91 95.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.787 0.267 . . . . 0.0 111.072 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.17 -42.16 84.76 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.982 -0.449 . . . . 0.0 110.848 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.32 -49.91 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.61 -43.18 78.71 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.02 -51.64 68.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 117.484 0.642 . . . . 0.0 111.131 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.5 mmm-85 -68.54 -29.58 68.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -40.86 88.05 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 120.123 1.328 . . . . 0.0 109.74 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -56.73 -53.16 60.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.36 -34.4 78.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.605 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -63.33 -37.9 89.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.798 -0.564 . . . . 0.0 110.726 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.63 -35.55 29.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.193 0.597 . . . . 0.0 111.548 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.07 -42.46 9.4 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.746 1.219 . . . . 0.0 111.72 -169.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 p -113.48 -18.18 12.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 111.056 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.82 65.85 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.036 -0.869 . . . . 0.0 111.981 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.245 0.866 0 C-N-CA 124.564 1.146 . . . . 0.0 108.137 -175.694 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 173.26 9.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.553 0.615 . . . . 0.0 110.138 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.33 141.03 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.53 149.76 16.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.091 0.956 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 131.69 32.65 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.523 0.729 . . . . 0.0 109.065 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.33 128.17 55.87 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.3 143.85 51.15 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.401 0.68 . . . . 0.0 110.585 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.51 174.68 10.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.367 1.079 . . . . 0.0 112.674 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.8 p -77.97 32.69 0.18 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.444 2.298 . . . . 0.0 110.616 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.01 113.73 0.83 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -173.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.31 53.98 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.264 1.026 . . . . 0.0 111.611 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 m -125.15 -19.67 5.08 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.1 m -138.81 -90.4 0.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.798 0.726 . . . . 0.0 109.1 -173.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -52.37 -53.25 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.041 0.936 . . . . 0.0 112.34 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 p -68.14 -38.35 82.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.658 0.663 . . . . 0.0 111.097 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -58.66 -54.86 42.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.962 0.905 . . . . 0.0 109.903 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.6 mtp -54.73 -46.05 74.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.57 1.548 . . . . 0.0 110.576 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.28 88.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.881 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.05 -37.8 72.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.445 0.566 . . . . 0.0 110.851 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.51 -54.03 41.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 123.829 0.728 . . . . 0.0 111.498 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -61.75 -41.81 98.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.313 0.557 . . . . 0.0 110.777 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.8 88.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.297 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -55.15 -36.33 65.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.873 1.215 . . . . 0.0 111.358 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -67.3 -56.96 7.61 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.363 0.414 . . . . 0.0 110.783 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -77.36 -44.47 29.28 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 84.4 mt -74.51 -37.07 63.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 111.071 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 173.03 42.95 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.41 -1.93 5.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.677 0.791 . . . . 0.0 111.634 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -57.89 -13.2 4.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.034 1.333 . . . . 0.0 111.325 169.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 13.7 m95 -129.13 115.49 17.78 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.246 -2.502 . . . . 0.0 104.246 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -66.34 100.79 0.67 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.68 133.37 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.602 0.761 . . . . 0.0 109.831 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.06 167.38 22.21 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.162 1.385 . . . . 0.0 109.459 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -140.41 151.33 44.84 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 109.92 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.02 -166.66 1.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.584 1.154 . . . . 0.0 109.812 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.52 -176.31 46.32 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 121.342 -0.849 . . . . 0.0 111.387 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.4 mt -54.95 -31.92 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.723 1.609 . . . . 0.0 110.806 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.11 167.06 25.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.027 1.331 . . . . 0.0 108.087 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.83 133.0 20.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -134.42 21.82 3.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.179 0.992 . . . . 0.0 109.347 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.12 165.25 33.89 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -87.02 147.88 25.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.07 0.548 . . . . 0.0 110.442 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -73.43 133.52 80.45 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.365 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.88 -34.38 45.23 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.884 2.389 . . . . 0.0 114.495 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -73.97 -27.85 61.19 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 121.385 -0.822 . . . . 0.0 110.929 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.56 75.88 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.1 -49.18 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.8 -43.61 94.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.052 0.541 . . . . 0.0 111.039 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.15 94.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.209 0.604 . . . . 0.0 110.255 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.2 mmm -69.72 -36.66 76.08 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.282 0.492 . . . . 0.0 111.318 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -27.34 69.25 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 120.797 -1.19 . . . . 0.0 111.446 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.17 -15.17 63.55 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.914 0.779 . . . . 0.0 110.825 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.79 -0.0 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.17 0.988 . . . . 0.0 112.079 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.59 17.44 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.64 160.51 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.85 145.31 50.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.56 2.98 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.859 1.264 . . . . 0.0 110.41 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -58.7 -29.52 66.71 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.214 -1.554 . . . . 0.0 111.086 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -65.64 -4.73 6.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.425 1.89 . . . . 0.0 115.334 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -135.45 48.47 2.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.444 1.474 . . . . 0.0 110.829 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -44.86 132.62 6.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.843 1.257 . . . . 0.0 111.111 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -57.29 154.81 9.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -168.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -154.15 155.7 35.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.108 1.363 . . . . 0.0 109.581 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.23 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.497 1.119 . . . . 0.0 109.784 172.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.77 153.16 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.058 1.343 . . . . 0.0 110.067 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.98 139.11 21.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.688 1.595 . . . . 0.0 108.643 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.34 -28.11 57.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.31 1.444 . . . . 0.0 113.464 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.04 -13.51 62.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.573 1.149 . . . . 0.0 112.286 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -113.36 -40.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.8 mt -48.09 -61.33 2.03 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.834 1.197 . . . . 0.0 111.603 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -3.27 35.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -111.94 -33.11 6.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.331 1.452 . . . . 0.0 110.941 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 122.65 15.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.48 1.512 . . . . 0.0 110.092 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.23 -23.38 66.41 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 111.197 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 tp -143.82 138.65 28.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.747 1.219 . . . . 0.0 107.936 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.6 145.4 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.14 124.85 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.29 127.11 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.41 24.57 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.896 0.855 . . . . 0.0 109.081 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.0 p -75.96 107.98 8.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.589 1.556 . . . . 0.0 110.029 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.147 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 171.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo . . . . . 0 CA--C 1.535 0.527 0 CA-C-O 121.146 0.394 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -74.1 155.66 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 0.0 109.833 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -132.17 161.6 61.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.879 2.071 . . . . 0.0 109.149 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.6 159.71 50.36 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 121.246 1.297 . . . . 0.0 109.583 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.72 -26.15 10.09 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.397 2.065 . . . . 0.0 112.422 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -74.9 -34.61 62.21 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.274 0.63 . . . . 0.0 112.45 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.73 153.43 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.542 0.687 . . . . 0.0 111.013 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -70.65 141.28 51.68 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -134.03 149.71 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.216 0.607 . . . . 0.0 109.902 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -127.07 157.14 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.702 2.001 . . . . 0.0 107.832 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -131.34 113.44 13.77 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -122.26 52.89 1.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.154 1.781 . . . . 0.0 106.797 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.15 128.67 34.07 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 120.747 -1.221 . . . . 0.0 111.654 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.98 160.83 39.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 105.911 169.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -68.73 144.05 54.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.431 0.634 . . . . 0.0 110.747 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.38 127.64 93.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.51 -23.07 50.73 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.162 1.241 . . . . 0.0 113.506 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.93 -11.45 60.35 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.454 1.025 . . . . 0.0 112.347 171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -111.49 3.23 17.93 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.879 1.272 . . . . 0.0 110.755 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.51 60.61 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.21 2.204 . . . . 0.0 110.844 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.43 138.2 57.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 110.587 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.68 -58.35 0.19 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -166.3 168.43 15.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.902 1.681 . . . . 0.0 107.339 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -30.3 70.15 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.781 -0.574 . . . . 0.0 111.394 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.75 -38.55 76.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.928 0.491 . . . . 0.0 110.585 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.57 -46.13 77.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -56.91 -49.95 74.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.168 0.587 . . . . 0.0 110.26 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -60.33 -37.16 79.75 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.866 0.757 . . . . 0.0 111.975 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.46 80.24 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.147 -0.97 . . . . 0.0 110.258 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.38 -32.69 74.46 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.948 -0.47 . . . . 0.0 111.477 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -57.42 -49.09 77.35 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.465 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -45.55 84.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 111.829 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -60.73 -48.78 80.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.002 0.819 . . . . 0.0 110.681 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.67 -39.65 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -55.85 -55.94 26.53 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 124.095 0.958 . . . . 0.0 108.956 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.52 -37.63 77.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 123.536 0.523 . . . . 0.0 110.502 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.01 -42.61 80.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.031 0.532 . . . . 0.0 111.255 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.3 mt -58.61 -52.19 62.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.94 56.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.909 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -61.61 -50.06 74.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.726 0.763 . . . . 0.0 111.066 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -69.57 -34.77 74.64 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.113 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -40.3 96.45 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.207 0.912 . . . . 0.0 109.742 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.32 -49.77 75.06 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.076 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.71 -43.63 98.32 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 110.131 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.18 -31.72 69.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.649 -1.282 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 -37.19 23.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.471 0.708 . . . . 0.0 112.212 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.6 -52.97 4.63 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.819 1.248 . . . . 0.0 110.728 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.2 p -103.03 -16.52 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.842 1.657 . . . . 0.0 110.414 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.34 86.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.486 1.041 . . . . 0.0 112.381 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 C--O 1.246 0.893 0 CA-C-N 118.694 1.247 . . . . 0.0 108.743 -172.533 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.08 -179.91 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.232 0.613 . . . . 0.0 109.919 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -140.91 142.49 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.82 150.32 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 118.87 0.759 . . . . 0.0 109.251 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -139.49 136.8 34.94 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.715 0.806 . . . . 0.0 109.508 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.49 133.05 54.6 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.564 1.146 . . . . 0.0 108.29 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.15 141.0 52.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.54 0.736 . . . . 0.0 110.244 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.93 168.97 18.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.173 1.389 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 p -55.5 -36.11 66.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.52 1.128 . . . . 0.0 110.939 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.2 141.47 9.39 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -77.44 51.22 0.86 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.42 1.088 . . . . 0.0 111.712 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.7 m -126.46 -15.58 5.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.771 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.98 -98.56 0.19 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -52.31 -50.29 62.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.081 0.953 . . . . 0.0 112.311 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -70.7 -36.32 73.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.78 0.264 . . . . 0.0 111.509 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -60.92 -53.78 53.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.247 1.019 . . . . 0.0 110.214 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.7 mtp -53.94 -46.84 71.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.182 1.393 . . . . 0.0 110.551 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.26 95.6 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.914 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -55.92 -41.44 74.57 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.223 0.465 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.27 -48.1 85.0 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.4 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -63.01 -43.57 98.4 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.834 0.817 . . . . 0.0 110.864 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.29 99.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.787 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -51.55 -38.31 53.69 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.068 0.849 . . . . 0.0 111.907 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -70.21 -62.66 1.3 Allowed 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 123.327 0.392 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -67.95 -37.78 82.0 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 78.5 mt -77.03 -1.36 28.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.682 0.793 . . . . 0.0 112.489 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.34 24.97 59.76 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.573 1.082 . . . . 0.0 113.738 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.12 16.06 2.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.768 2.027 . . . . 0.0 113.611 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.59 2.2 14.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.945 -1.097 . . . . 0.0 111.33 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.1 m95 -134.21 124.74 26.49 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.64 94.25 0.42 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.11 138.46 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -143.5 164.62 29.85 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.075 1.35 . . . . 0.0 109.695 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -146.42 156.56 43.39 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.783 0.833 . . . . 0.0 109.461 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 -166.89 2.07 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.224 1.009 . . . . 0.0 109.584 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.69 44.03 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mt -57.03 -25.57 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.927 1.291 . . . . 0.0 111.363 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.02 169.47 19.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.967 1.307 . . . . 0.0 108.825 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.21 135.48 21.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 169.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -129.18 11.12 5.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.723 1.209 . . . . 0.0 110.042 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 162.4 30.61 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -170.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.08 146.67 30.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.321 0.581 . . . . 0.0 111.045 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.16 133.68 83.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.147 -0.93 . . . . 0.0 108.945 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.53 -34.62 43.09 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.799 2.333 . . . . 0.0 114.563 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -73.41 -28.18 61.85 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.567 -0.708 . . . . 0.0 110.731 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.77 73.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -57.68 -48.05 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -60.04 -41.76 92.95 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.57 0.623 . . . . 0.0 110.764 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.47 94.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.14 0.576 . . . . 0.0 109.78 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.5 mmm -69.07 -38.52 79.07 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.415 0.15 . . . . 0.0 111.061 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.47 -25.1 67.85 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.85 -1.156 . . . . 0.0 111.483 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.79 -15.62 63.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.578 0.751 . . . . 0.0 110.42 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.25 0.82 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.927 0.891 . . . . 0.0 112.064 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.04 19.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.65 159.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -125.95 145.45 50.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 pt -127.97 2.7 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.977 1.311 . . . . 0.0 110.383 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.86 -27.98 67.13 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 119.978 -1.701 . . . . 0.0 111.2 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.84 -5.23 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.227 1.811 . . . . 0.0 115.107 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.18 49.61 2.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.253 1.388 . . . . 0.0 110.876 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -46.72 134.64 9.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.3 1.04 . . . . 0.0 110.967 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.26 155.51 8.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -154.48 156.18 36.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.967 1.307 . . . . 0.0 109.395 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.0 167.98 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 109.777 171.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.41 146.22 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.454 1.501 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -138.65 139.49 38.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.283 1.433 . . . . 0.0 109.773 170.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -55.81 -29.12 59.24 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.516 1.526 . . . . 0.0 113.259 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.75 -7.06 36.23 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 112.392 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.94 -44.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -45.7 -55.85 5.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.092 0.957 . . . . 0.0 112.305 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.7 51.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 112.925 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.8 -30.01 4.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 112.299 -168.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.97 130.37 46.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.778 1.231 . . . . 0.0 109.92 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.58 -22.98 64.43 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.223 0.609 . . . . 0.0 110.962 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.0 tp -146.44 142.18 27.89 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 108.829 170.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.9 145.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.48 135.48 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.56 107.67 13.56 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.68 8.32 34.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.409 0.683 . . . . 0.0 112.637 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.6 p -68.65 72.89 0.24 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.825 2.45 . . . . 0.0 114.669 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 O-C-N 120.575 -1.328 . . . . 0.0 112.827 174.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 0 CA--C 1.534 0.521 0 N-CA-C 113.245 0.441 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.01 138.24 58.23 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.902 0.881 . . . . 0.0 110.245 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -124.02 158.09 61.53 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.471 1.908 . . . . 0.0 109.689 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.5 153.39 76.66 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.82 1.68 . . . . 0.0 109.324 169.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.63 -23.97 16.41 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.478 2.119 . . . . 0.0 112.103 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -73.05 -32.83 65.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.645 0.778 . . . . 0.0 112.196 -173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.94 145.07 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.432 0.634 . . . . 0.0 109.799 -172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.86 130.99 44.97 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -134.54 150.4 50.76 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.021 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.78 160.68 30.15 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.317 2.247 . . . . 0.0 107.574 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -133.13 115.13 14.69 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -119.11 59.67 0.83 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.84 123.85 13.78 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.767 -171.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.94 160.13 43.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.61 1.964 . . . . 0.0 106.528 168.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -69.81 149.66 47.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.179 0.514 . . . . 0.0 110.591 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.2 128.61 80.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.49 -24.83 35.86 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.221 1.28 . . . . 0.0 113.515 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 -12.45 61.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.487 1.04 . . . . 0.0 111.722 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.0 ttp85 -101.93 2.0 37.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.889 1.275 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.93 67.2 0.82 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.115 1.366 . . . . 0.0 110.385 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.49 137.42 56.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.928 0.891 . . . . 0.0 110.464 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.42 -63.42 0.19 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.4 t -165.15 168.72 16.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 107.6 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.93 -29.53 68.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.386 0.675 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.64 -37.33 70.86 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.22 0.464 . . . . 0.0 110.836 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.23 -44.01 76.69 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -58.22 -48.02 81.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 122.856 0.462 . . . . 0.0 110.084 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -58.45 -39.89 81.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.561 0.744 . . . . 0.0 111.702 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.68 84.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.442 -0.787 . . . . 0.0 110.213 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.52 -34.12 77.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.07 0.548 . . . . 0.0 111.165 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -59.37 -48.14 82.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.909 . . . . 0.0 110.222 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -65.14 -36.36 84.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.491 0.587 . . . . 0.0 111.521 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -65.57 -50.36 65.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.265 0.484 . . . . 0.0 110.64 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.54 -39.37 84.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -54.44 -53.33 55.61 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.781 0.832 . . . . 0.0 109.352 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.56 -41.94 95.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.046 0.384 . . . . 0.0 111.035 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.18 -41.29 90.48 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.597 -0.689 . . . . 0.0 111.411 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.89 -53.03 50.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.55 -45.72 53.75 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 123.677 0.656 . . . . 0.0 111.754 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -60.46 -50.28 74.19 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.918 0.859 . . . . 0.0 111.174 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -70.79 -33.18 70.47 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.991 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -39.61 94.86 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.179 0.9 . . . . 0.0 109.969 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.83 -52.63 64.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.0 -35.29 80.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.255 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.56 -36.58 83.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.81 -0.556 . . . . 0.0 111.223 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.52 26.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 122.818 0.447 . . . . 0.0 111.44 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.42 -42.96 11.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.611 1.165 . . . . 0.0 111.628 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.0 p -113.29 -19.0 11.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.224 1.01 . . . . 0.0 111.161 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.77 10.54 75.83 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.209 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 118.654 1.227 . . . . 0.0 108.364 -174.677 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.85 175.1 6.07 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.37 140.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.78 148.94 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.4 131.66 30.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.71 131.24 56.99 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -125.91 139.59 53.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.639 0.776 . . . . 0.0 109.719 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.2 t -135.74 168.75 18.71 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.442 1.097 . . . . 0.0 109.406 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.8 p -58.77 -26.27 63.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.476 1.111 . . . . 0.0 111.314 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 138.04 5.94 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.03 53.45 0.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.603 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 m -126.85 -17.66 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.921 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.03 -90.93 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.876 0.762 . . . . 0.0 109.184 -170.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -56.46 -53.46 57.21 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.38 0.672 . . . . 0.0 111.542 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -67.68 -36.4 80.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.774 0.261 . . . . 0.0 111.197 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -59.61 -57.58 12.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.147 0.979 . . . . 0.0 110.085 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.8 mtm -56.86 -43.4 81.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.319 0.648 . . . . 0.0 111.517 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.28 99.15 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.482 0.583 . . . . 0.0 111.824 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.7 -39.74 77.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.237 0.471 . . . . 0.0 110.815 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.4 53.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 123.697 0.665 . . . . 0.0 111.546 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -61.32 -45.29 95.04 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.303 0.551 . . . . 0.0 110.98 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.25 97.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.34 0.656 . . . . 0.0 110.852 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -56.3 -34.21 66.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.055 0.843 . . . . 0.0 111.889 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -67.22 -61.61 1.84 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.131 0.423 . . . . 0.0 110.443 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.02 -42.71 80.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.35 0.26 . . . . 0.0 111.507 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.38 -7.84 58.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 0.0 112.241 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.93 56.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.859 1.219 . . . . 0.0 114.621 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.58 4.76 1.08 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.696 2.398 . . . . 0.0 114.107 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.29 -9.11 21.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.714 1.206 . . . . 0.0 110.384 169.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -129.37 118.84 22.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 172.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.64 99.7 0.81 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.1 141.47 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -144.01 165.31 28.12 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.941 1.696 . . . . 0.0 109.077 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.2 p -143.92 155.89 44.23 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.736 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.37 1.69 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.622 1.169 . . . . 0.0 109.459 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.09 179.83 45.19 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -54.39 -28.41 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.366 1.466 . . . . 0.0 111.387 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.06 170.61 16.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.966 1.307 . . . . 0.0 108.632 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.0 134.09 18.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -135.92 19.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.363 1.065 . . . . 0.0 109.81 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.09 163.15 29.73 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.97 146.21 28.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 110.696 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -70.66 134.13 86.38 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.036 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.23 -35.67 44.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.795 2.33 . . . . 0.0 114.259 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -72.75 -26.64 61.64 Favored 'General case' 0 C--O 1.227 -0.111 0 O-C-N 121.491 -0.756 . . . . 0.0 111.094 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -46.62 78.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.77 -47.98 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -57.16 -46.34 82.85 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.858 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.56 86.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -69.26 -37.69 78.04 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 110.852 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.01 -25.72 67.97 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.879 -1.138 . . . . 0.0 111.778 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -71.43 -12.35 61.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.453 1.101 . . . . 0.0 110.424 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.28 -1.66 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 112.735 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.23 33.13 10.94 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.24 162.89 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.5 146.37 50.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.2 pt -128.95 3.97 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.824 1.25 . . . . 0.0 110.589 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.32 -28.38 66.75 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.136 -1.603 . . . . 0.0 111.003 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -64.73 -5.58 6.11 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.291 1.836 . . . . 0.0 115.188 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -135.67 50.35 2.11 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.512 1.505 . . . . 0.0 110.426 -169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -46.21 133.28 9.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.493 1.117 . . . . 0.0 110.683 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 m -57.8 154.75 11.41 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -154.0 155.38 35.44 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.094 1.357 . . . . 0.0 109.522 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.42 166.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.354 1.062 . . . . 0.0 109.56 172.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.04 145.92 5.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.717 1.207 . . . . 0.0 109.898 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.07 135.97 33.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.391 1.076 . . . . 0.0 109.884 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -54.49 -28.35 44.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.426 1.49 . . . . 0.0 113.067 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.04 -11.98 61.28 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mt -114.52 -42.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.27 -57.5 6.69 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.928 1.24 . . . . 0.0 111.661 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -1.8 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -116.37 -32.58 5.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.214 1.405 . . . . 0.0 111.591 -168.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.46 128.25 35.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.32 1.448 . . . . 0.0 109.619 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.34 -29.85 71.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.863 0.865 . . . . 0.0 110.182 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.9 tp -147.3 140.43 25.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 108.647 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.84 154.72 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 t -140.09 136.43 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.06 135.65 47.14 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.39 10.46 37.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 110.613 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.2 p -64.21 116.98 6.52 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.643 1.177 . . . . 0.0 111.18 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.317 0 C-N-CA 124.909 1.242 . . . . 0.0 111.051 169.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 N--CA 1.459 -0.534 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -72.31 146.36 47.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.405 1.082 . . . . 0.0 110.098 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 p -129.46 160.22 65.45 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.607 1.963 . . . . 0.0 109.906 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.46 145.21 64.13 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.034 1.823 . . . . 0.0 109.895 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.5 -23.31 20.25 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.915 2.41 . . . . 0.0 112.185 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -85.01 6.58 24.66 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.067 0.947 . . . . 0.0 112.367 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.16 135.9 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.28 145.35 55.85 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -123.67 169.53 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.266 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -136.51 164.32 28.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.611 2.364 . . . . 0.0 106.794 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -134.02 113.25 11.93 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -121.63 61.82 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.06 131.3 11.66 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.304 -0.873 . . . . 0.0 112.885 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.28 160.46 40.81 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.396 2.278 . . . . 0.0 106.159 169.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -65.86 148.97 50.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.838 -0.539 . . . . 0.0 110.324 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -74.4 128.32 86.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.33 -21.23 54.6 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.063 1.175 . . . . 0.0 113.403 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.38 -18.3 65.07 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.399 1.0 . . . . 0.0 112.372 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -86.46 -8.67 57.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.457 1.026 . . . . 0.0 112.516 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 52.91 0.55 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 112.369 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.78 150.78 27.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.008 2.123 . . . . 0.0 112.063 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.62 -52.81 0.42 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -165.97 165.47 18.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.97 1.708 . . . . 0.0 107.263 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -28.54 67.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 0.0 111.223 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.78 -37.36 73.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.3 0.5 . . . . 0.0 110.903 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.9 -45.91 73.09 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.42 -49.37 74.72 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.923 0.489 . . . . 0.0 110.352 173.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.98 -39.71 86.62 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.631 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.232 -0.917 . . . . 0.0 110.838 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -67.41 -32.73 73.83 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.767 -0.583 . . . . 0.0 111.747 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.05 -44.64 91.84 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.693 0.679 . . . . 0.0 110.327 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.08 -38.05 89.65 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.635 0.652 . . . . 0.0 111.423 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -61.92 -51.16 69.26 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.109 0.868 . . . . 0.0 110.258 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.96 -38.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.332 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -63.91 -39.79 95.0 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.025 1.738 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.42 -45.37 80.13 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.239 0.472 . . . . 0.0 111.109 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.75 -41.81 95.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.002 -0.436 . . . . 0.0 110.874 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.05 -51.28 74.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.37 -46.31 57.81 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.566 -0.575 . . . . 0.0 111.786 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.89 -48.16 83.1 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.813 0.806 . . . . 0.0 110.826 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -35.11 76.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -41.45 93.71 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.821 -0.549 . . . . 0.0 110.079 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.89 -50.39 72.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.74 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.55 -45.33 94.61 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.57 -33.58 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.664 -1.273 . . . . 0.0 112.334 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.36 -32.89 20.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.414 0.686 . . . . 0.0 112.304 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.32 -53.68 3.53 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 -169.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.3 p -99.57 -15.54 18.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.49 1.516 . . . . 0.0 110.495 -170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.85 78.49 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.169 0.89 . . . . 0.0 111.815 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 117.868 0.834 . . . . 0.0 109.811 -179.228 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 10.7 mmpt? -97.19 170.13 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.021 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.24 142.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 tt -141.05 146.56 23.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.91 120.85 15.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -171.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -104.09 127.85 51.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.871 0.868 . . . . 0.0 108.936 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.08 140.81 51.45 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.768 1.227 . . . . 0.0 109.184 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 m -140.52 168.86 18.82 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.49 1.116 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.14 -25.15 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.009 0.924 . . . . 0.0 111.377 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.49 136.25 5.0 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 169.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.79 55.88 2.16 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.296 1.038 . . . . 0.0 110.724 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -122.18 -25.95 4.79 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.7 m -133.02 -94.67 0.33 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.319 0.963 . . . . 0.0 110.32 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.75 80.03 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -169.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -58.72 -49.7 76.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.348 0.659 . . . . 0.0 110.703 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -63.72 -43.9 95.16 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.562 0.745 . . . . 0.0 110.802 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.81 -44.94 95.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.679 0.391 . . . . 0.0 111.036 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.0 99.72 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.525 0.602 . . . . 0.0 111.091 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -57.59 -43.64 84.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.252 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.19 -53.37 43.22 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.823 0.725 . . . . 0.0 112.076 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -62.38 -44.31 96.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.194 0.497 . . . . 0.0 110.947 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.667 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -54.82 -35.19 63.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.425 1.011 . . . . 0.0 111.59 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -72.31 -62.82 1.3 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.122 0.419 . . . . 0.0 110.798 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -67.44 -37.51 83.12 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.0 -2.22 26.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.349 0.66 . . . . 0.0 112.364 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.55 57.49 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.559 1.552 . . . . 0.0 115.127 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 58.88 11.6 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.585 1.954 . . . . 0.0 113.363 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.39 -12.68 61.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.786 -1.196 . . . . 0.0 110.191 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -125.3 126.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.529 1.931 . . . . 0.0 106.513 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.2 mmpt? -70.3 108.86 4.4 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.79 137.59 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.79 165.3 27.76 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.584 1.154 . . . . 0.0 109.805 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.4 p -147.4 159.43 43.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.329 0.652 . . . . 0.0 109.831 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.96 -169.38 2.02 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.36 1.464 . . . . 0.0 109.635 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.42 -177.86 43.88 Favored Glycine 0 CA--C 1.52 0.386 0 O-C-N 121.47 -0.768 . . . . 0.0 112.055 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.89 -28.22 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.542 1.537 . . . . 0.0 111.292 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.4 170.08 17.56 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.835 1.254 . . . . 0.0 108.715 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.74 136.15 21.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -137.52 21.09 2.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.319 1.048 . . . . 0.0 109.846 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.09 153.35 29.33 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.51 150.66 47.8 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.41 0.624 . . . . 0.0 111.369 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -77.45 133.43 67.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.865 1.266 . . . . 0.0 109.123 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.5 -34.54 42.52 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.933 2.422 . . . . 0.0 114.592 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -72.28 -28.76 63.31 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.25 -0.906 . . . . 0.0 110.769 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -47.03 84.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.71 -48.86 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -60.73 -41.32 95.1 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.651 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.33 95.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.8 0.727 . . . . 0.0 109.845 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 77.2 mmm -69.47 -35.54 75.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.822 0.283 . . . . 0.0 111.402 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -28.15 69.31 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.848 -1.157 . . . . 0.0 111.7 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -66.21 -17.27 64.63 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.201 0.91 . . . . 0.0 110.81 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.15 0.4 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.95 0.9 . . . . 0.0 112.021 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.92 32.0 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.35 155.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.62 145.83 47.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.48 -1.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.796 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -58.21 -31.98 67.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.859 0.864 . . . . 0.0 110.958 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -64.49 7.26 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.443 1.897 . . . . 0.0 114.948 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -131.41 29.44 4.57 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.301 1.41 . . . . 0.0 112.527 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -41.48 127.43 3.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.25 1.02 . . . . 0.0 113.434 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 m -54.52 155.2 4.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.229 1.812 . . . . 0.0 115.49 -168.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -154.22 156.6 37.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.175 1.39 . . . . 0.0 109.376 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.41 163.3 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.946 0.898 . . . . 0.0 109.322 170.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.95 145.53 7.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.784 1.234 . . . . 0.0 109.834 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -136.36 133.84 37.21 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.629 1.172 . . . . 0.0 110.035 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.13 -27.99 56.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.625 1.57 . . . . 0.0 113.593 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.82 -0.04 49.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.631 0.651 . . . . 0.0 111.897 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -112.26 -41.79 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.4 mt -47.82 -56.8 6.64 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.351 0.978 . . . . 0.0 111.873 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -83.45 4.18 28.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.702 0.801 . . . . 0.0 112.659 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.88 -27.45 3.61 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.175 . . . . 0.0 112.043 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.83 135.15 56.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.914 1.286 . . . . 0.0 108.678 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.02 -34.23 77.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.4 137.3 25.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.623 1.169 . . . . 0.0 109.175 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.37 147.39 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.1 118.95 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -93.47 133.36 36.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.35 25.54 11.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.203 1.001 . . . . 0.0 108.884 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -72.35 103.87 3.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.765 -1.209 . . . . 0.0 111.263 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 C-N-CA 125.196 1.379 . . . . 0.0 109.768 169.372 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 CA--C 1.535 0.556 0 N-CA-C 112.633 0.205 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.08 149.2 43.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 p -131.22 158.58 74.84 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.957 2.103 . . . . 0.0 109.258 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.98 159.33 41.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.214 1.943 . . . . 0.0 110.352 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.09 -15.95 25.61 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.078 2.519 . . . . 0.0 111.126 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.31 -12.47 61.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.406 1.482 . . . . 0.0 112.908 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.72 148.26 27.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.223 0.92 . . . . 0.0 112.113 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -68.09 141.45 56.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -135.54 151.04 49.94 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.109 0.564 . . . . 0.0 110.683 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -127.81 161.14 29.71 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.226 2.21 . . . . 0.0 108.031 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -133.07 112.77 12.07 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.3 m0 -124.7 52.09 1.57 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.312 1.845 . . . . 0.0 107.282 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.43 135.07 31.09 Favored Glycine 0 CA--C 1.526 0.723 0 O-C-N 120.809 -1.182 . . . . 0.0 112.241 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.95 158.72 38.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.889 1.676 . . . . 0.0 107.515 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.02 133.42 56.08 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.043 1.737 . . . . 0.0 110.601 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.7 125.95 92.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.39 -24.92 56.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.229 1.286 . . . . 0.0 113.2 -174.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.36 -3.62 41.03 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.135 0.88 . . . . 0.0 112.506 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -123.86 7.0 8.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.221 1.408 . . . . 0.0 109.307 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 99.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.636 1.174 . . . . 0.0 108.472 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -57.27 122.85 13.47 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.977 0.911 . . . . 0.0 108.88 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.82 -105.83 0.25 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.467 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 10.6 p -140.56 171.68 13.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.38 1.872 . . . . 0.0 107.523 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.59 -29.25 70.46 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.235 -0.915 . . . . 0.0 111.216 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.23 -40.56 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.024 0.53 . . . . 0.0 109.896 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HB3' ' H ' ' A' ' 112' ' ' THR . 9.3 tp10 -63.98 -43.24 96.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -59.71 -47.32 86.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.432 0.693 . . . . 0.0 110.595 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -59.65 -36.59 76.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.984 0.811 . . . . 0.0 111.662 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.94 76.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 110.465 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -64.77 -31.09 72.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.268 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.73 -49.25 78.31 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.657 1.117 . . . . 0.0 109.406 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -56.38 -47.41 78.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.892 0.769 . . . . 0.0 111.819 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -60.68 -47.76 84.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.972 0.806 . . . . 0.0 110.695 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.14 -39.41 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -57.11 -53.98 51.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.073 0.851 . . . . 0.0 109.03 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.61 -39.17 80.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.35 0.406 . . . . 0.0 110.857 -170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -60.04 -48.15 82.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.482 0.713 . . . . 0.0 111.055 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.98 -48.94 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.73 -48.66 49.82 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.663 -0.521 . . . . 0.0 111.992 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.08 -47.29 87.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 117.816 0.808 . . . . 0.0 111.007 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -28.29 57.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.256 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -38.83 84.39 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.373 0.988 . . . . 0.0 109.799 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -56.77 -49.85 74.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.457 0.571 . . . . 0.0 109.561 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.662 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.5 -35.54 79.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.044 0.838 . . . . 0.0 111.223 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.69 -38.82 32.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.465 0.306 . . . . 0.0 111.19 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.7 -45.73 9.11 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.089 0.955 . . . . 0.0 111.11 -170.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.6 p -111.28 -19.14 12.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.43 1.092 . . . . 0.0 112.071 -169.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.24 18.06 80.1 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 119.047 1.423 . . . . 0.0 109.475 177.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.32 176.9 6.27 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.49 0.586 . . . . 0.0 110.407 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.23 141.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -145.09 149.1 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.246 0.93 . . . . 0.0 109.065 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.88 137.69 43.45 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.88 0.872 . . . . 0.0 109.017 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -119.83 130.54 54.95 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.62 141.75 51.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.544 0.737 . . . . 0.0 110.438 -169.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 95.4 m -140.63 169.98 16.63 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.015 0.926 . . . . 0.0 110.73 172.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 m -56.99 -25.25 58.12 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.36 1.464 . . . . 0.0 111.61 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.77 136.67 5.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.58 56.7 2.68 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.022 0.929 . . . . 0.0 110.51 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -120.43 -31.95 4.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -128.72 -87.59 0.54 Allowed 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.844 0.747 . . . . 0.0 110.248 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -58.92 -50.45 73.98 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -65.67 -36.36 83.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.346 0.521 . . . . 0.0 111.176 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -62.43 -55.24 29.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.559 1.144 . . . . 0.0 111.001 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -56.74 -44.74 81.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.757 0.823 . . . . 0.0 111.029 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.63 98.48 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.454 0.57 . . . . 0.0 111.635 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -56.51 -43.36 79.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.586 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.1 -49.54 77.39 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.713 0.688 . . . . 0.0 112.068 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.72 -45.32 93.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.952 0.876 . . . . 0.0 111.121 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.23 99.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.019 0.527 . . . . 0.0 110.522 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -54.22 -34.93 61.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.7 0.682 . . . . 0.0 111.81 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -71.33 -62.86 1.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.056 0.389 . . . . 0.0 110.554 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -67.54 -40.92 85.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.0 mt -75.88 -4.13 39.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.634 0.774 . . . . 0.0 112.472 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.84 56.34 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.637 1.113 . . . . 0.0 113.948 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.78 9.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.306 2.243 . . . . 0.0 114.098 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.3 -3.65 8.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.941 -1.1 . . . . 0.0 111.153 169.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -132.92 122.07 23.79 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -67.79 97.54 0.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.01 140.71 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.05 166.45 26.82 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.411 1.484 . . . . 0.0 109.348 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.0 p -143.99 157.43 44.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.766 0.827 . . . . 0.0 109.236 169.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.57 -167.45 1.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.79 -179.0 44.15 Favored Glycine 0 N--CA 1.447 -0.582 0 O-C-N 121.685 -0.634 . . . . 0.0 111.873 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.15 -31.06 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.031 1.332 . . . . 0.0 110.841 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.89 168.58 21.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.257 1.423 . . . . 0.0 108.75 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.0 138.14 25.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -130.02 12.15 5.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 109.641 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 162.49 29.95 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.54 152.77 35.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -77.58 133.05 67.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.63 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.96 -36.45 64.4 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.722 2.281 . . . . 0.0 114.207 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -71.94 -31.98 66.87 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.581 -0.699 . . . . 0.0 110.241 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.29 -44.53 94.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.78 -50.96 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -58.88 -40.78 85.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.642 0.656 . . . . 0.0 111.695 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.48 88.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.583 0.629 . . . . 0.0 109.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.8 mmm -66.51 -38.75 87.89 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.381 0.537 . . . . 0.0 110.857 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.6 -21.02 66.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.541 -1.349 . . . . 0.0 112.084 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.88 -30.44 68.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.927 0.785 . . . . 0.0 109.093 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.81 -33.87 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.9 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.147 0.879 . . . . 0.0 111.239 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.34 157.82 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.24 144.96 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -125.13 -0.52 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.958 1.303 . . . . 0.0 110.325 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -58.56 -30.99 67.56 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.212 -1.555 . . . . 0.0 111.432 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.61 -2.32 6.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 114.756 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.7 52.14 1.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.261 1.391 . . . . 0.0 110.085 -171.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -50.43 142.47 10.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 m -61.49 160.86 10.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.059 1.744 . . . . 0.0 114.915 -169.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -156.22 158.6 37.85 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.191 1.397 . . . . 0.0 109.712 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.49 166.69 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.214 1.006 . . . . 0.0 109.224 169.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.9 143.66 10.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.625 0.77 . . . . 0.0 108.977 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.78 140.71 42.72 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 109.855 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.57 -30.66 61.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.081 1.352 . . . . 0.0 113.166 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.78 -11.01 60.53 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.289 1.036 . . . . 0.0 112.094 -173.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.32 -43.86 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -56.97 -40.31 76.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.093 1.315 . . . . 0.0 112.289 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 4.69 51.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.886 0.875 . . . . 0.0 112.589 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -125.1 -26.99 3.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.815 1.246 . . . . 0.0 112.741 -168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 131.79 52.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.738 1.215 . . . . 0.0 109.26 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.3 -25.09 65.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.356 0.662 . . . . 0.0 110.741 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 tp -147.91 140.29 24.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.866 1.267 . . . . 0.0 108.34 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.49 147.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.91 127.73 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.66 132.02 44.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.88 10.3 38.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.944 0.498 . . . . 0.0 110.236 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.79 126.7 28.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.308 1.043 . . . . 0.0 110.954 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.285 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.007 171.333 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 CA--C 1.534 0.517 0 CA-C-O 120.701 0.209 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.04 153.21 38.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.665 0.786 . . . . 0.0 109.488 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 p -133.71 159.14 73.65 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.164 1.785 . . . . 0.0 109.746 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.56 139.81 38.29 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.793 1.662 . . . . 0.0 109.62 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.23 -20.34 24.78 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.887 2.391 . . . . 0.0 112.046 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -67.67 -20.04 65.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.561 1.144 . . . . 0.0 112.258 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.75 143.39 18.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 118.677 0.671 . . . . 0.0 109.226 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -61.69 137.09 58.22 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.83 150.37 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.68 0.792 . . . . 0.0 109.582 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.03 163.13 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 108.274 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -132.58 112.73 12.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -120.97 58.22 0.96 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 106.862 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.06 132.48 17.01 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 121.065 -1.022 . . . . 0.0 113.089 -171.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.8 156.6 31.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.919 2.088 . . . . 0.0 106.388 169.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -60.21 148.19 37.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 110.836 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.39 128.54 82.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.501 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.26 -24.61 72.12 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.48 1.453 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.68 -17.4 64.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.173 0.897 . . . . 0.0 112.434 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -105.02 2.37 29.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.567 1.147 . . . . 0.0 111.266 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 45.66 0.33 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.507 1.523 . . . . 0.0 111.579 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.38 153.19 12.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.847 1.259 . . . . 0.0 112.228 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.61 -53.71 0.39 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -167.01 165.41 15.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.54 1.936 . . . . 0.0 107.044 169.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.54 -28.02 66.72 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.487 0.715 . . . . 0.0 111.242 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -69.91 -39.52 76.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.282 0.492 . . . . 0.0 110.694 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.13 -44.33 76.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -55.81 -52.58 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.199 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -58.2 -40.33 81.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.722 0.809 . . . . 0.0 111.675 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.93 83.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.833 -0.542 . . . . 0.0 111.015 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.2 -34.97 73.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.666 -0.646 . . . . 0.0 111.468 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -59.45 -54.41 46.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.968 0.804 . . . . 0.0 109.973 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.9 -29.51 69.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.623 0.647 . . . . 0.0 111.755 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.27 -54.83 31.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.533 1.06 . . . . 0.0 111.259 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.66 -38.25 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -52.82 -57.3 10.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.135 0.974 . . . . 0.0 109.935 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.92 -41.21 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.279 0.232 . . . . 0.0 111.234 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.96 -39.94 87.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mt -58.74 -51.09 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.36 71.08 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.563 0.602 . . . . 0.0 111.777 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.91 -51.38 69.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 117.587 0.694 . . . . 0.0 110.34 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -70.74 -29.35 65.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.954 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -41.44 90.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.638 1.108 . . . . 0.0 110.199 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -57.15 -52.5 65.06 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.57 -35.25 80.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.059 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.93 -37.32 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.13 -36.18 30.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.633 0.373 . . . . 0.0 111.501 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.71 -40.16 10.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.701 1.201 . . . . 0.0 111.896 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -116.53 -19.16 10.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.338 1.055 . . . . 0.0 111.522 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.78 13.22 81.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.362 0.982 . . . . 0.0 112.76 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.248 0.974 0 CA-C-N 118.625 1.213 . . . . 0.0 110.037 -175.771 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -83.09 -175.33 5.78 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 110.269 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -146.42 144.9 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -149.18 152.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.175 0.898 . . . . 0.0 109.182 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 137.5 39.44 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.919 0.888 . . . . 0.0 109.151 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.58 125.09 45.92 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.81 1.244 . . . . 0.0 107.699 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.45 140.97 51.47 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.91 170.41 15.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.318 1.056 . . . . 0.0 112.042 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 p -76.08 35.23 0.13 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.707 2.003 . . . . 0.0 110.607 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.68 110.59 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.721 2.105 . . . . 0.0 108.601 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -75.67 56.33 0.91 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.574 1.15 . . . . 0.0 111.685 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.3 m -129.91 -18.02 3.46 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.2 m -137.1 -87.78 0.29 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.993 0.815 . . . . 0.0 109.187 -170.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -57.16 -53.88 53.04 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.799 0.84 . . . . 0.0 111.137 -170.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 p -67.2 -35.4 79.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.447 0.567 . . . . 0.0 111.536 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -60.53 -55.72 30.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.161 0.985 . . . . 0.0 110.345 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -57.66 -43.98 85.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.505 0.722 . . . . 0.0 111.253 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.02 96.22 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.569 0.622 . . . . 0.0 111.45 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -57.09 -40.55 77.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.565 0.346 . . . . 0.0 110.663 174.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.22 -50.39 67.63 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.738 0.685 . . . . 0.0 112.084 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.22 -45.07 95.01 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.504 0.652 . . . . 0.0 110.579 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.63 97.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.474 0.71 . . . . 0.0 110.474 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.68 -36.11 64.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.798 0.726 . . . . 0.0 111.45 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -70.72 -62.21 1.47 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.052 0.387 . . . . 0.0 110.789 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.11 -38.74 86.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 71.6 mt -75.65 0.88 16.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.082 0.953 . . . . 0.0 112.232 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.19 22.07 64.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.245 1.403 . . . . 0.0 113.567 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 55.47 13.73 1.0 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.758 2.023 . . . . 0.0 113.39 -169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.42 1.95 14.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.244 1.418 . . . . 0.0 111.284 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 14.8 m95 -129.49 128.89 43.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -67.44 89.35 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 143.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -146.96 163.08 37.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.918 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 79.9 p -141.17 156.07 45.99 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.619 0.768 . . . . 0.0 109.047 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.91 -169.3 2.48 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 110.281 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.41 -178.49 46.22 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.47 -27.62 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.765 1.226 . . . . 0.0 110.899 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -147.04 166.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.803 1.241 . . . . 0.0 108.124 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.75 134.08 21.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -134.96 24.48 3.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.308 1.043 . . . . 0.0 109.151 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.05 168.34 39.16 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.97 148.1 27.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.026 0.53 . . . . 0.0 110.53 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -74.37 133.67 77.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 118.117 -0.944 . . . . 0.0 109.129 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.94 -33.61 42.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.868 2.379 . . . . 0.0 114.589 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -72.46 -28.92 63.22 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.254 -0.903 . . . . 0.0 110.853 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.39 85.43 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.17 -49.37 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -43.47 90.31 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.113 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.19 93.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.06 0.846 . . . . 0.0 110.033 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -70.99 -38.21 72.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.717 0.235 . . . . 0.0 111.469 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -63.79 -24.99 67.98 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.794 -1.191 . . . . 0.0 111.393 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -69.55 -14.6 62.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.778 0.831 . . . . 0.0 110.866 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.4 -2.1 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.237 1.015 . . . . 0.0 112.091 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.89 32.36 10.05 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.81 161.07 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.94 146.12 51.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -127.14 -0.7 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.114 1.366 . . . . 0.0 110.447 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -57.95 -31.12 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.388 -1.445 . . . . 0.0 111.267 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -67.7 -4.28 11.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.006 1.723 . . . . 0.0 114.728 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -137.13 53.73 1.88 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.311 1.414 . . . . 0.0 109.678 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -50.16 144.2 7.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.274 1.03 . . . . 0.0 112.345 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 m -64.21 161.36 16.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 114.533 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -156.9 157.67 35.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.471 1.508 . . . . 0.0 109.7 170.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.18 165.35 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.756 0.822 . . . . 0.0 109.492 170.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.86 145.98 6.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.804 1.242 . . . . 0.0 110.128 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.4 134.61 32.66 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.661 1.184 . . . . 0.0 109.944 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.41 -28.42 53.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.396 1.478 . . . . 0.0 113.323 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.92 -11.42 60.86 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.782 1.233 . . . . 0.0 112.201 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.62 -41.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 mt -47.95 -59.08 3.62 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.703 1.138 . . . . 0.0 111.645 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -0.26 30.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.76 -30.74 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.061 1.344 . . . . 0.0 112.066 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.71 131.58 51.17 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 109.858 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.36 -26.06 67.85 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.778 0.431 . . . . 0.0 110.791 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 tp -148.49 142.04 25.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.522 1.129 . . . . 0.0 108.443 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.58 144.14 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.35 126.46 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 p -100.3 135.18 42.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.42 20.68 17.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.474 0.71 . . . . 0.0 109.54 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.1 p -68.1 112.93 5.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.928 1.291 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.157 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 CA--C 1.538 0.71 0 N-CA-C 114.647 0.979 . . . . 0.0 114.647 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -63.4 138.45 58.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.551 1.54 . . . . 0.0 110.333 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 p -131.6 154.46 81.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.146 1.779 . . . . 0.0 109.442 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.81 145.21 56.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.203 1.936 . . . . 0.0 110.053 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.87 -21.88 13.87 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.107 2.538 . . . . 0.0 112.073 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -85.8 7.7 22.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.497 1.119 . . . . 0.0 112.38 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.73 144.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.18 138.48 58.42 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -133.12 150.48 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.702 0.801 . . . . 0.0 109.767 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -125.44 159.34 32.14 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.557 1.943 . . . . 0.0 107.914 171.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -133.84 111.88 10.85 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -120.93 57.38 0.98 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.146 1.778 . . . . 0.0 106.741 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.55 132.61 29.78 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 120.915 -1.116 . . . . 0.0 111.998 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.09 160.18 35.41 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.62 1.968 . . . . 0.0 106.106 169.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.12 141.85 55.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.373 0.606 . . . . 0.0 110.785 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.36 127.28 93.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 -22.66 44.06 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.082 1.188 . . . . 0.0 113.329 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.21 -9.95 59.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.495 1.043 . . . . 0.0 112.228 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -111.39 0.69 16.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.051 1.34 . . . . 0.0 110.749 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.72 54.0 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.496 2.319 . . . . 0.0 111.174 170.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.59 144.97 46.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.659 1.983 . . . . 0.0 112.003 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.08 -54.97 0.28 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -165.66 167.0 17.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.939 1.696 . . . . 0.0 107.45 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.18 -29.98 70.13 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.104 0.562 . . . . 0.0 111.201 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.13 -37.43 75.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.878 0.471 . . . . 0.0 110.574 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.23 -46.58 73.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -56.56 -48.86 76.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.098 0.559 . . . . 0.0 110.359 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -61.23 -37.93 84.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.584 0.754 . . . . 0.0 112.001 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.61 80.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.242 -0.912 . . . . 0.0 109.909 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.97 -33.22 75.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.803 0.441 . . . . 0.0 111.153 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.88 -50.31 73.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.721 0.809 . . . . 0.0 110.155 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -64.77 -35.0 79.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.39 0.541 . . . . 0.0 111.584 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -66.29 -51.03 61.46 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.337 0.517 . . . . 0.0 110.662 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.36 -39.96 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -53.29 -54.06 41.92 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.321 1.049 . . . . 0.0 109.393 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.53 -44.4 90.97 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 123.206 0.316 . . . . 0.0 111.008 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.58 -39.79 88.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.647 -0.658 . . . . 0.0 111.216 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.08 -51.05 77.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.28 -45.42 64.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -60.69 -50.4 73.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 117.639 0.719 . . . . 0.0 111.105 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -70.18 -33.18 71.43 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.113 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -40.13 96.26 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.407 1.003 . . . . 0.0 109.976 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -57.77 -51.45 69.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.65 -35.74 82.01 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.267 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -63.67 -36.65 84.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.908 -0.495 . . . . 0.0 111.014 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.3 -37.96 27.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.568 0.347 . . . . 0.0 111.409 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.3 -46.83 8.14 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 110.857 -169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 p -108.49 -17.21 14.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -169.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.36 11.5 80.36 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.238 0.923 . . . . 0.0 112.291 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.472 1.136 . . . . 0.0 108.482 -174.646 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.65 168.86 18.48 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -144.29 139.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -144.71 150.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 109.084 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 137.14 37.93 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.002 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -119.51 130.97 55.46 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.02 137.56 51.4 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 111.028 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.5 174.32 10.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.245 1.018 . . . . 0.0 112.221 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -56.3 -27.51 55.79 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.991 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.4 142.01 8.27 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.6 58.45 2.73 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.752 0.821 . . . . 0.0 111.083 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -130.6 -18.63 3.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.3 m -133.01 -96.99 0.3 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.071 0.85 . . . . 0.0 108.901 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -54.28 -50.69 66.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.149 0.98 . . . . 0.0 111.952 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p -67.54 -38.57 84.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.738 0.699 . . . . 0.0 111.246 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -58.45 -54.81 42.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.072 0.949 . . . . 0.0 109.989 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.2 mtm -57.57 -44.83 85.6 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.43 0.692 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.27 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.165 0.586 . . . . 0.0 111.59 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.39 -40.64 78.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.214 0.461 . . . . 0.0 110.88 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.09 -53.47 45.31 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -60.97 -44.4 97.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.956 0.378 . . . . 0.0 111.166 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.82 97.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.81 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -59.0 -34.67 72.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.404 1.002 . . . . 0.0 111.576 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -65.42 -54.89 22.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.199 0.454 . . . . 0.0 110.809 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -78.17 -45.43 23.19 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -170.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 94.9 mt -72.07 -32.92 67.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.352 0.661 . . . . 0.0 111.542 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.02 175.31 44.26 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.95 -1.93 8.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.176 0.99 . . . . 0.0 111.22 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -61.63 -10.18 7.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.863 0.865 . . . . 0.0 110.723 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 18.7 m95 -127.39 124.89 39.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.655 1.982 . . . . 0.0 105.906 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -75.57 88.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.89 140.04 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.09 167.29 23.07 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.215 1.406 . . . . 0.0 109.314 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -142.79 155.64 44.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.03 0.932 . . . . 0.0 109.2 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.55 1.73 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.432 1.093 . . . . 0.0 109.257 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.78 -178.52 44.72 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -56.75 -28.63 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.028 1.331 . . . . 0.0 111.017 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.52 171.02 16.2 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.435 1.494 . . . . 0.0 108.784 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.29 22.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -129.71 10.78 5.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.765 1.226 . . . . 0.0 109.919 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.0 27.8 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -84.51 148.55 26.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -72.18 136.86 81.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 124.246 1.018 . . . . 0.0 108.752 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.51 -29.09 84.22 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.82 1.68 . . . . 0.0 112.891 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.83 -26.05 61.34 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.097 -1.002 . . . . 0.0 111.013 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -44.07 84.68 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.303 0.956 . . . . 0.0 109.084 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.25 -50.23 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -58.3 -41.8 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.97 89.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.541 0.736 . . . . 0.0 110.346 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 76.9 mmm -74.25 -34.2 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.698 0.227 . . . . 0.0 111.111 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.37 -23.18 66.91 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.66 -1.275 . . . . 0.0 111.553 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.39 -17.84 64.84 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.127 0.971 . . . . 0.0 110.634 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.33 -2.45 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.011 0.924 . . . . 0.0 112.6 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.86 32.65 9.76 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.95 155.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -140.28 82.18 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.153 0.978 . . . . 0.0 109.856 -169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.73 0.19 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.921 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -20.04 39.82 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 119.938 -1.726 . . . . 0.0 112.18 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -84.18 1.85 42.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.237 1.415 . . . . 0.0 112.659 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -133.86 49.92 2.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.488 1.04 . . . . 0.0 109.937 -172.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 p -46.98 134.09 10.66 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.909 1.284 . . . . 0.0 111.193 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -58.27 157.38 8.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.71 157.88 38.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.227 1.411 . . . . 0.0 109.398 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 168.59 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.573 1.149 . . . . 0.0 109.622 170.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.66 142.83 11.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.26 140.79 43.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.395 1.078 . . . . 0.0 109.723 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.73 -30.66 61.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.984 1.314 . . . . 0.0 113.135 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.69 -12.5 61.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.254 1.021 . . . . 0.0 111.884 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 mt -119.77 -43.22 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.61 -39.14 76.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.171 1.351 . . . . 0.0 112.193 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 6.49 48.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.864 0.866 . . . . 0.0 112.577 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -126.9 -29.39 2.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.717 1.207 . . . . 0.0 112.499 -168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.64 125.48 23.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.88 1.272 . . . . 0.0 109.49 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.48 -26.53 67.23 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -141.61 137.25 31.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.957 1.303 . . . . 0.0 107.784 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.19 146.13 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.34 129.63 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -101.04 131.68 46.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.62 16.22 26.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.297 0.639 . . . . 0.0 109.99 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.5 p -69.24 109.39 4.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 111.022 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 169.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo . . . . . 0 CA--C 1.538 0.675 0 N-CA-C 115.01 1.119 . . . . 0.0 115.01 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -62.26 139.17 58.51 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.626 1.57 . . . . 0.0 110.248 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -129.55 153.27 80.66 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 126.382 1.873 . . . . 0.0 108.677 171.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.95 162.86 39.94 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.408 1.405 . . . . 0.0 109.821 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.62 -22.76 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.523 2.149 . . . . 0.0 112.724 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -87.01 -21.43 26.13 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.61 154.46 5.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 119.439 1.018 . . . . 0.0 109.649 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -71.07 140.44 50.69 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -123.83 154.53 39.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.3 164.56 28.28 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.784 1.634 . . . . 0.0 107.568 169.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -131.68 113.78 13.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -120.74 53.64 1.11 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.667 1.587 . . . . 0.0 106.771 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 128.1 29.42 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 111.823 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.7 161.43 40.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.77 142.01 49.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.0 124.46 88.84 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.84 -22.29 56.6 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.193 1.262 . . . . 0.0 113.163 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.81 60.33 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.388 0.995 . . . . 0.0 112.5 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -115.22 12.38 16.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.85 1.26 . . . . 0.0 111.537 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.34 66.34 0.93 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.12 1.368 . . . . 0.0 109.694 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -57.1 138.01 55.04 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.063 0.945 . . . . 0.0 110.766 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.08 -61.44 0.2 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -166.67 168.87 14.05 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.764 1.625 . . . . 0.0 107.433 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -30.21 70.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.018 0.527 . . . . 0.0 111.416 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.39 -37.78 74.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.797 0.439 . . . . 0.0 110.651 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 -45.89 77.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -59.0 -45.86 89.61 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.01 0.524 . . . . 0.0 110.601 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -60.84 -39.48 89.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.868 0.758 . . . . 0.0 111.628 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.03 85.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -65.98 -34.76 78.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.795 0.438 . . . . 0.0 111.192 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -58.41 -46.84 85.64 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.015 0.926 . . . . 0.0 110.2 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -65.73 -36.25 83.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.4 0.546 . . . . 0.0 111.284 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -68.14 -45.09 74.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.231 . . . . 0.0 111.453 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.52 -42.87 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.971 0.805 . . . . 0.0 109.449 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -39.46 94.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.021 1.282 . . . . 0.0 110.13 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.47 -42.39 78.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.405 0.282 . . . . 0.0 111.611 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.81 -41.12 83.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.04 -0.413 . . . . 0.0 110.745 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.77 -52.75 56.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.77 55.36 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.577 0.626 . . . . 0.0 111.757 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -61.16 -49.69 76.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.561 0.681 . . . . 0.0 110.966 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -69.8 -30.92 68.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.784 -0.573 . . . . 0.0 110.438 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -41.9 82.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.343 0.974 . . . . 0.0 109.855 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.95 -52.27 65.87 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -69.33 -31.28 69.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.455 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -63.01 -37.9 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.4 1.0 . . . . 0.0 111.016 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.28 51.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.788 0.435 . . . . 0.0 111.084 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.38 -40.84 11.83 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.788 0.835 . . . . 0.0 111.736 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.2 p -117.61 -19.06 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.965 0.906 . . . . 0.0 111.929 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.82 10.02 83.69 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.841 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 119.058 1.429 . . . . 0.0 108.889 -175.088 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.34 175.66 6.7 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.5 144.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.91 151.59 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.511 1.05 . . . . 0.0 109.024 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -138.15 129.51 27.63 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 123.568 0.747 . . . . 0.0 109.466 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.15 130.63 55.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.495 1.118 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -131.91 136.58 47.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.491 0.716 . . . . 0.0 111.023 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -146.51 -175.39 4.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.948 0.34 . . . . 0.0 111.155 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -62.76 -19.11 63.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.194 0.998 . . . . 0.0 112.462 -170.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.93 143.01 9.16 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.48 51.19 1.21 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.312 1.056 . . . . 0.0 111.843 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -128.2 -9.98 5.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -168.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.4 p -140.23 -101.98 0.15 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.79 0.723 . . . . 0.0 110.207 -169.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -51.43 -47.63 62.95 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.821 1.648 . . . . 0.0 110.689 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.7 p -66.95 -43.07 84.11 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.133 0.271 . . . . 0.0 110.674 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.641 1.176 . . . . 0.0 110.814 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.5 mtm -61.42 -42.53 98.89 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 110.65 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.34 -44.73 94.06 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 118.646 -0.693 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.54 -44.73 73.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.454 0.57 . . . . 0.0 110.506 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.83 -51.85 55.64 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 119.339 -0.701 . . . . 0.0 111.526 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -62.95 -46.0 89.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.447 0.623 . . . . 0.0 111.023 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.49 94.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.564 0.745 . . . . 0.0 110.657 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -57.23 -35.42 69.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.937 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -68.81 -61.88 1.62 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.169 0.441 . . . . 0.0 110.723 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -64.53 -41.02 96.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.409 0.283 . . . . 0.0 111.426 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.14 -1.82 37.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.286 1.035 . . . . 0.0 112.123 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.6 24.5 53.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.149 1.357 . . . . 0.0 113.998 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 55.8 9.44 0.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.412 2.285 . . . . 0.0 113.972 -170.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -66.05 -5.99 11.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 110.515 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -130.41 115.6 17.09 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -68.7 88.55 0.36 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.171 1.388 . . . . 0.0 107.466 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.04 154.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -150.62 164.69 35.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.705 2.002 . . . . 0.0 107.438 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.9 p -141.21 154.29 45.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 169.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.48 -169.45 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 110.365 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.76 -179.5 42.79 Favored Glycine 0 N--CA 1.447 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.9 -27.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.33 1.452 . . . . 0.0 111.416 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -145.72 170.85 15.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 108.43 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.94 136.36 16.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.12 19.1 2.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.611 1.164 . . . . 0.0 110.093 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.54 -176.8 20.35 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.42 144.23 39.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.049 0.94 . . . . 0.0 109.797 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -70.51 134.5 86.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.024 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.2 -33.55 44.92 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.06 2.507 . . . . 0.0 114.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -78.09 -28.55 48.75 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 119.151 0.887 . . . . 0.0 110.504 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.66 75.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.39 -52.13 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.98 -38.77 87.15 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.908 0.776 . . . . 0.0 111.397 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.7 87.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.918 0.487 . . . . 0.0 109.825 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.22 -36.57 79.72 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.209 0.459 . . . . 0.0 111.028 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -63.57 -26.37 68.67 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 120.673 -1.267 . . . . 0.0 111.188 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.55 -16.57 63.45 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.69 0.677 . . . . 0.0 111.095 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.16 -1.07 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.715 0.806 . . . . 0.0 112.07 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.46 31.75 11.2 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -123.34 154.92 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -142.64 76.04 1.51 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.596 1.189 . . . . 0.0 110.371 -169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.4 pt -58.65 -15.12 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.28 1.032 . . . . 0.0 113.339 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.74 -24.84 24.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.62 1.1 . . . . 0.0 111.967 172.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.37 -21.03 33.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.79 -21.86 9.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.875 1.216 . . . . 0.0 114.005 -169.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.0 p 49.01 -164.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.359 1.064 . . . . 0.0 111.553 -169.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 m -129.69 156.19 44.66 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.138 -0.976 . . . . 0.0 111.579 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -155.91 156.11 34.03 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.788 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.87 164.54 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 147.38 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.084 1.354 . . . . 0.0 110.198 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.39 136.76 33.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.441 1.097 . . . . 0.0 110.051 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -53.86 -29.67 42.29 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.553 1.541 . . . . 0.0 113.074 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.78 -8.74 50.71 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.192 1.397 . . . . 0.0 112.257 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.4 mt -117.29 -42.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.5 mt -47.53 -56.9 6.14 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.693 1.133 . . . . 0.0 112.195 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.87 0.88 51.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.649 0.78 . . . . 0.0 112.813 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -117.89 -31.22 5.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.06 1.344 . . . . 0.0 111.745 -169.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.81 131.31 49.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.206 1.402 . . . . 0.0 109.02 173.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.43 -32.15 71.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.668 0.387 . . . . 0.0 109.969 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.34 139.58 28.59 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.323 1.049 . . . . 0.0 109.141 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.61 146.05 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.36 121.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -98.58 135.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.85 18.67 19.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.269 1.027 . . . . 0.0 109.844 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.2 p -70.33 117.23 11.62 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.798 1.239 . . . . 0.0 110.006 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.358 0 C-N-CA 124.861 1.219 . . . . 0.0 111.047 170.459 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 138.45 58.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 110.235 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.0 p -125.96 153.37 73.73 Favored Pre-proline 0 N--CA 1.448 -0.533 0 C-N-CA 126.206 1.802 . . . . 0.0 108.768 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.67 153.59 77.44 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.776 1.651 . . . . 0.0 109.301 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.8 -23.51 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.407 2.071 . . . . 0.0 111.937 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -76.81 -25.96 53.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.737 0.815 . . . . 0.0 112.65 -172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.27 144.39 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.855 0.752 . . . . 0.0 109.437 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.31 136.24 56.32 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -135.94 151.31 49.82 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.145 0.578 . . . . 0.0 110.455 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -126.55 159.42 33.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.028 2.131 . . . . 0.0 107.809 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -135.98 111.32 9.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -121.47 62.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.199 1.8 . . . . 0.0 106.661 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.99 134.06 21.31 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.252 -0.905 . . . . 0.0 112.224 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.21 161.05 39.26 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.966 2.107 . . . . 0.0 106.168 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.89 148.53 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.759 0.79 . . . . 0.0 110.667 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -71.76 120.88 82.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.811 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.13 -27.22 73.06 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.328 1.352 . . . . 0.0 112.868 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -6.4 41.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.742 0.701 . . . . 0.0 112.589 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -119.35 0.44 11.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.885 1.674 . . . . 0.0 109.846 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.21 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.279 1.432 . . . . 0.0 109.957 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -57.19 124.93 20.51 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.301 1.04 . . . . 0.0 109.6 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.46 -74.93 0.12 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -167.36 168.89 12.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.602 1.561 . . . . 0.0 107.52 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.59 -30.47 69.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.881 -0.512 . . . . 0.0 111.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.27 -38.63 78.47 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.647 0.379 . . . . 0.0 110.453 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -70.96 -38.52 72.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.683 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -59.51 -47.73 84.4 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 119.34 0.973 . . . . 0.0 110.45 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -58.64 -39.72 81.38 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.254 0.622 . . . . 0.0 111.189 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.64 78.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.639 -0.663 . . . . 0.0 111.03 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.76 -35.15 79.91 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.78 -52.93 63.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.701 0.8 . . . . 0.0 110.722 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.51 -30.61 70.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.728 0.695 . . . . 0.0 112.02 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -63.41 -53.92 44.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.431 1.014 . . . . 0.0 110.346 171.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.88 -37.59 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.528 0.603 . . . . 0.0 109.501 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -55.17 -54.15 46.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 123.786 0.834 . . . . 0.0 109.423 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.25 -43.05 99.1 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 123.256 0.347 . . . . 0.0 110.806 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.27 -40.45 90.11 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.766 -0.584 . . . . 0.0 111.314 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.54 -50.93 78.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.23 -46.23 57.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.02 -50.08 75.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 111.003 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -69.83 -30.29 67.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.496 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -39.7 81.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.588 1.085 . . . . 0.0 110.178 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -56.36 -50.08 72.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.31 -37.79 88.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 111.496 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -61.37 -35.71 78.21 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.11 -0.994 . . . . 0.0 111.753 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.11 -35.99 28.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.702 0.401 . . . . 0.0 111.358 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.72 -41.9 10.44 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.014 1.326 . . . . 0.0 111.682 -169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -115.15 -20.33 10.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.621 1.168 . . . . 0.0 111.579 -169.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.83 81.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.395 0.998 . . . . 0.0 112.768 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.407 1.103 . . . . 0.0 109.573 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -82.79 -176.63 6.39 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 122.683 0.393 . . . . 0.0 110.019 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.19 143.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.85 151.07 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.934 0.894 . . . . 0.0 109.087 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.91 138.02 38.61 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.877 0.871 . . . . 0.0 108.974 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.6 127.58 53.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -123.38 143.81 49.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.857 1.263 . . . . 0.0 109.976 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.1 m -142.12 176.53 8.89 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.374 1.07 . . . . 0.0 112.11 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -65.26 -18.24 65.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.623 1.169 . . . . 0.0 111.891 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.1 136.08 4.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -80.54 55.85 2.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.08 0.952 . . . . 0.0 111.684 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 m -125.74 -18.43 5.17 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.7 m -137.85 -88.39 0.26 Allowed 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 119.152 0.887 . . . . 0.0 109.563 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -56.62 -53.93 51.91 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.711 0.805 . . . . 0.0 111.18 -169.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -67.23 -35.45 79.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.083 0.401 . . . . 0.0 111.248 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.03 -54.7 41.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.177 0.991 . . . . 0.0 110.103 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.0 mtm -57.81 -41.88 83.11 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.465 0.706 . . . . 0.0 111.366 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.01 95.21 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.444 0.565 . . . . 0.0 111.735 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -55.37 -41.37 72.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.639 0.375 . . . . 0.0 110.784 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -49.89 73.62 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.337 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -62.64 -43.79 97.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.737 0.769 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.68 99.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.521 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -51.79 -38.54 56.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -69.52 -62.2 1.48 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.206 0.316 . . . . 0.0 110.419 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -68.9 -40.32 79.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.99 -6.47 54.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.23 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.06 24.36 58.34 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.822 1.201 . . . . 0.0 114.157 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.8 t70 57.87 9.93 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.307 2.243 . . . . 0.0 113.953 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -66.26 -5.67 11.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.021 1.328 . . . . 0.0 110.737 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -128.99 124.53 35.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 173.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.2 mmpt? -66.33 100.94 0.68 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.4 139.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -146.39 165.83 28.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.194 1.398 . . . . 0.0 109.294 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.8 p -144.02 157.44 44.33 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.593 0.757 . . . . 0.0 110.064 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.68 -167.31 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.93 -174.45 45.82 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.93 -30.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.998 1.319 . . . . 0.0 111.009 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 168.86 21.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 108.569 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.54 138.68 26.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.73 11.21 5.66 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.64 1.176 . . . . 0.0 110.056 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.4 163.84 33.17 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.74 148.55 30.05 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.371 0.605 . . . . 0.0 110.824 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.16 136.24 79.28 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.003 0.921 . . . . 0.0 109.761 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.99 -36.03 63.2 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.705 2.27 . . . . 0.0 113.893 174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -72.44 -30.3 64.48 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.621 -0.675 . . . . 0.0 110.547 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.55 90.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -59.05 -49.04 84.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -38.98 81.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.274 0.943 . . . . 0.0 111.009 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.92 -46.48 84.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.369 0.668 . . . . 0.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.6 mmm -68.5 -36.53 79.03 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 118.372 0.533 . . . . 0.0 111.021 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -65.81 -25.14 67.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.905 -1.122 . . . . 0.0 111.18 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -68.83 -17.37 63.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.265 0.626 . . . . 0.0 110.969 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.92 0.33 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.646 0.778 . . . . 0.0 111.921 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.98 32.28 18.14 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 174.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.4 159.74 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -124.66 144.42 50.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -128.6 3.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.856 1.262 . . . . 0.0 110.226 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.04 -28.76 68.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.129 -1.607 . . . . 0.0 111.119 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -64.63 -4.61 4.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.586 1.955 . . . . 0.0 115.17 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -137.92 49.7 1.95 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.294 1.406 . . . . 0.0 110.815 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -46.05 131.85 9.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.271 1.029 . . . . 0.0 110.723 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -55.71 155.88 5.41 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.185 1.794 . . . . 0.0 115.698 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -153.92 158.04 40.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.319 1.448 . . . . 0.0 109.211 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.5 168.7 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 169.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.7 mt -56.39 142.86 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.627 0.771 . . . . 0.0 109.141 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.23 135.71 47.6 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.091 1.356 . . . . 0.0 109.454 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -56.39 -31.27 63.7 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.022 1.329 . . . . 0.0 113.267 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -81.36 -5.15 57.55 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.853 -0.529 . . . . 0.0 111.749 -170.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.5 mt -111.39 -44.0 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.77 -39.88 86.37 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.846 1.203 . . . . 0.0 111.523 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.52 3.14 41.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -126.62 -27.0 3.17 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.999 0.92 . . . . 0.0 112.997 -168.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.91 20.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.513 1.125 . . . . 0.0 109.757 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.68 -28.43 69.9 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.907 0.483 . . . . 0.0 110.775 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.22 140.35 33.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.75 144.04 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 124.28 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.94 127.4 48.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.54 22.89 12.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.667 0.746 . . . . 0.0 109.343 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.94 107.26 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.468 1.507 . . . . 0.0 110.482 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 C-N-CA 125.066 1.317 . . . . 0.0 109.992 170.491 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 120.938 0.308 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.7 mtm -72.94 157.6 37.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.379 0.672 . . . . 0.0 109.494 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -129.98 162.31 54.5 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.893 2.077 . . . . 0.0 108.363 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.32 161.46 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.047 1.165 . . . . 0.0 109.503 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.13 -23.38 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.453 2.102 . . . . 0.0 111.985 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -75.48 -31.01 60.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.54 0.736 . . . . 0.0 112.63 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -81.21 152.04 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.753 0.787 . . . . 0.0 110.757 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.36 143.52 50.18 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -135.98 149.4 48.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.746 0.418 . . . . 0.0 110.541 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.69 157.82 38.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.816 2.047 . . . . 0.0 107.728 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -133.98 112.75 11.49 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -122.17 56.45 1.1 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.121 1.769 . . . . 0.0 107.216 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.09 125.2 21.33 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.707 -1.245 . . . . 0.0 111.93 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.89 162.21 41.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.697 1.999 . . . . 0.0 106.447 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -68.75 147.42 51.82 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.36 0.6 . . . . 0.0 111.17 -172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.91 126.37 91.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.524 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.17 -24.57 65.82 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.661 1.574 . . . . 0.0 113.663 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.83 -15.12 63.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.42 1.009 . . . . 0.0 112.34 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -108.61 2.45 22.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.432 1.093 . . . . 0.0 111.482 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 53.05 0.29 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.717 2.007 . . . . 0.0 111.508 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 147.84 37.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.828 2.051 . . . . 0.0 112.082 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.9 -53.29 0.36 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.94 165.79 17.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 107.386 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.06 -29.37 68.5 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.351 0.66 . . . . 0.0 111.132 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.13 -41.44 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.41 0.684 . . . . 0.0 110.206 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.49 -46.77 71.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.912 0.885 . . . . 0.0 108.849 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.53 -52.17 64.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 122.872 0.469 . . . . 0.0 110.185 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -58.45 -39.71 80.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.578 0.751 . . . . 0.0 111.609 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.0 93.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.542 -0.724 . . . . 0.0 110.428 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.39 -34.48 78.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.875 0.47 . . . . 0.0 111.64 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -58.82 -48.51 81.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.908 0.776 . . . . 0.0 109.929 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -64.16 -38.25 90.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.612 0.642 . . . . 0.0 111.254 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.7 mmm-85 -61.97 -51.65 67.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.983 0.811 . . . . 0.0 111.156 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.86 -39.34 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -53.81 -55.29 27.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.066 0.946 . . . . 0.0 109.467 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.51 -42.39 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.146 0.279 . . . . 0.0 110.858 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.5 -39.01 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.078 0.551 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.15 -50.65 79.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.38 73.47 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.68 0.657 . . . . 0.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -60.17 -51.98 67.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.599 0.7 . . . . 0.0 110.992 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -69.2 -29.08 66.98 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.87 -1.062 . . . . 0.0 111.405 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -42.02 87.89 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.798 1.181 . . . . 0.0 109.868 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.43 -51.54 69.0 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.61 -34.46 77.93 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.521 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.18 -38.71 90.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.591 0.632 . . . . 0.0 111.001 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.36 36.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.391 0.276 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -90.43 -48.15 7.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.609 1.163 . . . . 0.0 110.908 -169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.8 p -106.69 -18.91 13.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.209 1.004 . . . . 0.0 111.273 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.26 15.81 75.73 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.82 -0.989 . . . . 0.0 112.503 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-N 118.717 1.258 . . . . 0.0 108.644 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 174.52 8.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.63 142.44 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.01 148.63 21.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.903 0.774 . . . . 0.0 109.007 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.33 132.99 36.38 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -115.78 133.11 56.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.78 141.43 51.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.69 0.796 . . . . 0.0 110.009 -169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.54 169.29 17.88 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 122.103 0.954 . . . . 0.0 112.131 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -76.03 35.81 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.23 2.212 . . . . 0.0 110.857 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.45 112.51 0.86 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.49 54.45 0.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.656 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -128.46 -18.68 3.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.4 m -136.32 -89.61 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.176 0.898 . . . . 0.0 109.688 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -55.24 -52.46 63.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.197 0.999 . . . . 0.0 111.028 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 p -58.03 -47.57 82.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.531 1.133 . . . . 0.0 110.874 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.45 -56.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.89 1.276 . . . . 0.0 110.16 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.1 mtm -57.33 -45.52 84.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.732 . . . . 0.0 111.228 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.03 97.6 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.671 0.669 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.99 -34.57 75.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.832 0.453 . . . . 0.0 110.98 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.72 43.26 Favored Glycine 0 C--N 1.341 0.858 0 C-N-CA 123.706 0.669 . . . . 0.0 111.655 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.67 -43.27 94.04 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 117.533 0.666 . . . . 0.0 110.592 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.59 98.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.771 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -53.86 -37.62 63.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.907 1.231 . . . . 0.0 111.954 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -66.76 -57.28 7.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.008 0.367 . . . . 0.0 110.411 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.94 -42.1 61.05 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.094 0.158 . . . . 0.0 111.381 -171.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 -11.43 59.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 112.257 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 26.85 60.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.377 0.989 . . . . 0.0 114.168 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 60.89 6.03 1.11 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.626 2.37 . . . . 0.0 114.134 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.82 -9.68 22.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.56 100.33 0.86 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.12 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -143.27 166.61 24.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.584 1.553 . . . . 0.0 109.421 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -149.74 161.28 42.54 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.614 -0.679 . . . . 0.0 110.133 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.53 -166.64 1.39 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.998 1.319 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.58 -179.97 44.58 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 111.715 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mt -53.52 -29.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.352 1.461 . . . . 0.0 111.356 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.49 167.14 24.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.602 1.161 . . . . 0.0 108.307 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.49 21.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -135.37 24.96 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.38 1.072 . . . . 0.0 109.255 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.84 167.68 39.18 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.78 147.54 26.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.959 0.504 . . . . 0.0 110.508 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -73.7 133.75 79.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.089 -0.957 . . . . 0.0 109.303 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.02 -33.8 44.1 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.897 2.398 . . . . 0.0 114.584 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.68 -29.23 63.24 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 121.35 -0.844 . . . . 0.0 110.87 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.37 85.06 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.22 -49.21 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -44.21 91.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.18 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.07 92.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.927 0.785 . . . . 0.0 110.152 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.1 mmm -71.81 -37.4 70.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.81 0.277 . . . . 0.0 111.525 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -27.36 69.06 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.87 -1.144 . . . . 0.0 111.31 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.98 -13.07 62.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.715 0.806 . . . . 0.0 110.852 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.3 -2.42 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.528 1.131 . . . . 0.0 112.228 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.97 33.41 9.73 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.16 160.87 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -128.33 145.15 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.32 -1.04 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.367 1.467 . . . . 0.0 110.284 173.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -57.8 -29.9 65.26 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.602 -1.311 . . . . 0.0 110.97 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -60.79 -16.2 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.697 1.999 . . . . 0.0 114.537 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.1 54.92 1.88 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.713 1.142 . . . . 0.0 110.452 -169.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 p -49.78 140.94 10.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.93 0.892 . . . . 0.0 111.85 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 m -62.36 160.4 13.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.041 1.736 . . . . 0.0 114.517 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -155.98 156.46 34.53 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.963 1.305 . . . . 0.0 109.689 169.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 164.32 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.857 0.863 . . . . 0.0 109.331 170.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.43 146.92 5.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 110.308 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.54 136.01 32.44 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.392 1.077 . . . . 0.0 109.938 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.53 -28.65 46.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.454 1.502 . . . . 0.0 113.138 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.4 -10.83 59.69 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.966 1.306 . . . . 0.0 112.21 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.1 -42.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 mt -48.66 -58.41 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -1.31 36.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -116.38 -31.5 5.58 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.126 1.37 . . . . 0.0 111.7 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.03 44.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.153 1.381 . . . . 0.0 109.543 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.9 -26.22 67.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.443 0.697 . . . . 0.0 110.656 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -148.03 140.43 24.39 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.641 1.177 . . . . 0.0 108.803 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.69 148.13 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.53 130.76 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.29 132.09 45.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 170.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -102.96 23.21 12.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.904 0.882 . . . . 0.0 109.164 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.55 107.66 4.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.979 1.712 . . . . 0.0 110.45 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 171.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.537 0.644 0 N-CA-C 114.275 0.837 . . . . 0.0 114.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.8 ttm -75.19 149.24 39.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.895 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -132.65 161.23 64.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.744 2.017 . . . . 0.0 110.05 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.98 133.31 24.86 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.029 1.819 . . . . 0.0 109.278 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.03 -19.3 30.28 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.817 2.345 . . . . 0.0 112.318 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -68.15 -20.18 64.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 111.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.73 142.23 16.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -61.39 136.23 57.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -129.97 158.83 38.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.974 0.91 . . . . 0.0 109.298 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -137.92 166.47 23.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.988 1.715 . . . . 0.0 107.914 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -132.87 117.5 17.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -125.43 52.89 1.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.153 1.781 . . . . 0.0 107.314 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.12 132.17 33.45 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.73 -1.231 . . . . 0.0 112.367 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.23 159.65 36.28 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.501 1.92 . . . . 0.0 106.132 169.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -68.71 142.17 55.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.845 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.05 126.95 93.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.112 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.16 -23.53 45.54 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.115 1.21 . . . . 0.0 113.297 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.69 -9.13 58.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.399 1.0 . . . . 0.0 112.225 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -113.0 4.38 16.69 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.236 1.414 . . . . 0.0 110.667 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.38 63.28 0.37 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.725 2.01 . . . . 0.0 110.442 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -59.44 138.97 57.49 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.669 1.588 . . . . 0.0 110.718 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.1 -59.73 0.2 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -166.17 169.27 14.53 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.054 1.742 . . . . 0.0 107.398 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.98 -29.61 68.56 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.369 0.668 . . . . 0.0 111.416 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.79 -37.8 73.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.788 0.435 . . . . 0.0 110.654 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.6 -43.85 75.58 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -57.4 -48.42 79.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.778 0.431 . . . . 0.0 110.141 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -60.99 -38.06 84.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.4 0.68 . . . . 0.0 111.925 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.44 81.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.46 -33.42 75.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.018 0.527 . . . . 0.0 111.13 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.25 -50.04 74.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.957 0.903 . . . . 0.0 110.278 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -64.88 -34.36 78.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.347 0.522 . . . . 0.0 111.656 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.51 -49.72 62.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.623 0.647 . . . . 0.0 110.821 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.93 -39.86 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -53.72 -54.14 42.22 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.458 1.103 . . . . 0.0 109.601 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.87 -43.23 93.64 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.056 0.222 . . . . 0.0 110.911 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.65 -41.08 88.79 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.999 -0.438 . . . . 0.0 110.77 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.7 mt -59.59 -50.33 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.72 -46.67 66.61 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.763 0.71 . . . . 0.0 111.476 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -62.19 -46.36 89.26 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.404 0.602 . . . . 0.0 110.78 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -72.25 -30.58 65.0 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 -174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -42.19 82.44 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.734 0.814 . . . . 0.0 109.62 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.17 -48.78 75.67 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -37.64 86.24 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.451 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -60.32 -37.29 80.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.643 -0.661 . . . . 0.0 111.496 175.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.87 33.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.518 0.327 . . . . 0.0 111.661 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.96 -45.69 7.83 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.465 1.106 . . . . 0.0 111.128 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.5 p -106.88 -19.49 13.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.055 . . . . 0.0 110.902 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.93 79.1 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.215 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.6 mttt . . . . . 0 C--O 1.248 1.003 0 CA-C-N 118.562 1.181 . . . . 0.0 108.703 176.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 173.95 3.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.3 142.24 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.54 146.06 22.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 119.043 0.838 . . . . 0.0 108.824 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.55 124.02 22.13 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -107.6 128.39 54.49 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.62 145.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.158 0.583 . . . . 0.0 110.935 -169.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.7 m -141.42 178.83 7.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.755 1.622 . . . . 0.0 109.374 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -75.85 -19.15 59.11 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.654 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.34 131.65 4.15 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.31 54.33 2.27 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.769 0.828 . . . . 0.0 111.748 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -126.1 -16.88 5.42 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -131.84 -106.33 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -170.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -35.44 75.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -60.71 -47.77 84.8 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.18 0.9 . . . . 0.0 110.377 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -60.01 -49.71 76.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.237 1.015 . . . . 0.0 110.221 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.39 -44.74 89.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.16 0.584 . . . . 0.0 111.841 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.79 99.61 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.234 0.614 . . . . 0.0 111.015 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -56.13 -41.2 74.94 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.112 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.07 60.97 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.782 0.719 . . . . 0.0 112.309 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.54 -45.78 92.6 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.34 0.57 . . . . 0.0 110.812 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.57 99.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.846 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -52.77 -44.35 66.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.395 0.998 . . . . 0.0 111.568 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -74.8 -43.88 52.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.164 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -73.72 -44.58 55.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.494 0.588 . . . . 0.0 110.921 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.01 -9.64 59.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.161 0.984 . . . . 0.0 112.253 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.41 26.48 64.29 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.534 1.064 . . . . 0.0 113.956 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 60.72 5.82 1.01 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.625 2.37 . . . . 0.0 113.986 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.79 -9.32 19.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.641 1.176 . . . . 0.0 110.544 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.52 118.53 23.21 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 172.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -67.87 101.43 1.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.1 137.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.19 166.19 25.74 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.62 1.568 . . . . 0.0 109.529 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -147.88 157.06 43.34 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.482 0.713 . . . . 0.0 110.007 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.16 -168.03 1.62 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.546 1.139 . . . . 0.0 110.357 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.54 -175.45 42.09 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.442 -0.787 . . . . 0.0 112.598 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -55.09 -30.28 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.531 1.532 . . . . 0.0 110.681 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 169.6 17.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.776 1.23 . . . . 0.0 109.142 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.53 137.05 20.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -136.49 19.45 3.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.205 1.002 . . . . 0.0 109.777 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.71 29.09 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -94.42 146.95 23.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.342 0.657 . . . . 0.0 110.583 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.33 138.77 78.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.826 1.25 . . . . 0.0 109.455 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.15 -30.34 82.04 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.849 1.699 . . . . 0.0 113.255 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.92 -27.21 62.66 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.626 1.103 . . . . 0.0 110.483 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.31 -48.4 73.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.54 1.063 . . . . 0.0 108.941 171.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.68 -48.13 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -57.92 -47.08 83.88 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.933 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -43.68 81.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 0.0 109.389 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.8 mmm -71.25 -39.64 71.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.276 0.231 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.88 -27.09 69.11 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 120.888 -1.133 . . . . 0.0 111.259 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.2 -9.56 58.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.073 0.949 . . . . 0.0 109.957 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.55 -1.12 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.254 1.022 . . . . 0.0 112.591 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.65 33.52 11.28 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.1 161.54 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -125.58 143.35 51.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.58 3.63 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.03 1.332 . . . . 0.0 110.365 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -60.93 -28.06 68.66 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.2 -1.563 . . . . 0.0 110.965 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -65.5 -4.36 5.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.412 1.885 . . . . 0.0 115.322 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.82 47.87 2.03 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.274 1.397 . . . . 0.0 111.273 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 131.28 8.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.42 1.088 . . . . 0.0 110.789 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -54.82 154.42 5.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.448 1.899 . . . . 0.0 115.455 -169.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -152.22 156.0 38.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.206 1.403 . . . . 0.0 109.311 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.7 164.79 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.263 1.025 . . . . 0.0 109.346 171.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.1 mt -56.4 145.85 6.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.608 1.163 . . . . 0.0 109.671 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -136.93 134.42 36.74 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.404 1.082 . . . . 0.0 109.928 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.17 -27.64 55.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.635 1.574 . . . . 0.0 113.522 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.87 -4.18 57.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.527 0.603 . . . . 0.0 111.797 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -107.96 -42.24 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.6 mt -48.37 -60.45 2.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.388 0.995 . . . . 0.0 111.269 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -75.81 -1.94 27.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.371 0.668 . . . . 0.0 112.736 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -115.85 -31.51 5.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.932 1.293 . . . . 0.0 111.34 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.05 124.12 19.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.127 1.371 . . . . 0.0 109.848 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.7 -31.75 71.92 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.816 0.846 . . . . 0.0 110.184 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 tp -142.06 139.17 32.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.389 1.076 . . . . 0.0 108.547 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.41 147.08 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.95 126.83 51.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.29 118.39 36.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.342 0.519 . . . . 0.0 109.766 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.26 12.63 36.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.848 1.259 . . . . 0.0 110.749 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -65.53 119.18 10.61 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.328 171.667 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 N-CA-C 110.037 -0.793 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.8 tpp -130.23 159.07 37.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.472 1.109 . . . . 0.0 109.586 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 166.58 18.23 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.224 1.81 . . . . 0.0 110.457 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.97 161.34 33.55 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.558 1.505 . . . . 0.0 110.011 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.03 -9.12 17.94 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.096 2.531 . . . . 0.0 114.027 -169.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -115.0 -12.72 11.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.27 146.58 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.764 1.165 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.23 136.95 52.74 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -138.61 151.89 47.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.307 0.643 . . . . 0.0 109.987 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.34 161.71 29.66 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.137 2.175 . . . . 0.0 107.387 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -139.48 112.53 8.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.409 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 30.9 m0 -122.43 51.45 1.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.641 1.577 . . . . 0.0 107.062 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.88 132.18 31.32 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 120.885 -1.134 . . . . 0.0 111.88 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.97 35.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.028 1.731 . . . . 0.0 107.411 169.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.27 134.35 56.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.913 1.285 . . . . 0.0 109.842 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.42 124.7 91.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -23.91 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.432 1.421 . . . . 0.0 113.604 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.53 49.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.167 0.894 . . . . 0.0 112.273 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -110.33 8.51 23.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.615 1.166 . . . . 0.0 111.071 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.87 68.7 0.66 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.879 1.272 . . . . 0.0 109.777 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.13 136.34 57.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.792 0.837 . . . . 0.0 110.277 -171.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.55 -61.72 0.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -165.44 167.04 17.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.432 1.493 . . . . 0.0 107.72 171.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.49 -28.05 66.69 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.612 0.765 . . . . 0.0 111.431 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.7 -37.35 70.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.047 0.539 . . . . 0.0 110.941 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -69.39 -44.48 71.38 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.2 -45.96 83.29 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.776 0.431 . . . . 0.0 110.293 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -60.37 -40.47 90.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.47 0.708 . . . . 0.0 111.756 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.08 87.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.487 -0.758 . . . . 0.0 110.513 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -62.8 -37.47 86.85 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.007 0.523 . . . . 0.0 111.274 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.12 -48.95 77.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.364 0.665 . . . . 0.0 110.345 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.53 -36.34 83.46 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.438 0.563 . . . . 0.0 111.824 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -68.43 -47.44 67.22 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.995 0.816 . . . . 0.0 111.085 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.21 -41.41 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.82 -53.17 58.74 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.141 0.976 . . . . 0.0 109.758 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.59 -42.44 98.28 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.781 0.264 . . . . 0.0 110.954 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.6 -41.64 92.56 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.984 -0.447 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.51 -50.78 79.01 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.71 -45.63 60.25 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -61.13 -50.35 73.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 117.446 0.623 . . . . 0.0 111.1 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.409 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.9 tpt180 -68.69 -34.25 75.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.228 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -40.66 98.41 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.687 1.13 . . . . 0.0 109.695 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.79 -51.87 68.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.24 -36.08 83.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.908 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.65 -36.55 83.2 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.709 -0.619 . . . . 0.0 111.2 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.4 -37.85 31.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.652 0.381 . . . . 0.0 111.257 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.35 -46.92 8.07 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.393 1.077 . . . . 0.0 110.868 -170.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -109.41 -18.86 13.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.432 1.093 . . . . 0.0 111.638 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.46 13.16 82.13 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.586 -1.119 . . . . 0.0 112.942 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 119.225 1.512 . . . . 0.0 108.428 179.242 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -71.86 172.75 9.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.12 143.62 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -146.58 149.7 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 119.211 0.914 . . . . 0.0 109.233 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.23 131.55 32.55 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.586 0.754 . . . . 0.0 109.286 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.25 128.3 56.29 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.3 mt -125.03 141.35 52.18 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.072 0.949 . . . . 0.0 110.319 -169.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.3 m -141.12 168.85 18.79 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 122.223 1.011 . . . . 0.0 112.557 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -76.82 34.21 0.15 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.737 2.015 . . . . 0.0 110.479 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.65 109.15 0.67 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 126.351 1.929 . . . . 0.0 108.605 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.46 51.46 0.72 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.201 1.0 . . . . 0.0 111.746 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -120.99 -20.38 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 m -136.32 -92.85 0.25 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.254 0.933 . . . . 0.0 110.66 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -36.71 85.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -61.04 -47.33 86.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.336 0.654 . . . . 0.0 110.616 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -60.69 -49.98 75.34 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.177 0.991 . . . . 0.0 109.679 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 mtm -58.21 -44.46 88.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.061 0.544 . . . . 0.0 111.623 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.45 -44.21 97.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.794 0.725 . . . . 0.0 111.346 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -56.94 -41.84 78.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.449 0.3 . . . . 0.0 110.725 173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.92 -52.86 50.83 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.763 0.697 . . . . 0.0 112.119 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -61.32 -43.05 99.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.394 0.597 . . . . 0.0 110.82 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.07 99.74 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.923 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -55.08 -36.69 65.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.439 1.018 . . . . 0.0 111.553 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -68.4 -57.67 5.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.238 0.472 . . . . 0.0 110.921 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -76.19 -43.87 40.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.1 mt -72.56 -34.49 67.53 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.947 0.499 . . . . 0.0 111.46 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 173.57 42.13 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -1.48 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 111.607 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.83 -10.23 5.26 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.428 -0.795 . . . . 0.0 110.991 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.3 m95 -128.99 119.63 24.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -70.16 92.19 0.75 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.95 138.44 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.49 166.81 24.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.219 1.407 . . . . 0.0 109.46 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -147.71 159.89 43.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.429 0.692 . . . . 0.0 109.721 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.41 -166.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 109.304 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.06 43.61 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 121.311 -0.868 . . . . 0.0 111.776 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.45 -29.56 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.991 1.316 . . . . 0.0 110.734 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.8 166.48 29.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.325 1.45 . . . . 0.0 108.247 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.85 140.08 26.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.16 9.33 5.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.65 149.55 24.89 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.0 144.96 56.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.497 0.665 . . . . 0.0 111.413 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -73.21 133.31 81.28 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.575 1.15 . . . . 0.0 108.61 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.01 -34.37 37.7 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.872 2.381 . . . . 0.0 114.282 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.78 -28.47 63.65 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.498 -0.751 . . . . 0.0 110.896 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.01 77.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.34 -48.07 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -39.75 94.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.673 -0.68 . . . . 0.0 111.041 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.01 -44.53 97.28 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.304 0.956 . . . . 0.0 110.3 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 74.3 mmm -68.91 -36.27 77.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.642 0.655 . . . . 0.0 111.469 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.484 -1.385 . . . . 0.0 111.396 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -66.43 -17.35 64.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.93 0.786 . . . . 0.0 111.038 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.66 -0.64 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.08 0.952 . . . . 0.0 112.114 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.43 32.85 12.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.03 158.55 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.3 144.6 49.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.412 1.085 . . . . 0.0 108.153 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.99 4.14 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.977 1.311 . . . . 0.0 110.404 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.09 -27.57 67.11 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.113 -1.617 . . . . 0.0 111.153 172.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.38 -3.19 3.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.468 1.907 . . . . 0.0 115.295 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -139.9 47.65 1.82 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.302 1.41 . . . . 0.0 111.645 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 133.21 7.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.599 1.16 . . . . 0.0 111.356 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -57.51 156.61 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.069 1.748 . . . . 0.0 115.153 -169.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -155.95 158.51 38.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.079 1.352 . . . . 0.0 109.301 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.31 164.37 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 170.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.61 149.19 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.829 1.652 . . . . 0.0 110.991 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.53 136.06 32.51 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.705 1.202 . . . . 0.0 110.181 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.01 -29.39 57.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.576 1.551 . . . . 0.0 113.319 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.77 -9.01 52.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.912 1.285 . . . . 0.0 112.27 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.51 -42.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.1 mt -46.98 -57.5 4.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.586 1.085 . . . . 0.0 112.186 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.71 -0.06 52.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 112.801 -173.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.94 -31.92 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.135 1.374 . . . . 0.0 111.527 -169.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.83 130.39 45.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.426 1.491 . . . . 0.0 109.887 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -63.07 -28.12 69.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.712 0.805 . . . . 0.0 110.477 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -147.62 139.95 24.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.891 1.276 . . . . 0.0 108.671 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.66 147.76 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.75 124.29 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -99.44 132.86 44.48 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.65 22.9 15.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.682 0.793 . . . . 0.0 109.362 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.0 111.81 6.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.785 -1.197 . . . . 0.0 110.305 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 169.886 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.535 0.538 0 N-CA-C 113.224 0.432 . . . . 0.0 113.224 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.1 ttt -69.53 145.23 52.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.035 0.934 . . . . 0.0 109.663 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.9 p -126.01 160.23 57.95 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 126.432 1.893 . . . . 0.0 109.288 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.28 153.92 75.67 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 121.692 1.595 . . . . 0.0 109.226 169.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.45 -24.22 19.43 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.442 2.095 . . . . 0.0 112.004 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -78.45 -25.3 45.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.522 0.729 . . . . 0.0 112.732 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -78.47 147.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 118.822 0.737 . . . . 0.0 109.676 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -67.94 137.36 55.12 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -135.44 150.4 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.971 0.509 . . . . 0.0 110.401 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -126.91 159.85 32.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.127 2.171 . . . . 0.0 107.946 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -132.92 114.94 14.62 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 24.8 m0 -123.2 53.85 1.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.338 1.855 . . . . 0.0 107.055 -174.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.51 131.12 34.85 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 120.717 -1.24 . . . . 0.0 111.803 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 161.78 37.81 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.795 2.038 . . . . 0.0 106.056 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -68.55 141.61 55.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.227 0.537 . . . . 0.0 110.596 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.24 128.49 93.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.96 -24.38 45.78 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.116 1.077 . . . . 0.0 113.411 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.05 56.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.228 0.922 . . . . 0.0 112.221 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -111.9 3.28 17.46 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.26 . . . . 0.0 110.62 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 62.95 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.892 2.077 . . . . 0.0 110.427 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -60.03 138.96 57.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.722 1.609 . . . . 0.0 110.573 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.55 -59.09 0.21 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -166.36 168.95 14.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.985 1.714 . . . . 0.0 107.497 169.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.61 -29.36 67.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 111.314 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.9 -38.35 76.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.93 -43.74 74.5 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.04 -47.2 83.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.852 0.461 . . . . 0.0 110.346 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -61.63 -38.65 88.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.75 0.704 . . . . 0.0 111.722 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.08 82.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.168 -0.957 . . . . 0.0 110.334 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.13 -32.11 73.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.976 -0.453 . . . . 0.0 111.197 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.27 -50.37 73.11 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.492 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -45.41 80.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.827 0.74 . . . . 0.0 111.665 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -59.92 -49.73 76.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.866 0.757 . . . . 0.0 110.734 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.0 t -70.77 -39.12 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.78 -56.16 23.83 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 124.342 1.057 . . . . 0.0 108.75 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.57 -38.66 77.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 123.406 0.441 . . . . 0.0 110.7 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.42 -42.46 87.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.898 0.479 . . . . 0.0 111.025 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.79 -50.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.77 -47.58 46.38 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -60.93 -49.37 77.71 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 117.567 0.684 . . . . 0.0 111.479 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.43 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -69.55 -34.3 74.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.126 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.77 88.74 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.596 1.089 . . . . 0.0 109.744 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -55.21 -52.36 63.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.62 -34.83 78.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.56 -36.36 82.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.893 0.77 . . . . 0.0 111.071 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.73 28.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.147 0.579 . . . . 0.0 111.494 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.15 -41.45 11.01 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 111.952 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.2 p -115.05 -19.33 10.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.206 1.002 . . . . 0.0 111.17 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.61 76.92 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.837 -0.98 . . . . 0.0 112.869 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.6 mttt . . . . . 0 C--O 1.247 0.923 0 CA-C-N 118.879 1.339 . . . . 0.0 108.754 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 171.99 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -142.97 142.12 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.74 149.08 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 119.489 1.04 . . . . 0.0 109.039 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.72 134.87 41.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -118.4 130.62 56.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -125.74 138.93 53.89 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 110.088 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t -137.78 169.15 18.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.807 1.243 . . . . 0.0 109.875 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -58.49 -24.78 61.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.292 1.037 . . . . 0.0 111.737 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.25 139.51 6.49 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -77.98 51.91 1.01 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.154 0.982 . . . . 0.0 111.549 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.1 m -127.01 -15.91 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.312 -169.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.6 m -138.38 -95.6 0.19 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -54.8 -52.06 63.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.556 0.742 . . . . 0.0 111.661 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 p -68.9 -36.32 77.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.552 0.16 . . . . 0.0 111.312 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.15 -53.95 51.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.114 0.966 . . . . 0.0 110.469 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.8 mtm -57.88 -44.37 86.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.133 0.573 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.21 99.07 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.384 0.538 . . . . 0.0 111.517 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.41 -32.35 70.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.098 0.559 . . . . 0.0 111.878 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.71 29.71 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -60.16 -41.24 92.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 117.338 0.569 . . . . 0.0 110.647 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.51 99.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.287 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -55.09 -40.17 70.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.824 1.193 . . . . 0.0 111.22 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -64.29 -51.8 61.72 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.396 0.435 . . . . 0.0 110.872 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -82.6 -44.6 15.63 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -171.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 92.4 mt -73.48 -33.81 65.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.816 0.446 . . . . 0.0 111.939 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.72 175.95 46.95 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.96 -2.65 10.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.768 0.827 . . . . 0.0 111.399 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.51 -12.35 6.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.776 1.231 . . . . 0.0 111.299 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 17.2 m95 -129.35 117.84 21.27 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -69.2 97.29 0.91 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.23 136.87 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.77 164.23 31.08 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.54 1.536 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -146.59 159.19 43.76 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.533 0.733 . . . . 0.0 109.729 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.5 -166.97 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.521 1.128 . . . . 0.0 109.621 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.47 -178.96 44.76 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -55.53 -27.93 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.259 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.85 172.12 14.66 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.537 1.535 . . . . 0.0 108.367 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.94 137.66 25.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.85 7.72 5.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.553 1.141 . . . . 0.0 110.452 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 145.86 17.98 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.08 142.35 54.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.742 0.782 . . . . 0.0 112.034 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -69.41 138.88 89.11 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 108.963 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.75 -28.71 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.735 1.623 . . . . 0.0 112.983 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -72.3 -29.16 63.6 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 120.985 -1.072 . . . . 0.0 110.478 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -45.91 87.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.19 -52.65 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -59.96 -41.2 91.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.974 0.807 . . . . 0.0 111.478 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.25 91.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.605 0.639 . . . . 0.0 109.853 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.71 -35.15 72.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.174 -0.329 . . . . 0.0 111.035 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -31.65 70.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.059 -1.026 . . . . 0.0 110.966 174.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.45 -15.64 63.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.211 1.004 . . . . 0.0 110.94 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.59 1.16 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.262 1.025 . . . . 0.0 111.859 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.38 30.92 17.85 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.0 mt -120.75 153.59 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -137.51 80.56 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.5 1.12 . . . . 0.0 111.043 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.32 1.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.0 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 96.8 p -61.26 -19.84 62.17 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.208 1.822 . . . . 0.0 112.212 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -81.33 0.3 37.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 112.956 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.29 50.31 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.431 1.014 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -47.58 137.1 9.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.191 1.396 . . . . 0.0 111.547 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -60.07 157.74 12.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -156.35 157.7 36.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.246 1.418 . . . . 0.0 109.743 170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.5 166.49 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.742 1.217 . . . . 0.0 109.927 171.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.56 146.2 7.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.477 1.111 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.77 136.42 32.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.478 1.111 . . . . 0.0 109.908 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.75 -28.45 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.44 1.496 . . . . 0.0 113.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.38 -11.19 60.61 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.993 1.317 . . . . 0.0 112.231 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.2 mt -114.73 -42.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.4 mt -48.93 -58.79 4.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.814 1.188 . . . . 0.0 111.557 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -1.85 34.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -115.47 -31.92 5.75 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.083 1.353 . . . . 0.0 111.699 -169.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.2 130.62 47.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.286 1.434 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.61 -31.58 71.66 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.695 1.198 . . . . 0.0 109.857 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.87 141.61 24.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.135 1.374 . . . . 0.0 108.557 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.62 144.69 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.55 136.59 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 109.08 14.56 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.68 7.43 39.46 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.885 -0.51 . . . . 0.0 112.318 -168.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.93 120.4 11.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.566 1.147 . . . . 0.0 110.968 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.248 0 C-N-CA 125.327 1.441 . . . . 0.0 110.668 170.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 CA--C 1.536 0.589 0 N-CA-C 113.629 0.588 . . . . 0.0 113.629 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.8 ttp -70.45 140.17 51.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.242 1.017 . . . . 0.0 110.261 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.8 p -134.29 159.33 72.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.532 1.933 . . . . 0.0 110.04 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.66 143.6 46.92 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.115 1.877 . . . . 0.0 109.938 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.54 -20.23 20.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.935 2.423 . . . . 0.0 111.668 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -73.49 -7.71 52.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.117 1.367 . . . . 0.0 112.727 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.1 141.55 34.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.12 136.81 58.19 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -133.67 155.06 50.4 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.111 0.565 . . . . 0.0 110.236 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.92 158.76 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.149 173.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -131.49 115.51 16.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -122.48 59.84 1.02 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.5 133.18 23.36 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 121.408 -0.807 . . . . 0.0 112.119 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -162.21 161.56 27.93 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.628 1.971 . . . . 0.0 106.439 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -65.23 140.31 58.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.462 0.705 . . . . 0.0 110.692 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.27 128.44 91.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.29 -21.95 34.94 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 120.354 1.162 . . . . 0.0 113.338 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.89 -11.96 60.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.628 1.104 . . . . 0.0 111.855 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -107.79 -1.2 21.12 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.665 1.586 . . . . 0.0 110.677 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.84 52.8 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.781 2.432 . . . . 0.0 111.859 173.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -54.26 137.83 40.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.726 2.01 . . . . 0.0 111.796 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.37 -60.59 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -162.94 164.31 25.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.477 1.511 . . . . 0.0 107.585 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.14 -30.46 71.05 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.841 -0.537 . . . . 0.0 111.492 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.31 -37.04 77.58 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.858 0.463 . . . . 0.0 110.378 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.7 -43.34 69.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -55.64 -49.69 72.19 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.89 -0.506 . . . . 0.0 110.213 171.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -60.38 -36.13 77.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.769 0.713 . . . . 0.0 111.923 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.72 77.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.359 -0.838 . . . . 0.0 109.482 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -63.52 -31.47 72.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.094 -0.955 . . . . 0.0 112.532 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.35 -48.43 80.58 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 120.044 1.293 . . . . 0.0 109.862 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.27 -36.58 83.35 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.8 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -65.12 -50.43 66.07 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.778 0.717 . . . . 0.0 110.293 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.15 -38.27 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.92 -52.93 58.99 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 109.331 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.22 -44.52 91.65 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.112 0.258 . . . . 0.0 111.167 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.27 -39.73 89.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.61 -0.681 . . . . 0.0 111.283 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.6 mt -58.16 -52.77 54.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 172.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.86 61.51 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.35 -50.76 71.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 117.703 0.751 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.931 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.542 1.065 . . . . 0.0 109.737 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -57.01 -53.71 55.0 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.33 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.639 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -62.04 -36.8 82.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.575 -0.703 . . . . 0.0 111.157 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.84 28.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.122 0.569 . . . . 0.0 111.714 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.17 -41.52 10.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.611 1.164 . . . . 0.0 111.996 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.0 p -114.62 -19.1 11.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.154 0.981 . . . . 0.0 110.969 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.59 76.33 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.783 -1.01 . . . . 0.0 112.688 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.5 mttt . . . . . 0 C--O 1.246 0.876 0 CA-C-N 118.781 1.291 . . . . 0.0 108.504 179.317 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -127.8 1.1 6.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.92 0.888 . . . . 0.0 111.1 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.5 135.23 49.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.88 174.07 3.97 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.42 142.59 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.25 149.7 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 119.308 0.958 . . . . 0.0 109.189 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 138.3 42.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.842 0.857 . . . . 0.0 109.185 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.23 131.06 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.6 mt -127.94 140.08 52.21 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.785 0.834 . . . . 0.0 110.547 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -139.26 175.26 9.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.176 0.99 . . . . 0.0 111.887 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -55.36 -32.1 62.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.789 1.236 . . . . 0.0 111.142 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 143.27 9.9 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.12 57.83 2.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.094 0.958 . . . . 0.0 111.424 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 m -127.92 -20.22 3.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.0 m -134.33 -93.81 0.3 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.229 0.922 . . . . 0.0 109.052 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -55.36 -50.9 68.49 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.969 0.907 . . . . 0.0 111.518 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 p -67.58 -37.85 83.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.748 0.703 . . . . 0.0 111.501 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -60.5 -52.8 63.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.147 0.979 . . . . 0.0 110.347 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.1 mtm -59.9 -42.07 93.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.54 0.736 . . . . 0.0 111.358 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.91 -43.66 98.2 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.457 0.571 . . . . 0.0 111.329 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -55.96 -43.28 77.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.959 0.345 . . . . 0.0 110.332 171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' HA2' ' HE2' ' A' ' 25' ' ' LYS . . . -54.5 -52.26 46.21 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.34 -0.7 . . . . 0.0 112.754 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.525 0.662 . . . . 0.0 111.275 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.69 98.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.806 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.415 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 46.1 mtmt -51.09 -41.2 59.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.238 0.926 . . . . 0.0 111.325 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -67.32 -61.97 1.65 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.329 0.393 . . . . 0.0 110.566 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -69.48 -39.15 77.85 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.3 mt -77.84 -5.37 50.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.507 0.723 . . . . 0.0 112.542 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.57 55.96 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.559 1.076 . . . . 0.0 114.006 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 58.69 8.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.427 2.291 . . . . 0.0 114.292 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.82 -3.88 7.89 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.89 -1.131 . . . . 0.0 111.093 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.401 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 8.6 m95 -132.4 121.59 23.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.9 mmpt? -67.62 97.3 0.6 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 t -80.39 139.86 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -174.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -146.93 165.23 30.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.408 1.483 . . . . 0.0 109.501 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.0 p -144.5 157.48 44.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.734 0.814 . . . . 0.0 109.624 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.89 -166.31 1.57 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.87 1.268 . . . . 0.0 109.552 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -179.46 46.18 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mt -56.14 -27.66 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.997 1.319 . . . . 0.0 111.448 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.63 171.94 13.98 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.74 1.216 . . . . 0.0 108.968 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.65 135.36 17.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -137.03 17.46 3.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.24 1.016 . . . . 0.0 109.896 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.97 167.61 25.1 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -91.31 149.79 21.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.224 0.61 . . . . 0.0 110.721 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -74.47 134.14 76.65 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.872 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.87 -34.84 57.34 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.778 2.318 . . . . 0.0 114.115 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -72.98 -32.74 65.38 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.447 -0.783 . . . . 0.0 110.297 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -44.72 91.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.37 -51.22 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -58.07 -44.49 87.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.921 0.782 . . . . 0.0 111.511 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.0 86.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.39 -37.58 77.58 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.984 0.356 . . . . 0.0 111.333 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -27.58 69.31 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.927 -1.108 . . . . 0.0 111.309 174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.35 -16.27 63.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.018 0.826 . . . . 0.0 110.769 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.27 0.55 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.908 0.883 . . . . 0.0 112.052 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.45 18.75 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.35 160.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -125.05 141.88 51.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.67 0.788 . . . . 0.0 109.596 172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.76 -0.54 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.406 1.482 . . . . 0.0 109.826 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -58.62 -33.01 69.54 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.344 -1.473 . . . . 0.0 111.116 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -63.28 -17.75 62.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.254 1.821 . . . . 0.0 114.763 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -120.86 52.53 1.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.664 1.12 . . . . 0.0 110.569 -168.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -48.18 136.07 12.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 110.984 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -57.11 155.57 8.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -168.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -153.72 156.31 37.58 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.359 1.464 . . . . 0.0 109.395 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.55 168.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.544 1.138 . . . . 0.0 109.447 170.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -56.51 142.99 11.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.673 0.789 . . . . 0.0 108.935 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.61 140.88 43.15 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.513 1.125 . . . . 0.0 109.876 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.67 -30.56 61.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.066 1.346 . . . . 0.0 113.166 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -70.01 -11.12 60.65 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.278 1.031 . . . . 0.0 112.069 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.0 mt -121.06 -43.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 pp -56.93 -40.66 76.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.078 1.308 . . . . 0.0 112.341 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.2 4.84 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.901 0.881 . . . . 0.0 112.542 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -125.59 -26.42 3.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.813 1.245 . . . . 0.0 112.851 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.39 132.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.617 1.167 . . . . 0.0 109.384 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.03 -25.48 66.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.705 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.6 tp -147.77 141.97 26.14 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.672 1.189 . . . . 0.0 108.655 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.63 147.04 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.1 t -132.64 127.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -100.89 134.39 43.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.25 18.22 21.33 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.212 0.605 . . . . 0.0 109.971 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.6 p -67.98 116.04 8.18 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.25 29.4 0.25 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 170.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.71 -177.1 3.14 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 128.995 2.918 . . . . 0.0 112.907 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.84 -20.01 65.47 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.14 -39.72 6.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.497 1.044 . . . . 0.0 111.032 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 50.16 37.21 14.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.864 1.666 . . . . 0.0 114.081 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -63.87 -24.36 67.71 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.776 -1.202 . . . . 0.0 113.135 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.9 m 44.87 87.71 0.11 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.054 2.142 . . . . 0.0 113.314 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.37 135.92 11.73 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.269 3.312 . . . . 0.0 113.357 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -68.61 145.69 53.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.373 1.069 . . . . 0.0 109.57 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -130.2 158.23 74.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.095 1.758 . . . . 0.0 109.868 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 138.18 35.05 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 121.907 1.738 . . . . 0.0 109.291 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.63 -21.19 25.86 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.802 2.335 . . . . 0.0 112.306 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -67.89 -23.13 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.132 0.973 . . . . 0.0 112.083 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.98 142.21 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -170.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.05 139.24 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.984 0.914 . . . . 0.0 108.589 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -133.64 151.64 51.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.598 0.759 . . . . 0.0 110.123 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.92 159.23 34.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.781 2.033 . . . . 0.0 107.723 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -135.05 111.15 9.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -121.42 62.03 0.91 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.968 1.707 . . . . 0.0 106.847 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.37 133.4 23.81 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 121.198 -0.939 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 161.16 35.19 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.561 1.944 . . . . 0.0 106.126 169.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.23 143.2 55.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.237 0.542 . . . . 0.0 110.903 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.24 127.15 93.06 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.81 -23.73 62.23 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.176 1.251 . . . . 0.0 113.378 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.67 -14.66 63.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.334 0.97 . . . . 0.0 112.337 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -110.02 3.84 20.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.121 1.368 . . . . 0.0 111.294 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.22 61.66 0.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.406 1.882 . . . . 0.0 111.225 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -59.13 138.68 57.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.805 1.642 . . . . 0.0 110.701 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.09 -59.36 0.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.1 t -165.06 167.58 18.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.81 1.644 . . . . 0.0 107.402 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.28 -30.77 70.68 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.115 0.566 . . . . 0.0 111.283 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.63 -38.54 80.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.831 0.452 . . . . 0.0 110.379 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.27 -42.3 72.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -56.35 -52.21 65.43 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.114 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.8 t-105 -56.99 -40.34 76.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.89 0.768 . . . . 0.0 111.287 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.22 -40.98 97.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.511 0.596 . . . . 0.0 110.16 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -67.31 -29.86 69.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.634 -1.174 . . . . 0.0 113.139 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -60.55 -50.79 72.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.853 1.66 . . . . 0.0 109.813 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -65.9 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.94 0.791 . . . . 0.0 112.035 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -65.58 -51.81 56.93 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.359 0.982 . . . . 0.0 110.893 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.08 -37.9 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -54.65 -53.57 53.0 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.571 0.749 . . . . 0.0 109.581 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.06 -43.47 98.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.763 0.256 . . . . 0.0 110.963 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -40.45 91.21 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.737 -0.602 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -59.32 -50.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.02 63.79 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -59.64 -50.0 75.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.558 0.679 . . . . 0.0 110.895 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -70.32 -30.13 67.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 117.321 -1.323 . . . . 0.0 111.554 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -39.95 84.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.654 1.115 . . . . 0.0 110.104 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -56.4 -50.92 70.2 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.02 -36.17 83.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.201 0.455 . . . . 0.0 111.662 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.7 -36.63 83.57 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.357 -0.84 . . . . 0.0 111.539 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.37 -36.93 33.29 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.481 0.312 . . . . 0.0 111.173 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.4 -42.78 10.71 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.047 1.339 . . . . 0.0 111.797 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 p -115.05 -20.29 10.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.464 1.106 . . . . 0.0 111.475 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.35 82.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.939 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 119.12 1.46 . . . . 0.0 109.059 178.244 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.08 177.14 9.99 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.157 1.383 . . . . 0.0 108.826 -169.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -139.36 136.68 35.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -77.45 178.25 7.35 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.9 140.41 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -143.27 152.1 16.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.778 0.831 . . . . 0.0 109.325 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.62 136.45 29.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.095 0.958 . . . . 0.0 109.088 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.64 125.37 44.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.654 1.182 . . . . 0.0 108.261 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.3 142.41 49.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.755 1.222 . . . . 0.0 109.477 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -139.95 171.44 14.2 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.158 0.983 . . . . 0.0 111.833 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -60.04 -23.0 63.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.941 0.897 . . . . 0.0 111.795 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.96 134.88 4.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 169.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.82 55.01 1.96 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.289 1.036 . . . . 0.0 111.528 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -126.55 -16.86 5.22 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.4 m -137.88 -87.12 0.27 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.073 0.851 . . . . 0.0 109.478 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -57.99 -54.36 47.86 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.754 0.822 . . . . 0.0 111.192 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.8 p -67.01 -34.57 78.04 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.975 0.352 . . . . 0.0 111.238 -174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -62.16 -55.5 28.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.958 0.903 . . . . 0.0 109.998 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.5 mtm -58.06 -42.71 86.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.274 0.63 . . . . 0.0 111.484 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.92 97.96 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.621 0.646 . . . . 0.0 111.353 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -56.88 -41.68 78.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.933 0.333 . . . . 0.0 110.611 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.35 68.63 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.484 0.584 . . . . 0.0 112.41 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -63.53 -42.97 98.4 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.596 0.698 . . . . 0.0 111.089 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.35 99.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.564 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -52.0 -38.6 57.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.954 0.797 . . . . 0.0 111.643 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -70.51 -62.59 1.33 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.204 0.315 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -68.81 -36.87 78.75 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.427 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.2 mt -78.44 -2.11 36.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.353 0.661 . . . . 0.0 112.197 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.5 24.05 58.96 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.979 1.276 . . . . 0.0 113.961 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.14 14.32 1.97 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.031 2.132 . . . . 0.0 113.633 -172.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.15 -0.86 15.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.928 1.291 . . . . 0.0 110.91 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.427 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.7 m95 -133.46 122.52 23.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.54 97.42 0.59 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 t -82.1 140.88 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -144.76 166.13 26.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.166 1.387 . . . . 0.0 109.533 174.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 87.8 p -145.68 158.44 43.85 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.689 0.796 . . . . 0.0 109.888 169.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.34 -168.17 1.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.708 1.203 . . . . 0.0 110.205 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.0 179.96 46.82 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.534 -0.729 . . . . 0.0 111.325 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -56.38 -27.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.049 1.34 . . . . 0.0 111.304 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.11 168.94 21.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.915 1.286 . . . . 0.0 108.563 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.48 138.44 26.15 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.74 12.97 6.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.757 1.223 . . . . 0.0 109.826 172.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 163.77 34.43 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -170.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.53 146.21 38.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.217 0.532 . . . . 0.0 110.375 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -70.52 134.33 86.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.671 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.15 -35.62 43.11 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.657 2.238 . . . . 0.0 114.095 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.42 -27.26 63.18 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.451 -0.78 . . . . 0.0 111.011 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.9 85.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.36 -49.91 81.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -57.81 -40.24 79.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.395 0.998 . . . . 0.0 111.642 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.84 84.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.598 0.636 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.2 mmm -68.1 -35.3 77.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.423 0.556 . . . . 0.0 111.123 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -68.07 -23.72 64.98 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.669 -1.269 . . . . 0.0 111.308 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -67.13 -21.16 65.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.091 0.859 . . . . 0.0 110.398 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.59 -1.47 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.24 0.616 . . . . 0.0 112.133 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.0 33.28 15.46 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.64 159.28 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.94 144.39 49.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -128.82 3.53 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.984 1.314 . . . . 0.0 110.261 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.98 -28.66 67.87 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 111.061 171.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.49 -4.65 4.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.421 1.888 . . . . 0.0 115.192 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -138.16 49.23 1.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.425 1.466 . . . . 0.0 110.879 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 p -46.61 131.56 11.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 110.747 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -56.85 156.73 6.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.134 1.773 . . . . 0.0 115.179 -169.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -153.38 157.04 39.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.069 1.348 . . . . 0.0 109.132 171.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.77 164.89 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.867 0.867 . . . . 0.0 109.402 169.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.49 139.89 14.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 109.546 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.64 138.39 50.06 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.435 1.494 . . . . 0.0 109.671 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -57.56 -27.63 62.83 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.598 1.559 . . . . 0.0 113.29 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.05 -12.72 61.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.828 1.251 . . . . 0.0 112.075 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -112.73 -41.21 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.47 -58.56 4.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.836 1.198 . . . . 0.0 111.499 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.79 0.36 27.28 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -118.66 -31.75 4.76 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.984 1.314 . . . . 0.0 111.783 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 128.36 35.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 109.755 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.65 -25.41 64.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.174 0.59 . . . . 0.0 110.781 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.8 tp -145.53 141.08 27.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.44 1.096 . . . . 0.0 108.171 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.86 153.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.88 136.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -109.17 122.3 47.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.3 25.28 5.06 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.054 0.941 . . . . 0.0 109.52 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -75.42 68.34 2.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.019 2.127 . . . . 0.0 113.606 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.74 12.54 25.09 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.122 -0.987 . . . . 0.0 111.203 170.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.51 171.63 12.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.546 2.338 . . . . 0.0 111.992 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.02 -16.35 64.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.88 -37.46 9.81 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.644 1.111 . . . . 0.0 110.886 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.263 3.8 p-10 37.53 44.23 0.49 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.207 2.603 . . . . 0.0 114.684 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -66.23 -14.01 61.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.586 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.0 m 42.86 86.07 0.15 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.924 2.49 . . . . 0.0 113.245 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.52 139.29 9.96 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.418 3.412 . . . . 0.0 114.011 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 147.08 52.77 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.866 1.266 . . . . 0.0 111.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -133.39 159.38 72.8 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.967 2.107 . . . . 0.0 108.964 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.1 138.61 40.35 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.77 1.647 . . . . 0.0 109.429 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 -18.48 39.48 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.902 2.402 . . . . 0.0 112.129 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -64.45 -19.93 65.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.493 1.117 . . . . 0.0 112.019 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.5 t -110.99 136.66 46.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 118.937 0.79 . . . . 0.0 109.105 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -63.2 132.13 50.71 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.132 0.973 . . . . 0.0 108.746 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.99 159.55 28.11 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.598 0.759 . . . . 0.0 109.475 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -128.7 169.78 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.73 2.012 . . . . 0.0 107.188 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -136.11 122.49 20.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.61 58.6 1.3 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.86 1.664 . . . . 0.0 107.107 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.19 125.07 14.59 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.939 -1.101 . . . . 0.0 112.07 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.26 158.72 43.21 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.569 2.347 . . . . 0.0 105.806 168.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.27 149.5 48.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.198 0.523 . . . . 0.0 110.832 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.89 125.69 89.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.52 -25.11 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.378 1.385 . . . . 0.0 113.471 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.54 52.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.351 0.978 . . . . 0.0 112.115 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -114.57 3.74 14.94 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.951 1.3 . . . . 0.0 110.842 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.94 64.41 0.32 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.851 2.06 . . . . 0.0 110.308 169.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.51 139.67 56.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.495 1.518 . . . . 0.0 110.658 -171.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.67 -57.59 0.21 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.64 169.43 13.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.019 1.728 . . . . 0.0 107.378 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.97 -30.5 70.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.902 -0.499 . . . . 0.0 111.349 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.75 -36.93 73.37 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.762 0.425 . . . . 0.0 110.676 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.89 -46.34 75.23 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -57.04 -48.46 78.48 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.294 0.637 . . . . 0.0 110.17 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -61.24 -37.86 84.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.5 0.72 . . . . 0.0 111.972 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.47 82.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.43 -33.26 75.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.861 0.465 . . . . 0.0 110.931 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.85 -48.57 79.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.81 0.844 . . . . 0.0 110.459 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.27 -41.49 98.5 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.474 0.579 . . . . 0.0 110.752 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -62.89 -48.61 78.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.117 0.871 . . . . 0.0 111.172 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.84 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 118.613 0.642 . . . . 0.0 109.301 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -55.23 -53.81 51.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.029 0.831 . . . . 0.0 109.235 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.07 -40.89 91.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.319 0.387 . . . . 0.0 111.236 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.91 -45.89 87.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.38 0.672 . . . . 0.0 110.428 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.1 mt -58.13 -50.14 79.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.87 51.4 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.573 0.624 . . . . 0.0 111.842 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -59.48 -48.6 81.01 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 117.751 0.776 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.87 -25.83 53.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.656 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.67 -38.54 83.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 120.057 1.299 . . . . 0.0 109.673 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.61 -50.42 73.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.43 -42.32 98.57 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 110.503 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -58.78 -33.26 70.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 120.274 -1.516 . . . . 0.0 111.854 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.56 -35.4 24.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.702 0.401 . . . . 0.0 111.958 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.31 -45.47 8.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.774 1.23 . . . . 0.0 112.034 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.7 p -113.86 -20.14 11.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 110.835 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.21 11.01 81.6 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.585 1.088 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt . . . . . 0 C--O 1.246 0.907 0 CA-C-N 118.916 1.358 . . . . 0.0 110.379 -177.384 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -151.43 161.81 42.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.133 1.373 . . . . 0.0 107.566 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -137.94 140.62 40.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.71 172.9 9.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.15 142.37 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.58 151.5 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.083 0.953 . . . . 0.0 109.546 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.83 139.04 39.74 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.965 0.906 . . . . 0.0 109.321 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -122.54 128.59 50.95 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.406 1.082 . . . . 0.0 108.653 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.64 139.85 53.49 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.34 1.056 . . . . 0.0 110.015 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -139.93 175.03 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.184 1.793 . . . . 0.0 108.407 170.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -52.78 63.93 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 120.941 -1.099 . . . . 0.0 109.537 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.88 126.92 7.31 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.91 60.05 0.72 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.35 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -134.75 -20.67 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -126.49 -99.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -47.98 83.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 112.31 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.8 p -62.95 -38.41 90.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.425 0.557 . . . . 0.0 111.485 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -62.38 -55.21 30.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.193 0.997 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 49.7 mtm -55.91 -43.78 77.65 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.263 0.625 . . . . 0.0 111.316 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.3 99.34 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.362 0.665 . . . . 0.0 111.553 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.27 -41.19 79.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.918 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -49.48 78.19 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.707 0.685 . . . . 0.0 112.493 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -61.32 -46.25 91.05 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.579 0.69 . . . . 0.0 110.833 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.07 -40.78 97.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.315 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -51.31 -43.68 61.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.297 0.953 . . . . 0.0 111.006 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -71.15 -58.3 3.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 123.699 0.625 . . . . 0.0 111.206 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -64.37 -39.43 93.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.967 0.348 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.51 -2.86 54.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.178 0.991 . . . . 0.0 112.274 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.95 59.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.208 1.385 . . . . 0.0 114.629 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.56 5.8 0.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 0.0 113.97 -170.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.27 -7.55 19.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.837 -1.164 . . . . 0.0 110.343 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -128.08 121.02 28.63 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -68.92 97.86 0.89 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -83.01 140.69 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.35 167.06 23.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.337 1.455 . . . . 0.0 109.175 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.3 p -144.72 157.47 44.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.82 0.848 . . . . 0.0 109.692 170.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.9 -170.28 2.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 110.894 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.75 -177.55 42.18 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 122.052 -0.405 . . . . 0.0 113.069 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -56.48 -32.6 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.11 1.364 . . . . 0.0 109.637 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.07 169.07 19.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.867 1.667 . . . . 0.0 109.634 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.46 24.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.28 8.92 5.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.737 1.215 . . . . 0.0 110.087 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.96 165.58 25.92 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -170.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.27 150.08 25.03 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.047 0.539 . . . . 0.0 111.098 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -73.33 133.25 80.97 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.507 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.72 -36.29 61.29 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.732 2.288 . . . . 0.0 113.994 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -70.94 -32.97 70.03 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.723 -0.611 . . . . 0.0 110.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.5 90.88 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.67 -47.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -40.09 93.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.441 0.564 . . . . 0.0 111.184 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.27 99.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.626 0.771 . . . . 0.0 109.914 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.1 mmm -68.49 -38.0 80.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.23 0.468 . . . . 0.0 110.974 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -27.5 68.74 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 173.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.95 -16.77 64.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.869 0.758 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.63 1.47 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.157 0.983 . . . . 0.0 112.054 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.73 21.1 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -117.8 158.89 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.77 146.08 48.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.492 1.117 . . . . 0.0 108.506 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.27 3.31 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 110.431 170.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.06 -28.19 67.59 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 119.885 -1.76 . . . . 0.0 111.276 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.1 -5.45 4.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 115.091 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.48 50.83 1.95 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.993 1.269 . . . . 0.0 110.397 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 p -47.09 134.37 10.74 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.958 0.903 . . . . 0.0 110.724 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 m -56.79 156.23 6.81 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.033 1.733 . . . . 0.0 115.653 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -153.91 157.4 39.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.213 1.405 . . . . 0.0 109.465 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.5 169.04 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.193 . . . . 0.0 109.441 170.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.38 141.76 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.39 141.4 41.73 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.475 1.11 . . . . 0.0 109.844 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 m -55.4 -30.24 60.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.088 1.355 . . . . 0.0 113.299 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.21 -13.67 62.53 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.006 0.922 . . . . 0.0 111.984 -173.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -121.06 -42.46 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.383 1.073 . . . . 0.0 108.299 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.37 -39.05 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.329 1.422 . . . . 0.0 112.118 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.5 4.87 51.8 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.792 0.837 . . . . 0.0 112.705 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -125.32 -28.8 3.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.886 1.274 . . . . 0.0 112.435 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 128.71 38.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.043 1.337 . . . . 0.0 108.983 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.77 -23.25 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.85 139.89 26.66 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.746 1.218 . . . . 0.0 108.067 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.7 146.51 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 t -135.43 129.37 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.07 129.98 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.47 23.18 11.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.627 0.771 . . . . 0.0 109.379 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -76.56 104.26 6.98 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.379 -1.451 . . . . 0.0 112.317 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -123.76 -21.86 2.33 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 121.682 -0.636 . . . . 0.0 111.892 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.67 128.16 33.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.799 1.24 . . . . 0.0 107.826 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.41 -19.41 35.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.886 0.874 . . . . 0.0 113.282 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.21 22.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.154 0.888 . . . . 0.0 112.722 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.28 108.33 3.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -54.42 -14.22 1.17 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.8 m 60.51 95.58 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 127.023 2.129 . . . . 0.0 110.63 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.31 140.51 20.35 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.901 3.067 . . . . 0.0 113.115 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.4 mmt -73.84 152.82 40.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.565 0.746 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 p -133.2 165.29 37.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.528 1.931 . . . . 0.0 109.393 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.81 155.21 68.72 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 172.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.03 -9.29 14.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.229 2.619 . . . . 0.0 114.56 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -129.77 0.04 4.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.515 1.052 . . . . 0.0 113.492 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.6 t -85.93 145.5 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.17 133.11 55.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -130.24 149.54 51.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.879 0.872 . . . . 0.0 109.003 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -132.89 169.75 16.32 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.085 1.354 . . . . 0.0 108.6 170.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -134.78 115.76 14.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 23.3 m0 -121.63 61.43 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.486 1.515 . . . . 0.0 107.243 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.82 128.84 9.86 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.172 -0.955 . . . . 0.0 112.367 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.85 159.5 44.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.177 2.191 . . . . 0.0 106.401 168.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.0 153.8 43.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.573 0.749 . . . . 0.0 110.612 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.05 125.01 73.73 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 110.124 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.51 -26.34 62.35 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.691 1.594 . . . . 0.0 113.864 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.27 -13.12 62.02 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.022 0.828 . . . . 0.0 112.264 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mtm105 -114.39 13.9 17.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.264 0.938 . . . . 0.0 111.476 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.83 67.29 0.81 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 0.0 109.975 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -58.6 138.71 56.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.793 0.837 . . . . 0.0 110.383 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.24 -60.02 0.23 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 172.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -167.32 167.48 13.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.671 1.589 . . . . 0.0 107.522 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.12 -29.21 68.46 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.093 0.557 . . . . 0.0 111.291 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.97 -39.66 75.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.964 0.506 . . . . 0.0 110.681 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.58 -44.63 86.1 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.83 -50.33 74.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.711 -0.662 . . . . 0.0 110.503 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -57.39 -40.28 77.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.242 0.928 . . . . 0.0 111.153 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.08 74.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.627 -0.671 . . . . 0.0 110.892 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.93 -34.92 64.51 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.703 -1.248 . . . . 0.0 111.26 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -58.26 -52.54 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.962 0.801 . . . . 0.0 109.881 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.81 -30.97 71.68 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.513 0.597 . . . . 0.0 112.115 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.11 -49.68 69.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.631 1.105 . . . . 0.0 111.117 173.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.4 -39.61 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.708 0.686 . . . . 0.0 109.187 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -53.04 -52.85 57.15 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.26 1.024 . . . . 0.0 109.727 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.41 -41.06 89.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.145 0.278 . . . . 0.0 111.331 -172.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -64.15 -43.29 95.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.995 0.518 . . . . 0.0 110.421 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.36 -49.35 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.66 -47.35 64.52 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -59.74 -49.71 76.66 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 117.31 0.555 . . . . 0.0 110.391 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.14 69.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.312 -175.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -42.04 79.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.029 0.831 . . . . 0.0 110.069 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.07 -49.65 75.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.46 -36.35 82.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.743 -0.17 . . . . 0.0 111.237 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -61.51 -37.67 84.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.238 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.89 -37.0 41.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.451 0.3 . . . . 0.0 111.183 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.42 -48.32 6.71 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.727 1.211 . . . . 0.0 111.011 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.7 p -105.73 -20.49 13.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.749 1.22 . . . . 0.0 111.41 -169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.33 18.35 78.21 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.538 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.2 mttt . . . . . 0 C--O 1.248 1.021 0 CA-C-N 118.507 1.154 . . . . 0.0 109.51 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -126.69 1.01 6.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.847 0.859 . . . . 0.0 111.026 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.69 134.61 48.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 169.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 175.53 2.9 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.11 142.04 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 tt -143.36 151.05 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -137.8 135.8 36.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.901 0.881 . . . . 0.0 108.795 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -117.88 137.74 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 mt -133.65 145.63 50.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.222 0.609 . . . . 0.0 111.509 -169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.02 173.51 12.39 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.504 1.122 . . . . 0.0 112.359 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.8 m -57.79 -29.65 65.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.165 1.786 . . . . 0.0 111.433 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 141.36 8.29 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -83.78 55.8 3.4 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.508 0.654 . . . . 0.0 112.087 -169.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 m -132.6 -12.05 3.06 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.7 m -131.68 -105.81 0.26 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -50.89 -47.17 60.71 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.587 1.155 . . . . 0.0 111.688 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -61.9 -42.12 98.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -69.37 -45.03 70.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.504 0.722 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.5 -43.23 99.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.978 0.511 . . . . 0.0 110.221 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.4 98.49 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.377 0.671 . . . . 0.0 111.255 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -57.37 -40.94 79.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.068 0.395 . . . . 0.0 110.075 174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.86 -53.51 45.73 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.062 0.839 . . . . 0.0 111.532 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.52 -45.88 92.31 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.141 0.47 . . . . 0.0 110.686 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.39 93.83 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.316 0.646 . . . . 0.0 110.321 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -57.72 -33.58 68.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.869 0.759 . . . . 0.0 111.353 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.31 -62.28 1.45 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.16 0.437 . . . . 0.0 110.664 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -65.7 -43.06 90.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.337 0.255 . . . . 0.0 111.397 -169.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.78 -6.55 52.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.599 1.16 . . . . 0.0 112.112 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.56 51.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.972 1.272 . . . . 0.0 114.136 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t70 56.35 11.44 0.82 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.488 2.315 . . . . 0.0 114.081 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -64.89 -7.5 11.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.979 1.312 . . . . 0.0 110.484 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -126.65 118.78 25.48 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.67 98.78 0.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.8 t -80.08 138.77 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -174.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -140.11 166.06 25.69 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.772 1.629 . . . . 0.0 109.22 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -151.6 145.0 24.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.024 0.929 . . . . 0.0 108.711 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.39 -170.38 2.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.698 1.199 . . . . 0.0 112.02 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.06 -176.59 45.31 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.155 -0.966 . . . . 0.0 112.117 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.29 -30.38 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.862 1.265 . . . . 0.0 111.23 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.92 167.6 24.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.688 1.195 . . . . 0.0 109.193 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.82 141.9 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -132.16 1.59 3.87 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.574 1.15 . . . . 0.0 110.263 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.12 -166.25 22.81 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.04 149.85 40.97 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 110.322 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -72.0 134.2 83.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.759 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.38 -36.14 56.95 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.691 2.26 . . . . 0.0 113.895 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.46 -32.49 66.29 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.538 -0.726 . . . . 0.0 110.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.24 84.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.04 -52.04 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -58.91 -40.07 83.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.604 0.638 . . . . 0.0 111.633 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.89 94.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.512 0.596 . . . . 0.0 109.596 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.2 mmm -68.65 -36.83 79.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.28 0.491 . . . . 0.0 111.184 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.35 -25.21 67.93 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.886 -1.134 . . . . 0.0 111.524 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.32 -17.14 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.9 0.773 . . . . 0.0 110.885 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.52 -0.34 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.705 0.802 . . . . 0.0 112.108 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 31.68 13.9 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.21 159.74 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.77 145.54 51.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.96 -6.51 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.833 1.253 . . . . 0.0 110.625 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -57.59 -38.5 74.99 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.866 0.867 . . . . 0.0 110.894 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -18.59 37.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.845 1.258 . . . . 0.0 113.984 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.03 -40.73 18.01 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 119.639 1.109 . . . . 0.0 110.395 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 p 56.07 176.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.162 1.785 . . . . 0.0 111.069 -168.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -128.27 153.68 46.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.79 158.52 35.39 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.045 0.938 . . . . 0.0 109.467 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.37 163.48 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.647 0.779 . . . . 0.0 108.992 169.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.61 149.0 5.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.771 1.228 . . . . 0.0 110.209 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.54 136.6 33.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.354 1.062 . . . . 0.0 110.113 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.86 -28.64 51.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.392 1.477 . . . . 0.0 113.161 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.25 -11.15 60.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.034 1.333 . . . . 0.0 112.188 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -114.12 -42.76 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.23 -58.42 5.07 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.206 . . . . 0.0 111.504 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -0.93 30.52 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.45 -31.54 5.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.945 1.298 . . . . 0.0 111.928 -168.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.959 1.304 . . . . 0.0 109.705 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.3 -26.24 67.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.75 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 tp -147.28 142.65 27.4 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.534 1.134 . . . . 0.0 108.669 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.41 151.38 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -140.03 128.26 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.46 136.16 37.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.9 7.74 26.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.563 0.745 . . . . 0.0 111.054 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.95 126.7 28.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.898 1.279 . . . . 0.0 110.638 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.38 -3.12 0.21 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.226 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.81 150.95 34.2 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.278 1.539 . . . . 0.0 109.35 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.39 -17.02 41.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.938 1.295 . . . . 0.0 114.362 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.94 11.82 13.55 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 111.897 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.52 107.51 1.72 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -52.98 -37.03 60.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.047 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.56 122.62 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 128.455 2.702 . . . . 0.0 115.24 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.95 173.6 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.897 2.398 . . . . 0.0 112.431 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 48.3 tpp -124.73 156.35 37.79 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.71 1.604 . . . . 0.0 108.843 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p -128.43 161.17 58.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.622 1.569 . . . . 0.0 110.459 -169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.21 139.25 54.55 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.965 1.777 . . . . 0.0 109.576 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 -22.45 26.34 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.803 2.335 . . . . 0.0 112.25 -173.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -81.07 3.13 24.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.717 0.807 . . . . 0.0 112.48 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.37 134.55 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -64.39 132.05 48.96 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -123.34 159.07 29.63 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.663 0.785 . . . . 0.0 109.125 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.58 166.2 17.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.144 1.778 . . . . 0.0 107.337 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -133.56 113.17 12.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -119.9 58.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.847 1.659 . . . . 0.0 106.702 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.15 134.24 21.23 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.335 -0.853 . . . . 0.0 112.364 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.2 161.26 33.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.935 2.094 . . . . 0.0 106.118 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.71 146.95 24.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.663 1.185 . . . . 0.0 111.68 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.87 117.89 70.0 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 124.819 1.248 . . . . 0.0 108.937 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.38 -22.96 71.78 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.535 1.49 . . . . 0.0 113.628 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.41 61.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.427 1.012 . . . . 0.0 113.036 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -120.95 13.28 11.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.563 1.074 . . . . 0.0 112.094 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.22 55.65 0.21 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.306 1.842 . . . . 0.0 110.378 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.93 148.61 43.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.81 2.044 . . . . 0.0 112.201 -169.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.56 -54.05 0.34 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -166.42 166.93 16.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.106 1.763 . . . . 0.0 107.322 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.55 -29.66 69.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.177 0.591 . . . . 0.0 111.158 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.22 -37.07 74.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.896 0.479 . . . . 0.0 110.717 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.66 -47.33 69.83 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -54.54 -50.96 66.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.935 0.494 . . . . 0.0 110.086 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -58.84 -39.09 80.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.872 0.869 . . . . 0.0 112.027 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.07 86.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.496 -0.752 . . . . 0.0 110.114 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.58 -36.37 82.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.797 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.25 -47.37 83.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.411 1.005 . . . . 0.0 110.157 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -64.64 -39.18 93.24 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.645 0.657 . . . . 0.0 111.518 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -64.49 -49.09 72.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.242 0.928 . . . . 0.0 110.684 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.18 -39.2 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -54.05 -53.78 48.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.003 0.921 . . . . 0.0 109.442 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.2 -44.04 96.46 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.27 0.356 . . . . 0.0 111.29 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.12 -40.88 95.1 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.852 -0.53 . . . . 0.0 111.108 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.48 -49.68 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.18 -46.06 71.82 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -60.77 -46.95 88.48 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.465 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -72.7 -31.19 64.82 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.9 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -40.9 87.3 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.263 0.625 . . . . 0.0 110.017 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.42 -49.16 75.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.8 -43.82 98.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.095 0.474 . . . . 0.0 110.408 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.93 -33.82 69.21 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.804 -1.185 . . . . 0.0 112.334 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.43 22.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.019 0.528 . . . . 0.0 112.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -94.14 -52.39 4.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.001 1.321 . . . . 0.0 110.625 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.8 p -102.06 -14.69 17.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.344 1.457 . . . . 0.0 110.37 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.05 13.59 83.19 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.845 1.212 . . . . 0.0 112.052 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.245 0.862 0 CA-C-N 118.038 0.919 . . . . 0.0 109.572 -175.297 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.15 168.7 20.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.013 1.325 . . . . 0.0 108.373 171.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -147.48 141.09 25.53 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.06 176.17 7.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.619 0.645 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -142.51 143.13 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.24 149.71 17.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.611 0.765 . . . . 0.0 109.151 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.49 132.78 33.78 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.959 0.904 . . . . 0.0 108.733 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -115.9 129.99 56.64 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -129.08 139.38 52.02 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.59 0.756 . . . . 0.0 109.562 -169.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.7 p -150.16 -174.25 4.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.995 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -67.6 -9.46 43.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.252 1.021 . . . . 0.0 113.158 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.8 126.63 1.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.13 52.07 0.33 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.282 1.433 . . . . 0.0 113.293 -169.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 -18.63 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 m -136.3 -90.57 0.28 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.741 0.701 . . . . 0.0 109.379 -170.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -55.21 -53.2 58.98 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.748 0.819 . . . . 0.0 111.437 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.4 p -68.01 -35.73 78.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -173.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.63 -51.59 64.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.944 0.898 . . . . 0.0 110.836 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.5 mtm -60.66 -43.06 98.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.249 0.62 . . . . 0.0 110.69 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.5 97.22 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.455 0.57 . . . . 0.0 111.032 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -57.98 -41.32 82.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.695 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.34 -51.85 56.18 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.889 0.768 . . . . 0.0 111.973 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -62.9 -45.69 91.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 117.577 0.689 . . . . 0.0 110.711 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.53 99.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.235 0.614 . . . . 0.0 110.595 -175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -52.69 -36.29 56.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.866 0.757 . . . . 0.0 111.598 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -72.28 -62.79 1.31 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.368 0.531 . . . . 0.0 110.733 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -65.41 -41.26 93.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.521 0.328 . . . . 0.0 111.822 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.53 -5.85 53.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.819 0.848 . . . . 0.0 112.444 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.74 50.67 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.942 1.258 . . . . 0.0 114.601 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 59.21 6.24 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.211 2.205 . . . . 0.0 114.197 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.33 -7.42 18.76 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.929 -1.107 . . . . 0.0 110.358 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -130.93 121.75 25.72 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.46 97.62 1.02 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.08 134.73 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.53 168.3 20.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.24 1.416 . . . . 0.0 109.616 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.5 p -145.5 160.43 41.62 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.581 0.752 . . . . 0.0 110.12 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.51 -166.85 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.632 1.173 . . . . 0.0 109.842 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.27 -179.39 43.91 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 121.399 -0.813 . . . . 0.0 111.514 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.65 -27.65 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.349 1.46 . . . . 0.0 111.298 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -146.26 169.79 18.07 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.813 1.245 . . . . 0.0 108.405 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 136.33 18.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -136.79 26.26 3.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.716 1.206 . . . . 0.0 109.428 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.09 168.43 42.8 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -86.41 147.68 25.91 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.303 0.573 . . . . 0.0 110.779 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -73.97 133.74 78.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.081 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.51 -34.47 42.38 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.775 2.317 . . . . 0.0 114.438 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.23 -28.21 62.03 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.189 -0.944 . . . . 0.0 110.921 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.44 81.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.09 -49.59 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -59.92 -41.89 92.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.75 0.705 . . . . 0.0 111.592 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.78 92.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.448 0.567 . . . . 0.0 109.752 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.8 mmm -68.11 -36.22 79.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.401 0.546 . . . . 0.0 111.313 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 120.985 -1.072 . . . . 0.0 111.52 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.73 -17.54 64.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.036 0.835 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.72 -0.41 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.89 0.876 . . . . 0.0 112.167 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 32.59 13.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.3 160.83 20.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.22 145.97 52.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.2 pt -128.05 -9.93 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.811 1.644 . . . . 0.0 109.923 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.4 p -60.97 -25.84 67.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.844 1.202 . . . . 0.0 111.549 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.44 -27.39 69.08 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.431 1.493 . . . . 0.0 113.638 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -96.17 -29.24 14.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.47 1.032 . . . . 0.0 112.437 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.0 p 52.04 -173.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.882 1.673 . . . . 0.0 112.946 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -123.81 156.41 36.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.241 1.017 . . . . 0.0 111.234 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.56 157.24 35.0 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.125 0.97 . . . . 0.0 109.638 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.52 163.71 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.033 169.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.0 mt -56.56 146.71 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.905 1.282 . . . . 0.0 110.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.14 136.18 33.26 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.376 1.07 . . . . 0.0 110.067 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.71 -28.75 50.23 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.479 1.512 . . . . 0.0 113.188 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.61 -11.58 60.95 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.88 1.272 . . . . 0.0 112.177 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mt -114.47 -42.36 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 mt -48.52 -58.69 4.3 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.7 1.136 . . . . 0.0 111.775 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -1.12 34.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -116.14 -32.37 5.37 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.142 1.377 . . . . 0.0 111.614 -168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.53 126.77 28.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.291 1.436 . . . . 0.0 109.586 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.26 -24.55 66.6 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.22 0.608 . . . . 0.0 111.037 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.12 139.65 27.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.41 1.084 . . . . 0.0 108.554 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.88 145.26 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.32 129.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -97.55 132.7 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.34 19.13 20.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.593 1.157 . . . . 0.0 109.51 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.89 114.46 6.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 110.008 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.37 24.31 0.27 Allowed Glycine 0 CA--C 1.535 1.286 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.83 -177.57 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 128.501 2.721 . . . . 0.0 111.784 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.78 -25.62 68.32 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.95 -46.74 9.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.025 0.829 . . . . 0.0 110.379 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.5 t70 48.79 33.13 4.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.189 1.795 . . . . 0.0 114.082 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.3 -14.23 62.83 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.689 -1.257 . . . . 0.0 113.365 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.3 m 43.37 90.27 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.603 2.361 . . . . 0.0 113.945 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.41 136.48 19.92 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.884 3.056 . . . . 0.0 113.495 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -71.25 145.83 49.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.518 1.127 . . . . 0.0 110.007 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 p -131.22 158.84 74.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.328 1.851 . . . . 0.0 110.133 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.1 136.68 38.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.228 1.952 . . . . 0.0 109.327 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.25 -23.95 20.4 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.528 2.152 . . . . 0.0 112.641 -171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -79.11 -9.59 59.6 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.214 0.606 . . . . 0.0 112.532 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.96 138.48 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -62.04 132.25 52.28 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -130.46 156.91 43.99 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.485 1.114 . . . . 0.0 109.572 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -134.44 167.86 19.98 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.241 1.817 . . . . 0.0 108.341 169.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -135.86 118.15 15.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -125.34 57.66 1.31 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.377 1.871 . . . . 0.0 106.967 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.52 134.92 28.64 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.784 -1.198 . . . . 0.0 112.311 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 160.75 35.08 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.523 1.929 . . . . 0.0 106.089 169.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.71 143.83 55.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.92 126.25 92.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 -26.2 55.33 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.139 1.226 . . . . 0.0 112.921 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.48 -4.3 41.87 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.034 0.833 . . . . 0.0 112.538 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -120.43 0.44 10.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.992 1.717 . . . . 0.0 109.385 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.71 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.9 1.68 . . . . 0.0 109.192 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -58.16 123.27 15.42 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.33 -91.33 0.1 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.9 t -158.04 167.89 28.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.97 1.308 . . . . 0.0 108.023 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 -31.02 70.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.121 0.568 . . . . 0.0 111.874 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -39.48 84.3 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.64 0.376 . . . . 0.0 110.164 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.6 -38.5 70.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.72 -49.12 78.77 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 118.568 0.622 . . . . 0.0 110.186 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.23 -37.61 77.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.759 0.708 . . . . 0.0 111.207 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.65 84.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -63.32 -31.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.176 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.31 -52.06 66.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.251 1.387 . . . . 0.0 110.091 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.4 -34.63 78.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.869 0.759 . . . . 0.0 111.587 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -63.18 -52.6 61.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.836 1.198 . . . . 0.0 110.942 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.73 -37.5 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -54.32 -53.85 48.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.777 0.717 . . . . 0.0 109.409 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.34 -42.65 92.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.367 0.417 . . . . 0.0 110.58 -171.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.48 -41.1 93.67 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.959 -0.463 . . . . 0.0 111.195 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.38 -49.97 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.03 -46.57 61.29 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.589 0.631 . . . . 0.0 111.661 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.33 -48.8 80.2 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.618 0.709 . . . . 0.0 110.602 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -70.69 -30.0 66.46 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 117.297 -1.335 . . . . 0.0 111.611 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -39.82 82.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.93 1.241 . . . . 0.0 110.068 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.21 -49.41 74.18 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.445 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.67 -37.32 83.65 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.23 -35.84 35.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.496 0.318 . . . . 0.0 111.041 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.73 -42.18 10.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.513 1.125 . . . . 0.0 111.664 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.2 p -114.41 -20.81 10.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 0.0 111.817 -169.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.59 78.36 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.359 0.98 . . . . 0.0 112.836 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.245 0.853 0 CA-C-N 118.817 1.308 . . . . 0.0 109.958 -176.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.14 162.68 37.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.819 1.248 . . . . 0.0 107.975 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -68.49 139.51 55.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -71.26 170.27 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -145.16 143.12 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -147.62 152.67 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.598 0.759 . . . . 0.0 109.526 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.49 133.03 30.32 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.805 0.842 . . . . 0.0 109.248 -173.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.89 127.81 55.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -124.1 141.54 51.97 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.623 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t -144.19 172.12 13.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.993 0.917 . . . . 0.0 110.633 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 p -59.37 -28.61 67.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.337 1.455 . . . . 0.0 110.824 169.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.5 147.98 16.87 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.8 45.72 1.02 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.853 -0.792 . . . . 0.0 111.886 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -128.12 -3.13 5.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 p -145.91 -106.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.964 1.256 . . . . 0.0 110.982 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -55.31 -36.94 66.74 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.941 0.896 . . . . 0.0 112.163 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.5 -52.72 64.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.337 1.055 . . . . 0.0 111.169 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -60.06 -50.34 74.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.501 1.121 . . . . 0.0 110.363 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.3 mtm -58.41 -44.53 89.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.92 0.488 . . . . 0.0 111.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -44.57 96.9 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.626 0.648 . . . . 0.0 111.437 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -59.57 -42.74 93.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.38 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.86 -53.1 46.75 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.852 0.739 . . . . 0.0 112.073 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -61.55 -43.8 98.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.299 0.55 . . . . 0.0 110.838 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.29 99.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 117.618 -1.182 . . . . 0.0 111.193 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -55.92 -37.58 69.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.381 1.446 . . . . 0.0 111.102 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -67.52 -56.43 9.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.285 0.493 . . . . 0.0 110.887 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -73.09 -45.59 56.34 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.068 0.147 . . . . 0.0 111.189 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.9 mt -72.15 -32.84 67.27 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.131 0.572 . . . . 0.0 111.367 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.4 176.51 51.03 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.02 -8.86 13.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.182 1.393 . . . . 0.0 111.565 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.14 -6.79 7.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 111.398 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.475 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 24.2 m95 -129.18 128.8 44.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.109 1.764 . . . . 0.0 107.02 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -76.48 88.64 3.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.54 133.72 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -141.41 167.33 22.43 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.863 1.265 . . . . 0.0 109.527 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.7 p -146.9 159.51 43.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.801 0.84 . . . . 0.0 109.093 169.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -168.04 1.96 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.911 1.284 . . . . 0.0 109.189 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.3 -175.78 43.02 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 121.427 -0.795 . . . . 0.0 111.517 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 mt -55.96 -28.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.716 1.606 . . . . 0.0 111.059 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -146.29 173.0 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.686 1.194 . . . . 0.0 109.455 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.26 18.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -139.13 10.7 2.58 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.788 0.835 . . . . 0.0 111.259 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.01 136.09 9.2 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -62.2 145.41 53.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.823 0.849 . . . . 0.0 112.686 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -72.26 133.62 83.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.685 1.194 . . . . 0.0 108.86 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.29 -34.63 41.07 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.823 2.349 . . . . 0.0 114.353 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -73.06 -29.33 62.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.751 0.705 . . . . 0.0 110.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.13 -49.3 74.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.7 -49.87 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.37 -39.88 92.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.964 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.9 96.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.713 0.688 . . . . 0.0 110.228 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.5 mmm -68.6 -36.39 78.64 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.807 -0.558 . . . . 0.0 111.28 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.712 -1.243 . . . . 0.0 111.485 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.65 -17.46 64.85 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.003 0.819 . . . . 0.0 110.935 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.57 -0.43 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.894 0.877 . . . . 0.0 112.125 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.15 32.45 14.13 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.53 159.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -127.31 146.3 50.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.25 0.65 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.182 1.393 . . . . 0.0 110.391 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -58.58 -28.74 65.84 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.285 -1.509 . . . . 0.0 111.15 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -67.42 -4.38 11.02 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.972 1.709 . . . . 0.0 115.001 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.82 49.81 2.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.577 1.535 . . . . 0.0 110.256 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 p -48.18 144.5 3.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 112.647 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -56.78 148.71 19.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.929 1.691 . . . . 0.0 113.936 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.44 153.52 31.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.281 1.433 . . . . 0.0 109.911 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.99 165.72 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.448 1.099 . . . . 0.0 109.68 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.37 145.87 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.552 1.141 . . . . 0.0 110.047 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -140.04 134.99 32.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.452 1.101 . . . . 0.0 109.872 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.0 -28.11 49.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.472 . . . . 0.0 113.168 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.12 -11.87 61.18 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.104 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -114.42 -41.54 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 mt -48.77 -57.62 6.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.035 1.288 . . . . 0.0 111.557 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.25 1.29 29.08 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -119.83 -32.14 4.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.007 1.323 . . . . 0.0 111.862 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.65 128.41 36.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.237 1.415 . . . . 0.0 109.44 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.59 -23.48 65.4 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.944 0.498 . . . . 0.0 110.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.3 tp -146.47 142.07 27.73 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.67 1.188 . . . . 0.0 107.993 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.02 152.86 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.46 129.0 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.9 134.72 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.12 3.57 30.46 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.883 0.873 . . . . 0.0 111.485 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.3 p -65.9 110.31 2.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.912 1.285 . . . . 0.0 111.688 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.11 21.05 0.86 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.353 0.978 . . . . 0.0 111.746 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -81.49 -177.78 6.66 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.409 2.283 . . . . 0.0 110.624 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.45 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.01 -33.87 10.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.542 1.064 . . . . 0.0 111.218 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 33.17 56.77 0.48 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.17 2.588 . . . . 0.0 114.134 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.96 -22.21 66.64 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.04 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.8 m 44.05 94.63 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.811 2.444 . . . . 0.0 114.792 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.93 138.74 42.4 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.574 2.182 . . . . 0.0 112.099 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.6 mtm -79.39 156.31 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.781 0.833 . . . . 0.0 109.962 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -131.38 161.94 58.99 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.291 1.836 . . . . 0.0 110.263 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.5 140.52 52.57 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.904 1.736 . . . . 0.0 109.948 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.98 -22.01 20.14 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.917 2.412 . . . . 0.0 112.044 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -81.76 6.15 16.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.195 0.998 . . . . 0.0 112.461 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.01 140.71 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.97 136.42 57.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -128.31 156.22 43.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -124.3 164.51 19.45 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.606 . . . . 0.0 107.497 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -131.33 109.92 10.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -116.4 55.54 0.81 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.83 126.99 32.95 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.68 166.0 33.53 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.506 1.922 . . . . 0.0 106.628 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -64.24 149.76 47.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.665 0.745 . . . . 0.0 110.772 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.95 118.03 70.62 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.72 -23.13 63.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.617 1.544 . . . . 0.0 112.949 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.4 63.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.35 0.977 . . . . 0.0 112.214 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -111.27 4.79 19.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.47 1.508 . . . . 0.0 111.497 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.01 60.91 0.79 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.231 1.812 . . . . 0.0 111.55 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.16 141.67 53.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.016 1.726 . . . . 0.0 110.983 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.86 -58.41 0.23 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -165.94 167.29 16.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.033 1.733 . . . . 0.0 107.13 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.19 -30.16 70.24 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.86 -0.525 . . . . 0.0 111.416 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.912 0.485 . . . . 0.0 110.491 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.45 -43.25 67.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.323 0.649 . . . . 0.0 109.315 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.62 -48.32 75.11 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 121.85 -0.531 . . . . 0.0 110.394 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -60.76 -37.45 81.88 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.788 0.722 . . . . 0.0 111.704 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.93 77.77 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.296 -0.877 . . . . 0.0 110.5 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.211 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.35 -48.77 79.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.437 1.017 . . . . 0.0 109.3 171.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -47.61 79.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.571 1.078 . . . . 0.0 112.0 172.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -60.34 -47.91 84.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.663 0.665 . . . . 0.0 110.383 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.59 -37.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -56.02 -54.8 40.47 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.487 1.04 . . . . 0.0 108.693 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -65.9 -43.39 88.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.506 0.504 . . . . 0.0 110.436 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.04 -34.48 73.3 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.256 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -59.14 -52.22 63.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 169.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.09 -46.79 61.57 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.75 -37.29 85.95 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.603 0.702 . . . . 0.0 111.541 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -78.96 -30.85 44.78 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.371 -0.831 . . . . 0.0 111.111 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -40.1 81.22 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.86 174.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -51.29 -50.17 59.84 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.874 0.87 . . . . 0.0 109.674 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.83 -45.08 87.67 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 117.657 0.208 . . . . 0.0 110.82 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -57.32 -33.3 67.57 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.902 -1.124 . . . . 0.0 112.32 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.55 -37.88 24.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.934 0.493 . . . . 0.0 111.996 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.45 -51.71 5.28 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.444 1.097 . . . . 0.0 111.014 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.8 p -104.07 -17.15 15.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 110.722 -169.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.63 80.09 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.291 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 118.926 1.363 . . . . 0.0 108.864 175.225 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.36 168.66 24.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.262 1.425 . . . . 0.0 108.627 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.59 135.82 50.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.05 170.14 8.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.48 141.57 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.85 149.71 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 119.021 0.828 . . . . 0.0 108.947 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.37 134.72 36.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.87 121.15 42.34 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.68 143.56 45.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 110.15 -169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -153.17 -176.16 5.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.477 0.711 . . . . 0.0 111.389 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 p -86.4 -0.98 57.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.159 1.384 . . . . 0.0 112.808 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.44 114.09 0.44 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.67 50.71 0.25 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.879 1.272 . . . . 0.0 114.332 -169.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 m -124.88 -20.11 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 121.206 -0.934 . . . . 0.0 113.444 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.0 m -128.86 -106.08 0.3 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.042 0.837 . . . . 0.0 109.426 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -40.25 46.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.391 1.476 . . . . 0.0 113.553 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 p -65.99 -45.99 79.64 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.706 0.802 . . . . 0.0 110.911 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.56 -46.39 90.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.841 0.857 . . . . 0.0 110.049 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 mtm -59.45 -45.38 91.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.043 0.537 . . . . 0.0 111.033 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.05 95.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.449 0.568 . . . . 0.0 111.334 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -56.73 -42.96 80.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.825 0.45 . . . . 0.0 110.594 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.14 -52.19 53.94 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.297 -0.724 . . . . 0.0 112.135 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -60.03 -43.92 94.99 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.503 0.651 . . . . 0.0 110.627 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.85 98.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.307 -174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -55.77 -36.2 67.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.73 1.15 . . . . 0.0 111.307 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -69.44 -58.03 4.5 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.5 0.591 . . . . 0.0 110.792 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -73.08 -46.01 53.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.995 0.118 . . . . 0.0 111.106 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 87.0 mt -73.08 -36.36 66.8 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.762 0.425 . . . . 0.0 111.487 -176.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.14 173.28 43.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -169.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.33 -2.36 5.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.958 0.903 . . . . 0.0 111.666 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -58.89 -13.11 5.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 111.289 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.3 m95 -128.45 120.97 27.9 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -71.15 95.4 1.24 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.4 t -83.96 133.54 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -173.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -143.28 167.52 21.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.212 1.405 . . . . 0.0 109.59 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.0 p -145.0 159.64 42.62 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.768 0.827 . . . . 0.0 109.36 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.7 -170.96 2.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.652 1.181 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.02 -172.43 41.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.0 mt -57.38 -28.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.958 1.303 . . . . 0.0 110.942 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.32 166.73 29.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.627 1.171 . . . . 0.0 109.568 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.65 26.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.128 1.371 . . . . 0.0 107.773 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.13 17.46 4.11 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.093 1.357 . . . . 0.0 110.258 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 168.41 44.74 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.68 149.41 25.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.469 0.652 . . . . 0.0 111.831 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.91 138.13 57.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.299 1.439 . . . . 0.0 109.746 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.52 -28.61 70.39 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.79 1.66 . . . . 0.0 112.959 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -71.99 -33.56 68.2 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.97 92.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -57.3 -50.1 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.333 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -57.93 -44.75 87.08 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.159 0.89 . . . . 0.0 111.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.87 87.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.7 mmm -68.88 -37.86 79.32 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.157 0.183 . . . . 0.0 111.008 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -32.53 69.7 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.287 -0.883 . . . . 0.0 111.121 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.51 -11.32 60.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.343 1.057 . . . . 0.0 110.477 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -115.68 0.45 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.328 1.051 . . . . 0.0 112.031 173.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 30.76 13.09 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -120.55 160.11 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.85 145.52 51.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.31 -8.32 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.676 1.591 . . . . 0.0 110.436 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -55.97 -32.67 64.11 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.87 0.868 . . . . 0.0 111.119 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.76 -14.34 61.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.381 1.472 . . . . 0.0 114.371 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -107.69 -30.08 8.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 -169.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.0 p 51.2 -175.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.283 1.833 . . . . 0.0 113.716 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 m -119.88 155.87 31.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.68 1.192 . . . . 0.0 111.0 -170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -158.43 158.9 35.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 109.629 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.14 165.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.26 144.25 9.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.921 0.888 . . . . 0.0 109.466 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -136.46 140.18 42.91 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.773 1.229 . . . . 0.0 110.129 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.63 -29.91 62.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.187 1.395 . . . . 0.0 113.449 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.33 -12.28 61.48 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 111.95 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.45 -44.64 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.45 -40.59 78.79 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.1 1.318 . . . . 0.0 112.712 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -1.64 55.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -117.69 -26.35 6.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.126 1.37 . . . . 0.0 112.831 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.36 124.65 18.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.198 1.399 . . . . 0.0 110.08 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -32.43 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.247 1.419 . . . . 0.0 109.817 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.07 144.33 30.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.197 1.399 . . . . 0.0 108.106 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -117.66 153.21 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.91 138.61 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 p -113.46 131.98 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.44 21.69 16.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.809 1.244 . . . . 0.0 108.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -82.79 99.37 9.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.019 1.327 . . . . 0.0 109.718 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.06 -0.98 1.16 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 123.929 0.776 . . . . 0.0 111.441 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -74.55 -179.67 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.776 2.031 . . . . 0.0 112.9 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.33 -28.9 68.51 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.98 -52.42 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.436 0.562 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 40.84 37.07 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.682 1.993 . . . . 0.0 114.03 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -65.84 -25.7 67.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.561 -1.337 . . . . 0.0 111.542 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.4 t 37.32 112.19 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 131.634 3.974 . . . . 0.0 116.555 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.41 140.82 96.06 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 110.57 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.52 158.25 36.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 109.97 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -123.06 157.02 61.84 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.948 1.699 . . . . 0.0 109.147 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 162.17 34.13 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 121.567 1.512 . . . . 0.0 110.36 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.22 -17.66 24.23 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.949 2.433 . . . . 0.0 111.591 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -65.91 -22.63 66.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.252 1.021 . . . . 0.0 112.352 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.98 150.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.637 0.653 . . . . 0.0 111.11 -172.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -72.6 149.56 43.85 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -132.55 156.69 46.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 111.363 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.74 162.14 26.52 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.009 2.523 . . . . 0.0 106.822 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -144.86 114.76 7.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -122.38 10.67 9.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.517 1.527 . . . . 0.0 111.49 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.7 138.22 5.32 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.938 1.256 . . . . 0.0 114.844 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 -100.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.868 1.667 . . . . 0.0 107.177 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -154.86 152.69 30.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.62 126.41 86.08 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.04 -25.58 66.24 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.34 1.36 . . . . 0.0 113.939 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.89 -13.09 62.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.346 0.975 . . . . 0.0 112.368 172.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mtm-85 -111.96 6.24 19.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.259 . . . . 0.0 111.378 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.66 60.9 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.335 1.854 . . . . 0.0 110.737 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.56 141.76 54.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.919 1.688 . . . . 0.0 111.137 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.66 -59.29 0.22 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -166.38 169.61 13.84 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 107.108 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -30.12 68.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.279 0.631 . . . . 0.0 111.292 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.84 -37.8 73.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.832 0.453 . . . . 0.0 110.766 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.64 -43.56 76.02 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -57.01 -51.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.81 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -58.06 -38.4 76.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.792 0.837 . . . . 0.0 111.903 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.69 87.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.443 -0.785 . . . . 0.0 109.863 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -63.95 -34.92 79.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.988 0.515 . . . . 0.0 111.85 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -57.76 -49.96 74.83 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.172 0.896 . . . . 0.0 109.798 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -63.91 -36.06 82.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.293 0.497 . . . . 0.0 111.76 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.52 -48.05 68.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.637 0.653 . . . . 0.0 111.014 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.09 -41.85 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -54.29 -53.61 51.38 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.02 0.928 . . . . 0.0 109.537 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.54 -42.91 95.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.787 0.267 . . . . 0.0 111.072 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.17 -42.16 84.76 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.982 -0.449 . . . . 0.0 110.848 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.32 -49.91 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.61 -43.18 78.71 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.02 -51.64 68.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 117.484 0.642 . . . . 0.0 111.131 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.5 mmm-85 -68.54 -29.58 68.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -40.86 88.05 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 120.123 1.328 . . . . 0.0 109.74 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -56.73 -53.16 60.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.36 -34.4 78.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.605 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -63.33 -37.9 89.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.798 -0.564 . . . . 0.0 110.726 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.63 -35.55 29.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.193 0.597 . . . . 0.0 111.548 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.07 -42.46 9.4 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.746 1.219 . . . . 0.0 111.72 -169.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 p -113.48 -18.18 12.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 111.056 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.82 65.85 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.036 -0.869 . . . . 0.0 111.981 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.245 0.866 0 C-N-CA 124.564 1.146 . . . . 0.0 108.137 -175.694 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -151.08 159.95 44.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.043 1.337 . . . . 0.0 107.558 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -141.52 134.3 28.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 173.26 9.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.553 0.615 . . . . 0.0 110.138 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.33 141.03 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.53 149.76 16.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.091 0.956 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 131.69 32.65 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.523 0.729 . . . . 0.0 109.065 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.33 128.17 55.87 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.3 143.85 51.15 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.401 0.68 . . . . 0.0 110.585 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.51 174.68 10.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.367 1.079 . . . . 0.0 112.674 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.8 p -77.97 32.69 0.18 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.444 2.298 . . . . 0.0 110.616 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.01 113.73 0.83 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -173.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.31 53.98 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.264 1.026 . . . . 0.0 111.611 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 m -125.15 -19.67 5.08 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.1 m -138.81 -90.4 0.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.798 0.726 . . . . 0.0 109.1 -173.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -52.37 -53.25 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.041 0.936 . . . . 0.0 112.34 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 p -68.14 -38.35 82.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.658 0.663 . . . . 0.0 111.097 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -58.66 -54.86 42.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.962 0.905 . . . . 0.0 109.903 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.6 mtp -54.73 -46.05 74.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.57 1.548 . . . . 0.0 110.576 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.28 88.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.881 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -57.05 -37.8 72.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.445 0.566 . . . . 0.0 110.851 175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.51 -54.03 41.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 123.829 0.728 . . . . 0.0 111.498 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -61.75 -41.81 98.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.313 0.557 . . . . 0.0 110.777 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.8 88.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.297 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -55.15 -36.33 65.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.873 1.215 . . . . 0.0 111.358 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -67.3 -56.96 7.61 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.363 0.414 . . . . 0.0 110.783 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -77.36 -44.47 29.28 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -169.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 84.4 mt -74.51 -37.07 63.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 111.071 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 173.03 42.95 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.41 -1.93 5.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.677 0.791 . . . . 0.0 111.634 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -57.89 -13.2 4.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.034 1.333 . . . . 0.0 111.325 169.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 13.7 m95 -129.13 115.49 17.78 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.246 -2.502 . . . . 0.0 104.246 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -66.34 100.79 0.67 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.8 p -107.68 133.37 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.602 0.761 . . . . 0.0 109.831 -168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.06 167.38 22.21 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.162 1.385 . . . . 0.0 109.459 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -140.41 151.33 44.84 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 109.92 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.02 -166.66 1.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.584 1.154 . . . . 0.0 109.812 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.52 -176.31 46.32 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 121.342 -0.849 . . . . 0.0 111.387 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.4 mt -54.95 -31.92 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.723 1.609 . . . . 0.0 110.806 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.11 167.06 25.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.027 1.331 . . . . 0.0 108.087 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.83 133.0 20.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -134.42 21.82 3.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.179 0.992 . . . . 0.0 109.347 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.12 165.25 33.89 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -87.02 147.88 25.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.07 0.548 . . . . 0.0 110.442 -178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -73.43 133.52 80.45 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.365 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.88 -34.38 45.23 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.884 2.389 . . . . 0.0 114.495 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -73.97 -27.85 61.19 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 121.385 -0.822 . . . . 0.0 110.929 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.56 75.88 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.1 -49.18 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.8 -43.61 94.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.052 0.541 . . . . 0.0 111.039 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.15 94.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.209 0.604 . . . . 0.0 110.255 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.2 mmm -69.72 -36.66 76.08 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.282 0.492 . . . . 0.0 111.318 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -27.34 69.25 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 120.797 -1.19 . . . . 0.0 111.446 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.17 -15.17 63.55 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.914 0.779 . . . . 0.0 110.825 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.79 -0.0 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.17 0.988 . . . . 0.0 112.079 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.59 17.44 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 174.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.64 160.51 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.85 145.31 50.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.56 2.98 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.859 1.264 . . . . 0.0 110.41 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -58.7 -29.52 66.71 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.214 -1.554 . . . . 0.0 111.086 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -65.64 -4.73 6.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.425 1.89 . . . . 0.0 115.334 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -135.45 48.47 2.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.444 1.474 . . . . 0.0 110.829 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -44.86 132.62 6.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.843 1.257 . . . . 0.0 111.111 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -57.29 154.81 9.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -168.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -154.15 155.7 35.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.108 1.363 . . . . 0.0 109.581 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.23 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.497 1.119 . . . . 0.0 109.784 172.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.77 153.16 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.058 1.343 . . . . 0.0 110.067 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.98 139.11 21.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.688 1.595 . . . . 0.0 108.643 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.34 -28.11 57.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.31 1.444 . . . . 0.0 113.464 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.04 -13.51 62.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.573 1.149 . . . . 0.0 112.286 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -113.36 -40.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.8 mt -48.09 -61.33 2.03 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.834 1.197 . . . . 0.0 111.603 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -3.27 35.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -111.94 -33.11 6.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.331 1.452 . . . . 0.0 110.941 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 122.65 15.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.48 1.512 . . . . 0.0 110.092 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.23 -23.38 66.41 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 111.197 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 tp -143.82 138.65 28.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.747 1.219 . . . . 0.0 107.936 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.6 145.4 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.14 124.85 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.29 127.11 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.41 24.57 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.896 0.855 . . . . 0.0 109.081 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.0 p -75.96 107.98 8.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.589 1.556 . . . . 0.0 110.029 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.7 26.91 0.46 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -106.84 -177.02 3.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.479 2.312 . . . . 0.0 113.43 -169.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.09 66.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.014 0.925 . . . . 0.0 113.388 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.19 -52.57 6.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.502 0.592 . . . . 0.0 110.224 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 46.44 28.83 0.78 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.498 1.919 . . . . 0.0 114.249 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.1 mtpt -61.57 -32.33 72.41 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.539 -1.351 . . . . 0.0 111.466 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 54.69 109.88 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 129.772 3.229 . . . . 0.0 114.575 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.6 146.05 96.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.452 2.101 . . . . 0.0 112.101 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -74.1 155.66 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 0.0 109.833 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -132.17 161.6 61.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.879 2.071 . . . . 0.0 109.149 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.6 159.71 50.36 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 121.246 1.297 . . . . 0.0 109.583 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.72 -26.15 10.09 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.397 2.065 . . . . 0.0 112.422 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -74.9 -34.61 62.21 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.274 0.63 . . . . 0.0 112.45 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.73 153.43 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.542 0.687 . . . . 0.0 111.013 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -70.65 141.28 51.68 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -134.03 149.71 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.216 0.607 . . . . 0.0 109.902 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -127.07 157.14 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.702 2.001 . . . . 0.0 107.832 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -131.34 113.44 13.77 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.8 m0 -122.26 52.89 1.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.154 1.781 . . . . 0.0 106.797 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.15 128.67 34.07 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 120.747 -1.221 . . . . 0.0 111.654 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.98 160.83 39.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 105.911 169.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -68.73 144.05 54.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.431 0.634 . . . . 0.0 110.747 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.38 127.64 93.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.51 -23.07 50.73 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.162 1.241 . . . . 0.0 113.506 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.93 -11.45 60.35 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.454 1.025 . . . . 0.0 112.347 171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -111.49 3.23 17.93 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.879 1.272 . . . . 0.0 110.755 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.51 60.61 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.21 2.204 . . . . 0.0 110.844 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.43 138.2 57.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 110.587 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.68 -58.35 0.19 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -166.3 168.43 15.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.902 1.681 . . . . 0.0 107.339 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -30.3 70.15 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.781 -0.574 . . . . 0.0 111.394 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.75 -38.55 76.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.928 0.491 . . . . 0.0 110.585 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.57 -46.13 77.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -56.91 -49.95 74.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.168 0.587 . . . . 0.0 110.26 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -60.33 -37.16 79.75 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.866 0.757 . . . . 0.0 111.975 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.46 80.24 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.147 -0.97 . . . . 0.0 110.258 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.38 -32.69 74.46 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.948 -0.47 . . . . 0.0 111.477 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -57.42 -49.09 77.35 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.465 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -45.55 84.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 111.829 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -60.73 -48.78 80.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.002 0.819 . . . . 0.0 110.681 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.67 -39.65 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -55.85 -55.94 26.53 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 124.095 0.958 . . . . 0.0 108.956 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.52 -37.63 77.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 123.536 0.523 . . . . 0.0 110.502 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.01 -42.61 80.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.031 0.532 . . . . 0.0 111.255 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.3 mt -58.61 -52.19 62.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.94 56.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.909 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -61.61 -50.06 74.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.726 0.763 . . . . 0.0 111.066 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -69.57 -34.77 74.64 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.113 -176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -40.3 96.45 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.207 0.912 . . . . 0.0 109.742 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.32 -49.77 75.06 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.076 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.71 -43.63 98.32 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 110.131 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.18 -31.72 69.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.649 -1.282 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 -37.19 23.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.471 0.708 . . . . 0.0 112.212 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.6 -52.97 4.63 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.819 1.248 . . . . 0.0 110.728 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.2 p -103.03 -16.52 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.842 1.657 . . . . 0.0 110.414 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.34 86.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.486 1.041 . . . . 0.0 112.381 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 C--O 1.246 0.893 0 CA-C-N 118.694 1.247 . . . . 0.0 108.743 -172.533 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.21 -38.81 82.31 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.927 -0.483 . . . . 0.0 110.869 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.19 126.28 28.71 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.08 -179.91 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.232 0.613 . . . . 0.0 109.919 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -140.91 142.49 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.82 150.32 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 118.87 0.759 . . . . 0.0 109.251 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -139.49 136.8 34.94 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.715 0.806 . . . . 0.0 109.508 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.49 133.05 54.6 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.564 1.146 . . . . 0.0 108.29 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.15 141.0 52.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.54 0.736 . . . . 0.0 110.244 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.93 168.97 18.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.173 1.389 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 p -55.5 -36.11 66.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.52 1.128 . . . . 0.0 110.939 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.2 141.47 9.39 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -77.44 51.22 0.86 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.42 1.088 . . . . 0.0 111.712 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.7 m -126.46 -15.58 5.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.771 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.98 -98.56 0.19 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -52.31 -50.29 62.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.081 0.953 . . . . 0.0 112.311 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -70.7 -36.32 73.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.78 0.264 . . . . 0.0 111.509 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -60.92 -53.78 53.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.247 1.019 . . . . 0.0 110.214 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.7 mtp -53.94 -46.84 71.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.182 1.393 . . . . 0.0 110.551 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.26 95.6 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.914 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -55.92 -41.44 74.57 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.223 0.465 . . . . 0.0 110.728 174.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.27 -48.1 85.0 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.4 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -63.01 -43.57 98.4 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.834 0.817 . . . . 0.0 110.864 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.29 99.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.787 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -51.55 -38.31 53.69 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.068 0.849 . . . . 0.0 111.907 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -70.21 -62.66 1.3 Allowed 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 123.327 0.392 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -67.95 -37.78 82.0 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 78.5 mt -77.03 -1.36 28.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.682 0.793 . . . . 0.0 112.489 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.34 24.97 59.76 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.573 1.082 . . . . 0.0 113.738 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.12 16.06 2.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.768 2.027 . . . . 0.0 113.611 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.59 2.2 14.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.945 -1.097 . . . . 0.0 111.33 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.443 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.1 m95 -134.21 124.74 26.49 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.64 94.25 0.42 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.11 138.46 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -143.5 164.62 29.85 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.075 1.35 . . . . 0.0 109.695 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -146.42 156.56 43.39 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.783 0.833 . . . . 0.0 109.461 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 -166.89 2.07 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.224 1.009 . . . . 0.0 109.584 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.69 44.03 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mt -57.03 -25.57 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.927 1.291 . . . . 0.0 111.363 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.02 169.47 19.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.967 1.307 . . . . 0.0 108.825 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.21 135.48 21.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 169.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -129.18 11.12 5.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.723 1.209 . . . . 0.0 110.042 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 162.4 30.61 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -170.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.08 146.67 30.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.321 0.581 . . . . 0.0 111.045 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.16 133.68 83.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.147 -0.93 . . . . 0.0 108.945 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.53 -34.62 43.09 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.799 2.333 . . . . 0.0 114.563 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -73.41 -28.18 61.85 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.567 -0.708 . . . . 0.0 110.731 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.77 73.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -57.68 -48.05 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -60.04 -41.76 92.95 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.57 0.623 . . . . 0.0 110.764 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.47 94.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.14 0.576 . . . . 0.0 109.78 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.5 mmm -69.07 -38.52 79.07 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.415 0.15 . . . . 0.0 111.061 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.47 -25.1 67.85 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.85 -1.156 . . . . 0.0 111.483 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.79 -15.62 63.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.578 0.751 . . . . 0.0 110.42 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.25 0.82 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.927 0.891 . . . . 0.0 112.064 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.04 19.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.65 159.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -125.95 145.45 50.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 pt -127.97 2.7 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.977 1.311 . . . . 0.0 110.383 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.86 -27.98 67.13 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 119.978 -1.701 . . . . 0.0 111.2 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.84 -5.23 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.227 1.811 . . . . 0.0 115.107 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.18 49.61 2.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.253 1.388 . . . . 0.0 110.876 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -46.72 134.64 9.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.3 1.04 . . . . 0.0 110.967 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.26 155.51 8.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -154.48 156.18 36.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.967 1.307 . . . . 0.0 109.395 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.0 167.98 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 109.777 171.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.41 146.22 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.454 1.501 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -138.65 139.49 38.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.283 1.433 . . . . 0.0 109.773 170.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -55.81 -29.12 59.24 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.516 1.526 . . . . 0.0 113.259 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.75 -7.06 36.23 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 112.392 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.94 -44.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -45.7 -55.85 5.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.092 0.957 . . . . 0.0 112.305 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.7 51.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 112.925 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.8 -30.01 4.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 112.299 -168.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.97 130.37 46.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.778 1.231 . . . . 0.0 109.92 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.58 -22.98 64.43 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.223 0.609 . . . . 0.0 110.962 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.0 tp -146.44 142.18 27.89 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 108.829 170.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.9 145.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.48 135.48 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.56 107.67 13.56 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.68 8.32 34.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.409 0.683 . . . . 0.0 112.637 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.6 p -68.65 72.89 0.24 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.825 2.45 . . . . 0.0 114.669 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.06 18.94 11.2 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.575 -1.328 . . . . 0.0 112.827 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.3 175.86 9.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.301 1.84 . . . . 0.0 111.219 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.0 64.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.86 -32.66 11.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.297 0.953 . . . . 0.0 111.035 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 34.64 55.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.26 2.624 . . . . 0.0 113.885 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.29 -25.05 66.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.632 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.8 m 42.51 84.8 0.18 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 127.324 2.249 . . . . 0.0 112.883 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -45.06 135.2 10.89 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.442 3.428 . . . . 0.0 113.245 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.01 138.24 58.23 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.902 0.881 . . . . 0.0 110.245 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -124.02 158.09 61.53 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.471 1.908 . . . . 0.0 109.689 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.5 153.39 76.66 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.82 1.68 . . . . 0.0 109.324 169.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.63 -23.97 16.41 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.478 2.119 . . . . 0.0 112.103 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -73.05 -32.83 65.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.645 0.778 . . . . 0.0 112.196 -173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.94 145.07 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.432 0.634 . . . . 0.0 109.799 -172.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.86 130.99 44.97 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -134.54 150.4 50.76 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.021 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.78 160.68 30.15 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.317 2.247 . . . . 0.0 107.574 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -133.13 115.13 14.69 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.6 m0 -119.11 59.67 0.83 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.84 123.85 13.78 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.767 -171.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.94 160.13 43.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.61 1.964 . . . . 0.0 106.528 168.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -69.81 149.66 47.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.179 0.514 . . . . 0.0 110.591 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.2 128.61 80.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.49 -24.83 35.86 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.221 1.28 . . . . 0.0 113.515 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 -12.45 61.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.487 1.04 . . . . 0.0 111.722 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.0 ttp85 -101.93 2.0 37.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.889 1.275 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.93 67.2 0.82 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.115 1.366 . . . . 0.0 110.385 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.49 137.42 56.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.928 0.891 . . . . 0.0 110.464 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.42 -63.42 0.19 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.4 t -165.15 168.72 16.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 107.6 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.93 -29.53 68.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.386 0.675 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.64 -37.33 70.86 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.22 0.464 . . . . 0.0 110.836 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.23 -44.01 76.69 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -58.22 -48.02 81.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 122.856 0.462 . . . . 0.0 110.084 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -58.45 -39.89 81.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.561 0.744 . . . . 0.0 111.702 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.68 84.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.442 -0.787 . . . . 0.0 110.213 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.52 -34.12 77.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.07 0.548 . . . . 0.0 111.165 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -59.37 -48.14 82.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.909 . . . . 0.0 110.222 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -65.14 -36.36 84.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.491 0.587 . . . . 0.0 111.521 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -65.57 -50.36 65.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.265 0.484 . . . . 0.0 110.64 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.54 -39.37 84.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -54.44 -53.33 55.61 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.781 0.832 . . . . 0.0 109.352 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.56 -41.94 95.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.046 0.384 . . . . 0.0 111.035 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.18 -41.29 90.48 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.597 -0.689 . . . . 0.0 111.411 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.89 -53.03 50.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.55 -45.72 53.75 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 123.677 0.656 . . . . 0.0 111.754 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -60.46 -50.28 74.19 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.918 0.859 . . . . 0.0 111.174 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -70.79 -33.18 70.47 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.991 -176.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -39.61 94.86 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.179 0.9 . . . . 0.0 109.969 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.83 -52.63 64.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.0 -35.29 80.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.255 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.56 -36.58 83.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.81 -0.556 . . . . 0.0 111.223 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.52 26.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 122.818 0.447 . . . . 0.0 111.44 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.42 -42.96 11.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.611 1.165 . . . . 0.0 111.628 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.0 p -113.29 -19.0 11.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.224 1.01 . . . . 0.0 111.161 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.77 10.54 75.83 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.209 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 118.654 1.227 . . . . 0.0 108.364 -174.677 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -150.82 157.57 43.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.954 1.302 . . . . 0.0 107.719 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -132.97 133.54 43.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.85 175.1 6.07 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.37 140.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.78 148.94 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.4 131.66 30.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.71 131.24 56.99 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -125.91 139.59 53.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.639 0.776 . . . . 0.0 109.719 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.2 t -135.74 168.75 18.71 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.442 1.097 . . . . 0.0 109.406 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.8 p -58.77 -26.27 63.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.476 1.111 . . . . 0.0 111.314 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 138.04 5.94 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.03 53.45 0.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.603 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 m -126.85 -17.66 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.921 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.03 -90.93 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.876 0.762 . . . . 0.0 109.184 -170.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -56.46 -53.46 57.21 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.38 0.672 . . . . 0.0 111.542 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -67.68 -36.4 80.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.774 0.261 . . . . 0.0 111.197 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -59.61 -57.58 12.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.147 0.979 . . . . 0.0 110.085 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.8 mtm -56.86 -43.4 81.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.319 0.648 . . . . 0.0 111.517 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.28 99.15 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.482 0.583 . . . . 0.0 111.824 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -57.7 -39.74 77.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.237 0.471 . . . . 0.0 110.815 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.4 53.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 123.697 0.665 . . . . 0.0 111.546 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -61.32 -45.29 95.04 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.303 0.551 . . . . 0.0 110.98 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.7 -44.25 97.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.34 0.656 . . . . 0.0 110.852 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -56.3 -34.21 66.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.055 0.843 . . . . 0.0 111.889 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -67.22 -61.61 1.84 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.131 0.423 . . . . 0.0 110.443 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.02 -42.71 80.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.35 0.26 . . . . 0.0 111.507 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.38 -7.84 58.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 0.0 112.241 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.93 56.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.859 1.219 . . . . 0.0 114.621 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.58 4.76 1.08 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.696 2.398 . . . . 0.0 114.107 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.29 -9.11 21.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.714 1.206 . . . . 0.0 110.384 169.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -129.37 118.84 22.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 172.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.64 99.7 0.81 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.1 141.47 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -144.01 165.31 28.12 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.941 1.696 . . . . 0.0 109.077 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.2 p -143.92 155.89 44.23 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.736 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.37 1.69 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.622 1.169 . . . . 0.0 109.459 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.09 179.83 45.19 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -54.39 -28.41 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.366 1.466 . . . . 0.0 111.387 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.06 170.61 16.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.966 1.307 . . . . 0.0 108.632 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.0 134.09 18.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -135.92 19.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.363 1.065 . . . . 0.0 109.81 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.09 163.15 29.73 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -83.97 146.21 28.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 110.696 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -70.66 134.13 86.38 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.036 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.23 -35.67 44.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.795 2.33 . . . . 0.0 114.259 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -72.75 -26.64 61.64 Favored 'General case' 0 C--O 1.227 -0.111 0 O-C-N 121.491 -0.756 . . . . 0.0 111.094 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -46.62 78.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.77 -47.98 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -57.16 -46.34 82.85 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.858 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.56 86.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -69.26 -37.69 78.04 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 110.852 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.01 -25.72 67.97 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.879 -1.138 . . . . 0.0 111.778 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -71.43 -12.35 61.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.453 1.101 . . . . 0.0 110.424 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.28 -1.66 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 112.735 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.23 33.13 10.94 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.24 162.89 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.5 146.37 50.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.2 pt -128.95 3.97 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.824 1.25 . . . . 0.0 110.589 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.32 -28.38 66.75 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.136 -1.603 . . . . 0.0 111.003 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -64.73 -5.58 6.11 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.291 1.836 . . . . 0.0 115.188 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -135.67 50.35 2.11 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.512 1.505 . . . . 0.0 110.426 -169.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -46.21 133.28 9.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.493 1.117 . . . . 0.0 110.683 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 m -57.8 154.75 11.41 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -154.0 155.38 35.44 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.094 1.357 . . . . 0.0 109.522 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.42 166.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.354 1.062 . . . . 0.0 109.56 172.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.04 145.92 5.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.717 1.207 . . . . 0.0 109.898 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.07 135.97 33.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.391 1.076 . . . . 0.0 109.884 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -54.49 -28.35 44.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.426 1.49 . . . . 0.0 113.067 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.04 -11.98 61.28 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mt -114.52 -42.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.27 -57.5 6.69 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.928 1.24 . . . . 0.0 111.661 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -1.8 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -116.37 -32.58 5.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.214 1.405 . . . . 0.0 111.591 -168.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.46 128.25 35.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.32 1.448 . . . . 0.0 109.619 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.34 -29.85 71.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.863 0.865 . . . . 0.0 110.182 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.9 tp -147.3 140.43 25.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 108.647 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.84 154.72 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 t -140.09 136.43 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.06 135.65 47.14 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.39 10.46 37.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 110.613 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.2 p -64.21 116.98 6.52 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.643 1.177 . . . . 0.0 111.18 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.3 15.17 0.48 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.909 1.242 . . . . 0.0 111.051 169.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.51 176.0 9.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 109.546 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.55 -16.98 59.47 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.19 -35.48 21.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.511 1.051 . . . . 0.0 110.265 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.277 1.2 p-10 37.65 48.45 0.94 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.817 2.847 . . . . 0.0 114.253 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -66.78 -14.02 62.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.537 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.5 m 34.49 85.39 0.16 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.569 2.748 . . . . 0.0 113.971 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -44.78 133.21 10.48 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.685 3.59 . . . . 0.0 114.089 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -72.31 146.36 47.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.405 1.082 . . . . 0.0 110.098 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 p -129.46 160.22 65.45 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.607 1.963 . . . . 0.0 109.906 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.46 145.21 64.13 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.034 1.823 . . . . 0.0 109.895 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.5 -23.31 20.25 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.915 2.41 . . . . 0.0 112.185 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -85.01 6.58 24.66 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.067 0.947 . . . . 0.0 112.367 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.16 135.9 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.28 145.35 55.85 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -123.67 169.53 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.266 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -136.51 164.32 28.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.611 2.364 . . . . 0.0 106.794 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -134.02 113.25 11.93 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -121.63 61.82 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.06 131.3 11.66 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.304 -0.873 . . . . 0.0 112.885 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.28 160.46 40.81 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.396 2.278 . . . . 0.0 106.159 169.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -65.86 148.97 50.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.838 -0.539 . . . . 0.0 110.324 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -74.4 128.32 86.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.33 -21.23 54.6 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.063 1.175 . . . . 0.0 113.403 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.38 -18.3 65.07 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.399 1.0 . . . . 0.0 112.372 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -86.46 -8.67 57.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.457 1.026 . . . . 0.0 112.516 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 52.91 0.55 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 112.369 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.78 150.78 27.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.008 2.123 . . . . 0.0 112.063 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.62 -52.81 0.42 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -165.97 165.47 18.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.97 1.708 . . . . 0.0 107.263 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -28.54 67.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 0.0 111.223 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.78 -37.36 73.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.3 0.5 . . . . 0.0 110.903 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.9 -45.91 73.09 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.42 -49.37 74.72 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.923 0.489 . . . . 0.0 110.352 173.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.98 -39.71 86.62 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.631 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.232 -0.917 . . . . 0.0 110.838 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -67.41 -32.73 73.83 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.767 -0.583 . . . . 0.0 111.747 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.05 -44.64 91.84 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.693 0.679 . . . . 0.0 110.327 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.08 -38.05 89.65 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.635 0.652 . . . . 0.0 111.423 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -61.92 -51.16 69.26 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.109 0.868 . . . . 0.0 110.258 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.96 -38.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.332 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -63.91 -39.79 95.0 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.025 1.738 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.42 -45.37 80.13 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.239 0.472 . . . . 0.0 111.109 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.75 -41.81 95.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.002 -0.436 . . . . 0.0 110.874 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.05 -51.28 74.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.37 -46.31 57.81 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.566 -0.575 . . . . 0.0 111.786 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.89 -48.16 83.1 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.813 0.806 . . . . 0.0 110.826 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -35.11 76.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -41.45 93.71 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.821 -0.549 . . . . 0.0 110.079 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.89 -50.39 72.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.74 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.55 -45.33 94.61 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.57 -33.58 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.664 -1.273 . . . . 0.0 112.334 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.36 -32.89 20.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.414 0.686 . . . . 0.0 112.304 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.32 -53.68 3.53 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 -169.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.3 p -99.57 -15.54 18.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.49 1.516 . . . . 0.0 110.495 -170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.85 78.49 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.169 0.89 . . . . 0.0 111.815 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 117.868 0.834 . . . . 0.0 109.811 -179.228 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.567 0.223 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.39 -16.51 58.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.125 0.57 . . . . 0.0 112.109 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -52.79 133.64 37.1 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.517 0.727 . . . . 0.0 109.498 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 10.7 mmpt? -97.19 170.13 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.021 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.24 142.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 tt -141.05 146.56 23.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.91 120.85 15.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -171.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -104.09 127.85 51.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.871 0.868 . . . . 0.0 108.936 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.08 140.81 51.45 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.768 1.227 . . . . 0.0 109.184 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 m -140.52 168.86 18.82 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.49 1.116 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.14 -25.15 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.009 0.924 . . . . 0.0 111.377 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.49 136.25 5.0 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 169.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.79 55.88 2.16 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.296 1.038 . . . . 0.0 110.724 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -122.18 -25.95 4.79 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.7 m -133.02 -94.67 0.33 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.319 0.963 . . . . 0.0 110.32 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.75 80.03 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -169.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -58.72 -49.7 76.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.348 0.659 . . . . 0.0 110.703 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -63.72 -43.9 95.16 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.562 0.745 . . . . 0.0 110.802 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.81 -44.94 95.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.679 0.391 . . . . 0.0 111.036 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.0 99.72 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.525 0.602 . . . . 0.0 111.091 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 58.2 tt0 -57.59 -43.64 84.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.252 173.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.19 -53.37 43.22 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.823 0.725 . . . . 0.0 112.076 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -62.38 -44.31 96.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.194 0.497 . . . . 0.0 110.947 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.667 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -54.82 -35.19 63.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.425 1.011 . . . . 0.0 111.59 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -72.31 -62.82 1.3 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.122 0.419 . . . . 0.0 110.798 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -67.44 -37.51 83.12 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.0 -2.22 26.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.349 0.66 . . . . 0.0 112.364 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.55 57.49 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.559 1.552 . . . . 0.0 115.127 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 58.88 11.6 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.585 1.954 . . . . 0.0 113.363 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.39 -12.68 61.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.786 -1.196 . . . . 0.0 110.191 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -125.3 126.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.529 1.931 . . . . 0.0 106.513 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.2 mmpt? -70.3 108.86 4.4 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t -96.79 137.59 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.79 165.3 27.76 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.584 1.154 . . . . 0.0 109.805 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.4 p -147.4 159.43 43.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.329 0.652 . . . . 0.0 109.831 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.96 -169.38 2.02 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.36 1.464 . . . . 0.0 109.635 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.42 -177.86 43.88 Favored Glycine 0 CA--C 1.52 0.386 0 O-C-N 121.47 -0.768 . . . . 0.0 112.055 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.89 -28.22 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.542 1.537 . . . . 0.0 111.292 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.4 170.08 17.56 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.835 1.254 . . . . 0.0 108.715 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.74 136.15 21.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -137.52 21.09 2.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.319 1.048 . . . . 0.0 109.846 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.09 153.35 29.33 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.51 150.66 47.8 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.41 0.624 . . . . 0.0 111.369 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -77.45 133.43 67.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.865 1.266 . . . . 0.0 109.123 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.5 -34.54 42.52 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.933 2.422 . . . . 0.0 114.592 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -72.28 -28.76 63.31 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.25 -0.906 . . . . 0.0 110.769 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -47.03 84.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.71 -48.86 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -60.73 -41.32 95.1 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.651 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.33 95.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.8 0.727 . . . . 0.0 109.845 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 77.2 mmm -69.47 -35.54 75.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.822 0.283 . . . . 0.0 111.402 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -28.15 69.31 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.848 -1.157 . . . . 0.0 111.7 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -66.21 -17.27 64.63 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.201 0.91 . . . . 0.0 110.81 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.15 0.4 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.95 0.9 . . . . 0.0 112.021 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.92 32.0 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.35 155.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.62 145.83 47.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.48 -1.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.796 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -58.21 -31.98 67.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.859 0.864 . . . . 0.0 110.958 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -64.49 7.26 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.443 1.897 . . . . 0.0 114.948 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -131.41 29.44 4.57 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.301 1.41 . . . . 0.0 112.527 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -41.48 127.43 3.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.25 1.02 . . . . 0.0 113.434 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 m -54.52 155.2 4.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.229 1.812 . . . . 0.0 115.49 -168.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -154.22 156.6 37.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.175 1.39 . . . . 0.0 109.376 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.41 163.3 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.946 0.898 . . . . 0.0 109.322 170.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.95 145.53 7.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.784 1.234 . . . . 0.0 109.834 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -136.36 133.84 37.21 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.629 1.172 . . . . 0.0 110.035 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.13 -27.99 56.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.625 1.57 . . . . 0.0 113.593 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.82 -0.04 49.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.631 0.651 . . . . 0.0 111.897 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -112.26 -41.79 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.4 mt -47.82 -56.8 6.64 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.351 0.978 . . . . 0.0 111.873 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -83.45 4.18 28.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.702 0.801 . . . . 0.0 112.659 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.88 -27.45 3.61 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.175 . . . . 0.0 112.043 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.83 135.15 56.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.914 1.286 . . . . 0.0 108.678 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.02 -34.23 77.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.4 137.3 25.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.623 1.169 . . . . 0.0 109.175 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.37 147.39 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.1 118.95 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -93.47 133.36 36.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.35 25.54 11.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.203 1.001 . . . . 0.0 108.884 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -72.35 103.87 3.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.765 -1.209 . . . . 0.0 111.263 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.37 15.99 0.76 Allowed Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.196 1.379 . . . . 0.0 109.768 169.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.57 173.35 8.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.583 2.353 . . . . 0.0 111.126 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.34 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.342 -0.848 . . . . 0.0 111.855 169.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.89 -47.1 48.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.242 0.617 . . . . 0.0 111.555 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 43.59 43.26 4.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.92 2.088 . . . . 0.0 113.915 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -73.65 -21.54 60.25 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.981 -1.075 . . . . 0.0 112.442 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.0 m 46.54 95.79 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 127.679 2.391 . . . . 0.0 113.631 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.84 139.16 19.81 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.593 2.862 . . . . 0.0 112.633 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.08 149.2 43.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 p -131.22 158.58 74.84 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.957 2.103 . . . . 0.0 109.258 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.98 159.33 41.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.214 1.943 . . . . 0.0 110.352 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.09 -15.95 25.61 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.078 2.519 . . . . 0.0 111.126 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.31 -12.47 61.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.406 1.482 . . . . 0.0 112.908 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.72 148.26 27.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.223 0.92 . . . . 0.0 112.113 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -68.09 141.45 56.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -135.54 151.04 49.94 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.109 0.564 . . . . 0.0 110.683 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -127.81 161.14 29.71 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.226 2.21 . . . . 0.0 108.031 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -133.07 112.77 12.07 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.3 m0 -124.7 52.09 1.57 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.312 1.845 . . . . 0.0 107.282 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.43 135.07 31.09 Favored Glycine 0 CA--C 1.526 0.723 0 O-C-N 120.809 -1.182 . . . . 0.0 112.241 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.95 158.72 38.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.889 1.676 . . . . 0.0 107.515 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.02 133.42 56.08 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.043 1.737 . . . . 0.0 110.601 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.7 125.95 92.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.39 -24.92 56.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.229 1.286 . . . . 0.0 113.2 -174.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.36 -3.62 41.03 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.135 0.88 . . . . 0.0 112.506 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -123.86 7.0 8.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.221 1.408 . . . . 0.0 109.307 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 99.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.636 1.174 . . . . 0.0 108.472 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -57.27 122.85 13.47 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.977 0.911 . . . . 0.0 108.88 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.82 -105.83 0.25 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.467 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 10.6 p -140.56 171.68 13.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.38 1.872 . . . . 0.0 107.523 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.59 -29.25 70.46 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.235 -0.915 . . . . 0.0 111.216 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.23 -40.56 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.024 0.53 . . . . 0.0 109.896 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HB3' ' H ' ' A' ' 112' ' ' THR . 9.3 tp10 -63.98 -43.24 96.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -59.71 -47.32 86.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.432 0.693 . . . . 0.0 110.595 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -59.65 -36.59 76.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.984 0.811 . . . . 0.0 111.662 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.94 76.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 110.465 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -64.77 -31.09 72.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.268 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.73 -49.25 78.31 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.657 1.117 . . . . 0.0 109.406 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -56.38 -47.41 78.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.892 0.769 . . . . 0.0 111.819 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -60.68 -47.76 84.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.972 0.806 . . . . 0.0 110.695 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.14 -39.41 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -57.11 -53.98 51.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.073 0.851 . . . . 0.0 109.03 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.61 -39.17 80.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.35 0.406 . . . . 0.0 110.857 -170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -60.04 -48.15 82.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.482 0.713 . . . . 0.0 111.055 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.98 -48.94 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.73 -48.66 49.82 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.663 -0.521 . . . . 0.0 111.992 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.08 -47.29 87.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 117.816 0.808 . . . . 0.0 111.007 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -28.29 57.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.256 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -38.83 84.39 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.373 0.988 . . . . 0.0 109.799 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -56.77 -49.85 74.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.457 0.571 . . . . 0.0 109.561 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.662 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.5 -35.54 79.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.044 0.838 . . . . 0.0 111.223 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.69 -38.82 32.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.465 0.306 . . . . 0.0 111.19 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.7 -45.73 9.11 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.089 0.955 . . . . 0.0 111.11 -170.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.6 p -111.28 -19.14 12.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.43 1.092 . . . . 0.0 112.071 -169.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.24 18.06 80.1 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 119.047 1.423 . . . . 0.0 109.475 177.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.867 0.365 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.92 174.02 13.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.214 1.405 . . . . 0.0 108.712 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.55 139.18 28.01 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.32 176.9 6.27 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.49 0.586 . . . . 0.0 110.407 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.23 141.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -145.09 149.1 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.246 0.93 . . . . 0.0 109.065 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.88 137.69 43.45 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.88 0.872 . . . . 0.0 109.017 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -119.83 130.54 54.95 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.62 141.75 51.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.544 0.737 . . . . 0.0 110.438 -169.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 95.4 m -140.63 169.98 16.63 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.015 0.926 . . . . 0.0 110.73 172.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 m -56.99 -25.25 58.12 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.36 1.464 . . . . 0.0 111.61 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.77 136.67 5.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.58 56.7 2.68 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.022 0.929 . . . . 0.0 110.51 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -120.43 -31.95 4.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -128.72 -87.59 0.54 Allowed 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.844 0.747 . . . . 0.0 110.248 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -58.92 -50.45 73.98 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -65.67 -36.36 83.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.346 0.521 . . . . 0.0 111.176 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -62.43 -55.24 29.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.559 1.144 . . . . 0.0 111.001 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -56.74 -44.74 81.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.757 0.823 . . . . 0.0 111.029 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.63 98.48 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.454 0.57 . . . . 0.0 111.635 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -56.51 -43.36 79.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.586 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.1 -49.54 77.39 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.713 0.688 . . . . 0.0 112.068 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.72 -45.32 93.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.952 0.876 . . . . 0.0 111.121 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.23 99.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.019 0.527 . . . . 0.0 110.522 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -54.22 -34.93 61.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.7 0.682 . . . . 0.0 111.81 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -71.33 -62.86 1.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.056 0.389 . . . . 0.0 110.554 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -67.54 -40.92 85.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -169.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.0 mt -75.88 -4.13 39.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.634 0.774 . . . . 0.0 112.472 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.84 56.34 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.637 1.113 . . . . 0.0 113.948 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.78 9.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.306 2.243 . . . . 0.0 114.098 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.3 -3.65 8.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.941 -1.1 . . . . 0.0 111.153 169.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -132.92 122.07 23.79 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -67.79 97.54 0.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.01 140.71 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.05 166.45 26.82 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.411 1.484 . . . . 0.0 109.348 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 90.0 p -143.99 157.43 44.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.766 0.827 . . . . 0.0 109.236 169.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.57 -167.45 1.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.79 -179.0 44.15 Favored Glycine 0 N--CA 1.447 -0.582 0 O-C-N 121.685 -0.634 . . . . 0.0 111.873 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.15 -31.06 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.031 1.332 . . . . 0.0 110.841 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.89 168.58 21.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.257 1.423 . . . . 0.0 108.75 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.0 138.14 25.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -130.02 12.15 5.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 109.641 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 162.49 29.95 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.54 152.77 35.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -77.58 133.05 67.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.63 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.96 -36.45 64.4 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.722 2.281 . . . . 0.0 114.207 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -71.94 -31.98 66.87 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.581 -0.699 . . . . 0.0 110.241 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.29 -44.53 94.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.78 -50.96 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -58.88 -40.78 85.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.642 0.656 . . . . 0.0 111.695 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.48 88.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.583 0.629 . . . . 0.0 109.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.8 mmm -66.51 -38.75 87.89 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.381 0.537 . . . . 0.0 110.857 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.6 -21.02 66.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.541 -1.349 . . . . 0.0 112.084 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.88 -30.44 68.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.927 0.785 . . . . 0.0 109.093 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.81 -33.87 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.9 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.147 0.879 . . . . 0.0 111.239 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.34 157.82 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.24 144.96 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -125.13 -0.52 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.958 1.303 . . . . 0.0 110.325 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -58.56 -30.99 67.56 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.212 -1.555 . . . . 0.0 111.432 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.61 -2.32 6.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 114.756 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.7 52.14 1.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.261 1.391 . . . . 0.0 110.085 -171.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -50.43 142.47 10.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 m -61.49 160.86 10.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.059 1.744 . . . . 0.0 114.915 -169.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -156.22 158.6 37.85 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.191 1.397 . . . . 0.0 109.712 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.49 166.69 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.214 1.006 . . . . 0.0 109.224 169.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.9 143.66 10.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.625 0.77 . . . . 0.0 108.977 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.78 140.71 42.72 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 109.855 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.57 -30.66 61.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.081 1.352 . . . . 0.0 113.166 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.78 -11.01 60.53 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.289 1.036 . . . . 0.0 112.094 -173.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.32 -43.86 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -56.97 -40.31 76.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.093 1.315 . . . . 0.0 112.289 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 4.69 51.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.886 0.875 . . . . 0.0 112.589 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -125.1 -26.99 3.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.815 1.246 . . . . 0.0 112.741 -168.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 131.79 52.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.738 1.215 . . . . 0.0 109.26 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.3 -25.09 65.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.356 0.662 . . . . 0.0 110.741 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 tp -147.91 140.29 24.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.866 1.267 . . . . 0.0 108.34 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.49 147.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.91 127.73 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.66 132.02 44.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.88 10.3 38.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.944 0.498 . . . . 0.0 110.236 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.79 126.7 28.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.308 1.043 . . . . 0.0 110.954 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.39 -3.78 0.14 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.007 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.76 153.74 38.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.51 1.655 . . . . 0.0 109.595 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.1 -20.31 62.48 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.971 1.308 . . . . 0.0 113.801 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.72 8.63 19.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.155 0.889 . . . . 0.0 112.489 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -67.94 110.48 3.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 169.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -60.23 -22.67 63.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.045 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.6 m 61.23 106.48 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.306 2.243 . . . . 0.0 111.201 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -51.92 139.61 50.34 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.996 2.464 . . . . 0.0 112.227 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.04 153.21 38.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.665 0.786 . . . . 0.0 109.488 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 p -133.71 159.14 73.65 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.164 1.785 . . . . 0.0 109.746 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.56 139.81 38.29 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.793 1.662 . . . . 0.0 109.62 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.23 -20.34 24.78 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.887 2.391 . . . . 0.0 112.046 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -67.67 -20.04 65.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.561 1.144 . . . . 0.0 112.258 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.75 143.39 18.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 118.677 0.671 . . . . 0.0 109.226 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -61.69 137.09 58.22 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.83 150.37 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.68 0.792 . . . . 0.0 109.582 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.03 163.13 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 108.274 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -132.58 112.73 12.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -120.97 58.22 0.96 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 106.862 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.06 132.48 17.01 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 121.065 -1.022 . . . . 0.0 113.089 -171.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.8 156.6 31.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.919 2.088 . . . . 0.0 106.388 169.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -60.21 148.19 37.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 110.836 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.39 128.54 82.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.501 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.26 -24.61 72.12 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.48 1.453 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.68 -17.4 64.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.173 0.897 . . . . 0.0 112.434 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -105.02 2.37 29.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.567 1.147 . . . . 0.0 111.266 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 45.66 0.33 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.507 1.523 . . . . 0.0 111.579 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.38 153.19 12.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.847 1.259 . . . . 0.0 112.228 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.61 -53.71 0.39 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -167.01 165.41 15.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.54 1.936 . . . . 0.0 107.044 169.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.54 -28.02 66.72 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.487 0.715 . . . . 0.0 111.242 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -69.91 -39.52 76.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.282 0.492 . . . . 0.0 110.694 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.13 -44.33 76.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -55.81 -52.58 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.199 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -58.2 -40.33 81.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.722 0.809 . . . . 0.0 111.675 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.93 83.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.833 -0.542 . . . . 0.0 111.015 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.2 -34.97 73.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.666 -0.646 . . . . 0.0 111.468 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -59.45 -54.41 46.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.968 0.804 . . . . 0.0 109.973 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.9 -29.51 69.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.623 0.647 . . . . 0.0 111.755 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.27 -54.83 31.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.533 1.06 . . . . 0.0 111.259 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.66 -38.25 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -52.82 -57.3 10.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.135 0.974 . . . . 0.0 109.935 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.92 -41.21 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.279 0.232 . . . . 0.0 111.234 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.96 -39.94 87.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mt -58.74 -51.09 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.36 71.08 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.563 0.602 . . . . 0.0 111.777 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.91 -51.38 69.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 117.587 0.694 . . . . 0.0 110.34 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -70.74 -29.35 65.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.954 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -41.44 90.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.638 1.108 . . . . 0.0 110.199 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -57.15 -52.5 65.06 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.57 -35.25 80.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.059 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.93 -37.32 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.13 -36.18 30.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.633 0.373 . . . . 0.0 111.501 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.71 -40.16 10.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.701 1.201 . . . . 0.0 111.896 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -116.53 -19.16 10.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.338 1.055 . . . . 0.0 111.522 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.78 13.22 81.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.362 0.982 . . . . 0.0 112.76 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.248 0.974 0 CA-C-N 118.625 1.213 . . . . 0.0 110.037 -175.771 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -151.52 173.72 14.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.146 1.378 . . . . 0.0 108.638 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -142.2 134.94 28.39 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -83.09 -175.33 5.78 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 110.269 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -146.42 144.9 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -149.18 152.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.175 0.898 . . . . 0.0 109.182 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 137.5 39.44 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.919 0.888 . . . . 0.0 109.151 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.58 125.09 45.92 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.81 1.244 . . . . 0.0 107.699 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.45 140.97 51.47 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.91 170.41 15.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.318 1.056 . . . . 0.0 112.042 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 p -76.08 35.23 0.13 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.707 2.003 . . . . 0.0 110.607 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.68 110.59 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.721 2.105 . . . . 0.0 108.601 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -75.67 56.33 0.91 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.574 1.15 . . . . 0.0 111.685 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.3 m -129.91 -18.02 3.46 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.2 m -137.1 -87.78 0.29 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.993 0.815 . . . . 0.0 109.187 -170.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -57.16 -53.88 53.04 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.799 0.84 . . . . 0.0 111.137 -170.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 p -67.2 -35.4 79.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.447 0.567 . . . . 0.0 111.536 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -60.53 -55.72 30.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.161 0.985 . . . . 0.0 110.345 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -57.66 -43.98 85.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.505 0.722 . . . . 0.0 111.253 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.02 96.22 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.569 0.622 . . . . 0.0 111.45 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -57.09 -40.55 77.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.565 0.346 . . . . 0.0 110.663 174.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.22 -50.39 67.63 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.738 0.685 . . . . 0.0 112.084 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.22 -45.07 95.01 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.504 0.652 . . . . 0.0 110.579 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.63 97.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.474 0.71 . . . . 0.0 110.474 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.68 -36.11 64.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.798 0.726 . . . . 0.0 111.45 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -70.72 -62.21 1.47 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.052 0.387 . . . . 0.0 110.789 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.11 -38.74 86.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -169.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 71.6 mt -75.65 0.88 16.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.082 0.953 . . . . 0.0 112.232 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.19 22.07 64.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.245 1.403 . . . . 0.0 113.567 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 55.47 13.73 1.0 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.758 2.023 . . . . 0.0 113.39 -169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.42 1.95 14.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.244 1.418 . . . . 0.0 111.284 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 14.8 m95 -129.49 128.89 43.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -67.44 89.35 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 143.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -146.96 163.08 37.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.918 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 79.9 p -141.17 156.07 45.99 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.619 0.768 . . . . 0.0 109.047 169.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.91 -169.3 2.48 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 110.281 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.41 -178.49 46.22 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.47 -27.62 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.765 1.226 . . . . 0.0 110.899 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -147.04 166.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.803 1.241 . . . . 0.0 108.124 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.75 134.08 21.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -134.96 24.48 3.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.308 1.043 . . . . 0.0 109.151 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.05 168.34 39.16 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.97 148.1 27.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.026 0.53 . . . . 0.0 110.53 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -74.37 133.67 77.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 118.117 -0.944 . . . . 0.0 109.129 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.94 -33.61 42.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.868 2.379 . . . . 0.0 114.589 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -72.46 -28.92 63.22 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.254 -0.903 . . . . 0.0 110.853 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.39 85.43 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.17 -49.37 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -43.47 90.31 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.113 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.19 93.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.06 0.846 . . . . 0.0 110.033 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -70.99 -38.21 72.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.717 0.235 . . . . 0.0 111.469 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -63.79 -24.99 67.98 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.794 -1.191 . . . . 0.0 111.393 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -69.55 -14.6 62.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.778 0.831 . . . . 0.0 110.866 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.4 -2.1 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.237 1.015 . . . . 0.0 112.091 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.89 32.36 10.05 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.81 161.07 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.94 146.12 51.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -127.14 -0.7 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.114 1.366 . . . . 0.0 110.447 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -57.95 -31.12 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.388 -1.445 . . . . 0.0 111.267 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -67.7 -4.28 11.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.006 1.723 . . . . 0.0 114.728 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -137.13 53.73 1.88 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.311 1.414 . . . . 0.0 109.678 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -50.16 144.2 7.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.274 1.03 . . . . 0.0 112.345 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 m -64.21 161.36 16.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 114.533 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -156.9 157.67 35.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.471 1.508 . . . . 0.0 109.7 170.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.18 165.35 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.756 0.822 . . . . 0.0 109.492 170.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.86 145.98 6.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.804 1.242 . . . . 0.0 110.128 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.4 134.61 32.66 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.661 1.184 . . . . 0.0 109.944 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.41 -28.42 53.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.396 1.478 . . . . 0.0 113.323 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.92 -11.42 60.86 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.782 1.233 . . . . 0.0 112.201 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.62 -41.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 mt -47.95 -59.08 3.62 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.703 1.138 . . . . 0.0 111.645 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -0.26 30.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.76 -30.74 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.061 1.344 . . . . 0.0 112.066 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.71 131.58 51.17 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 109.858 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.36 -26.06 67.85 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.778 0.431 . . . . 0.0 110.791 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 tp -148.49 142.04 25.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.522 1.129 . . . . 0.0 108.443 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.58 144.14 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.35 126.46 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 p -100.3 135.18 42.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.42 20.68 17.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.474 0.71 . . . . 0.0 109.54 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.1 p -68.1 112.93 5.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.928 1.291 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.55 27.06 0.31 Allowed Glycine 0 CA--C 1.533 1.157 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -111.06 -175.58 2.74 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.101 2.56 . . . . 0.0 112.525 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.0 65.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.43 -49.24 10.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.316 0.646 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 45.57 30.87 0.83 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.571 1.948 . . . . 0.0 114.67 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.28 -21.18 66.27 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.436 -1.415 . . . . 0.0 113.045 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 78.2 m 45.41 92.59 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.383 2.273 . . . . 0.0 113.549 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.14 148.38 9.96 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.9 3.066 . . . . 0.0 114.647 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -63.4 138.45 58.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.551 1.54 . . . . 0.0 110.333 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 p -131.6 154.46 81.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.146 1.779 . . . . 0.0 109.442 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.81 145.21 56.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.203 1.936 . . . . 0.0 110.053 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.87 -21.88 13.87 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.107 2.538 . . . . 0.0 112.073 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -85.8 7.7 22.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.497 1.119 . . . . 0.0 112.38 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.73 144.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.18 138.48 58.42 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -133.12 150.48 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.702 0.801 . . . . 0.0 109.767 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -125.44 159.34 32.14 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.557 1.943 . . . . 0.0 107.914 171.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -133.84 111.88 10.85 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -120.93 57.38 0.98 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.146 1.778 . . . . 0.0 106.741 -174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.55 132.61 29.78 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 120.915 -1.116 . . . . 0.0 111.998 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.09 160.18 35.41 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.62 1.968 . . . . 0.0 106.106 169.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.12 141.85 55.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.373 0.606 . . . . 0.0 110.785 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.36 127.28 93.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 -22.66 44.06 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.082 1.188 . . . . 0.0 113.329 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.21 -9.95 59.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.495 1.043 . . . . 0.0 112.228 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -111.39 0.69 16.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.051 1.34 . . . . 0.0 110.749 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.72 54.0 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.496 2.319 . . . . 0.0 111.174 170.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.59 144.97 46.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.659 1.983 . . . . 0.0 112.003 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.08 -54.97 0.28 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -165.66 167.0 17.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.939 1.696 . . . . 0.0 107.45 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.18 -29.98 70.13 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.104 0.562 . . . . 0.0 111.201 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.13 -37.43 75.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.878 0.471 . . . . 0.0 110.574 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.23 -46.58 73.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -56.56 -48.86 76.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.098 0.559 . . . . 0.0 110.359 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -61.23 -37.93 84.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.584 0.754 . . . . 0.0 112.001 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.61 80.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.242 -0.912 . . . . 0.0 109.909 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.97 -33.22 75.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.803 0.441 . . . . 0.0 111.153 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.88 -50.31 73.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.721 0.809 . . . . 0.0 110.155 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -64.77 -35.0 79.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.39 0.541 . . . . 0.0 111.584 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -66.29 -51.03 61.46 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.337 0.517 . . . . 0.0 110.662 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.36 -39.96 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -53.29 -54.06 41.92 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.321 1.049 . . . . 0.0 109.393 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.53 -44.4 90.97 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 123.206 0.316 . . . . 0.0 111.008 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.58 -39.79 88.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.647 -0.658 . . . . 0.0 111.216 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.08 -51.05 77.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.28 -45.42 64.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -60.69 -50.4 73.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 117.639 0.719 . . . . 0.0 111.105 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -70.18 -33.18 71.43 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.113 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -40.13 96.26 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.407 1.003 . . . . 0.0 109.976 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -57.77 -51.45 69.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.65 -35.74 82.01 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.267 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -63.67 -36.65 84.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.908 -0.495 . . . . 0.0 111.014 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.3 -37.96 27.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.568 0.347 . . . . 0.0 111.409 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.3 -46.83 8.14 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 110.857 -169.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 p -108.49 -17.21 14.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -169.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.36 11.5 80.36 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.238 0.923 . . . . 0.0 112.291 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.472 1.136 . . . . 0.0 108.482 -174.646 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -160.47 173.89 14.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.188 1.395 . . . . 0.0 108.892 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -144.43 145.87 32.16 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.65 168.86 18.48 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -144.29 139.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -144.71 150.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 109.084 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 137.14 37.93 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.002 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -119.51 130.97 55.46 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.02 137.56 51.4 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 111.028 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.5 174.32 10.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.245 1.018 . . . . 0.0 112.221 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -56.3 -27.51 55.79 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.991 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.4 142.01 8.27 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.6 58.45 2.73 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.752 0.821 . . . . 0.0 111.083 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -130.6 -18.63 3.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.3 m -133.01 -96.99 0.3 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.071 0.85 . . . . 0.0 108.901 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -54.28 -50.69 66.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.149 0.98 . . . . 0.0 111.952 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p -67.54 -38.57 84.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.738 0.699 . . . . 0.0 111.246 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -58.45 -54.81 42.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.072 0.949 . . . . 0.0 109.989 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.2 mtm -57.57 -44.83 85.6 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.43 0.692 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.27 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.165 0.586 . . . . 0.0 111.59 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.39 -40.64 78.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.214 0.461 . . . . 0.0 110.88 174.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.09 -53.47 45.31 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -60.97 -44.4 97.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.956 0.378 . . . . 0.0 111.166 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.38 -43.82 97.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.81 -172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -59.0 -34.67 72.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.404 1.002 . . . . 0.0 111.576 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -65.42 -54.89 22.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.199 0.454 . . . . 0.0 110.809 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -78.17 -45.43 23.19 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -170.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 94.9 mt -72.07 -32.92 67.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.352 0.661 . . . . 0.0 111.542 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.02 175.31 44.26 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.95 -1.93 8.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.176 0.99 . . . . 0.0 111.22 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -61.63 -10.18 7.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.863 0.865 . . . . 0.0 110.723 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 18.7 m95 -127.39 124.89 39.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.655 1.982 . . . . 0.0 105.906 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -75.57 88.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t -77.89 140.04 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.09 167.29 23.07 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.215 1.406 . . . . 0.0 109.314 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -142.79 155.64 44.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.03 0.932 . . . . 0.0 109.2 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.55 1.73 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.432 1.093 . . . . 0.0 109.257 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.78 -178.52 44.72 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -56.75 -28.63 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.028 1.331 . . . . 0.0 111.017 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.52 171.02 16.2 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.435 1.494 . . . . 0.0 108.784 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.29 22.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -129.71 10.78 5.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.765 1.226 . . . . 0.0 109.919 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.0 27.8 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -84.51 148.55 26.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 -177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -72.18 136.86 81.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 124.246 1.018 . . . . 0.0 108.752 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.51 -29.09 84.22 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.82 1.68 . . . . 0.0 112.891 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.83 -26.05 61.34 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.097 -1.002 . . . . 0.0 111.013 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -44.07 84.68 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.303 0.956 . . . . 0.0 109.084 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.25 -50.23 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -58.3 -41.8 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.97 89.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.541 0.736 . . . . 0.0 110.346 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 76.9 mmm -74.25 -34.2 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.698 0.227 . . . . 0.0 111.111 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.37 -23.18 66.91 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.66 -1.275 . . . . 0.0 111.553 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.39 -17.84 64.84 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.127 0.971 . . . . 0.0 110.634 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.33 -2.45 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.011 0.924 . . . . 0.0 112.6 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.86 32.65 9.76 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.95 155.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -140.28 82.18 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.153 0.978 . . . . 0.0 109.856 -169.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.73 0.19 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.921 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -20.04 39.82 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 119.938 -1.726 . . . . 0.0 112.18 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -84.18 1.85 42.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.237 1.415 . . . . 0.0 112.659 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -133.86 49.92 2.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.488 1.04 . . . . 0.0 109.937 -172.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 p -46.98 134.09 10.66 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.909 1.284 . . . . 0.0 111.193 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -58.27 157.38 8.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.71 157.88 38.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.227 1.411 . . . . 0.0 109.398 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.35 168.59 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.573 1.149 . . . . 0.0 109.622 170.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.66 142.83 11.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.26 140.79 43.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.395 1.078 . . . . 0.0 109.723 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.73 -30.66 61.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.984 1.314 . . . . 0.0 113.135 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.69 -12.5 61.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.254 1.021 . . . . 0.0 111.884 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 mt -119.77 -43.22 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.61 -39.14 76.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.171 1.351 . . . . 0.0 112.193 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 6.49 48.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.864 0.866 . . . . 0.0 112.577 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -126.9 -29.39 2.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.717 1.207 . . . . 0.0 112.499 -168.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.64 125.48 23.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.88 1.272 . . . . 0.0 109.49 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.48 -26.53 67.23 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -141.61 137.25 31.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.957 1.303 . . . . 0.0 107.784 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.19 146.13 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.34 129.63 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -101.04 131.68 46.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.62 16.22 26.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.297 0.639 . . . . 0.0 109.99 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.5 p -69.24 109.39 4.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 111.022 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 31.36 0.58 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.7 -177.64 3.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.704 2.801 . . . . 0.0 113.414 -169.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.04 -11.61 30.93 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.64 -37.92 2.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.638 1.108 . . . . 0.0 111.447 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.261 2.3 p-10 36.76 47.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.385 2.674 . . . . 0.0 114.789 170.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.57 -13.71 62.3 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.121 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.9 m 44.63 88.56 0.1 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.896 2.479 . . . . 0.0 113.687 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -47.9 148.41 6.48 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.611 3.541 . . . . 0.0 115.01 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -62.26 139.17 58.51 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.626 1.57 . . . . 0.0 110.248 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -129.55 153.27 80.66 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 126.382 1.873 . . . . 0.0 108.677 171.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.95 162.86 39.94 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.408 1.405 . . . . 0.0 109.821 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.62 -22.76 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.523 2.149 . . . . 0.0 112.724 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -87.01 -21.43 26.13 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.61 154.46 5.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 119.439 1.018 . . . . 0.0 109.649 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -71.07 140.44 50.69 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -123.83 154.53 39.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.3 164.56 28.28 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.784 1.634 . . . . 0.0 107.568 169.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -131.68 113.78 13.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -120.74 53.64 1.11 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.667 1.587 . . . . 0.0 106.771 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 128.1 29.42 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 111.823 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.7 161.43 40.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.77 142.01 49.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.0 124.46 88.84 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.84 -22.29 56.6 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.193 1.262 . . . . 0.0 113.163 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.81 60.33 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.388 0.995 . . . . 0.0 112.5 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -115.22 12.38 16.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.85 1.26 . . . . 0.0 111.537 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.34 66.34 0.93 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.12 1.368 . . . . 0.0 109.694 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -57.1 138.01 55.04 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.063 0.945 . . . . 0.0 110.766 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.08 -61.44 0.2 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -166.67 168.87 14.05 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.764 1.625 . . . . 0.0 107.433 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -30.21 70.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.018 0.527 . . . . 0.0 111.416 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.39 -37.78 74.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.797 0.439 . . . . 0.0 110.651 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 -45.89 77.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -59.0 -45.86 89.61 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.01 0.524 . . . . 0.0 110.601 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -60.84 -39.48 89.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.868 0.758 . . . . 0.0 111.628 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.03 85.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -65.98 -34.76 78.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.795 0.438 . . . . 0.0 111.192 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -58.41 -46.84 85.64 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.015 0.926 . . . . 0.0 110.2 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -65.73 -36.25 83.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.4 0.546 . . . . 0.0 111.284 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -68.14 -45.09 74.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.231 . . . . 0.0 111.453 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.52 -42.87 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.971 0.805 . . . . 0.0 109.449 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -39.46 94.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.021 1.282 . . . . 0.0 110.13 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.47 -42.39 78.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.405 0.282 . . . . 0.0 111.611 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.81 -41.12 83.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.04 -0.413 . . . . 0.0 110.745 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.77 -52.75 56.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.77 55.36 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.577 0.626 . . . . 0.0 111.757 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -61.16 -49.69 76.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.561 0.681 . . . . 0.0 110.966 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -69.8 -30.92 68.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.784 -0.573 . . . . 0.0 110.438 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -41.9 82.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.343 0.974 . . . . 0.0 109.855 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.95 -52.27 65.87 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -69.33 -31.28 69.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.455 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -63.01 -37.9 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.4 1.0 . . . . 0.0 111.016 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.28 51.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.788 0.435 . . . . 0.0 111.084 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.38 -40.84 11.83 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.788 0.835 . . . . 0.0 111.736 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.2 p -117.61 -19.06 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.965 0.906 . . . . 0.0 111.929 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.82 10.02 83.69 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.841 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 119.058 1.429 . . . . 0.0 108.889 -175.088 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 118.946 -0.549 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -152.79 157.65 41.1 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.1 137.08 27.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.34 175.66 6.7 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.5 144.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.91 151.59 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.511 1.05 . . . . 0.0 109.024 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -138.15 129.51 27.63 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 123.568 0.747 . . . . 0.0 109.466 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.15 130.63 55.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.495 1.118 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -131.91 136.58 47.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.491 0.716 . . . . 0.0 111.023 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -146.51 -175.39 4.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.948 0.34 . . . . 0.0 111.155 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -62.76 -19.11 63.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.194 0.998 . . . . 0.0 112.462 -170.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.93 143.01 9.16 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.48 51.19 1.21 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.312 1.056 . . . . 0.0 111.843 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -128.2 -9.98 5.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -168.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.4 p -140.23 -101.98 0.15 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.79 0.723 . . . . 0.0 110.207 -169.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -51.43 -47.63 62.95 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.821 1.648 . . . . 0.0 110.689 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.7 p -66.95 -43.07 84.11 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.133 0.271 . . . . 0.0 110.674 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.641 1.176 . . . . 0.0 110.814 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.5 mtm -61.42 -42.53 98.89 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 110.65 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.34 -44.73 94.06 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 118.646 -0.693 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.54 -44.73 73.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.454 0.57 . . . . 0.0 110.506 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.83 -51.85 55.64 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 119.339 -0.701 . . . . 0.0 111.526 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -62.95 -46.0 89.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.447 0.623 . . . . 0.0 111.023 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.49 94.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.564 0.745 . . . . 0.0 110.657 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -57.23 -35.42 69.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.937 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -68.81 -61.88 1.62 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.169 0.441 . . . . 0.0 110.723 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -64.53 -41.02 96.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.409 0.283 . . . . 0.0 111.426 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.14 -1.82 37.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.286 1.035 . . . . 0.0 112.123 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.6 24.5 53.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.149 1.357 . . . . 0.0 113.998 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 55.8 9.44 0.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.412 2.285 . . . . 0.0 113.972 -170.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -66.05 -5.99 11.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 110.515 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -130.41 115.6 17.09 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -68.7 88.55 0.36 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.171 1.388 . . . . 0.0 107.466 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.04 154.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -150.62 164.69 35.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.705 2.002 . . . . 0.0 107.438 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.9 p -141.21 154.29 45.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 169.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.48 -169.45 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 110.365 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.76 -179.5 42.79 Favored Glycine 0 N--CA 1.447 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.9 -27.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.33 1.452 . . . . 0.0 111.416 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -145.72 170.85 15.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 108.43 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.94 136.36 16.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.12 19.1 2.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.611 1.164 . . . . 0.0 110.093 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.54 -176.8 20.35 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -110.42 144.23 39.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.049 0.94 . . . . 0.0 109.797 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -70.51 134.5 86.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.024 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.2 -33.55 44.92 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.06 2.507 . . . . 0.0 114.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -78.09 -28.55 48.75 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 119.151 0.887 . . . . 0.0 110.504 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.66 75.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.39 -52.13 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.98 -38.77 87.15 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.908 0.776 . . . . 0.0 111.397 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.7 87.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.918 0.487 . . . . 0.0 109.825 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.22 -36.57 79.72 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.209 0.459 . . . . 0.0 111.028 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -63.57 -26.37 68.67 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 120.673 -1.267 . . . . 0.0 111.188 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.55 -16.57 63.45 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.69 0.677 . . . . 0.0 111.095 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.16 -1.07 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.715 0.806 . . . . 0.0 112.07 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.46 31.75 11.2 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -123.34 154.92 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -142.64 76.04 1.51 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.596 1.189 . . . . 0.0 110.371 -169.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.4 pt -58.65 -15.12 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.28 1.032 . . . . 0.0 113.339 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.74 -24.84 24.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.62 1.1 . . . . 0.0 111.967 172.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.37 -21.03 33.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.79 -21.86 9.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.875 1.216 . . . . 0.0 114.005 -169.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.0 p 49.01 -164.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.359 1.064 . . . . 0.0 111.553 -169.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 m -129.69 156.19 44.66 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.138 -0.976 . . . . 0.0 111.579 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -155.91 156.11 34.03 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.788 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.87 164.54 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 171.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 147.38 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.084 1.354 . . . . 0.0 110.198 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.39 136.76 33.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.441 1.097 . . . . 0.0 110.051 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -53.86 -29.67 42.29 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.553 1.541 . . . . 0.0 113.074 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.78 -8.74 50.71 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.192 1.397 . . . . 0.0 112.257 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.4 mt -117.29 -42.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.5 mt -47.53 -56.9 6.14 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.693 1.133 . . . . 0.0 112.195 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.87 0.88 51.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.649 0.78 . . . . 0.0 112.813 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -117.89 -31.22 5.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.06 1.344 . . . . 0.0 111.745 -169.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.81 131.31 49.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.206 1.402 . . . . 0.0 109.02 173.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -60.43 -32.15 71.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.668 0.387 . . . . 0.0 109.969 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.34 139.58 28.59 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.323 1.049 . . . . 0.0 109.141 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.61 146.05 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.36 121.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -98.58 135.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.85 18.67 19.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.269 1.027 . . . . 0.0 109.844 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.2 p -70.33 117.23 11.62 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.798 1.239 . . . . 0.0 110.006 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 19.68 0.19 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.861 1.219 . . . . 0.0 111.047 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -88.83 -176.47 5.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.718 3.207 . . . . 0.0 110.672 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.77 -23.14 59.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.1 -41.75 13.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.217 0.917 . . . . 0.0 109.741 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.99 40.51 13.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.009 2.124 . . . . 0.0 113.406 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -68.69 -12.38 61.34 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.806 -1.092 . . . . 0.0 113.21 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.8 m 35.96 88.51 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.202 2.601 . . . . 0.0 113.821 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.96 140.39 13.43 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.959 3.106 . . . . 0.0 113.877 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 138.45 58.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 110.235 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.0 p -125.96 153.37 73.73 Favored Pre-proline 0 N--CA 1.448 -0.533 0 C-N-CA 126.206 1.802 . . . . 0.0 108.768 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.67 153.59 77.44 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.776 1.651 . . . . 0.0 109.301 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.8 -23.51 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.407 2.071 . . . . 0.0 111.937 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -76.81 -25.96 53.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.737 0.815 . . . . 0.0 112.65 -172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.27 144.39 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.855 0.752 . . . . 0.0 109.437 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -65.31 136.24 56.32 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -135.94 151.31 49.82 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.145 0.578 . . . . 0.0 110.455 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -126.55 159.42 33.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.028 2.131 . . . . 0.0 107.809 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -135.98 111.32 9.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -121.47 62.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.199 1.8 . . . . 0.0 106.661 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.99 134.06 21.31 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.252 -0.905 . . . . 0.0 112.224 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.21 161.05 39.26 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.966 2.107 . . . . 0.0 106.168 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.89 148.53 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.759 0.79 . . . . 0.0 110.667 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -71.76 120.88 82.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.811 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.13 -27.22 73.06 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.328 1.352 . . . . 0.0 112.868 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -6.4 41.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.742 0.701 . . . . 0.0 112.589 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -119.35 0.44 11.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.885 1.674 . . . . 0.0 109.846 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.21 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.279 1.432 . . . . 0.0 109.957 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -57.19 124.93 20.51 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.301 1.04 . . . . 0.0 109.6 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.46 -74.93 0.12 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -167.36 168.89 12.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.602 1.561 . . . . 0.0 107.52 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.59 -30.47 69.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.881 -0.512 . . . . 0.0 111.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.27 -38.63 78.47 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.647 0.379 . . . . 0.0 110.453 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -70.96 -38.52 72.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.683 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -59.51 -47.73 84.4 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 119.34 0.973 . . . . 0.0 110.45 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -58.64 -39.72 81.38 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.254 0.622 . . . . 0.0 111.189 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.64 78.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.639 -0.663 . . . . 0.0 111.03 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.76 -35.15 79.91 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.78 -52.93 63.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.701 0.8 . . . . 0.0 110.722 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.51 -30.61 70.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.728 0.695 . . . . 0.0 112.02 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -63.41 -53.92 44.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.431 1.014 . . . . 0.0 110.346 171.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.88 -37.59 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.528 0.603 . . . . 0.0 109.501 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -55.17 -54.15 46.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 123.786 0.834 . . . . 0.0 109.423 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.25 -43.05 99.1 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 123.256 0.347 . . . . 0.0 110.806 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.27 -40.45 90.11 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.766 -0.584 . . . . 0.0 111.314 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.54 -50.93 78.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.23 -46.23 57.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.02 -50.08 75.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 111.003 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -69.83 -30.29 67.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.496 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -39.7 81.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.588 1.085 . . . . 0.0 110.178 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -56.36 -50.08 72.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.31 -37.79 88.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 111.496 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -61.37 -35.71 78.21 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.11 -0.994 . . . . 0.0 111.753 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.11 -35.99 28.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.702 0.401 . . . . 0.0 111.358 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.72 -41.9 10.44 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.014 1.326 . . . . 0.0 111.682 -169.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -115.15 -20.33 10.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.621 1.168 . . . . 0.0 111.579 -169.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.83 81.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.395 0.998 . . . . 0.0 112.768 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.407 1.103 . . . . 0.0 109.573 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -149.9 154.02 37.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.396 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -145.1 134.37 22.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -82.79 -176.63 6.39 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 122.683 0.393 . . . . 0.0 110.019 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.19 143.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.85 151.07 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.934 0.894 . . . . 0.0 109.087 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.91 138.02 38.61 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.877 0.871 . . . . 0.0 108.974 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.6 127.58 53.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -123.38 143.81 49.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.857 1.263 . . . . 0.0 109.976 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.1 m -142.12 176.53 8.89 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.374 1.07 . . . . 0.0 112.11 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -65.26 -18.24 65.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.623 1.169 . . . . 0.0 111.891 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.1 136.08 4.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -80.54 55.85 2.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.08 0.952 . . . . 0.0 111.684 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 m -125.74 -18.43 5.17 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.7 m -137.85 -88.39 0.26 Allowed 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 119.152 0.887 . . . . 0.0 109.563 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -56.62 -53.93 51.91 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.711 0.805 . . . . 0.0 111.18 -169.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -67.23 -35.45 79.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.083 0.401 . . . . 0.0 111.248 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.03 -54.7 41.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.177 0.991 . . . . 0.0 110.103 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.0 mtm -57.81 -41.88 83.11 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.465 0.706 . . . . 0.0 111.366 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.01 95.21 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.444 0.565 . . . . 0.0 111.735 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 58.7 tt0 -55.37 -41.37 72.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.639 0.375 . . . . 0.0 110.784 173.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -49.89 73.62 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.337 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -62.64 -43.79 97.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.737 0.769 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.62 -42.68 99.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.521 -174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -51.79 -38.54 56.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 174.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -69.52 -62.2 1.48 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.206 0.316 . . . . 0.0 110.419 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -68.9 -40.32 79.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.99 -6.47 54.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.23 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.06 24.36 58.34 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.822 1.201 . . . . 0.0 114.157 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.8 t70 57.87 9.93 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.307 2.243 . . . . 0.0 113.953 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -66.26 -5.67 11.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.021 1.328 . . . . 0.0 110.737 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -128.99 124.53 35.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 173.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.2 mmpt? -66.33 100.94 0.68 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.0 t -85.4 139.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -146.39 165.83 28.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.194 1.398 . . . . 0.0 109.294 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.8 p -144.02 157.44 44.33 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.593 0.757 . . . . 0.0 110.064 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.68 -167.31 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.93 -174.45 45.82 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.93 -30.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.998 1.319 . . . . 0.0 111.009 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 168.86 21.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 108.569 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.54 138.68 26.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.73 11.21 5.66 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.64 1.176 . . . . 0.0 110.056 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.4 163.84 33.17 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.74 148.55 30.05 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.371 0.605 . . . . 0.0 110.824 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.16 136.24 79.28 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.003 0.921 . . . . 0.0 109.761 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.99 -36.03 63.2 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.705 2.27 . . . . 0.0 113.893 174.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -72.44 -30.3 64.48 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.621 -0.675 . . . . 0.0 110.547 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.55 90.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -59.05 -49.04 84.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -38.98 81.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.274 0.943 . . . . 0.0 111.009 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.92 -46.48 84.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.369 0.668 . . . . 0.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.6 mmm -68.5 -36.53 79.03 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 118.372 0.533 . . . . 0.0 111.021 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -65.81 -25.14 67.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.905 -1.122 . . . . 0.0 111.18 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -68.83 -17.37 63.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.265 0.626 . . . . 0.0 110.969 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.92 0.33 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.646 0.778 . . . . 0.0 111.921 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.98 32.28 18.14 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 174.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.4 159.74 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -124.66 144.42 50.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -128.6 3.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.856 1.262 . . . . 0.0 110.226 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.04 -28.76 68.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.129 -1.607 . . . . 0.0 111.119 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -64.63 -4.61 4.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.586 1.955 . . . . 0.0 115.17 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -137.92 49.7 1.95 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.294 1.406 . . . . 0.0 110.815 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -46.05 131.85 9.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.271 1.029 . . . . 0.0 110.723 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -55.71 155.88 5.41 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.185 1.794 . . . . 0.0 115.698 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -153.92 158.04 40.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.319 1.448 . . . . 0.0 109.211 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.5 168.7 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 169.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.7 mt -56.39 142.86 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.627 0.771 . . . . 0.0 109.141 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.23 135.71 47.6 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.091 1.356 . . . . 0.0 109.454 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -56.39 -31.27 63.7 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.022 1.329 . . . . 0.0 113.267 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -81.36 -5.15 57.55 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.853 -0.529 . . . . 0.0 111.749 -170.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.5 mt -111.39 -44.0 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.77 -39.88 86.37 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.846 1.203 . . . . 0.0 111.523 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.52 3.14 41.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -126.62 -27.0 3.17 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.999 0.92 . . . . 0.0 112.997 -168.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.91 20.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.513 1.125 . . . . 0.0 109.757 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.68 -28.43 69.9 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.907 0.483 . . . . 0.0 110.775 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.22 140.35 33.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.75 144.04 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 124.28 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.94 127.4 48.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.54 22.89 12.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.667 0.746 . . . . 0.0 109.343 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.94 107.26 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.468 1.507 . . . . 0.0 110.482 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.82 20.25 0.68 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.066 1.317 . . . . 0.0 109.992 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -86.05 175.32 8.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 129.52 3.128 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.84 65.35 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.82 -50.2 8.33 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.181 0.901 . . . . 0.0 109.258 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.73 34.33 1.15 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.808 2.043 . . . . 0.0 113.377 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -62.73 -27.34 69.2 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.702 -1.248 . . . . 0.0 111.392 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.7 t 41.53 110.65 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 131.279 3.832 . . . . 0.0 115.725 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.58 143.79 93.94 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.531 2.154 . . . . 0.0 111.781 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.7 mtm -72.94 157.6 37.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.379 0.672 . . . . 0.0 109.494 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -129.98 162.31 54.5 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.893 2.077 . . . . 0.0 108.363 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.32 161.46 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.047 1.165 . . . . 0.0 109.503 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.13 -23.38 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.453 2.102 . . . . 0.0 111.985 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -75.48 -31.01 60.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.54 0.736 . . . . 0.0 112.63 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -81.21 152.04 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.753 0.787 . . . . 0.0 110.757 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.36 143.52 50.18 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -135.98 149.4 48.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.746 0.418 . . . . 0.0 110.541 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.69 157.82 38.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.816 2.047 . . . . 0.0 107.728 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -133.98 112.75 11.49 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -122.17 56.45 1.1 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.121 1.769 . . . . 0.0 107.216 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.09 125.2 21.33 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.707 -1.245 . . . . 0.0 111.93 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.89 162.21 41.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.697 1.999 . . . . 0.0 106.447 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -68.75 147.42 51.82 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.36 0.6 . . . . 0.0 111.17 -172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.91 126.37 91.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.524 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.17 -24.57 65.82 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.661 1.574 . . . . 0.0 113.663 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.83 -15.12 63.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.42 1.009 . . . . 0.0 112.34 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -108.61 2.45 22.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.432 1.093 . . . . 0.0 111.482 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 53.05 0.29 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.717 2.007 . . . . 0.0 111.508 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 147.84 37.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.828 2.051 . . . . 0.0 112.082 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.9 -53.29 0.36 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.94 165.79 17.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 107.386 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.06 -29.37 68.5 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.351 0.66 . . . . 0.0 111.132 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.13 -41.44 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.41 0.684 . . . . 0.0 110.206 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.49 -46.77 71.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.912 0.885 . . . . 0.0 108.849 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.53 -52.17 64.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 122.872 0.469 . . . . 0.0 110.185 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -58.45 -39.71 80.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.578 0.751 . . . . 0.0 111.609 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.0 93.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.542 -0.724 . . . . 0.0 110.428 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.39 -34.48 78.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.875 0.47 . . . . 0.0 111.64 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -58.82 -48.51 81.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.908 0.776 . . . . 0.0 109.929 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -64.16 -38.25 90.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.612 0.642 . . . . 0.0 111.254 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.7 mmm-85 -61.97 -51.65 67.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.983 0.811 . . . . 0.0 111.156 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.86 -39.34 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -53.81 -55.29 27.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.066 0.946 . . . . 0.0 109.467 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.51 -42.39 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.146 0.279 . . . . 0.0 110.858 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.5 -39.01 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.078 0.551 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.15 -50.65 79.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.38 73.47 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.68 0.657 . . . . 0.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -60.17 -51.98 67.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.599 0.7 . . . . 0.0 110.992 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -69.2 -29.08 66.98 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.87 -1.062 . . . . 0.0 111.405 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -42.02 87.89 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.798 1.181 . . . . 0.0 109.868 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.43 -51.54 69.0 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.61 -34.46 77.93 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.521 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.18 -38.71 90.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.591 0.632 . . . . 0.0 111.001 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.36 36.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.391 0.276 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -90.43 -48.15 7.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.609 1.163 . . . . 0.0 110.908 -169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.8 p -106.69 -18.91 13.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.209 1.004 . . . . 0.0 111.273 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.26 15.81 75.73 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.82 -0.989 . . . . 0.0 112.503 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-N 118.717 1.258 . . . . 0.0 108.644 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.66 171.77 17.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.201 1.4 . . . . 0.0 108.652 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -145.52 140.41 27.47 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 174.52 8.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.63 142.44 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.01 148.63 21.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.903 0.774 . . . . 0.0 109.007 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.33 132.99 36.38 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -115.78 133.11 56.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.78 141.43 51.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.69 0.796 . . . . 0.0 110.009 -169.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.54 169.29 17.88 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 122.103 0.954 . . . . 0.0 112.131 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -76.03 35.81 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.23 2.212 . . . . 0.0 110.857 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.45 112.51 0.86 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.49 54.45 0.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.656 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -128.46 -18.68 3.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.4 m -136.32 -89.61 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.176 0.898 . . . . 0.0 109.688 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -55.24 -52.46 63.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.197 0.999 . . . . 0.0 111.028 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 p -58.03 -47.57 82.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.531 1.133 . . . . 0.0 110.874 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.45 -56.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.89 1.276 . . . . 0.0 110.16 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.1 mtm -57.33 -45.52 84.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.732 . . . . 0.0 111.228 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.03 97.6 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.671 0.669 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -60.99 -34.57 75.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.832 0.453 . . . . 0.0 110.98 176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.72 43.26 Favored Glycine 0 C--N 1.341 0.858 0 C-N-CA 123.706 0.669 . . . . 0.0 111.655 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.67 -43.27 94.04 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 117.533 0.666 . . . . 0.0 110.592 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.59 98.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.771 -176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -53.86 -37.62 63.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.907 1.231 . . . . 0.0 111.954 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -66.76 -57.28 7.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.008 0.367 . . . . 0.0 110.411 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.94 -42.1 61.05 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.094 0.158 . . . . 0.0 111.381 -171.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 -11.43 59.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 112.257 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 26.85 60.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.377 0.989 . . . . 0.0 114.168 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 60.89 6.03 1.11 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.626 2.37 . . . . 0.0 114.134 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.82 -9.68 22.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.56 100.33 0.86 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.1 t -83.12 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -143.27 166.61 24.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.584 1.553 . . . . 0.0 109.421 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -149.74 161.28 42.54 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.614 -0.679 . . . . 0.0 110.133 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.53 -166.64 1.39 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.998 1.319 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.58 -179.97 44.58 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 111.715 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mt -53.52 -29.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.352 1.461 . . . . 0.0 111.356 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.49 167.14 24.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.602 1.161 . . . . 0.0 108.307 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.49 21.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -135.37 24.96 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.38 1.072 . . . . 0.0 109.255 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.84 167.68 39.18 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -84.78 147.54 26.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.959 0.504 . . . . 0.0 110.508 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -73.7 133.75 79.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.089 -0.957 . . . . 0.0 109.303 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.02 -33.8 44.1 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.897 2.398 . . . . 0.0 114.584 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.68 -29.23 63.24 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 121.35 -0.844 . . . . 0.0 110.87 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.37 85.06 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.22 -49.21 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -44.21 91.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.18 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.07 92.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.927 0.785 . . . . 0.0 110.152 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.1 mmm -71.81 -37.4 70.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.81 0.277 . . . . 0.0 111.525 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -27.36 69.06 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.87 -1.144 . . . . 0.0 111.31 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.98 -13.07 62.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.715 0.806 . . . . 0.0 110.852 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.3 -2.42 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.528 1.131 . . . . 0.0 112.228 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.97 33.41 9.73 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.16 160.87 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -128.33 145.15 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.32 -1.04 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.367 1.467 . . . . 0.0 110.284 173.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -57.8 -29.9 65.26 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.602 -1.311 . . . . 0.0 110.97 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -60.79 -16.2 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.697 1.999 . . . . 0.0 114.537 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.1 54.92 1.88 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.713 1.142 . . . . 0.0 110.452 -169.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 p -49.78 140.94 10.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.93 0.892 . . . . 0.0 111.85 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 m -62.36 160.4 13.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.041 1.736 . . . . 0.0 114.517 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -155.98 156.46 34.53 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.963 1.305 . . . . 0.0 109.689 169.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -70.12 164.32 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.857 0.863 . . . . 0.0 109.331 170.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.43 146.92 5.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 110.308 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.54 136.01 32.44 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.392 1.077 . . . . 0.0 109.938 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.53 -28.65 46.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.454 1.502 . . . . 0.0 113.138 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.4 -10.83 59.69 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.966 1.306 . . . . 0.0 112.21 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.1 -42.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 mt -48.66 -58.41 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -1.31 36.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -116.38 -31.5 5.58 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.126 1.37 . . . . 0.0 111.7 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.03 44.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.153 1.381 . . . . 0.0 109.543 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.9 -26.22 67.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.443 0.697 . . . . 0.0 110.656 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -148.03 140.43 24.39 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.641 1.177 . . . . 0.0 108.803 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.69 148.13 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.53 130.76 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.29 132.09 45.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 170.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -102.96 23.21 12.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.904 0.882 . . . . 0.0 109.164 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.55 107.66 4.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.979 1.712 . . . . 0.0 110.45 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.97 26.69 0.44 Allowed Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -109.29 -177.45 3.3 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.429 2.291 . . . . 0.0 113.169 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.42 69.13 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.75 -52.12 7.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.533 0.606 . . . . 0.0 110.117 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.4 t70 45.31 32.91 1.09 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.482 1.913 . . . . 0.0 113.994 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -63.93 -21.65 66.57 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.562 -1.336 . . . . 0.0 112.1 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 44.18 96.7 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 129.568 3.147 . . . . 0.0 114.661 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.09 139.77 25.96 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.91 3.073 . . . . 0.0 114.275 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.8 ttm -75.19 149.24 39.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.895 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -132.65 161.23 64.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.744 2.017 . . . . 0.0 110.05 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.98 133.31 24.86 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.029 1.819 . . . . 0.0 109.278 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.03 -19.3 30.28 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.817 2.345 . . . . 0.0 112.318 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -68.15 -20.18 64.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 111.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.73 142.23 16.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -61.39 136.23 57.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -129.97 158.83 38.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.974 0.91 . . . . 0.0 109.298 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -137.92 166.47 23.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.988 1.715 . . . . 0.0 107.914 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -132.87 117.5 17.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -125.43 52.89 1.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.153 1.781 . . . . 0.0 107.314 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.12 132.17 33.45 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.73 -1.231 . . . . 0.0 112.367 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.23 159.65 36.28 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.501 1.92 . . . . 0.0 106.132 169.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -68.71 142.17 55.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.845 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.05 126.95 93.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.112 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.16 -23.53 45.54 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.115 1.21 . . . . 0.0 113.297 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.69 -9.13 58.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.399 1.0 . . . . 0.0 112.225 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -113.0 4.38 16.69 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.236 1.414 . . . . 0.0 110.667 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.38 63.28 0.37 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.725 2.01 . . . . 0.0 110.442 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -59.44 138.97 57.49 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.669 1.588 . . . . 0.0 110.718 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.1 -59.73 0.2 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -166.17 169.27 14.53 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.054 1.742 . . . . 0.0 107.398 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.98 -29.61 68.56 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.369 0.668 . . . . 0.0 111.416 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.79 -37.8 73.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.788 0.435 . . . . 0.0 110.654 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.6 -43.85 75.58 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -57.4 -48.42 79.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.778 0.431 . . . . 0.0 110.141 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -60.99 -38.06 84.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.4 0.68 . . . . 0.0 111.925 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.44 81.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.46 -33.42 75.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.018 0.527 . . . . 0.0 111.13 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.25 -50.04 74.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.957 0.903 . . . . 0.0 110.278 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -64.88 -34.36 78.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.347 0.522 . . . . 0.0 111.656 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.51 -49.72 62.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.623 0.647 . . . . 0.0 110.821 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.93 -39.86 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -53.72 -54.14 42.22 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.458 1.103 . . . . 0.0 109.601 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.87 -43.23 93.64 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.056 0.222 . . . . 0.0 110.911 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.65 -41.08 88.79 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.999 -0.438 . . . . 0.0 110.77 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.7 mt -59.59 -50.33 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.72 -46.67 66.61 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.763 0.71 . . . . 0.0 111.476 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -62.19 -46.36 89.26 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.404 0.602 . . . . 0.0 110.78 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -72.25 -30.58 65.0 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 -174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -42.19 82.44 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.734 0.814 . . . . 0.0 109.62 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.17 -48.78 75.67 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -37.64 86.24 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.451 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -60.32 -37.29 80.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.643 -0.661 . . . . 0.0 111.496 175.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.87 33.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.518 0.327 . . . . 0.0 111.661 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.96 -45.69 7.83 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.465 1.106 . . . . 0.0 111.128 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.5 p -106.88 -19.49 13.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.055 . . . . 0.0 110.902 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.93 79.1 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.215 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.6 mttt . . . . . 0 C--O 1.248 1.003 0 CA-C-N 118.562 1.181 . . . . 0.0 108.703 176.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 tpp . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.89 10.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.289 0.95 . . . . 0.0 111.83 -172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.63 129.98 41.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 169.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 173.95 3.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.3 142.24 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.54 146.06 22.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 119.043 0.838 . . . . 0.0 108.824 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.55 124.02 22.13 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -107.6 128.39 54.49 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.62 145.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.158 0.583 . . . . 0.0 110.935 -169.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.7 m -141.42 178.83 7.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.755 1.622 . . . . 0.0 109.374 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -75.85 -19.15 59.11 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.654 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.34 131.65 4.15 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.31 54.33 2.27 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.769 0.828 . . . . 0.0 111.748 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -126.1 -16.88 5.42 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -131.84 -106.33 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -170.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -35.44 75.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -60.71 -47.77 84.8 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.18 0.9 . . . . 0.0 110.377 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -60.01 -49.71 76.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.237 1.015 . . . . 0.0 110.221 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.39 -44.74 89.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.16 0.584 . . . . 0.0 111.841 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.79 99.61 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.234 0.614 . . . . 0.0 111.015 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -56.13 -41.2 74.94 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.112 173.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.07 60.97 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.782 0.719 . . . . 0.0 112.309 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.54 -45.78 92.6 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.34 0.57 . . . . 0.0 110.812 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.33 -42.57 99.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.846 -175.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -52.77 -44.35 66.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.395 0.998 . . . . 0.0 111.568 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -74.8 -43.88 52.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.164 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -73.72 -44.58 55.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.494 0.588 . . . . 0.0 110.921 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.01 -9.64 59.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.161 0.984 . . . . 0.0 112.253 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.41 26.48 64.29 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.534 1.064 . . . . 0.0 113.956 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 60.72 5.82 1.01 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.625 2.37 . . . . 0.0 113.986 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.79 -9.32 19.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.641 1.176 . . . . 0.0 110.544 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.52 118.53 23.21 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 172.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -67.87 101.43 1.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.1 137.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -172.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.19 166.19 25.74 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.62 1.568 . . . . 0.0 109.529 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -147.88 157.06 43.34 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.482 0.713 . . . . 0.0 110.007 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.16 -168.03 1.62 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.546 1.139 . . . . 0.0 110.357 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.54 -175.45 42.09 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.442 -0.787 . . . . 0.0 112.598 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -55.09 -30.28 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.531 1.532 . . . . 0.0 110.681 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 169.6 17.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.776 1.23 . . . . 0.0 109.142 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.53 137.05 20.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -136.49 19.45 3.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.205 1.002 . . . . 0.0 109.777 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.71 29.09 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -94.42 146.95 23.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.342 0.657 . . . . 0.0 110.583 -176.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.33 138.77 78.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.826 1.25 . . . . 0.0 109.455 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.15 -30.34 82.04 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.849 1.699 . . . . 0.0 113.255 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.92 -27.21 62.66 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.626 1.103 . . . . 0.0 110.483 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.31 -48.4 73.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.54 1.063 . . . . 0.0 108.941 171.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.68 -48.13 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -57.92 -47.08 83.88 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.933 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -43.68 81.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 0.0 109.389 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.8 mmm -71.25 -39.64 71.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.276 0.231 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.88 -27.09 69.11 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 120.888 -1.133 . . . . 0.0 111.259 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.2 -9.56 58.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.073 0.949 . . . . 0.0 109.957 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.55 -1.12 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.254 1.022 . . . . 0.0 112.591 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.65 33.52 11.28 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.1 161.54 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -125.58 143.35 51.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.58 3.63 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.03 1.332 . . . . 0.0 110.365 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -60.93 -28.06 68.66 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.2 -1.563 . . . . 0.0 110.965 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -65.5 -4.36 5.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.412 1.885 . . . . 0.0 115.322 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.82 47.87 2.03 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.274 1.397 . . . . 0.0 111.273 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 131.28 8.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.42 1.088 . . . . 0.0 110.789 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -54.82 154.42 5.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.448 1.899 . . . . 0.0 115.455 -169.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -152.22 156.0 38.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.206 1.403 . . . . 0.0 109.311 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.7 164.79 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.263 1.025 . . . . 0.0 109.346 171.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.1 mt -56.4 145.85 6.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.608 1.163 . . . . 0.0 109.671 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -136.93 134.42 36.74 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.404 1.082 . . . . 0.0 109.928 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.17 -27.64 55.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.635 1.574 . . . . 0.0 113.522 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.87 -4.18 57.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.527 0.603 . . . . 0.0 111.797 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -107.96 -42.24 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.6 mt -48.37 -60.45 2.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.388 0.995 . . . . 0.0 111.269 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -75.81 -1.94 27.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.371 0.668 . . . . 0.0 112.736 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -115.85 -31.51 5.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.932 1.293 . . . . 0.0 111.34 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.05 124.12 19.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.127 1.371 . . . . 0.0 109.848 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.7 -31.75 71.92 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.816 0.846 . . . . 0.0 110.184 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 tp -142.06 139.17 32.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.389 1.076 . . . . 0.0 108.547 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.41 147.08 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.95 126.83 51.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.29 118.39 36.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.342 0.519 . . . . 0.0 109.766 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.26 12.63 36.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.848 1.259 . . . . 0.0 110.749 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -65.53 119.18 10.61 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.27 -12.97 0.23 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.328 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -70.37 148.92 47.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.174 1.487 . . . . 0.0 108.722 169.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.97 -16.94 48.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.134 1.374 . . . . 0.0 114.377 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -116.76 10.12 14.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.349 0.977 . . . . 0.0 111.684 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.51 90.26 6.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 170.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -52.25 -27.43 14.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.857 1.263 . . . . 0.0 113.584 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 78.7 m 76.5 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 128.424 2.689 . . . . 0.0 111.02 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.23 178.15 3.25 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.335 2.024 . . . . 0.0 110.037 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.8 tpp -130.23 159.07 37.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.472 1.109 . . . . 0.0 109.586 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 166.58 18.23 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.224 1.81 . . . . 0.0 110.457 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.97 161.34 33.55 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.558 1.505 . . . . 0.0 110.011 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.03 -9.12 17.94 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.096 2.531 . . . . 0.0 114.027 -169.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -115.0 -12.72 11.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.27 146.58 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.764 1.165 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.23 136.95 52.74 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -138.61 151.89 47.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.307 0.643 . . . . 0.0 109.987 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.34 161.71 29.66 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.137 2.175 . . . . 0.0 107.387 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -139.48 112.53 8.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.409 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 30.9 m0 -122.43 51.45 1.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.641 1.577 . . . . 0.0 107.062 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.88 132.18 31.32 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 120.885 -1.134 . . . . 0.0 111.88 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.97 35.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.028 1.731 . . . . 0.0 107.411 169.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.27 134.35 56.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.913 1.285 . . . . 0.0 109.842 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.42 124.7 91.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -23.91 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.432 1.421 . . . . 0.0 113.604 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.53 49.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.167 0.894 . . . . 0.0 112.273 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -110.33 8.51 23.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.615 1.166 . . . . 0.0 111.071 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.87 68.7 0.66 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.879 1.272 . . . . 0.0 109.777 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.13 136.34 57.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.792 0.837 . . . . 0.0 110.277 -171.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.55 -61.72 0.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -165.44 167.04 17.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.432 1.493 . . . . 0.0 107.72 171.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.49 -28.05 66.69 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.612 0.765 . . . . 0.0 111.431 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.7 -37.35 70.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.047 0.539 . . . . 0.0 110.941 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -69.39 -44.48 71.38 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.2 -45.96 83.29 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.776 0.431 . . . . 0.0 110.293 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -60.37 -40.47 90.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.47 0.708 . . . . 0.0 111.756 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.08 87.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.487 -0.758 . . . . 0.0 110.513 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -62.8 -37.47 86.85 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.007 0.523 . . . . 0.0 111.274 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.12 -48.95 77.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.364 0.665 . . . . 0.0 110.345 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.53 -36.34 83.46 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.438 0.563 . . . . 0.0 111.824 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -68.43 -47.44 67.22 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.995 0.816 . . . . 0.0 111.085 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.21 -41.41 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.82 -53.17 58.74 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.141 0.976 . . . . 0.0 109.758 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.59 -42.44 98.28 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.781 0.264 . . . . 0.0 110.954 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.6 -41.64 92.56 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.984 -0.447 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.51 -50.78 79.01 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.71 -45.63 60.25 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -61.13 -50.35 73.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 117.446 0.623 . . . . 0.0 111.1 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.409 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.9 tpt180 -68.69 -34.25 75.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.228 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -40.66 98.41 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.687 1.13 . . . . 0.0 109.695 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.79 -51.87 68.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.24 -36.08 83.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.908 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.65 -36.55 83.2 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.709 -0.619 . . . . 0.0 111.2 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.4 -37.85 31.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.652 0.381 . . . . 0.0 111.257 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.35 -46.92 8.07 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.393 1.077 . . . . 0.0 110.868 -170.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -109.41 -18.86 13.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.432 1.093 . . . . 0.0 111.638 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.46 13.16 82.13 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.586 -1.119 . . . . 0.0 112.942 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 119.225 1.512 . . . . 0.0 108.428 179.242 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -152.15 157.26 41.3 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.148 1.379 . . . . 0.0 107.609 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.94 133.61 45.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -71.86 172.75 9.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.12 143.62 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -146.58 149.7 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 119.211 0.914 . . . . 0.0 109.233 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.23 131.55 32.55 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.586 0.754 . . . . 0.0 109.286 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.25 128.3 56.29 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.3 mt -125.03 141.35 52.18 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.072 0.949 . . . . 0.0 110.319 -169.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.3 m -141.12 168.85 18.79 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 122.223 1.011 . . . . 0.0 112.557 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -76.82 34.21 0.15 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.737 2.015 . . . . 0.0 110.479 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.65 109.15 0.67 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 126.351 1.929 . . . . 0.0 108.605 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.46 51.46 0.72 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.201 1.0 . . . . 0.0 111.746 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -120.99 -20.38 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 m -136.32 -92.85 0.25 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.254 0.933 . . . . 0.0 110.66 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -36.71 85.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -61.04 -47.33 86.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.336 0.654 . . . . 0.0 110.616 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -60.69 -49.98 75.34 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.177 0.991 . . . . 0.0 109.679 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 mtm -58.21 -44.46 88.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.061 0.544 . . . . 0.0 111.623 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.45 -44.21 97.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.794 0.725 . . . . 0.0 111.346 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -56.94 -41.84 78.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.449 0.3 . . . . 0.0 110.725 173.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.92 -52.86 50.83 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.763 0.697 . . . . 0.0 112.119 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -61.32 -43.05 99.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.394 0.597 . . . . 0.0 110.82 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.07 99.74 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.923 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -55.08 -36.69 65.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.439 1.018 . . . . 0.0 111.553 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -68.4 -57.67 5.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.238 0.472 . . . . 0.0 110.921 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -76.19 -43.87 40.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.476 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.1 mt -72.56 -34.49 67.53 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.947 0.499 . . . . 0.0 111.46 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 173.57 42.13 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -1.48 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 111.607 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.83 -10.23 5.26 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.428 -0.795 . . . . 0.0 110.991 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.476 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.3 m95 -128.99 119.63 24.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -70.16 92.19 0.75 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.9 t -78.95 138.44 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.49 166.81 24.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.219 1.407 . . . . 0.0 109.46 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -147.71 159.89 43.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.429 0.692 . . . . 0.0 109.721 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.41 -166.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 109.304 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.06 43.61 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 121.311 -0.868 . . . . 0.0 111.776 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.45 -29.56 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.991 1.316 . . . . 0.0 110.734 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.8 166.48 29.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.325 1.45 . . . . 0.0 108.247 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.85 140.08 26.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.16 9.33 5.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.65 149.55 24.89 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -172.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.0 144.96 56.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.497 0.665 . . . . 0.0 111.413 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -73.21 133.31 81.28 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.575 1.15 . . . . 0.0 108.61 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.01 -34.37 37.7 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.872 2.381 . . . . 0.0 114.282 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.78 -28.47 63.65 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.498 -0.751 . . . . 0.0 110.896 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.01 77.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.34 -48.07 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -39.75 94.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.673 -0.68 . . . . 0.0 111.041 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.01 -44.53 97.28 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.304 0.956 . . . . 0.0 110.3 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 74.3 mmm -68.91 -36.27 77.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.642 0.655 . . . . 0.0 111.469 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.484 -1.385 . . . . 0.0 111.396 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -66.43 -17.35 64.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.93 0.786 . . . . 0.0 111.038 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.66 -0.64 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.08 0.952 . . . . 0.0 112.114 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.43 32.85 12.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.03 158.55 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.3 144.6 49.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.412 1.085 . . . . 0.0 108.153 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.99 4.14 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.977 1.311 . . . . 0.0 110.404 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.09 -27.57 67.11 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.113 -1.617 . . . . 0.0 111.153 172.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.38 -3.19 3.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.468 1.907 . . . . 0.0 115.295 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -139.9 47.65 1.82 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.302 1.41 . . . . 0.0 111.645 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 133.21 7.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.599 1.16 . . . . 0.0 111.356 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -57.51 156.61 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.069 1.748 . . . . 0.0 115.153 -169.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -155.95 158.51 38.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.079 1.352 . . . . 0.0 109.301 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.31 164.37 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 170.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.61 149.19 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.829 1.652 . . . . 0.0 110.991 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.53 136.06 32.51 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.705 1.202 . . . . 0.0 110.181 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.01 -29.39 57.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.576 1.551 . . . . 0.0 113.319 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.77 -9.01 52.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.912 1.285 . . . . 0.0 112.27 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.51 -42.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.1 mt -46.98 -57.5 4.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.586 1.085 . . . . 0.0 112.186 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.71 -0.06 52.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 112.801 -173.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.94 -31.92 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.135 1.374 . . . . 0.0 111.527 -169.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.83 130.39 45.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.426 1.491 . . . . 0.0 109.887 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -63.07 -28.12 69.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.712 0.805 . . . . 0.0 110.477 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -147.62 139.95 24.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.891 1.276 . . . . 0.0 108.671 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.66 147.76 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.75 124.29 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -99.44 132.86 44.48 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.65 22.9 15.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.682 0.793 . . . . 0.0 109.362 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.0 111.81 6.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.785 -1.197 . . . . 0.0 110.305 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.53 26.03 0.34 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.14 -175.19 2.67 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.906 2.482 . . . . 0.0 112.549 -169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.34 -32.43 64.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.07 -49.58 10.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.342 0.657 . . . . 0.0 110.89 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 45.57 30.98 0.85 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.554 1.941 . . . . 0.0 114.662 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.06 -22.15 66.41 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.476 -1.39 . . . . 0.0 113.075 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.2 m 47.32 94.36 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.324 2.25 . . . . 0.0 113.73 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.17 134.4 19.18 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.67 2.914 . . . . 0.0 113.224 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.1 ttt -69.53 145.23 52.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.035 0.934 . . . . 0.0 109.663 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.9 p -126.01 160.23 57.95 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 126.432 1.893 . . . . 0.0 109.288 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.28 153.92 75.67 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 121.692 1.595 . . . . 0.0 109.226 169.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.45 -24.22 19.43 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.442 2.095 . . . . 0.0 112.004 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -78.45 -25.3 45.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.522 0.729 . . . . 0.0 112.732 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -78.47 147.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 118.822 0.737 . . . . 0.0 109.676 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -67.94 137.36 55.12 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -135.44 150.4 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.971 0.509 . . . . 0.0 110.401 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -126.91 159.85 32.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.127 2.171 . . . . 0.0 107.946 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -132.92 114.94 14.62 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 24.8 m0 -123.2 53.85 1.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.338 1.855 . . . . 0.0 107.055 -174.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.51 131.12 34.85 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 120.717 -1.24 . . . . 0.0 111.803 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 161.78 37.81 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.795 2.038 . . . . 0.0 106.056 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -68.55 141.61 55.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.227 0.537 . . . . 0.0 110.596 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.24 128.49 93.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.96 -24.38 45.78 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.116 1.077 . . . . 0.0 113.411 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.05 56.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.228 0.922 . . . . 0.0 112.221 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -111.9 3.28 17.46 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.26 . . . . 0.0 110.62 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 62.95 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.892 2.077 . . . . 0.0 110.427 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -60.03 138.96 57.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.722 1.609 . . . . 0.0 110.573 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.55 -59.09 0.21 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 175.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -166.36 168.95 14.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.985 1.714 . . . . 0.0 107.497 169.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.61 -29.36 67.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 111.314 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.9 -38.35 76.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.93 -43.74 74.5 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.04 -47.2 83.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.852 0.461 . . . . 0.0 110.346 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -61.63 -38.65 88.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.75 0.704 . . . . 0.0 111.722 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.08 82.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.168 -0.957 . . . . 0.0 110.334 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.13 -32.11 73.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.976 -0.453 . . . . 0.0 111.197 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.27 -50.37 73.11 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.492 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -45.41 80.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.827 0.74 . . . . 0.0 111.665 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -59.92 -49.73 76.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.866 0.757 . . . . 0.0 110.734 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.0 t -70.77 -39.12 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.78 -56.16 23.83 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 124.342 1.057 . . . . 0.0 108.75 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.57 -38.66 77.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 123.406 0.441 . . . . 0.0 110.7 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.42 -42.46 87.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.898 0.479 . . . . 0.0 111.025 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.79 -50.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.77 -47.58 46.38 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -60.93 -49.37 77.71 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 117.567 0.684 . . . . 0.0 111.479 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.43 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -69.55 -34.3 74.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.126 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.77 88.74 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.596 1.089 . . . . 0.0 109.744 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -55.21 -52.36 63.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.62 -34.83 78.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.56 -36.36 82.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.893 0.77 . . . . 0.0 111.071 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.73 28.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.147 0.579 . . . . 0.0 111.494 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.15 -41.45 11.01 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 111.952 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.2 p -115.05 -19.33 10.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.206 1.002 . . . . 0.0 111.17 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.61 76.92 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.837 -0.98 . . . . 0.0 112.869 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.6 mttt . . . . . 0 C--O 1.247 0.923 0 CA-C-N 118.879 1.339 . . . . 0.0 108.754 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -77.11 -28.57 54.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.124 0.569 . . . . 0.0 111.404 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.77 133.07 51.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 171.99 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -142.97 142.12 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 175.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.74 149.08 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 119.489 1.04 . . . . 0.0 109.039 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.72 134.87 41.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -118.4 130.62 56.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -125.74 138.93 53.89 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 110.088 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t -137.78 169.15 18.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.807 1.243 . . . . 0.0 109.875 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -58.49 -24.78 61.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.292 1.037 . . . . 0.0 111.737 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.25 139.51 6.49 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -77.98 51.91 1.01 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.154 0.982 . . . . 0.0 111.549 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.1 m -127.01 -15.91 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.312 -169.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.6 m -138.38 -95.6 0.19 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -54.8 -52.06 63.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.556 0.742 . . . . 0.0 111.661 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.5 p -68.9 -36.32 77.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.552 0.16 . . . . 0.0 111.312 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.15 -53.95 51.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.114 0.966 . . . . 0.0 110.469 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.8 mtm -57.88 -44.37 86.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.133 0.573 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.21 99.07 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.384 0.538 . . . . 0.0 111.517 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.41 -32.35 70.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.098 0.559 . . . . 0.0 111.878 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.71 29.71 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -60.16 -41.24 92.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 117.338 0.569 . . . . 0.0 110.647 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.51 99.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.287 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -55.09 -40.17 70.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.824 1.193 . . . . 0.0 111.22 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -64.29 -51.8 61.72 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.396 0.435 . . . . 0.0 110.872 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -82.6 -44.6 15.63 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -171.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 92.4 mt -73.48 -33.81 65.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.816 0.446 . . . . 0.0 111.939 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.72 175.95 46.95 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.96 -2.65 10.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.768 0.827 . . . . 0.0 111.399 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.51 -12.35 6.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.776 1.231 . . . . 0.0 111.299 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 17.2 m95 -129.35 117.84 21.27 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -69.2 97.29 0.91 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.23 136.87 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.77 164.23 31.08 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.54 1.536 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.8 p -146.59 159.19 43.76 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.533 0.733 . . . . 0.0 109.729 169.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.5 -166.97 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.521 1.128 . . . . 0.0 109.621 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.47 -178.96 44.76 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -55.53 -27.93 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.259 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.85 172.12 14.66 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.537 1.535 . . . . 0.0 108.367 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.94 137.66 25.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.85 7.72 5.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.553 1.141 . . . . 0.0 110.452 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 145.86 17.98 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.08 142.35 54.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.742 0.782 . . . . 0.0 112.034 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -69.41 138.88 89.11 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 108.963 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.75 -28.71 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.735 1.623 . . . . 0.0 112.983 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -72.3 -29.16 63.6 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 120.985 -1.072 . . . . 0.0 110.478 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -45.91 87.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.19 -52.65 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -59.96 -41.2 91.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.974 0.807 . . . . 0.0 111.478 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.25 91.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.605 0.639 . . . . 0.0 109.853 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.71 -35.15 72.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.174 -0.329 . . . . 0.0 111.035 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -31.65 70.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.059 -1.026 . . . . 0.0 110.966 174.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.45 -15.64 63.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.211 1.004 . . . . 0.0 110.94 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.59 1.16 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.262 1.025 . . . . 0.0 111.859 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.38 30.92 17.85 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.0 mt -120.75 153.59 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -137.51 80.56 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.5 1.12 . . . . 0.0 111.043 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.32 1.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.0 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 96.8 p -61.26 -19.84 62.17 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.208 1.822 . . . . 0.0 112.212 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -81.33 0.3 37.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 112.956 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.29 50.31 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.431 1.014 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -47.58 137.1 9.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.191 1.396 . . . . 0.0 111.547 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -60.07 157.74 12.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -156.35 157.7 36.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.246 1.418 . . . . 0.0 109.743 170.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.5 166.49 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.742 1.217 . . . . 0.0 109.927 171.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.56 146.2 7.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.477 1.111 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.77 136.42 32.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.478 1.111 . . . . 0.0 109.908 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.75 -28.45 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.44 1.496 . . . . 0.0 113.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.38 -11.19 60.61 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.993 1.317 . . . . 0.0 112.231 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.2 mt -114.73 -42.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.4 mt -48.93 -58.79 4.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.814 1.188 . . . . 0.0 111.557 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -1.85 34.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -115.47 -31.92 5.75 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.083 1.353 . . . . 0.0 111.699 -169.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.2 130.62 47.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.286 1.434 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.61 -31.58 71.66 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.695 1.198 . . . . 0.0 109.857 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.87 141.61 24.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.135 1.374 . . . . 0.0 108.557 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.62 144.69 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.55 136.59 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 109.08 14.56 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.68 7.43 39.46 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.885 -0.51 . . . . 0.0 112.318 -168.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.93 120.4 11.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.566 1.147 . . . . 0.0 110.968 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.26 30.72 0.2 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.327 1.441 . . . . 0.0 110.668 170.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -109.79 -174.11 2.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.704 2.802 . . . . 0.0 112.311 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.73 65.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.15 -40.2 7.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.466 1.03 . . . . 0.0 110.561 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 49.78 39.31 17.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.441 1.896 . . . . 0.0 114.014 169.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.42 -10.54 58.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 117.856 -1.069 . . . . 0.0 113.883 -171.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 75.1 m 34.93 88.05 0.1 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.161 2.585 . . . . 0.0 114.17 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.25 139.07 16.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.248 3.298 . . . . 0.0 113.629 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.8 ttp -70.45 140.17 51.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.242 1.017 . . . . 0.0 110.261 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.8 p -134.29 159.33 72.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.532 1.933 . . . . 0.0 110.04 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.66 143.6 46.92 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.115 1.877 . . . . 0.0 109.938 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.54 -20.23 20.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.935 2.423 . . . . 0.0 111.668 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -73.49 -7.71 52.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.117 1.367 . . . . 0.0 112.727 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.1 141.55 34.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.12 136.81 58.19 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -133.67 155.06 50.4 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.111 0.565 . . . . 0.0 110.236 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.92 158.76 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.149 173.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -131.49 115.51 16.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -122.48 59.84 1.02 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -174.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.5 133.18 23.36 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 121.408 -0.807 . . . . 0.0 112.119 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -162.21 161.56 27.93 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.628 1.971 . . . . 0.0 106.439 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -65.23 140.31 58.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.462 0.705 . . . . 0.0 110.692 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.27 128.44 91.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.29 -21.95 34.94 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 120.354 1.162 . . . . 0.0 113.338 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.89 -11.96 60.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.628 1.104 . . . . 0.0 111.855 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -107.79 -1.2 21.12 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.665 1.586 . . . . 0.0 110.677 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.84 52.8 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.781 2.432 . . . . 0.0 111.859 173.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -54.26 137.83 40.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.726 2.01 . . . . 0.0 111.796 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.37 -60.59 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -162.94 164.31 25.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.477 1.511 . . . . 0.0 107.585 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.14 -30.46 71.05 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.841 -0.537 . . . . 0.0 111.492 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.31 -37.04 77.58 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.858 0.463 . . . . 0.0 110.378 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.7 -43.34 69.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -55.64 -49.69 72.19 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.89 -0.506 . . . . 0.0 110.213 171.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -60.38 -36.13 77.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.769 0.713 . . . . 0.0 111.923 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.72 77.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.359 -0.838 . . . . 0.0 109.482 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -63.52 -31.47 72.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.094 -0.955 . . . . 0.0 112.532 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.35 -48.43 80.58 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 120.044 1.293 . . . . 0.0 109.862 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.27 -36.58 83.35 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.8 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -65.12 -50.43 66.07 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.778 0.717 . . . . 0.0 110.293 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.15 -38.27 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.92 -52.93 58.99 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 109.331 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.22 -44.52 91.65 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.112 0.258 . . . . 0.0 111.167 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.27 -39.73 89.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.61 -0.681 . . . . 0.0 111.283 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.6 mt -58.16 -52.77 54.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 172.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.86 61.51 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.35 -50.76 71.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 117.703 0.751 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.931 -176.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.542 1.065 . . . . 0.0 109.737 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -57.01 -53.71 55.0 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.33 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.639 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -62.04 -36.8 82.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.575 -0.703 . . . . 0.0 111.157 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.84 28.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.122 0.569 . . . . 0.0 111.714 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.17 -41.52 10.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.611 1.164 . . . . 0.0 111.996 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.0 p -114.62 -19.1 11.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.154 0.981 . . . . 0.0 110.969 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.59 76.33 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.783 -1.01 . . . . 0.0 112.688 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.5 mttt . . . . . 0 C--O 1.246 0.876 0 CA-C-N 118.781 1.291 . . . . 0.0 108.504 179.317 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.88 174.07 3.97 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.42 142.59 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.25 149.7 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 119.308 0.958 . . . . 0.0 109.189 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 138.3 42.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.842 0.857 . . . . 0.0 109.185 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.23 131.06 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.6 mt -127.94 140.08 52.21 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.785 0.834 . . . . 0.0 110.547 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -139.26 175.26 9.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.176 0.99 . . . . 0.0 111.887 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -55.36 -32.1 62.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.789 1.236 . . . . 0.0 111.142 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 143.27 9.9 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.12 57.83 2.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.094 0.958 . . . . 0.0 111.424 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 m -127.92 -20.22 3.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.0 m -134.33 -93.81 0.3 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.229 0.922 . . . . 0.0 109.052 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -55.36 -50.9 68.49 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.969 0.907 . . . . 0.0 111.518 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 p -67.58 -37.85 83.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.748 0.703 . . . . 0.0 111.501 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -60.5 -52.8 63.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.147 0.979 . . . . 0.0 110.347 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.1 mtm -59.9 -42.07 93.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.54 0.736 . . . . 0.0 111.358 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.91 -43.66 98.2 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.457 0.571 . . . . 0.0 111.329 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 79.7 tt0 -55.96 -43.28 77.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.959 0.345 . . . . 0.0 110.332 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 25' ' ' LYS . . . -54.5 -52.26 46.21 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.34 -0.7 . . . . 0.0 112.754 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.525 0.662 . . . . 0.0 111.275 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.69 98.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.806 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 46.1 mtmt -51.09 -41.2 59.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.238 0.926 . . . . 0.0 111.325 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -67.32 -61.97 1.65 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.329 0.393 . . . . 0.0 110.566 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -69.48 -39.15 77.85 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.3 mt -77.84 -5.37 50.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.507 0.723 . . . . 0.0 112.542 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.57 55.96 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.559 1.076 . . . . 0.0 114.006 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 58.69 8.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.427 2.291 . . . . 0.0 114.292 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.82 -3.88 7.89 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.89 -1.131 . . . . 0.0 111.093 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 8.6 m95 -132.4 121.59 23.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.9 mmpt? -67.62 97.3 0.6 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -80.39 139.86 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -146.93 165.23 30.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.408 1.483 . . . . 0.0 109.501 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.0 p -144.5 157.48 44.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.734 0.814 . . . . 0.0 109.624 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.89 -166.31 1.57 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.87 1.268 . . . . 0.0 109.552 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -179.46 46.18 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mt -56.14 -27.66 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.997 1.319 . . . . 0.0 111.448 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.63 171.94 13.98 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.74 1.216 . . . . 0.0 108.968 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.65 135.36 17.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -137.03 17.46 3.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.24 1.016 . . . . 0.0 109.896 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.97 167.61 25.1 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -91.31 149.79 21.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.224 0.61 . . . . 0.0 110.721 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -74.47 134.14 76.65 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.872 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.87 -34.84 57.34 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.778 2.318 . . . . 0.0 114.115 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -72.98 -32.74 65.38 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.447 -0.783 . . . . 0.0 110.297 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -44.72 91.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.37 -51.22 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -58.07 -44.49 87.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.921 0.782 . . . . 0.0 111.511 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.0 86.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.39 -37.58 77.58 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.984 0.356 . . . . 0.0 111.333 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -63.69 -27.58 69.31 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.927 -1.108 . . . . 0.0 111.309 174.655 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.35 -16.27 63.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.018 0.826 . . . . 0.0 110.769 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.27 0.55 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.908 0.883 . . . . 0.0 112.052 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.45 18.75 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.35 160.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 53' ' ' LYS . 28.5 t70 -125.05 141.88 51.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.67 0.788 . . . . 0.0 109.596 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.76 -0.54 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.406 1.482 . . . . 0.0 109.826 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -58.62 -33.01 69.54 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.344 -1.473 . . . . 0.0 111.116 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -63.28 -17.75 62.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.254 1.821 . . . . 0.0 114.763 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -120.86 52.53 1.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.664 1.12 . . . . 0.0 110.569 -168.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -48.18 136.07 12.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 110.984 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -57.11 155.57 8.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -168.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -153.72 156.31 37.58 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.359 1.464 . . . . 0.0 109.395 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.55 168.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.544 1.138 . . . . 0.0 109.447 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -56.51 142.99 11.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.673 0.789 . . . . 0.0 108.935 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.61 140.88 43.15 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.513 1.125 . . . . 0.0 109.876 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.67 -30.56 61.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.066 1.346 . . . . 0.0 113.166 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -70.01 -11.12 60.65 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.278 1.031 . . . . 0.0 112.069 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.0 mt -121.06 -43.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 pp -56.93 -40.66 76.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.078 1.308 . . . . 0.0 112.341 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.2 4.84 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.901 0.881 . . . . 0.0 112.542 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -125.59 -26.42 3.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.813 1.245 . . . . 0.0 112.851 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.39 132.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.617 1.167 . . . . 0.0 109.384 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.03 -25.48 66.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.705 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.6 tp -147.77 141.97 26.14 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.672 1.189 . . . . 0.0 108.655 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.63 147.04 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.1 t -132.64 127.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -100.89 134.39 43.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.25 18.22 21.33 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.212 0.605 . . . . 0.0 109.971 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.6 p -67.98 116.04 8.18 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 170.892 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 113.357 0.483 . . . . 0.0 113.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -68.61 145.69 53.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.373 1.069 . . . . 0.0 109.57 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -130.2 158.23 74.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.095 1.758 . . . . 0.0 109.868 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 138.18 35.05 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 121.907 1.738 . . . . 0.0 109.291 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.63 -21.19 25.86 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.802 2.335 . . . . 0.0 112.306 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -67.89 -23.13 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.132 0.973 . . . . 0.0 112.083 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.98 142.21 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -170.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.05 139.24 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.984 0.914 . . . . 0.0 108.589 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -133.64 151.64 51.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.598 0.759 . . . . 0.0 110.123 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.92 159.23 34.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.781 2.033 . . . . 0.0 107.723 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -135.05 111.15 9.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -121.42 62.03 0.91 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.968 1.707 . . . . 0.0 106.847 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.37 133.4 23.81 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 121.198 -0.939 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 161.16 35.19 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.561 1.944 . . . . 0.0 106.126 169.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.23 143.2 55.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.237 0.542 . . . . 0.0 110.903 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.24 127.15 93.06 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.81 -23.73 62.23 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.176 1.251 . . . . 0.0 113.378 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.67 -14.66 63.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.334 0.97 . . . . 0.0 112.337 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -110.02 3.84 20.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.121 1.368 . . . . 0.0 111.294 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.22 61.66 0.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.406 1.882 . . . . 0.0 111.225 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -59.13 138.68 57.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.805 1.642 . . . . 0.0 110.701 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.09 -59.36 0.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.1 t -165.06 167.58 18.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.81 1.644 . . . . 0.0 107.402 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.28 -30.77 70.68 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.115 0.566 . . . . 0.0 111.283 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.63 -38.54 80.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.831 0.452 . . . . 0.0 110.379 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.27 -42.3 72.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -56.35 -52.21 65.43 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.114 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.8 t-105 -56.99 -40.34 76.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.89 0.768 . . . . 0.0 111.287 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.22 -40.98 97.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.511 0.596 . . . . 0.0 110.16 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -67.31 -29.86 69.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.634 -1.174 . . . . 0.0 113.139 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -60.55 -50.79 72.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.853 1.66 . . . . 0.0 109.813 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -65.9 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.94 0.791 . . . . 0.0 112.035 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -65.58 -51.81 56.93 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.359 0.982 . . . . 0.0 110.893 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.08 -37.9 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -54.65 -53.57 53.0 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.571 0.749 . . . . 0.0 109.581 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.06 -43.47 98.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.763 0.256 . . . . 0.0 110.963 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -40.45 91.21 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.737 -0.602 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -59.32 -50.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.02 63.79 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -59.64 -50.0 75.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.558 0.679 . . . . 0.0 110.895 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -70.32 -30.13 67.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 117.321 -1.323 . . . . 0.0 111.554 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -39.95 84.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.654 1.115 . . . . 0.0 110.104 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -56.4 -50.92 70.2 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.02 -36.17 83.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.201 0.455 . . . . 0.0 111.662 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.7 -36.63 83.57 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.357 -0.84 . . . . 0.0 111.539 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.37 -36.93 33.29 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.481 0.312 . . . . 0.0 111.173 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.4 -42.78 10.71 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.047 1.339 . . . . 0.0 111.797 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 p -115.05 -20.29 10.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.464 1.106 . . . . 0.0 111.475 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.35 82.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.939 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 119.12 1.46 . . . . 0.0 109.059 178.244 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -77.45 178.25 7.35 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.9 140.41 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -143.27 152.1 16.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.778 0.831 . . . . 0.0 109.325 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.62 136.45 29.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.095 0.958 . . . . 0.0 109.088 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.64 125.37 44.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.654 1.182 . . . . 0.0 108.261 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.3 142.41 49.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.755 1.222 . . . . 0.0 109.477 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -139.95 171.44 14.2 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.158 0.983 . . . . 0.0 111.833 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -60.04 -23.0 63.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.941 0.897 . . . . 0.0 111.795 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.96 134.88 4.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 169.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.82 55.01 1.96 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.289 1.036 . . . . 0.0 111.528 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -126.55 -16.86 5.22 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.4 m -137.88 -87.12 0.27 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.073 0.851 . . . . 0.0 109.478 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -57.99 -54.36 47.86 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.754 0.822 . . . . 0.0 111.192 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 10.8 p -67.01 -34.57 78.04 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.975 0.352 . . . . 0.0 111.238 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -62.16 -55.5 28.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.958 0.903 . . . . 0.0 109.998 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.5 mtm -58.06 -42.71 86.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.274 0.63 . . . . 0.0 111.484 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.92 97.96 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.621 0.646 . . . . 0.0 111.353 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.6 tt0 -56.88 -41.68 78.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.933 0.333 . . . . 0.0 110.611 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.35 68.63 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.484 0.584 . . . . 0.0 112.41 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -63.53 -42.97 98.4 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.596 0.698 . . . . 0.0 111.089 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.35 99.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.564 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -52.0 -38.6 57.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.954 0.797 . . . . 0.0 111.643 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -70.51 -62.59 1.33 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.204 0.315 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -68.81 -36.87 78.75 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.2 mt -78.44 -2.11 36.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.353 0.661 . . . . 0.0 112.197 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.5 24.05 58.96 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.979 1.276 . . . . 0.0 113.961 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.14 14.32 1.97 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.031 2.132 . . . . 0.0 113.633 -172.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.15 -0.86 15.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.928 1.291 . . . . 0.0 110.91 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.7 m95 -133.46 122.52 23.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.54 97.42 0.59 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 24' ' ' ALA . 1.9 t -82.1 140.88 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -144.76 166.13 26.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.166 1.387 . . . . 0.0 109.533 174.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 87.8 p -145.68 158.44 43.85 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.689 0.796 . . . . 0.0 109.888 169.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.34 -168.17 1.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.708 1.203 . . . . 0.0 110.205 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.0 179.96 46.82 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.534 -0.729 . . . . 0.0 111.325 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -56.38 -27.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.049 1.34 . . . . 0.0 111.304 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.11 168.94 21.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.915 1.286 . . . . 0.0 108.563 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.48 138.44 26.15 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.74 12.97 6.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.757 1.223 . . . . 0.0 109.826 172.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 163.77 34.43 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -170.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.53 146.21 38.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.217 0.532 . . . . 0.0 110.375 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -70.52 134.33 86.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.671 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.15 -35.62 43.11 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.657 2.238 . . . . 0.0 114.095 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.42 -27.26 63.18 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.451 -0.78 . . . . 0.0 111.011 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.9 85.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.36 -49.91 81.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -57.81 -40.24 79.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.395 0.998 . . . . 0.0 111.642 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.84 84.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.598 0.636 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.2 mmm -68.1 -35.3 77.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.423 0.556 . . . . 0.0 111.123 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -68.07 -23.72 64.98 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.669 -1.269 . . . . 0.0 111.308 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -67.13 -21.16 65.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.091 0.859 . . . . 0.0 110.398 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.59 -1.47 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.24 0.616 . . . . 0.0 112.133 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.0 33.28 15.46 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.64 159.28 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.94 144.39 49.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -128.82 3.53 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.984 1.314 . . . . 0.0 110.261 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.98 -28.66 67.87 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 111.061 171.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.49 -4.65 4.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.421 1.888 . . . . 0.0 115.192 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -138.16 49.23 1.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.425 1.466 . . . . 0.0 110.879 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 p -46.61 131.56 11.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 110.747 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -56.85 156.73 6.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.134 1.773 . . . . 0.0 115.179 -169.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -153.38 157.04 39.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.069 1.348 . . . . 0.0 109.132 171.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.77 164.89 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.867 0.867 . . . . 0.0 109.402 169.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.49 139.89 14.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 109.546 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.64 138.39 50.06 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.435 1.494 . . . . 0.0 109.671 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -57.56 -27.63 62.83 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.598 1.559 . . . . 0.0 113.29 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.05 -12.72 61.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.828 1.251 . . . . 0.0 112.075 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -112.73 -41.21 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.47 -58.56 4.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.836 1.198 . . . . 0.0 111.499 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.79 0.36 27.28 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -118.66 -31.75 4.76 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.984 1.314 . . . . 0.0 111.783 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 128.36 35.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 109.755 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.65 -25.41 64.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.174 0.59 . . . . 0.0 110.781 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.8 tp -145.53 141.08 27.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.44 1.096 . . . . 0.0 108.171 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.86 153.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.88 136.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -109.17 122.3 47.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.3 25.28 5.06 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.054 0.941 . . . . 0.0 109.52 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -75.42 68.34 2.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.019 2.127 . . . . 0.0 113.606 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.228 0 O-C-N 121.122 -0.987 . . . . 0.0 111.203 170.981 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.534 0.494 0 N-CA-C 114.011 0.735 . . . . 0.0 114.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 147.08 52.77 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.866 1.266 . . . . 0.0 111.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -133.39 159.38 72.8 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.967 2.107 . . . . 0.0 108.964 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.1 138.61 40.35 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.77 1.647 . . . . 0.0 109.429 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 -18.48 39.48 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.902 2.402 . . . . 0.0 112.129 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -64.45 -19.93 65.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.493 1.117 . . . . 0.0 112.019 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.5 t -110.99 136.66 46.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 118.937 0.79 . . . . 0.0 109.105 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -63.2 132.13 50.71 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.132 0.973 . . . . 0.0 108.746 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.99 159.55 28.11 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.598 0.759 . . . . 0.0 109.475 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -128.7 169.78 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.73 2.012 . . . . 0.0 107.188 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -136.11 122.49 20.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.61 58.6 1.3 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.86 1.664 . . . . 0.0 107.107 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.19 125.07 14.59 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.939 -1.101 . . . . 0.0 112.07 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.26 158.72 43.21 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.569 2.347 . . . . 0.0 105.806 168.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.27 149.5 48.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.198 0.523 . . . . 0.0 110.832 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.89 125.69 89.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.52 -25.11 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.378 1.385 . . . . 0.0 113.471 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.54 52.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.351 0.978 . . . . 0.0 112.115 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -114.57 3.74 14.94 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.951 1.3 . . . . 0.0 110.842 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.94 64.41 0.32 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.851 2.06 . . . . 0.0 110.308 169.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.51 139.67 56.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.495 1.518 . . . . 0.0 110.658 -171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.67 -57.59 0.21 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.64 169.43 13.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.019 1.728 . . . . 0.0 107.378 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.97 -30.5 70.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.902 -0.499 . . . . 0.0 111.349 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.75 -36.93 73.37 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.762 0.425 . . . . 0.0 110.676 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.89 -46.34 75.23 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -57.04 -48.46 78.48 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.294 0.637 . . . . 0.0 110.17 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -61.24 -37.86 84.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.5 0.72 . . . . 0.0 111.972 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.47 82.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.43 -33.26 75.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.861 0.465 . . . . 0.0 110.931 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.85 -48.57 79.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.81 0.844 . . . . 0.0 110.459 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.27 -41.49 98.5 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.474 0.579 . . . . 0.0 110.752 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -62.89 -48.61 78.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.117 0.871 . . . . 0.0 111.172 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.84 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 118.613 0.642 . . . . 0.0 109.301 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -55.23 -53.81 51.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.029 0.831 . . . . 0.0 109.235 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.07 -40.89 91.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.319 0.387 . . . . 0.0 111.236 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.91 -45.89 87.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.38 0.672 . . . . 0.0 110.428 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.1 mt -58.13 -50.14 79.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.87 51.4 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.573 0.624 . . . . 0.0 111.842 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -59.48 -48.6 81.01 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 117.751 0.776 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.87 -25.83 53.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.656 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.67 -38.54 83.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 120.057 1.299 . . . . 0.0 109.673 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.61 -50.42 73.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.43 -42.32 98.57 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 110.503 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -58.78 -33.26 70.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 120.274 -1.516 . . . . 0.0 111.854 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.56 -35.4 24.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.702 0.401 . . . . 0.0 111.958 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.31 -45.47 8.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.774 1.23 . . . . 0.0 112.034 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.7 p -113.86 -20.14 11.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 110.835 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.21 11.01 81.6 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.585 1.088 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt . . . . . 0 C--O 1.246 0.907 0 CA-C-N 118.916 1.358 . . . . 0.0 110.379 -177.384 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.71 172.9 9.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.15 142.37 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.58 151.5 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.083 0.953 . . . . 0.0 109.546 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.83 139.04 39.74 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.965 0.906 . . . . 0.0 109.321 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -122.54 128.59 50.95 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.406 1.082 . . . . 0.0 108.653 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.64 139.85 53.49 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.34 1.056 . . . . 0.0 110.015 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -139.93 175.03 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.184 1.793 . . . . 0.0 108.407 170.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -52.78 63.93 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 120.941 -1.099 . . . . 0.0 109.537 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.88 126.92 7.31 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.91 60.05 0.72 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.35 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -134.75 -20.67 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -126.49 -99.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -47.98 83.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 112.31 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 18.8 p -62.95 -38.41 90.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.425 0.557 . . . . 0.0 111.485 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -62.38 -55.21 30.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.193 0.997 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 49.7 mtm -55.91 -43.78 77.65 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.263 0.625 . . . . 0.0 111.316 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.3 99.34 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.362 0.665 . . . . 0.0 111.553 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.3 tt0 -57.27 -41.19 79.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.918 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -49.48 78.19 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.707 0.685 . . . . 0.0 112.493 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -61.32 -46.25 91.05 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.579 0.69 . . . . 0.0 110.833 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -64.07 -40.78 97.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.315 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -51.31 -43.68 61.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.297 0.953 . . . . 0.0 111.006 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -71.15 -58.3 3.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 123.699 0.625 . . . . 0.0 111.206 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -64.37 -39.43 93.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.967 0.348 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.51 -2.86 54.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.178 0.991 . . . . 0.0 112.274 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.95 59.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.208 1.385 . . . . 0.0 114.629 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.56 5.8 0.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 0.0 113.97 -170.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.27 -7.55 19.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.837 -1.164 . . . . 0.0 110.343 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -128.08 121.02 28.63 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -68.92 97.86 0.89 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 24' ' ' ALA . 2.5 t -83.01 140.69 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.35 167.06 23.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.337 1.455 . . . . 0.0 109.175 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 85.3 p -144.72 157.47 44.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.82 0.848 . . . . 0.0 109.692 170.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.9 -170.28 2.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 110.894 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.75 -177.55 42.18 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 122.052 -0.405 . . . . 0.0 113.069 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -56.48 -32.6 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.11 1.364 . . . . 0.0 109.637 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.07 169.07 19.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.867 1.667 . . . . 0.0 109.634 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.46 24.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.28 8.92 5.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.737 1.215 . . . . 0.0 110.087 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.96 165.58 25.92 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -170.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -85.27 150.08 25.03 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.047 0.539 . . . . 0.0 111.098 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -73.33 133.25 80.97 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.507 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.72 -36.29 61.29 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.732 2.288 . . . . 0.0 113.994 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -70.94 -32.97 70.03 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.723 -0.611 . . . . 0.0 110.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.5 90.88 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.67 -47.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -40.09 93.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.441 0.564 . . . . 0.0 111.184 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.27 99.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.626 0.771 . . . . 0.0 109.914 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.1 mmm -68.49 -38.0 80.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.23 0.468 . . . . 0.0 110.974 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -27.5 68.74 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 173.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.95 -16.77 64.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.869 0.758 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.63 1.47 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.157 0.983 . . . . 0.0 112.054 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.73 21.1 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -117.8 158.89 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.77 146.08 48.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.492 1.117 . . . . 0.0 108.506 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.27 3.31 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 110.431 170.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.06 -28.19 67.59 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 119.885 -1.76 . . . . 0.0 111.276 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.1 -5.45 4.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 115.091 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.48 50.83 1.95 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.993 1.269 . . . . 0.0 110.397 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 p -47.09 134.37 10.74 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.958 0.903 . . . . 0.0 110.724 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 m -56.79 156.23 6.81 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.033 1.733 . . . . 0.0 115.653 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -153.91 157.4 39.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.213 1.405 . . . . 0.0 109.465 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 169.04 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.193 . . . . 0.0 109.441 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.38 141.76 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.39 141.4 41.73 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.475 1.11 . . . . 0.0 109.844 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 m -55.4 -30.24 60.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.088 1.355 . . . . 0.0 113.299 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.21 -13.67 62.53 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.006 0.922 . . . . 0.0 111.984 -173.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -121.06 -42.46 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.383 1.073 . . . . 0.0 108.299 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.37 -39.05 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.329 1.422 . . . . 0.0 112.118 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.5 4.87 51.8 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.792 0.837 . . . . 0.0 112.705 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -125.32 -28.8 3.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.886 1.274 . . . . 0.0 112.435 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 128.71 38.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.043 1.337 . . . . 0.0 108.983 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.77 -23.25 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.85 139.89 26.66 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.746 1.218 . . . . 0.0 108.067 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.7 146.51 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 t -135.43 129.37 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.07 129.98 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.47 23.18 11.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.627 0.771 . . . . 0.0 109.379 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -76.56 104.26 6.98 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.379 -1.451 . . . . 0.0 112.317 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.187 0 O-C-N 121.682 -0.636 . . . . 0.0 111.892 169.255 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.461 -0.425 0 N-CA-C 113.115 0.391 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.4 mmt -73.84 152.82 40.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.565 0.746 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 p -133.2 165.29 37.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.528 1.931 . . . . 0.0 109.393 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.81 155.21 68.72 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 172.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.03 -9.29 14.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.229 2.619 . . . . 0.0 114.56 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -129.77 0.04 4.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.515 1.052 . . . . 0.0 113.492 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.6 t -85.93 145.5 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.17 133.11 55.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -130.24 149.54 51.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.879 0.872 . . . . 0.0 109.003 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -132.89 169.75 16.32 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.085 1.354 . . . . 0.0 108.6 170.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -134.78 115.76 14.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 23.3 m0 -121.63 61.43 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.486 1.515 . . . . 0.0 107.243 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.82 128.84 9.86 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.172 -0.955 . . . . 0.0 112.367 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.85 159.5 44.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.177 2.191 . . . . 0.0 106.401 168.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.0 153.8 43.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.573 0.749 . . . . 0.0 110.612 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.05 125.01 73.73 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 110.124 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.51 -26.34 62.35 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.691 1.594 . . . . 0.0 113.864 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.27 -13.12 62.02 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.022 0.828 . . . . 0.0 112.264 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mtm105 -114.39 13.9 17.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.264 0.938 . . . . 0.0 111.476 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.83 67.29 0.81 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 0.0 109.975 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -58.6 138.71 56.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.793 0.837 . . . . 0.0 110.383 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.24 -60.02 0.23 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 172.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -167.32 167.48 13.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.671 1.589 . . . . 0.0 107.522 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.12 -29.21 68.46 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.093 0.557 . . . . 0.0 111.291 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.97 -39.66 75.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.964 0.506 . . . . 0.0 110.681 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.58 -44.63 86.1 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.83 -50.33 74.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.711 -0.662 . . . . 0.0 110.503 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -57.39 -40.28 77.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.242 0.928 . . . . 0.0 111.153 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.08 74.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.627 -0.671 . . . . 0.0 110.892 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.93 -34.92 64.51 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.703 -1.248 . . . . 0.0 111.26 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -58.26 -52.54 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.962 0.801 . . . . 0.0 109.881 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.81 -30.97 71.68 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.513 0.597 . . . . 0.0 112.115 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.11 -49.68 69.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.631 1.105 . . . . 0.0 111.117 173.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.4 -39.61 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.708 0.686 . . . . 0.0 109.187 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -53.04 -52.85 57.15 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.26 1.024 . . . . 0.0 109.727 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.41 -41.06 89.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.145 0.278 . . . . 0.0 111.331 -172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -64.15 -43.29 95.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.995 0.518 . . . . 0.0 110.421 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.36 -49.35 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.66 -47.35 64.52 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -59.74 -49.71 76.66 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 117.31 0.555 . . . . 0.0 110.391 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.14 69.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.312 -175.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -42.04 79.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.029 0.831 . . . . 0.0 110.069 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.07 -49.65 75.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.46 -36.35 82.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.743 -0.17 . . . . 0.0 111.237 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -61.51 -37.67 84.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.238 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.89 -37.0 41.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.451 0.3 . . . . 0.0 111.183 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.42 -48.32 6.71 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.727 1.211 . . . . 0.0 111.011 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.7 p -105.73 -20.49 13.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.749 1.22 . . . . 0.0 111.41 -169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.33 18.35 78.21 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.538 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.2 mttt . . . . . 0 C--O 1.248 1.021 0 CA-C-N 118.507 1.154 . . . . 0.0 109.51 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 175.53 2.9 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.11 142.04 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 tt -143.36 151.05 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -137.8 135.8 36.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.901 0.881 . . . . 0.0 108.795 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -117.88 137.74 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 mt -133.65 145.63 50.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.222 0.609 . . . . 0.0 111.509 -169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.02 173.51 12.39 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.504 1.122 . . . . 0.0 112.359 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.8 m -57.79 -29.65 65.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.165 1.786 . . . . 0.0 111.433 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 141.36 8.29 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -83.78 55.8 3.4 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.508 0.654 . . . . 0.0 112.087 -169.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 m -132.6 -12.05 3.06 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.7 m -131.68 -105.81 0.26 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -50.89 -47.17 60.71 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.587 1.155 . . . . 0.0 111.688 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -61.9 -42.12 98.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -69.37 -45.03 70.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.504 0.722 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.5 -43.23 99.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.978 0.511 . . . . 0.0 110.221 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.4 98.49 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.377 0.671 . . . . 0.0 111.255 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' HG12 ' A' ' 34' ' ' VAL . 17.1 tt0 -57.37 -40.94 79.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.068 0.395 . . . . 0.0 110.075 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.86 -53.51 45.73 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.062 0.839 . . . . 0.0 111.532 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.52 -45.88 92.31 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.141 0.47 . . . . 0.0 110.686 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.39 93.83 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.316 0.646 . . . . 0.0 110.321 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -57.72 -33.58 68.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.869 0.759 . . . . 0.0 111.353 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.31 -62.28 1.45 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.16 0.437 . . . . 0.0 110.664 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -65.7 -43.06 90.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.337 0.255 . . . . 0.0 111.397 -169.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.78 -6.55 52.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.599 1.16 . . . . 0.0 112.112 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.56 51.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.972 1.272 . . . . 0.0 114.136 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t70 56.35 11.44 0.82 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.488 2.315 . . . . 0.0 114.081 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -64.89 -7.5 11.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.979 1.312 . . . . 0.0 110.484 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -126.65 118.78 25.48 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.67 98.78 0.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 t -80.08 138.77 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -140.11 166.06 25.69 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.772 1.629 . . . . 0.0 109.22 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -151.6 145.0 24.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.024 0.929 . . . . 0.0 108.711 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.39 -170.38 2.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.698 1.199 . . . . 0.0 112.02 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.06 -176.59 45.31 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.155 -0.966 . . . . 0.0 112.117 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.29 -30.38 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.862 1.265 . . . . 0.0 111.23 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.92 167.6 24.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.688 1.195 . . . . 0.0 109.193 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.82 141.9 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -132.16 1.59 3.87 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.574 1.15 . . . . 0.0 110.263 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.12 -166.25 22.81 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.2 pt? -119.04 149.85 40.97 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 110.322 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -72.0 134.2 83.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.759 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.38 -36.14 56.95 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.691 2.26 . . . . 0.0 113.895 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.46 -32.49 66.29 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.538 -0.726 . . . . 0.0 110.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.24 84.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.04 -52.04 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -58.91 -40.07 83.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.604 0.638 . . . . 0.0 111.633 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.89 94.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.512 0.596 . . . . 0.0 109.596 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.2 mmm -68.65 -36.83 79.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.28 0.491 . . . . 0.0 111.184 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.35 -25.21 67.93 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.886 -1.134 . . . . 0.0 111.524 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.32 -17.14 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.9 0.773 . . . . 0.0 110.885 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.52 -0.34 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.705 0.802 . . . . 0.0 112.108 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 31.68 13.9 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.21 159.74 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.77 145.54 51.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.96 -6.51 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.833 1.253 . . . . 0.0 110.625 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -57.59 -38.5 74.99 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.866 0.867 . . . . 0.0 110.894 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -18.59 37.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.845 1.258 . . . . 0.0 113.984 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.03 -40.73 18.01 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 119.639 1.109 . . . . 0.0 110.395 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 p 56.07 176.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.162 1.785 . . . . 0.0 111.069 -168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -128.27 153.68 46.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.79 158.52 35.39 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.045 0.938 . . . . 0.0 109.467 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.37 163.48 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.647 0.779 . . . . 0.0 108.992 169.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.61 149.0 5.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.771 1.228 . . . . 0.0 110.209 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.54 136.6 33.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.354 1.062 . . . . 0.0 110.113 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.86 -28.64 51.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.392 1.477 . . . . 0.0 113.161 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.25 -11.15 60.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.034 1.333 . . . . 0.0 112.188 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -114.12 -42.76 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.23 -58.42 5.07 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.206 . . . . 0.0 111.504 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -0.93 30.52 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.45 -31.54 5.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.945 1.298 . . . . 0.0 111.928 -168.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.959 1.304 . . . . 0.0 109.705 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.3 -26.24 67.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.75 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 tp -147.28 142.65 27.4 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.534 1.134 . . . . 0.0 108.669 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.41 151.38 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -140.03 128.26 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.46 136.16 37.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.9 7.74 26.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.563 0.745 . . . . 0.0 111.054 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.95 126.7 28.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.898 1.279 . . . . 0.0 110.638 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.929 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.226 170.266 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 CA--C 1.541 0.833 0 CA-C-O 121.606 0.586 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 48.3 tpp -124.73 156.35 37.79 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.71 1.604 . . . . 0.0 108.843 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p -128.43 161.17 58.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.622 1.569 . . . . 0.0 110.459 -169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.21 139.25 54.55 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.965 1.777 . . . . 0.0 109.576 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 -22.45 26.34 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.803 2.335 . . . . 0.0 112.25 -173.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -81.07 3.13 24.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.717 0.807 . . . . 0.0 112.48 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.37 134.55 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -64.39 132.05 48.96 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -123.34 159.07 29.63 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.663 0.785 . . . . 0.0 109.125 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.58 166.2 17.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.144 1.778 . . . . 0.0 107.337 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -133.56 113.17 12.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -119.9 58.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.847 1.659 . . . . 0.0 106.702 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.15 134.24 21.23 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.335 -0.853 . . . . 0.0 112.364 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.2 161.26 33.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.935 2.094 . . . . 0.0 106.118 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.71 146.95 24.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.663 1.185 . . . . 0.0 111.68 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.87 117.89 70.0 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 124.819 1.248 . . . . 0.0 108.937 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.38 -22.96 71.78 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.535 1.49 . . . . 0.0 113.628 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.41 61.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.427 1.012 . . . . 0.0 113.036 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -120.95 13.28 11.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.563 1.074 . . . . 0.0 112.094 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.22 55.65 0.21 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.306 1.842 . . . . 0.0 110.378 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.93 148.61 43.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.81 2.044 . . . . 0.0 112.201 -169.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.56 -54.05 0.34 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -166.42 166.93 16.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.106 1.763 . . . . 0.0 107.322 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.55 -29.66 69.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.177 0.591 . . . . 0.0 111.158 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.22 -37.07 74.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.896 0.479 . . . . 0.0 110.717 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.66 -47.33 69.83 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -54.54 -50.96 66.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.935 0.494 . . . . 0.0 110.086 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -58.84 -39.09 80.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.872 0.869 . . . . 0.0 112.027 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.07 86.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.496 -0.752 . . . . 0.0 110.114 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.58 -36.37 82.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.797 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.25 -47.37 83.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.411 1.005 . . . . 0.0 110.157 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -64.64 -39.18 93.24 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.645 0.657 . . . . 0.0 111.518 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -64.49 -49.09 72.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.242 0.928 . . . . 0.0 110.684 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.18 -39.2 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -54.05 -53.78 48.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.003 0.921 . . . . 0.0 109.442 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.2 -44.04 96.46 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.27 0.356 . . . . 0.0 111.29 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.12 -40.88 95.1 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.852 -0.53 . . . . 0.0 111.108 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.48 -49.68 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.18 -46.06 71.82 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -60.77 -46.95 88.48 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.465 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -72.7 -31.19 64.82 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.9 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -40.9 87.3 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.263 0.625 . . . . 0.0 110.017 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.42 -49.16 75.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.8 -43.82 98.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.095 0.474 . . . . 0.0 110.408 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.93 -33.82 69.21 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.804 -1.185 . . . . 0.0 112.334 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.43 22.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.019 0.528 . . . . 0.0 112.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -94.14 -52.39 4.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.001 1.321 . . . . 0.0 110.625 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.8 p -102.06 -14.69 17.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.344 1.457 . . . . 0.0 110.37 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.05 13.59 83.19 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.845 1.212 . . . . 0.0 112.052 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.245 0.862 0 CA-C-N 118.038 0.919 . . . . 0.0 109.572 -175.297 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--O 1.235 0.305 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.06 176.17 7.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.619 0.645 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -142.51 143.13 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.24 149.71 17.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.611 0.765 . . . . 0.0 109.151 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.49 132.78 33.78 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.959 0.904 . . . . 0.0 108.733 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -115.9 129.99 56.64 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -129.08 139.38 52.02 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.59 0.756 . . . . 0.0 109.562 -169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.7 p -150.16 -174.25 4.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.995 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -67.6 -9.46 43.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.252 1.021 . . . . 0.0 113.158 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.8 126.63 1.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.13 52.07 0.33 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.282 1.433 . . . . 0.0 113.293 -169.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 -18.63 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 m -136.3 -90.57 0.28 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.741 0.701 . . . . 0.0 109.379 -170.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -55.21 -53.2 58.98 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.748 0.819 . . . . 0.0 111.437 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.4 p -68.01 -35.73 78.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -173.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.63 -51.59 64.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.944 0.898 . . . . 0.0 110.836 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.5 mtm -60.66 -43.06 98.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.249 0.62 . . . . 0.0 110.69 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.5 97.22 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.455 0.57 . . . . 0.0 111.032 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' HG12 ' A' ' 34' ' ' VAL . 68.7 tt0 -57.98 -41.32 82.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.695 173.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.34 -51.85 56.18 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.889 0.768 . . . . 0.0 111.973 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -62.9 -45.69 91.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 117.577 0.689 . . . . 0.0 110.711 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.53 99.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.235 0.614 . . . . 0.0 110.595 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -52.69 -36.29 56.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.866 0.757 . . . . 0.0 111.598 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -72.28 -62.79 1.31 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.368 0.531 . . . . 0.0 110.733 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -65.41 -41.26 93.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.521 0.328 . . . . 0.0 111.822 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.53 -5.85 53.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.819 0.848 . . . . 0.0 112.444 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.74 50.67 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.942 1.258 . . . . 0.0 114.601 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 59.21 6.24 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.211 2.205 . . . . 0.0 114.197 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.33 -7.42 18.76 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.929 -1.107 . . . . 0.0 110.358 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -130.93 121.75 25.72 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.46 97.62 1.02 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -85.08 134.73 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.53 168.3 20.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.24 1.416 . . . . 0.0 109.616 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 95.5 p -145.5 160.43 41.62 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.581 0.752 . . . . 0.0 110.12 169.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.51 -166.85 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.632 1.173 . . . . 0.0 109.842 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.27 -179.39 43.91 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 121.399 -0.813 . . . . 0.0 111.514 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.65 -27.65 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.349 1.46 . . . . 0.0 111.298 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -146.26 169.79 18.07 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.813 1.245 . . . . 0.0 108.405 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 136.33 18.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -136.79 26.26 3.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.716 1.206 . . . . 0.0 109.428 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.09 168.43 42.8 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 60' ' ' SER . 1.3 pt? -86.41 147.68 25.91 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.303 0.573 . . . . 0.0 110.779 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -73.97 133.74 78.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.081 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.51 -34.47 42.38 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.775 2.317 . . . . 0.0 114.438 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.23 -28.21 62.03 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.189 -0.944 . . . . 0.0 110.921 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.44 81.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.09 -49.59 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -59.92 -41.89 92.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.75 0.705 . . . . 0.0 111.592 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.78 92.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.448 0.567 . . . . 0.0 109.752 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.8 mmm -68.11 -36.22 79.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.401 0.546 . . . . 0.0 111.313 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 120.985 -1.072 . . . . 0.0 111.52 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.73 -17.54 64.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.036 0.835 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.72 -0.41 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.89 0.876 . . . . 0.0 112.167 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 32.59 13.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.3 160.83 20.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.22 145.97 52.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.2 pt -128.05 -9.93 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.811 1.644 . . . . 0.0 109.923 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 44' ' ' LEU . 92.4 p -60.97 -25.84 67.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.844 1.202 . . . . 0.0 111.549 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.44 -27.39 69.08 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.431 1.493 . . . . 0.0 113.638 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -96.17 -29.24 14.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.47 1.032 . . . . 0.0 112.437 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.0 p 52.04 -173.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.882 1.673 . . . . 0.0 112.946 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -123.81 156.41 36.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.241 1.017 . . . . 0.0 111.234 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.56 157.24 35.0 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.125 0.97 . . . . 0.0 109.638 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.52 163.71 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.033 169.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.0 mt -56.56 146.71 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.905 1.282 . . . . 0.0 110.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.14 136.18 33.26 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.376 1.07 . . . . 0.0 110.067 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.71 -28.75 50.23 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.479 1.512 . . . . 0.0 113.188 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.61 -11.58 60.95 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.88 1.272 . . . . 0.0 112.177 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mt -114.47 -42.36 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 mt -48.52 -58.69 4.3 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.7 1.136 . . . . 0.0 111.775 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -1.12 34.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -116.14 -32.37 5.37 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.142 1.377 . . . . 0.0 111.614 -168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.53 126.77 28.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.291 1.436 . . . . 0.0 109.586 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.26 -24.55 66.6 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.22 0.608 . . . . 0.0 111.037 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.12 139.65 27.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.41 1.084 . . . . 0.0 108.554 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.88 145.26 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.32 129.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -97.55 132.7 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.34 19.13 20.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.593 1.157 . . . . 0.0 109.51 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.89 114.46 6.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 110.008 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.286 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 170.099 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 CA--C 1.533 0.462 0 N-CA-C 113.495 0.537 . . . . 0.0 113.495 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -71.25 145.83 49.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.518 1.127 . . . . 0.0 110.007 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 p -131.22 158.84 74.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.328 1.851 . . . . 0.0 110.133 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.1 136.68 38.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.228 1.952 . . . . 0.0 109.327 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.25 -23.95 20.4 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.528 2.152 . . . . 0.0 112.641 -171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -79.11 -9.59 59.6 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.214 0.606 . . . . 0.0 112.532 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.96 138.48 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -62.04 132.25 52.28 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -130.46 156.91 43.99 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.485 1.114 . . . . 0.0 109.572 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -134.44 167.86 19.98 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.241 1.817 . . . . 0.0 108.341 169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -135.86 118.15 15.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -125.34 57.66 1.31 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.377 1.871 . . . . 0.0 106.967 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.52 134.92 28.64 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.784 -1.198 . . . . 0.0 112.311 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 160.75 35.08 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.523 1.929 . . . . 0.0 106.089 169.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.71 143.83 55.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.92 126.25 92.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 -26.2 55.33 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.139 1.226 . . . . 0.0 112.921 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.48 -4.3 41.87 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.034 0.833 . . . . 0.0 112.538 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -120.43 0.44 10.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.992 1.717 . . . . 0.0 109.385 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.71 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.9 1.68 . . . . 0.0 109.192 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -58.16 123.27 15.42 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.33 -91.33 0.1 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.9 t -158.04 167.89 28.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.97 1.308 . . . . 0.0 108.023 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 -31.02 70.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.121 0.568 . . . . 0.0 111.874 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -39.48 84.3 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.64 0.376 . . . . 0.0 110.164 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.6 -38.5 70.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.72 -49.12 78.77 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 118.568 0.622 . . . . 0.0 110.186 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.23 -37.61 77.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.759 0.708 . . . . 0.0 111.207 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.65 84.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -63.32 -31.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.176 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.31 -52.06 66.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.251 1.387 . . . . 0.0 110.091 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.4 -34.63 78.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.869 0.759 . . . . 0.0 111.587 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -63.18 -52.6 61.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.836 1.198 . . . . 0.0 110.942 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.73 -37.5 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -54.32 -53.85 48.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.777 0.717 . . . . 0.0 109.409 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.34 -42.65 92.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.367 0.417 . . . . 0.0 110.58 -171.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.48 -41.1 93.67 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.959 -0.463 . . . . 0.0 111.195 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.38 -49.97 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.03 -46.57 61.29 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.589 0.631 . . . . 0.0 111.661 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.33 -48.8 80.2 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.618 0.709 . . . . 0.0 110.602 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -70.69 -30.0 66.46 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 117.297 -1.335 . . . . 0.0 111.611 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -39.82 82.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.93 1.241 . . . . 0.0 110.068 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.21 -49.41 74.18 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.445 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.67 -37.32 83.65 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.23 -35.84 35.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.496 0.318 . . . . 0.0 111.041 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.73 -42.18 10.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.513 1.125 . . . . 0.0 111.664 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.2 p -114.41 -20.81 10.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 0.0 111.817 -169.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.59 78.36 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.359 0.98 . . . . 0.0 112.836 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.245 0.853 0 CA-C-N 118.817 1.308 . . . . 0.0 109.958 -176.51 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -71.26 170.27 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -145.16 143.12 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -147.62 152.67 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.598 0.759 . . . . 0.0 109.526 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.49 133.03 30.32 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.805 0.842 . . . . 0.0 109.248 -173.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.89 127.81 55.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -124.1 141.54 51.97 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.623 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t -144.19 172.12 13.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.993 0.917 . . . . 0.0 110.633 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 p -59.37 -28.61 67.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.337 1.455 . . . . 0.0 110.824 169.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.5 147.98 16.87 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.8 45.72 1.02 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.853 -0.792 . . . . 0.0 111.886 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -128.12 -3.13 5.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 p -145.91 -106.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.964 1.256 . . . . 0.0 110.982 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -55.31 -36.94 66.74 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.941 0.896 . . . . 0.0 112.163 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.5 -52.72 64.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.337 1.055 . . . . 0.0 111.169 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -60.06 -50.34 74.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.501 1.121 . . . . 0.0 110.363 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.3 mtm -58.41 -44.53 89.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.92 0.488 . . . . 0.0 111.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -44.57 96.9 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.626 0.648 . . . . 0.0 111.437 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.9 tt0 -59.57 -42.74 93.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.38 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.86 -53.1 46.75 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.852 0.739 . . . . 0.0 112.073 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -61.55 -43.8 98.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.299 0.55 . . . . 0.0 110.838 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.98 -42.29 99.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 117.618 -1.182 . . . . 0.0 111.193 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -55.92 -37.58 69.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.381 1.446 . . . . 0.0 111.102 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -67.52 -56.43 9.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.285 0.493 . . . . 0.0 110.887 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -73.09 -45.59 56.34 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.068 0.147 . . . . 0.0 111.189 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.9 mt -72.15 -32.84 67.27 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.131 0.572 . . . . 0.0 111.367 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.4 176.51 51.03 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.02 -8.86 13.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.182 1.393 . . . . 0.0 111.565 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.14 -6.79 7.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 111.398 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.489 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 24.2 m95 -129.18 128.8 44.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.109 1.764 . . . . 0.0 107.02 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -76.48 88.64 3.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.5 t -80.54 133.72 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -141.41 167.33 22.43 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.863 1.265 . . . . 0.0 109.527 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.7 p -146.9 159.51 43.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.801 0.84 . . . . 0.0 109.093 169.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -168.04 1.96 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.911 1.284 . . . . 0.0 109.189 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.3 -175.78 43.02 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 121.427 -0.795 . . . . 0.0 111.517 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 mt -55.96 -28.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.716 1.606 . . . . 0.0 111.059 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -146.29 173.0 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.686 1.194 . . . . 0.0 109.455 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.26 18.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -139.13 10.7 2.58 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.788 0.835 . . . . 0.0 111.259 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.01 136.09 9.2 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -62.2 145.41 53.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.823 0.849 . . . . 0.0 112.686 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -72.26 133.62 83.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.685 1.194 . . . . 0.0 108.86 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.29 -34.63 41.07 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.823 2.349 . . . . 0.0 114.353 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -73.06 -29.33 62.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.751 0.705 . . . . 0.0 110.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.13 -49.3 74.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.7 -49.87 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.37 -39.88 92.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.964 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.9 96.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.713 0.688 . . . . 0.0 110.228 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.5 mmm -68.6 -36.39 78.64 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.807 -0.558 . . . . 0.0 111.28 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.712 -1.243 . . . . 0.0 111.485 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.65 -17.46 64.85 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.003 0.819 . . . . 0.0 110.935 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.57 -0.43 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.894 0.877 . . . . 0.0 112.125 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.15 32.45 14.13 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.53 159.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -127.31 146.3 50.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.25 0.65 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.182 1.393 . . . . 0.0 110.391 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -58.58 -28.74 65.84 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.285 -1.509 . . . . 0.0 111.15 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -67.42 -4.38 11.02 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.972 1.709 . . . . 0.0 115.001 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.82 49.81 2.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.577 1.535 . . . . 0.0 110.256 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 p -48.18 144.5 3.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 112.647 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -56.78 148.71 19.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.929 1.691 . . . . 0.0 113.936 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.44 153.52 31.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.281 1.433 . . . . 0.0 109.911 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.99 165.72 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.448 1.099 . . . . 0.0 109.68 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.37 145.87 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.552 1.141 . . . . 0.0 110.047 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -140.04 134.99 32.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.452 1.101 . . . . 0.0 109.872 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.0 -28.11 49.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.472 . . . . 0.0 113.168 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.12 -11.87 61.18 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.104 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -114.42 -41.54 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 mt -48.77 -57.62 6.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.035 1.288 . . . . 0.0 111.557 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.25 1.29 29.08 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -119.83 -32.14 4.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.007 1.323 . . . . 0.0 111.862 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.65 128.41 36.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.237 1.415 . . . . 0.0 109.44 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.59 -23.48 65.4 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.944 0.498 . . . . 0.0 110.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.3 tp -146.47 142.07 27.73 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.67 1.188 . . . . 0.0 107.993 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.02 152.86 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.46 129.0 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.9 134.72 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.12 3.57 30.46 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.883 0.873 . . . . 0.0 111.485 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.3 p -65.9 110.31 2.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.912 1.285 . . . . 0.0 111.688 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.191 0 C-N-CA 124.353 0.978 . . . . 0.0 111.746 169.793 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 120.567 0.153 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.6 mtm -79.39 156.31 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.781 0.833 . . . . 0.0 109.962 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -131.38 161.94 58.99 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.291 1.836 . . . . 0.0 110.263 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.5 140.52 52.57 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.904 1.736 . . . . 0.0 109.948 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.98 -22.01 20.14 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.917 2.412 . . . . 0.0 112.044 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -81.76 6.15 16.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.195 0.998 . . . . 0.0 112.461 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.01 140.71 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.97 136.42 57.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -128.31 156.22 43.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -124.3 164.51 19.45 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.606 . . . . 0.0 107.497 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -131.33 109.92 10.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -116.4 55.54 0.81 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.83 126.99 32.95 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.68 166.0 33.53 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.506 1.922 . . . . 0.0 106.628 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -64.24 149.76 47.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.665 0.745 . . . . 0.0 110.772 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.95 118.03 70.62 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.72 -23.13 63.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.617 1.544 . . . . 0.0 112.949 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.4 63.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.35 0.977 . . . . 0.0 112.214 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -111.27 4.79 19.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.47 1.508 . . . . 0.0 111.497 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.01 60.91 0.79 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.231 1.812 . . . . 0.0 111.55 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.16 141.67 53.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.016 1.726 . . . . 0.0 110.983 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.86 -58.41 0.23 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -165.94 167.29 16.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.033 1.733 . . . . 0.0 107.13 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.19 -30.16 70.24 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.86 -0.525 . . . . 0.0 111.416 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.912 0.485 . . . . 0.0 110.491 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.45 -43.25 67.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.323 0.649 . . . . 0.0 109.315 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.62 -48.32 75.11 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 121.85 -0.531 . . . . 0.0 110.394 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -60.76 -37.45 81.88 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.788 0.722 . . . . 0.0 111.704 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.93 77.77 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.296 -0.877 . . . . 0.0 110.5 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.211 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.35 -48.77 79.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.437 1.017 . . . . 0.0 109.3 171.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -47.61 79.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.571 1.078 . . . . 0.0 112.0 172.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -60.34 -47.91 84.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.663 0.665 . . . . 0.0 110.383 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.59 -37.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -56.02 -54.8 40.47 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.487 1.04 . . . . 0.0 108.693 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -65.9 -43.39 88.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.506 0.504 . . . . 0.0 110.436 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.04 -34.48 73.3 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.256 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -59.14 -52.22 63.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 169.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.09 -46.79 61.57 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.75 -37.29 85.95 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.603 0.702 . . . . 0.0 111.541 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -78.96 -30.85 44.78 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.371 -0.831 . . . . 0.0 111.111 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -40.1 81.22 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.86 174.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -51.29 -50.17 59.84 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.874 0.87 . . . . 0.0 109.674 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.83 -45.08 87.67 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 117.657 0.208 . . . . 0.0 110.82 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -57.32 -33.3 67.57 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.902 -1.124 . . . . 0.0 112.32 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.55 -37.88 24.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.934 0.493 . . . . 0.0 111.996 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.45 -51.71 5.28 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.444 1.097 . . . . 0.0 111.014 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.8 p -104.07 -17.15 15.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 110.722 -169.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.63 80.09 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.291 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 118.926 1.363 . . . . 0.0 108.864 175.225 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.05 170.14 8.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.48 141.57 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.85 149.71 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 119.021 0.828 . . . . 0.0 108.947 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.37 134.72 36.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.87 121.15 42.34 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.68 143.56 45.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 110.15 -169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -153.17 -176.16 5.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.477 0.711 . . . . 0.0 111.389 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 p -86.4 -0.98 57.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.159 1.384 . . . . 0.0 112.808 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.44 114.09 0.44 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.67 50.71 0.25 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.879 1.272 . . . . 0.0 114.332 -169.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 m -124.88 -20.11 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 121.206 -0.934 . . . . 0.0 113.444 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.0 m -128.86 -106.08 0.3 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.042 0.837 . . . . 0.0 109.426 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -40.25 46.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.391 1.476 . . . . 0.0 113.553 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 p -65.99 -45.99 79.64 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.706 0.802 . . . . 0.0 110.911 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.56 -46.39 90.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.841 0.857 . . . . 0.0 110.049 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 mtm -59.45 -45.38 91.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.043 0.537 . . . . 0.0 111.033 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.05 95.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.449 0.568 . . . . 0.0 111.334 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HG3' HG12 ' A' ' 34' ' ' VAL . 42.8 tt0 -56.73 -42.96 80.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.825 0.45 . . . . 0.0 110.594 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.14 -52.19 53.94 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.297 -0.724 . . . . 0.0 112.135 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -60.03 -43.92 94.99 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.503 0.651 . . . . 0.0 110.627 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -63.63 -42.85 98.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.307 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -55.77 -36.2 67.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.73 1.15 . . . . 0.0 111.307 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -69.44 -58.03 4.5 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.5 0.591 . . . . 0.0 110.792 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -73.08 -46.01 53.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.995 0.118 . . . . 0.0 111.106 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 87.0 mt -73.08 -36.36 66.8 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.762 0.425 . . . . 0.0 111.487 -176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.14 173.28 43.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -169.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.33 -2.36 5.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.958 0.903 . . . . 0.0 111.666 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -58.89 -13.11 5.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 111.289 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.3 m95 -128.45 120.97 27.9 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -71.15 95.4 1.24 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.508 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.4 t -83.96 133.54 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -173.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -143.28 167.52 21.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.212 1.405 . . . . 0.0 109.59 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.0 p -145.0 159.64 42.62 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.768 0.827 . . . . 0.0 109.36 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.7 -170.96 2.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.652 1.181 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.02 -172.43 41.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.0 mt -57.38 -28.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.958 1.303 . . . . 0.0 110.942 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.32 166.73 29.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.627 1.171 . . . . 0.0 109.568 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.65 26.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.128 1.371 . . . . 0.0 107.773 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.13 17.46 4.11 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.093 1.357 . . . . 0.0 110.258 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 168.41 44.74 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.68 149.41 25.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.469 0.652 . . . . 0.0 111.831 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.91 138.13 57.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.299 1.439 . . . . 0.0 109.746 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.52 -28.61 70.39 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.79 1.66 . . . . 0.0 112.959 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -71.99 -33.56 68.2 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.97 92.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -57.3 -50.1 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.333 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -57.93 -44.75 87.08 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.159 0.89 . . . . 0.0 111.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.87 87.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.7 mmm -68.88 -37.86 79.32 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.157 0.183 . . . . 0.0 111.008 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -32.53 69.7 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.287 -0.883 . . . . 0.0 111.121 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.51 -11.32 60.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.343 1.057 . . . . 0.0 110.477 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -115.68 0.45 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.328 1.051 . . . . 0.0 112.031 173.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 30.76 13.09 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -120.55 160.11 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.85 145.52 51.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.31 -8.32 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.676 1.591 . . . . 0.0 110.436 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -55.97 -32.67 64.11 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.87 0.868 . . . . 0.0 111.119 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.76 -14.34 61.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.381 1.472 . . . . 0.0 114.371 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -107.69 -30.08 8.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 -169.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.0 p 51.2 -175.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.283 1.833 . . . . 0.0 113.716 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 m -119.88 155.87 31.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.68 1.192 . . . . 0.0 111.0 -170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -158.43 158.9 35.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 109.629 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.14 165.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.26 144.25 9.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.921 0.888 . . . . 0.0 109.466 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -136.46 140.18 42.91 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.773 1.229 . . . . 0.0 110.129 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.63 -29.91 62.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.187 1.395 . . . . 0.0 113.449 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.33 -12.28 61.48 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 111.95 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.45 -44.64 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.45 -40.59 78.79 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.1 1.318 . . . . 0.0 112.712 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -1.64 55.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -117.69 -26.35 6.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.126 1.37 . . . . 0.0 112.831 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.36 124.65 18.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.198 1.399 . . . . 0.0 110.08 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -32.43 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.247 1.419 . . . . 0.0 109.817 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.07 144.33 30.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.197 1.399 . . . . 0.0 108.106 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -117.66 153.21 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.91 138.61 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 p -113.46 131.98 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.44 21.69 16.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.809 1.244 . . . . 0.0 108.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -82.79 99.37 9.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.019 1.327 . . . . 0.0 109.718 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.498 0 C-N-CA 123.929 0.776 . . . . 0.0 111.441 169.638 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 110.57 -0.589 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.52 158.25 36.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 109.97 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -123.06 157.02 61.84 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.948 1.699 . . . . 0.0 109.147 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG2' HG22 ' A' ' 96' ' ' VAL . 80.5 Cg_endo -76.29 162.17 34.13 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 121.567 1.512 . . . . 0.0 110.36 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.22 -17.66 24.23 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.949 2.433 . . . . 0.0 111.591 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -65.91 -22.63 66.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.252 1.021 . . . . 0.0 112.352 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 93' ' ' PRO . 26.2 m -113.98 150.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.637 0.653 . . . . 0.0 111.11 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -72.6 149.56 43.85 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -132.55 156.69 46.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 111.363 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.74 162.14 26.52 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.009 2.523 . . . . 0.0 106.822 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -144.86 114.76 7.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -122.38 10.67 9.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.517 1.527 . . . . 0.0 111.49 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.7 138.22 5.32 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.938 1.256 . . . . 0.0 114.844 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 -100.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.868 1.667 . . . . 0.0 107.177 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -154.86 152.69 30.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.62 126.41 86.08 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.04 -25.58 66.24 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.34 1.36 . . . . 0.0 113.939 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.89 -13.09 62.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.346 0.975 . . . . 0.0 112.368 172.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mtm-85 -111.96 6.24 19.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.259 . . . . 0.0 111.378 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.66 60.9 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.335 1.854 . . . . 0.0 110.737 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.56 141.76 54.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.919 1.688 . . . . 0.0 111.137 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.66 -59.29 0.22 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -166.38 169.61 13.84 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 107.108 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -30.12 68.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.279 0.631 . . . . 0.0 111.292 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.84 -37.8 73.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.832 0.453 . . . . 0.0 110.766 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.64 -43.56 76.02 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -57.01 -51.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.81 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -58.06 -38.4 76.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.792 0.837 . . . . 0.0 111.903 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.69 87.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.443 -0.785 . . . . 0.0 109.863 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -63.95 -34.92 79.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.988 0.515 . . . . 0.0 111.85 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -57.76 -49.96 74.83 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.172 0.896 . . . . 0.0 109.798 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -63.91 -36.06 82.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.293 0.497 . . . . 0.0 111.76 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.52 -48.05 68.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.637 0.653 . . . . 0.0 111.014 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.09 -41.85 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -54.29 -53.61 51.38 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.02 0.928 . . . . 0.0 109.537 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.54 -42.91 95.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.787 0.267 . . . . 0.0 111.072 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.17 -42.16 84.76 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.982 -0.449 . . . . 0.0 110.848 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.32 -49.91 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.61 -43.18 78.71 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.02 -51.64 68.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 117.484 0.642 . . . . 0.0 111.131 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.5 mmm-85 -68.54 -29.58 68.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -40.86 88.05 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 120.123 1.328 . . . . 0.0 109.74 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -56.73 -53.16 60.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.36 -34.4 78.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.605 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -63.33 -37.9 89.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.798 -0.564 . . . . 0.0 110.726 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.63 -35.55 29.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.193 0.597 . . . . 0.0 111.548 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.07 -42.46 9.4 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.746 1.219 . . . . 0.0 111.72 -169.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 p -113.48 -18.18 12.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 111.056 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.82 65.85 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.036 -0.869 . . . . 0.0 111.981 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.245 0.866 0 C-N-CA 124.564 1.146 . . . . 0.0 108.137 -175.694 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 173.26 9.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.553 0.615 . . . . 0.0 110.138 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.33 141.03 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.53 149.76 16.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.091 0.956 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 131.69 32.65 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.523 0.729 . . . . 0.0 109.065 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.33 128.17 55.87 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.3 143.85 51.15 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.401 0.68 . . . . 0.0 110.585 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.51 174.68 10.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.367 1.079 . . . . 0.0 112.674 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.8 p -77.97 32.69 0.18 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.444 2.298 . . . . 0.0 110.616 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.01 113.73 0.83 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -173.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.31 53.98 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.264 1.026 . . . . 0.0 111.611 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 m -125.15 -19.67 5.08 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.1 m -138.81 -90.4 0.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.798 0.726 . . . . 0.0 109.1 -173.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -52.37 -53.25 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.041 0.936 . . . . 0.0 112.34 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 p -68.14 -38.35 82.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.658 0.663 . . . . 0.0 111.097 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -58.66 -54.86 42.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.962 0.905 . . . . 0.0 109.903 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.6 mtp -54.73 -46.05 74.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.57 1.548 . . . . 0.0 110.576 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.28 88.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.881 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 34' ' ' VAL . 23.6 tt0 -57.05 -37.8 72.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.445 0.566 . . . . 0.0 110.851 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.51 -54.03 41.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 123.829 0.728 . . . . 0.0 111.498 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -61.75 -41.81 98.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.313 0.557 . . . . 0.0 110.777 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.8 88.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.297 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -55.15 -36.33 65.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.873 1.215 . . . . 0.0 111.358 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -67.3 -56.96 7.61 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.363 0.414 . . . . 0.0 110.783 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -77.36 -44.47 29.28 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 84.4 mt -74.51 -37.07 63.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 111.071 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 173.03 42.95 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.41 -1.93 5.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.677 0.791 . . . . 0.0 111.634 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -57.89 -13.2 4.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.034 1.333 . . . . 0.0 111.325 169.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 13.7 m95 -129.13 115.49 17.78 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.246 -2.502 . . . . 0.0 104.246 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -66.34 100.79 0.67 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 21' ' ' GLU . 2.8 p -107.68 133.37 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.602 0.761 . . . . 0.0 109.831 -168.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.06 167.38 22.21 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.162 1.385 . . . . 0.0 109.459 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -140.41 151.33 44.84 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 109.92 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.02 -166.66 1.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.584 1.154 . . . . 0.0 109.812 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.52 -176.31 46.32 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 121.342 -0.849 . . . . 0.0 111.387 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.4 mt -54.95 -31.92 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.723 1.609 . . . . 0.0 110.806 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.11 167.06 25.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.027 1.331 . . . . 0.0 108.087 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.83 133.0 20.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -134.42 21.82 3.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.179 0.992 . . . . 0.0 109.347 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.12 165.25 33.89 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -87.02 147.88 25.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.07 0.548 . . . . 0.0 110.442 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -73.43 133.52 80.45 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.365 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.88 -34.38 45.23 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.884 2.389 . . . . 0.0 114.495 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -73.97 -27.85 61.19 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 121.385 -0.822 . . . . 0.0 110.929 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.56 75.88 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.1 -49.18 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.8 -43.61 94.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.052 0.541 . . . . 0.0 111.039 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.15 94.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.209 0.604 . . . . 0.0 110.255 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.2 mmm -69.72 -36.66 76.08 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.282 0.492 . . . . 0.0 111.318 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -27.34 69.25 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 120.797 -1.19 . . . . 0.0 111.446 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.17 -15.17 63.55 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.914 0.779 . . . . 0.0 110.825 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.79 -0.0 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.17 0.988 . . . . 0.0 112.079 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.59 17.44 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.64 160.51 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.85 145.31 50.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.56 2.98 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.859 1.264 . . . . 0.0 110.41 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -58.7 -29.52 66.71 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.214 -1.554 . . . . 0.0 111.086 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -65.64 -4.73 6.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.425 1.89 . . . . 0.0 115.334 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -135.45 48.47 2.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.444 1.474 . . . . 0.0 110.829 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -44.86 132.62 6.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.843 1.257 . . . . 0.0 111.111 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -57.29 154.81 9.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -168.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -154.15 155.7 35.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.108 1.363 . . . . 0.0 109.581 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.23 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.497 1.119 . . . . 0.0 109.784 172.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.77 153.16 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.058 1.343 . . . . 0.0 110.067 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.98 139.11 21.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.688 1.595 . . . . 0.0 108.643 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.34 -28.11 57.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.31 1.444 . . . . 0.0 113.464 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.04 -13.51 62.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.573 1.149 . . . . 0.0 112.286 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -113.36 -40.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.8 mt -48.09 -61.33 2.03 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.834 1.197 . . . . 0.0 111.603 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -3.27 35.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -111.94 -33.11 6.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.331 1.452 . . . . 0.0 110.941 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 122.65 15.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.48 1.512 . . . . 0.0 110.092 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.23 -23.38 66.41 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 111.197 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 tp -143.82 138.65 28.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.747 1.219 . . . . 0.0 107.936 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.6 145.4 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.14 124.85 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.29 127.11 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.41 24.57 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.896 0.855 . . . . 0.0 109.081 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.0 p -75.96 107.98 8.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.589 1.556 . . . . 0.0 110.029 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.147 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 171.781 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo . . . . . 0 CA--C 1.535 0.527 0 CA-C-O 121.146 0.394 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -74.1 155.66 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 0.0 109.833 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -132.17 161.6 61.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.879 2.071 . . . . 0.0 109.149 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.6 159.71 50.36 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 121.246 1.297 . . . . 0.0 109.583 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.72 -26.15 10.09 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.397 2.065 . . . . 0.0 112.422 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -74.9 -34.61 62.21 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.274 0.63 . . . . 0.0 112.45 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.73 153.43 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.542 0.687 . . . . 0.0 111.013 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -70.65 141.28 51.68 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -134.03 149.71 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.216 0.607 . . . . 0.0 109.902 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -127.07 157.14 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.702 2.001 . . . . 0.0 107.832 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -131.34 113.44 13.77 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.8 m0 -122.26 52.89 1.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.154 1.781 . . . . 0.0 106.797 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.15 128.67 34.07 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 120.747 -1.221 . . . . 0.0 111.654 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.98 160.83 39.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 105.911 169.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -68.73 144.05 54.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.431 0.634 . . . . 0.0 110.747 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.38 127.64 93.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.51 -23.07 50.73 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.162 1.241 . . . . 0.0 113.506 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.93 -11.45 60.35 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.454 1.025 . . . . 0.0 112.347 171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -111.49 3.23 17.93 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.879 1.272 . . . . 0.0 110.755 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.51 60.61 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.21 2.204 . . . . 0.0 110.844 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.43 138.2 57.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 110.587 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.68 -58.35 0.19 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -166.3 168.43 15.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.902 1.681 . . . . 0.0 107.339 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -30.3 70.15 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.781 -0.574 . . . . 0.0 111.394 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.75 -38.55 76.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.928 0.491 . . . . 0.0 110.585 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.57 -46.13 77.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -56.91 -49.95 74.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.168 0.587 . . . . 0.0 110.26 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -60.33 -37.16 79.75 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.866 0.757 . . . . 0.0 111.975 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.46 80.24 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.147 -0.97 . . . . 0.0 110.258 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.38 -32.69 74.46 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.948 -0.47 . . . . 0.0 111.477 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -57.42 -49.09 77.35 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.465 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -45.55 84.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 111.829 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -60.73 -48.78 80.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.002 0.819 . . . . 0.0 110.681 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.67 -39.65 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -55.85 -55.94 26.53 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 124.095 0.958 . . . . 0.0 108.956 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.52 -37.63 77.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 123.536 0.523 . . . . 0.0 110.502 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.01 -42.61 80.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.031 0.532 . . . . 0.0 111.255 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.3 mt -58.61 -52.19 62.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.94 56.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.909 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -61.61 -50.06 74.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.726 0.763 . . . . 0.0 111.066 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.41 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.57 -34.77 74.64 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.113 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -40.3 96.45 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.207 0.912 . . . . 0.0 109.742 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.32 -49.77 75.06 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.076 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.71 -43.63 98.32 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 110.131 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.18 -31.72 69.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.649 -1.282 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 -37.19 23.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.471 0.708 . . . . 0.0 112.212 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.6 -52.97 4.63 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.819 1.248 . . . . 0.0 110.728 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.2 p -103.03 -16.52 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.842 1.657 . . . . 0.0 110.414 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.34 86.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.486 1.041 . . . . 0.0 112.381 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 C--O 1.246 0.893 0 CA-C-N 118.694 1.247 . . . . 0.0 108.743 -172.533 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.08 -179.91 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.232 0.613 . . . . 0.0 109.919 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -140.91 142.49 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.82 150.32 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 118.87 0.759 . . . . 0.0 109.251 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -139.49 136.8 34.94 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.715 0.806 . . . . 0.0 109.508 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.49 133.05 54.6 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.564 1.146 . . . . 0.0 108.29 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.15 141.0 52.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.54 0.736 . . . . 0.0 110.244 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.93 168.97 18.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.173 1.389 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 p -55.5 -36.11 66.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.52 1.128 . . . . 0.0 110.939 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.2 141.47 9.39 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -77.44 51.22 0.86 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.42 1.088 . . . . 0.0 111.712 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.7 m -126.46 -15.58 5.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.771 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.98 -98.56 0.19 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -52.31 -50.29 62.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.081 0.953 . . . . 0.0 112.311 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -70.7 -36.32 73.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.78 0.264 . . . . 0.0 111.509 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -60.92 -53.78 53.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.247 1.019 . . . . 0.0 110.214 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.7 mtp -53.94 -46.84 71.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.182 1.393 . . . . 0.0 110.551 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.26 95.6 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.914 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 54.7 tt0 -55.92 -41.44 74.57 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.223 0.465 . . . . 0.0 110.728 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.27 -48.1 85.0 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.4 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -63.01 -43.57 98.4 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.834 0.817 . . . . 0.0 110.864 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.29 99.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.787 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -51.55 -38.31 53.69 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.068 0.849 . . . . 0.0 111.907 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -70.21 -62.66 1.3 Allowed 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 123.327 0.392 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -67.95 -37.78 82.0 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 78.5 mt -77.03 -1.36 28.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.682 0.793 . . . . 0.0 112.489 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.34 24.97 59.76 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.573 1.082 . . . . 0.0 113.738 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.12 16.06 2.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.768 2.027 . . . . 0.0 113.611 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.59 2.2 14.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.945 -1.097 . . . . 0.0 111.33 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.1 m95 -134.21 124.74 26.49 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.64 94.25 0.42 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.6 t -79.11 138.46 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -143.5 164.62 29.85 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.075 1.35 . . . . 0.0 109.695 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -146.42 156.56 43.39 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.783 0.833 . . . . 0.0 109.461 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 -166.89 2.07 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.224 1.009 . . . . 0.0 109.584 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.69 44.03 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mt -57.03 -25.57 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.927 1.291 . . . . 0.0 111.363 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.02 169.47 19.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.967 1.307 . . . . 0.0 108.825 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.21 135.48 21.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 169.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -129.18 11.12 5.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.723 1.209 . . . . 0.0 110.042 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 162.4 30.61 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -170.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.08 146.67 30.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.321 0.581 . . . . 0.0 111.045 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.16 133.68 83.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.147 -0.93 . . . . 0.0 108.945 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.53 -34.62 43.09 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.799 2.333 . . . . 0.0 114.563 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -73.41 -28.18 61.85 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.567 -0.708 . . . . 0.0 110.731 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.77 73.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -57.68 -48.05 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -60.04 -41.76 92.95 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.57 0.623 . . . . 0.0 110.764 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.47 94.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.14 0.576 . . . . 0.0 109.78 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.5 mmm -69.07 -38.52 79.07 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.415 0.15 . . . . 0.0 111.061 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.47 -25.1 67.85 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.85 -1.156 . . . . 0.0 111.483 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.79 -15.62 63.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.578 0.751 . . . . 0.0 110.42 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.25 0.82 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.927 0.891 . . . . 0.0 112.064 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.04 19.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.65 159.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -125.95 145.45 50.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 pt -127.97 2.7 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.977 1.311 . . . . 0.0 110.383 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.86 -27.98 67.13 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 119.978 -1.701 . . . . 0.0 111.2 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.84 -5.23 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.227 1.811 . . . . 0.0 115.107 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.18 49.61 2.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.253 1.388 . . . . 0.0 110.876 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -46.72 134.64 9.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.3 1.04 . . . . 0.0 110.967 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.26 155.51 8.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -154.48 156.18 36.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.967 1.307 . . . . 0.0 109.395 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.0 167.98 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 109.777 171.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.41 146.22 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.454 1.501 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -138.65 139.49 38.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.283 1.433 . . . . 0.0 109.773 170.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -55.81 -29.12 59.24 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.516 1.526 . . . . 0.0 113.259 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.75 -7.06 36.23 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 112.392 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.94 -44.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -45.7 -55.85 5.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.092 0.957 . . . . 0.0 112.305 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.7 51.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 112.925 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.8 -30.01 4.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 112.299 -168.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.97 130.37 46.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.778 1.231 . . . . 0.0 109.92 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.58 -22.98 64.43 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.223 0.609 . . . . 0.0 110.962 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.0 tp -146.44 142.18 27.89 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 108.829 170.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.9 145.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.48 135.48 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.56 107.67 13.56 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.68 8.32 34.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.409 0.683 . . . . 0.0 112.637 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.6 p -68.65 72.89 0.24 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.825 2.45 . . . . 0.0 114.669 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 O-C-N 120.575 -1.328 . . . . 0.0 112.827 174.747 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 0 CA--C 1.534 0.521 0 N-CA-C 113.245 0.441 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.01 138.24 58.23 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.902 0.881 . . . . 0.0 110.245 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -124.02 158.09 61.53 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.471 1.908 . . . . 0.0 109.689 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.5 153.39 76.66 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.82 1.68 . . . . 0.0 109.324 169.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.63 -23.97 16.41 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.478 2.119 . . . . 0.0 112.103 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -73.05 -32.83 65.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.645 0.778 . . . . 0.0 112.196 -173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.94 145.07 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.432 0.634 . . . . 0.0 109.799 -172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.86 130.99 44.97 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -134.54 150.4 50.76 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.021 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.78 160.68 30.15 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.317 2.247 . . . . 0.0 107.574 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -133.13 115.13 14.69 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.406 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 33.6 m0 -119.11 59.67 0.83 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.84 123.85 13.78 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.767 -171.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.94 160.13 43.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.61 1.964 . . . . 0.0 106.528 168.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -69.81 149.66 47.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.179 0.514 . . . . 0.0 110.591 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.2 128.61 80.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.49 -24.83 35.86 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.221 1.28 . . . . 0.0 113.515 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 -12.45 61.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.487 1.04 . . . . 0.0 111.722 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.0 ttp85 -101.93 2.0 37.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.889 1.275 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.93 67.2 0.82 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.115 1.366 . . . . 0.0 110.385 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.49 137.42 56.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.928 0.891 . . . . 0.0 110.464 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.42 -63.42 0.19 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.4 t -165.15 168.72 16.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 107.6 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.93 -29.53 68.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.386 0.675 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.64 -37.33 70.86 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.22 0.464 . . . . 0.0 110.836 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.23 -44.01 76.69 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -58.22 -48.02 81.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 122.856 0.462 . . . . 0.0 110.084 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -58.45 -39.89 81.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.561 0.744 . . . . 0.0 111.702 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.68 84.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.442 -0.787 . . . . 0.0 110.213 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.52 -34.12 77.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.07 0.548 . . . . 0.0 111.165 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -59.37 -48.14 82.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.909 . . . . 0.0 110.222 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -65.14 -36.36 84.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.491 0.587 . . . . 0.0 111.521 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -65.57 -50.36 65.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.265 0.484 . . . . 0.0 110.64 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.54 -39.37 84.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -54.44 -53.33 55.61 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.781 0.832 . . . . 0.0 109.352 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.56 -41.94 95.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.046 0.384 . . . . 0.0 111.035 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.18 -41.29 90.48 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.597 -0.689 . . . . 0.0 111.411 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.89 -53.03 50.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.55 -45.72 53.75 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 123.677 0.656 . . . . 0.0 111.754 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -60.46 -50.28 74.19 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.918 0.859 . . . . 0.0 111.174 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -70.79 -33.18 70.47 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.991 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -39.61 94.86 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.179 0.9 . . . . 0.0 109.969 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.83 -52.63 64.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.0 -35.29 80.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.255 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.56 -36.58 83.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.81 -0.556 . . . . 0.0 111.223 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.52 26.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 122.818 0.447 . . . . 0.0 111.44 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.42 -42.96 11.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.611 1.165 . . . . 0.0 111.628 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.0 p -113.29 -19.0 11.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.224 1.01 . . . . 0.0 111.161 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.77 10.54 75.83 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.209 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 118.654 1.227 . . . . 0.0 108.364 -174.677 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.85 175.1 6.07 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.37 140.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.78 148.94 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.4 131.66 30.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.71 131.24 56.99 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -125.91 139.59 53.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.639 0.776 . . . . 0.0 109.719 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.2 t -135.74 168.75 18.71 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.442 1.097 . . . . 0.0 109.406 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.8 p -58.77 -26.27 63.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.476 1.111 . . . . 0.0 111.314 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 138.04 5.94 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.03 53.45 0.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.603 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 m -126.85 -17.66 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.921 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.03 -90.93 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.876 0.762 . . . . 0.0 109.184 -170.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -56.46 -53.46 57.21 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.38 0.672 . . . . 0.0 111.542 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -67.68 -36.4 80.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.774 0.261 . . . . 0.0 111.197 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -59.61 -57.58 12.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.147 0.979 . . . . 0.0 110.085 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.8 mtm -56.86 -43.4 81.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.319 0.648 . . . . 0.0 111.517 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.28 99.15 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.482 0.583 . . . . 0.0 111.824 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.6 tt0 -57.7 -39.74 77.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.237 0.471 . . . . 0.0 110.815 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.4 53.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 123.697 0.665 . . . . 0.0 111.546 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -61.32 -45.29 95.04 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.303 0.551 . . . . 0.0 110.98 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.7 -44.25 97.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.34 0.656 . . . . 0.0 110.852 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -56.3 -34.21 66.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.055 0.843 . . . . 0.0 111.889 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -67.22 -61.61 1.84 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.131 0.423 . . . . 0.0 110.443 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.02 -42.71 80.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.35 0.26 . . . . 0.0 111.507 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.38 -7.84 58.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 0.0 112.241 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.93 56.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.859 1.219 . . . . 0.0 114.621 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.58 4.76 1.08 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.696 2.398 . . . . 0.0 114.107 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.29 -9.11 21.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.714 1.206 . . . . 0.0 110.384 169.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -129.37 118.84 22.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 172.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.64 99.7 0.81 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -84.1 141.47 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -144.01 165.31 28.12 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.941 1.696 . . . . 0.0 109.077 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.2 p -143.92 155.89 44.23 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.736 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.37 1.69 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.622 1.169 . . . . 0.0 109.459 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.09 179.83 45.19 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -54.39 -28.41 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.366 1.466 . . . . 0.0 111.387 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.06 170.61 16.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.966 1.307 . . . . 0.0 108.632 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.0 134.09 18.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -135.92 19.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.363 1.065 . . . . 0.0 109.81 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.09 163.15 29.73 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -83.97 146.21 28.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 110.696 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -70.66 134.13 86.38 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.036 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.23 -35.67 44.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.795 2.33 . . . . 0.0 114.259 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -72.75 -26.64 61.64 Favored 'General case' 0 C--O 1.227 -0.111 0 O-C-N 121.491 -0.756 . . . . 0.0 111.094 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -46.62 78.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.77 -47.98 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -57.16 -46.34 82.85 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.858 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.56 86.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -69.26 -37.69 78.04 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 110.852 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.01 -25.72 67.97 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.879 -1.138 . . . . 0.0 111.778 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -71.43 -12.35 61.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.453 1.101 . . . . 0.0 110.424 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.28 -1.66 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 112.735 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.23 33.13 10.94 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.24 162.89 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.5 146.37 50.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.2 pt -128.95 3.97 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.824 1.25 . . . . 0.0 110.589 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.32 -28.38 66.75 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.136 -1.603 . . . . 0.0 111.003 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -64.73 -5.58 6.11 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.291 1.836 . . . . 0.0 115.188 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -135.67 50.35 2.11 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.512 1.505 . . . . 0.0 110.426 -169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -46.21 133.28 9.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.493 1.117 . . . . 0.0 110.683 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 m -57.8 154.75 11.41 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -154.0 155.38 35.44 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.094 1.357 . . . . 0.0 109.522 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.42 166.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.354 1.062 . . . . 0.0 109.56 172.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.04 145.92 5.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.717 1.207 . . . . 0.0 109.898 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.07 135.97 33.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.391 1.076 . . . . 0.0 109.884 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -54.49 -28.35 44.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.426 1.49 . . . . 0.0 113.067 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.04 -11.98 61.28 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mt -114.52 -42.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.27 -57.5 6.69 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.928 1.24 . . . . 0.0 111.661 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -1.8 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -116.37 -32.58 5.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.214 1.405 . . . . 0.0 111.591 -168.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.46 128.25 35.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.32 1.448 . . . . 0.0 109.619 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.34 -29.85 71.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.863 0.865 . . . . 0.0 110.182 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.9 tp -147.3 140.43 25.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 108.647 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.84 154.72 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 t -140.09 136.43 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.06 135.65 47.14 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.39 10.46 37.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 110.613 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.2 p -64.21 116.98 6.52 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.643 1.177 . . . . 0.0 111.18 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.317 0 C-N-CA 124.909 1.242 . . . . 0.0 111.051 169.671 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 N--CA 1.459 -0.534 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -72.31 146.36 47.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.405 1.082 . . . . 0.0 110.098 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 p -129.46 160.22 65.45 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.607 1.963 . . . . 0.0 109.906 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.46 145.21 64.13 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.034 1.823 . . . . 0.0 109.895 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.5 -23.31 20.25 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.915 2.41 . . . . 0.0 112.185 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -85.01 6.58 24.66 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.067 0.947 . . . . 0.0 112.367 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.16 135.9 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.28 145.35 55.85 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -123.67 169.53 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.266 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -136.51 164.32 28.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.611 2.364 . . . . 0.0 106.794 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -134.02 113.25 11.93 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -121.63 61.82 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.06 131.3 11.66 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.304 -0.873 . . . . 0.0 112.885 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.28 160.46 40.81 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.396 2.278 . . . . 0.0 106.159 169.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -65.86 148.97 50.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.838 -0.539 . . . . 0.0 110.324 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -74.4 128.32 86.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.33 -21.23 54.6 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.063 1.175 . . . . 0.0 113.403 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.38 -18.3 65.07 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.399 1.0 . . . . 0.0 112.372 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -86.46 -8.67 57.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.457 1.026 . . . . 0.0 112.516 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 52.91 0.55 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 112.369 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.78 150.78 27.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.008 2.123 . . . . 0.0 112.063 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.62 -52.81 0.42 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -165.97 165.47 18.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.97 1.708 . . . . 0.0 107.263 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -28.54 67.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 0.0 111.223 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.78 -37.36 73.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.3 0.5 . . . . 0.0 110.903 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.9 -45.91 73.09 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.42 -49.37 74.72 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.923 0.489 . . . . 0.0 110.352 173.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.98 -39.71 86.62 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.631 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.232 -0.917 . . . . 0.0 110.838 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -67.41 -32.73 73.83 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.767 -0.583 . . . . 0.0 111.747 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.05 -44.64 91.84 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.693 0.679 . . . . 0.0 110.327 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.08 -38.05 89.65 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.635 0.652 . . . . 0.0 111.423 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -61.92 -51.16 69.26 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.109 0.868 . . . . 0.0 110.258 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.96 -38.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.332 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -63.91 -39.79 95.0 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.025 1.738 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.42 -45.37 80.13 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.239 0.472 . . . . 0.0 111.109 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.75 -41.81 95.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.002 -0.436 . . . . 0.0 110.874 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.05 -51.28 74.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.37 -46.31 57.81 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.566 -0.575 . . . . 0.0 111.786 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.89 -48.16 83.1 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.813 0.806 . . . . 0.0 110.826 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -35.11 76.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -41.45 93.71 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.821 -0.549 . . . . 0.0 110.079 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.89 -50.39 72.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.74 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.55 -45.33 94.61 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.57 -33.58 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.664 -1.273 . . . . 0.0 112.334 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.36 -32.89 20.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.414 0.686 . . . . 0.0 112.304 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.32 -53.68 3.53 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 -169.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.3 p -99.57 -15.54 18.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.49 1.516 . . . . 0.0 110.495 -170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.85 78.49 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.169 0.89 . . . . 0.0 111.815 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 117.868 0.834 . . . . 0.0 109.811 -179.228 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.441 HD22 ' HG2' ' A' ' 33' ' ' LYS . 4.2 t30 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 10.7 mmpt? -97.19 170.13 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.021 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.24 142.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 tt -141.05 146.56 23.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.91 120.85 15.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -171.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -104.09 127.85 51.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.871 0.868 . . . . 0.0 108.936 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.08 140.81 51.45 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.768 1.227 . . . . 0.0 109.184 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 m -140.52 168.86 18.82 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.49 1.116 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.14 -25.15 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.009 0.924 . . . . 0.0 111.377 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.49 136.25 5.0 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 169.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.79 55.88 2.16 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.296 1.038 . . . . 0.0 110.724 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -122.18 -25.95 4.79 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.7 m -133.02 -94.67 0.33 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.319 0.963 . . . . 0.0 110.32 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.75 80.03 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -169.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -58.72 -49.7 76.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.348 0.659 . . . . 0.0 110.703 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -63.72 -43.9 95.16 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.562 0.745 . . . . 0.0 110.802 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.81 -44.94 95.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.679 0.391 . . . . 0.0 111.036 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.0 99.72 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.525 0.602 . . . . 0.0 111.091 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.2 tt0 -57.59 -43.64 84.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.252 173.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.19 -53.37 43.22 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.823 0.725 . . . . 0.0 112.076 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -62.38 -44.31 96.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.194 0.497 . . . . 0.0 110.947 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.667 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -54.82 -35.19 63.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.425 1.011 . . . . 0.0 111.59 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -72.31 -62.82 1.3 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.122 0.419 . . . . 0.0 110.798 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -67.44 -37.51 83.12 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.0 -2.22 26.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.349 0.66 . . . . 0.0 112.364 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.55 57.49 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.559 1.552 . . . . 0.0 115.127 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 58.88 11.6 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.585 1.954 . . . . 0.0 113.363 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.39 -12.68 61.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.786 -1.196 . . . . 0.0 110.191 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -125.3 126.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.529 1.931 . . . . 0.0 106.513 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.2 mmpt? -70.3 108.86 4.4 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -96.79 137.59 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.79 165.3 27.76 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.584 1.154 . . . . 0.0 109.805 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.4 p -147.4 159.43 43.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.329 0.652 . . . . 0.0 109.831 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.96 -169.38 2.02 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.36 1.464 . . . . 0.0 109.635 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.42 -177.86 43.88 Favored Glycine 0 CA--C 1.52 0.386 0 O-C-N 121.47 -0.768 . . . . 0.0 112.055 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.89 -28.22 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.542 1.537 . . . . 0.0 111.292 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.4 170.08 17.56 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.835 1.254 . . . . 0.0 108.715 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.74 136.15 21.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -137.52 21.09 2.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.319 1.048 . . . . 0.0 109.846 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.09 153.35 29.33 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.51 150.66 47.8 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.41 0.624 . . . . 0.0 111.369 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -77.45 133.43 67.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.865 1.266 . . . . 0.0 109.123 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.5 -34.54 42.52 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.933 2.422 . . . . 0.0 114.592 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -72.28 -28.76 63.31 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.25 -0.906 . . . . 0.0 110.769 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -47.03 84.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.71 -48.86 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -60.73 -41.32 95.1 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.651 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.33 95.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.8 0.727 . . . . 0.0 109.845 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 77.2 mmm -69.47 -35.54 75.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.822 0.283 . . . . 0.0 111.402 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -28.15 69.31 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.848 -1.157 . . . . 0.0 111.7 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -66.21 -17.27 64.63 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.201 0.91 . . . . 0.0 110.81 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.15 0.4 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.95 0.9 . . . . 0.0 112.021 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.92 32.0 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.35 155.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.62 145.83 47.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.48 -1.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.796 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -58.21 -31.98 67.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.859 0.864 . . . . 0.0 110.958 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -64.49 7.26 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.443 1.897 . . . . 0.0 114.948 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -131.41 29.44 4.57 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.301 1.41 . . . . 0.0 112.527 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -41.48 127.43 3.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.25 1.02 . . . . 0.0 113.434 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 m -54.52 155.2 4.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.229 1.812 . . . . 0.0 115.49 -168.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -154.22 156.6 37.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.175 1.39 . . . . 0.0 109.376 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.41 163.3 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.946 0.898 . . . . 0.0 109.322 170.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.95 145.53 7.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.784 1.234 . . . . 0.0 109.834 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -136.36 133.84 37.21 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.629 1.172 . . . . 0.0 110.035 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.13 -27.99 56.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.625 1.57 . . . . 0.0 113.593 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.82 -0.04 49.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.631 0.651 . . . . 0.0 111.897 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -112.26 -41.79 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.4 mt -47.82 -56.8 6.64 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.351 0.978 . . . . 0.0 111.873 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -83.45 4.18 28.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.702 0.801 . . . . 0.0 112.659 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.88 -27.45 3.61 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.175 . . . . 0.0 112.043 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.83 135.15 56.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.914 1.286 . . . . 0.0 108.678 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.02 -34.23 77.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.4 137.3 25.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.623 1.169 . . . . 0.0 109.175 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.37 147.39 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.1 118.95 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -93.47 133.36 36.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.35 25.54 11.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.203 1.001 . . . . 0.0 108.884 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -72.35 103.87 3.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.765 -1.209 . . . . 0.0 111.263 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 C-N-CA 125.196 1.379 . . . . 0.0 109.768 169.372 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 CA--C 1.535 0.556 0 N-CA-C 112.633 0.205 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.08 149.2 43.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 p -131.22 158.58 74.84 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.957 2.103 . . . . 0.0 109.258 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.98 159.33 41.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.214 1.943 . . . . 0.0 110.352 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.09 -15.95 25.61 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.078 2.519 . . . . 0.0 111.126 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.31 -12.47 61.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.406 1.482 . . . . 0.0 112.908 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.72 148.26 27.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.223 0.92 . . . . 0.0 112.113 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -68.09 141.45 56.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -135.54 151.04 49.94 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.109 0.564 . . . . 0.0 110.683 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -127.81 161.14 29.71 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.226 2.21 . . . . 0.0 108.031 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -133.07 112.77 12.07 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.3 m0 -124.7 52.09 1.57 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.312 1.845 . . . . 0.0 107.282 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.43 135.07 31.09 Favored Glycine 0 CA--C 1.526 0.723 0 O-C-N 120.809 -1.182 . . . . 0.0 112.241 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.95 158.72 38.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.889 1.676 . . . . 0.0 107.515 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.02 133.42 56.08 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.043 1.737 . . . . 0.0 110.601 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.7 125.95 92.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.39 -24.92 56.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.229 1.286 . . . . 0.0 113.2 -174.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.36 -3.62 41.03 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.135 0.88 . . . . 0.0 112.506 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -123.86 7.0 8.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.221 1.408 . . . . 0.0 109.307 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 99.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.636 1.174 . . . . 0.0 108.472 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -57.27 122.85 13.47 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.977 0.911 . . . . 0.0 108.88 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.82 -105.83 0.25 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 10.6 p -140.56 171.68 13.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.38 1.872 . . . . 0.0 107.523 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.59 -29.25 70.46 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.235 -0.915 . . . . 0.0 111.216 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.23 -40.56 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.024 0.53 . . . . 0.0 109.896 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.504 ' HB3' ' H ' ' A' ' 112' ' ' THR . 9.3 tp10 -63.98 -43.24 96.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -59.71 -47.32 86.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.432 0.693 . . . . 0.0 110.595 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -59.65 -36.59 76.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.984 0.811 . . . . 0.0 111.662 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.94 76.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 110.465 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -64.77 -31.09 72.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.268 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.73 -49.25 78.31 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.657 1.117 . . . . 0.0 109.406 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -56.38 -47.41 78.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.892 0.769 . . . . 0.0 111.819 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -60.68 -47.76 84.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.972 0.806 . . . . 0.0 110.695 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.14 -39.41 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -57.11 -53.98 51.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.073 0.851 . . . . 0.0 109.03 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.61 -39.17 80.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.35 0.406 . . . . 0.0 110.857 -170.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -60.04 -48.15 82.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.482 0.713 . . . . 0.0 111.055 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.98 -48.94 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.73 -48.66 49.82 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.663 -0.521 . . . . 0.0 111.992 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.08 -47.29 87.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 117.816 0.808 . . . . 0.0 111.007 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -28.29 57.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.256 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -38.83 84.39 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.373 0.988 . . . . 0.0 109.799 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -56.77 -49.85 74.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.457 0.571 . . . . 0.0 109.561 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.662 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.5 -35.54 79.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.044 0.838 . . . . 0.0 111.223 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.69 -38.82 32.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.465 0.306 . . . . 0.0 111.19 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.7 -45.73 9.11 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.089 0.955 . . . . 0.0 111.11 -170.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.6 p -111.28 -19.14 12.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.43 1.092 . . . . 0.0 112.071 -169.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.24 18.06 80.1 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 119.047 1.423 . . . . 0.0 109.475 177.863 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.32 176.9 6.27 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.49 0.586 . . . . 0.0 110.407 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.23 141.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -145.09 149.1 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.246 0.93 . . . . 0.0 109.065 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.88 137.69 43.45 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.88 0.872 . . . . 0.0 109.017 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -119.83 130.54 54.95 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.62 141.75 51.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.544 0.737 . . . . 0.0 110.438 -169.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 95.4 m -140.63 169.98 16.63 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.015 0.926 . . . . 0.0 110.73 172.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 m -56.99 -25.25 58.12 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.36 1.464 . . . . 0.0 111.61 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.77 136.67 5.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.58 56.7 2.68 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.022 0.929 . . . . 0.0 110.51 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -120.43 -31.95 4.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -128.72 -87.59 0.54 Allowed 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.844 0.747 . . . . 0.0 110.248 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -58.92 -50.45 73.98 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 11.7 p -65.67 -36.36 83.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.346 0.521 . . . . 0.0 111.176 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -62.43 -55.24 29.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.559 1.144 . . . . 0.0 111.001 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -56.74 -44.74 81.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.757 0.823 . . . . 0.0 111.029 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.63 98.48 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.454 0.57 . . . . 0.0 111.635 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -56.51 -43.36 79.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.586 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.1 -49.54 77.39 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.713 0.688 . . . . 0.0 112.068 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.72 -45.32 93.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.952 0.876 . . . . 0.0 111.121 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.23 99.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.019 0.527 . . . . 0.0 110.522 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -54.22 -34.93 61.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.7 0.682 . . . . 0.0 111.81 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -71.33 -62.86 1.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.056 0.389 . . . . 0.0 110.554 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -67.54 -40.92 85.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.0 mt -75.88 -4.13 39.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.634 0.774 . . . . 0.0 112.472 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.84 56.34 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.637 1.113 . . . . 0.0 113.948 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.78 9.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.306 2.243 . . . . 0.0 114.098 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.3 -3.65 8.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.941 -1.1 . . . . 0.0 111.153 169.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -132.92 122.07 23.79 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -67.79 97.54 0.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 172.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.01 140.71 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.05 166.45 26.82 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.411 1.484 . . . . 0.0 109.348 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 90.0 p -143.99 157.43 44.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.766 0.827 . . . . 0.0 109.236 169.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.57 -167.45 1.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.79 -179.0 44.15 Favored Glycine 0 N--CA 1.447 -0.582 0 O-C-N 121.685 -0.634 . . . . 0.0 111.873 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.15 -31.06 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.031 1.332 . . . . 0.0 110.841 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.89 168.58 21.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.257 1.423 . . . . 0.0 108.75 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.0 138.14 25.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -130.02 12.15 5.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 109.641 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 162.49 29.95 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.54 152.77 35.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -77.58 133.05 67.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.63 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.96 -36.45 64.4 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.722 2.281 . . . . 0.0 114.207 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -71.94 -31.98 66.87 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.581 -0.699 . . . . 0.0 110.241 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.29 -44.53 94.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.78 -50.96 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -58.88 -40.78 85.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.642 0.656 . . . . 0.0 111.695 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.48 88.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.583 0.629 . . . . 0.0 109.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.8 mmm -66.51 -38.75 87.89 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.381 0.537 . . . . 0.0 110.857 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.6 -21.02 66.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.541 -1.349 . . . . 0.0 112.084 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.88 -30.44 68.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.927 0.785 . . . . 0.0 109.093 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.81 -33.87 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.9 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.147 0.879 . . . . 0.0 111.239 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.34 157.82 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.24 144.96 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -125.13 -0.52 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.958 1.303 . . . . 0.0 110.325 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -58.56 -30.99 67.56 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.212 -1.555 . . . . 0.0 111.432 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.61 -2.32 6.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 114.756 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.7 52.14 1.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.261 1.391 . . . . 0.0 110.085 -171.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -50.43 142.47 10.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 m -61.49 160.86 10.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.059 1.744 . . . . 0.0 114.915 -169.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -156.22 158.6 37.85 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.191 1.397 . . . . 0.0 109.712 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.49 166.69 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.214 1.006 . . . . 0.0 109.224 169.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.9 143.66 10.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.625 0.77 . . . . 0.0 108.977 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.78 140.71 42.72 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 109.855 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.57 -30.66 61.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.081 1.352 . . . . 0.0 113.166 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.78 -11.01 60.53 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.289 1.036 . . . . 0.0 112.094 -173.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.32 -43.86 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -56.97 -40.31 76.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.093 1.315 . . . . 0.0 112.289 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 4.69 51.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.886 0.875 . . . . 0.0 112.589 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -125.1 -26.99 3.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.815 1.246 . . . . 0.0 112.741 -168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 131.79 52.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.738 1.215 . . . . 0.0 109.26 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.3 -25.09 65.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.356 0.662 . . . . 0.0 110.741 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 tp -147.91 140.29 24.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.866 1.267 . . . . 0.0 108.34 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.49 147.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.91 127.73 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.66 132.02 44.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.88 10.3 38.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.944 0.498 . . . . 0.0 110.236 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.79 126.7 28.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.308 1.043 . . . . 0.0 110.954 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.285 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.007 171.333 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 CA--C 1.534 0.517 0 CA-C-O 120.701 0.209 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.04 153.21 38.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.665 0.786 . . . . 0.0 109.488 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 p -133.71 159.14 73.65 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.164 1.785 . . . . 0.0 109.746 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.56 139.81 38.29 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.793 1.662 . . . . 0.0 109.62 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.23 -20.34 24.78 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.887 2.391 . . . . 0.0 112.046 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -67.67 -20.04 65.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.561 1.144 . . . . 0.0 112.258 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.75 143.39 18.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 118.677 0.671 . . . . 0.0 109.226 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -61.69 137.09 58.22 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.83 150.37 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.68 0.792 . . . . 0.0 109.582 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.03 163.13 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 108.274 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -132.58 112.73 12.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -120.97 58.22 0.96 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 106.862 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.06 132.48 17.01 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 121.065 -1.022 . . . . 0.0 113.089 -171.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.8 156.6 31.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.919 2.088 . . . . 0.0 106.388 169.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -60.21 148.19 37.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 110.836 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.39 128.54 82.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.501 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.26 -24.61 72.12 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.48 1.453 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.68 -17.4 64.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.173 0.897 . . . . 0.0 112.434 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -105.02 2.37 29.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.567 1.147 . . . . 0.0 111.266 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 45.66 0.33 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.507 1.523 . . . . 0.0 111.579 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.38 153.19 12.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.847 1.259 . . . . 0.0 112.228 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.61 -53.71 0.39 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -167.01 165.41 15.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.54 1.936 . . . . 0.0 107.044 169.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.54 -28.02 66.72 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.487 0.715 . . . . 0.0 111.242 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -69.91 -39.52 76.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.282 0.492 . . . . 0.0 110.694 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.13 -44.33 76.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -55.81 -52.58 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.199 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -58.2 -40.33 81.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.722 0.809 . . . . 0.0 111.675 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.93 83.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.833 -0.542 . . . . 0.0 111.015 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.2 -34.97 73.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.666 -0.646 . . . . 0.0 111.468 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -59.45 -54.41 46.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.968 0.804 . . . . 0.0 109.973 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.9 -29.51 69.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.623 0.647 . . . . 0.0 111.755 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.27 -54.83 31.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.533 1.06 . . . . 0.0 111.259 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.66 -38.25 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -52.82 -57.3 10.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.135 0.974 . . . . 0.0 109.935 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.92 -41.21 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.279 0.232 . . . . 0.0 111.234 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.96 -39.94 87.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mt -58.74 -51.09 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.36 71.08 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.563 0.602 . . . . 0.0 111.777 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.91 -51.38 69.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 117.587 0.694 . . . . 0.0 110.34 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -70.74 -29.35 65.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.954 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -41.44 90.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.638 1.108 . . . . 0.0 110.199 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -57.15 -52.5 65.06 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.57 -35.25 80.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.059 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.93 -37.32 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.13 -36.18 30.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.633 0.373 . . . . 0.0 111.501 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.71 -40.16 10.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.701 1.201 . . . . 0.0 111.896 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -116.53 -19.16 10.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.338 1.055 . . . . 0.0 111.522 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.78 13.22 81.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.362 0.982 . . . . 0.0 112.76 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.248 0.974 0 CA-C-N 118.625 1.213 . . . . 0.0 110.037 -175.771 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -83.09 -175.33 5.78 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 110.269 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -146.42 144.9 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -149.18 152.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.175 0.898 . . . . 0.0 109.182 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 137.5 39.44 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.919 0.888 . . . . 0.0 109.151 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.58 125.09 45.92 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.81 1.244 . . . . 0.0 107.699 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.45 140.97 51.47 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.91 170.41 15.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.318 1.056 . . . . 0.0 112.042 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 p -76.08 35.23 0.13 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.707 2.003 . . . . 0.0 110.607 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.68 110.59 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.721 2.105 . . . . 0.0 108.601 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -75.67 56.33 0.91 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.574 1.15 . . . . 0.0 111.685 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.3 m -129.91 -18.02 3.46 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.2 m -137.1 -87.78 0.29 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.993 0.815 . . . . 0.0 109.187 -170.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -57.16 -53.88 53.04 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.799 0.84 . . . . 0.0 111.137 -170.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 12.2 p -67.2 -35.4 79.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.447 0.567 . . . . 0.0 111.536 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -60.53 -55.72 30.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.161 0.985 . . . . 0.0 110.345 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -57.66 -43.98 85.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.505 0.722 . . . . 0.0 111.253 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.02 96.22 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.569 0.622 . . . . 0.0 111.45 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -57.09 -40.55 77.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.565 0.346 . . . . 0.0 110.663 174.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.22 -50.39 67.63 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.738 0.685 . . . . 0.0 112.084 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.22 -45.07 95.01 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.504 0.652 . . . . 0.0 110.579 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.63 97.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.474 0.71 . . . . 0.0 110.474 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.68 -36.11 64.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.798 0.726 . . . . 0.0 111.45 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -70.72 -62.21 1.47 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.052 0.387 . . . . 0.0 110.789 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.11 -38.74 86.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 71.6 mt -75.65 0.88 16.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.082 0.953 . . . . 0.0 112.232 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.19 22.07 64.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.245 1.403 . . . . 0.0 113.567 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 55.47 13.73 1.0 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.758 2.023 . . . . 0.0 113.39 -169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.42 1.95 14.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.244 1.418 . . . . 0.0 111.284 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 14.8 m95 -129.49 128.89 43.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -67.44 89.35 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 143.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -146.96 163.08 37.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.918 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 79.9 p -141.17 156.07 45.99 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.619 0.768 . . . . 0.0 109.047 169.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.91 -169.3 2.48 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 110.281 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.41 -178.49 46.22 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.47 -27.62 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.765 1.226 . . . . 0.0 110.899 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -147.04 166.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.803 1.241 . . . . 0.0 108.124 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.75 134.08 21.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -134.96 24.48 3.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.308 1.043 . . . . 0.0 109.151 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.05 168.34 39.16 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.97 148.1 27.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.026 0.53 . . . . 0.0 110.53 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -74.37 133.67 77.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 118.117 -0.944 . . . . 0.0 109.129 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.94 -33.61 42.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.868 2.379 . . . . 0.0 114.589 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -72.46 -28.92 63.22 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.254 -0.903 . . . . 0.0 110.853 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.39 85.43 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.17 -49.37 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -43.47 90.31 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.113 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.19 93.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.06 0.846 . . . . 0.0 110.033 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -70.99 -38.21 72.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.717 0.235 . . . . 0.0 111.469 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -63.79 -24.99 67.98 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.794 -1.191 . . . . 0.0 111.393 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -69.55 -14.6 62.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.778 0.831 . . . . 0.0 110.866 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.4 -2.1 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.237 1.015 . . . . 0.0 112.091 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.89 32.36 10.05 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.81 161.07 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.94 146.12 51.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -127.14 -0.7 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.114 1.366 . . . . 0.0 110.447 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -57.95 -31.12 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.388 -1.445 . . . . 0.0 111.267 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -67.7 -4.28 11.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.006 1.723 . . . . 0.0 114.728 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -137.13 53.73 1.88 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.311 1.414 . . . . 0.0 109.678 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -50.16 144.2 7.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.274 1.03 . . . . 0.0 112.345 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 m -64.21 161.36 16.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 114.533 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -156.9 157.67 35.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.471 1.508 . . . . 0.0 109.7 170.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.18 165.35 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.756 0.822 . . . . 0.0 109.492 170.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.86 145.98 6.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.804 1.242 . . . . 0.0 110.128 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.4 134.61 32.66 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.661 1.184 . . . . 0.0 109.944 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.41 -28.42 53.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.396 1.478 . . . . 0.0 113.323 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.92 -11.42 60.86 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.782 1.233 . . . . 0.0 112.201 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.62 -41.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 mt -47.95 -59.08 3.62 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.703 1.138 . . . . 0.0 111.645 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -0.26 30.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.76 -30.74 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.061 1.344 . . . . 0.0 112.066 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.71 131.58 51.17 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 109.858 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.36 -26.06 67.85 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.778 0.431 . . . . 0.0 110.791 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 tp -148.49 142.04 25.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.522 1.129 . . . . 0.0 108.443 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.58 144.14 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.35 126.46 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 p -100.3 135.18 42.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.42 20.68 17.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.474 0.71 . . . . 0.0 109.54 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.1 p -68.1 112.93 5.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.928 1.291 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.157 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.844 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 CA--C 1.538 0.71 0 N-CA-C 114.647 0.979 . . . . 0.0 114.647 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -63.4 138.45 58.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.551 1.54 . . . . 0.0 110.333 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 p -131.6 154.46 81.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.146 1.779 . . . . 0.0 109.442 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.81 145.21 56.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.203 1.936 . . . . 0.0 110.053 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.87 -21.88 13.87 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.107 2.538 . . . . 0.0 112.073 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -85.8 7.7 22.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.497 1.119 . . . . 0.0 112.38 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.73 144.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.18 138.48 58.42 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -133.12 150.48 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.702 0.801 . . . . 0.0 109.767 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -125.44 159.34 32.14 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.557 1.943 . . . . 0.0 107.914 171.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -133.84 111.88 10.85 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.423 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 32.5 m0 -120.93 57.38 0.98 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.146 1.778 . . . . 0.0 106.741 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.55 132.61 29.78 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 120.915 -1.116 . . . . 0.0 111.998 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.09 160.18 35.41 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.62 1.968 . . . . 0.0 106.106 169.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.12 141.85 55.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.373 0.606 . . . . 0.0 110.785 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.36 127.28 93.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 -22.66 44.06 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.082 1.188 . . . . 0.0 113.329 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.21 -9.95 59.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.495 1.043 . . . . 0.0 112.228 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -111.39 0.69 16.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.051 1.34 . . . . 0.0 110.749 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.72 54.0 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.496 2.319 . . . . 0.0 111.174 170.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.59 144.97 46.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.659 1.983 . . . . 0.0 112.003 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.08 -54.97 0.28 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -165.66 167.0 17.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.939 1.696 . . . . 0.0 107.45 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.18 -29.98 70.13 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.104 0.562 . . . . 0.0 111.201 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.13 -37.43 75.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.878 0.471 . . . . 0.0 110.574 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.23 -46.58 73.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -56.56 -48.86 76.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.098 0.559 . . . . 0.0 110.359 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -61.23 -37.93 84.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.584 0.754 . . . . 0.0 112.001 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.61 80.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.242 -0.912 . . . . 0.0 109.909 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.97 -33.22 75.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.803 0.441 . . . . 0.0 111.153 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.88 -50.31 73.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.721 0.809 . . . . 0.0 110.155 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -64.77 -35.0 79.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.39 0.541 . . . . 0.0 111.584 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -66.29 -51.03 61.46 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.337 0.517 . . . . 0.0 110.662 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.36 -39.96 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -53.29 -54.06 41.92 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.321 1.049 . . . . 0.0 109.393 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.53 -44.4 90.97 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 123.206 0.316 . . . . 0.0 111.008 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.58 -39.79 88.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.647 -0.658 . . . . 0.0 111.216 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.08 -51.05 77.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.28 -45.42 64.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -60.69 -50.4 73.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 117.639 0.719 . . . . 0.0 111.105 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.423 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.4 tpt180 -70.18 -33.18 71.43 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.113 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -40.13 96.26 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.407 1.003 . . . . 0.0 109.976 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -57.77 -51.45 69.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.65 -35.74 82.01 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.267 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -63.67 -36.65 84.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.908 -0.495 . . . . 0.0 111.014 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.3 -37.96 27.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.568 0.347 . . . . 0.0 111.409 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.3 -46.83 8.14 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 110.857 -169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 p -108.49 -17.21 14.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -169.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.36 11.5 80.36 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.238 0.923 . . . . 0.0 112.291 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.472 1.136 . . . . 0.0 108.482 -174.646 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.65 168.86 18.48 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -144.29 139.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -144.71 150.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 109.084 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 137.14 37.93 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.002 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -119.51 130.97 55.46 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.02 137.56 51.4 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 111.028 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.5 174.32 10.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.245 1.018 . . . . 0.0 112.221 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -56.3 -27.51 55.79 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.991 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.4 142.01 8.27 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.6 58.45 2.73 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.752 0.821 . . . . 0.0 111.083 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -130.6 -18.63 3.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.3 m -133.01 -96.99 0.3 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.071 0.85 . . . . 0.0 108.901 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -54.28 -50.69 66.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.149 0.98 . . . . 0.0 111.952 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p -67.54 -38.57 84.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.738 0.699 . . . . 0.0 111.246 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -58.45 -54.81 42.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.072 0.949 . . . . 0.0 109.989 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.2 mtm -57.57 -44.83 85.6 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.43 0.692 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.27 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.165 0.586 . . . . 0.0 111.59 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.0 tt0 -57.39 -40.64 78.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.214 0.461 . . . . 0.0 110.88 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.09 -53.47 45.31 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -60.97 -44.4 97.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.956 0.378 . . . . 0.0 111.166 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.38 -43.82 97.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.81 -172.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -59.0 -34.67 72.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.404 1.002 . . . . 0.0 111.576 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -65.42 -54.89 22.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.199 0.454 . . . . 0.0 110.809 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -78.17 -45.43 23.19 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -170.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 94.9 mt -72.07 -32.92 67.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.352 0.661 . . . . 0.0 111.542 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.02 175.31 44.26 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.95 -1.93 8.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.176 0.99 . . . . 0.0 111.22 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -61.63 -10.18 7.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.863 0.865 . . . . 0.0 110.723 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 18.7 m95 -127.39 124.89 39.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.655 1.982 . . . . 0.0 105.906 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -75.57 88.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -77.89 140.04 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.09 167.29 23.07 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.215 1.406 . . . . 0.0 109.314 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -142.79 155.64 44.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.03 0.932 . . . . 0.0 109.2 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.55 1.73 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.432 1.093 . . . . 0.0 109.257 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.78 -178.52 44.72 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -56.75 -28.63 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.028 1.331 . . . . 0.0 111.017 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.52 171.02 16.2 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.435 1.494 . . . . 0.0 108.784 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.29 22.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -129.71 10.78 5.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.765 1.226 . . . . 0.0 109.919 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.0 27.8 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -84.51 148.55 26.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -72.18 136.86 81.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 124.246 1.018 . . . . 0.0 108.752 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.51 -29.09 84.22 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.82 1.68 . . . . 0.0 112.891 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.83 -26.05 61.34 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.097 -1.002 . . . . 0.0 111.013 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -44.07 84.68 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.303 0.956 . . . . 0.0 109.084 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.25 -50.23 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -58.3 -41.8 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.97 89.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.541 0.736 . . . . 0.0 110.346 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 76.9 mmm -74.25 -34.2 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.698 0.227 . . . . 0.0 111.111 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.37 -23.18 66.91 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.66 -1.275 . . . . 0.0 111.553 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.39 -17.84 64.84 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.127 0.971 . . . . 0.0 110.634 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.33 -2.45 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.011 0.924 . . . . 0.0 112.6 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.86 32.65 9.76 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.95 155.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -140.28 82.18 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.153 0.978 . . . . 0.0 109.856 -169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.73 0.19 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.921 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -20.04 39.82 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 119.938 -1.726 . . . . 0.0 112.18 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -84.18 1.85 42.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.237 1.415 . . . . 0.0 112.659 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -133.86 49.92 2.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.488 1.04 . . . . 0.0 109.937 -172.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 p -46.98 134.09 10.66 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.909 1.284 . . . . 0.0 111.193 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -58.27 157.38 8.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.71 157.88 38.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.227 1.411 . . . . 0.0 109.398 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.35 168.59 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.573 1.149 . . . . 0.0 109.622 170.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.66 142.83 11.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.26 140.79 43.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.395 1.078 . . . . 0.0 109.723 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.73 -30.66 61.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.984 1.314 . . . . 0.0 113.135 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.69 -12.5 61.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.254 1.021 . . . . 0.0 111.884 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 mt -119.77 -43.22 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.61 -39.14 76.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.171 1.351 . . . . 0.0 112.193 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 6.49 48.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.864 0.866 . . . . 0.0 112.577 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -126.9 -29.39 2.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.717 1.207 . . . . 0.0 112.499 -168.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.64 125.48 23.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.88 1.272 . . . . 0.0 109.49 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.48 -26.53 67.23 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -141.61 137.25 31.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.957 1.303 . . . . 0.0 107.784 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.19 146.13 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.34 129.63 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -101.04 131.68 46.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.62 16.22 26.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.297 0.639 . . . . 0.0 109.99 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.5 p -69.24 109.39 4.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 111.022 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 169.981 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo . . . . . 0 CA--C 1.538 0.675 0 N-CA-C 115.01 1.119 . . . . 0.0 115.01 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -62.26 139.17 58.51 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.626 1.57 . . . . 0.0 110.248 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -129.55 153.27 80.66 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 126.382 1.873 . . . . 0.0 108.677 171.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.95 162.86 39.94 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.408 1.405 . . . . 0.0 109.821 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.62 -22.76 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.523 2.149 . . . . 0.0 112.724 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -87.01 -21.43 26.13 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.61 154.46 5.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 119.439 1.018 . . . . 0.0 109.649 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -71.07 140.44 50.69 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -123.83 154.53 39.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.3 164.56 28.28 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.784 1.634 . . . . 0.0 107.568 169.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -131.68 113.78 13.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -120.74 53.64 1.11 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.667 1.587 . . . . 0.0 106.771 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 128.1 29.42 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 111.823 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.7 161.43 40.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.77 142.01 49.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.0 124.46 88.84 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.84 -22.29 56.6 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.193 1.262 . . . . 0.0 113.163 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.81 60.33 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.388 0.995 . . . . 0.0 112.5 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -115.22 12.38 16.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.85 1.26 . . . . 0.0 111.537 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.34 66.34 0.93 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.12 1.368 . . . . 0.0 109.694 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -57.1 138.01 55.04 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.063 0.945 . . . . 0.0 110.766 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.08 -61.44 0.2 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -166.67 168.87 14.05 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.764 1.625 . . . . 0.0 107.433 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -30.21 70.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.018 0.527 . . . . 0.0 111.416 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.39 -37.78 74.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.797 0.439 . . . . 0.0 110.651 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 -45.89 77.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -59.0 -45.86 89.61 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.01 0.524 . . . . 0.0 110.601 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -60.84 -39.48 89.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.868 0.758 . . . . 0.0 111.628 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.03 85.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -65.98 -34.76 78.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.795 0.438 . . . . 0.0 111.192 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -58.41 -46.84 85.64 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.015 0.926 . . . . 0.0 110.2 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -65.73 -36.25 83.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.4 0.546 . . . . 0.0 111.284 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -68.14 -45.09 74.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.231 . . . . 0.0 111.453 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.52 -42.87 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.971 0.805 . . . . 0.0 109.449 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -39.46 94.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.021 1.282 . . . . 0.0 110.13 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.47 -42.39 78.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.405 0.282 . . . . 0.0 111.611 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.81 -41.12 83.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.04 -0.413 . . . . 0.0 110.745 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.77 -52.75 56.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.77 55.36 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.577 0.626 . . . . 0.0 111.757 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -61.16 -49.69 76.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.561 0.681 . . . . 0.0 110.966 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -69.8 -30.92 68.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.784 -0.573 . . . . 0.0 110.438 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -41.9 82.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.343 0.974 . . . . 0.0 109.855 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.95 -52.27 65.87 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -69.33 -31.28 69.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.455 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -63.01 -37.9 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.4 1.0 . . . . 0.0 111.016 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.28 51.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.788 0.435 . . . . 0.0 111.084 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.38 -40.84 11.83 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.788 0.835 . . . . 0.0 111.736 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.2 p -117.61 -19.06 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.965 0.906 . . . . 0.0 111.929 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.82 10.02 83.69 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.841 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 119.058 1.429 . . . . 0.0 108.889 -175.088 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.34 175.66 6.7 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.5 144.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.91 151.59 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.511 1.05 . . . . 0.0 109.024 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -138.15 129.51 27.63 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 123.568 0.747 . . . . 0.0 109.466 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.15 130.63 55.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.495 1.118 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -131.91 136.58 47.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.491 0.716 . . . . 0.0 111.023 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -146.51 -175.39 4.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.948 0.34 . . . . 0.0 111.155 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -62.76 -19.11 63.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.194 0.998 . . . . 0.0 112.462 -170.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.93 143.01 9.16 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.48 51.19 1.21 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.312 1.056 . . . . 0.0 111.843 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -128.2 -9.98 5.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -168.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.4 p -140.23 -101.98 0.15 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.79 0.723 . . . . 0.0 110.207 -169.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -51.43 -47.63 62.95 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.821 1.648 . . . . 0.0 110.689 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.7 p -66.95 -43.07 84.11 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.133 0.271 . . . . 0.0 110.674 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.641 1.176 . . . . 0.0 110.814 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.5 mtm -61.42 -42.53 98.89 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 110.65 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.34 -44.73 94.06 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 118.646 -0.693 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.54 -44.73 73.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.454 0.57 . . . . 0.0 110.506 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.83 -51.85 55.64 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 119.339 -0.701 . . . . 0.0 111.526 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -62.95 -46.0 89.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.447 0.623 . . . . 0.0 111.023 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.49 94.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.564 0.745 . . . . 0.0 110.657 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -57.23 -35.42 69.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.937 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -68.81 -61.88 1.62 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.169 0.441 . . . . 0.0 110.723 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -64.53 -41.02 96.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.409 0.283 . . . . 0.0 111.426 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.14 -1.82 37.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.286 1.035 . . . . 0.0 112.123 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.6 24.5 53.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.149 1.357 . . . . 0.0 113.998 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 55.8 9.44 0.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.412 2.285 . . . . 0.0 113.972 -170.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -66.05 -5.99 11.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 110.515 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -130.41 115.6 17.09 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -68.7 88.55 0.36 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.171 1.388 . . . . 0.0 107.466 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.04 154.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -150.62 164.69 35.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.705 2.002 . . . . 0.0 107.438 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.9 p -141.21 154.29 45.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 169.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.48 -169.45 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 110.365 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.76 -179.5 42.79 Favored Glycine 0 N--CA 1.447 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.9 -27.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.33 1.452 . . . . 0.0 111.416 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -145.72 170.85 15.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 108.43 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.94 136.36 16.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.12 19.1 2.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.611 1.164 . . . . 0.0 110.093 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.54 -176.8 20.35 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -110.42 144.23 39.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.049 0.94 . . . . 0.0 109.797 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -70.51 134.5 86.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.024 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.2 -33.55 44.92 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.06 2.507 . . . . 0.0 114.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -78.09 -28.55 48.75 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 119.151 0.887 . . . . 0.0 110.504 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.66 75.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.39 -52.13 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.98 -38.77 87.15 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.908 0.776 . . . . 0.0 111.397 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.7 87.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.918 0.487 . . . . 0.0 109.825 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.22 -36.57 79.72 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.209 0.459 . . . . 0.0 111.028 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -63.57 -26.37 68.67 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 120.673 -1.267 . . . . 0.0 111.188 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.55 -16.57 63.45 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.69 0.677 . . . . 0.0 111.095 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.16 -1.07 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.715 0.806 . . . . 0.0 112.07 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.46 31.75 11.2 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -123.34 154.92 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -142.64 76.04 1.51 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.596 1.189 . . . . 0.0 110.371 -169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.4 pt -58.65 -15.12 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.28 1.032 . . . . 0.0 113.339 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.74 -24.84 24.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.62 1.1 . . . . 0.0 111.967 172.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.37 -21.03 33.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.79 -21.86 9.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.875 1.216 . . . . 0.0 114.005 -169.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.0 p 49.01 -164.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.359 1.064 . . . . 0.0 111.553 -169.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 m -129.69 156.19 44.66 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.138 -0.976 . . . . 0.0 111.579 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -155.91 156.11 34.03 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.788 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.87 164.54 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 171.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 147.38 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.084 1.354 . . . . 0.0 110.198 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.39 136.76 33.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.441 1.097 . . . . 0.0 110.051 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -53.86 -29.67 42.29 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.553 1.541 . . . . 0.0 113.074 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.78 -8.74 50.71 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.192 1.397 . . . . 0.0 112.257 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.4 mt -117.29 -42.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.5 mt -47.53 -56.9 6.14 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.693 1.133 . . . . 0.0 112.195 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.87 0.88 51.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.649 0.78 . . . . 0.0 112.813 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -117.89 -31.22 5.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.06 1.344 . . . . 0.0 111.745 -169.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.81 131.31 49.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.206 1.402 . . . . 0.0 109.02 173.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 26.4 t70 -60.43 -32.15 71.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.668 0.387 . . . . 0.0 109.969 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.34 139.58 28.59 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.323 1.049 . . . . 0.0 109.141 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.61 146.05 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.36 121.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -98.58 135.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.85 18.67 19.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.269 1.027 . . . . 0.0 109.844 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.2 p -70.33 117.23 11.62 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.798 1.239 . . . . 0.0 110.006 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.358 0 C-N-CA 124.861 1.219 . . . . 0.0 111.047 170.459 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 138.45 58.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 110.235 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.0 p -125.96 153.37 73.73 Favored Pre-proline 0 N--CA 1.448 -0.533 0 C-N-CA 126.206 1.802 . . . . 0.0 108.768 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.67 153.59 77.44 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.776 1.651 . . . . 0.0 109.301 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.8 -23.51 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.407 2.071 . . . . 0.0 111.937 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -76.81 -25.96 53.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.737 0.815 . . . . 0.0 112.65 -172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.27 144.39 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.855 0.752 . . . . 0.0 109.437 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 76' ' ' ASP . 38.3 ttpt -65.31 136.24 56.32 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -135.94 151.31 49.82 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.145 0.578 . . . . 0.0 110.455 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -126.55 159.42 33.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.028 2.131 . . . . 0.0 107.809 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -135.98 111.32 9.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -121.47 62.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.199 1.8 . . . . 0.0 106.661 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.99 134.06 21.31 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.252 -0.905 . . . . 0.0 112.224 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.21 161.05 39.26 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.966 2.107 . . . . 0.0 106.168 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.89 148.53 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.759 0.79 . . . . 0.0 110.667 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -71.76 120.88 82.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.811 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.13 -27.22 73.06 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.328 1.352 . . . . 0.0 112.868 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -6.4 41.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.742 0.701 . . . . 0.0 112.589 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -119.35 0.44 11.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.885 1.674 . . . . 0.0 109.846 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.21 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.279 1.432 . . . . 0.0 109.957 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -57.19 124.93 20.51 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.301 1.04 . . . . 0.0 109.6 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.46 -74.93 0.12 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -167.36 168.89 12.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.602 1.561 . . . . 0.0 107.52 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.59 -30.47 69.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.881 -0.512 . . . . 0.0 111.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.27 -38.63 78.47 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.647 0.379 . . . . 0.0 110.453 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -70.96 -38.52 72.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.683 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -59.51 -47.73 84.4 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 119.34 0.973 . . . . 0.0 110.45 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -58.64 -39.72 81.38 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.254 0.622 . . . . 0.0 111.189 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.64 78.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.639 -0.663 . . . . 0.0 111.03 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.76 -35.15 79.91 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.78 -52.93 63.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.701 0.8 . . . . 0.0 110.722 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.51 -30.61 70.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.728 0.695 . . . . 0.0 112.02 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -63.41 -53.92 44.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.431 1.014 . . . . 0.0 110.346 171.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.88 -37.59 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.528 0.603 . . . . 0.0 109.501 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -55.17 -54.15 46.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 123.786 0.834 . . . . 0.0 109.423 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.25 -43.05 99.1 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 123.256 0.347 . . . . 0.0 110.806 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.27 -40.45 90.11 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.766 -0.584 . . . . 0.0 111.314 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.54 -50.93 78.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.23 -46.23 57.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.02 -50.08 75.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 111.003 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -69.83 -30.29 67.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.496 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -39.7 81.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.588 1.085 . . . . 0.0 110.178 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -56.36 -50.08 72.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.31 -37.79 88.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 111.496 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -61.37 -35.71 78.21 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.11 -0.994 . . . . 0.0 111.753 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.11 -35.99 28.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.702 0.401 . . . . 0.0 111.358 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.72 -41.9 10.44 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.014 1.326 . . . . 0.0 111.682 -169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -115.15 -20.33 10.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.621 1.168 . . . . 0.0 111.579 -169.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.83 81.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.395 0.998 . . . . 0.0 112.768 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.407 1.103 . . . . 0.0 109.573 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -82.79 -176.63 6.39 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 122.683 0.393 . . . . 0.0 110.019 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.19 143.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.85 151.07 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.934 0.894 . . . . 0.0 109.087 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.91 138.02 38.61 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.877 0.871 . . . . 0.0 108.974 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.6 127.58 53.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -123.38 143.81 49.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.857 1.263 . . . . 0.0 109.976 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.1 m -142.12 176.53 8.89 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.374 1.07 . . . . 0.0 112.11 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -65.26 -18.24 65.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.623 1.169 . . . . 0.0 111.891 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.1 136.08 4.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -80.54 55.85 2.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.08 0.952 . . . . 0.0 111.684 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 m -125.74 -18.43 5.17 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.7 m -137.85 -88.39 0.26 Allowed 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 119.152 0.887 . . . . 0.0 109.563 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -56.62 -53.93 51.91 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.711 0.805 . . . . 0.0 111.18 -169.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -67.23 -35.45 79.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.083 0.401 . . . . 0.0 111.248 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.03 -54.7 41.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.177 0.991 . . . . 0.0 110.103 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.0 mtm -57.81 -41.88 83.11 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.465 0.706 . . . . 0.0 111.366 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.01 95.21 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.444 0.565 . . . . 0.0 111.735 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.7 tt0 -55.37 -41.37 72.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.639 0.375 . . . . 0.0 110.784 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -49.89 73.62 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.337 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -62.64 -43.79 97.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.737 0.769 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.62 -42.68 99.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.521 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -51.79 -38.54 56.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -69.52 -62.2 1.48 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.206 0.316 . . . . 0.0 110.419 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -68.9 -40.32 79.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.99 -6.47 54.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.23 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.06 24.36 58.34 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.822 1.201 . . . . 0.0 114.157 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.8 t70 57.87 9.93 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.307 2.243 . . . . 0.0 113.953 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -66.26 -5.67 11.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.021 1.328 . . . . 0.0 110.737 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -128.99 124.53 35.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 173.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.2 mmpt? -66.33 100.94 0.68 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 t -85.4 139.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -146.39 165.83 28.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.194 1.398 . . . . 0.0 109.294 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.8 p -144.02 157.44 44.33 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.593 0.757 . . . . 0.0 110.064 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.68 -167.31 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.93 -174.45 45.82 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.93 -30.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.998 1.319 . . . . 0.0 111.009 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 168.86 21.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 108.569 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.54 138.68 26.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.73 11.21 5.66 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.64 1.176 . . . . 0.0 110.056 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.4 163.84 33.17 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.74 148.55 30.05 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.371 0.605 . . . . 0.0 110.824 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.16 136.24 79.28 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.003 0.921 . . . . 0.0 109.761 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.99 -36.03 63.2 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.705 2.27 . . . . 0.0 113.893 174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -72.44 -30.3 64.48 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.621 -0.675 . . . . 0.0 110.547 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.55 90.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -59.05 -49.04 84.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -38.98 81.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.274 0.943 . . . . 0.0 111.009 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.92 -46.48 84.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.369 0.668 . . . . 0.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.6 mmm -68.5 -36.53 79.03 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 118.372 0.533 . . . . 0.0 111.021 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -65.81 -25.14 67.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.905 -1.122 . . . . 0.0 111.18 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -68.83 -17.37 63.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.265 0.626 . . . . 0.0 110.969 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.92 0.33 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.646 0.778 . . . . 0.0 111.921 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.98 32.28 18.14 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 174.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.4 159.74 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -124.66 144.42 50.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -128.6 3.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.856 1.262 . . . . 0.0 110.226 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.04 -28.76 68.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.129 -1.607 . . . . 0.0 111.119 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -64.63 -4.61 4.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.586 1.955 . . . . 0.0 115.17 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -137.92 49.7 1.95 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.294 1.406 . . . . 0.0 110.815 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -46.05 131.85 9.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.271 1.029 . . . . 0.0 110.723 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -55.71 155.88 5.41 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.185 1.794 . . . . 0.0 115.698 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -153.92 158.04 40.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.319 1.448 . . . . 0.0 109.211 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 168.7 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 169.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.7 mt -56.39 142.86 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.627 0.771 . . . . 0.0 109.141 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.23 135.71 47.6 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.091 1.356 . . . . 0.0 109.454 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -56.39 -31.27 63.7 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.022 1.329 . . . . 0.0 113.267 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -81.36 -5.15 57.55 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.853 -0.529 . . . . 0.0 111.749 -170.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.5 mt -111.39 -44.0 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.77 -39.88 86.37 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.846 1.203 . . . . 0.0 111.523 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.52 3.14 41.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -126.62 -27.0 3.17 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.999 0.92 . . . . 0.0 112.997 -168.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.91 20.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.513 1.125 . . . . 0.0 109.757 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.68 -28.43 69.9 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.907 0.483 . . . . 0.0 110.775 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.22 140.35 33.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.75 144.04 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 124.28 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.94 127.4 48.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.54 22.89 12.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.667 0.746 . . . . 0.0 109.343 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.94 107.26 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.468 1.507 . . . . 0.0 110.482 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 C-N-CA 125.066 1.317 . . . . 0.0 109.992 170.491 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 120.938 0.308 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.7 mtm -72.94 157.6 37.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.379 0.672 . . . . 0.0 109.494 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -129.98 162.31 54.5 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.893 2.077 . . . . 0.0 108.363 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.32 161.46 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.047 1.165 . . . . 0.0 109.503 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.13 -23.38 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.453 2.102 . . . . 0.0 111.985 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -75.48 -31.01 60.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.54 0.736 . . . . 0.0 112.63 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -81.21 152.04 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.753 0.787 . . . . 0.0 110.757 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.36 143.52 50.18 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -135.98 149.4 48.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.746 0.418 . . . . 0.0 110.541 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.69 157.82 38.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.816 2.047 . . . . 0.0 107.728 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -133.98 112.75 11.49 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -122.17 56.45 1.1 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.121 1.769 . . . . 0.0 107.216 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.09 125.2 21.33 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.707 -1.245 . . . . 0.0 111.93 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.89 162.21 41.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.697 1.999 . . . . 0.0 106.447 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -68.75 147.42 51.82 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.36 0.6 . . . . 0.0 111.17 -172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.91 126.37 91.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.524 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.17 -24.57 65.82 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.661 1.574 . . . . 0.0 113.663 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.83 -15.12 63.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.42 1.009 . . . . 0.0 112.34 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -108.61 2.45 22.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.432 1.093 . . . . 0.0 111.482 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 53.05 0.29 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.717 2.007 . . . . 0.0 111.508 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 147.84 37.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.828 2.051 . . . . 0.0 112.082 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.9 -53.29 0.36 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.94 165.79 17.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 107.386 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.06 -29.37 68.5 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.351 0.66 . . . . 0.0 111.132 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.13 -41.44 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.41 0.684 . . . . 0.0 110.206 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.49 -46.77 71.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.912 0.885 . . . . 0.0 108.849 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.53 -52.17 64.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 122.872 0.469 . . . . 0.0 110.185 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -58.45 -39.71 80.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.578 0.751 . . . . 0.0 111.609 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.0 93.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.542 -0.724 . . . . 0.0 110.428 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.39 -34.48 78.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.875 0.47 . . . . 0.0 111.64 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -58.82 -48.51 81.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.908 0.776 . . . . 0.0 109.929 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -64.16 -38.25 90.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.612 0.642 . . . . 0.0 111.254 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.7 mmm-85 -61.97 -51.65 67.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.983 0.811 . . . . 0.0 111.156 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.86 -39.34 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -53.81 -55.29 27.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.066 0.946 . . . . 0.0 109.467 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.51 -42.39 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.146 0.279 . . . . 0.0 110.858 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.5 -39.01 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.078 0.551 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.15 -50.65 79.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.38 73.47 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.68 0.657 . . . . 0.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -60.17 -51.98 67.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.599 0.7 . . . . 0.0 110.992 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -69.2 -29.08 66.98 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.87 -1.062 . . . . 0.0 111.405 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -42.02 87.89 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.798 1.181 . . . . 0.0 109.868 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.43 -51.54 69.0 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.61 -34.46 77.93 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.521 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.18 -38.71 90.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.591 0.632 . . . . 0.0 111.001 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.36 36.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.391 0.276 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -90.43 -48.15 7.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.609 1.163 . . . . 0.0 110.908 -169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.8 p -106.69 -18.91 13.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.209 1.004 . . . . 0.0 111.273 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.26 15.81 75.73 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.82 -0.989 . . . . 0.0 112.503 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-N 118.717 1.258 . . . . 0.0 108.644 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 174.52 8.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.63 142.44 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.01 148.63 21.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.903 0.774 . . . . 0.0 109.007 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.33 132.99 36.38 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -115.78 133.11 56.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.78 141.43 51.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.69 0.796 . . . . 0.0 110.009 -169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.54 169.29 17.88 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 122.103 0.954 . . . . 0.0 112.131 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -76.03 35.81 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.23 2.212 . . . . 0.0 110.857 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.45 112.51 0.86 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.49 54.45 0.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.656 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -128.46 -18.68 3.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.4 m -136.32 -89.61 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.176 0.898 . . . . 0.0 109.688 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -55.24 -52.46 63.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.197 0.999 . . . . 0.0 111.028 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 p -58.03 -47.57 82.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.531 1.133 . . . . 0.0 110.874 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.45 -56.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.89 1.276 . . . . 0.0 110.16 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.1 mtm -57.33 -45.52 84.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.732 . . . . 0.0 111.228 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.03 97.6 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.671 0.669 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' HG12 ' A' ' 34' ' ' VAL . 23.9 tt0 -60.99 -34.57 75.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.832 0.453 . . . . 0.0 110.98 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.72 43.26 Favored Glycine 0 C--N 1.341 0.858 0 C-N-CA 123.706 0.669 . . . . 0.0 111.655 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.67 -43.27 94.04 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 117.533 0.666 . . . . 0.0 110.592 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.73 -43.59 98.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.771 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -53.86 -37.62 63.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.907 1.231 . . . . 0.0 111.954 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -66.76 -57.28 7.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.008 0.367 . . . . 0.0 110.411 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.94 -42.1 61.05 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.094 0.158 . . . . 0.0 111.381 -171.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 -11.43 59.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 112.257 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 26.85 60.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.377 0.989 . . . . 0.0 114.168 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 60.89 6.03 1.11 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.626 2.37 . . . . 0.0 114.134 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.82 -9.68 22.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.56 100.33 0.86 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.456 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.1 t -83.12 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -143.27 166.61 24.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.584 1.553 . . . . 0.0 109.421 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -149.74 161.28 42.54 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.614 -0.679 . . . . 0.0 110.133 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.53 -166.64 1.39 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.998 1.319 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.58 -179.97 44.58 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 111.715 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mt -53.52 -29.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.352 1.461 . . . . 0.0 111.356 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.49 167.14 24.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.602 1.161 . . . . 0.0 108.307 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.49 21.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -135.37 24.96 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.38 1.072 . . . . 0.0 109.255 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.84 167.68 39.18 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -84.78 147.54 26.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.959 0.504 . . . . 0.0 110.508 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -73.7 133.75 79.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.089 -0.957 . . . . 0.0 109.303 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.02 -33.8 44.1 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.897 2.398 . . . . 0.0 114.584 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.68 -29.23 63.24 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 121.35 -0.844 . . . . 0.0 110.87 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.37 85.06 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.22 -49.21 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -44.21 91.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.18 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.07 92.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.927 0.785 . . . . 0.0 110.152 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.1 mmm -71.81 -37.4 70.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.81 0.277 . . . . 0.0 111.525 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -27.36 69.06 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.87 -1.144 . . . . 0.0 111.31 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.98 -13.07 62.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.715 0.806 . . . . 0.0 110.852 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.3 -2.42 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.528 1.131 . . . . 0.0 112.228 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.97 33.41 9.73 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.16 160.87 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -128.33 145.15 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.32 -1.04 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.367 1.467 . . . . 0.0 110.284 173.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -57.8 -29.9 65.26 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.602 -1.311 . . . . 0.0 110.97 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -60.79 -16.2 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.697 1.999 . . . . 0.0 114.537 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' A' ' 21' ' ' GLU . 8.4 pt20 -131.1 54.92 1.88 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.713 1.142 . . . . 0.0 110.452 -169.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 p -49.78 140.94 10.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.93 0.892 . . . . 0.0 111.85 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 m -62.36 160.4 13.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.041 1.736 . . . . 0.0 114.517 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -155.98 156.46 34.53 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.963 1.305 . . . . 0.0 109.689 169.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.12 164.32 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.857 0.863 . . . . 0.0 109.331 170.142 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.43 146.92 5.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 110.308 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.54 136.01 32.44 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.392 1.077 . . . . 0.0 109.938 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.53 -28.65 46.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.454 1.502 . . . . 0.0 113.138 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.4 -10.83 59.69 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.966 1.306 . . . . 0.0 112.21 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.1 -42.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 mt -48.66 -58.41 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -1.31 36.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -116.38 -31.5 5.58 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.126 1.37 . . . . 0.0 111.7 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.03 44.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.153 1.381 . . . . 0.0 109.543 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.9 -26.22 67.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.443 0.697 . . . . 0.0 110.656 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -148.03 140.43 24.39 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.641 1.177 . . . . 0.0 108.803 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.69 148.13 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.53 130.76 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.29 132.09 45.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 170.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -102.96 23.21 12.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.904 0.882 . . . . 0.0 109.164 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.55 107.66 4.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.979 1.712 . . . . 0.0 110.45 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 171.993 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.537 0.644 0 N-CA-C 114.275 0.837 . . . . 0.0 114.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.8 ttm -75.19 149.24 39.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.895 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -132.65 161.23 64.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.744 2.017 . . . . 0.0 110.05 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.98 133.31 24.86 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.029 1.819 . . . . 0.0 109.278 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.03 -19.3 30.28 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.817 2.345 . . . . 0.0 112.318 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -68.15 -20.18 64.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 111.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.73 142.23 16.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -61.39 136.23 57.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -129.97 158.83 38.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.974 0.91 . . . . 0.0 109.298 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -137.92 166.47 23.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.988 1.715 . . . . 0.0 107.914 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -132.87 117.5 17.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -125.43 52.89 1.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.153 1.781 . . . . 0.0 107.314 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.12 132.17 33.45 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.73 -1.231 . . . . 0.0 112.367 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.23 159.65 36.28 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.501 1.92 . . . . 0.0 106.132 169.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -68.71 142.17 55.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.845 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.05 126.95 93.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.112 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.16 -23.53 45.54 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.115 1.21 . . . . 0.0 113.297 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.69 -9.13 58.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.399 1.0 . . . . 0.0 112.225 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -113.0 4.38 16.69 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.236 1.414 . . . . 0.0 110.667 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.38 63.28 0.37 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.725 2.01 . . . . 0.0 110.442 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -59.44 138.97 57.49 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.669 1.588 . . . . 0.0 110.718 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.1 -59.73 0.2 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -166.17 169.27 14.53 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.054 1.742 . . . . 0.0 107.398 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.98 -29.61 68.56 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.369 0.668 . . . . 0.0 111.416 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.79 -37.8 73.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.788 0.435 . . . . 0.0 110.654 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.6 -43.85 75.58 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -57.4 -48.42 79.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.778 0.431 . . . . 0.0 110.141 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -60.99 -38.06 84.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.4 0.68 . . . . 0.0 111.925 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.44 81.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.46 -33.42 75.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.018 0.527 . . . . 0.0 111.13 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.25 -50.04 74.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.957 0.903 . . . . 0.0 110.278 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -64.88 -34.36 78.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.347 0.522 . . . . 0.0 111.656 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.51 -49.72 62.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.623 0.647 . . . . 0.0 110.821 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.93 -39.86 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -53.72 -54.14 42.22 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.458 1.103 . . . . 0.0 109.601 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.87 -43.23 93.64 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.056 0.222 . . . . 0.0 110.911 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.65 -41.08 88.79 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.999 -0.438 . . . . 0.0 110.77 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.7 mt -59.59 -50.33 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.72 -46.67 66.61 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.763 0.71 . . . . 0.0 111.476 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -62.19 -46.36 89.26 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.404 0.602 . . . . 0.0 110.78 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -72.25 -30.58 65.0 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 -174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -42.19 82.44 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.734 0.814 . . . . 0.0 109.62 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.17 -48.78 75.67 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -37.64 86.24 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.451 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -60.32 -37.29 80.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.643 -0.661 . . . . 0.0 111.496 175.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.87 33.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.518 0.327 . . . . 0.0 111.661 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.96 -45.69 7.83 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.465 1.106 . . . . 0.0 111.128 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.5 p -106.88 -19.49 13.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.055 . . . . 0.0 110.902 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.93 79.1 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.215 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.6 mttt . . . . . 0 C--O 1.248 1.003 0 CA-C-N 118.562 1.181 . . . . 0.0 108.703 176.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 173.95 3.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.3 142.24 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.54 146.06 22.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 119.043 0.838 . . . . 0.0 108.824 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.55 124.02 22.13 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -107.6 128.39 54.49 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.62 145.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.158 0.583 . . . . 0.0 110.935 -169.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.7 m -141.42 178.83 7.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.755 1.622 . . . . 0.0 109.374 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -75.85 -19.15 59.11 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.654 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.34 131.65 4.15 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.31 54.33 2.27 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.769 0.828 . . . . 0.0 111.748 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -126.1 -16.88 5.42 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -131.84 -106.33 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -170.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -35.44 75.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -60.71 -47.77 84.8 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.18 0.9 . . . . 0.0 110.377 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -60.01 -49.71 76.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.237 1.015 . . . . 0.0 110.221 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.39 -44.74 89.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.16 0.584 . . . . 0.0 111.841 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.79 99.61 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.234 0.614 . . . . 0.0 111.015 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG12 ' A' ' 34' ' ' VAL . 61.0 tt0 -56.13 -41.2 74.94 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.112 173.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.07 60.97 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.782 0.719 . . . . 0.0 112.309 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.54 -45.78 92.6 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.34 0.57 . . . . 0.0 110.812 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.33 -42.57 99.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.846 -175.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -52.77 -44.35 66.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.395 0.998 . . . . 0.0 111.568 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -74.8 -43.88 52.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.164 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -73.72 -44.58 55.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.494 0.588 . . . . 0.0 110.921 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.01 -9.64 59.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.161 0.984 . . . . 0.0 112.253 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.41 26.48 64.29 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.534 1.064 . . . . 0.0 113.956 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 60.72 5.82 1.01 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.625 2.37 . . . . 0.0 113.986 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.79 -9.32 19.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.641 1.176 . . . . 0.0 110.544 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.52 118.53 23.21 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 172.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -67.87 101.43 1.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -85.1 137.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.19 166.19 25.74 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.62 1.568 . . . . 0.0 109.529 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -147.88 157.06 43.34 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.482 0.713 . . . . 0.0 110.007 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.16 -168.03 1.62 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.546 1.139 . . . . 0.0 110.357 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.54 -175.45 42.09 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.442 -0.787 . . . . 0.0 112.598 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -55.09 -30.28 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.531 1.532 . . . . 0.0 110.681 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 169.6 17.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.776 1.23 . . . . 0.0 109.142 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.53 137.05 20.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -136.49 19.45 3.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.205 1.002 . . . . 0.0 109.777 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.71 29.09 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -94.42 146.95 23.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.342 0.657 . . . . 0.0 110.583 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.33 138.77 78.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.826 1.25 . . . . 0.0 109.455 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.15 -30.34 82.04 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.849 1.699 . . . . 0.0 113.255 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.92 -27.21 62.66 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.626 1.103 . . . . 0.0 110.483 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.31 -48.4 73.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.54 1.063 . . . . 0.0 108.941 171.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.68 -48.13 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -57.92 -47.08 83.88 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.933 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -43.68 81.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 0.0 109.389 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.8 mmm -71.25 -39.64 71.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.276 0.231 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.88 -27.09 69.11 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 120.888 -1.133 . . . . 0.0 111.259 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.2 -9.56 58.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.073 0.949 . . . . 0.0 109.957 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.55 -1.12 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.254 1.022 . . . . 0.0 112.591 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.65 33.52 11.28 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.1 161.54 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -125.58 143.35 51.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.58 3.63 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.03 1.332 . . . . 0.0 110.365 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -60.93 -28.06 68.66 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.2 -1.563 . . . . 0.0 110.965 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -65.5 -4.36 5.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.412 1.885 . . . . 0.0 115.322 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.82 47.87 2.03 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.274 1.397 . . . . 0.0 111.273 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 131.28 8.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.42 1.088 . . . . 0.0 110.789 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -54.82 154.42 5.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.448 1.899 . . . . 0.0 115.455 -169.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -152.22 156.0 38.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.206 1.403 . . . . 0.0 109.311 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.7 164.79 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.263 1.025 . . . . 0.0 109.346 171.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.1 mt -56.4 145.85 6.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.608 1.163 . . . . 0.0 109.671 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -136.93 134.42 36.74 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.404 1.082 . . . . 0.0 109.928 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.17 -27.64 55.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.635 1.574 . . . . 0.0 113.522 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.87 -4.18 57.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.527 0.603 . . . . 0.0 111.797 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -107.96 -42.24 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.6 mt -48.37 -60.45 2.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.388 0.995 . . . . 0.0 111.269 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -75.81 -1.94 27.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.371 0.668 . . . . 0.0 112.736 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -115.85 -31.51 5.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.932 1.293 . . . . 0.0 111.34 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.05 124.12 19.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.127 1.371 . . . . 0.0 109.848 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.7 -31.75 71.92 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.816 0.846 . . . . 0.0 110.184 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 tp -142.06 139.17 32.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.389 1.076 . . . . 0.0 108.547 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.41 147.08 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.95 126.83 51.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.29 118.39 36.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.342 0.519 . . . . 0.0 109.766 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.26 12.63 36.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.848 1.259 . . . . 0.0 110.749 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -65.53 119.18 10.61 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.328 171.667 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 N-CA-C 110.037 -0.793 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.8 tpp -130.23 159.07 37.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.472 1.109 . . . . 0.0 109.586 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 166.58 18.23 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.224 1.81 . . . . 0.0 110.457 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.97 161.34 33.55 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.558 1.505 . . . . 0.0 110.011 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.03 -9.12 17.94 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.096 2.531 . . . . 0.0 114.027 -169.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -115.0 -12.72 11.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.27 146.58 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.764 1.165 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.23 136.95 52.74 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -138.61 151.89 47.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.307 0.643 . . . . 0.0 109.987 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.34 161.71 29.66 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.137 2.175 . . . . 0.0 107.387 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -139.48 112.53 8.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 30.9 m0 -122.43 51.45 1.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.641 1.577 . . . . 0.0 107.062 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.88 132.18 31.32 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 120.885 -1.134 . . . . 0.0 111.88 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.97 35.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.028 1.731 . . . . 0.0 107.411 169.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.27 134.35 56.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.913 1.285 . . . . 0.0 109.842 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.42 124.7 91.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -23.91 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.432 1.421 . . . . 0.0 113.604 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.53 49.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.167 0.894 . . . . 0.0 112.273 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -110.33 8.51 23.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.615 1.166 . . . . 0.0 111.071 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.87 68.7 0.66 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.879 1.272 . . . . 0.0 109.777 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.13 136.34 57.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.792 0.837 . . . . 0.0 110.277 -171.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.55 -61.72 0.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -165.44 167.04 17.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.432 1.493 . . . . 0.0 107.72 171.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.49 -28.05 66.69 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.612 0.765 . . . . 0.0 111.431 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.7 -37.35 70.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.047 0.539 . . . . 0.0 110.941 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -69.39 -44.48 71.38 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.2 -45.96 83.29 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.776 0.431 . . . . 0.0 110.293 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -60.37 -40.47 90.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.47 0.708 . . . . 0.0 111.756 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.08 87.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.487 -0.758 . . . . 0.0 110.513 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -62.8 -37.47 86.85 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.007 0.523 . . . . 0.0 111.274 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.12 -48.95 77.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.364 0.665 . . . . 0.0 110.345 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.53 -36.34 83.46 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.438 0.563 . . . . 0.0 111.824 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -68.43 -47.44 67.22 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.995 0.816 . . . . 0.0 111.085 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.21 -41.41 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.82 -53.17 58.74 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.141 0.976 . . . . 0.0 109.758 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.59 -42.44 98.28 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.781 0.264 . . . . 0.0 110.954 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.6 -41.64 92.56 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.984 -0.447 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.51 -50.78 79.01 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.71 -45.63 60.25 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -61.13 -50.35 73.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 117.446 0.623 . . . . 0.0 111.1 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.436 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.9 tpt180 -68.69 -34.25 75.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.228 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -40.66 98.41 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.687 1.13 . . . . 0.0 109.695 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.79 -51.87 68.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.24 -36.08 83.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.908 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.65 -36.55 83.2 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.709 -0.619 . . . . 0.0 111.2 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.4 -37.85 31.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.652 0.381 . . . . 0.0 111.257 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.35 -46.92 8.07 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.393 1.077 . . . . 0.0 110.868 -170.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -109.41 -18.86 13.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.432 1.093 . . . . 0.0 111.638 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.46 13.16 82.13 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.586 -1.119 . . . . 0.0 112.942 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 119.225 1.512 . . . . 0.0 108.428 179.242 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -71.86 172.75 9.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.12 143.62 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -146.58 149.7 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 119.211 0.914 . . . . 0.0 109.233 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.23 131.55 32.55 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.586 0.754 . . . . 0.0 109.286 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.25 128.3 56.29 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.3 mt -125.03 141.35 52.18 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.072 0.949 . . . . 0.0 110.319 -169.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.3 m -141.12 168.85 18.79 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 122.223 1.011 . . . . 0.0 112.557 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -76.82 34.21 0.15 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.737 2.015 . . . . 0.0 110.479 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.65 109.15 0.67 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 126.351 1.929 . . . . 0.0 108.605 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.46 51.46 0.72 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.201 1.0 . . . . 0.0 111.746 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -120.99 -20.38 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 m -136.32 -92.85 0.25 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.254 0.933 . . . . 0.0 110.66 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -36.71 85.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -61.04 -47.33 86.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.336 0.654 . . . . 0.0 110.616 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -60.69 -49.98 75.34 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.177 0.991 . . . . 0.0 109.679 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 mtm -58.21 -44.46 88.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.061 0.544 . . . . 0.0 111.623 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.45 -44.21 97.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.794 0.725 . . . . 0.0 111.346 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.6 tt0 -56.94 -41.84 78.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.449 0.3 . . . . 0.0 110.725 173.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.92 -52.86 50.83 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.763 0.697 . . . . 0.0 112.119 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -61.32 -43.05 99.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.394 0.597 . . . . 0.0 110.82 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.07 99.74 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.923 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -55.08 -36.69 65.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.439 1.018 . . . . 0.0 111.553 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -68.4 -57.67 5.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.238 0.472 . . . . 0.0 110.921 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -76.19 -43.87 40.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.1 mt -72.56 -34.49 67.53 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.947 0.499 . . . . 0.0 111.46 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 173.57 42.13 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -1.48 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 111.607 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.83 -10.23 5.26 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.428 -0.795 . . . . 0.0 110.991 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.3 m95 -128.99 119.63 24.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -70.16 92.19 0.75 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -78.95 138.44 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.49 166.81 24.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.219 1.407 . . . . 0.0 109.46 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -147.71 159.89 43.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.429 0.692 . . . . 0.0 109.721 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.41 -166.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 109.304 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.06 43.61 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 121.311 -0.868 . . . . 0.0 111.776 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.45 -29.56 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.991 1.316 . . . . 0.0 110.734 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.8 166.48 29.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.325 1.45 . . . . 0.0 108.247 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.85 140.08 26.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.16 9.33 5.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.65 149.55 24.89 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.0 144.96 56.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.497 0.665 . . . . 0.0 111.413 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -73.21 133.31 81.28 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.575 1.15 . . . . 0.0 108.61 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.01 -34.37 37.7 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.872 2.381 . . . . 0.0 114.282 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.78 -28.47 63.65 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.498 -0.751 . . . . 0.0 110.896 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.01 77.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.34 -48.07 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -39.75 94.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.673 -0.68 . . . . 0.0 111.041 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.01 -44.53 97.28 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.304 0.956 . . . . 0.0 110.3 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 74.3 mmm -68.91 -36.27 77.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.642 0.655 . . . . 0.0 111.469 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.484 -1.385 . . . . 0.0 111.396 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -66.43 -17.35 64.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.93 0.786 . . . . 0.0 111.038 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.66 -0.64 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.08 0.952 . . . . 0.0 112.114 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.43 32.85 12.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.03 158.55 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.3 144.6 49.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.412 1.085 . . . . 0.0 108.153 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.99 4.14 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.977 1.311 . . . . 0.0 110.404 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.09 -27.57 67.11 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.113 -1.617 . . . . 0.0 111.153 172.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.38 -3.19 3.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.468 1.907 . . . . 0.0 115.295 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -139.9 47.65 1.82 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.302 1.41 . . . . 0.0 111.645 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 133.21 7.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.599 1.16 . . . . 0.0 111.356 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -57.51 156.61 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.069 1.748 . . . . 0.0 115.153 -169.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -155.95 158.51 38.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.079 1.352 . . . . 0.0 109.301 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.414 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.31 164.37 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 170.255 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.61 149.19 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.829 1.652 . . . . 0.0 110.991 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.53 136.06 32.51 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.705 1.202 . . . . 0.0 110.181 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.01 -29.39 57.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.576 1.551 . . . . 0.0 113.319 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.77 -9.01 52.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.912 1.285 . . . . 0.0 112.27 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.51 -42.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.1 mt -46.98 -57.5 4.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.586 1.085 . . . . 0.0 112.186 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.71 -0.06 52.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 112.801 -173.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.94 -31.92 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.135 1.374 . . . . 0.0 111.527 -169.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.83 130.39 45.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.426 1.491 . . . . 0.0 109.887 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -63.07 -28.12 69.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.712 0.805 . . . . 0.0 110.477 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -147.62 139.95 24.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.891 1.276 . . . . 0.0 108.671 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.66 147.76 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.75 124.29 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -99.44 132.86 44.48 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.65 22.9 15.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.682 0.793 . . . . 0.0 109.362 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.0 111.81 6.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.785 -1.197 . . . . 0.0 110.305 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 169.886 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.535 0.538 0 N-CA-C 113.224 0.432 . . . . 0.0 113.224 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.1 ttt -69.53 145.23 52.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.035 0.934 . . . . 0.0 109.663 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.9 p -126.01 160.23 57.95 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 126.432 1.893 . . . . 0.0 109.288 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.28 153.92 75.67 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 121.692 1.595 . . . . 0.0 109.226 169.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.45 -24.22 19.43 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.442 2.095 . . . . 0.0 112.004 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -78.45 -25.3 45.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.522 0.729 . . . . 0.0 112.732 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -78.47 147.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 118.822 0.737 . . . . 0.0 109.676 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -67.94 137.36 55.12 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -135.44 150.4 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.971 0.509 . . . . 0.0 110.401 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -126.91 159.85 32.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.127 2.171 . . . . 0.0 107.946 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -132.92 114.94 14.62 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.46 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 24.8 m0 -123.2 53.85 1.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.338 1.855 . . . . 0.0 107.055 -174.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.51 131.12 34.85 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 120.717 -1.24 . . . . 0.0 111.803 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 161.78 37.81 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.795 2.038 . . . . 0.0 106.056 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -68.55 141.61 55.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.227 0.537 . . . . 0.0 110.596 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.24 128.49 93.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.96 -24.38 45.78 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.116 1.077 . . . . 0.0 113.411 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.05 56.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.228 0.922 . . . . 0.0 112.221 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -111.9 3.28 17.46 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.26 . . . . 0.0 110.62 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 62.95 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.892 2.077 . . . . 0.0 110.427 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -60.03 138.96 57.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.722 1.609 . . . . 0.0 110.573 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.55 -59.09 0.21 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 175.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -166.36 168.95 14.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.985 1.714 . . . . 0.0 107.497 169.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.61 -29.36 67.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 111.314 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.9 -38.35 76.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.93 -43.74 74.5 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.04 -47.2 83.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.852 0.461 . . . . 0.0 110.346 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -61.63 -38.65 88.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.75 0.704 . . . . 0.0 111.722 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.08 82.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.168 -0.957 . . . . 0.0 110.334 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.13 -32.11 73.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.976 -0.453 . . . . 0.0 111.197 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.27 -50.37 73.11 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.492 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -45.41 80.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.827 0.74 . . . . 0.0 111.665 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -59.92 -49.73 76.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.866 0.757 . . . . 0.0 110.734 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.0 t -70.77 -39.12 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.78 -56.16 23.83 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 124.342 1.057 . . . . 0.0 108.75 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.57 -38.66 77.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 123.406 0.441 . . . . 0.0 110.7 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.42 -42.46 87.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.898 0.479 . . . . 0.0 111.025 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.79 -50.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.77 -47.58 46.38 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -60.93 -49.37 77.71 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 117.567 0.684 . . . . 0.0 111.479 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -69.55 -34.3 74.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.126 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.77 88.74 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.596 1.089 . . . . 0.0 109.744 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -55.21 -52.36 63.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.62 -34.83 78.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.56 -36.36 82.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.893 0.77 . . . . 0.0 111.071 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.73 28.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.147 0.579 . . . . 0.0 111.494 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.15 -41.45 11.01 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 111.952 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.2 p -115.05 -19.33 10.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.206 1.002 . . . . 0.0 111.17 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.61 76.92 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.837 -0.98 . . . . 0.0 112.869 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.6 mttt . . . . . 0 C--O 1.247 0.923 0 CA-C-N 118.879 1.339 . . . . 0.0 108.754 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 171.99 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -142.97 142.12 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.74 149.08 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 119.489 1.04 . . . . 0.0 109.039 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.72 134.87 41.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -118.4 130.62 56.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -125.74 138.93 53.89 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 110.088 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t -137.78 169.15 18.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.807 1.243 . . . . 0.0 109.875 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -58.49 -24.78 61.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.292 1.037 . . . . 0.0 111.737 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.25 139.51 6.49 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -77.98 51.91 1.01 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.154 0.982 . . . . 0.0 111.549 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.1 m -127.01 -15.91 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.312 -169.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.6 m -138.38 -95.6 0.19 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -54.8 -52.06 63.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.556 0.742 . . . . 0.0 111.661 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 17.5 p -68.9 -36.32 77.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.552 0.16 . . . . 0.0 111.312 -172.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.15 -53.95 51.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.114 0.966 . . . . 0.0 110.469 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.8 mtm -57.88 -44.37 86.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.133 0.573 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.21 99.07 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.384 0.538 . . . . 0.0 111.517 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.41 -32.35 70.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.098 0.559 . . . . 0.0 111.878 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.71 29.71 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -60.16 -41.24 92.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 117.338 0.569 . . . . 0.0 110.647 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.51 99.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.287 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -55.09 -40.17 70.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.824 1.193 . . . . 0.0 111.22 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -64.29 -51.8 61.72 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.396 0.435 . . . . 0.0 110.872 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -82.6 -44.6 15.63 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -171.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 92.4 mt -73.48 -33.81 65.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.816 0.446 . . . . 0.0 111.939 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.72 175.95 46.95 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.96 -2.65 10.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.768 0.827 . . . . 0.0 111.399 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.51 -12.35 6.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.776 1.231 . . . . 0.0 111.299 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 17.2 m95 -129.35 117.84 21.27 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -69.2 97.29 0.91 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.23 136.87 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.77 164.23 31.08 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.54 1.536 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 89.8 p -146.59 159.19 43.76 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.533 0.733 . . . . 0.0 109.729 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.5 -166.97 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.521 1.128 . . . . 0.0 109.621 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.47 -178.96 44.76 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -55.53 -27.93 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.259 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.85 172.12 14.66 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.537 1.535 . . . . 0.0 108.367 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.94 137.66 25.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.85 7.72 5.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.553 1.141 . . . . 0.0 110.452 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 145.86 17.98 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.08 142.35 54.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.742 0.782 . . . . 0.0 112.034 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -69.41 138.88 89.11 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 108.963 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.75 -28.71 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.735 1.623 . . . . 0.0 112.983 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -72.3 -29.16 63.6 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 120.985 -1.072 . . . . 0.0 110.478 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -45.91 87.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.19 -52.65 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -59.96 -41.2 91.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.974 0.807 . . . . 0.0 111.478 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.25 91.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.605 0.639 . . . . 0.0 109.853 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.71 -35.15 72.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.174 -0.329 . . . . 0.0 111.035 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -31.65 70.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.059 -1.026 . . . . 0.0 110.966 174.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.45 -15.64 63.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.211 1.004 . . . . 0.0 110.94 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.59 1.16 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.262 1.025 . . . . 0.0 111.859 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.38 30.92 17.85 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.0 mt -120.75 153.59 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -137.51 80.56 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.5 1.12 . . . . 0.0 111.043 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.32 1.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.0 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 96.8 p -61.26 -19.84 62.17 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.208 1.822 . . . . 0.0 112.212 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -81.33 0.3 37.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 112.956 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.29 50.31 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.431 1.014 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -47.58 137.1 9.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.191 1.396 . . . . 0.0 111.547 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -60.07 157.74 12.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -156.35 157.7 36.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.246 1.418 . . . . 0.0 109.743 170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.5 166.49 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.742 1.217 . . . . 0.0 109.927 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.56 146.2 7.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.477 1.111 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.77 136.42 32.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.478 1.111 . . . . 0.0 109.908 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.75 -28.45 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.44 1.496 . . . . 0.0 113.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.38 -11.19 60.61 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.993 1.317 . . . . 0.0 112.231 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.2 mt -114.73 -42.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.4 mt -48.93 -58.79 4.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.814 1.188 . . . . 0.0 111.557 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -1.85 34.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -115.47 -31.92 5.75 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.083 1.353 . . . . 0.0 111.699 -169.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.2 130.62 47.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.286 1.434 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.61 -31.58 71.66 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.695 1.198 . . . . 0.0 109.857 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.87 141.61 24.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.135 1.374 . . . . 0.0 108.557 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.62 144.69 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.55 136.59 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 109.08 14.56 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.68 7.43 39.46 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.885 -0.51 . . . . 0.0 112.318 -168.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.93 120.4 11.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.566 1.147 . . . . 0.0 110.968 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.248 0 C-N-CA 125.327 1.441 . . . . 0.0 110.668 170.898 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 CA--C 1.536 0.589 0 N-CA-C 113.629 0.588 . . . . 0.0 113.629 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.8 ttp -70.45 140.17 51.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.242 1.017 . . . . 0.0 110.261 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.8 p -134.29 159.33 72.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.532 1.933 . . . . 0.0 110.04 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.66 143.6 46.92 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.115 1.877 . . . . 0.0 109.938 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.54 -20.23 20.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.935 2.423 . . . . 0.0 111.668 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -73.49 -7.71 52.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.117 1.367 . . . . 0.0 112.727 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.1 141.55 34.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.12 136.81 58.19 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -133.67 155.06 50.4 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.111 0.565 . . . . 0.0 110.236 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.92 158.76 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.149 173.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -131.49 115.51 16.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.1 m0 -122.48 59.84 1.02 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -174.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.5 133.18 23.36 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 121.408 -0.807 . . . . 0.0 112.119 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -162.21 161.56 27.93 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.628 1.971 . . . . 0.0 106.439 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -65.23 140.31 58.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.462 0.705 . . . . 0.0 110.692 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.27 128.44 91.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.29 -21.95 34.94 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 120.354 1.162 . . . . 0.0 113.338 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.89 -11.96 60.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.628 1.104 . . . . 0.0 111.855 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -107.79 -1.2 21.12 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.665 1.586 . . . . 0.0 110.677 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.84 52.8 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.781 2.432 . . . . 0.0 111.859 173.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -54.26 137.83 40.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.726 2.01 . . . . 0.0 111.796 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.37 -60.59 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -162.94 164.31 25.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.477 1.511 . . . . 0.0 107.585 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.14 -30.46 71.05 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.841 -0.537 . . . . 0.0 111.492 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.31 -37.04 77.58 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.858 0.463 . . . . 0.0 110.378 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.7 -43.34 69.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -55.64 -49.69 72.19 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.89 -0.506 . . . . 0.0 110.213 171.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -60.38 -36.13 77.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.769 0.713 . . . . 0.0 111.923 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.72 77.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.359 -0.838 . . . . 0.0 109.482 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -63.52 -31.47 72.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.094 -0.955 . . . . 0.0 112.532 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.35 -48.43 80.58 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 120.044 1.293 . . . . 0.0 109.862 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.27 -36.58 83.35 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.8 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -65.12 -50.43 66.07 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.778 0.717 . . . . 0.0 110.293 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.15 -38.27 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.92 -52.93 58.99 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 109.331 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.22 -44.52 91.65 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.112 0.258 . . . . 0.0 111.167 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.27 -39.73 89.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.61 -0.681 . . . . 0.0 111.283 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.6 mt -58.16 -52.77 54.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 172.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.86 61.51 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.35 -50.76 71.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 117.703 0.751 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.931 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.542 1.065 . . . . 0.0 109.737 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -57.01 -53.71 55.0 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.33 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.639 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -62.04 -36.8 82.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.575 -0.703 . . . . 0.0 111.157 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.84 28.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.122 0.569 . . . . 0.0 111.714 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.17 -41.52 10.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.611 1.164 . . . . 0.0 111.996 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.0 p -114.62 -19.1 11.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.154 0.981 . . . . 0.0 110.969 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.59 76.33 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.783 -1.01 . . . . 0.0 112.688 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.5 mttt . . . . . 0 C--O 1.246 0.876 0 CA-C-N 118.781 1.291 . . . . 0.0 108.504 179.317 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -127.8 1.1 6.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.92 0.888 . . . . 0.0 111.1 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.5 135.23 49.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.88 174.07 3.97 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.42 142.59 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.25 149.7 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 119.308 0.958 . . . . 0.0 109.189 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 138.3 42.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.842 0.857 . . . . 0.0 109.185 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.23 131.06 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.6 mt -127.94 140.08 52.21 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.785 0.834 . . . . 0.0 110.547 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -139.26 175.26 9.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.176 0.99 . . . . 0.0 111.887 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -55.36 -32.1 62.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.789 1.236 . . . . 0.0 111.142 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 143.27 9.9 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.12 57.83 2.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.094 0.958 . . . . 0.0 111.424 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 m -127.92 -20.22 3.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.0 m -134.33 -93.81 0.3 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.229 0.922 . . . . 0.0 109.052 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -55.36 -50.9 68.49 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.969 0.907 . . . . 0.0 111.518 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 p -67.58 -37.85 83.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.748 0.703 . . . . 0.0 111.501 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -60.5 -52.8 63.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.147 0.979 . . . . 0.0 110.347 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.1 mtm -59.9 -42.07 93.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.54 0.736 . . . . 0.0 111.358 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.91 -43.66 98.2 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.457 0.571 . . . . 0.0 111.329 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 79.7 tt0 -55.96 -43.28 77.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.959 0.345 . . . . 0.0 110.332 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 25' ' ' LYS . . . -54.5 -52.26 46.21 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.34 -0.7 . . . . 0.0 112.754 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.525 0.662 . . . . 0.0 111.275 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.69 98.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.806 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 46.1 mtmt -51.09 -41.2 59.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.238 0.926 . . . . 0.0 111.325 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -67.32 -61.97 1.65 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.329 0.393 . . . . 0.0 110.566 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -69.48 -39.15 77.85 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.3 mt -77.84 -5.37 50.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.507 0.723 . . . . 0.0 112.542 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.57 55.96 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.559 1.076 . . . . 0.0 114.006 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 58.69 8.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.427 2.291 . . . . 0.0 114.292 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.82 -3.88 7.89 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.89 -1.131 . . . . 0.0 111.093 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 8.6 m95 -132.4 121.59 23.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.9 mmpt? -67.62 97.3 0.6 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -80.39 139.86 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -146.93 165.23 30.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.408 1.483 . . . . 0.0 109.501 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.0 p -144.5 157.48 44.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.734 0.814 . . . . 0.0 109.624 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.89 -166.31 1.57 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.87 1.268 . . . . 0.0 109.552 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -179.46 46.18 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mt -56.14 -27.66 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.997 1.319 . . . . 0.0 111.448 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.63 171.94 13.98 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.74 1.216 . . . . 0.0 108.968 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.65 135.36 17.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -137.03 17.46 3.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.24 1.016 . . . . 0.0 109.896 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.97 167.61 25.1 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -91.31 149.79 21.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.224 0.61 . . . . 0.0 110.721 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -74.47 134.14 76.65 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.872 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.87 -34.84 57.34 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.778 2.318 . . . . 0.0 114.115 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -72.98 -32.74 65.38 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.447 -0.783 . . . . 0.0 110.297 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -44.72 91.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.37 -51.22 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -58.07 -44.49 87.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.921 0.782 . . . . 0.0 111.511 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.0 86.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.39 -37.58 77.58 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.984 0.356 . . . . 0.0 111.333 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -63.69 -27.58 69.31 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.927 -1.108 . . . . 0.0 111.309 174.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.35 -16.27 63.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.018 0.826 . . . . 0.0 110.769 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.27 0.55 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.908 0.883 . . . . 0.0 112.052 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.45 18.75 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.35 160.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 53' ' ' LYS . 28.5 t70 -125.05 141.88 51.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.67 0.788 . . . . 0.0 109.596 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.76 -0.54 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.406 1.482 . . . . 0.0 109.826 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -58.62 -33.01 69.54 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.344 -1.473 . . . . 0.0 111.116 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -63.28 -17.75 62.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.254 1.821 . . . . 0.0 114.763 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -120.86 52.53 1.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.664 1.12 . . . . 0.0 110.569 -168.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -48.18 136.07 12.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 110.984 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -57.11 155.57 8.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -168.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -153.72 156.31 37.58 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.359 1.464 . . . . 0.0 109.395 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.55 168.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.544 1.138 . . . . 0.0 109.447 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -56.51 142.99 11.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.673 0.789 . . . . 0.0 108.935 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.61 140.88 43.15 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.513 1.125 . . . . 0.0 109.876 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.67 -30.56 61.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.066 1.346 . . . . 0.0 113.166 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -70.01 -11.12 60.65 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.278 1.031 . . . . 0.0 112.069 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.0 mt -121.06 -43.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 pp -56.93 -40.66 76.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.078 1.308 . . . . 0.0 112.341 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.2 4.84 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.901 0.881 . . . . 0.0 112.542 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -125.59 -26.42 3.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.813 1.245 . . . . 0.0 112.851 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.39 132.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.617 1.167 . . . . 0.0 109.384 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.03 -25.48 66.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.705 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.6 tp -147.77 141.97 26.14 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.672 1.189 . . . . 0.0 108.655 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.63 147.04 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.1 t -132.64 127.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -100.89 134.39 43.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.25 18.22 21.33 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.212 0.605 . . . . 0.0 109.971 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.6 p -67.98 116.04 8.18 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.25 29.4 0.25 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 170.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.71 -177.1 3.14 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 128.995 2.918 . . . . 0.0 112.907 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.84 -20.01 65.47 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.14 -39.72 6.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.497 1.044 . . . . 0.0 111.032 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 50.16 37.21 14.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.864 1.666 . . . . 0.0 114.081 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -63.87 -24.36 67.71 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.776 -1.202 . . . . 0.0 113.135 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.9 m 44.87 87.71 0.11 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.054 2.142 . . . . 0.0 113.314 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.37 135.92 11.73 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.269 3.312 . . . . 0.0 113.357 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -68.61 145.69 53.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.373 1.069 . . . . 0.0 109.57 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -130.2 158.23 74.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.095 1.758 . . . . 0.0 109.868 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 138.18 35.05 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 121.907 1.738 . . . . 0.0 109.291 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.63 -21.19 25.86 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.802 2.335 . . . . 0.0 112.306 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -67.89 -23.13 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.132 0.973 . . . . 0.0 112.083 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.98 142.21 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -170.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.05 139.24 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.984 0.914 . . . . 0.0 108.589 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -133.64 151.64 51.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.598 0.759 . . . . 0.0 110.123 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.92 159.23 34.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.781 2.033 . . . . 0.0 107.723 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -135.05 111.15 9.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -121.42 62.03 0.91 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.968 1.707 . . . . 0.0 106.847 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.37 133.4 23.81 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 121.198 -0.939 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 161.16 35.19 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.561 1.944 . . . . 0.0 106.126 169.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.23 143.2 55.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.237 0.542 . . . . 0.0 110.903 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.24 127.15 93.06 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.81 -23.73 62.23 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.176 1.251 . . . . 0.0 113.378 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.67 -14.66 63.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.334 0.97 . . . . 0.0 112.337 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -110.02 3.84 20.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.121 1.368 . . . . 0.0 111.294 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.22 61.66 0.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.406 1.882 . . . . 0.0 111.225 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -59.13 138.68 57.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.805 1.642 . . . . 0.0 110.701 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.09 -59.36 0.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.1 t -165.06 167.58 18.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.81 1.644 . . . . 0.0 107.402 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.28 -30.77 70.68 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.115 0.566 . . . . 0.0 111.283 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.63 -38.54 80.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.831 0.452 . . . . 0.0 110.379 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.27 -42.3 72.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -56.35 -52.21 65.43 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.114 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.8 t-105 -56.99 -40.34 76.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.89 0.768 . . . . 0.0 111.287 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.22 -40.98 97.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.511 0.596 . . . . 0.0 110.16 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -67.31 -29.86 69.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.634 -1.174 . . . . 0.0 113.139 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -60.55 -50.79 72.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.853 1.66 . . . . 0.0 109.813 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -65.9 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.94 0.791 . . . . 0.0 112.035 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -65.58 -51.81 56.93 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.359 0.982 . . . . 0.0 110.893 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.08 -37.9 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -54.65 -53.57 53.0 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.571 0.749 . . . . 0.0 109.581 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.06 -43.47 98.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.763 0.256 . . . . 0.0 110.963 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -40.45 91.21 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.737 -0.602 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -59.32 -50.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.02 63.79 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -59.64 -50.0 75.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.558 0.679 . . . . 0.0 110.895 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -70.32 -30.13 67.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 117.321 -1.323 . . . . 0.0 111.554 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -39.95 84.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.654 1.115 . . . . 0.0 110.104 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -56.4 -50.92 70.2 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.02 -36.17 83.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.201 0.455 . . . . 0.0 111.662 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.7 -36.63 83.57 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.357 -0.84 . . . . 0.0 111.539 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.37 -36.93 33.29 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.481 0.312 . . . . 0.0 111.173 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.4 -42.78 10.71 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.047 1.339 . . . . 0.0 111.797 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 p -115.05 -20.29 10.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.464 1.106 . . . . 0.0 111.475 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.35 82.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.939 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 119.12 1.46 . . . . 0.0 109.059 178.244 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.08 177.14 9.99 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.157 1.383 . . . . 0.0 108.826 -169.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -139.36 136.68 35.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -77.45 178.25 7.35 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.9 140.41 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -143.27 152.1 16.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.778 0.831 . . . . 0.0 109.325 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.62 136.45 29.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.095 0.958 . . . . 0.0 109.088 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.64 125.37 44.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.654 1.182 . . . . 0.0 108.261 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.3 142.41 49.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.755 1.222 . . . . 0.0 109.477 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -139.95 171.44 14.2 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.158 0.983 . . . . 0.0 111.833 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -60.04 -23.0 63.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.941 0.897 . . . . 0.0 111.795 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.96 134.88 4.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 169.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.82 55.01 1.96 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.289 1.036 . . . . 0.0 111.528 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -126.55 -16.86 5.22 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.4 m -137.88 -87.12 0.27 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.073 0.851 . . . . 0.0 109.478 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -57.99 -54.36 47.86 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.754 0.822 . . . . 0.0 111.192 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 10.8 p -67.01 -34.57 78.04 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.975 0.352 . . . . 0.0 111.238 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -62.16 -55.5 28.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.958 0.903 . . . . 0.0 109.998 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.5 mtm -58.06 -42.71 86.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.274 0.63 . . . . 0.0 111.484 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.92 97.96 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.621 0.646 . . . . 0.0 111.353 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.6 tt0 -56.88 -41.68 78.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.933 0.333 . . . . 0.0 110.611 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.35 68.63 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.484 0.584 . . . . 0.0 112.41 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -63.53 -42.97 98.4 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.596 0.698 . . . . 0.0 111.089 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.35 99.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.564 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -52.0 -38.6 57.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.954 0.797 . . . . 0.0 111.643 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -70.51 -62.59 1.33 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.204 0.315 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -68.81 -36.87 78.75 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.2 mt -78.44 -2.11 36.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.353 0.661 . . . . 0.0 112.197 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.5 24.05 58.96 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.979 1.276 . . . . 0.0 113.961 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.14 14.32 1.97 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.031 2.132 . . . . 0.0 113.633 -172.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.15 -0.86 15.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.928 1.291 . . . . 0.0 110.91 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.7 m95 -133.46 122.52 23.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.54 97.42 0.59 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 24' ' ' ALA . 1.9 t -82.1 140.88 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -144.76 166.13 26.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.166 1.387 . . . . 0.0 109.533 174.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 87.8 p -145.68 158.44 43.85 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.689 0.796 . . . . 0.0 109.888 169.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.34 -168.17 1.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.708 1.203 . . . . 0.0 110.205 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.0 179.96 46.82 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.534 -0.729 . . . . 0.0 111.325 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -56.38 -27.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.049 1.34 . . . . 0.0 111.304 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.11 168.94 21.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.915 1.286 . . . . 0.0 108.563 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.48 138.44 26.15 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.74 12.97 6.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.757 1.223 . . . . 0.0 109.826 172.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 163.77 34.43 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -170.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.53 146.21 38.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.217 0.532 . . . . 0.0 110.375 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -70.52 134.33 86.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.671 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.15 -35.62 43.11 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.657 2.238 . . . . 0.0 114.095 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.42 -27.26 63.18 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.451 -0.78 . . . . 0.0 111.011 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.9 85.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.36 -49.91 81.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -57.81 -40.24 79.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.395 0.998 . . . . 0.0 111.642 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.84 84.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.598 0.636 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.2 mmm -68.1 -35.3 77.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.423 0.556 . . . . 0.0 111.123 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -68.07 -23.72 64.98 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.669 -1.269 . . . . 0.0 111.308 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -67.13 -21.16 65.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.091 0.859 . . . . 0.0 110.398 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.59 -1.47 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.24 0.616 . . . . 0.0 112.133 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.0 33.28 15.46 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.64 159.28 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.94 144.39 49.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -128.82 3.53 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.984 1.314 . . . . 0.0 110.261 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.98 -28.66 67.87 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 111.061 171.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.49 -4.65 4.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.421 1.888 . . . . 0.0 115.192 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -138.16 49.23 1.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.425 1.466 . . . . 0.0 110.879 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 p -46.61 131.56 11.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 110.747 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -56.85 156.73 6.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.134 1.773 . . . . 0.0 115.179 -169.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -153.38 157.04 39.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.069 1.348 . . . . 0.0 109.132 171.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.77 164.89 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.867 0.867 . . . . 0.0 109.402 169.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.49 139.89 14.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 109.546 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.64 138.39 50.06 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.435 1.494 . . . . 0.0 109.671 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -57.56 -27.63 62.83 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.598 1.559 . . . . 0.0 113.29 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.05 -12.72 61.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.828 1.251 . . . . 0.0 112.075 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -112.73 -41.21 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.47 -58.56 4.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.836 1.198 . . . . 0.0 111.499 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.79 0.36 27.28 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -118.66 -31.75 4.76 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.984 1.314 . . . . 0.0 111.783 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 128.36 35.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 109.755 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.65 -25.41 64.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.174 0.59 . . . . 0.0 110.781 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.8 tp -145.53 141.08 27.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.44 1.096 . . . . 0.0 108.171 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.86 153.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.88 136.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -109.17 122.3 47.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.3 25.28 5.06 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.054 0.941 . . . . 0.0 109.52 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -75.42 68.34 2.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.019 2.127 . . . . 0.0 113.606 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.74 12.54 25.09 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.122 -0.987 . . . . 0.0 111.203 170.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.51 171.63 12.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.546 2.338 . . . . 0.0 111.992 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.02 -16.35 64.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.88 -37.46 9.81 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.644 1.111 . . . . 0.0 110.886 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.263 3.8 p-10 37.53 44.23 0.49 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.207 2.603 . . . . 0.0 114.684 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -66.23 -14.01 61.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.586 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.0 m 42.86 86.07 0.15 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.924 2.49 . . . . 0.0 113.245 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.52 139.29 9.96 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.418 3.412 . . . . 0.0 114.011 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 147.08 52.77 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.866 1.266 . . . . 0.0 111.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -133.39 159.38 72.8 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.967 2.107 . . . . 0.0 108.964 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.1 138.61 40.35 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.77 1.647 . . . . 0.0 109.429 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 -18.48 39.48 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.902 2.402 . . . . 0.0 112.129 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -64.45 -19.93 65.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.493 1.117 . . . . 0.0 112.019 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.5 t -110.99 136.66 46.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 118.937 0.79 . . . . 0.0 109.105 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -63.2 132.13 50.71 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.132 0.973 . . . . 0.0 108.746 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.99 159.55 28.11 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.598 0.759 . . . . 0.0 109.475 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -128.7 169.78 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.73 2.012 . . . . 0.0 107.188 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -136.11 122.49 20.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.61 58.6 1.3 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.86 1.664 . . . . 0.0 107.107 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.19 125.07 14.59 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.939 -1.101 . . . . 0.0 112.07 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.26 158.72 43.21 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.569 2.347 . . . . 0.0 105.806 168.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.27 149.5 48.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.198 0.523 . . . . 0.0 110.832 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.89 125.69 89.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.52 -25.11 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.378 1.385 . . . . 0.0 113.471 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.54 52.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.351 0.978 . . . . 0.0 112.115 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -114.57 3.74 14.94 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.951 1.3 . . . . 0.0 110.842 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.94 64.41 0.32 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.851 2.06 . . . . 0.0 110.308 169.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.51 139.67 56.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.495 1.518 . . . . 0.0 110.658 -171.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.67 -57.59 0.21 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.64 169.43 13.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.019 1.728 . . . . 0.0 107.378 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.97 -30.5 70.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.902 -0.499 . . . . 0.0 111.349 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.75 -36.93 73.37 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.762 0.425 . . . . 0.0 110.676 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.89 -46.34 75.23 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -57.04 -48.46 78.48 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.294 0.637 . . . . 0.0 110.17 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -61.24 -37.86 84.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.5 0.72 . . . . 0.0 111.972 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.47 82.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.43 -33.26 75.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.861 0.465 . . . . 0.0 110.931 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.85 -48.57 79.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.81 0.844 . . . . 0.0 110.459 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.27 -41.49 98.5 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.474 0.579 . . . . 0.0 110.752 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -62.89 -48.61 78.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.117 0.871 . . . . 0.0 111.172 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.84 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 118.613 0.642 . . . . 0.0 109.301 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -55.23 -53.81 51.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.029 0.831 . . . . 0.0 109.235 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.07 -40.89 91.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.319 0.387 . . . . 0.0 111.236 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.91 -45.89 87.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.38 0.672 . . . . 0.0 110.428 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.1 mt -58.13 -50.14 79.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.87 51.4 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.573 0.624 . . . . 0.0 111.842 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -59.48 -48.6 81.01 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 117.751 0.776 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.87 -25.83 53.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.656 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.67 -38.54 83.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 120.057 1.299 . . . . 0.0 109.673 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.61 -50.42 73.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.43 -42.32 98.57 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 110.503 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -58.78 -33.26 70.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 120.274 -1.516 . . . . 0.0 111.854 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.56 -35.4 24.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.702 0.401 . . . . 0.0 111.958 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.31 -45.47 8.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.774 1.23 . . . . 0.0 112.034 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.7 p -113.86 -20.14 11.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 110.835 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.21 11.01 81.6 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.585 1.088 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt . . . . . 0 C--O 1.246 0.907 0 CA-C-N 118.916 1.358 . . . . 0.0 110.379 -177.384 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -151.43 161.81 42.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.133 1.373 . . . . 0.0 107.566 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -137.94 140.62 40.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.71 172.9 9.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.15 142.37 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.58 151.5 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.083 0.953 . . . . 0.0 109.546 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.83 139.04 39.74 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.965 0.906 . . . . 0.0 109.321 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -122.54 128.59 50.95 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.406 1.082 . . . . 0.0 108.653 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.64 139.85 53.49 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.34 1.056 . . . . 0.0 110.015 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -139.93 175.03 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.184 1.793 . . . . 0.0 108.407 170.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -52.78 63.93 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 120.941 -1.099 . . . . 0.0 109.537 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.88 126.92 7.31 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.91 60.05 0.72 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.35 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -134.75 -20.67 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -126.49 -99.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -47.98 83.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 112.31 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 18.8 p -62.95 -38.41 90.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.425 0.557 . . . . 0.0 111.485 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -62.38 -55.21 30.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.193 0.997 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 49.7 mtm -55.91 -43.78 77.65 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.263 0.625 . . . . 0.0 111.316 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.3 99.34 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.362 0.665 . . . . 0.0 111.553 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.3 tt0 -57.27 -41.19 79.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.918 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -49.48 78.19 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.707 0.685 . . . . 0.0 112.493 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -61.32 -46.25 91.05 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.579 0.69 . . . . 0.0 110.833 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -64.07 -40.78 97.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.315 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -51.31 -43.68 61.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.297 0.953 . . . . 0.0 111.006 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -71.15 -58.3 3.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 123.699 0.625 . . . . 0.0 111.206 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -64.37 -39.43 93.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.967 0.348 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.51 -2.86 54.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.178 0.991 . . . . 0.0 112.274 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.95 59.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.208 1.385 . . . . 0.0 114.629 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.56 5.8 0.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 0.0 113.97 -170.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.27 -7.55 19.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.837 -1.164 . . . . 0.0 110.343 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -128.08 121.02 28.63 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -68.92 97.86 0.89 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 24' ' ' ALA . 2.5 t -83.01 140.69 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.35 167.06 23.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.337 1.455 . . . . 0.0 109.175 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 85.3 p -144.72 157.47 44.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.82 0.848 . . . . 0.0 109.692 170.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.9 -170.28 2.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 110.894 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.75 -177.55 42.18 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 122.052 -0.405 . . . . 0.0 113.069 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -56.48 -32.6 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.11 1.364 . . . . 0.0 109.637 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.07 169.07 19.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.867 1.667 . . . . 0.0 109.634 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.46 24.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.28 8.92 5.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.737 1.215 . . . . 0.0 110.087 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.96 165.58 25.92 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -170.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -85.27 150.08 25.03 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.047 0.539 . . . . 0.0 111.098 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -73.33 133.25 80.97 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.507 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.72 -36.29 61.29 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.732 2.288 . . . . 0.0 113.994 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -70.94 -32.97 70.03 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.723 -0.611 . . . . 0.0 110.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.5 90.88 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.67 -47.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -40.09 93.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.441 0.564 . . . . 0.0 111.184 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.27 99.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.626 0.771 . . . . 0.0 109.914 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.1 mmm -68.49 -38.0 80.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.23 0.468 . . . . 0.0 110.974 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -27.5 68.74 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 173.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.95 -16.77 64.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.869 0.758 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.63 1.47 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.157 0.983 . . . . 0.0 112.054 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.73 21.1 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -117.8 158.89 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.77 146.08 48.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.492 1.117 . . . . 0.0 108.506 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.27 3.31 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 110.431 170.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.06 -28.19 67.59 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 119.885 -1.76 . . . . 0.0 111.276 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.1 -5.45 4.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 115.091 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.48 50.83 1.95 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.993 1.269 . . . . 0.0 110.397 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 p -47.09 134.37 10.74 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.958 0.903 . . . . 0.0 110.724 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 m -56.79 156.23 6.81 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.033 1.733 . . . . 0.0 115.653 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -153.91 157.4 39.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.213 1.405 . . . . 0.0 109.465 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 169.04 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.193 . . . . 0.0 109.441 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.38 141.76 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.39 141.4 41.73 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.475 1.11 . . . . 0.0 109.844 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 m -55.4 -30.24 60.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.088 1.355 . . . . 0.0 113.299 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.21 -13.67 62.53 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.006 0.922 . . . . 0.0 111.984 -173.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -121.06 -42.46 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.383 1.073 . . . . 0.0 108.299 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.37 -39.05 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.329 1.422 . . . . 0.0 112.118 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.5 4.87 51.8 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.792 0.837 . . . . 0.0 112.705 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -125.32 -28.8 3.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.886 1.274 . . . . 0.0 112.435 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 128.71 38.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.043 1.337 . . . . 0.0 108.983 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.77 -23.25 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.85 139.89 26.66 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.746 1.218 . . . . 0.0 108.067 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.7 146.51 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 t -135.43 129.37 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.07 129.98 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.47 23.18 11.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.627 0.771 . . . . 0.0 109.379 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -76.56 104.26 6.98 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.379 -1.451 . . . . 0.0 112.317 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -123.76 -21.86 2.33 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 121.682 -0.636 . . . . 0.0 111.892 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.67 128.16 33.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.799 1.24 . . . . 0.0 107.826 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.41 -19.41 35.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.886 0.874 . . . . 0.0 113.282 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.21 22.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.154 0.888 . . . . 0.0 112.722 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.28 108.33 3.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -54.42 -14.22 1.17 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.8 m 60.51 95.58 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 127.023 2.129 . . . . 0.0 110.63 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.31 140.51 20.35 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.901 3.067 . . . . 0.0 113.115 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.4 mmt -73.84 152.82 40.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.565 0.746 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 p -133.2 165.29 37.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.528 1.931 . . . . 0.0 109.393 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.81 155.21 68.72 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 172.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.03 -9.29 14.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.229 2.619 . . . . 0.0 114.56 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -129.77 0.04 4.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.515 1.052 . . . . 0.0 113.492 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.6 t -85.93 145.5 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.17 133.11 55.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -130.24 149.54 51.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.879 0.872 . . . . 0.0 109.003 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -132.89 169.75 16.32 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.085 1.354 . . . . 0.0 108.6 170.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -134.78 115.76 14.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 23.3 m0 -121.63 61.43 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.486 1.515 . . . . 0.0 107.243 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.82 128.84 9.86 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.172 -0.955 . . . . 0.0 112.367 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.85 159.5 44.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.177 2.191 . . . . 0.0 106.401 168.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.0 153.8 43.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.573 0.749 . . . . 0.0 110.612 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.05 125.01 73.73 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 110.124 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.51 -26.34 62.35 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.691 1.594 . . . . 0.0 113.864 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.27 -13.12 62.02 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.022 0.828 . . . . 0.0 112.264 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mtm105 -114.39 13.9 17.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.264 0.938 . . . . 0.0 111.476 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.83 67.29 0.81 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 0.0 109.975 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -58.6 138.71 56.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.793 0.837 . . . . 0.0 110.383 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.24 -60.02 0.23 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 172.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -167.32 167.48 13.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.671 1.589 . . . . 0.0 107.522 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.12 -29.21 68.46 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.093 0.557 . . . . 0.0 111.291 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.97 -39.66 75.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.964 0.506 . . . . 0.0 110.681 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.58 -44.63 86.1 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.83 -50.33 74.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.711 -0.662 . . . . 0.0 110.503 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -57.39 -40.28 77.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.242 0.928 . . . . 0.0 111.153 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.08 74.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.627 -0.671 . . . . 0.0 110.892 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.93 -34.92 64.51 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.703 -1.248 . . . . 0.0 111.26 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -58.26 -52.54 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.962 0.801 . . . . 0.0 109.881 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.81 -30.97 71.68 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.513 0.597 . . . . 0.0 112.115 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.11 -49.68 69.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.631 1.105 . . . . 0.0 111.117 173.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.4 -39.61 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.708 0.686 . . . . 0.0 109.187 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -53.04 -52.85 57.15 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.26 1.024 . . . . 0.0 109.727 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.41 -41.06 89.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.145 0.278 . . . . 0.0 111.331 -172.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -64.15 -43.29 95.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.995 0.518 . . . . 0.0 110.421 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.36 -49.35 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.66 -47.35 64.52 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -59.74 -49.71 76.66 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 117.31 0.555 . . . . 0.0 110.391 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.14 69.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.312 -175.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -42.04 79.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.029 0.831 . . . . 0.0 110.069 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.07 -49.65 75.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.46 -36.35 82.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.743 -0.17 . . . . 0.0 111.237 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -61.51 -37.67 84.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.238 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.89 -37.0 41.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.451 0.3 . . . . 0.0 111.183 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.42 -48.32 6.71 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.727 1.211 . . . . 0.0 111.011 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.7 p -105.73 -20.49 13.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.749 1.22 . . . . 0.0 111.41 -169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.33 18.35 78.21 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.538 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.2 mttt . . . . . 0 C--O 1.248 1.021 0 CA-C-N 118.507 1.154 . . . . 0.0 109.51 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -126.69 1.01 6.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.847 0.859 . . . . 0.0 111.026 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.69 134.61 48.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 169.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 175.53 2.9 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.11 142.04 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 tt -143.36 151.05 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -137.8 135.8 36.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.901 0.881 . . . . 0.0 108.795 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -117.88 137.74 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 mt -133.65 145.63 50.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.222 0.609 . . . . 0.0 111.509 -169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.02 173.51 12.39 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.504 1.122 . . . . 0.0 112.359 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.8 m -57.79 -29.65 65.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.165 1.786 . . . . 0.0 111.433 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 141.36 8.29 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -83.78 55.8 3.4 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.508 0.654 . . . . 0.0 112.087 -169.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 m -132.6 -12.05 3.06 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.7 m -131.68 -105.81 0.26 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -50.89 -47.17 60.71 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.587 1.155 . . . . 0.0 111.688 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -61.9 -42.12 98.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -69.37 -45.03 70.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.504 0.722 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.5 -43.23 99.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.978 0.511 . . . . 0.0 110.221 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.4 98.49 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.377 0.671 . . . . 0.0 111.255 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' HG12 ' A' ' 34' ' ' VAL . 17.1 tt0 -57.37 -40.94 79.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.068 0.395 . . . . 0.0 110.075 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.86 -53.51 45.73 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.062 0.839 . . . . 0.0 111.532 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.52 -45.88 92.31 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.141 0.47 . . . . 0.0 110.686 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.39 93.83 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.316 0.646 . . . . 0.0 110.321 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -57.72 -33.58 68.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.869 0.759 . . . . 0.0 111.353 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.31 -62.28 1.45 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.16 0.437 . . . . 0.0 110.664 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -65.7 -43.06 90.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.337 0.255 . . . . 0.0 111.397 -169.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.78 -6.55 52.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.599 1.16 . . . . 0.0 112.112 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.56 51.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.972 1.272 . . . . 0.0 114.136 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t70 56.35 11.44 0.82 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.488 2.315 . . . . 0.0 114.081 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -64.89 -7.5 11.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.979 1.312 . . . . 0.0 110.484 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -126.65 118.78 25.48 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.67 98.78 0.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 t -80.08 138.77 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -140.11 166.06 25.69 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.772 1.629 . . . . 0.0 109.22 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -151.6 145.0 24.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.024 0.929 . . . . 0.0 108.711 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.39 -170.38 2.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.698 1.199 . . . . 0.0 112.02 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.06 -176.59 45.31 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.155 -0.966 . . . . 0.0 112.117 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.29 -30.38 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.862 1.265 . . . . 0.0 111.23 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.92 167.6 24.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.688 1.195 . . . . 0.0 109.193 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.82 141.9 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -132.16 1.59 3.87 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.574 1.15 . . . . 0.0 110.263 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.12 -166.25 22.81 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.2 pt? -119.04 149.85 40.97 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 110.322 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -72.0 134.2 83.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.759 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.38 -36.14 56.95 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.691 2.26 . . . . 0.0 113.895 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.46 -32.49 66.29 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.538 -0.726 . . . . 0.0 110.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.24 84.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.04 -52.04 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -58.91 -40.07 83.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.604 0.638 . . . . 0.0 111.633 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.89 94.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.512 0.596 . . . . 0.0 109.596 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.2 mmm -68.65 -36.83 79.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.28 0.491 . . . . 0.0 111.184 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.35 -25.21 67.93 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.886 -1.134 . . . . 0.0 111.524 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.32 -17.14 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.9 0.773 . . . . 0.0 110.885 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.52 -0.34 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.705 0.802 . . . . 0.0 112.108 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 31.68 13.9 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.21 159.74 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.77 145.54 51.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.96 -6.51 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.833 1.253 . . . . 0.0 110.625 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -57.59 -38.5 74.99 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.866 0.867 . . . . 0.0 110.894 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -18.59 37.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.845 1.258 . . . . 0.0 113.984 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.03 -40.73 18.01 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 119.639 1.109 . . . . 0.0 110.395 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 p 56.07 176.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.162 1.785 . . . . 0.0 111.069 -168.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -128.27 153.68 46.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.79 158.52 35.39 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.045 0.938 . . . . 0.0 109.467 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.37 163.48 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.647 0.779 . . . . 0.0 108.992 169.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.61 149.0 5.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.771 1.228 . . . . 0.0 110.209 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.54 136.6 33.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.354 1.062 . . . . 0.0 110.113 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.86 -28.64 51.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.392 1.477 . . . . 0.0 113.161 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.25 -11.15 60.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.034 1.333 . . . . 0.0 112.188 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -114.12 -42.76 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.23 -58.42 5.07 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.206 . . . . 0.0 111.504 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -0.93 30.52 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.45 -31.54 5.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.945 1.298 . . . . 0.0 111.928 -168.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.959 1.304 . . . . 0.0 109.705 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.3 -26.24 67.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.75 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 tp -147.28 142.65 27.4 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.534 1.134 . . . . 0.0 108.669 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.41 151.38 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -140.03 128.26 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.46 136.16 37.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.9 7.74 26.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.563 0.745 . . . . 0.0 111.054 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.95 126.7 28.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.898 1.279 . . . . 0.0 110.638 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.38 -3.12 0.21 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.226 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.81 150.95 34.2 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.278 1.539 . . . . 0.0 109.35 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.39 -17.02 41.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.938 1.295 . . . . 0.0 114.362 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.94 11.82 13.55 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 111.897 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.52 107.51 1.72 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -52.98 -37.03 60.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.047 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.56 122.62 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 128.455 2.702 . . . . 0.0 115.24 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.95 173.6 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.897 2.398 . . . . 0.0 112.431 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 48.3 tpp -124.73 156.35 37.79 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.71 1.604 . . . . 0.0 108.843 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p -128.43 161.17 58.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.622 1.569 . . . . 0.0 110.459 -169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.21 139.25 54.55 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.965 1.777 . . . . 0.0 109.576 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 -22.45 26.34 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.803 2.335 . . . . 0.0 112.25 -173.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -81.07 3.13 24.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.717 0.807 . . . . 0.0 112.48 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.37 134.55 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -64.39 132.05 48.96 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -123.34 159.07 29.63 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.663 0.785 . . . . 0.0 109.125 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.58 166.2 17.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.144 1.778 . . . . 0.0 107.337 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -133.56 113.17 12.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -119.9 58.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.847 1.659 . . . . 0.0 106.702 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.15 134.24 21.23 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.335 -0.853 . . . . 0.0 112.364 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.2 161.26 33.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.935 2.094 . . . . 0.0 106.118 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.71 146.95 24.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.663 1.185 . . . . 0.0 111.68 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.87 117.89 70.0 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 124.819 1.248 . . . . 0.0 108.937 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.38 -22.96 71.78 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.535 1.49 . . . . 0.0 113.628 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.41 61.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.427 1.012 . . . . 0.0 113.036 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -120.95 13.28 11.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.563 1.074 . . . . 0.0 112.094 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.22 55.65 0.21 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.306 1.842 . . . . 0.0 110.378 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.93 148.61 43.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.81 2.044 . . . . 0.0 112.201 -169.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.56 -54.05 0.34 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -166.42 166.93 16.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.106 1.763 . . . . 0.0 107.322 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.55 -29.66 69.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.177 0.591 . . . . 0.0 111.158 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.22 -37.07 74.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.896 0.479 . . . . 0.0 110.717 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.66 -47.33 69.83 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -54.54 -50.96 66.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.935 0.494 . . . . 0.0 110.086 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -58.84 -39.09 80.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.872 0.869 . . . . 0.0 112.027 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.07 86.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.496 -0.752 . . . . 0.0 110.114 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.58 -36.37 82.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.797 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.25 -47.37 83.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.411 1.005 . . . . 0.0 110.157 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -64.64 -39.18 93.24 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.645 0.657 . . . . 0.0 111.518 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -64.49 -49.09 72.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.242 0.928 . . . . 0.0 110.684 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.18 -39.2 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -54.05 -53.78 48.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.003 0.921 . . . . 0.0 109.442 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.2 -44.04 96.46 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.27 0.356 . . . . 0.0 111.29 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.12 -40.88 95.1 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.852 -0.53 . . . . 0.0 111.108 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.48 -49.68 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.18 -46.06 71.82 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -60.77 -46.95 88.48 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.465 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -72.7 -31.19 64.82 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.9 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -40.9 87.3 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.263 0.625 . . . . 0.0 110.017 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.42 -49.16 75.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.8 -43.82 98.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.095 0.474 . . . . 0.0 110.408 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.93 -33.82 69.21 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.804 -1.185 . . . . 0.0 112.334 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.43 22.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.019 0.528 . . . . 0.0 112.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -94.14 -52.39 4.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.001 1.321 . . . . 0.0 110.625 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.8 p -102.06 -14.69 17.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.344 1.457 . . . . 0.0 110.37 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.05 13.59 83.19 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.845 1.212 . . . . 0.0 112.052 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.245 0.862 0 CA-C-N 118.038 0.919 . . . . 0.0 109.572 -175.297 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.15 168.7 20.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.013 1.325 . . . . 0.0 108.373 171.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -147.48 141.09 25.53 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.06 176.17 7.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.619 0.645 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -142.51 143.13 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.24 149.71 17.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.611 0.765 . . . . 0.0 109.151 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.49 132.78 33.78 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.959 0.904 . . . . 0.0 108.733 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -115.9 129.99 56.64 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -129.08 139.38 52.02 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.59 0.756 . . . . 0.0 109.562 -169.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.7 p -150.16 -174.25 4.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.995 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -67.6 -9.46 43.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.252 1.021 . . . . 0.0 113.158 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.8 126.63 1.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.13 52.07 0.33 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.282 1.433 . . . . 0.0 113.293 -169.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 -18.63 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 m -136.3 -90.57 0.28 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.741 0.701 . . . . 0.0 109.379 -170.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -55.21 -53.2 58.98 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.748 0.819 . . . . 0.0 111.437 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.4 p -68.01 -35.73 78.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -173.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.63 -51.59 64.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.944 0.898 . . . . 0.0 110.836 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.5 mtm -60.66 -43.06 98.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.249 0.62 . . . . 0.0 110.69 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.5 97.22 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.455 0.57 . . . . 0.0 111.032 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' HG12 ' A' ' 34' ' ' VAL . 68.7 tt0 -57.98 -41.32 82.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.695 173.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.34 -51.85 56.18 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.889 0.768 . . . . 0.0 111.973 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -62.9 -45.69 91.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 117.577 0.689 . . . . 0.0 110.711 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.53 99.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.235 0.614 . . . . 0.0 110.595 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -52.69 -36.29 56.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.866 0.757 . . . . 0.0 111.598 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -72.28 -62.79 1.31 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.368 0.531 . . . . 0.0 110.733 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -65.41 -41.26 93.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.521 0.328 . . . . 0.0 111.822 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.53 -5.85 53.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.819 0.848 . . . . 0.0 112.444 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.74 50.67 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.942 1.258 . . . . 0.0 114.601 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 59.21 6.24 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.211 2.205 . . . . 0.0 114.197 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.33 -7.42 18.76 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.929 -1.107 . . . . 0.0 110.358 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -130.93 121.75 25.72 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.46 97.62 1.02 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -85.08 134.73 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.53 168.3 20.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.24 1.416 . . . . 0.0 109.616 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 95.5 p -145.5 160.43 41.62 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.581 0.752 . . . . 0.0 110.12 169.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.51 -166.85 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.632 1.173 . . . . 0.0 109.842 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.27 -179.39 43.91 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 121.399 -0.813 . . . . 0.0 111.514 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.65 -27.65 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.349 1.46 . . . . 0.0 111.298 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -146.26 169.79 18.07 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.813 1.245 . . . . 0.0 108.405 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 136.33 18.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -136.79 26.26 3.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.716 1.206 . . . . 0.0 109.428 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.09 168.43 42.8 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 60' ' ' SER . 1.3 pt? -86.41 147.68 25.91 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.303 0.573 . . . . 0.0 110.779 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -73.97 133.74 78.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.081 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.51 -34.47 42.38 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.775 2.317 . . . . 0.0 114.438 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.23 -28.21 62.03 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.189 -0.944 . . . . 0.0 110.921 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.44 81.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.09 -49.59 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -59.92 -41.89 92.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.75 0.705 . . . . 0.0 111.592 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.78 92.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.448 0.567 . . . . 0.0 109.752 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.8 mmm -68.11 -36.22 79.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.401 0.546 . . . . 0.0 111.313 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 120.985 -1.072 . . . . 0.0 111.52 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.73 -17.54 64.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.036 0.835 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.72 -0.41 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.89 0.876 . . . . 0.0 112.167 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 32.59 13.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.3 160.83 20.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.22 145.97 52.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.2 pt -128.05 -9.93 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.811 1.644 . . . . 0.0 109.923 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 44' ' ' LEU . 92.4 p -60.97 -25.84 67.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.844 1.202 . . . . 0.0 111.549 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.44 -27.39 69.08 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.431 1.493 . . . . 0.0 113.638 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -96.17 -29.24 14.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.47 1.032 . . . . 0.0 112.437 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.0 p 52.04 -173.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.882 1.673 . . . . 0.0 112.946 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -123.81 156.41 36.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.241 1.017 . . . . 0.0 111.234 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.56 157.24 35.0 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.125 0.97 . . . . 0.0 109.638 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.52 163.71 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.033 169.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.0 mt -56.56 146.71 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.905 1.282 . . . . 0.0 110.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.14 136.18 33.26 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.376 1.07 . . . . 0.0 110.067 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.71 -28.75 50.23 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.479 1.512 . . . . 0.0 113.188 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.61 -11.58 60.95 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.88 1.272 . . . . 0.0 112.177 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mt -114.47 -42.36 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 mt -48.52 -58.69 4.3 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.7 1.136 . . . . 0.0 111.775 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -1.12 34.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -116.14 -32.37 5.37 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.142 1.377 . . . . 0.0 111.614 -168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.53 126.77 28.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.291 1.436 . . . . 0.0 109.586 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.26 -24.55 66.6 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.22 0.608 . . . . 0.0 111.037 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.12 139.65 27.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.41 1.084 . . . . 0.0 108.554 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.88 145.26 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.32 129.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -97.55 132.7 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.34 19.13 20.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.593 1.157 . . . . 0.0 109.51 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.89 114.46 6.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 110.008 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.37 24.31 0.27 Allowed Glycine 0 CA--C 1.535 1.286 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.83 -177.57 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 128.501 2.721 . . . . 0.0 111.784 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.78 -25.62 68.32 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.95 -46.74 9.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.025 0.829 . . . . 0.0 110.379 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.5 t70 48.79 33.13 4.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.189 1.795 . . . . 0.0 114.082 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.3 -14.23 62.83 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.689 -1.257 . . . . 0.0 113.365 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.3 m 43.37 90.27 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.603 2.361 . . . . 0.0 113.945 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.41 136.48 19.92 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.884 3.056 . . . . 0.0 113.495 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -71.25 145.83 49.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.518 1.127 . . . . 0.0 110.007 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 p -131.22 158.84 74.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.328 1.851 . . . . 0.0 110.133 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.1 136.68 38.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.228 1.952 . . . . 0.0 109.327 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.25 -23.95 20.4 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.528 2.152 . . . . 0.0 112.641 -171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -79.11 -9.59 59.6 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.214 0.606 . . . . 0.0 112.532 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.96 138.48 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -62.04 132.25 52.28 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -130.46 156.91 43.99 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.485 1.114 . . . . 0.0 109.572 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -134.44 167.86 19.98 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.241 1.817 . . . . 0.0 108.341 169.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -135.86 118.15 15.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -125.34 57.66 1.31 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.377 1.871 . . . . 0.0 106.967 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.52 134.92 28.64 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.784 -1.198 . . . . 0.0 112.311 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 160.75 35.08 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.523 1.929 . . . . 0.0 106.089 169.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.71 143.83 55.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.92 126.25 92.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 -26.2 55.33 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.139 1.226 . . . . 0.0 112.921 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.48 -4.3 41.87 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.034 0.833 . . . . 0.0 112.538 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -120.43 0.44 10.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.992 1.717 . . . . 0.0 109.385 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.71 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.9 1.68 . . . . 0.0 109.192 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -58.16 123.27 15.42 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.33 -91.33 0.1 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.9 t -158.04 167.89 28.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.97 1.308 . . . . 0.0 108.023 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 -31.02 70.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.121 0.568 . . . . 0.0 111.874 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -39.48 84.3 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.64 0.376 . . . . 0.0 110.164 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.6 -38.5 70.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.72 -49.12 78.77 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 118.568 0.622 . . . . 0.0 110.186 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.23 -37.61 77.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.759 0.708 . . . . 0.0 111.207 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.65 84.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -63.32 -31.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.176 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.31 -52.06 66.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.251 1.387 . . . . 0.0 110.091 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.4 -34.63 78.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.869 0.759 . . . . 0.0 111.587 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -63.18 -52.6 61.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.836 1.198 . . . . 0.0 110.942 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.73 -37.5 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -54.32 -53.85 48.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.777 0.717 . . . . 0.0 109.409 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.34 -42.65 92.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.367 0.417 . . . . 0.0 110.58 -171.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.48 -41.1 93.67 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.959 -0.463 . . . . 0.0 111.195 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.38 -49.97 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.03 -46.57 61.29 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.589 0.631 . . . . 0.0 111.661 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.33 -48.8 80.2 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.618 0.709 . . . . 0.0 110.602 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -70.69 -30.0 66.46 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 117.297 -1.335 . . . . 0.0 111.611 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -39.82 82.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.93 1.241 . . . . 0.0 110.068 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.21 -49.41 74.18 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.445 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.67 -37.32 83.65 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.23 -35.84 35.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.496 0.318 . . . . 0.0 111.041 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.73 -42.18 10.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.513 1.125 . . . . 0.0 111.664 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.2 p -114.41 -20.81 10.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 0.0 111.817 -169.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.59 78.36 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.359 0.98 . . . . 0.0 112.836 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.245 0.853 0 CA-C-N 118.817 1.308 . . . . 0.0 109.958 -176.51 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.14 162.68 37.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.819 1.248 . . . . 0.0 107.975 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -68.49 139.51 55.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -71.26 170.27 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -145.16 143.12 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -147.62 152.67 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.598 0.759 . . . . 0.0 109.526 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.49 133.03 30.32 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.805 0.842 . . . . 0.0 109.248 -173.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.89 127.81 55.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -124.1 141.54 51.97 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.623 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t -144.19 172.12 13.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.993 0.917 . . . . 0.0 110.633 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 p -59.37 -28.61 67.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.337 1.455 . . . . 0.0 110.824 169.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.5 147.98 16.87 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.8 45.72 1.02 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.853 -0.792 . . . . 0.0 111.886 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -128.12 -3.13 5.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 p -145.91 -106.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.964 1.256 . . . . 0.0 110.982 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -55.31 -36.94 66.74 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.941 0.896 . . . . 0.0 112.163 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.5 -52.72 64.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.337 1.055 . . . . 0.0 111.169 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -60.06 -50.34 74.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.501 1.121 . . . . 0.0 110.363 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.3 mtm -58.41 -44.53 89.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.92 0.488 . . . . 0.0 111.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -44.57 96.9 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.626 0.648 . . . . 0.0 111.437 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.9 tt0 -59.57 -42.74 93.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.38 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.86 -53.1 46.75 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.852 0.739 . . . . 0.0 112.073 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -61.55 -43.8 98.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.299 0.55 . . . . 0.0 110.838 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.98 -42.29 99.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 117.618 -1.182 . . . . 0.0 111.193 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -55.92 -37.58 69.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.381 1.446 . . . . 0.0 111.102 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -67.52 -56.43 9.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.285 0.493 . . . . 0.0 110.887 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -73.09 -45.59 56.34 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.068 0.147 . . . . 0.0 111.189 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.9 mt -72.15 -32.84 67.27 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.131 0.572 . . . . 0.0 111.367 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.4 176.51 51.03 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.02 -8.86 13.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.182 1.393 . . . . 0.0 111.565 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.14 -6.79 7.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 111.398 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.489 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 24.2 m95 -129.18 128.8 44.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.109 1.764 . . . . 0.0 107.02 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -76.48 88.64 3.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.5 t -80.54 133.72 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -141.41 167.33 22.43 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.863 1.265 . . . . 0.0 109.527 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.7 p -146.9 159.51 43.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.801 0.84 . . . . 0.0 109.093 169.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -168.04 1.96 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.911 1.284 . . . . 0.0 109.189 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.3 -175.78 43.02 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 121.427 -0.795 . . . . 0.0 111.517 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 mt -55.96 -28.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.716 1.606 . . . . 0.0 111.059 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -146.29 173.0 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.686 1.194 . . . . 0.0 109.455 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.26 18.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -139.13 10.7 2.58 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.788 0.835 . . . . 0.0 111.259 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.01 136.09 9.2 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -62.2 145.41 53.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.823 0.849 . . . . 0.0 112.686 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -72.26 133.62 83.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.685 1.194 . . . . 0.0 108.86 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.29 -34.63 41.07 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.823 2.349 . . . . 0.0 114.353 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -73.06 -29.33 62.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.751 0.705 . . . . 0.0 110.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.13 -49.3 74.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.7 -49.87 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.37 -39.88 92.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.964 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.9 96.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.713 0.688 . . . . 0.0 110.228 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.5 mmm -68.6 -36.39 78.64 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.807 -0.558 . . . . 0.0 111.28 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.712 -1.243 . . . . 0.0 111.485 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.65 -17.46 64.85 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.003 0.819 . . . . 0.0 110.935 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.57 -0.43 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.894 0.877 . . . . 0.0 112.125 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.15 32.45 14.13 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.53 159.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -127.31 146.3 50.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.25 0.65 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.182 1.393 . . . . 0.0 110.391 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -58.58 -28.74 65.84 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.285 -1.509 . . . . 0.0 111.15 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -67.42 -4.38 11.02 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.972 1.709 . . . . 0.0 115.001 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.82 49.81 2.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.577 1.535 . . . . 0.0 110.256 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 p -48.18 144.5 3.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 112.647 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -56.78 148.71 19.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.929 1.691 . . . . 0.0 113.936 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.44 153.52 31.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.281 1.433 . . . . 0.0 109.911 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.99 165.72 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.448 1.099 . . . . 0.0 109.68 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.37 145.87 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.552 1.141 . . . . 0.0 110.047 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -140.04 134.99 32.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.452 1.101 . . . . 0.0 109.872 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.0 -28.11 49.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.472 . . . . 0.0 113.168 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.12 -11.87 61.18 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.104 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -114.42 -41.54 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 mt -48.77 -57.62 6.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.035 1.288 . . . . 0.0 111.557 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.25 1.29 29.08 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -119.83 -32.14 4.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.007 1.323 . . . . 0.0 111.862 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.65 128.41 36.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.237 1.415 . . . . 0.0 109.44 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.59 -23.48 65.4 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.944 0.498 . . . . 0.0 110.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.3 tp -146.47 142.07 27.73 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.67 1.188 . . . . 0.0 107.993 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.02 152.86 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.46 129.0 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.9 134.72 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.12 3.57 30.46 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.883 0.873 . . . . 0.0 111.485 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.3 p -65.9 110.31 2.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.912 1.285 . . . . 0.0 111.688 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.11 21.05 0.86 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.353 0.978 . . . . 0.0 111.746 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -81.49 -177.78 6.66 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.409 2.283 . . . . 0.0 110.624 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.45 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.01 -33.87 10.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.542 1.064 . . . . 0.0 111.218 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 33.17 56.77 0.48 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.17 2.588 . . . . 0.0 114.134 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.96 -22.21 66.64 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.04 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 90' ' ' PRO . 70.8 m 44.05 94.63 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.811 2.444 . . . . 0.0 114.792 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 89' ' ' CYS . 9.7 Cg_endo -50.93 138.74 42.4 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.574 2.182 . . . . 0.0 112.099 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.6 mtm -79.39 156.31 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.781 0.833 . . . . 0.0 109.962 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -131.38 161.94 58.99 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.291 1.836 . . . . 0.0 110.263 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.5 140.52 52.57 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.904 1.736 . . . . 0.0 109.948 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.98 -22.01 20.14 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.917 2.412 . . . . 0.0 112.044 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -81.76 6.15 16.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.195 0.998 . . . . 0.0 112.461 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.01 140.71 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.97 136.42 57.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -128.31 156.22 43.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -124.3 164.51 19.45 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.606 . . . . 0.0 107.497 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -131.33 109.92 10.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -116.4 55.54 0.81 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.83 126.99 32.95 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.68 166.0 33.53 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.506 1.922 . . . . 0.0 106.628 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -64.24 149.76 47.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.665 0.745 . . . . 0.0 110.772 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.95 118.03 70.62 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.72 -23.13 63.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.617 1.544 . . . . 0.0 112.949 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.4 63.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.35 0.977 . . . . 0.0 112.214 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -111.27 4.79 19.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.47 1.508 . . . . 0.0 111.497 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.01 60.91 0.79 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.231 1.812 . . . . 0.0 111.55 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.16 141.67 53.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.016 1.726 . . . . 0.0 110.983 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.86 -58.41 0.23 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -165.94 167.29 16.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.033 1.733 . . . . 0.0 107.13 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.19 -30.16 70.24 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.86 -0.525 . . . . 0.0 111.416 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.912 0.485 . . . . 0.0 110.491 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.45 -43.25 67.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.323 0.649 . . . . 0.0 109.315 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.62 -48.32 75.11 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 121.85 -0.531 . . . . 0.0 110.394 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -60.76 -37.45 81.88 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.788 0.722 . . . . 0.0 111.704 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.93 77.77 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.296 -0.877 . . . . 0.0 110.5 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.211 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.35 -48.77 79.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.437 1.017 . . . . 0.0 109.3 171.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -47.61 79.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.571 1.078 . . . . 0.0 112.0 172.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -60.34 -47.91 84.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.663 0.665 . . . . 0.0 110.383 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.59 -37.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -56.02 -54.8 40.47 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.487 1.04 . . . . 0.0 108.693 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -65.9 -43.39 88.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.506 0.504 . . . . 0.0 110.436 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.04 -34.48 73.3 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.256 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -59.14 -52.22 63.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 169.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.09 -46.79 61.57 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.75 -37.29 85.95 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.603 0.702 . . . . 0.0 111.541 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -78.96 -30.85 44.78 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.371 -0.831 . . . . 0.0 111.111 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -40.1 81.22 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.86 174.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -51.29 -50.17 59.84 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.874 0.87 . . . . 0.0 109.674 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.83 -45.08 87.67 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 117.657 0.208 . . . . 0.0 110.82 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -57.32 -33.3 67.57 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.902 -1.124 . . . . 0.0 112.32 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.55 -37.88 24.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.934 0.493 . . . . 0.0 111.996 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.45 -51.71 5.28 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.444 1.097 . . . . 0.0 111.014 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.8 p -104.07 -17.15 15.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 110.722 -169.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.63 80.09 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.291 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 118.926 1.363 . . . . 0.0 108.864 175.225 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.36 168.66 24.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.262 1.425 . . . . 0.0 108.627 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.59 135.82 50.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.05 170.14 8.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.48 141.57 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.85 149.71 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 119.021 0.828 . . . . 0.0 108.947 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.37 134.72 36.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.87 121.15 42.34 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.68 143.56 45.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 110.15 -169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -153.17 -176.16 5.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.477 0.711 . . . . 0.0 111.389 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 p -86.4 -0.98 57.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.159 1.384 . . . . 0.0 112.808 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.44 114.09 0.44 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.67 50.71 0.25 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.879 1.272 . . . . 0.0 114.332 -169.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 m -124.88 -20.11 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 121.206 -0.934 . . . . 0.0 113.444 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.0 m -128.86 -106.08 0.3 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.042 0.837 . . . . 0.0 109.426 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -40.25 46.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.391 1.476 . . . . 0.0 113.553 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 p -65.99 -45.99 79.64 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.706 0.802 . . . . 0.0 110.911 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.56 -46.39 90.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.841 0.857 . . . . 0.0 110.049 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 mtm -59.45 -45.38 91.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.043 0.537 . . . . 0.0 111.033 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.05 95.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.449 0.568 . . . . 0.0 111.334 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HG3' HG12 ' A' ' 34' ' ' VAL . 42.8 tt0 -56.73 -42.96 80.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.825 0.45 . . . . 0.0 110.594 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.14 -52.19 53.94 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.297 -0.724 . . . . 0.0 112.135 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -60.03 -43.92 94.99 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.503 0.651 . . . . 0.0 110.627 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -63.63 -42.85 98.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.307 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -55.77 -36.2 67.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.73 1.15 . . . . 0.0 111.307 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -69.44 -58.03 4.5 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.5 0.591 . . . . 0.0 110.792 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -73.08 -46.01 53.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.995 0.118 . . . . 0.0 111.106 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 87.0 mt -73.08 -36.36 66.8 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.762 0.425 . . . . 0.0 111.487 -176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.14 173.28 43.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -169.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.33 -2.36 5.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.958 0.903 . . . . 0.0 111.666 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -58.89 -13.11 5.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 111.289 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.3 m95 -128.45 120.97 27.9 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -71.15 95.4 1.24 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.508 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.4 t -83.96 133.54 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -173.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -143.28 167.52 21.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.212 1.405 . . . . 0.0 109.59 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.0 p -145.0 159.64 42.62 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.768 0.827 . . . . 0.0 109.36 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.7 -170.96 2.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.652 1.181 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.02 -172.43 41.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.0 mt -57.38 -28.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.958 1.303 . . . . 0.0 110.942 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.32 166.73 29.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.627 1.171 . . . . 0.0 109.568 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.65 26.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.128 1.371 . . . . 0.0 107.773 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.13 17.46 4.11 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.093 1.357 . . . . 0.0 110.258 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 168.41 44.74 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.68 149.41 25.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.469 0.652 . . . . 0.0 111.831 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.91 138.13 57.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.299 1.439 . . . . 0.0 109.746 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.52 -28.61 70.39 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.79 1.66 . . . . 0.0 112.959 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -71.99 -33.56 68.2 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.97 92.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -57.3 -50.1 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.333 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -57.93 -44.75 87.08 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.159 0.89 . . . . 0.0 111.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.87 87.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.7 mmm -68.88 -37.86 79.32 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.157 0.183 . . . . 0.0 111.008 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -32.53 69.7 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.287 -0.883 . . . . 0.0 111.121 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.51 -11.32 60.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.343 1.057 . . . . 0.0 110.477 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -115.68 0.45 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.328 1.051 . . . . 0.0 112.031 173.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 30.76 13.09 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -120.55 160.11 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.85 145.52 51.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.31 -8.32 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.676 1.591 . . . . 0.0 110.436 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -55.97 -32.67 64.11 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.87 0.868 . . . . 0.0 111.119 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.76 -14.34 61.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.381 1.472 . . . . 0.0 114.371 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -107.69 -30.08 8.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 -169.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.0 p 51.2 -175.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.283 1.833 . . . . 0.0 113.716 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 m -119.88 155.87 31.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.68 1.192 . . . . 0.0 111.0 -170.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -158.43 158.9 35.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 109.629 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.14 165.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.26 144.25 9.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.921 0.888 . . . . 0.0 109.466 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -136.46 140.18 42.91 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.773 1.229 . . . . 0.0 110.129 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.63 -29.91 62.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.187 1.395 . . . . 0.0 113.449 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.33 -12.28 61.48 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 111.95 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.45 -44.64 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.45 -40.59 78.79 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.1 1.318 . . . . 0.0 112.712 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -1.64 55.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -117.69 -26.35 6.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.126 1.37 . . . . 0.0 112.831 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.36 124.65 18.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.198 1.399 . . . . 0.0 110.08 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -32.43 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.247 1.419 . . . . 0.0 109.817 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.07 144.33 30.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.197 1.399 . . . . 0.0 108.106 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -117.66 153.21 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.91 138.61 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 p -113.46 131.98 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.44 21.69 16.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.809 1.244 . . . . 0.0 108.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -82.79 99.37 9.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.019 1.327 . . . . 0.0 109.718 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.06 -0.98 1.16 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 123.929 0.776 . . . . 0.0 111.441 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -74.55 -179.67 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.776 2.031 . . . . 0.0 112.9 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.33 -28.9 68.51 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.98 -52.42 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.436 0.562 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 40.84 37.07 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.682 1.993 . . . . 0.0 114.03 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -65.84 -25.7 67.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.561 -1.337 . . . . 0.0 111.542 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.4 t 37.32 112.19 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 131.634 3.974 . . . . 0.0 116.555 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.41 140.82 96.06 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 110.57 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.52 158.25 36.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 109.97 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -123.06 157.02 61.84 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.948 1.699 . . . . 0.0 109.147 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG2' HG22 ' A' ' 96' ' ' VAL . 80.5 Cg_endo -76.29 162.17 34.13 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 121.567 1.512 . . . . 0.0 110.36 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.22 -17.66 24.23 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.949 2.433 . . . . 0.0 111.591 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -65.91 -22.63 66.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.252 1.021 . . . . 0.0 112.352 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 93' ' ' PRO . 26.2 m -113.98 150.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.637 0.653 . . . . 0.0 111.11 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -72.6 149.56 43.85 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -132.55 156.69 46.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 111.363 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.74 162.14 26.52 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.009 2.523 . . . . 0.0 106.822 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -144.86 114.76 7.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -122.38 10.67 9.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.517 1.527 . . . . 0.0 111.49 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.7 138.22 5.32 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.938 1.256 . . . . 0.0 114.844 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 -100.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.868 1.667 . . . . 0.0 107.177 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -154.86 152.69 30.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.62 126.41 86.08 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.04 -25.58 66.24 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.34 1.36 . . . . 0.0 113.939 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.89 -13.09 62.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.346 0.975 . . . . 0.0 112.368 172.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mtm-85 -111.96 6.24 19.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.259 . . . . 0.0 111.378 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.66 60.9 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.335 1.854 . . . . 0.0 110.737 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.56 141.76 54.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.919 1.688 . . . . 0.0 111.137 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.66 -59.29 0.22 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -166.38 169.61 13.84 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 107.108 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -30.12 68.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.279 0.631 . . . . 0.0 111.292 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.84 -37.8 73.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.832 0.453 . . . . 0.0 110.766 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.64 -43.56 76.02 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -57.01 -51.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.81 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -58.06 -38.4 76.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.792 0.837 . . . . 0.0 111.903 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.69 87.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.443 -0.785 . . . . 0.0 109.863 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -63.95 -34.92 79.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.988 0.515 . . . . 0.0 111.85 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -57.76 -49.96 74.83 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.172 0.896 . . . . 0.0 109.798 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -63.91 -36.06 82.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.293 0.497 . . . . 0.0 111.76 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.52 -48.05 68.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.637 0.653 . . . . 0.0 111.014 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.09 -41.85 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -54.29 -53.61 51.38 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.02 0.928 . . . . 0.0 109.537 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.54 -42.91 95.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.787 0.267 . . . . 0.0 111.072 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.17 -42.16 84.76 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.982 -0.449 . . . . 0.0 110.848 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.32 -49.91 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.61 -43.18 78.71 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.02 -51.64 68.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 117.484 0.642 . . . . 0.0 111.131 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.5 mmm-85 -68.54 -29.58 68.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -40.86 88.05 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 120.123 1.328 . . . . 0.0 109.74 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -56.73 -53.16 60.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.36 -34.4 78.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.605 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -63.33 -37.9 89.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.798 -0.564 . . . . 0.0 110.726 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.63 -35.55 29.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.193 0.597 . . . . 0.0 111.548 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.07 -42.46 9.4 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.746 1.219 . . . . 0.0 111.72 -169.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 p -113.48 -18.18 12.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 111.056 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.82 65.85 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.036 -0.869 . . . . 0.0 111.981 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.245 0.866 0 C-N-CA 124.564 1.146 . . . . 0.0 108.137 -175.694 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -151.08 159.95 44.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.043 1.337 . . . . 0.0 107.558 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -141.52 134.3 28.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 173.26 9.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.553 0.615 . . . . 0.0 110.138 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.33 141.03 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.53 149.76 16.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.091 0.956 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 131.69 32.65 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.523 0.729 . . . . 0.0 109.065 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.33 128.17 55.87 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.3 143.85 51.15 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.401 0.68 . . . . 0.0 110.585 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.51 174.68 10.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.367 1.079 . . . . 0.0 112.674 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.8 p -77.97 32.69 0.18 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.444 2.298 . . . . 0.0 110.616 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.01 113.73 0.83 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -173.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.31 53.98 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.264 1.026 . . . . 0.0 111.611 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 m -125.15 -19.67 5.08 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.1 m -138.81 -90.4 0.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.798 0.726 . . . . 0.0 109.1 -173.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -52.37 -53.25 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.041 0.936 . . . . 0.0 112.34 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 p -68.14 -38.35 82.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.658 0.663 . . . . 0.0 111.097 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -58.66 -54.86 42.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.962 0.905 . . . . 0.0 109.903 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.6 mtp -54.73 -46.05 74.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.57 1.548 . . . . 0.0 110.576 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.28 88.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.881 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 34' ' ' VAL . 23.6 tt0 -57.05 -37.8 72.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.445 0.566 . . . . 0.0 110.851 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.51 -54.03 41.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 123.829 0.728 . . . . 0.0 111.498 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -61.75 -41.81 98.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.313 0.557 . . . . 0.0 110.777 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.8 88.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.297 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -55.15 -36.33 65.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.873 1.215 . . . . 0.0 111.358 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -67.3 -56.96 7.61 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.363 0.414 . . . . 0.0 110.783 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -77.36 -44.47 29.28 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -169.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 84.4 mt -74.51 -37.07 63.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 111.071 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 173.03 42.95 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.41 -1.93 5.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.677 0.791 . . . . 0.0 111.634 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -57.89 -13.2 4.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.034 1.333 . . . . 0.0 111.325 169.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 13.7 m95 -129.13 115.49 17.78 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.246 -2.502 . . . . 0.0 104.246 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -66.34 100.79 0.67 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 21' ' ' GLU . 2.8 p -107.68 133.37 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.602 0.761 . . . . 0.0 109.831 -168.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.06 167.38 22.21 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.162 1.385 . . . . 0.0 109.459 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -140.41 151.33 44.84 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 109.92 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.02 -166.66 1.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.584 1.154 . . . . 0.0 109.812 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.52 -176.31 46.32 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 121.342 -0.849 . . . . 0.0 111.387 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.4 mt -54.95 -31.92 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.723 1.609 . . . . 0.0 110.806 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.11 167.06 25.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.027 1.331 . . . . 0.0 108.087 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.83 133.0 20.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -134.42 21.82 3.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.179 0.992 . . . . 0.0 109.347 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.12 165.25 33.89 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -87.02 147.88 25.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.07 0.548 . . . . 0.0 110.442 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -73.43 133.52 80.45 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.365 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.88 -34.38 45.23 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.884 2.389 . . . . 0.0 114.495 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -73.97 -27.85 61.19 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 121.385 -0.822 . . . . 0.0 110.929 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.56 75.88 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.1 -49.18 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.8 -43.61 94.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.052 0.541 . . . . 0.0 111.039 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.15 94.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.209 0.604 . . . . 0.0 110.255 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.2 mmm -69.72 -36.66 76.08 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.282 0.492 . . . . 0.0 111.318 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -27.34 69.25 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 120.797 -1.19 . . . . 0.0 111.446 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.17 -15.17 63.55 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.914 0.779 . . . . 0.0 110.825 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.79 -0.0 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.17 0.988 . . . . 0.0 112.079 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.59 17.44 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 174.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.64 160.51 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.85 145.31 50.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.56 2.98 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.859 1.264 . . . . 0.0 110.41 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -58.7 -29.52 66.71 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.214 -1.554 . . . . 0.0 111.086 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -65.64 -4.73 6.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.425 1.89 . . . . 0.0 115.334 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -135.45 48.47 2.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.444 1.474 . . . . 0.0 110.829 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -44.86 132.62 6.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.843 1.257 . . . . 0.0 111.111 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -57.29 154.81 9.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -168.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -154.15 155.7 35.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.108 1.363 . . . . 0.0 109.581 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.23 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.497 1.119 . . . . 0.0 109.784 172.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.77 153.16 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.058 1.343 . . . . 0.0 110.067 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.98 139.11 21.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.688 1.595 . . . . 0.0 108.643 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.34 -28.11 57.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.31 1.444 . . . . 0.0 113.464 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.04 -13.51 62.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.573 1.149 . . . . 0.0 112.286 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -113.36 -40.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.8 mt -48.09 -61.33 2.03 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.834 1.197 . . . . 0.0 111.603 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -3.27 35.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -111.94 -33.11 6.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.331 1.452 . . . . 0.0 110.941 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 122.65 15.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.48 1.512 . . . . 0.0 110.092 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.23 -23.38 66.41 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 111.197 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 tp -143.82 138.65 28.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.747 1.219 . . . . 0.0 107.936 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.6 145.4 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.14 124.85 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.29 127.11 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.41 24.57 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.896 0.855 . . . . 0.0 109.081 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.0 p -75.96 107.98 8.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.589 1.556 . . . . 0.0 110.029 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.7 26.91 0.46 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.8 p-10 -106.84 -177.02 3.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.479 2.312 . . . . 0.0 113.43 -169.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.09 66.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.014 0.925 . . . . 0.0 113.388 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.19 -52.57 6.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.502 0.592 . . . . 0.0 110.224 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 46.44 28.83 0.78 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.498 1.919 . . . . 0.0 114.249 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.1 mtpt -61.57 -32.33 72.41 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.539 -1.351 . . . . 0.0 111.466 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 54.69 109.88 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 129.772 3.229 . . . . 0.0 114.575 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.6 146.05 96.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.452 2.101 . . . . 0.0 112.101 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -74.1 155.66 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 0.0 109.833 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -132.17 161.6 61.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.879 2.071 . . . . 0.0 109.149 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.6 159.71 50.36 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 121.246 1.297 . . . . 0.0 109.583 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.72 -26.15 10.09 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.397 2.065 . . . . 0.0 112.422 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -74.9 -34.61 62.21 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.274 0.63 . . . . 0.0 112.45 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.73 153.43 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.542 0.687 . . . . 0.0 111.013 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -70.65 141.28 51.68 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -134.03 149.71 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.216 0.607 . . . . 0.0 109.902 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -127.07 157.14 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.702 2.001 . . . . 0.0 107.832 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -131.34 113.44 13.77 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.8 m0 -122.26 52.89 1.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.154 1.781 . . . . 0.0 106.797 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.15 128.67 34.07 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 120.747 -1.221 . . . . 0.0 111.654 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.98 160.83 39.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 105.911 169.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 30.0 t0 -68.73 144.05 54.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.431 0.634 . . . . 0.0 110.747 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.38 127.64 93.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.51 -23.07 50.73 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.162 1.241 . . . . 0.0 113.506 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.93 -11.45 60.35 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.454 1.025 . . . . 0.0 112.347 171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -111.49 3.23 17.93 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.879 1.272 . . . . 0.0 110.755 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.51 60.61 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.21 2.204 . . . . 0.0 110.844 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.43 138.2 57.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 110.587 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.68 -58.35 0.19 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -166.3 168.43 15.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.902 1.681 . . . . 0.0 107.339 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -30.3 70.15 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.781 -0.574 . . . . 0.0 111.394 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.75 -38.55 76.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.928 0.491 . . . . 0.0 110.585 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.57 -46.13 77.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -56.91 -49.95 74.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.168 0.587 . . . . 0.0 110.26 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -60.33 -37.16 79.75 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.866 0.757 . . . . 0.0 111.975 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.46 80.24 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.147 -0.97 . . . . 0.0 110.258 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.38 -32.69 74.46 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.948 -0.47 . . . . 0.0 111.477 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -57.42 -49.09 77.35 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.465 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -45.55 84.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 111.829 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -60.73 -48.78 80.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.002 0.819 . . . . 0.0 110.681 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.67 -39.65 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -55.85 -55.94 26.53 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 124.095 0.958 . . . . 0.0 108.956 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.52 -37.63 77.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 123.536 0.523 . . . . 0.0 110.502 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.01 -42.61 80.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.031 0.532 . . . . 0.0 111.255 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.3 mt -58.61 -52.19 62.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.94 56.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.909 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -61.61 -50.06 74.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.726 0.763 . . . . 0.0 111.066 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.41 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.57 -34.77 74.64 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.113 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -40.3 96.45 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.207 0.912 . . . . 0.0 109.742 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.32 -49.77 75.06 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.076 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.71 -43.63 98.32 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 110.131 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.18 -31.72 69.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.649 -1.282 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 -37.19 23.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.471 0.708 . . . . 0.0 112.212 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.6 -52.97 4.63 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.819 1.248 . . . . 0.0 110.728 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.2 p -103.03 -16.52 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.842 1.657 . . . . 0.0 110.414 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.34 86.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.486 1.041 . . . . 0.0 112.381 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 C--O 1.246 0.893 0 CA-C-N 118.694 1.247 . . . . 0.0 108.743 -172.533 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.21 -38.81 82.31 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.927 -0.483 . . . . 0.0 110.869 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.19 126.28 28.71 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.08 -179.91 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.232 0.613 . . . . 0.0 109.919 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -140.91 142.49 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.82 150.32 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 118.87 0.759 . . . . 0.0 109.251 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -139.49 136.8 34.94 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.715 0.806 . . . . 0.0 109.508 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.49 133.05 54.6 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.564 1.146 . . . . 0.0 108.29 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.15 141.0 52.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.54 0.736 . . . . 0.0 110.244 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.93 168.97 18.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.173 1.389 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 p -55.5 -36.11 66.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.52 1.128 . . . . 0.0 110.939 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.2 141.47 9.39 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -77.44 51.22 0.86 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.42 1.088 . . . . 0.0 111.712 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.7 m -126.46 -15.58 5.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.771 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.98 -98.56 0.19 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -52.31 -50.29 62.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.081 0.953 . . . . 0.0 112.311 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -70.7 -36.32 73.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.78 0.264 . . . . 0.0 111.509 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -60.92 -53.78 53.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.247 1.019 . . . . 0.0 110.214 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.7 mtp -53.94 -46.84 71.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.182 1.393 . . . . 0.0 110.551 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.26 95.6 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.914 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 54.7 tt0 -55.92 -41.44 74.57 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.223 0.465 . . . . 0.0 110.728 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.27 -48.1 85.0 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.4 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -63.01 -43.57 98.4 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.834 0.817 . . . . 0.0 110.864 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.29 99.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.787 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -51.55 -38.31 53.69 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.068 0.849 . . . . 0.0 111.907 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -70.21 -62.66 1.3 Allowed 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 123.327 0.392 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -67.95 -37.78 82.0 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 78.5 mt -77.03 -1.36 28.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.682 0.793 . . . . 0.0 112.489 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.34 24.97 59.76 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.573 1.082 . . . . 0.0 113.738 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.12 16.06 2.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.768 2.027 . . . . 0.0 113.611 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.59 2.2 14.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.945 -1.097 . . . . 0.0 111.33 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.1 m95 -134.21 124.74 26.49 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.64 94.25 0.42 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.6 t -79.11 138.46 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -143.5 164.62 29.85 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.075 1.35 . . . . 0.0 109.695 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -146.42 156.56 43.39 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.783 0.833 . . . . 0.0 109.461 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 -166.89 2.07 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.224 1.009 . . . . 0.0 109.584 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.69 44.03 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mt -57.03 -25.57 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.927 1.291 . . . . 0.0 111.363 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.02 169.47 19.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.967 1.307 . . . . 0.0 108.825 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.21 135.48 21.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 169.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -129.18 11.12 5.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.723 1.209 . . . . 0.0 110.042 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 162.4 30.61 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -170.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.08 146.67 30.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.321 0.581 . . . . 0.0 111.045 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.16 133.68 83.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.147 -0.93 . . . . 0.0 108.945 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.53 -34.62 43.09 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.799 2.333 . . . . 0.0 114.563 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -73.41 -28.18 61.85 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.567 -0.708 . . . . 0.0 110.731 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.77 73.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -57.68 -48.05 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -60.04 -41.76 92.95 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.57 0.623 . . . . 0.0 110.764 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.47 94.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.14 0.576 . . . . 0.0 109.78 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.5 mmm -69.07 -38.52 79.07 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.415 0.15 . . . . 0.0 111.061 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.47 -25.1 67.85 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.85 -1.156 . . . . 0.0 111.483 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.79 -15.62 63.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.578 0.751 . . . . 0.0 110.42 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.25 0.82 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.927 0.891 . . . . 0.0 112.064 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.04 19.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.65 159.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -125.95 145.45 50.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 pt -127.97 2.7 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.977 1.311 . . . . 0.0 110.383 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.86 -27.98 67.13 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 119.978 -1.701 . . . . 0.0 111.2 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.84 -5.23 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.227 1.811 . . . . 0.0 115.107 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.18 49.61 2.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.253 1.388 . . . . 0.0 110.876 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -46.72 134.64 9.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.3 1.04 . . . . 0.0 110.967 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.26 155.51 8.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -154.48 156.18 36.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.967 1.307 . . . . 0.0 109.395 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.0 167.98 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 109.777 171.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.41 146.22 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.454 1.501 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -138.65 139.49 38.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.283 1.433 . . . . 0.0 109.773 170.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -55.81 -29.12 59.24 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.516 1.526 . . . . 0.0 113.259 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.75 -7.06 36.23 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 112.392 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.94 -44.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -45.7 -55.85 5.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.092 0.957 . . . . 0.0 112.305 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.7 51.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 112.925 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.8 -30.01 4.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 112.299 -168.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.97 130.37 46.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.778 1.231 . . . . 0.0 109.92 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.58 -22.98 64.43 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.223 0.609 . . . . 0.0 110.962 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.0 tp -146.44 142.18 27.89 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 108.829 170.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.9 145.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.48 135.48 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.56 107.67 13.56 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.68 8.32 34.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.409 0.683 . . . . 0.0 112.637 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.6 p -68.65 72.89 0.24 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.825 2.45 . . . . 0.0 114.669 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.06 18.94 11.2 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.575 -1.328 . . . . 0.0 112.827 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.3 175.86 9.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.301 1.84 . . . . 0.0 111.219 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.0 64.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.86 -32.66 11.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.297 0.953 . . . . 0.0 111.035 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 34.64 55.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.26 2.624 . . . . 0.0 113.885 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.29 -25.05 66.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.632 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.8 m 42.51 84.8 0.18 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 127.324 2.249 . . . . 0.0 112.883 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -45.06 135.2 10.89 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.442 3.428 . . . . 0.0 113.245 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.01 138.24 58.23 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.902 0.881 . . . . 0.0 110.245 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -124.02 158.09 61.53 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.471 1.908 . . . . 0.0 109.689 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.5 153.39 76.66 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.82 1.68 . . . . 0.0 109.324 169.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.63 -23.97 16.41 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.478 2.119 . . . . 0.0 112.103 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -73.05 -32.83 65.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.645 0.778 . . . . 0.0 112.196 -173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.94 145.07 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.432 0.634 . . . . 0.0 109.799 -172.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.86 130.99 44.97 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -134.54 150.4 50.76 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.021 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.78 160.68 30.15 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.317 2.247 . . . . 0.0 107.574 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -133.13 115.13 14.69 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.406 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 33.6 m0 -119.11 59.67 0.83 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.84 123.85 13.78 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.767 -171.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.94 160.13 43.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.61 1.964 . . . . 0.0 106.528 168.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -69.81 149.66 47.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.179 0.514 . . . . 0.0 110.591 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.2 128.61 80.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.49 -24.83 35.86 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.221 1.28 . . . . 0.0 113.515 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 -12.45 61.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.487 1.04 . . . . 0.0 111.722 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.0 ttp85 -101.93 2.0 37.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.889 1.275 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.93 67.2 0.82 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.115 1.366 . . . . 0.0 110.385 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.49 137.42 56.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.928 0.891 . . . . 0.0 110.464 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.42 -63.42 0.19 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.4 t -165.15 168.72 16.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 107.6 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.93 -29.53 68.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.386 0.675 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.64 -37.33 70.86 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.22 0.464 . . . . 0.0 110.836 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.23 -44.01 76.69 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -58.22 -48.02 81.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 122.856 0.462 . . . . 0.0 110.084 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -58.45 -39.89 81.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.561 0.744 . . . . 0.0 111.702 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.68 84.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.442 -0.787 . . . . 0.0 110.213 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.52 -34.12 77.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.07 0.548 . . . . 0.0 111.165 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -59.37 -48.14 82.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.909 . . . . 0.0 110.222 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -65.14 -36.36 84.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.491 0.587 . . . . 0.0 111.521 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -65.57 -50.36 65.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.265 0.484 . . . . 0.0 110.64 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.54 -39.37 84.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -54.44 -53.33 55.61 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.781 0.832 . . . . 0.0 109.352 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.56 -41.94 95.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.046 0.384 . . . . 0.0 111.035 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.18 -41.29 90.48 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.597 -0.689 . . . . 0.0 111.411 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.89 -53.03 50.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.55 -45.72 53.75 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 123.677 0.656 . . . . 0.0 111.754 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -60.46 -50.28 74.19 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.918 0.859 . . . . 0.0 111.174 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -70.79 -33.18 70.47 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.991 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -39.61 94.86 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.179 0.9 . . . . 0.0 109.969 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.83 -52.63 64.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.0 -35.29 80.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.255 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.56 -36.58 83.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.81 -0.556 . . . . 0.0 111.223 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.52 26.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 122.818 0.447 . . . . 0.0 111.44 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.42 -42.96 11.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.611 1.165 . . . . 0.0 111.628 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.0 p -113.29 -19.0 11.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.224 1.01 . . . . 0.0 111.161 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.77 10.54 75.83 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.209 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 118.654 1.227 . . . . 0.0 108.364 -174.677 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -150.82 157.57 43.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.954 1.302 . . . . 0.0 107.719 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -132.97 133.54 43.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.85 175.1 6.07 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.37 140.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.78 148.94 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.4 131.66 30.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.71 131.24 56.99 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -125.91 139.59 53.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.639 0.776 . . . . 0.0 109.719 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.2 t -135.74 168.75 18.71 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.442 1.097 . . . . 0.0 109.406 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.8 p -58.77 -26.27 63.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.476 1.111 . . . . 0.0 111.314 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 138.04 5.94 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.03 53.45 0.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.603 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 m -126.85 -17.66 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.921 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.03 -90.93 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.876 0.762 . . . . 0.0 109.184 -170.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -56.46 -53.46 57.21 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.38 0.672 . . . . 0.0 111.542 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -67.68 -36.4 80.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.774 0.261 . . . . 0.0 111.197 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -59.61 -57.58 12.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.147 0.979 . . . . 0.0 110.085 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.8 mtm -56.86 -43.4 81.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.319 0.648 . . . . 0.0 111.517 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.28 99.15 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.482 0.583 . . . . 0.0 111.824 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.6 tt0 -57.7 -39.74 77.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.237 0.471 . . . . 0.0 110.815 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.4 53.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 123.697 0.665 . . . . 0.0 111.546 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -61.32 -45.29 95.04 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.303 0.551 . . . . 0.0 110.98 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.7 -44.25 97.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.34 0.656 . . . . 0.0 110.852 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -56.3 -34.21 66.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.055 0.843 . . . . 0.0 111.889 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -67.22 -61.61 1.84 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.131 0.423 . . . . 0.0 110.443 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.02 -42.71 80.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.35 0.26 . . . . 0.0 111.507 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.38 -7.84 58.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 0.0 112.241 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.93 56.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.859 1.219 . . . . 0.0 114.621 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.58 4.76 1.08 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.696 2.398 . . . . 0.0 114.107 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.29 -9.11 21.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.714 1.206 . . . . 0.0 110.384 169.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -129.37 118.84 22.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 172.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.64 99.7 0.81 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -84.1 141.47 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -144.01 165.31 28.12 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.941 1.696 . . . . 0.0 109.077 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.2 p -143.92 155.89 44.23 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.736 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.37 1.69 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.622 1.169 . . . . 0.0 109.459 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.09 179.83 45.19 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -54.39 -28.41 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.366 1.466 . . . . 0.0 111.387 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.06 170.61 16.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.966 1.307 . . . . 0.0 108.632 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.0 134.09 18.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -135.92 19.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.363 1.065 . . . . 0.0 109.81 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.09 163.15 29.73 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -83.97 146.21 28.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 110.696 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -70.66 134.13 86.38 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.036 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.23 -35.67 44.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.795 2.33 . . . . 0.0 114.259 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -72.75 -26.64 61.64 Favored 'General case' 0 C--O 1.227 -0.111 0 O-C-N 121.491 -0.756 . . . . 0.0 111.094 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -46.62 78.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.77 -47.98 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -57.16 -46.34 82.85 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.858 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.56 86.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -69.26 -37.69 78.04 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 110.852 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.01 -25.72 67.97 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.879 -1.138 . . . . 0.0 111.778 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -71.43 -12.35 61.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.453 1.101 . . . . 0.0 110.424 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.28 -1.66 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 112.735 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.23 33.13 10.94 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.24 162.89 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.5 146.37 50.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.2 pt -128.95 3.97 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.824 1.25 . . . . 0.0 110.589 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.32 -28.38 66.75 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.136 -1.603 . . . . 0.0 111.003 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -64.73 -5.58 6.11 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.291 1.836 . . . . 0.0 115.188 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -135.67 50.35 2.11 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.512 1.505 . . . . 0.0 110.426 -169.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -46.21 133.28 9.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.493 1.117 . . . . 0.0 110.683 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 m -57.8 154.75 11.41 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -154.0 155.38 35.44 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.094 1.357 . . . . 0.0 109.522 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.42 166.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.354 1.062 . . . . 0.0 109.56 172.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.04 145.92 5.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.717 1.207 . . . . 0.0 109.898 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.07 135.97 33.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.391 1.076 . . . . 0.0 109.884 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -54.49 -28.35 44.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.426 1.49 . . . . 0.0 113.067 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.04 -11.98 61.28 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mt -114.52 -42.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.27 -57.5 6.69 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.928 1.24 . . . . 0.0 111.661 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -1.8 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -116.37 -32.58 5.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.214 1.405 . . . . 0.0 111.591 -168.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.46 128.25 35.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.32 1.448 . . . . 0.0 109.619 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.34 -29.85 71.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.863 0.865 . . . . 0.0 110.182 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.9 tp -147.3 140.43 25.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 108.647 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.84 154.72 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 t -140.09 136.43 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.06 135.65 47.14 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.39 10.46 37.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 110.613 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.2 p -64.21 116.98 6.52 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.643 1.177 . . . . 0.0 111.18 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.3 15.17 0.48 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.909 1.242 . . . . 0.0 111.051 169.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.51 176.0 9.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 109.546 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.55 -16.98 59.47 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.19 -35.48 21.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.511 1.051 . . . . 0.0 110.265 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.277 1.2 p-10 37.65 48.45 0.94 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.817 2.847 . . . . 0.0 114.253 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -66.78 -14.02 62.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.537 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.5 m 34.49 85.39 0.16 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.569 2.748 . . . . 0.0 113.971 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -44.78 133.21 10.48 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.685 3.59 . . . . 0.0 114.089 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -72.31 146.36 47.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.405 1.082 . . . . 0.0 110.098 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 p -129.46 160.22 65.45 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.607 1.963 . . . . 0.0 109.906 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.46 145.21 64.13 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.034 1.823 . . . . 0.0 109.895 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.5 -23.31 20.25 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.915 2.41 . . . . 0.0 112.185 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -85.01 6.58 24.66 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.067 0.947 . . . . 0.0 112.367 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.16 135.9 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.28 145.35 55.85 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -123.67 169.53 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.266 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -136.51 164.32 28.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.611 2.364 . . . . 0.0 106.794 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -134.02 113.25 11.93 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -121.63 61.82 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.06 131.3 11.66 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.304 -0.873 . . . . 0.0 112.885 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.28 160.46 40.81 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.396 2.278 . . . . 0.0 106.159 169.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -65.86 148.97 50.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.838 -0.539 . . . . 0.0 110.324 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -74.4 128.32 86.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.33 -21.23 54.6 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.063 1.175 . . . . 0.0 113.403 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.38 -18.3 65.07 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.399 1.0 . . . . 0.0 112.372 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -86.46 -8.67 57.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.457 1.026 . . . . 0.0 112.516 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 52.91 0.55 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 112.369 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.78 150.78 27.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.008 2.123 . . . . 0.0 112.063 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.62 -52.81 0.42 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -165.97 165.47 18.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.97 1.708 . . . . 0.0 107.263 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -28.54 67.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 0.0 111.223 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.78 -37.36 73.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.3 0.5 . . . . 0.0 110.903 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.9 -45.91 73.09 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.42 -49.37 74.72 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.923 0.489 . . . . 0.0 110.352 173.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.98 -39.71 86.62 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.631 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.232 -0.917 . . . . 0.0 110.838 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -67.41 -32.73 73.83 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.767 -0.583 . . . . 0.0 111.747 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.05 -44.64 91.84 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.693 0.679 . . . . 0.0 110.327 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.08 -38.05 89.65 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.635 0.652 . . . . 0.0 111.423 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -61.92 -51.16 69.26 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.109 0.868 . . . . 0.0 110.258 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.96 -38.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.332 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -63.91 -39.79 95.0 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.025 1.738 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.42 -45.37 80.13 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.239 0.472 . . . . 0.0 111.109 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.75 -41.81 95.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.002 -0.436 . . . . 0.0 110.874 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.05 -51.28 74.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.37 -46.31 57.81 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.566 -0.575 . . . . 0.0 111.786 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.89 -48.16 83.1 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.813 0.806 . . . . 0.0 110.826 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -35.11 76.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -41.45 93.71 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.821 -0.549 . . . . 0.0 110.079 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.89 -50.39 72.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.74 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.55 -45.33 94.61 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.57 -33.58 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.664 -1.273 . . . . 0.0 112.334 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.36 -32.89 20.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.414 0.686 . . . . 0.0 112.304 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.32 -53.68 3.53 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 -169.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.3 p -99.57 -15.54 18.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.49 1.516 . . . . 0.0 110.495 -170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.85 78.49 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.169 0.89 . . . . 0.0 111.815 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 117.868 0.834 . . . . 0.0 109.811 -179.228 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.567 0.223 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.39 -16.51 58.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.125 0.57 . . . . 0.0 112.109 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.441 HD22 ' HG2' ' A' ' 33' ' ' LYS . 4.2 t30 -52.79 133.64 37.1 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.517 0.727 . . . . 0.0 109.498 175.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 10.7 mmpt? -97.19 170.13 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.021 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.24 142.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 tt -141.05 146.56 23.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.91 120.85 15.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -171.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -104.09 127.85 51.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.871 0.868 . . . . 0.0 108.936 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.08 140.81 51.45 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.768 1.227 . . . . 0.0 109.184 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 m -140.52 168.86 18.82 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.49 1.116 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.14 -25.15 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.009 0.924 . . . . 0.0 111.377 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.49 136.25 5.0 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 169.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.79 55.88 2.16 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.296 1.038 . . . . 0.0 110.724 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -122.18 -25.95 4.79 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.7 m -133.02 -94.67 0.33 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.319 0.963 . . . . 0.0 110.32 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.75 80.03 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -169.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -58.72 -49.7 76.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.348 0.659 . . . . 0.0 110.703 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -63.72 -43.9 95.16 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.562 0.745 . . . . 0.0 110.802 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.81 -44.94 95.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.679 0.391 . . . . 0.0 111.036 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.0 99.72 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.525 0.602 . . . . 0.0 111.091 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.2 tt0 -57.59 -43.64 84.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.252 173.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.19 -53.37 43.22 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.823 0.725 . . . . 0.0 112.076 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -62.38 -44.31 96.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.194 0.497 . . . . 0.0 110.947 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.667 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -54.82 -35.19 63.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.425 1.011 . . . . 0.0 111.59 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -72.31 -62.82 1.3 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.122 0.419 . . . . 0.0 110.798 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -67.44 -37.51 83.12 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.0 -2.22 26.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.349 0.66 . . . . 0.0 112.364 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.55 57.49 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.559 1.552 . . . . 0.0 115.127 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 58.88 11.6 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.585 1.954 . . . . 0.0 113.363 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.39 -12.68 61.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.786 -1.196 . . . . 0.0 110.191 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -125.3 126.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.529 1.931 . . . . 0.0 106.513 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.2 mmpt? -70.3 108.86 4.4 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -96.79 137.59 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.79 165.3 27.76 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.584 1.154 . . . . 0.0 109.805 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.4 p -147.4 159.43 43.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.329 0.652 . . . . 0.0 109.831 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.96 -169.38 2.02 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.36 1.464 . . . . 0.0 109.635 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.42 -177.86 43.88 Favored Glycine 0 CA--C 1.52 0.386 0 O-C-N 121.47 -0.768 . . . . 0.0 112.055 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.89 -28.22 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.542 1.537 . . . . 0.0 111.292 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.4 170.08 17.56 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.835 1.254 . . . . 0.0 108.715 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.74 136.15 21.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -137.52 21.09 2.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.319 1.048 . . . . 0.0 109.846 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.09 153.35 29.33 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.51 150.66 47.8 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.41 0.624 . . . . 0.0 111.369 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -77.45 133.43 67.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.865 1.266 . . . . 0.0 109.123 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.5 -34.54 42.52 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.933 2.422 . . . . 0.0 114.592 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -72.28 -28.76 63.31 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.25 -0.906 . . . . 0.0 110.769 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -47.03 84.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.71 -48.86 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -60.73 -41.32 95.1 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.651 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.33 95.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.8 0.727 . . . . 0.0 109.845 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 77.2 mmm -69.47 -35.54 75.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.822 0.283 . . . . 0.0 111.402 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -28.15 69.31 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.848 -1.157 . . . . 0.0 111.7 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -66.21 -17.27 64.63 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.201 0.91 . . . . 0.0 110.81 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.15 0.4 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.95 0.9 . . . . 0.0 112.021 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.92 32.0 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.35 155.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.62 145.83 47.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.48 -1.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.796 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -58.21 -31.98 67.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.859 0.864 . . . . 0.0 110.958 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -64.49 7.26 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.443 1.897 . . . . 0.0 114.948 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -131.41 29.44 4.57 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.301 1.41 . . . . 0.0 112.527 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -41.48 127.43 3.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.25 1.02 . . . . 0.0 113.434 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 m -54.52 155.2 4.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.229 1.812 . . . . 0.0 115.49 -168.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -154.22 156.6 37.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.175 1.39 . . . . 0.0 109.376 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.41 163.3 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.946 0.898 . . . . 0.0 109.322 170.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.95 145.53 7.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.784 1.234 . . . . 0.0 109.834 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -136.36 133.84 37.21 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.629 1.172 . . . . 0.0 110.035 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.13 -27.99 56.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.625 1.57 . . . . 0.0 113.593 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.82 -0.04 49.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.631 0.651 . . . . 0.0 111.897 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -112.26 -41.79 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.4 mt -47.82 -56.8 6.64 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.351 0.978 . . . . 0.0 111.873 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -83.45 4.18 28.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.702 0.801 . . . . 0.0 112.659 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.88 -27.45 3.61 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.175 . . . . 0.0 112.043 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.83 135.15 56.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.914 1.286 . . . . 0.0 108.678 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.02 -34.23 77.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.4 137.3 25.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.623 1.169 . . . . 0.0 109.175 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.37 147.39 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.1 118.95 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -93.47 133.36 36.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.35 25.54 11.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.203 1.001 . . . . 0.0 108.884 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -72.35 103.87 3.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.765 -1.209 . . . . 0.0 111.263 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.37 15.99 0.76 Allowed Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.196 1.379 . . . . 0.0 109.768 169.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.57 173.35 8.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.583 2.353 . . . . 0.0 111.126 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.34 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.342 -0.848 . . . . 0.0 111.855 169.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.89 -47.1 48.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.242 0.617 . . . . 0.0 111.555 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 43.59 43.26 4.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.92 2.088 . . . . 0.0 113.915 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -73.65 -21.54 60.25 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.981 -1.075 . . . . 0.0 112.442 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.0 m 46.54 95.79 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 127.679 2.391 . . . . 0.0 113.631 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.84 139.16 19.81 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.593 2.862 . . . . 0.0 112.633 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.08 149.2 43.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 p -131.22 158.58 74.84 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.957 2.103 . . . . 0.0 109.258 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.98 159.33 41.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.214 1.943 . . . . 0.0 110.352 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.09 -15.95 25.61 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.078 2.519 . . . . 0.0 111.126 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.31 -12.47 61.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.406 1.482 . . . . 0.0 112.908 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.72 148.26 27.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.223 0.92 . . . . 0.0 112.113 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -68.09 141.45 56.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -135.54 151.04 49.94 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.109 0.564 . . . . 0.0 110.683 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -127.81 161.14 29.71 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.226 2.21 . . . . 0.0 108.031 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -133.07 112.77 12.07 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.3 m0 -124.7 52.09 1.57 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.312 1.845 . . . . 0.0 107.282 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.43 135.07 31.09 Favored Glycine 0 CA--C 1.526 0.723 0 O-C-N 120.809 -1.182 . . . . 0.0 112.241 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.95 158.72 38.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.889 1.676 . . . . 0.0 107.515 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.02 133.42 56.08 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.043 1.737 . . . . 0.0 110.601 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.7 125.95 92.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.39 -24.92 56.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.229 1.286 . . . . 0.0 113.2 -174.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.36 -3.62 41.03 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.135 0.88 . . . . 0.0 112.506 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -123.86 7.0 8.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.221 1.408 . . . . 0.0 109.307 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 99.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.636 1.174 . . . . 0.0 108.472 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -57.27 122.85 13.47 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.977 0.911 . . . . 0.0 108.88 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.82 -105.83 0.25 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 10.6 p -140.56 171.68 13.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.38 1.872 . . . . 0.0 107.523 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.59 -29.25 70.46 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.235 -0.915 . . . . 0.0 111.216 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.23 -40.56 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.024 0.53 . . . . 0.0 109.896 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.504 ' HB3' ' H ' ' A' ' 112' ' ' THR . 9.3 tp10 -63.98 -43.24 96.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -59.71 -47.32 86.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.432 0.693 . . . . 0.0 110.595 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -59.65 -36.59 76.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.984 0.811 . . . . 0.0 111.662 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.94 76.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 110.465 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -64.77 -31.09 72.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.268 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.73 -49.25 78.31 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.657 1.117 . . . . 0.0 109.406 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -56.38 -47.41 78.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.892 0.769 . . . . 0.0 111.819 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -60.68 -47.76 84.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.972 0.806 . . . . 0.0 110.695 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.14 -39.41 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -57.11 -53.98 51.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.073 0.851 . . . . 0.0 109.03 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.61 -39.17 80.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.35 0.406 . . . . 0.0 110.857 -170.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -60.04 -48.15 82.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.482 0.713 . . . . 0.0 111.055 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.98 -48.94 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.73 -48.66 49.82 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.663 -0.521 . . . . 0.0 111.992 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.08 -47.29 87.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 117.816 0.808 . . . . 0.0 111.007 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -28.29 57.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.256 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -38.83 84.39 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.373 0.988 . . . . 0.0 109.799 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -56.77 -49.85 74.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.457 0.571 . . . . 0.0 109.561 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.662 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.5 -35.54 79.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.044 0.838 . . . . 0.0 111.223 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.69 -38.82 32.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.465 0.306 . . . . 0.0 111.19 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.7 -45.73 9.11 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.089 0.955 . . . . 0.0 111.11 -170.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.6 p -111.28 -19.14 12.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.43 1.092 . . . . 0.0 112.071 -169.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.24 18.06 80.1 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 119.047 1.423 . . . . 0.0 109.475 177.863 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.867 0.365 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.92 174.02 13.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.214 1.405 . . . . 0.0 108.712 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.55 139.18 28.01 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.32 176.9 6.27 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.49 0.586 . . . . 0.0 110.407 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.23 141.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -145.09 149.1 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.246 0.93 . . . . 0.0 109.065 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.88 137.69 43.45 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.88 0.872 . . . . 0.0 109.017 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -119.83 130.54 54.95 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.62 141.75 51.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.544 0.737 . . . . 0.0 110.438 -169.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 95.4 m -140.63 169.98 16.63 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.015 0.926 . . . . 0.0 110.73 172.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 m -56.99 -25.25 58.12 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.36 1.464 . . . . 0.0 111.61 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.77 136.67 5.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.58 56.7 2.68 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.022 0.929 . . . . 0.0 110.51 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -120.43 -31.95 4.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -128.72 -87.59 0.54 Allowed 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.844 0.747 . . . . 0.0 110.248 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -58.92 -50.45 73.98 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 11.7 p -65.67 -36.36 83.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.346 0.521 . . . . 0.0 111.176 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -62.43 -55.24 29.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.559 1.144 . . . . 0.0 111.001 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -56.74 -44.74 81.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.757 0.823 . . . . 0.0 111.029 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.63 98.48 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.454 0.57 . . . . 0.0 111.635 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -56.51 -43.36 79.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.586 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.1 -49.54 77.39 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.713 0.688 . . . . 0.0 112.068 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.72 -45.32 93.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.952 0.876 . . . . 0.0 111.121 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.23 99.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.019 0.527 . . . . 0.0 110.522 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -54.22 -34.93 61.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.7 0.682 . . . . 0.0 111.81 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -71.33 -62.86 1.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.056 0.389 . . . . 0.0 110.554 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -67.54 -40.92 85.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -169.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.0 mt -75.88 -4.13 39.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.634 0.774 . . . . 0.0 112.472 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.84 56.34 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.637 1.113 . . . . 0.0 113.948 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.78 9.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.306 2.243 . . . . 0.0 114.098 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.3 -3.65 8.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.941 -1.1 . . . . 0.0 111.153 169.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -132.92 122.07 23.79 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -67.79 97.54 0.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 172.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.01 140.71 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.05 166.45 26.82 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.411 1.484 . . . . 0.0 109.348 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 90.0 p -143.99 157.43 44.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.766 0.827 . . . . 0.0 109.236 169.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.57 -167.45 1.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.79 -179.0 44.15 Favored Glycine 0 N--CA 1.447 -0.582 0 O-C-N 121.685 -0.634 . . . . 0.0 111.873 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.15 -31.06 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.031 1.332 . . . . 0.0 110.841 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.89 168.58 21.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.257 1.423 . . . . 0.0 108.75 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.0 138.14 25.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -130.02 12.15 5.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 109.641 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 162.49 29.95 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.54 152.77 35.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -77.58 133.05 67.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.63 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.96 -36.45 64.4 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.722 2.281 . . . . 0.0 114.207 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -71.94 -31.98 66.87 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.581 -0.699 . . . . 0.0 110.241 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.29 -44.53 94.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.78 -50.96 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -58.88 -40.78 85.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.642 0.656 . . . . 0.0 111.695 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.48 88.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.583 0.629 . . . . 0.0 109.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.8 mmm -66.51 -38.75 87.89 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.381 0.537 . . . . 0.0 110.857 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.6 -21.02 66.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.541 -1.349 . . . . 0.0 112.084 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.88 -30.44 68.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.927 0.785 . . . . 0.0 109.093 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.81 -33.87 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.9 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.147 0.879 . . . . 0.0 111.239 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.34 157.82 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.24 144.96 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -125.13 -0.52 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.958 1.303 . . . . 0.0 110.325 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -58.56 -30.99 67.56 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.212 -1.555 . . . . 0.0 111.432 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.61 -2.32 6.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 114.756 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.7 52.14 1.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.261 1.391 . . . . 0.0 110.085 -171.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -50.43 142.47 10.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 m -61.49 160.86 10.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.059 1.744 . . . . 0.0 114.915 -169.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -156.22 158.6 37.85 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.191 1.397 . . . . 0.0 109.712 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.49 166.69 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.214 1.006 . . . . 0.0 109.224 169.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.9 143.66 10.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.625 0.77 . . . . 0.0 108.977 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.78 140.71 42.72 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 109.855 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.57 -30.66 61.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.081 1.352 . . . . 0.0 113.166 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.78 -11.01 60.53 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.289 1.036 . . . . 0.0 112.094 -173.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.32 -43.86 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -56.97 -40.31 76.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.093 1.315 . . . . 0.0 112.289 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 4.69 51.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.886 0.875 . . . . 0.0 112.589 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -125.1 -26.99 3.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.815 1.246 . . . . 0.0 112.741 -168.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 131.79 52.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.738 1.215 . . . . 0.0 109.26 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.3 -25.09 65.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.356 0.662 . . . . 0.0 110.741 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 tp -147.91 140.29 24.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.866 1.267 . . . . 0.0 108.34 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.49 147.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.91 127.73 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.66 132.02 44.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.88 10.3 38.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.944 0.498 . . . . 0.0 110.236 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 10.5 p -63.79 126.7 28.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.308 1.043 . . . . 0.0 110.954 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.39 -3.78 0.14 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.007 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.76 153.74 38.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.51 1.655 . . . . 0.0 109.595 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.1 -20.31 62.48 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.971 1.308 . . . . 0.0 113.801 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.72 8.63 19.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.155 0.889 . . . . 0.0 112.489 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' CYS . 39.4 m-20 -67.94 110.48 3.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -60.23 -22.67 63.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.045 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.6 m 61.23 106.48 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.306 2.243 . . . . 0.0 111.201 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -51.92 139.61 50.34 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.996 2.464 . . . . 0.0 112.227 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.04 153.21 38.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.665 0.786 . . . . 0.0 109.488 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 p -133.71 159.14 73.65 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.164 1.785 . . . . 0.0 109.746 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.56 139.81 38.29 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.793 1.662 . . . . 0.0 109.62 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.23 -20.34 24.78 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.887 2.391 . . . . 0.0 112.046 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -67.67 -20.04 65.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.561 1.144 . . . . 0.0 112.258 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.75 143.39 18.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 118.677 0.671 . . . . 0.0 109.226 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -61.69 137.09 58.22 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.83 150.37 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.68 0.792 . . . . 0.0 109.582 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.03 163.13 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 108.274 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -132.58 112.73 12.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -120.97 58.22 0.96 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 106.862 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.06 132.48 17.01 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 121.065 -1.022 . . . . 0.0 113.089 -171.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.8 156.6 31.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.919 2.088 . . . . 0.0 106.388 169.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -60.21 148.19 37.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 110.836 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.39 128.54 82.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.501 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.26 -24.61 72.12 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.48 1.453 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.68 -17.4 64.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.173 0.897 . . . . 0.0 112.434 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -105.02 2.37 29.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.567 1.147 . . . . 0.0 111.266 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 45.66 0.33 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.507 1.523 . . . . 0.0 111.579 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.38 153.19 12.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.847 1.259 . . . . 0.0 112.228 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.61 -53.71 0.39 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -167.01 165.41 15.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.54 1.936 . . . . 0.0 107.044 169.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.54 -28.02 66.72 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.487 0.715 . . . . 0.0 111.242 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -69.91 -39.52 76.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.282 0.492 . . . . 0.0 110.694 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.13 -44.33 76.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -55.81 -52.58 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.199 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -58.2 -40.33 81.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.722 0.809 . . . . 0.0 111.675 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.93 83.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.833 -0.542 . . . . 0.0 111.015 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.2 -34.97 73.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.666 -0.646 . . . . 0.0 111.468 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -59.45 -54.41 46.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.968 0.804 . . . . 0.0 109.973 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.9 -29.51 69.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.623 0.647 . . . . 0.0 111.755 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.27 -54.83 31.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.533 1.06 . . . . 0.0 111.259 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.66 -38.25 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -52.82 -57.3 10.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.135 0.974 . . . . 0.0 109.935 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.92 -41.21 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.279 0.232 . . . . 0.0 111.234 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.96 -39.94 87.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mt -58.74 -51.09 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.36 71.08 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.563 0.602 . . . . 0.0 111.777 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.91 -51.38 69.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 117.587 0.694 . . . . 0.0 110.34 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -70.74 -29.35 65.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.954 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -41.44 90.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.638 1.108 . . . . 0.0 110.199 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -57.15 -52.5 65.06 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.57 -35.25 80.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.059 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.93 -37.32 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.13 -36.18 30.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.633 0.373 . . . . 0.0 111.501 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.71 -40.16 10.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.701 1.201 . . . . 0.0 111.896 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -116.53 -19.16 10.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.338 1.055 . . . . 0.0 111.522 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.78 13.22 81.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.362 0.982 . . . . 0.0 112.76 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.248 0.974 0 CA-C-N 118.625 1.213 . . . . 0.0 110.037 -175.771 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -151.52 173.72 14.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.146 1.378 . . . . 0.0 108.638 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -142.2 134.94 28.39 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -83.09 -175.33 5.78 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 110.269 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -146.42 144.9 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -149.18 152.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.175 0.898 . . . . 0.0 109.182 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 137.5 39.44 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.919 0.888 . . . . 0.0 109.151 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.58 125.09 45.92 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.81 1.244 . . . . 0.0 107.699 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.45 140.97 51.47 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.91 170.41 15.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.318 1.056 . . . . 0.0 112.042 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 p -76.08 35.23 0.13 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.707 2.003 . . . . 0.0 110.607 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.68 110.59 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.721 2.105 . . . . 0.0 108.601 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -75.67 56.33 0.91 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.574 1.15 . . . . 0.0 111.685 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.3 m -129.91 -18.02 3.46 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.2 m -137.1 -87.78 0.29 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.993 0.815 . . . . 0.0 109.187 -170.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -57.16 -53.88 53.04 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.799 0.84 . . . . 0.0 111.137 -170.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 12.2 p -67.2 -35.4 79.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.447 0.567 . . . . 0.0 111.536 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -60.53 -55.72 30.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.161 0.985 . . . . 0.0 110.345 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -57.66 -43.98 85.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.505 0.722 . . . . 0.0 111.253 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.02 96.22 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.569 0.622 . . . . 0.0 111.45 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -57.09 -40.55 77.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.565 0.346 . . . . 0.0 110.663 174.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.22 -50.39 67.63 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.738 0.685 . . . . 0.0 112.084 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.22 -45.07 95.01 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.504 0.652 . . . . 0.0 110.579 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.63 97.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.474 0.71 . . . . 0.0 110.474 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.68 -36.11 64.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.798 0.726 . . . . 0.0 111.45 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -70.72 -62.21 1.47 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.052 0.387 . . . . 0.0 110.789 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.11 -38.74 86.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -169.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 71.6 mt -75.65 0.88 16.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.082 0.953 . . . . 0.0 112.232 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.19 22.07 64.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.245 1.403 . . . . 0.0 113.567 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 55.47 13.73 1.0 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.758 2.023 . . . . 0.0 113.39 -169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.42 1.95 14.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.244 1.418 . . . . 0.0 111.284 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 14.8 m95 -129.49 128.89 43.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -67.44 89.35 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 143.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -146.96 163.08 37.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.918 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 79.9 p -141.17 156.07 45.99 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.619 0.768 . . . . 0.0 109.047 169.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.91 -169.3 2.48 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 110.281 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.41 -178.49 46.22 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.47 -27.62 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.765 1.226 . . . . 0.0 110.899 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -147.04 166.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.803 1.241 . . . . 0.0 108.124 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.75 134.08 21.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -134.96 24.48 3.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.308 1.043 . . . . 0.0 109.151 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.05 168.34 39.16 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.97 148.1 27.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.026 0.53 . . . . 0.0 110.53 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -74.37 133.67 77.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 118.117 -0.944 . . . . 0.0 109.129 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.94 -33.61 42.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.868 2.379 . . . . 0.0 114.589 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -72.46 -28.92 63.22 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.254 -0.903 . . . . 0.0 110.853 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.39 85.43 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.17 -49.37 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -43.47 90.31 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.113 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.19 93.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.06 0.846 . . . . 0.0 110.033 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -70.99 -38.21 72.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.717 0.235 . . . . 0.0 111.469 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -63.79 -24.99 67.98 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.794 -1.191 . . . . 0.0 111.393 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -69.55 -14.6 62.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.778 0.831 . . . . 0.0 110.866 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.4 -2.1 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.237 1.015 . . . . 0.0 112.091 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.89 32.36 10.05 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.81 161.07 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.94 146.12 51.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -127.14 -0.7 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.114 1.366 . . . . 0.0 110.447 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -57.95 -31.12 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.388 -1.445 . . . . 0.0 111.267 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -67.7 -4.28 11.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.006 1.723 . . . . 0.0 114.728 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -137.13 53.73 1.88 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.311 1.414 . . . . 0.0 109.678 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -50.16 144.2 7.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.274 1.03 . . . . 0.0 112.345 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 m -64.21 161.36 16.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 114.533 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -156.9 157.67 35.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.471 1.508 . . . . 0.0 109.7 170.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.18 165.35 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.756 0.822 . . . . 0.0 109.492 170.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.86 145.98 6.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.804 1.242 . . . . 0.0 110.128 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.4 134.61 32.66 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.661 1.184 . . . . 0.0 109.944 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.41 -28.42 53.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.396 1.478 . . . . 0.0 113.323 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.92 -11.42 60.86 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.782 1.233 . . . . 0.0 112.201 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.62 -41.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 mt -47.95 -59.08 3.62 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.703 1.138 . . . . 0.0 111.645 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -0.26 30.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.76 -30.74 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.061 1.344 . . . . 0.0 112.066 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.71 131.58 51.17 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 109.858 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.36 -26.06 67.85 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.778 0.431 . . . . 0.0 110.791 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 tp -148.49 142.04 25.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.522 1.129 . . . . 0.0 108.443 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.58 144.14 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.35 126.46 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 p -100.3 135.18 42.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.42 20.68 17.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.474 0.71 . . . . 0.0 109.54 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.1 p -68.1 112.93 5.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.928 1.291 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.55 27.06 0.31 Allowed Glycine 0 CA--C 1.533 1.157 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -111.06 -175.58 2.74 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.101 2.56 . . . . 0.0 112.525 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.0 65.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.43 -49.24 10.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.316 0.646 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 45.57 30.87 0.83 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.571 1.948 . . . . 0.0 114.67 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.28 -21.18 66.27 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.436 -1.415 . . . . 0.0 113.045 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 78.2 m 45.41 92.59 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.383 2.273 . . . . 0.0 113.549 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.14 148.38 9.96 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.9 3.066 . . . . 0.0 114.647 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -63.4 138.45 58.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.551 1.54 . . . . 0.0 110.333 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 p -131.6 154.46 81.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.146 1.779 . . . . 0.0 109.442 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.81 145.21 56.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.203 1.936 . . . . 0.0 110.053 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.87 -21.88 13.87 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.107 2.538 . . . . 0.0 112.073 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -85.8 7.7 22.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.497 1.119 . . . . 0.0 112.38 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.73 144.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.18 138.48 58.42 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -133.12 150.48 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.702 0.801 . . . . 0.0 109.767 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -125.44 159.34 32.14 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.557 1.943 . . . . 0.0 107.914 171.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -133.84 111.88 10.85 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.423 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 32.5 m0 -120.93 57.38 0.98 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.146 1.778 . . . . 0.0 106.741 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.55 132.61 29.78 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 120.915 -1.116 . . . . 0.0 111.998 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.09 160.18 35.41 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.62 1.968 . . . . 0.0 106.106 169.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.12 141.85 55.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.373 0.606 . . . . 0.0 110.785 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.36 127.28 93.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 -22.66 44.06 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.082 1.188 . . . . 0.0 113.329 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.21 -9.95 59.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.495 1.043 . . . . 0.0 112.228 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -111.39 0.69 16.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.051 1.34 . . . . 0.0 110.749 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.72 54.0 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.496 2.319 . . . . 0.0 111.174 170.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.59 144.97 46.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.659 1.983 . . . . 0.0 112.003 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.08 -54.97 0.28 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -165.66 167.0 17.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.939 1.696 . . . . 0.0 107.45 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.18 -29.98 70.13 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.104 0.562 . . . . 0.0 111.201 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.13 -37.43 75.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.878 0.471 . . . . 0.0 110.574 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.23 -46.58 73.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -56.56 -48.86 76.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.098 0.559 . . . . 0.0 110.359 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -61.23 -37.93 84.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.584 0.754 . . . . 0.0 112.001 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.61 80.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.242 -0.912 . . . . 0.0 109.909 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.97 -33.22 75.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.803 0.441 . . . . 0.0 111.153 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.88 -50.31 73.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.721 0.809 . . . . 0.0 110.155 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -64.77 -35.0 79.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.39 0.541 . . . . 0.0 111.584 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -66.29 -51.03 61.46 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.337 0.517 . . . . 0.0 110.662 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.36 -39.96 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -53.29 -54.06 41.92 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.321 1.049 . . . . 0.0 109.393 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.53 -44.4 90.97 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 123.206 0.316 . . . . 0.0 111.008 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.58 -39.79 88.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.647 -0.658 . . . . 0.0 111.216 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.08 -51.05 77.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.28 -45.42 64.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -60.69 -50.4 73.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 117.639 0.719 . . . . 0.0 111.105 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.423 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.4 tpt180 -70.18 -33.18 71.43 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.113 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -40.13 96.26 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.407 1.003 . . . . 0.0 109.976 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -57.77 -51.45 69.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.65 -35.74 82.01 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.267 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -63.67 -36.65 84.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.908 -0.495 . . . . 0.0 111.014 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.3 -37.96 27.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.568 0.347 . . . . 0.0 111.409 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.3 -46.83 8.14 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 110.857 -169.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 p -108.49 -17.21 14.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -169.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.36 11.5 80.36 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.238 0.923 . . . . 0.0 112.291 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.472 1.136 . . . . 0.0 108.482 -174.646 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -160.47 173.89 14.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.188 1.395 . . . . 0.0 108.892 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -144.43 145.87 32.16 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.65 168.86 18.48 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -144.29 139.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -144.71 150.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 109.084 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 137.14 37.93 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.002 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -119.51 130.97 55.46 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.02 137.56 51.4 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 111.028 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.5 174.32 10.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.245 1.018 . . . . 0.0 112.221 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -56.3 -27.51 55.79 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.991 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.4 142.01 8.27 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.6 58.45 2.73 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.752 0.821 . . . . 0.0 111.083 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -130.6 -18.63 3.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.3 m -133.01 -96.99 0.3 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.071 0.85 . . . . 0.0 108.901 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -54.28 -50.69 66.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.149 0.98 . . . . 0.0 111.952 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p -67.54 -38.57 84.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.738 0.699 . . . . 0.0 111.246 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -58.45 -54.81 42.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.072 0.949 . . . . 0.0 109.989 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.2 mtm -57.57 -44.83 85.6 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.43 0.692 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.27 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.165 0.586 . . . . 0.0 111.59 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.0 tt0 -57.39 -40.64 78.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.214 0.461 . . . . 0.0 110.88 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.09 -53.47 45.31 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -60.97 -44.4 97.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.956 0.378 . . . . 0.0 111.166 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.38 -43.82 97.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.81 -172.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -59.0 -34.67 72.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.404 1.002 . . . . 0.0 111.576 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -65.42 -54.89 22.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.199 0.454 . . . . 0.0 110.809 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -78.17 -45.43 23.19 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -170.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 94.9 mt -72.07 -32.92 67.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.352 0.661 . . . . 0.0 111.542 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.02 175.31 44.26 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.95 -1.93 8.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.176 0.99 . . . . 0.0 111.22 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -61.63 -10.18 7.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.863 0.865 . . . . 0.0 110.723 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 18.7 m95 -127.39 124.89 39.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.655 1.982 . . . . 0.0 105.906 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -75.57 88.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -77.89 140.04 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.09 167.29 23.07 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.215 1.406 . . . . 0.0 109.314 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -142.79 155.64 44.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.03 0.932 . . . . 0.0 109.2 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.55 1.73 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.432 1.093 . . . . 0.0 109.257 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.78 -178.52 44.72 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -56.75 -28.63 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.028 1.331 . . . . 0.0 111.017 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.52 171.02 16.2 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.435 1.494 . . . . 0.0 108.784 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.29 22.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -129.71 10.78 5.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.765 1.226 . . . . 0.0 109.919 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.0 27.8 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -84.51 148.55 26.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -72.18 136.86 81.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 124.246 1.018 . . . . 0.0 108.752 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.51 -29.09 84.22 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.82 1.68 . . . . 0.0 112.891 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.83 -26.05 61.34 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.097 -1.002 . . . . 0.0 111.013 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -44.07 84.68 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.303 0.956 . . . . 0.0 109.084 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.25 -50.23 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -58.3 -41.8 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.97 89.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.541 0.736 . . . . 0.0 110.346 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 76.9 mmm -74.25 -34.2 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.698 0.227 . . . . 0.0 111.111 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.37 -23.18 66.91 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.66 -1.275 . . . . 0.0 111.553 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.39 -17.84 64.84 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.127 0.971 . . . . 0.0 110.634 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.33 -2.45 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.011 0.924 . . . . 0.0 112.6 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.86 32.65 9.76 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.95 155.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -140.28 82.18 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.153 0.978 . . . . 0.0 109.856 -169.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.73 0.19 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.921 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -20.04 39.82 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 119.938 -1.726 . . . . 0.0 112.18 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -84.18 1.85 42.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.237 1.415 . . . . 0.0 112.659 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -133.86 49.92 2.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.488 1.04 . . . . 0.0 109.937 -172.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 p -46.98 134.09 10.66 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.909 1.284 . . . . 0.0 111.193 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -58.27 157.38 8.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.71 157.88 38.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.227 1.411 . . . . 0.0 109.398 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.35 168.59 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.573 1.149 . . . . 0.0 109.622 170.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.66 142.83 11.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.26 140.79 43.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.395 1.078 . . . . 0.0 109.723 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.73 -30.66 61.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.984 1.314 . . . . 0.0 113.135 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.69 -12.5 61.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.254 1.021 . . . . 0.0 111.884 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 mt -119.77 -43.22 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.61 -39.14 76.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.171 1.351 . . . . 0.0 112.193 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 6.49 48.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.864 0.866 . . . . 0.0 112.577 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -126.9 -29.39 2.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.717 1.207 . . . . 0.0 112.499 -168.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.64 125.48 23.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.88 1.272 . . . . 0.0 109.49 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.48 -26.53 67.23 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -141.61 137.25 31.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.957 1.303 . . . . 0.0 107.784 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.19 146.13 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.34 129.63 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -101.04 131.68 46.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.62 16.22 26.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.297 0.639 . . . . 0.0 109.99 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.5 p -69.24 109.39 4.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 111.022 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 31.36 0.58 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.7 -177.64 3.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.704 2.801 . . . . 0.0 113.414 -169.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.04 -11.61 30.93 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.64 -37.92 2.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.638 1.108 . . . . 0.0 111.447 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.261 2.3 p-10 36.76 47.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.385 2.674 . . . . 0.0 114.789 170.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.57 -13.71 62.3 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.121 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.9 m 44.63 88.56 0.1 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.896 2.479 . . . . 0.0 113.687 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -47.9 148.41 6.48 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.611 3.541 . . . . 0.0 115.01 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -62.26 139.17 58.51 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.626 1.57 . . . . 0.0 110.248 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -129.55 153.27 80.66 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 126.382 1.873 . . . . 0.0 108.677 171.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.95 162.86 39.94 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.408 1.405 . . . . 0.0 109.821 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.62 -22.76 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.523 2.149 . . . . 0.0 112.724 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -87.01 -21.43 26.13 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.61 154.46 5.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 119.439 1.018 . . . . 0.0 109.649 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -71.07 140.44 50.69 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -123.83 154.53 39.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.3 164.56 28.28 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.784 1.634 . . . . 0.0 107.568 169.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -131.68 113.78 13.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -120.74 53.64 1.11 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.667 1.587 . . . . 0.0 106.771 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 128.1 29.42 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 111.823 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.7 161.43 40.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.77 142.01 49.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.0 124.46 88.84 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.84 -22.29 56.6 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.193 1.262 . . . . 0.0 113.163 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.81 60.33 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.388 0.995 . . . . 0.0 112.5 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -115.22 12.38 16.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.85 1.26 . . . . 0.0 111.537 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.34 66.34 0.93 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.12 1.368 . . . . 0.0 109.694 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -57.1 138.01 55.04 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.063 0.945 . . . . 0.0 110.766 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.08 -61.44 0.2 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -166.67 168.87 14.05 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.764 1.625 . . . . 0.0 107.433 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -30.21 70.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.018 0.527 . . . . 0.0 111.416 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.39 -37.78 74.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.797 0.439 . . . . 0.0 110.651 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 -45.89 77.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -59.0 -45.86 89.61 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.01 0.524 . . . . 0.0 110.601 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -60.84 -39.48 89.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.868 0.758 . . . . 0.0 111.628 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.03 85.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -65.98 -34.76 78.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.795 0.438 . . . . 0.0 111.192 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -58.41 -46.84 85.64 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.015 0.926 . . . . 0.0 110.2 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -65.73 -36.25 83.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.4 0.546 . . . . 0.0 111.284 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -68.14 -45.09 74.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.231 . . . . 0.0 111.453 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.52 -42.87 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.971 0.805 . . . . 0.0 109.449 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -39.46 94.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.021 1.282 . . . . 0.0 110.13 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.47 -42.39 78.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.405 0.282 . . . . 0.0 111.611 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.81 -41.12 83.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.04 -0.413 . . . . 0.0 110.745 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.77 -52.75 56.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.77 55.36 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.577 0.626 . . . . 0.0 111.757 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -61.16 -49.69 76.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.561 0.681 . . . . 0.0 110.966 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -69.8 -30.92 68.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.784 -0.573 . . . . 0.0 110.438 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -41.9 82.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.343 0.974 . . . . 0.0 109.855 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.95 -52.27 65.87 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -69.33 -31.28 69.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.455 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -63.01 -37.9 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.4 1.0 . . . . 0.0 111.016 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.28 51.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.788 0.435 . . . . 0.0 111.084 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.38 -40.84 11.83 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.788 0.835 . . . . 0.0 111.736 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.2 p -117.61 -19.06 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.965 0.906 . . . . 0.0 111.929 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.82 10.02 83.69 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.841 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 119.058 1.429 . . . . 0.0 108.889 -175.088 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 118.946 -0.549 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -152.79 157.65 41.1 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.1 137.08 27.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.34 175.66 6.7 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.5 144.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.91 151.59 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.511 1.05 . . . . 0.0 109.024 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -138.15 129.51 27.63 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 123.568 0.747 . . . . 0.0 109.466 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.15 130.63 55.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.495 1.118 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -131.91 136.58 47.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.491 0.716 . . . . 0.0 111.023 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -146.51 -175.39 4.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.948 0.34 . . . . 0.0 111.155 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -62.76 -19.11 63.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.194 0.998 . . . . 0.0 112.462 -170.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.93 143.01 9.16 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.48 51.19 1.21 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.312 1.056 . . . . 0.0 111.843 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -128.2 -9.98 5.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -168.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.4 p -140.23 -101.98 0.15 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.79 0.723 . . . . 0.0 110.207 -169.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -51.43 -47.63 62.95 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.821 1.648 . . . . 0.0 110.689 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.7 p -66.95 -43.07 84.11 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.133 0.271 . . . . 0.0 110.674 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.641 1.176 . . . . 0.0 110.814 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.5 mtm -61.42 -42.53 98.89 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 110.65 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.34 -44.73 94.06 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 118.646 -0.693 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.54 -44.73 73.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.454 0.57 . . . . 0.0 110.506 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.83 -51.85 55.64 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 119.339 -0.701 . . . . 0.0 111.526 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -62.95 -46.0 89.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.447 0.623 . . . . 0.0 111.023 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.49 94.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.564 0.745 . . . . 0.0 110.657 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -57.23 -35.42 69.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.937 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -68.81 -61.88 1.62 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.169 0.441 . . . . 0.0 110.723 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -64.53 -41.02 96.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.409 0.283 . . . . 0.0 111.426 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.14 -1.82 37.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.286 1.035 . . . . 0.0 112.123 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.6 24.5 53.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.149 1.357 . . . . 0.0 113.998 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 55.8 9.44 0.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.412 2.285 . . . . 0.0 113.972 -170.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -66.05 -5.99 11.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 110.515 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -130.41 115.6 17.09 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -68.7 88.55 0.36 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.171 1.388 . . . . 0.0 107.466 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.04 154.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -150.62 164.69 35.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.705 2.002 . . . . 0.0 107.438 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.9 p -141.21 154.29 45.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 169.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.48 -169.45 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 110.365 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.76 -179.5 42.79 Favored Glycine 0 N--CA 1.447 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.9 -27.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.33 1.452 . . . . 0.0 111.416 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -145.72 170.85 15.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 108.43 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.94 136.36 16.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.12 19.1 2.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.611 1.164 . . . . 0.0 110.093 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.54 -176.8 20.35 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -110.42 144.23 39.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.049 0.94 . . . . 0.0 109.797 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -70.51 134.5 86.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.024 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.2 -33.55 44.92 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.06 2.507 . . . . 0.0 114.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -78.09 -28.55 48.75 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 119.151 0.887 . . . . 0.0 110.504 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.66 75.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.39 -52.13 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.98 -38.77 87.15 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.908 0.776 . . . . 0.0 111.397 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.7 87.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.918 0.487 . . . . 0.0 109.825 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.22 -36.57 79.72 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.209 0.459 . . . . 0.0 111.028 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -63.57 -26.37 68.67 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 120.673 -1.267 . . . . 0.0 111.188 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.55 -16.57 63.45 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.69 0.677 . . . . 0.0 111.095 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.16 -1.07 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.715 0.806 . . . . 0.0 112.07 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.46 31.75 11.2 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -123.34 154.92 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -142.64 76.04 1.51 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.596 1.189 . . . . 0.0 110.371 -169.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.4 pt -58.65 -15.12 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.28 1.032 . . . . 0.0 113.339 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.74 -24.84 24.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.62 1.1 . . . . 0.0 111.967 172.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.37 -21.03 33.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.79 -21.86 9.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.875 1.216 . . . . 0.0 114.005 -169.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.0 p 49.01 -164.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.359 1.064 . . . . 0.0 111.553 -169.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 m -129.69 156.19 44.66 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.138 -0.976 . . . . 0.0 111.579 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -155.91 156.11 34.03 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.788 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.87 164.54 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 171.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 147.38 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.084 1.354 . . . . 0.0 110.198 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.39 136.76 33.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.441 1.097 . . . . 0.0 110.051 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -53.86 -29.67 42.29 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.553 1.541 . . . . 0.0 113.074 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.78 -8.74 50.71 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.192 1.397 . . . . 0.0 112.257 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.4 mt -117.29 -42.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.5 mt -47.53 -56.9 6.14 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.693 1.133 . . . . 0.0 112.195 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.87 0.88 51.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.649 0.78 . . . . 0.0 112.813 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -117.89 -31.22 5.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.06 1.344 . . . . 0.0 111.745 -169.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.81 131.31 49.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.206 1.402 . . . . 0.0 109.02 173.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 26.4 t70 -60.43 -32.15 71.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.668 0.387 . . . . 0.0 109.969 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.34 139.58 28.59 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.323 1.049 . . . . 0.0 109.141 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.61 146.05 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.36 121.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -98.58 135.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.85 18.67 19.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.269 1.027 . . . . 0.0 109.844 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.2 p -70.33 117.23 11.62 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.798 1.239 . . . . 0.0 110.006 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 19.68 0.19 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.861 1.219 . . . . 0.0 111.047 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -88.83 -176.47 5.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.718 3.207 . . . . 0.0 110.672 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.77 -23.14 59.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.1 -41.75 13.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.217 0.917 . . . . 0.0 109.741 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.99 40.51 13.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.009 2.124 . . . . 0.0 113.406 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -68.69 -12.38 61.34 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.806 -1.092 . . . . 0.0 113.21 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.8 m 35.96 88.51 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.202 2.601 . . . . 0.0 113.821 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.96 140.39 13.43 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.959 3.106 . . . . 0.0 113.877 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 138.45 58.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 110.235 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.0 p -125.96 153.37 73.73 Favored Pre-proline 0 N--CA 1.448 -0.533 0 C-N-CA 126.206 1.802 . . . . 0.0 108.768 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.67 153.59 77.44 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.776 1.651 . . . . 0.0 109.301 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.8 -23.51 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.407 2.071 . . . . 0.0 111.937 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -76.81 -25.96 53.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.737 0.815 . . . . 0.0 112.65 -172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.27 144.39 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.855 0.752 . . . . 0.0 109.437 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 76' ' ' ASP . 38.3 ttpt -65.31 136.24 56.32 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -135.94 151.31 49.82 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.145 0.578 . . . . 0.0 110.455 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -126.55 159.42 33.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.028 2.131 . . . . 0.0 107.809 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -135.98 111.32 9.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -121.47 62.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.199 1.8 . . . . 0.0 106.661 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.99 134.06 21.31 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.252 -0.905 . . . . 0.0 112.224 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.21 161.05 39.26 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.966 2.107 . . . . 0.0 106.168 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.89 148.53 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.759 0.79 . . . . 0.0 110.667 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -71.76 120.88 82.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.811 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.13 -27.22 73.06 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.328 1.352 . . . . 0.0 112.868 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -6.4 41.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.742 0.701 . . . . 0.0 112.589 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -119.35 0.44 11.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.885 1.674 . . . . 0.0 109.846 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.21 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.279 1.432 . . . . 0.0 109.957 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -57.19 124.93 20.51 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.301 1.04 . . . . 0.0 109.6 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.46 -74.93 0.12 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -167.36 168.89 12.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.602 1.561 . . . . 0.0 107.52 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.59 -30.47 69.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.881 -0.512 . . . . 0.0 111.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.27 -38.63 78.47 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.647 0.379 . . . . 0.0 110.453 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -70.96 -38.52 72.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.683 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -59.51 -47.73 84.4 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 119.34 0.973 . . . . 0.0 110.45 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -58.64 -39.72 81.38 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.254 0.622 . . . . 0.0 111.189 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.64 78.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.639 -0.663 . . . . 0.0 111.03 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.76 -35.15 79.91 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.78 -52.93 63.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.701 0.8 . . . . 0.0 110.722 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.51 -30.61 70.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.728 0.695 . . . . 0.0 112.02 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -63.41 -53.92 44.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.431 1.014 . . . . 0.0 110.346 171.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.88 -37.59 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.528 0.603 . . . . 0.0 109.501 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -55.17 -54.15 46.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 123.786 0.834 . . . . 0.0 109.423 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.25 -43.05 99.1 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 123.256 0.347 . . . . 0.0 110.806 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.27 -40.45 90.11 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.766 -0.584 . . . . 0.0 111.314 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.54 -50.93 78.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.23 -46.23 57.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.02 -50.08 75.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 111.003 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -69.83 -30.29 67.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.496 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -39.7 81.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.588 1.085 . . . . 0.0 110.178 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -56.36 -50.08 72.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.31 -37.79 88.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 111.496 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -61.37 -35.71 78.21 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.11 -0.994 . . . . 0.0 111.753 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.11 -35.99 28.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.702 0.401 . . . . 0.0 111.358 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.72 -41.9 10.44 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.014 1.326 . . . . 0.0 111.682 -169.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -115.15 -20.33 10.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.621 1.168 . . . . 0.0 111.579 -169.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.83 81.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.395 0.998 . . . . 0.0 112.768 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.407 1.103 . . . . 0.0 109.573 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -149.9 154.02 37.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.396 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -145.1 134.37 22.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -82.79 -176.63 6.39 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 122.683 0.393 . . . . 0.0 110.019 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.19 143.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.85 151.07 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.934 0.894 . . . . 0.0 109.087 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.91 138.02 38.61 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.877 0.871 . . . . 0.0 108.974 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.6 127.58 53.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -123.38 143.81 49.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.857 1.263 . . . . 0.0 109.976 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.1 m -142.12 176.53 8.89 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.374 1.07 . . . . 0.0 112.11 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -65.26 -18.24 65.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.623 1.169 . . . . 0.0 111.891 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.1 136.08 4.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -80.54 55.85 2.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.08 0.952 . . . . 0.0 111.684 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 m -125.74 -18.43 5.17 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.7 m -137.85 -88.39 0.26 Allowed 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 119.152 0.887 . . . . 0.0 109.563 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -56.62 -53.93 51.91 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.711 0.805 . . . . 0.0 111.18 -169.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -67.23 -35.45 79.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.083 0.401 . . . . 0.0 111.248 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.03 -54.7 41.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.177 0.991 . . . . 0.0 110.103 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.0 mtm -57.81 -41.88 83.11 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.465 0.706 . . . . 0.0 111.366 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.01 95.21 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.444 0.565 . . . . 0.0 111.735 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.7 tt0 -55.37 -41.37 72.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.639 0.375 . . . . 0.0 110.784 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -49.89 73.62 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.337 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -62.64 -43.79 97.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.737 0.769 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.62 -42.68 99.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.521 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -51.79 -38.54 56.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 174.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -69.52 -62.2 1.48 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.206 0.316 . . . . 0.0 110.419 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -68.9 -40.32 79.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.99 -6.47 54.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.23 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.06 24.36 58.34 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.822 1.201 . . . . 0.0 114.157 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.8 t70 57.87 9.93 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.307 2.243 . . . . 0.0 113.953 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -66.26 -5.67 11.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.021 1.328 . . . . 0.0 110.737 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -128.99 124.53 35.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 173.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.2 mmpt? -66.33 100.94 0.68 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 t -85.4 139.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -146.39 165.83 28.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.194 1.398 . . . . 0.0 109.294 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.8 p -144.02 157.44 44.33 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.593 0.757 . . . . 0.0 110.064 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.68 -167.31 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.93 -174.45 45.82 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.93 -30.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.998 1.319 . . . . 0.0 111.009 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 168.86 21.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 108.569 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.54 138.68 26.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.73 11.21 5.66 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.64 1.176 . . . . 0.0 110.056 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.4 163.84 33.17 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.74 148.55 30.05 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.371 0.605 . . . . 0.0 110.824 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.16 136.24 79.28 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.003 0.921 . . . . 0.0 109.761 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.99 -36.03 63.2 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.705 2.27 . . . . 0.0 113.893 174.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -72.44 -30.3 64.48 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.621 -0.675 . . . . 0.0 110.547 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.55 90.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -59.05 -49.04 84.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -38.98 81.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.274 0.943 . . . . 0.0 111.009 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.92 -46.48 84.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.369 0.668 . . . . 0.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.6 mmm -68.5 -36.53 79.03 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 118.372 0.533 . . . . 0.0 111.021 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -65.81 -25.14 67.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.905 -1.122 . . . . 0.0 111.18 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -68.83 -17.37 63.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.265 0.626 . . . . 0.0 110.969 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.92 0.33 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.646 0.778 . . . . 0.0 111.921 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.98 32.28 18.14 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 174.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.4 159.74 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -124.66 144.42 50.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -128.6 3.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.856 1.262 . . . . 0.0 110.226 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.04 -28.76 68.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.129 -1.607 . . . . 0.0 111.119 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -64.63 -4.61 4.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.586 1.955 . . . . 0.0 115.17 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -137.92 49.7 1.95 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.294 1.406 . . . . 0.0 110.815 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -46.05 131.85 9.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.271 1.029 . . . . 0.0 110.723 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -55.71 155.88 5.41 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.185 1.794 . . . . 0.0 115.698 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -153.92 158.04 40.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.319 1.448 . . . . 0.0 109.211 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 168.7 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 169.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.7 mt -56.39 142.86 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.627 0.771 . . . . 0.0 109.141 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.23 135.71 47.6 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.091 1.356 . . . . 0.0 109.454 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -56.39 -31.27 63.7 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.022 1.329 . . . . 0.0 113.267 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -81.36 -5.15 57.55 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.853 -0.529 . . . . 0.0 111.749 -170.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.5 mt -111.39 -44.0 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.77 -39.88 86.37 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.846 1.203 . . . . 0.0 111.523 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.52 3.14 41.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -126.62 -27.0 3.17 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.999 0.92 . . . . 0.0 112.997 -168.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.91 20.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.513 1.125 . . . . 0.0 109.757 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.68 -28.43 69.9 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.907 0.483 . . . . 0.0 110.775 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.22 140.35 33.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.75 144.04 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 124.28 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.94 127.4 48.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.54 22.89 12.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.667 0.746 . . . . 0.0 109.343 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.94 107.26 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.468 1.507 . . . . 0.0 110.482 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.82 20.25 0.68 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.066 1.317 . . . . 0.0 109.992 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -86.05 175.32 8.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 129.52 3.128 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.84 65.35 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.82 -50.2 8.33 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.181 0.901 . . . . 0.0 109.258 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.73 34.33 1.15 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.808 2.043 . . . . 0.0 113.377 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -62.73 -27.34 69.2 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.702 -1.248 . . . . 0.0 111.392 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.7 t 41.53 110.65 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 131.279 3.832 . . . . 0.0 115.725 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.58 143.79 93.94 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.531 2.154 . . . . 0.0 111.781 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.7 mtm -72.94 157.6 37.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.379 0.672 . . . . 0.0 109.494 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -129.98 162.31 54.5 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.893 2.077 . . . . 0.0 108.363 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.32 161.46 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.047 1.165 . . . . 0.0 109.503 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.13 -23.38 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.453 2.102 . . . . 0.0 111.985 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -75.48 -31.01 60.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.54 0.736 . . . . 0.0 112.63 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -81.21 152.04 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.753 0.787 . . . . 0.0 110.757 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.36 143.52 50.18 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -135.98 149.4 48.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.746 0.418 . . . . 0.0 110.541 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.69 157.82 38.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.816 2.047 . . . . 0.0 107.728 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -133.98 112.75 11.49 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -122.17 56.45 1.1 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.121 1.769 . . . . 0.0 107.216 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.09 125.2 21.33 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.707 -1.245 . . . . 0.0 111.93 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.89 162.21 41.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.697 1.999 . . . . 0.0 106.447 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -68.75 147.42 51.82 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.36 0.6 . . . . 0.0 111.17 -172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.91 126.37 91.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.524 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.17 -24.57 65.82 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.661 1.574 . . . . 0.0 113.663 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.83 -15.12 63.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.42 1.009 . . . . 0.0 112.34 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -108.61 2.45 22.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.432 1.093 . . . . 0.0 111.482 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 53.05 0.29 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.717 2.007 . . . . 0.0 111.508 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 147.84 37.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.828 2.051 . . . . 0.0 112.082 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.9 -53.29 0.36 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.94 165.79 17.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 107.386 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.06 -29.37 68.5 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.351 0.66 . . . . 0.0 111.132 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.13 -41.44 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.41 0.684 . . . . 0.0 110.206 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.49 -46.77 71.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.912 0.885 . . . . 0.0 108.849 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.53 -52.17 64.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 122.872 0.469 . . . . 0.0 110.185 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -58.45 -39.71 80.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.578 0.751 . . . . 0.0 111.609 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.0 93.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.542 -0.724 . . . . 0.0 110.428 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.39 -34.48 78.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.875 0.47 . . . . 0.0 111.64 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -58.82 -48.51 81.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.908 0.776 . . . . 0.0 109.929 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -64.16 -38.25 90.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.612 0.642 . . . . 0.0 111.254 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.7 mmm-85 -61.97 -51.65 67.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.983 0.811 . . . . 0.0 111.156 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.86 -39.34 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -53.81 -55.29 27.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.066 0.946 . . . . 0.0 109.467 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.51 -42.39 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.146 0.279 . . . . 0.0 110.858 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.5 -39.01 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.078 0.551 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.15 -50.65 79.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.38 73.47 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.68 0.657 . . . . 0.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -60.17 -51.98 67.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.599 0.7 . . . . 0.0 110.992 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -69.2 -29.08 66.98 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.87 -1.062 . . . . 0.0 111.405 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -42.02 87.89 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.798 1.181 . . . . 0.0 109.868 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.43 -51.54 69.0 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.61 -34.46 77.93 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.521 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.18 -38.71 90.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.591 0.632 . . . . 0.0 111.001 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.36 36.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.391 0.276 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -90.43 -48.15 7.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.609 1.163 . . . . 0.0 110.908 -169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.8 p -106.69 -18.91 13.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.209 1.004 . . . . 0.0 111.273 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.26 15.81 75.73 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.82 -0.989 . . . . 0.0 112.503 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-N 118.717 1.258 . . . . 0.0 108.644 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.66 171.77 17.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.201 1.4 . . . . 0.0 108.652 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -145.52 140.41 27.47 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 174.52 8.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.63 142.44 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.01 148.63 21.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.903 0.774 . . . . 0.0 109.007 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.33 132.99 36.38 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -115.78 133.11 56.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.78 141.43 51.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.69 0.796 . . . . 0.0 110.009 -169.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.54 169.29 17.88 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 122.103 0.954 . . . . 0.0 112.131 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -76.03 35.81 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.23 2.212 . . . . 0.0 110.857 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.45 112.51 0.86 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.49 54.45 0.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.656 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -128.46 -18.68 3.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.4 m -136.32 -89.61 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.176 0.898 . . . . 0.0 109.688 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -55.24 -52.46 63.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.197 0.999 . . . . 0.0 111.028 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 p -58.03 -47.57 82.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.531 1.133 . . . . 0.0 110.874 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.45 -56.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.89 1.276 . . . . 0.0 110.16 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.1 mtm -57.33 -45.52 84.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.732 . . . . 0.0 111.228 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.03 97.6 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.671 0.669 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' HG12 ' A' ' 34' ' ' VAL . 23.9 tt0 -60.99 -34.57 75.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.832 0.453 . . . . 0.0 110.98 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.72 43.26 Favored Glycine 0 C--N 1.341 0.858 0 C-N-CA 123.706 0.669 . . . . 0.0 111.655 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.67 -43.27 94.04 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 117.533 0.666 . . . . 0.0 110.592 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.73 -43.59 98.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.771 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -53.86 -37.62 63.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.907 1.231 . . . . 0.0 111.954 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -66.76 -57.28 7.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.008 0.367 . . . . 0.0 110.411 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.94 -42.1 61.05 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.094 0.158 . . . . 0.0 111.381 -171.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 -11.43 59.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 112.257 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 26.85 60.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.377 0.989 . . . . 0.0 114.168 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 60.89 6.03 1.11 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.626 2.37 . . . . 0.0 114.134 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.82 -9.68 22.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.56 100.33 0.86 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.456 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.1 t -83.12 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -143.27 166.61 24.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.584 1.553 . . . . 0.0 109.421 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -149.74 161.28 42.54 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.614 -0.679 . . . . 0.0 110.133 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.53 -166.64 1.39 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.998 1.319 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.58 -179.97 44.58 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 111.715 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mt -53.52 -29.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.352 1.461 . . . . 0.0 111.356 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.49 167.14 24.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.602 1.161 . . . . 0.0 108.307 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.49 21.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -135.37 24.96 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.38 1.072 . . . . 0.0 109.255 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.84 167.68 39.18 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -84.78 147.54 26.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.959 0.504 . . . . 0.0 110.508 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -73.7 133.75 79.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.089 -0.957 . . . . 0.0 109.303 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.02 -33.8 44.1 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.897 2.398 . . . . 0.0 114.584 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.68 -29.23 63.24 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 121.35 -0.844 . . . . 0.0 110.87 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.37 85.06 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.22 -49.21 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -44.21 91.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.18 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.07 92.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.927 0.785 . . . . 0.0 110.152 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.1 mmm -71.81 -37.4 70.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.81 0.277 . . . . 0.0 111.525 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -27.36 69.06 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.87 -1.144 . . . . 0.0 111.31 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.98 -13.07 62.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.715 0.806 . . . . 0.0 110.852 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.3 -2.42 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.528 1.131 . . . . 0.0 112.228 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.97 33.41 9.73 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.16 160.87 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -128.33 145.15 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.32 -1.04 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.367 1.467 . . . . 0.0 110.284 173.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -57.8 -29.9 65.26 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.602 -1.311 . . . . 0.0 110.97 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -60.79 -16.2 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.697 1.999 . . . . 0.0 114.537 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' A' ' 21' ' ' GLU . 8.4 pt20 -131.1 54.92 1.88 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.713 1.142 . . . . 0.0 110.452 -169.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 p -49.78 140.94 10.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.93 0.892 . . . . 0.0 111.85 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 m -62.36 160.4 13.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.041 1.736 . . . . 0.0 114.517 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -155.98 156.46 34.53 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.963 1.305 . . . . 0.0 109.689 169.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.12 164.32 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.857 0.863 . . . . 0.0 109.331 170.142 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.43 146.92 5.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 110.308 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.54 136.01 32.44 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.392 1.077 . . . . 0.0 109.938 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.53 -28.65 46.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.454 1.502 . . . . 0.0 113.138 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.4 -10.83 59.69 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.966 1.306 . . . . 0.0 112.21 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.1 -42.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 mt -48.66 -58.41 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -1.31 36.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -116.38 -31.5 5.58 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.126 1.37 . . . . 0.0 111.7 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.03 44.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.153 1.381 . . . . 0.0 109.543 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.9 -26.22 67.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.443 0.697 . . . . 0.0 110.656 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -148.03 140.43 24.39 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.641 1.177 . . . . 0.0 108.803 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.69 148.13 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.53 130.76 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.29 132.09 45.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 170.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -102.96 23.21 12.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.904 0.882 . . . . 0.0 109.164 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.55 107.66 4.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.979 1.712 . . . . 0.0 110.45 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.97 26.69 0.44 Allowed Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -109.29 -177.45 3.3 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.429 2.291 . . . . 0.0 113.169 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.42 69.13 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.75 -52.12 7.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.533 0.606 . . . . 0.0 110.117 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.4 t70 45.31 32.91 1.09 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.482 1.913 . . . . 0.0 113.994 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -63.93 -21.65 66.57 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.562 -1.336 . . . . 0.0 112.1 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 44.18 96.7 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 129.568 3.147 . . . . 0.0 114.661 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.09 139.77 25.96 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.91 3.073 . . . . 0.0 114.275 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.8 ttm -75.19 149.24 39.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.895 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -132.65 161.23 64.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.744 2.017 . . . . 0.0 110.05 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.98 133.31 24.86 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.029 1.819 . . . . 0.0 109.278 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.03 -19.3 30.28 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.817 2.345 . . . . 0.0 112.318 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -68.15 -20.18 64.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 111.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.73 142.23 16.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -61.39 136.23 57.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -129.97 158.83 38.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.974 0.91 . . . . 0.0 109.298 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -137.92 166.47 23.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.988 1.715 . . . . 0.0 107.914 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -132.87 117.5 17.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -125.43 52.89 1.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.153 1.781 . . . . 0.0 107.314 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.12 132.17 33.45 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.73 -1.231 . . . . 0.0 112.367 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.23 159.65 36.28 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.501 1.92 . . . . 0.0 106.132 169.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -68.71 142.17 55.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.845 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.05 126.95 93.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.112 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.16 -23.53 45.54 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.115 1.21 . . . . 0.0 113.297 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.69 -9.13 58.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.399 1.0 . . . . 0.0 112.225 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -113.0 4.38 16.69 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.236 1.414 . . . . 0.0 110.667 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.38 63.28 0.37 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.725 2.01 . . . . 0.0 110.442 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -59.44 138.97 57.49 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.669 1.588 . . . . 0.0 110.718 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.1 -59.73 0.2 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -166.17 169.27 14.53 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.054 1.742 . . . . 0.0 107.398 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.98 -29.61 68.56 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.369 0.668 . . . . 0.0 111.416 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.79 -37.8 73.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.788 0.435 . . . . 0.0 110.654 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.6 -43.85 75.58 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -57.4 -48.42 79.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.778 0.431 . . . . 0.0 110.141 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -60.99 -38.06 84.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.4 0.68 . . . . 0.0 111.925 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.44 81.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.46 -33.42 75.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.018 0.527 . . . . 0.0 111.13 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.25 -50.04 74.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.957 0.903 . . . . 0.0 110.278 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -64.88 -34.36 78.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.347 0.522 . . . . 0.0 111.656 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.51 -49.72 62.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.623 0.647 . . . . 0.0 110.821 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.93 -39.86 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -53.72 -54.14 42.22 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.458 1.103 . . . . 0.0 109.601 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.87 -43.23 93.64 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.056 0.222 . . . . 0.0 110.911 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.65 -41.08 88.79 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.999 -0.438 . . . . 0.0 110.77 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.7 mt -59.59 -50.33 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.72 -46.67 66.61 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.763 0.71 . . . . 0.0 111.476 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -62.19 -46.36 89.26 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.404 0.602 . . . . 0.0 110.78 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -72.25 -30.58 65.0 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 -174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -42.19 82.44 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.734 0.814 . . . . 0.0 109.62 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.17 -48.78 75.67 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -37.64 86.24 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.451 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -60.32 -37.29 80.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.643 -0.661 . . . . 0.0 111.496 175.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.87 33.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.518 0.327 . . . . 0.0 111.661 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.96 -45.69 7.83 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.465 1.106 . . . . 0.0 111.128 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.5 p -106.88 -19.49 13.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.055 . . . . 0.0 110.902 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.93 79.1 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.215 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.6 mttt . . . . . 0 C--O 1.248 1.003 0 CA-C-N 118.562 1.181 . . . . 0.0 108.703 176.913 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 tpp . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.89 10.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.289 0.95 . . . . 0.0 111.83 -172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.63 129.98 41.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 169.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 173.95 3.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.3 142.24 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.54 146.06 22.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 119.043 0.838 . . . . 0.0 108.824 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.55 124.02 22.13 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -107.6 128.39 54.49 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.62 145.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.158 0.583 . . . . 0.0 110.935 -169.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.7 m -141.42 178.83 7.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.755 1.622 . . . . 0.0 109.374 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -75.85 -19.15 59.11 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.654 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.34 131.65 4.15 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.31 54.33 2.27 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.769 0.828 . . . . 0.0 111.748 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -126.1 -16.88 5.42 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -131.84 -106.33 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -170.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -35.44 75.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -60.71 -47.77 84.8 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.18 0.9 . . . . 0.0 110.377 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -60.01 -49.71 76.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.237 1.015 . . . . 0.0 110.221 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.39 -44.74 89.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.16 0.584 . . . . 0.0 111.841 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.79 99.61 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.234 0.614 . . . . 0.0 111.015 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG12 ' A' ' 34' ' ' VAL . 61.0 tt0 -56.13 -41.2 74.94 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.112 173.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.07 60.97 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.782 0.719 . . . . 0.0 112.309 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.54 -45.78 92.6 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.34 0.57 . . . . 0.0 110.812 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.33 -42.57 99.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.846 -175.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -52.77 -44.35 66.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.395 0.998 . . . . 0.0 111.568 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -74.8 -43.88 52.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.164 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -73.72 -44.58 55.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.494 0.588 . . . . 0.0 110.921 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.01 -9.64 59.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.161 0.984 . . . . 0.0 112.253 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.41 26.48 64.29 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.534 1.064 . . . . 0.0 113.956 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 60.72 5.82 1.01 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.625 2.37 . . . . 0.0 113.986 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.79 -9.32 19.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.641 1.176 . . . . 0.0 110.544 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.52 118.53 23.21 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 172.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -67.87 101.43 1.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -85.1 137.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.19 166.19 25.74 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.62 1.568 . . . . 0.0 109.529 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -147.88 157.06 43.34 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.482 0.713 . . . . 0.0 110.007 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.16 -168.03 1.62 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.546 1.139 . . . . 0.0 110.357 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.54 -175.45 42.09 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.442 -0.787 . . . . 0.0 112.598 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -55.09 -30.28 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.531 1.532 . . . . 0.0 110.681 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 169.6 17.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.776 1.23 . . . . 0.0 109.142 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.53 137.05 20.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -136.49 19.45 3.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.205 1.002 . . . . 0.0 109.777 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.71 29.09 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -94.42 146.95 23.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.342 0.657 . . . . 0.0 110.583 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.33 138.77 78.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.826 1.25 . . . . 0.0 109.455 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.15 -30.34 82.04 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.849 1.699 . . . . 0.0 113.255 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.92 -27.21 62.66 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.626 1.103 . . . . 0.0 110.483 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.31 -48.4 73.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.54 1.063 . . . . 0.0 108.941 171.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.68 -48.13 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -57.92 -47.08 83.88 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.933 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -43.68 81.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 0.0 109.389 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.8 mmm -71.25 -39.64 71.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.276 0.231 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.88 -27.09 69.11 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 120.888 -1.133 . . . . 0.0 111.259 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.2 -9.56 58.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.073 0.949 . . . . 0.0 109.957 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.55 -1.12 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.254 1.022 . . . . 0.0 112.591 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.65 33.52 11.28 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.1 161.54 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -125.58 143.35 51.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.58 3.63 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.03 1.332 . . . . 0.0 110.365 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -60.93 -28.06 68.66 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.2 -1.563 . . . . 0.0 110.965 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -65.5 -4.36 5.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.412 1.885 . . . . 0.0 115.322 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.82 47.87 2.03 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.274 1.397 . . . . 0.0 111.273 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 131.28 8.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.42 1.088 . . . . 0.0 110.789 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -54.82 154.42 5.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.448 1.899 . . . . 0.0 115.455 -169.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -152.22 156.0 38.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.206 1.403 . . . . 0.0 109.311 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.7 164.79 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.263 1.025 . . . . 0.0 109.346 171.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.1 mt -56.4 145.85 6.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.608 1.163 . . . . 0.0 109.671 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -136.93 134.42 36.74 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.404 1.082 . . . . 0.0 109.928 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.17 -27.64 55.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.635 1.574 . . . . 0.0 113.522 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.87 -4.18 57.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.527 0.603 . . . . 0.0 111.797 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -107.96 -42.24 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.6 mt -48.37 -60.45 2.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.388 0.995 . . . . 0.0 111.269 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -75.81 -1.94 27.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.371 0.668 . . . . 0.0 112.736 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -115.85 -31.51 5.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.932 1.293 . . . . 0.0 111.34 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.05 124.12 19.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.127 1.371 . . . . 0.0 109.848 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.7 -31.75 71.92 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.816 0.846 . . . . 0.0 110.184 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 tp -142.06 139.17 32.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.389 1.076 . . . . 0.0 108.547 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.41 147.08 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.95 126.83 51.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.29 118.39 36.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.342 0.519 . . . . 0.0 109.766 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.26 12.63 36.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.848 1.259 . . . . 0.0 110.749 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -65.53 119.18 10.61 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.27 -12.97 0.23 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.328 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -70.37 148.92 47.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.174 1.487 . . . . 0.0 108.722 169.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.97 -16.94 48.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.134 1.374 . . . . 0.0 114.377 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -116.76 10.12 14.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.349 0.977 . . . . 0.0 111.684 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.51 90.26 6.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 170.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -52.25 -27.43 14.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.857 1.263 . . . . 0.0 113.584 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 78.7 m 76.5 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 128.424 2.689 . . . . 0.0 111.02 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.23 178.15 3.25 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.335 2.024 . . . . 0.0 110.037 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.8 tpp -130.23 159.07 37.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.472 1.109 . . . . 0.0 109.586 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 166.58 18.23 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.224 1.81 . . . . 0.0 110.457 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.97 161.34 33.55 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.558 1.505 . . . . 0.0 110.011 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.03 -9.12 17.94 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.096 2.531 . . . . 0.0 114.027 -169.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -115.0 -12.72 11.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.27 146.58 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.764 1.165 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.23 136.95 52.74 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -138.61 151.89 47.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.307 0.643 . . . . 0.0 109.987 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.34 161.71 29.66 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.137 2.175 . . . . 0.0 107.387 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -139.48 112.53 8.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 30.9 m0 -122.43 51.45 1.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.641 1.577 . . . . 0.0 107.062 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.88 132.18 31.32 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 120.885 -1.134 . . . . 0.0 111.88 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.97 35.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.028 1.731 . . . . 0.0 107.411 169.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.27 134.35 56.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.913 1.285 . . . . 0.0 109.842 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.42 124.7 91.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -23.91 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.432 1.421 . . . . 0.0 113.604 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.53 49.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.167 0.894 . . . . 0.0 112.273 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -110.33 8.51 23.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.615 1.166 . . . . 0.0 111.071 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.87 68.7 0.66 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.879 1.272 . . . . 0.0 109.777 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.13 136.34 57.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.792 0.837 . . . . 0.0 110.277 -171.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.55 -61.72 0.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -165.44 167.04 17.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.432 1.493 . . . . 0.0 107.72 171.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.49 -28.05 66.69 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.612 0.765 . . . . 0.0 111.431 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.7 -37.35 70.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.047 0.539 . . . . 0.0 110.941 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -69.39 -44.48 71.38 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.2 -45.96 83.29 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.776 0.431 . . . . 0.0 110.293 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -60.37 -40.47 90.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.47 0.708 . . . . 0.0 111.756 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.08 87.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.487 -0.758 . . . . 0.0 110.513 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -62.8 -37.47 86.85 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.007 0.523 . . . . 0.0 111.274 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.12 -48.95 77.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.364 0.665 . . . . 0.0 110.345 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.53 -36.34 83.46 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.438 0.563 . . . . 0.0 111.824 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -68.43 -47.44 67.22 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.995 0.816 . . . . 0.0 111.085 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.21 -41.41 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.82 -53.17 58.74 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.141 0.976 . . . . 0.0 109.758 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.59 -42.44 98.28 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.781 0.264 . . . . 0.0 110.954 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.6 -41.64 92.56 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.984 -0.447 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.51 -50.78 79.01 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.71 -45.63 60.25 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -61.13 -50.35 73.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 117.446 0.623 . . . . 0.0 111.1 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.436 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.9 tpt180 -68.69 -34.25 75.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.228 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -40.66 98.41 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.687 1.13 . . . . 0.0 109.695 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.79 -51.87 68.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.24 -36.08 83.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.908 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.65 -36.55 83.2 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.709 -0.619 . . . . 0.0 111.2 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.4 -37.85 31.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.652 0.381 . . . . 0.0 111.257 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.35 -46.92 8.07 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.393 1.077 . . . . 0.0 110.868 -170.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -109.41 -18.86 13.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.432 1.093 . . . . 0.0 111.638 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.46 13.16 82.13 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.586 -1.119 . . . . 0.0 112.942 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 119.225 1.512 . . . . 0.0 108.428 179.242 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -152.15 157.26 41.3 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.148 1.379 . . . . 0.0 107.609 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.94 133.61 45.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -71.86 172.75 9.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.12 143.62 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -146.58 149.7 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 119.211 0.914 . . . . 0.0 109.233 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.23 131.55 32.55 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.586 0.754 . . . . 0.0 109.286 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.25 128.3 56.29 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.3 mt -125.03 141.35 52.18 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.072 0.949 . . . . 0.0 110.319 -169.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.3 m -141.12 168.85 18.79 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 122.223 1.011 . . . . 0.0 112.557 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -76.82 34.21 0.15 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.737 2.015 . . . . 0.0 110.479 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.65 109.15 0.67 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 126.351 1.929 . . . . 0.0 108.605 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.46 51.46 0.72 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.201 1.0 . . . . 0.0 111.746 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -120.99 -20.38 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 m -136.32 -92.85 0.25 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.254 0.933 . . . . 0.0 110.66 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -36.71 85.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -61.04 -47.33 86.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.336 0.654 . . . . 0.0 110.616 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -60.69 -49.98 75.34 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.177 0.991 . . . . 0.0 109.679 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 mtm -58.21 -44.46 88.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.061 0.544 . . . . 0.0 111.623 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.45 -44.21 97.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.794 0.725 . . . . 0.0 111.346 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.6 tt0 -56.94 -41.84 78.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.449 0.3 . . . . 0.0 110.725 173.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.92 -52.86 50.83 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.763 0.697 . . . . 0.0 112.119 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -61.32 -43.05 99.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.394 0.597 . . . . 0.0 110.82 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.07 99.74 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.923 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -55.08 -36.69 65.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.439 1.018 . . . . 0.0 111.553 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -68.4 -57.67 5.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.238 0.472 . . . . 0.0 110.921 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -76.19 -43.87 40.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.1 mt -72.56 -34.49 67.53 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.947 0.499 . . . . 0.0 111.46 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 173.57 42.13 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -1.48 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 111.607 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.83 -10.23 5.26 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.428 -0.795 . . . . 0.0 110.991 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.3 m95 -128.99 119.63 24.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -70.16 92.19 0.75 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -78.95 138.44 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.49 166.81 24.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.219 1.407 . . . . 0.0 109.46 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -147.71 159.89 43.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.429 0.692 . . . . 0.0 109.721 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.41 -166.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 109.304 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.06 43.61 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 121.311 -0.868 . . . . 0.0 111.776 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.45 -29.56 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.991 1.316 . . . . 0.0 110.734 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.8 166.48 29.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.325 1.45 . . . . 0.0 108.247 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.85 140.08 26.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.16 9.33 5.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.65 149.55 24.89 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -172.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.0 144.96 56.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.497 0.665 . . . . 0.0 111.413 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -73.21 133.31 81.28 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.575 1.15 . . . . 0.0 108.61 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.01 -34.37 37.7 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.872 2.381 . . . . 0.0 114.282 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.78 -28.47 63.65 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.498 -0.751 . . . . 0.0 110.896 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.01 77.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.34 -48.07 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -39.75 94.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.673 -0.68 . . . . 0.0 111.041 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.01 -44.53 97.28 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.304 0.956 . . . . 0.0 110.3 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 74.3 mmm -68.91 -36.27 77.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.642 0.655 . . . . 0.0 111.469 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.484 -1.385 . . . . 0.0 111.396 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -66.43 -17.35 64.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.93 0.786 . . . . 0.0 111.038 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.66 -0.64 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.08 0.952 . . . . 0.0 112.114 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.43 32.85 12.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.03 158.55 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.3 144.6 49.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.412 1.085 . . . . 0.0 108.153 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.99 4.14 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.977 1.311 . . . . 0.0 110.404 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.09 -27.57 67.11 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.113 -1.617 . . . . 0.0 111.153 172.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.38 -3.19 3.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.468 1.907 . . . . 0.0 115.295 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -139.9 47.65 1.82 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.302 1.41 . . . . 0.0 111.645 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 133.21 7.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.599 1.16 . . . . 0.0 111.356 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -57.51 156.61 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.069 1.748 . . . . 0.0 115.153 -169.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -155.95 158.51 38.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.079 1.352 . . . . 0.0 109.301 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.414 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.31 164.37 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 170.255 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.61 149.19 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.829 1.652 . . . . 0.0 110.991 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.53 136.06 32.51 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.705 1.202 . . . . 0.0 110.181 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.01 -29.39 57.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.576 1.551 . . . . 0.0 113.319 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.77 -9.01 52.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.912 1.285 . . . . 0.0 112.27 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.51 -42.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.1 mt -46.98 -57.5 4.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.586 1.085 . . . . 0.0 112.186 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.71 -0.06 52.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 112.801 -173.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.94 -31.92 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.135 1.374 . . . . 0.0 111.527 -169.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.83 130.39 45.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.426 1.491 . . . . 0.0 109.887 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -63.07 -28.12 69.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.712 0.805 . . . . 0.0 110.477 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -147.62 139.95 24.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.891 1.276 . . . . 0.0 108.671 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.66 147.76 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.75 124.29 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -99.44 132.86 44.48 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.65 22.9 15.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.682 0.793 . . . . 0.0 109.362 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.0 111.81 6.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.785 -1.197 . . . . 0.0 110.305 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.53 26.03 0.34 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.14 -175.19 2.67 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.906 2.482 . . . . 0.0 112.549 -169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.34 -32.43 64.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.07 -49.58 10.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.342 0.657 . . . . 0.0 110.89 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 45.57 30.98 0.85 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.554 1.941 . . . . 0.0 114.662 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.06 -22.15 66.41 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.476 -1.39 . . . . 0.0 113.075 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.2 m 47.32 94.36 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.324 2.25 . . . . 0.0 113.73 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.17 134.4 19.18 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.67 2.914 . . . . 0.0 113.224 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.1 ttt -69.53 145.23 52.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.035 0.934 . . . . 0.0 109.663 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.9 p -126.01 160.23 57.95 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 126.432 1.893 . . . . 0.0 109.288 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.28 153.92 75.67 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 121.692 1.595 . . . . 0.0 109.226 169.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.45 -24.22 19.43 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.442 2.095 . . . . 0.0 112.004 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -78.45 -25.3 45.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.522 0.729 . . . . 0.0 112.732 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -78.47 147.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 118.822 0.737 . . . . 0.0 109.676 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -67.94 137.36 55.12 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -135.44 150.4 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.971 0.509 . . . . 0.0 110.401 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -126.91 159.85 32.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.127 2.171 . . . . 0.0 107.946 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -132.92 114.94 14.62 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.46 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 24.8 m0 -123.2 53.85 1.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.338 1.855 . . . . 0.0 107.055 -174.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.51 131.12 34.85 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 120.717 -1.24 . . . . 0.0 111.803 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 161.78 37.81 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.795 2.038 . . . . 0.0 106.056 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -68.55 141.61 55.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.227 0.537 . . . . 0.0 110.596 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.24 128.49 93.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.96 -24.38 45.78 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.116 1.077 . . . . 0.0 113.411 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.05 56.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.228 0.922 . . . . 0.0 112.221 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -111.9 3.28 17.46 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.26 . . . . 0.0 110.62 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 62.95 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.892 2.077 . . . . 0.0 110.427 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -60.03 138.96 57.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.722 1.609 . . . . 0.0 110.573 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.55 -59.09 0.21 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 175.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -166.36 168.95 14.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.985 1.714 . . . . 0.0 107.497 169.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.61 -29.36 67.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 111.314 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.9 -38.35 76.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.93 -43.74 74.5 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.04 -47.2 83.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.852 0.461 . . . . 0.0 110.346 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -61.63 -38.65 88.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.75 0.704 . . . . 0.0 111.722 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.08 82.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.168 -0.957 . . . . 0.0 110.334 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.13 -32.11 73.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.976 -0.453 . . . . 0.0 111.197 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.27 -50.37 73.11 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.492 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -45.41 80.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.827 0.74 . . . . 0.0 111.665 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -59.92 -49.73 76.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.866 0.757 . . . . 0.0 110.734 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.0 t -70.77 -39.12 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.78 -56.16 23.83 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 124.342 1.057 . . . . 0.0 108.75 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.57 -38.66 77.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 123.406 0.441 . . . . 0.0 110.7 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.42 -42.46 87.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.898 0.479 . . . . 0.0 111.025 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.79 -50.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.77 -47.58 46.38 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -60.93 -49.37 77.71 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 117.567 0.684 . . . . 0.0 111.479 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -69.55 -34.3 74.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.126 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.77 88.74 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.596 1.089 . . . . 0.0 109.744 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -55.21 -52.36 63.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.62 -34.83 78.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.56 -36.36 82.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.893 0.77 . . . . 0.0 111.071 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.73 28.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.147 0.579 . . . . 0.0 111.494 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.15 -41.45 11.01 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 111.952 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.2 p -115.05 -19.33 10.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.206 1.002 . . . . 0.0 111.17 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.61 76.92 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.837 -0.98 . . . . 0.0 112.869 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.6 mttt . . . . . 0 C--O 1.247 0.923 0 CA-C-N 118.879 1.339 . . . . 0.0 108.754 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -77.11 -28.57 54.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.124 0.569 . . . . 0.0 111.404 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.77 133.07 51.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 171.99 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -142.97 142.12 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 175.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.74 149.08 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 119.489 1.04 . . . . 0.0 109.039 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.72 134.87 41.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -118.4 130.62 56.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -125.74 138.93 53.89 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 110.088 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t -137.78 169.15 18.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.807 1.243 . . . . 0.0 109.875 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -58.49 -24.78 61.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.292 1.037 . . . . 0.0 111.737 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.25 139.51 6.49 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -77.98 51.91 1.01 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.154 0.982 . . . . 0.0 111.549 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.1 m -127.01 -15.91 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.312 -169.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.6 m -138.38 -95.6 0.19 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -54.8 -52.06 63.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.556 0.742 . . . . 0.0 111.661 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 17.5 p -68.9 -36.32 77.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.552 0.16 . . . . 0.0 111.312 -172.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.15 -53.95 51.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.114 0.966 . . . . 0.0 110.469 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.8 mtm -57.88 -44.37 86.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.133 0.573 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.21 99.07 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.384 0.538 . . . . 0.0 111.517 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.41 -32.35 70.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.098 0.559 . . . . 0.0 111.878 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.71 29.71 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -60.16 -41.24 92.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 117.338 0.569 . . . . 0.0 110.647 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.51 99.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.287 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -55.09 -40.17 70.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.824 1.193 . . . . 0.0 111.22 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -64.29 -51.8 61.72 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.396 0.435 . . . . 0.0 110.872 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -82.6 -44.6 15.63 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -171.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 92.4 mt -73.48 -33.81 65.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.816 0.446 . . . . 0.0 111.939 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.72 175.95 46.95 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.96 -2.65 10.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.768 0.827 . . . . 0.0 111.399 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.51 -12.35 6.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.776 1.231 . . . . 0.0 111.299 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 17.2 m95 -129.35 117.84 21.27 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -69.2 97.29 0.91 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.23 136.87 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.77 164.23 31.08 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.54 1.536 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 89.8 p -146.59 159.19 43.76 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.533 0.733 . . . . 0.0 109.729 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.5 -166.97 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.521 1.128 . . . . 0.0 109.621 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.47 -178.96 44.76 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -55.53 -27.93 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.259 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.85 172.12 14.66 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.537 1.535 . . . . 0.0 108.367 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.94 137.66 25.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.85 7.72 5.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.553 1.141 . . . . 0.0 110.452 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 145.86 17.98 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.08 142.35 54.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.742 0.782 . . . . 0.0 112.034 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -69.41 138.88 89.11 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 108.963 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.75 -28.71 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.735 1.623 . . . . 0.0 112.983 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -72.3 -29.16 63.6 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 120.985 -1.072 . . . . 0.0 110.478 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -45.91 87.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.19 -52.65 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -59.96 -41.2 91.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.974 0.807 . . . . 0.0 111.478 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.25 91.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.605 0.639 . . . . 0.0 109.853 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.71 -35.15 72.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.174 -0.329 . . . . 0.0 111.035 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -31.65 70.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.059 -1.026 . . . . 0.0 110.966 174.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.45 -15.64 63.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.211 1.004 . . . . 0.0 110.94 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.59 1.16 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.262 1.025 . . . . 0.0 111.859 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.38 30.92 17.85 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.0 mt -120.75 153.59 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -137.51 80.56 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.5 1.12 . . . . 0.0 111.043 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.32 1.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.0 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 96.8 p -61.26 -19.84 62.17 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.208 1.822 . . . . 0.0 112.212 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -81.33 0.3 37.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 112.956 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.29 50.31 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.431 1.014 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -47.58 137.1 9.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.191 1.396 . . . . 0.0 111.547 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -60.07 157.74 12.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -156.35 157.7 36.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.246 1.418 . . . . 0.0 109.743 170.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.5 166.49 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.742 1.217 . . . . 0.0 109.927 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.56 146.2 7.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.477 1.111 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.77 136.42 32.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.478 1.111 . . . . 0.0 109.908 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.75 -28.45 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.44 1.496 . . . . 0.0 113.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.38 -11.19 60.61 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.993 1.317 . . . . 0.0 112.231 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.2 mt -114.73 -42.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.4 mt -48.93 -58.79 4.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.814 1.188 . . . . 0.0 111.557 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -1.85 34.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -115.47 -31.92 5.75 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.083 1.353 . . . . 0.0 111.699 -169.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.2 130.62 47.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.286 1.434 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.61 -31.58 71.66 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.695 1.198 . . . . 0.0 109.857 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.87 141.61 24.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.135 1.374 . . . . 0.0 108.557 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.62 144.69 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.55 136.59 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 109.08 14.56 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.68 7.43 39.46 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.885 -0.51 . . . . 0.0 112.318 -168.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.93 120.4 11.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.566 1.147 . . . . 0.0 110.968 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.26 30.72 0.2 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.327 1.441 . . . . 0.0 110.668 170.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -109.79 -174.11 2.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.704 2.802 . . . . 0.0 112.311 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.73 65.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.15 -40.2 7.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.466 1.03 . . . . 0.0 110.561 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 49.78 39.31 17.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.441 1.896 . . . . 0.0 114.014 169.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.42 -10.54 58.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 117.856 -1.069 . . . . 0.0 113.883 -171.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 75.1 m 34.93 88.05 0.1 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.161 2.585 . . . . 0.0 114.17 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.25 139.07 16.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.248 3.298 . . . . 0.0 113.629 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.8 ttp -70.45 140.17 51.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.242 1.017 . . . . 0.0 110.261 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.8 p -134.29 159.33 72.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.532 1.933 . . . . 0.0 110.04 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.66 143.6 46.92 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.115 1.877 . . . . 0.0 109.938 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.54 -20.23 20.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.935 2.423 . . . . 0.0 111.668 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -73.49 -7.71 52.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.117 1.367 . . . . 0.0 112.727 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.1 141.55 34.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.12 136.81 58.19 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -133.67 155.06 50.4 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.111 0.565 . . . . 0.0 110.236 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.92 158.76 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.149 173.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -131.49 115.51 16.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.1 m0 -122.48 59.84 1.02 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -174.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.5 133.18 23.36 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 121.408 -0.807 . . . . 0.0 112.119 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -162.21 161.56 27.93 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.628 1.971 . . . . 0.0 106.439 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -65.23 140.31 58.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.462 0.705 . . . . 0.0 110.692 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.27 128.44 91.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.29 -21.95 34.94 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 120.354 1.162 . . . . 0.0 113.338 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.89 -11.96 60.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.628 1.104 . . . . 0.0 111.855 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -107.79 -1.2 21.12 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.665 1.586 . . . . 0.0 110.677 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.84 52.8 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.781 2.432 . . . . 0.0 111.859 173.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -54.26 137.83 40.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.726 2.01 . . . . 0.0 111.796 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.37 -60.59 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -162.94 164.31 25.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.477 1.511 . . . . 0.0 107.585 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.14 -30.46 71.05 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.841 -0.537 . . . . 0.0 111.492 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.31 -37.04 77.58 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.858 0.463 . . . . 0.0 110.378 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.7 -43.34 69.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -55.64 -49.69 72.19 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.89 -0.506 . . . . 0.0 110.213 171.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -60.38 -36.13 77.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.769 0.713 . . . . 0.0 111.923 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.72 77.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.359 -0.838 . . . . 0.0 109.482 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -63.52 -31.47 72.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.094 -0.955 . . . . 0.0 112.532 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.35 -48.43 80.58 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 120.044 1.293 . . . . 0.0 109.862 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.27 -36.58 83.35 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.8 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -65.12 -50.43 66.07 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.778 0.717 . . . . 0.0 110.293 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.15 -38.27 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.92 -52.93 58.99 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 109.331 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.22 -44.52 91.65 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.112 0.258 . . . . 0.0 111.167 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.27 -39.73 89.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.61 -0.681 . . . . 0.0 111.283 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.6 mt -58.16 -52.77 54.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 172.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.86 61.51 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.35 -50.76 71.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 117.703 0.751 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.931 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.542 1.065 . . . . 0.0 109.737 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -57.01 -53.71 55.0 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.33 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.639 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -62.04 -36.8 82.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.575 -0.703 . . . . 0.0 111.157 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.84 28.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.122 0.569 . . . . 0.0 111.714 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.17 -41.52 10.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.611 1.164 . . . . 0.0 111.996 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.0 p -114.62 -19.1 11.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.154 0.981 . . . . 0.0 110.969 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.59 76.33 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.783 -1.01 . . . . 0.0 112.688 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.5 mttt . . . . . 0 C--O 1.246 0.876 0 CA-C-N 118.781 1.291 . . . . 0.0 108.504 179.317 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.234 0.257 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.88 174.07 3.97 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.42 142.59 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.25 149.7 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 119.308 0.958 . . . . 0.0 109.189 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 138.3 42.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.842 0.857 . . . . 0.0 109.185 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.23 131.06 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.6 mt -127.94 140.08 52.21 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.785 0.834 . . . . 0.0 110.547 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -139.26 175.26 9.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.176 0.99 . . . . 0.0 111.887 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -55.36 -32.1 62.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.789 1.236 . . . . 0.0 111.142 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 143.27 9.9 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.12 57.83 2.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.094 0.958 . . . . 0.0 111.424 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 m -127.92 -20.22 3.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.0 m -134.33 -93.81 0.3 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.229 0.922 . . . . 0.0 109.052 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -55.36 -50.9 68.49 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.969 0.907 . . . . 0.0 111.518 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 p -67.58 -37.85 83.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.748 0.703 . . . . 0.0 111.501 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -60.5 -52.8 63.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.147 0.979 . . . . 0.0 110.347 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.1 mtm -59.9 -42.07 93.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.54 0.736 . . . . 0.0 111.358 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.91 -43.66 98.2 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.457 0.571 . . . . 0.0 111.329 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 79.7 tt0 -55.96 -43.28 77.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.959 0.345 . . . . 0.0 110.332 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 25' ' ' LYS . . . -54.5 -52.26 46.21 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.34 -0.7 . . . . 0.0 112.754 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.525 0.662 . . . . 0.0 111.275 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.69 98.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.806 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 46.1 mtmt -51.09 -41.2 59.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.238 0.926 . . . . 0.0 111.325 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -67.32 -61.97 1.65 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.329 0.393 . . . . 0.0 110.566 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -69.48 -39.15 77.85 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.3 mt -77.84 -5.37 50.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.507 0.723 . . . . 0.0 112.542 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.57 55.96 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.559 1.076 . . . . 0.0 114.006 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 58.69 8.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.427 2.291 . . . . 0.0 114.292 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.82 -3.88 7.89 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.89 -1.131 . . . . 0.0 111.093 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 8.6 m95 -132.4 121.59 23.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.9 mmpt? -67.62 97.3 0.6 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -80.39 139.86 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -146.93 165.23 30.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.408 1.483 . . . . 0.0 109.501 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.0 p -144.5 157.48 44.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.734 0.814 . . . . 0.0 109.624 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.89 -166.31 1.57 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.87 1.268 . . . . 0.0 109.552 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -179.46 46.18 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mt -56.14 -27.66 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.997 1.319 . . . . 0.0 111.448 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.63 171.94 13.98 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.74 1.216 . . . . 0.0 108.968 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.65 135.36 17.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -137.03 17.46 3.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.24 1.016 . . . . 0.0 109.896 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.97 167.61 25.1 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -91.31 149.79 21.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.224 0.61 . . . . 0.0 110.721 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -74.47 134.14 76.65 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.872 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.87 -34.84 57.34 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.778 2.318 . . . . 0.0 114.115 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -72.98 -32.74 65.38 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.447 -0.783 . . . . 0.0 110.297 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -44.72 91.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.37 -51.22 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -58.07 -44.49 87.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.921 0.782 . . . . 0.0 111.511 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.0 86.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.39 -37.58 77.58 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.984 0.356 . . . . 0.0 111.333 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -63.69 -27.58 69.31 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.927 -1.108 . . . . 0.0 111.309 174.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.35 -16.27 63.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.018 0.826 . . . . 0.0 110.769 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.27 0.55 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.908 0.883 . . . . 0.0 112.052 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.45 18.75 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.35 160.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 53' ' ' LYS . 28.5 t70 -125.05 141.88 51.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.67 0.788 . . . . 0.0 109.596 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.76 -0.54 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.406 1.482 . . . . 0.0 109.826 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -58.62 -33.01 69.54 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.344 -1.473 . . . . 0.0 111.116 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -63.28 -17.75 62.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.254 1.821 . . . . 0.0 114.763 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -120.86 52.53 1.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.664 1.12 . . . . 0.0 110.569 -168.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -48.18 136.07 12.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 110.984 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -57.11 155.57 8.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -168.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -153.72 156.31 37.58 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.359 1.464 . . . . 0.0 109.395 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.55 168.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.544 1.138 . . . . 0.0 109.447 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -56.51 142.99 11.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.673 0.789 . . . . 0.0 108.935 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.61 140.88 43.15 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.513 1.125 . . . . 0.0 109.876 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.67 -30.56 61.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.066 1.346 . . . . 0.0 113.166 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -70.01 -11.12 60.65 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.278 1.031 . . . . 0.0 112.069 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.0 mt -121.06 -43.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 pp -56.93 -40.66 76.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.078 1.308 . . . . 0.0 112.341 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.2 4.84 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.901 0.881 . . . . 0.0 112.542 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -125.59 -26.42 3.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.813 1.245 . . . . 0.0 112.851 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.39 132.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.617 1.167 . . . . 0.0 109.384 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.03 -25.48 66.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.705 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.6 tp -147.77 141.97 26.14 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.672 1.189 . . . . 0.0 108.655 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.63 147.04 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.1 t -132.64 127.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -100.89 134.39 43.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.25 18.22 21.33 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.212 0.605 . . . . 0.0 109.971 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.6 p -67.98 116.04 8.18 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.145 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 170.892 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 113.357 0.483 . . . . 0.0 113.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -68.61 145.69 53.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.373 1.069 . . . . 0.0 109.57 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -130.2 158.23 74.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.095 1.758 . . . . 0.0 109.868 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 138.18 35.05 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 121.907 1.738 . . . . 0.0 109.291 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.63 -21.19 25.86 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.802 2.335 . . . . 0.0 112.306 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -67.89 -23.13 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.132 0.973 . . . . 0.0 112.083 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.98 142.21 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -170.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.05 139.24 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.984 0.914 . . . . 0.0 108.589 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -133.64 151.64 51.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.598 0.759 . . . . 0.0 110.123 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.92 159.23 34.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.781 2.033 . . . . 0.0 107.723 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -135.05 111.15 9.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -121.42 62.03 0.91 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.968 1.707 . . . . 0.0 106.847 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.37 133.4 23.81 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 121.198 -0.939 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 161.16 35.19 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.561 1.944 . . . . 0.0 106.126 169.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.23 143.2 55.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.237 0.542 . . . . 0.0 110.903 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.24 127.15 93.06 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.81 -23.73 62.23 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.176 1.251 . . . . 0.0 113.378 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.67 -14.66 63.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.334 0.97 . . . . 0.0 112.337 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -110.02 3.84 20.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.121 1.368 . . . . 0.0 111.294 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.22 61.66 0.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.406 1.882 . . . . 0.0 111.225 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -59.13 138.68 57.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.805 1.642 . . . . 0.0 110.701 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.09 -59.36 0.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.1 t -165.06 167.58 18.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.81 1.644 . . . . 0.0 107.402 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.28 -30.77 70.68 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.115 0.566 . . . . 0.0 111.283 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.63 -38.54 80.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.831 0.452 . . . . 0.0 110.379 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.27 -42.3 72.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -56.35 -52.21 65.43 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.114 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.8 t-105 -56.99 -40.34 76.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.89 0.768 . . . . 0.0 111.287 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.22 -40.98 97.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.511 0.596 . . . . 0.0 110.16 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -67.31 -29.86 69.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.634 -1.174 . . . . 0.0 113.139 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -60.55 -50.79 72.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.853 1.66 . . . . 0.0 109.813 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -65.9 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.94 0.791 . . . . 0.0 112.035 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -65.58 -51.81 56.93 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.359 0.982 . . . . 0.0 110.893 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.08 -37.9 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -54.65 -53.57 53.0 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.571 0.749 . . . . 0.0 109.581 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.06 -43.47 98.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.763 0.256 . . . . 0.0 110.963 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -40.45 91.21 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.737 -0.602 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -59.32 -50.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.02 63.79 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -59.64 -50.0 75.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.558 0.679 . . . . 0.0 110.895 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -70.32 -30.13 67.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 117.321 -1.323 . . . . 0.0 111.554 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -39.95 84.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.654 1.115 . . . . 0.0 110.104 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -56.4 -50.92 70.2 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.02 -36.17 83.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.201 0.455 . . . . 0.0 111.662 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.7 -36.63 83.57 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.357 -0.84 . . . . 0.0 111.539 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.37 -36.93 33.29 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.481 0.312 . . . . 0.0 111.173 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.4 -42.78 10.71 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.047 1.339 . . . . 0.0 111.797 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 p -115.05 -20.29 10.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.464 1.106 . . . . 0.0 111.475 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.35 82.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.939 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 119.12 1.46 . . . . 0.0 109.059 178.244 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -77.45 178.25 7.35 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.9 140.41 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -143.27 152.1 16.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.778 0.831 . . . . 0.0 109.325 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.62 136.45 29.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.095 0.958 . . . . 0.0 109.088 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.64 125.37 44.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.654 1.182 . . . . 0.0 108.261 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.3 142.41 49.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.755 1.222 . . . . 0.0 109.477 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -139.95 171.44 14.2 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.158 0.983 . . . . 0.0 111.833 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -60.04 -23.0 63.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.941 0.897 . . . . 0.0 111.795 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.96 134.88 4.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 169.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.82 55.01 1.96 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.289 1.036 . . . . 0.0 111.528 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -126.55 -16.86 5.22 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.4 m -137.88 -87.12 0.27 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.073 0.851 . . . . 0.0 109.478 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -57.99 -54.36 47.86 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.754 0.822 . . . . 0.0 111.192 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 10.8 p -67.01 -34.57 78.04 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.975 0.352 . . . . 0.0 111.238 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -62.16 -55.5 28.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.958 0.903 . . . . 0.0 109.998 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.5 mtm -58.06 -42.71 86.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.274 0.63 . . . . 0.0 111.484 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.92 97.96 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.621 0.646 . . . . 0.0 111.353 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.6 tt0 -56.88 -41.68 78.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.933 0.333 . . . . 0.0 110.611 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.35 68.63 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.484 0.584 . . . . 0.0 112.41 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -63.53 -42.97 98.4 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.596 0.698 . . . . 0.0 111.089 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.35 99.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.564 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -52.0 -38.6 57.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.954 0.797 . . . . 0.0 111.643 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -70.51 -62.59 1.33 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.204 0.315 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -68.81 -36.87 78.75 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.2 mt -78.44 -2.11 36.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.353 0.661 . . . . 0.0 112.197 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.5 24.05 58.96 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.979 1.276 . . . . 0.0 113.961 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.14 14.32 1.97 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.031 2.132 . . . . 0.0 113.633 -172.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.15 -0.86 15.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.928 1.291 . . . . 0.0 110.91 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.7 m95 -133.46 122.52 23.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.54 97.42 0.59 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 24' ' ' ALA . 1.9 t -82.1 140.88 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -144.76 166.13 26.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.166 1.387 . . . . 0.0 109.533 174.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 87.8 p -145.68 158.44 43.85 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.689 0.796 . . . . 0.0 109.888 169.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.34 -168.17 1.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.708 1.203 . . . . 0.0 110.205 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.0 179.96 46.82 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.534 -0.729 . . . . 0.0 111.325 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -56.38 -27.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.049 1.34 . . . . 0.0 111.304 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.11 168.94 21.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.915 1.286 . . . . 0.0 108.563 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.48 138.44 26.15 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.74 12.97 6.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.757 1.223 . . . . 0.0 109.826 172.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 163.77 34.43 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -170.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.53 146.21 38.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.217 0.532 . . . . 0.0 110.375 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -70.52 134.33 86.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.671 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.15 -35.62 43.11 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.657 2.238 . . . . 0.0 114.095 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.42 -27.26 63.18 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.451 -0.78 . . . . 0.0 111.011 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.9 85.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.36 -49.91 81.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -57.81 -40.24 79.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.395 0.998 . . . . 0.0 111.642 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.84 84.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.598 0.636 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.2 mmm -68.1 -35.3 77.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.423 0.556 . . . . 0.0 111.123 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -68.07 -23.72 64.98 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.669 -1.269 . . . . 0.0 111.308 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -67.13 -21.16 65.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.091 0.859 . . . . 0.0 110.398 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.59 -1.47 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.24 0.616 . . . . 0.0 112.133 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.0 33.28 15.46 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.64 159.28 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.94 144.39 49.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -128.82 3.53 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.984 1.314 . . . . 0.0 110.261 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.98 -28.66 67.87 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 111.061 171.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.49 -4.65 4.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.421 1.888 . . . . 0.0 115.192 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -138.16 49.23 1.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.425 1.466 . . . . 0.0 110.879 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 p -46.61 131.56 11.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 110.747 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -56.85 156.73 6.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.134 1.773 . . . . 0.0 115.179 -169.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -153.38 157.04 39.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.069 1.348 . . . . 0.0 109.132 171.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.77 164.89 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.867 0.867 . . . . 0.0 109.402 169.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.49 139.89 14.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 109.546 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.64 138.39 50.06 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.435 1.494 . . . . 0.0 109.671 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -57.56 -27.63 62.83 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.598 1.559 . . . . 0.0 113.29 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.05 -12.72 61.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.828 1.251 . . . . 0.0 112.075 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -112.73 -41.21 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.47 -58.56 4.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.836 1.198 . . . . 0.0 111.499 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.79 0.36 27.28 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -118.66 -31.75 4.76 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.984 1.314 . . . . 0.0 111.783 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 128.36 35.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 109.755 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.65 -25.41 64.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.174 0.59 . . . . 0.0 110.781 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.8 tp -145.53 141.08 27.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.44 1.096 . . . . 0.0 108.171 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.86 153.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.88 136.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -109.17 122.3 47.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.3 25.28 5.06 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.054 0.941 . . . . 0.0 109.52 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -75.42 68.34 2.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.019 2.127 . . . . 0.0 113.606 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.228 0 O-C-N 121.122 -0.987 . . . . 0.0 111.203 170.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.534 0.494 0 N-CA-C 114.011 0.735 . . . . 0.0 114.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 147.08 52.77 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.866 1.266 . . . . 0.0 111.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -133.39 159.38 72.8 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.967 2.107 . . . . 0.0 108.964 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.1 138.61 40.35 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.77 1.647 . . . . 0.0 109.429 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 -18.48 39.48 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.902 2.402 . . . . 0.0 112.129 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -64.45 -19.93 65.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.493 1.117 . . . . 0.0 112.019 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.5 t -110.99 136.66 46.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 118.937 0.79 . . . . 0.0 109.105 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -63.2 132.13 50.71 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.132 0.973 . . . . 0.0 108.746 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.99 159.55 28.11 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.598 0.759 . . . . 0.0 109.475 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -128.7 169.78 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.73 2.012 . . . . 0.0 107.188 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -136.11 122.49 20.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.61 58.6 1.3 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.86 1.664 . . . . 0.0 107.107 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.19 125.07 14.59 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.939 -1.101 . . . . 0.0 112.07 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.26 158.72 43.21 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.569 2.347 . . . . 0.0 105.806 168.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.27 149.5 48.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.198 0.523 . . . . 0.0 110.832 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.89 125.69 89.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.52 -25.11 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.378 1.385 . . . . 0.0 113.471 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.54 52.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.351 0.978 . . . . 0.0 112.115 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -114.57 3.74 14.94 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.951 1.3 . . . . 0.0 110.842 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.94 64.41 0.32 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.851 2.06 . . . . 0.0 110.308 169.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.51 139.67 56.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.495 1.518 . . . . 0.0 110.658 -171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.67 -57.59 0.21 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.64 169.43 13.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.019 1.728 . . . . 0.0 107.378 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.97 -30.5 70.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.902 -0.499 . . . . 0.0 111.349 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.75 -36.93 73.37 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.762 0.425 . . . . 0.0 110.676 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.89 -46.34 75.23 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -57.04 -48.46 78.48 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.294 0.637 . . . . 0.0 110.17 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -61.24 -37.86 84.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.5 0.72 . . . . 0.0 111.972 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.47 82.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.43 -33.26 75.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.861 0.465 . . . . 0.0 110.931 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.85 -48.57 79.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.81 0.844 . . . . 0.0 110.459 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.27 -41.49 98.5 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.474 0.579 . . . . 0.0 110.752 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -62.89 -48.61 78.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.117 0.871 . . . . 0.0 111.172 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.84 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 118.613 0.642 . . . . 0.0 109.301 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -55.23 -53.81 51.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.029 0.831 . . . . 0.0 109.235 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.07 -40.89 91.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.319 0.387 . . . . 0.0 111.236 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.91 -45.89 87.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.38 0.672 . . . . 0.0 110.428 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.1 mt -58.13 -50.14 79.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.87 51.4 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.573 0.624 . . . . 0.0 111.842 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -59.48 -48.6 81.01 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 117.751 0.776 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.87 -25.83 53.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.656 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.67 -38.54 83.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 120.057 1.299 . . . . 0.0 109.673 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.61 -50.42 73.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.43 -42.32 98.57 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 110.503 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -58.78 -33.26 70.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 120.274 -1.516 . . . . 0.0 111.854 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.56 -35.4 24.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.702 0.401 . . . . 0.0 111.958 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.31 -45.47 8.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.774 1.23 . . . . 0.0 112.034 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.7 p -113.86 -20.14 11.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 110.835 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.21 11.01 81.6 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.585 1.088 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt . . . . . 0 C--O 1.246 0.907 0 CA-C-N 118.916 1.358 . . . . 0.0 110.379 -177.384 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 C--O 1.234 0.25 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.71 172.9 9.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.15 142.37 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.58 151.5 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.083 0.953 . . . . 0.0 109.546 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.83 139.04 39.74 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.965 0.906 . . . . 0.0 109.321 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -122.54 128.59 50.95 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.406 1.082 . . . . 0.0 108.653 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.64 139.85 53.49 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.34 1.056 . . . . 0.0 110.015 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -139.93 175.03 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.184 1.793 . . . . 0.0 108.407 170.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -52.78 63.93 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 120.941 -1.099 . . . . 0.0 109.537 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.88 126.92 7.31 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.91 60.05 0.72 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.35 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -134.75 -20.67 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -126.49 -99.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -47.98 83.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 112.31 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 18.8 p -62.95 -38.41 90.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.425 0.557 . . . . 0.0 111.485 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -62.38 -55.21 30.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.193 0.997 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 49.7 mtm -55.91 -43.78 77.65 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.263 0.625 . . . . 0.0 111.316 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.3 99.34 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.362 0.665 . . . . 0.0 111.553 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.3 tt0 -57.27 -41.19 79.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.918 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -49.48 78.19 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.707 0.685 . . . . 0.0 112.493 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -61.32 -46.25 91.05 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.579 0.69 . . . . 0.0 110.833 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -64.07 -40.78 97.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.315 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -51.31 -43.68 61.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.297 0.953 . . . . 0.0 111.006 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -71.15 -58.3 3.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 123.699 0.625 . . . . 0.0 111.206 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -64.37 -39.43 93.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.967 0.348 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.51 -2.86 54.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.178 0.991 . . . . 0.0 112.274 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.95 59.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.208 1.385 . . . . 0.0 114.629 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.56 5.8 0.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 0.0 113.97 -170.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.27 -7.55 19.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.837 -1.164 . . . . 0.0 110.343 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -128.08 121.02 28.63 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -68.92 97.86 0.89 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 24' ' ' ALA . 2.5 t -83.01 140.69 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.35 167.06 23.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.337 1.455 . . . . 0.0 109.175 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 85.3 p -144.72 157.47 44.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.82 0.848 . . . . 0.0 109.692 170.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.9 -170.28 2.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 110.894 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.75 -177.55 42.18 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 122.052 -0.405 . . . . 0.0 113.069 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -56.48 -32.6 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.11 1.364 . . . . 0.0 109.637 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.07 169.07 19.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.867 1.667 . . . . 0.0 109.634 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.46 24.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.28 8.92 5.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.737 1.215 . . . . 0.0 110.087 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.96 165.58 25.92 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -170.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -85.27 150.08 25.03 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.047 0.539 . . . . 0.0 111.098 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -73.33 133.25 80.97 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.507 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.72 -36.29 61.29 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.732 2.288 . . . . 0.0 113.994 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -70.94 -32.97 70.03 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.723 -0.611 . . . . 0.0 110.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.5 90.88 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.67 -47.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -40.09 93.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.441 0.564 . . . . 0.0 111.184 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.27 99.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.626 0.771 . . . . 0.0 109.914 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.1 mmm -68.49 -38.0 80.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.23 0.468 . . . . 0.0 110.974 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -27.5 68.74 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 173.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.95 -16.77 64.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.869 0.758 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.63 1.47 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.157 0.983 . . . . 0.0 112.054 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.73 21.1 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -117.8 158.89 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.77 146.08 48.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.492 1.117 . . . . 0.0 108.506 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.27 3.31 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 110.431 170.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.06 -28.19 67.59 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 119.885 -1.76 . . . . 0.0 111.276 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.1 -5.45 4.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 115.091 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.48 50.83 1.95 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.993 1.269 . . . . 0.0 110.397 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 p -47.09 134.37 10.74 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.958 0.903 . . . . 0.0 110.724 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 m -56.79 156.23 6.81 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.033 1.733 . . . . 0.0 115.653 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -153.91 157.4 39.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.213 1.405 . . . . 0.0 109.465 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 169.04 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.193 . . . . 0.0 109.441 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.38 141.76 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.39 141.4 41.73 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.475 1.11 . . . . 0.0 109.844 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 m -55.4 -30.24 60.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.088 1.355 . . . . 0.0 113.299 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.21 -13.67 62.53 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.006 0.922 . . . . 0.0 111.984 -173.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -121.06 -42.46 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.383 1.073 . . . . 0.0 108.299 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.37 -39.05 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.329 1.422 . . . . 0.0 112.118 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.5 4.87 51.8 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.792 0.837 . . . . 0.0 112.705 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -125.32 -28.8 3.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.886 1.274 . . . . 0.0 112.435 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 128.71 38.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.043 1.337 . . . . 0.0 108.983 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.77 -23.25 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.85 139.89 26.66 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.746 1.218 . . . . 0.0 108.067 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.7 146.51 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 t -135.43 129.37 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.07 129.98 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.47 23.18 11.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.627 0.771 . . . . 0.0 109.379 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -76.56 104.26 6.98 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.379 -1.451 . . . . 0.0 112.317 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.187 0 O-C-N 121.682 -0.636 . . . . 0.0 111.892 169.255 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.461 -0.425 0 N-CA-C 113.115 0.391 . . . . 0.0 113.115 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.4 mmt -73.84 152.82 40.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.565 0.746 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 p -133.2 165.29 37.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.528 1.931 . . . . 0.0 109.393 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.81 155.21 68.72 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 172.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.03 -9.29 14.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.229 2.619 . . . . 0.0 114.56 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -129.77 0.04 4.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.515 1.052 . . . . 0.0 113.492 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.6 t -85.93 145.5 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.17 133.11 55.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -130.24 149.54 51.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.879 0.872 . . . . 0.0 109.003 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -132.89 169.75 16.32 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.085 1.354 . . . . 0.0 108.6 170.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -134.78 115.76 14.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 23.3 m0 -121.63 61.43 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.486 1.515 . . . . 0.0 107.243 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.82 128.84 9.86 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.172 -0.955 . . . . 0.0 112.367 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.85 159.5 44.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.177 2.191 . . . . 0.0 106.401 168.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.0 153.8 43.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.573 0.749 . . . . 0.0 110.612 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.05 125.01 73.73 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 110.124 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.51 -26.34 62.35 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.691 1.594 . . . . 0.0 113.864 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.27 -13.12 62.02 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.022 0.828 . . . . 0.0 112.264 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mtm105 -114.39 13.9 17.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.264 0.938 . . . . 0.0 111.476 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.83 67.29 0.81 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 0.0 109.975 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -58.6 138.71 56.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.793 0.837 . . . . 0.0 110.383 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.24 -60.02 0.23 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 172.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -167.32 167.48 13.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.671 1.589 . . . . 0.0 107.522 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.12 -29.21 68.46 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.093 0.557 . . . . 0.0 111.291 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.97 -39.66 75.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.964 0.506 . . . . 0.0 110.681 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.58 -44.63 86.1 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.83 -50.33 74.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.711 -0.662 . . . . 0.0 110.503 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -57.39 -40.28 77.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.242 0.928 . . . . 0.0 111.153 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.08 74.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.627 -0.671 . . . . 0.0 110.892 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.93 -34.92 64.51 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.703 -1.248 . . . . 0.0 111.26 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -58.26 -52.54 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.962 0.801 . . . . 0.0 109.881 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.81 -30.97 71.68 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.513 0.597 . . . . 0.0 112.115 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.11 -49.68 69.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.631 1.105 . . . . 0.0 111.117 173.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.4 -39.61 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.708 0.686 . . . . 0.0 109.187 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -53.04 -52.85 57.15 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.26 1.024 . . . . 0.0 109.727 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.41 -41.06 89.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.145 0.278 . . . . 0.0 111.331 -172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -64.15 -43.29 95.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.995 0.518 . . . . 0.0 110.421 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.36 -49.35 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.66 -47.35 64.52 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -59.74 -49.71 76.66 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 117.31 0.555 . . . . 0.0 110.391 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.14 69.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.312 -175.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -42.04 79.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.029 0.831 . . . . 0.0 110.069 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.07 -49.65 75.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.46 -36.35 82.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.743 -0.17 . . . . 0.0 111.237 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -61.51 -37.67 84.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.238 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.89 -37.0 41.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.451 0.3 . . . . 0.0 111.183 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.42 -48.32 6.71 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.727 1.211 . . . . 0.0 111.011 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.7 p -105.73 -20.49 13.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.749 1.22 . . . . 0.0 111.41 -169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.33 18.35 78.21 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.538 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.2 mttt . . . . . 0 C--O 1.248 1.021 0 CA-C-N 118.507 1.154 . . . . 0.0 109.51 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 t30 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 175.53 2.9 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.11 142.04 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 tt -143.36 151.05 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -137.8 135.8 36.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.901 0.881 . . . . 0.0 108.795 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -117.88 137.74 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 mt -133.65 145.63 50.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.222 0.609 . . . . 0.0 111.509 -169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.02 173.51 12.39 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.504 1.122 . . . . 0.0 112.359 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.8 m -57.79 -29.65 65.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.165 1.786 . . . . 0.0 111.433 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 141.36 8.29 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -83.78 55.8 3.4 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.508 0.654 . . . . 0.0 112.087 -169.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 m -132.6 -12.05 3.06 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.7 m -131.68 -105.81 0.26 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -50.89 -47.17 60.71 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.587 1.155 . . . . 0.0 111.688 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -61.9 -42.12 98.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -69.37 -45.03 70.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.504 0.722 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.5 -43.23 99.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.978 0.511 . . . . 0.0 110.221 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.4 98.49 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.377 0.671 . . . . 0.0 111.255 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' HG12 ' A' ' 34' ' ' VAL . 17.1 tt0 -57.37 -40.94 79.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.068 0.395 . . . . 0.0 110.075 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.86 -53.51 45.73 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.062 0.839 . . . . 0.0 111.532 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.52 -45.88 92.31 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.141 0.47 . . . . 0.0 110.686 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.39 93.83 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.316 0.646 . . . . 0.0 110.321 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -57.72 -33.58 68.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.869 0.759 . . . . 0.0 111.353 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.31 -62.28 1.45 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.16 0.437 . . . . 0.0 110.664 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -65.7 -43.06 90.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.337 0.255 . . . . 0.0 111.397 -169.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.78 -6.55 52.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.599 1.16 . . . . 0.0 112.112 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.56 51.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.972 1.272 . . . . 0.0 114.136 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t70 56.35 11.44 0.82 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.488 2.315 . . . . 0.0 114.081 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -64.89 -7.5 11.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.979 1.312 . . . . 0.0 110.484 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -126.65 118.78 25.48 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.67 98.78 0.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.474 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 t -80.08 138.77 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -140.11 166.06 25.69 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.772 1.629 . . . . 0.0 109.22 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -151.6 145.0 24.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.024 0.929 . . . . 0.0 108.711 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.39 -170.38 2.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.698 1.199 . . . . 0.0 112.02 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.06 -176.59 45.31 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.155 -0.966 . . . . 0.0 112.117 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.29 -30.38 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.862 1.265 . . . . 0.0 111.23 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.92 167.6 24.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.688 1.195 . . . . 0.0 109.193 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.82 141.9 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -132.16 1.59 3.87 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.574 1.15 . . . . 0.0 110.263 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.12 -166.25 22.81 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.2 pt? -119.04 149.85 40.97 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 110.322 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -72.0 134.2 83.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.759 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.38 -36.14 56.95 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.691 2.26 . . . . 0.0 113.895 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.46 -32.49 66.29 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.538 -0.726 . . . . 0.0 110.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.24 84.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.04 -52.04 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -58.91 -40.07 83.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.604 0.638 . . . . 0.0 111.633 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.89 94.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.512 0.596 . . . . 0.0 109.596 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.2 mmm -68.65 -36.83 79.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.28 0.491 . . . . 0.0 111.184 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.35 -25.21 67.93 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.886 -1.134 . . . . 0.0 111.524 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.32 -17.14 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.9 0.773 . . . . 0.0 110.885 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.52 -0.34 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.705 0.802 . . . . 0.0 112.108 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 31.68 13.9 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.21 159.74 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.77 145.54 51.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.96 -6.51 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.833 1.253 . . . . 0.0 110.625 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -57.59 -38.5 74.99 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.866 0.867 . . . . 0.0 110.894 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -18.59 37.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.845 1.258 . . . . 0.0 113.984 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.03 -40.73 18.01 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 119.639 1.109 . . . . 0.0 110.395 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 p 56.07 176.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.162 1.785 . . . . 0.0 111.069 -168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -128.27 153.68 46.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.79 158.52 35.39 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.045 0.938 . . . . 0.0 109.467 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.37 163.48 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.647 0.779 . . . . 0.0 108.992 169.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.61 149.0 5.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.771 1.228 . . . . 0.0 110.209 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.54 136.6 33.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.354 1.062 . . . . 0.0 110.113 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.86 -28.64 51.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.392 1.477 . . . . 0.0 113.161 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.25 -11.15 60.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.034 1.333 . . . . 0.0 112.188 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -114.12 -42.76 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.23 -58.42 5.07 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.206 . . . . 0.0 111.504 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -0.93 30.52 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.45 -31.54 5.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.945 1.298 . . . . 0.0 111.928 -168.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.959 1.304 . . . . 0.0 109.705 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.3 -26.24 67.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.75 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 tp -147.28 142.65 27.4 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.534 1.134 . . . . 0.0 108.669 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.41 151.38 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -140.03 128.26 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.46 136.16 37.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.9 7.74 26.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.563 0.745 . . . . 0.0 111.054 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.95 126.7 28.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.898 1.279 . . . . 0.0 110.638 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.929 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.226 170.266 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo . . . . . 0 CA--C 1.541 0.833 0 CA-C-O 121.606 0.586 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 48.3 tpp -124.73 156.35 37.79 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.71 1.604 . . . . 0.0 108.843 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p -128.43 161.17 58.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.622 1.569 . . . . 0.0 110.459 -169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.21 139.25 54.55 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.965 1.777 . . . . 0.0 109.576 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 -22.45 26.34 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.803 2.335 . . . . 0.0 112.25 -173.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -81.07 3.13 24.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.717 0.807 . . . . 0.0 112.48 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.37 134.55 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -64.39 132.05 48.96 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -123.34 159.07 29.63 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.663 0.785 . . . . 0.0 109.125 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.58 166.2 17.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.144 1.778 . . . . 0.0 107.337 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -133.56 113.17 12.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -119.9 58.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.847 1.659 . . . . 0.0 106.702 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.15 134.24 21.23 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.335 -0.853 . . . . 0.0 112.364 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.2 161.26 33.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.935 2.094 . . . . 0.0 106.118 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.71 146.95 24.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.663 1.185 . . . . 0.0 111.68 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.87 117.89 70.0 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 124.819 1.248 . . . . 0.0 108.937 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.38 -22.96 71.78 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.535 1.49 . . . . 0.0 113.628 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.41 61.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.427 1.012 . . . . 0.0 113.036 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -120.95 13.28 11.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.563 1.074 . . . . 0.0 112.094 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.22 55.65 0.21 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.306 1.842 . . . . 0.0 110.378 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.93 148.61 43.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.81 2.044 . . . . 0.0 112.201 -169.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.56 -54.05 0.34 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -166.42 166.93 16.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.106 1.763 . . . . 0.0 107.322 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.55 -29.66 69.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.177 0.591 . . . . 0.0 111.158 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.22 -37.07 74.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.896 0.479 . . . . 0.0 110.717 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.66 -47.33 69.83 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -54.54 -50.96 66.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.935 0.494 . . . . 0.0 110.086 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -58.84 -39.09 80.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.872 0.869 . . . . 0.0 112.027 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.07 86.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.496 -0.752 . . . . 0.0 110.114 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.58 -36.37 82.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.797 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.25 -47.37 83.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.411 1.005 . . . . 0.0 110.157 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -64.64 -39.18 93.24 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.645 0.657 . . . . 0.0 111.518 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -64.49 -49.09 72.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.242 0.928 . . . . 0.0 110.684 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.18 -39.2 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -54.05 -53.78 48.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.003 0.921 . . . . 0.0 109.442 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.2 -44.04 96.46 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.27 0.356 . . . . 0.0 111.29 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.12 -40.88 95.1 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.852 -0.53 . . . . 0.0 111.108 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.48 -49.68 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.18 -46.06 71.82 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -60.77 -46.95 88.48 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.465 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -72.7 -31.19 64.82 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.9 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -40.9 87.3 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.263 0.625 . . . . 0.0 110.017 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.42 -49.16 75.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.8 -43.82 98.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.095 0.474 . . . . 0.0 110.408 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.93 -33.82 69.21 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.804 -1.185 . . . . 0.0 112.334 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.43 22.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.019 0.528 . . . . 0.0 112.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -94.14 -52.39 4.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.001 1.321 . . . . 0.0 110.625 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.8 p -102.06 -14.69 17.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.344 1.457 . . . . 0.0 110.37 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.05 13.59 83.19 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.845 1.212 . . . . 0.0 112.052 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.245 0.862 0 CA-C-N 118.038 0.919 . . . . 0.0 109.572 -175.297 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--O 1.235 0.305 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.06 176.17 7.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.619 0.645 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -142.51 143.13 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.24 149.71 17.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.611 0.765 . . . . 0.0 109.151 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.49 132.78 33.78 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.959 0.904 . . . . 0.0 108.733 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -115.9 129.99 56.64 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -129.08 139.38 52.02 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.59 0.756 . . . . 0.0 109.562 -169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.7 p -150.16 -174.25 4.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.995 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -67.6 -9.46 43.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.252 1.021 . . . . 0.0 113.158 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.8 126.63 1.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.13 52.07 0.33 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.282 1.433 . . . . 0.0 113.293 -169.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 -18.63 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 m -136.3 -90.57 0.28 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.741 0.701 . . . . 0.0 109.379 -170.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -55.21 -53.2 58.98 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.748 0.819 . . . . 0.0 111.437 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.4 p -68.01 -35.73 78.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -173.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.63 -51.59 64.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.944 0.898 . . . . 0.0 110.836 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.5 mtm -60.66 -43.06 98.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.249 0.62 . . . . 0.0 110.69 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.5 97.22 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.455 0.57 . . . . 0.0 111.032 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' HG12 ' A' ' 34' ' ' VAL . 68.7 tt0 -57.98 -41.32 82.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.695 173.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.34 -51.85 56.18 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.889 0.768 . . . . 0.0 111.973 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -62.9 -45.69 91.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 117.577 0.689 . . . . 0.0 110.711 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.53 99.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.235 0.614 . . . . 0.0 110.595 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -52.69 -36.29 56.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.866 0.757 . . . . 0.0 111.598 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -72.28 -62.79 1.31 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.368 0.531 . . . . 0.0 110.733 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -65.41 -41.26 93.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.521 0.328 . . . . 0.0 111.822 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.53 -5.85 53.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.819 0.848 . . . . 0.0 112.444 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.74 50.67 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.942 1.258 . . . . 0.0 114.601 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 59.21 6.24 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.211 2.205 . . . . 0.0 114.197 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.33 -7.42 18.76 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.929 -1.107 . . . . 0.0 110.358 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -130.93 121.75 25.72 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.46 97.62 1.02 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -85.08 134.73 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.53 168.3 20.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.24 1.416 . . . . 0.0 109.616 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 95.5 p -145.5 160.43 41.62 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.581 0.752 . . . . 0.0 110.12 169.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.51 -166.85 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.632 1.173 . . . . 0.0 109.842 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.27 -179.39 43.91 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 121.399 -0.813 . . . . 0.0 111.514 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.65 -27.65 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.349 1.46 . . . . 0.0 111.298 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -146.26 169.79 18.07 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.813 1.245 . . . . 0.0 108.405 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 136.33 18.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -136.79 26.26 3.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.716 1.206 . . . . 0.0 109.428 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.09 168.43 42.8 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 60' ' ' SER . 1.3 pt? -86.41 147.68 25.91 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.303 0.573 . . . . 0.0 110.779 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -73.97 133.74 78.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.081 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.51 -34.47 42.38 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.775 2.317 . . . . 0.0 114.438 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.23 -28.21 62.03 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.189 -0.944 . . . . 0.0 110.921 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.44 81.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.09 -49.59 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -59.92 -41.89 92.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.75 0.705 . . . . 0.0 111.592 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.78 92.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.448 0.567 . . . . 0.0 109.752 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.8 mmm -68.11 -36.22 79.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.401 0.546 . . . . 0.0 111.313 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 120.985 -1.072 . . . . 0.0 111.52 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.73 -17.54 64.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.036 0.835 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.72 -0.41 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.89 0.876 . . . . 0.0 112.167 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 32.59 13.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.3 160.83 20.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.22 145.97 52.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.2 pt -128.05 -9.93 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.811 1.644 . . . . 0.0 109.923 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 44' ' ' LEU . 92.4 p -60.97 -25.84 67.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.844 1.202 . . . . 0.0 111.549 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.44 -27.39 69.08 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.431 1.493 . . . . 0.0 113.638 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -96.17 -29.24 14.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.47 1.032 . . . . 0.0 112.437 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.0 p 52.04 -173.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.882 1.673 . . . . 0.0 112.946 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -123.81 156.41 36.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.241 1.017 . . . . 0.0 111.234 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.56 157.24 35.0 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.125 0.97 . . . . 0.0 109.638 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.52 163.71 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.033 169.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.0 mt -56.56 146.71 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.905 1.282 . . . . 0.0 110.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.14 136.18 33.26 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.376 1.07 . . . . 0.0 110.067 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.71 -28.75 50.23 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.479 1.512 . . . . 0.0 113.188 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.61 -11.58 60.95 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.88 1.272 . . . . 0.0 112.177 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mt -114.47 -42.36 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 mt -48.52 -58.69 4.3 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.7 1.136 . . . . 0.0 111.775 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -1.12 34.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -116.14 -32.37 5.37 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.142 1.377 . . . . 0.0 111.614 -168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.53 126.77 28.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.291 1.436 . . . . 0.0 109.586 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.26 -24.55 66.6 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.22 0.608 . . . . 0.0 111.037 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.12 139.65 27.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.41 1.084 . . . . 0.0 108.554 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.88 145.26 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.32 129.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -97.55 132.7 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.34 19.13 20.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.593 1.157 . . . . 0.0 109.51 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.89 114.46 6.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 110.008 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.286 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 170.099 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo . . . . . 0 CA--C 1.533 0.462 0 N-CA-C 113.495 0.537 . . . . 0.0 113.495 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -71.25 145.83 49.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.518 1.127 . . . . 0.0 110.007 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 p -131.22 158.84 74.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.328 1.851 . . . . 0.0 110.133 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.1 136.68 38.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.228 1.952 . . . . 0.0 109.327 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.25 -23.95 20.4 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.528 2.152 . . . . 0.0 112.641 -171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -79.11 -9.59 59.6 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.214 0.606 . . . . 0.0 112.532 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.96 138.48 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -62.04 132.25 52.28 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -130.46 156.91 43.99 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.485 1.114 . . . . 0.0 109.572 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -134.44 167.86 19.98 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.241 1.817 . . . . 0.0 108.341 169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -135.86 118.15 15.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -125.34 57.66 1.31 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.377 1.871 . . . . 0.0 106.967 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.52 134.92 28.64 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.784 -1.198 . . . . 0.0 112.311 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 160.75 35.08 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.523 1.929 . . . . 0.0 106.089 169.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.71 143.83 55.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.92 126.25 92.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 -26.2 55.33 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.139 1.226 . . . . 0.0 112.921 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.48 -4.3 41.87 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.034 0.833 . . . . 0.0 112.538 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -120.43 0.44 10.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.992 1.717 . . . . 0.0 109.385 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.71 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.9 1.68 . . . . 0.0 109.192 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -58.16 123.27 15.42 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.33 -91.33 0.1 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.9 t -158.04 167.89 28.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.97 1.308 . . . . 0.0 108.023 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 -31.02 70.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.121 0.568 . . . . 0.0 111.874 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -39.48 84.3 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.64 0.376 . . . . 0.0 110.164 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.6 -38.5 70.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.72 -49.12 78.77 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 118.568 0.622 . . . . 0.0 110.186 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.23 -37.61 77.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.759 0.708 . . . . 0.0 111.207 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.65 84.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -63.32 -31.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.176 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.31 -52.06 66.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.251 1.387 . . . . 0.0 110.091 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.4 -34.63 78.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.869 0.759 . . . . 0.0 111.587 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -63.18 -52.6 61.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.836 1.198 . . . . 0.0 110.942 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.73 -37.5 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -54.32 -53.85 48.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.777 0.717 . . . . 0.0 109.409 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.34 -42.65 92.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.367 0.417 . . . . 0.0 110.58 -171.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.48 -41.1 93.67 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.959 -0.463 . . . . 0.0 111.195 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.38 -49.97 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.03 -46.57 61.29 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.589 0.631 . . . . 0.0 111.661 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.33 -48.8 80.2 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.618 0.709 . . . . 0.0 110.602 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -70.69 -30.0 66.46 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 117.297 -1.335 . . . . 0.0 111.611 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -39.82 82.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.93 1.241 . . . . 0.0 110.068 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.21 -49.41 74.18 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.445 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.67 -37.32 83.65 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.23 -35.84 35.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.496 0.318 . . . . 0.0 111.041 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.73 -42.18 10.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.513 1.125 . . . . 0.0 111.664 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.2 p -114.41 -20.81 10.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 0.0 111.817 -169.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.59 78.36 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.359 0.98 . . . . 0.0 112.836 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.245 0.853 0 CA-C-N 118.817 1.308 . . . . 0.0 109.958 -176.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -71.26 170.27 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -145.16 143.12 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -147.62 152.67 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.598 0.759 . . . . 0.0 109.526 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.49 133.03 30.32 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.805 0.842 . . . . 0.0 109.248 -173.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.89 127.81 55.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -124.1 141.54 51.97 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.623 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t -144.19 172.12 13.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.993 0.917 . . . . 0.0 110.633 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 p -59.37 -28.61 67.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.337 1.455 . . . . 0.0 110.824 169.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.5 147.98 16.87 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.8 45.72 1.02 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.853 -0.792 . . . . 0.0 111.886 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -128.12 -3.13 5.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 p -145.91 -106.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.964 1.256 . . . . 0.0 110.982 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -55.31 -36.94 66.74 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.941 0.896 . . . . 0.0 112.163 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.5 -52.72 64.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.337 1.055 . . . . 0.0 111.169 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -60.06 -50.34 74.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.501 1.121 . . . . 0.0 110.363 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.3 mtm -58.41 -44.53 89.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.92 0.488 . . . . 0.0 111.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -44.57 96.9 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.626 0.648 . . . . 0.0 111.437 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.9 tt0 -59.57 -42.74 93.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.38 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.86 -53.1 46.75 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.852 0.739 . . . . 0.0 112.073 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -61.55 -43.8 98.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.299 0.55 . . . . 0.0 110.838 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.98 -42.29 99.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 117.618 -1.182 . . . . 0.0 111.193 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -55.92 -37.58 69.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.381 1.446 . . . . 0.0 111.102 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -67.52 -56.43 9.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.285 0.493 . . . . 0.0 110.887 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -73.09 -45.59 56.34 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.068 0.147 . . . . 0.0 111.189 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.9 mt -72.15 -32.84 67.27 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.131 0.572 . . . . 0.0 111.367 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.4 176.51 51.03 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.02 -8.86 13.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.182 1.393 . . . . 0.0 111.565 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.14 -6.79 7.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 111.398 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.489 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 24.2 m95 -129.18 128.8 44.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.109 1.764 . . . . 0.0 107.02 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -76.48 88.64 3.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.5 t -80.54 133.72 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -141.41 167.33 22.43 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.863 1.265 . . . . 0.0 109.527 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.7 p -146.9 159.51 43.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.801 0.84 . . . . 0.0 109.093 169.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -168.04 1.96 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.911 1.284 . . . . 0.0 109.189 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.3 -175.78 43.02 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 121.427 -0.795 . . . . 0.0 111.517 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 mt -55.96 -28.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.716 1.606 . . . . 0.0 111.059 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -146.29 173.0 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.686 1.194 . . . . 0.0 109.455 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.26 18.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -139.13 10.7 2.58 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.788 0.835 . . . . 0.0 111.259 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.01 136.09 9.2 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -62.2 145.41 53.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.823 0.849 . . . . 0.0 112.686 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -72.26 133.62 83.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.685 1.194 . . . . 0.0 108.86 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.29 -34.63 41.07 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.823 2.349 . . . . 0.0 114.353 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -73.06 -29.33 62.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.751 0.705 . . . . 0.0 110.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.13 -49.3 74.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.7 -49.87 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.37 -39.88 92.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.964 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.9 96.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.713 0.688 . . . . 0.0 110.228 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.5 mmm -68.6 -36.39 78.64 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.807 -0.558 . . . . 0.0 111.28 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.712 -1.243 . . . . 0.0 111.485 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.65 -17.46 64.85 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.003 0.819 . . . . 0.0 110.935 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.57 -0.43 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.894 0.877 . . . . 0.0 112.125 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.15 32.45 14.13 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.53 159.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -127.31 146.3 50.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.25 0.65 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.182 1.393 . . . . 0.0 110.391 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -58.58 -28.74 65.84 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.285 -1.509 . . . . 0.0 111.15 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -67.42 -4.38 11.02 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.972 1.709 . . . . 0.0 115.001 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.82 49.81 2.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.577 1.535 . . . . 0.0 110.256 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 p -48.18 144.5 3.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 112.647 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -56.78 148.71 19.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.929 1.691 . . . . 0.0 113.936 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.44 153.52 31.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.281 1.433 . . . . 0.0 109.911 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.99 165.72 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.448 1.099 . . . . 0.0 109.68 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.37 145.87 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.552 1.141 . . . . 0.0 110.047 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -140.04 134.99 32.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.452 1.101 . . . . 0.0 109.872 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.0 -28.11 49.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.472 . . . . 0.0 113.168 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.12 -11.87 61.18 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.104 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -114.42 -41.54 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 mt -48.77 -57.62 6.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.035 1.288 . . . . 0.0 111.557 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.25 1.29 29.08 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -119.83 -32.14 4.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.007 1.323 . . . . 0.0 111.862 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.65 128.41 36.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.237 1.415 . . . . 0.0 109.44 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.59 -23.48 65.4 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.944 0.498 . . . . 0.0 110.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.3 tp -146.47 142.07 27.73 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.67 1.188 . . . . 0.0 107.993 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.02 152.86 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.46 129.0 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.9 134.72 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.12 3.57 30.46 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.883 0.873 . . . . 0.0 111.485 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.3 p -65.9 110.31 2.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.912 1.285 . . . . 0.0 111.688 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.191 0 C-N-CA 124.353 0.978 . . . . 0.0 111.746 169.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 120.567 0.153 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.6 mtm -79.39 156.31 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.781 0.833 . . . . 0.0 109.962 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -131.38 161.94 58.99 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.291 1.836 . . . . 0.0 110.263 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.5 140.52 52.57 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.904 1.736 . . . . 0.0 109.948 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.98 -22.01 20.14 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.917 2.412 . . . . 0.0 112.044 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -81.76 6.15 16.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.195 0.998 . . . . 0.0 112.461 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.01 140.71 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.97 136.42 57.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -128.31 156.22 43.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -124.3 164.51 19.45 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.606 . . . . 0.0 107.497 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -131.33 109.92 10.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -116.4 55.54 0.81 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.83 126.99 32.95 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.68 166.0 33.53 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.506 1.922 . . . . 0.0 106.628 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -64.24 149.76 47.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.665 0.745 . . . . 0.0 110.772 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.95 118.03 70.62 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.72 -23.13 63.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.617 1.544 . . . . 0.0 112.949 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.4 63.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.35 0.977 . . . . 0.0 112.214 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -111.27 4.79 19.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.47 1.508 . . . . 0.0 111.497 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.01 60.91 0.79 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.231 1.812 . . . . 0.0 111.55 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.16 141.67 53.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.016 1.726 . . . . 0.0 110.983 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.86 -58.41 0.23 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -165.94 167.29 16.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.033 1.733 . . . . 0.0 107.13 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.19 -30.16 70.24 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.86 -0.525 . . . . 0.0 111.416 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.912 0.485 . . . . 0.0 110.491 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.45 -43.25 67.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.323 0.649 . . . . 0.0 109.315 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.62 -48.32 75.11 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 121.85 -0.531 . . . . 0.0 110.394 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -60.76 -37.45 81.88 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.788 0.722 . . . . 0.0 111.704 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.93 77.77 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.296 -0.877 . . . . 0.0 110.5 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.211 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.35 -48.77 79.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.437 1.017 . . . . 0.0 109.3 171.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -47.61 79.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.571 1.078 . . . . 0.0 112.0 172.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -60.34 -47.91 84.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.663 0.665 . . . . 0.0 110.383 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.59 -37.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -56.02 -54.8 40.47 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.487 1.04 . . . . 0.0 108.693 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -65.9 -43.39 88.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.506 0.504 . . . . 0.0 110.436 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.04 -34.48 73.3 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.256 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -59.14 -52.22 63.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 169.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.09 -46.79 61.57 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.75 -37.29 85.95 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.603 0.702 . . . . 0.0 111.541 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -78.96 -30.85 44.78 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.371 -0.831 . . . . 0.0 111.111 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -40.1 81.22 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.86 174.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -51.29 -50.17 59.84 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.874 0.87 . . . . 0.0 109.674 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.83 -45.08 87.67 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 117.657 0.208 . . . . 0.0 110.82 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -57.32 -33.3 67.57 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.902 -1.124 . . . . 0.0 112.32 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.55 -37.88 24.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.934 0.493 . . . . 0.0 111.996 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.45 -51.71 5.28 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.444 1.097 . . . . 0.0 111.014 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.8 p -104.07 -17.15 15.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 110.722 -169.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.63 80.09 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.291 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 118.926 1.363 . . . . 0.0 108.864 175.225 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.05 170.14 8.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.48 141.57 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.85 149.71 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 119.021 0.828 . . . . 0.0 108.947 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.37 134.72 36.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.87 121.15 42.34 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.68 143.56 45.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 110.15 -169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -153.17 -176.16 5.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.477 0.711 . . . . 0.0 111.389 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 p -86.4 -0.98 57.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.159 1.384 . . . . 0.0 112.808 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.44 114.09 0.44 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.67 50.71 0.25 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.879 1.272 . . . . 0.0 114.332 -169.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 m -124.88 -20.11 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 121.206 -0.934 . . . . 0.0 113.444 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.0 m -128.86 -106.08 0.3 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.042 0.837 . . . . 0.0 109.426 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -40.25 46.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.391 1.476 . . . . 0.0 113.553 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 p -65.99 -45.99 79.64 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.706 0.802 . . . . 0.0 110.911 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.56 -46.39 90.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.841 0.857 . . . . 0.0 110.049 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 mtm -59.45 -45.38 91.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.043 0.537 . . . . 0.0 111.033 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.05 95.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.449 0.568 . . . . 0.0 111.334 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HG3' HG12 ' A' ' 34' ' ' VAL . 42.8 tt0 -56.73 -42.96 80.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.825 0.45 . . . . 0.0 110.594 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.14 -52.19 53.94 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.297 -0.724 . . . . 0.0 112.135 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -60.03 -43.92 94.99 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.503 0.651 . . . . 0.0 110.627 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -63.63 -42.85 98.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.307 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -55.77 -36.2 67.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.73 1.15 . . . . 0.0 111.307 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -69.44 -58.03 4.5 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.5 0.591 . . . . 0.0 110.792 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -73.08 -46.01 53.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.995 0.118 . . . . 0.0 111.106 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 87.0 mt -73.08 -36.36 66.8 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.762 0.425 . . . . 0.0 111.487 -176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.14 173.28 43.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -169.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.33 -2.36 5.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.958 0.903 . . . . 0.0 111.666 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -58.89 -13.11 5.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 111.289 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.3 m95 -128.45 120.97 27.9 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -71.15 95.4 1.24 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.508 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.4 t -83.96 133.54 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -173.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -143.28 167.52 21.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.212 1.405 . . . . 0.0 109.59 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.0 p -145.0 159.64 42.62 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.768 0.827 . . . . 0.0 109.36 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.7 -170.96 2.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.652 1.181 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.02 -172.43 41.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.0 mt -57.38 -28.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.958 1.303 . . . . 0.0 110.942 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.32 166.73 29.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.627 1.171 . . . . 0.0 109.568 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.65 26.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.128 1.371 . . . . 0.0 107.773 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.13 17.46 4.11 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.093 1.357 . . . . 0.0 110.258 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 168.41 44.74 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.68 149.41 25.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.469 0.652 . . . . 0.0 111.831 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.91 138.13 57.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.299 1.439 . . . . 0.0 109.746 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.52 -28.61 70.39 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.79 1.66 . . . . 0.0 112.959 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -71.99 -33.56 68.2 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.97 92.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -57.3 -50.1 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.333 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -57.93 -44.75 87.08 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.159 0.89 . . . . 0.0 111.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.87 87.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.7 mmm -68.88 -37.86 79.32 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.157 0.183 . . . . 0.0 111.008 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -32.53 69.7 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.287 -0.883 . . . . 0.0 111.121 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.51 -11.32 60.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.343 1.057 . . . . 0.0 110.477 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -115.68 0.45 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.328 1.051 . . . . 0.0 112.031 173.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 30.76 13.09 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -120.55 160.11 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.85 145.52 51.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.31 -8.32 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.676 1.591 . . . . 0.0 110.436 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -55.97 -32.67 64.11 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.87 0.868 . . . . 0.0 111.119 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.76 -14.34 61.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.381 1.472 . . . . 0.0 114.371 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -107.69 -30.08 8.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 -169.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.0 p 51.2 -175.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.283 1.833 . . . . 0.0 113.716 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 m -119.88 155.87 31.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.68 1.192 . . . . 0.0 111.0 -170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -158.43 158.9 35.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 109.629 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.14 165.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.26 144.25 9.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.921 0.888 . . . . 0.0 109.466 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -136.46 140.18 42.91 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.773 1.229 . . . . 0.0 110.129 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.63 -29.91 62.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.187 1.395 . . . . 0.0 113.449 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.33 -12.28 61.48 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 111.95 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.45 -44.64 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.45 -40.59 78.79 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.1 1.318 . . . . 0.0 112.712 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -1.64 55.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -117.69 -26.35 6.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.126 1.37 . . . . 0.0 112.831 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.36 124.65 18.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.198 1.399 . . . . 0.0 110.08 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -32.43 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.247 1.419 . . . . 0.0 109.817 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.07 144.33 30.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.197 1.399 . . . . 0.0 108.106 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -117.66 153.21 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.91 138.61 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 p -113.46 131.98 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.44 21.69 16.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.809 1.244 . . . . 0.0 108.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -82.79 99.37 9.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.019 1.327 . . . . 0.0 109.718 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 1.498 0 C-N-CA 123.929 0.776 . . . . 0.0 111.441 169.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 CA--C 1.537 0.671 0 N-CA-C 110.57 -0.589 . . . . 0.0 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.52 158.25 36.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 109.97 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -123.06 157.02 61.84 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.948 1.699 . . . . 0.0 109.147 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG2' HG22 ' A' ' 96' ' ' VAL . 80.5 Cg_endo -76.29 162.17 34.13 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 121.567 1.512 . . . . 0.0 110.36 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.22 -17.66 24.23 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.949 2.433 . . . . 0.0 111.591 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -65.91 -22.63 66.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.252 1.021 . . . . 0.0 112.352 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 93' ' ' PRO . 26.2 m -113.98 150.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.637 0.653 . . . . 0.0 111.11 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -72.6 149.56 43.85 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -132.55 156.69 46.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 111.363 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.74 162.14 26.52 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.009 2.523 . . . . 0.0 106.822 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -144.86 114.76 7.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -122.38 10.67 9.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.517 1.527 . . . . 0.0 111.49 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.7 138.22 5.32 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.938 1.256 . . . . 0.0 114.844 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 -100.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.868 1.667 . . . . 0.0 107.177 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -154.86 152.69 30.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.62 126.41 86.08 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.04 -25.58 66.24 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.34 1.36 . . . . 0.0 113.939 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.89 -13.09 62.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.346 0.975 . . . . 0.0 112.368 172.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mtm-85 -111.96 6.24 19.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.259 . . . . 0.0 111.378 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.66 60.9 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.335 1.854 . . . . 0.0 110.737 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.56 141.76 54.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.919 1.688 . . . . 0.0 111.137 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.66 -59.29 0.22 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -166.38 169.61 13.84 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 107.108 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -30.12 68.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.279 0.631 . . . . 0.0 111.292 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.84 -37.8 73.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.832 0.453 . . . . 0.0 110.766 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.64 -43.56 76.02 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -57.01 -51.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.81 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -58.06 -38.4 76.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.792 0.837 . . . . 0.0 111.903 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.69 87.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.443 -0.785 . . . . 0.0 109.863 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -63.95 -34.92 79.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.988 0.515 . . . . 0.0 111.85 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -57.76 -49.96 74.83 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.172 0.896 . . . . 0.0 109.798 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -63.91 -36.06 82.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.293 0.497 . . . . 0.0 111.76 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.52 -48.05 68.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.637 0.653 . . . . 0.0 111.014 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.09 -41.85 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -54.29 -53.61 51.38 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.02 0.928 . . . . 0.0 109.537 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.54 -42.91 95.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.787 0.267 . . . . 0.0 111.072 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.17 -42.16 84.76 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.982 -0.449 . . . . 0.0 110.848 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.32 -49.91 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.61 -43.18 78.71 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.02 -51.64 68.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 117.484 0.642 . . . . 0.0 111.131 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.5 mmm-85 -68.54 -29.58 68.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -40.86 88.05 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 120.123 1.328 . . . . 0.0 109.74 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -56.73 -53.16 60.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.36 -34.4 78.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.605 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -63.33 -37.9 89.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.798 -0.564 . . . . 0.0 110.726 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.63 -35.55 29.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.193 0.597 . . . . 0.0 111.548 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.07 -42.46 9.4 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.746 1.219 . . . . 0.0 111.72 -169.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 p -113.48 -18.18 12.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 111.056 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.82 65.85 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.036 -0.869 . . . . 0.0 111.981 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.245 0.866 0 C-N-CA 124.564 1.146 . . . . 0.0 108.137 -175.694 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 173.26 9.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.553 0.615 . . . . 0.0 110.138 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.33 141.03 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.53 149.76 16.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.091 0.956 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 131.69 32.65 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.523 0.729 . . . . 0.0 109.065 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.33 128.17 55.87 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.3 143.85 51.15 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.401 0.68 . . . . 0.0 110.585 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.51 174.68 10.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.367 1.079 . . . . 0.0 112.674 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.8 p -77.97 32.69 0.18 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.444 2.298 . . . . 0.0 110.616 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.01 113.73 0.83 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -173.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.31 53.98 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.264 1.026 . . . . 0.0 111.611 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 m -125.15 -19.67 5.08 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.1 m -138.81 -90.4 0.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.798 0.726 . . . . 0.0 109.1 -173.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -52.37 -53.25 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.041 0.936 . . . . 0.0 112.34 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 p -68.14 -38.35 82.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.658 0.663 . . . . 0.0 111.097 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -58.66 -54.86 42.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.962 0.905 . . . . 0.0 109.903 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.6 mtp -54.73 -46.05 74.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.57 1.548 . . . . 0.0 110.576 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.28 88.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.881 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 34' ' ' VAL . 23.6 tt0 -57.05 -37.8 72.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.445 0.566 . . . . 0.0 110.851 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.51 -54.03 41.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 123.829 0.728 . . . . 0.0 111.498 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -61.75 -41.81 98.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.313 0.557 . . . . 0.0 110.777 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.8 88.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.297 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -55.15 -36.33 65.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.873 1.215 . . . . 0.0 111.358 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -67.3 -56.96 7.61 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.363 0.414 . . . . 0.0 110.783 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -77.36 -44.47 29.28 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 84.4 mt -74.51 -37.07 63.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 111.071 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 173.03 42.95 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.41 -1.93 5.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.677 0.791 . . . . 0.0 111.634 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -57.89 -13.2 4.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.034 1.333 . . . . 0.0 111.325 169.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 13.7 m95 -129.13 115.49 17.78 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.246 -2.502 . . . . 0.0 104.246 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -66.34 100.79 0.67 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 21' ' ' GLU . 2.8 p -107.68 133.37 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.602 0.761 . . . . 0.0 109.831 -168.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.06 167.38 22.21 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.162 1.385 . . . . 0.0 109.459 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -140.41 151.33 44.84 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 109.92 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.02 -166.66 1.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.584 1.154 . . . . 0.0 109.812 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.52 -176.31 46.32 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 121.342 -0.849 . . . . 0.0 111.387 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.4 mt -54.95 -31.92 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.723 1.609 . . . . 0.0 110.806 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.11 167.06 25.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.027 1.331 . . . . 0.0 108.087 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.83 133.0 20.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -134.42 21.82 3.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.179 0.992 . . . . 0.0 109.347 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.12 165.25 33.89 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -87.02 147.88 25.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.07 0.548 . . . . 0.0 110.442 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -73.43 133.52 80.45 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.365 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.88 -34.38 45.23 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.884 2.389 . . . . 0.0 114.495 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -73.97 -27.85 61.19 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 121.385 -0.822 . . . . 0.0 110.929 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.56 75.88 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.1 -49.18 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.8 -43.61 94.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.052 0.541 . . . . 0.0 111.039 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.15 94.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.209 0.604 . . . . 0.0 110.255 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.2 mmm -69.72 -36.66 76.08 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.282 0.492 . . . . 0.0 111.318 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -27.34 69.25 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 120.797 -1.19 . . . . 0.0 111.446 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.17 -15.17 63.55 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.914 0.779 . . . . 0.0 110.825 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.79 -0.0 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.17 0.988 . . . . 0.0 112.079 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.59 17.44 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.64 160.51 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.85 145.31 50.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.56 2.98 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.859 1.264 . . . . 0.0 110.41 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -58.7 -29.52 66.71 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.214 -1.554 . . . . 0.0 111.086 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -65.64 -4.73 6.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.425 1.89 . . . . 0.0 115.334 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -135.45 48.47 2.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.444 1.474 . . . . 0.0 110.829 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -44.86 132.62 6.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.843 1.257 . . . . 0.0 111.111 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -57.29 154.81 9.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -168.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -154.15 155.7 35.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.108 1.363 . . . . 0.0 109.581 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.23 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.497 1.119 . . . . 0.0 109.784 172.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.77 153.16 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.058 1.343 . . . . 0.0 110.067 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.98 139.11 21.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.688 1.595 . . . . 0.0 108.643 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.34 -28.11 57.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.31 1.444 . . . . 0.0 113.464 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.04 -13.51 62.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.573 1.149 . . . . 0.0 112.286 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -113.36 -40.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.8 mt -48.09 -61.33 2.03 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.834 1.197 . . . . 0.0 111.603 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -3.27 35.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -111.94 -33.11 6.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.331 1.452 . . . . 0.0 110.941 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 122.65 15.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.48 1.512 . . . . 0.0 110.092 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.23 -23.38 66.41 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 111.197 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 tp -143.82 138.65 28.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.747 1.219 . . . . 0.0 107.936 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.6 145.4 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.14 124.85 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.29 127.11 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.41 24.57 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.896 0.855 . . . . 0.0 109.081 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.0 p -75.96 107.98 8.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.589 1.556 . . . . 0.0 110.029 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.147 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 171.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo . . . . . 0 CA--C 1.535 0.527 0 CA-C-O 121.146 0.394 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -74.1 155.66 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 0.0 109.833 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -132.17 161.6 61.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.879 2.071 . . . . 0.0 109.149 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.6 159.71 50.36 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 121.246 1.297 . . . . 0.0 109.583 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.72 -26.15 10.09 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.397 2.065 . . . . 0.0 112.422 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -74.9 -34.61 62.21 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.274 0.63 . . . . 0.0 112.45 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.73 153.43 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.542 0.687 . . . . 0.0 111.013 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -70.65 141.28 51.68 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -134.03 149.71 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.216 0.607 . . . . 0.0 109.902 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -127.07 157.14 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.702 2.001 . . . . 0.0 107.832 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -131.34 113.44 13.77 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.8 m0 -122.26 52.89 1.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.154 1.781 . . . . 0.0 106.797 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.15 128.67 34.07 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 120.747 -1.221 . . . . 0.0 111.654 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.98 160.83 39.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 105.911 169.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -68.73 144.05 54.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.431 0.634 . . . . 0.0 110.747 -174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.38 127.64 93.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.51 -23.07 50.73 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.162 1.241 . . . . 0.0 113.506 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.93 -11.45 60.35 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.454 1.025 . . . . 0.0 112.347 171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -111.49 3.23 17.93 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.879 1.272 . . . . 0.0 110.755 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.51 60.61 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.21 2.204 . . . . 0.0 110.844 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.43 138.2 57.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 110.587 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.68 -58.35 0.19 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -166.3 168.43 15.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.902 1.681 . . . . 0.0 107.339 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -30.3 70.15 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.781 -0.574 . . . . 0.0 111.394 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.75 -38.55 76.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.928 0.491 . . . . 0.0 110.585 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.57 -46.13 77.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -56.91 -49.95 74.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.168 0.587 . . . . 0.0 110.26 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -60.33 -37.16 79.75 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.866 0.757 . . . . 0.0 111.975 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.46 80.24 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.147 -0.97 . . . . 0.0 110.258 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.38 -32.69 74.46 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.948 -0.47 . . . . 0.0 111.477 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -57.42 -49.09 77.35 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.465 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -45.55 84.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 111.829 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -60.73 -48.78 80.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.002 0.819 . . . . 0.0 110.681 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.67 -39.65 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -55.85 -55.94 26.53 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 124.095 0.958 . . . . 0.0 108.956 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.52 -37.63 77.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 123.536 0.523 . . . . 0.0 110.502 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.01 -42.61 80.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.031 0.532 . . . . 0.0 111.255 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.3 mt -58.61 -52.19 62.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.94 56.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.909 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -61.61 -50.06 74.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.726 0.763 . . . . 0.0 111.066 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.41 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.57 -34.77 74.64 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.113 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -40.3 96.45 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.207 0.912 . . . . 0.0 109.742 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.32 -49.77 75.06 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.076 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.71 -43.63 98.32 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 110.131 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.18 -31.72 69.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.649 -1.282 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 -37.19 23.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.471 0.708 . . . . 0.0 112.212 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.6 -52.97 4.63 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.819 1.248 . . . . 0.0 110.728 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.2 p -103.03 -16.52 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.842 1.657 . . . . 0.0 110.414 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.34 86.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.486 1.041 . . . . 0.0 112.381 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 C--O 1.246 0.893 0 CA-C-N 118.694 1.247 . . . . 0.0 108.743 -172.533 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.08 -179.91 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.232 0.613 . . . . 0.0 109.919 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -140.91 142.49 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.82 150.32 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 118.87 0.759 . . . . 0.0 109.251 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -139.49 136.8 34.94 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.715 0.806 . . . . 0.0 109.508 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.49 133.05 54.6 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.564 1.146 . . . . 0.0 108.29 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.15 141.0 52.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.54 0.736 . . . . 0.0 110.244 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.93 168.97 18.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.173 1.389 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 p -55.5 -36.11 66.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.52 1.128 . . . . 0.0 110.939 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.2 141.47 9.39 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -77.44 51.22 0.86 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.42 1.088 . . . . 0.0 111.712 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.7 m -126.46 -15.58 5.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.771 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.98 -98.56 0.19 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -52.31 -50.29 62.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.081 0.953 . . . . 0.0 112.311 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -70.7 -36.32 73.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.78 0.264 . . . . 0.0 111.509 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -60.92 -53.78 53.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.247 1.019 . . . . 0.0 110.214 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.7 mtp -53.94 -46.84 71.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.182 1.393 . . . . 0.0 110.551 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.26 95.6 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.914 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 54.7 tt0 -55.92 -41.44 74.57 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.223 0.465 . . . . 0.0 110.728 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.27 -48.1 85.0 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.4 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -63.01 -43.57 98.4 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.834 0.817 . . . . 0.0 110.864 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.29 99.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.787 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -51.55 -38.31 53.69 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.068 0.849 . . . . 0.0 111.907 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -70.21 -62.66 1.3 Allowed 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 123.327 0.392 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -67.95 -37.78 82.0 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 78.5 mt -77.03 -1.36 28.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.682 0.793 . . . . 0.0 112.489 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.34 24.97 59.76 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.573 1.082 . . . . 0.0 113.738 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.12 16.06 2.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.768 2.027 . . . . 0.0 113.611 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.59 2.2 14.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.945 -1.097 . . . . 0.0 111.33 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.1 m95 -134.21 124.74 26.49 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.64 94.25 0.42 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.6 t -79.11 138.46 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -143.5 164.62 29.85 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.075 1.35 . . . . 0.0 109.695 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -146.42 156.56 43.39 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.783 0.833 . . . . 0.0 109.461 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 -166.89 2.07 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.224 1.009 . . . . 0.0 109.584 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.69 44.03 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mt -57.03 -25.57 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.927 1.291 . . . . 0.0 111.363 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.02 169.47 19.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.967 1.307 . . . . 0.0 108.825 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.21 135.48 21.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 169.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -129.18 11.12 5.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.723 1.209 . . . . 0.0 110.042 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 162.4 30.61 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -170.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.08 146.67 30.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.321 0.581 . . . . 0.0 111.045 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.16 133.68 83.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.147 -0.93 . . . . 0.0 108.945 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.53 -34.62 43.09 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.799 2.333 . . . . 0.0 114.563 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -73.41 -28.18 61.85 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.567 -0.708 . . . . 0.0 110.731 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.77 73.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -57.68 -48.05 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -60.04 -41.76 92.95 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.57 0.623 . . . . 0.0 110.764 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.47 94.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.14 0.576 . . . . 0.0 109.78 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.5 mmm -69.07 -38.52 79.07 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.415 0.15 . . . . 0.0 111.061 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.47 -25.1 67.85 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.85 -1.156 . . . . 0.0 111.483 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.79 -15.62 63.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.578 0.751 . . . . 0.0 110.42 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.25 0.82 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.927 0.891 . . . . 0.0 112.064 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.04 19.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.65 159.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -125.95 145.45 50.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 pt -127.97 2.7 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.977 1.311 . . . . 0.0 110.383 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.86 -27.98 67.13 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 119.978 -1.701 . . . . 0.0 111.2 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.84 -5.23 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.227 1.811 . . . . 0.0 115.107 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.18 49.61 2.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.253 1.388 . . . . 0.0 110.876 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -46.72 134.64 9.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.3 1.04 . . . . 0.0 110.967 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.26 155.51 8.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -154.48 156.18 36.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.967 1.307 . . . . 0.0 109.395 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.0 167.98 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 109.777 171.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.41 146.22 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.454 1.501 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -138.65 139.49 38.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.283 1.433 . . . . 0.0 109.773 170.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -55.81 -29.12 59.24 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.516 1.526 . . . . 0.0 113.259 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.75 -7.06 36.23 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 112.392 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.94 -44.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -45.7 -55.85 5.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.092 0.957 . . . . 0.0 112.305 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.7 51.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 112.925 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.8 -30.01 4.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 112.299 -168.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.97 130.37 46.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.778 1.231 . . . . 0.0 109.92 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.58 -22.98 64.43 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.223 0.609 . . . . 0.0 110.962 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.0 tp -146.44 142.18 27.89 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 108.829 170.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.9 145.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.48 135.48 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.56 107.67 13.56 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.68 8.32 34.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.409 0.683 . . . . 0.0 112.637 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.6 p -68.65 72.89 0.24 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.825 2.45 . . . . 0.0 114.669 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 O-C-N 120.575 -1.328 . . . . 0.0 112.827 174.747 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 0 CA--C 1.534 0.521 0 N-CA-C 113.245 0.441 . . . . 0.0 113.245 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.01 138.24 58.23 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.902 0.881 . . . . 0.0 110.245 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -124.02 158.09 61.53 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.471 1.908 . . . . 0.0 109.689 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.5 153.39 76.66 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.82 1.68 . . . . 0.0 109.324 169.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.63 -23.97 16.41 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.478 2.119 . . . . 0.0 112.103 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -73.05 -32.83 65.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.645 0.778 . . . . 0.0 112.196 -173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.94 145.07 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.432 0.634 . . . . 0.0 109.799 -172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.86 130.99 44.97 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -134.54 150.4 50.76 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.021 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.78 160.68 30.15 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.317 2.247 . . . . 0.0 107.574 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -133.13 115.13 14.69 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.406 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 33.6 m0 -119.11 59.67 0.83 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.84 123.85 13.78 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.767 -171.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.94 160.13 43.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.61 1.964 . . . . 0.0 106.528 168.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -69.81 149.66 47.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.179 0.514 . . . . 0.0 110.591 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.2 128.61 80.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.49 -24.83 35.86 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.221 1.28 . . . . 0.0 113.515 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 -12.45 61.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.487 1.04 . . . . 0.0 111.722 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.0 ttp85 -101.93 2.0 37.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.889 1.275 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.93 67.2 0.82 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.115 1.366 . . . . 0.0 110.385 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.49 137.42 56.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.928 0.891 . . . . 0.0 110.464 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.42 -63.42 0.19 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.4 t -165.15 168.72 16.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 107.6 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.93 -29.53 68.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.386 0.675 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.64 -37.33 70.86 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.22 0.464 . . . . 0.0 110.836 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.23 -44.01 76.69 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -58.22 -48.02 81.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 122.856 0.462 . . . . 0.0 110.084 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -58.45 -39.89 81.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.561 0.744 . . . . 0.0 111.702 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.68 84.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.442 -0.787 . . . . 0.0 110.213 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.52 -34.12 77.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.07 0.548 . . . . 0.0 111.165 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -59.37 -48.14 82.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.909 . . . . 0.0 110.222 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -65.14 -36.36 84.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.491 0.587 . . . . 0.0 111.521 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -65.57 -50.36 65.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.265 0.484 . . . . 0.0 110.64 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.54 -39.37 84.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -54.44 -53.33 55.61 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.781 0.832 . . . . 0.0 109.352 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.56 -41.94 95.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.046 0.384 . . . . 0.0 111.035 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.18 -41.29 90.48 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.597 -0.689 . . . . 0.0 111.411 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.89 -53.03 50.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.55 -45.72 53.75 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 123.677 0.656 . . . . 0.0 111.754 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -60.46 -50.28 74.19 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.918 0.859 . . . . 0.0 111.174 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -70.79 -33.18 70.47 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.991 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -39.61 94.86 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.179 0.9 . . . . 0.0 109.969 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.83 -52.63 64.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.0 -35.29 80.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.255 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.56 -36.58 83.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.81 -0.556 . . . . 0.0 111.223 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.52 26.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 122.818 0.447 . . . . 0.0 111.44 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.42 -42.96 11.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.611 1.165 . . . . 0.0 111.628 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.0 p -113.29 -19.0 11.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.224 1.01 . . . . 0.0 111.161 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.77 10.54 75.83 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.209 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 118.654 1.227 . . . . 0.0 108.364 -174.677 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.235 0.301 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.85 175.1 6.07 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.37 140.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.78 148.94 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.4 131.66 30.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.71 131.24 56.99 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -125.91 139.59 53.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.639 0.776 . . . . 0.0 109.719 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.2 t -135.74 168.75 18.71 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.442 1.097 . . . . 0.0 109.406 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.8 p -58.77 -26.27 63.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.476 1.111 . . . . 0.0 111.314 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 138.04 5.94 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.03 53.45 0.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.603 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 m -126.85 -17.66 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.921 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.03 -90.93 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.876 0.762 . . . . 0.0 109.184 -170.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -56.46 -53.46 57.21 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.38 0.672 . . . . 0.0 111.542 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -67.68 -36.4 80.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.774 0.261 . . . . 0.0 111.197 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -59.61 -57.58 12.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.147 0.979 . . . . 0.0 110.085 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.8 mtm -56.86 -43.4 81.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.319 0.648 . . . . 0.0 111.517 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.28 99.15 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.482 0.583 . . . . 0.0 111.824 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.6 tt0 -57.7 -39.74 77.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.237 0.471 . . . . 0.0 110.815 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.4 53.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 123.697 0.665 . . . . 0.0 111.546 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -61.32 -45.29 95.04 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.303 0.551 . . . . 0.0 110.98 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.7 -44.25 97.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.34 0.656 . . . . 0.0 110.852 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -56.3 -34.21 66.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.055 0.843 . . . . 0.0 111.889 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -67.22 -61.61 1.84 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.131 0.423 . . . . 0.0 110.443 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.02 -42.71 80.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.35 0.26 . . . . 0.0 111.507 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.38 -7.84 58.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 0.0 112.241 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.93 56.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.859 1.219 . . . . 0.0 114.621 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.58 4.76 1.08 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.696 2.398 . . . . 0.0 114.107 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.29 -9.11 21.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.714 1.206 . . . . 0.0 110.384 169.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -129.37 118.84 22.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 172.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.64 99.7 0.81 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -84.1 141.47 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -144.01 165.31 28.12 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.941 1.696 . . . . 0.0 109.077 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.2 p -143.92 155.89 44.23 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.736 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.37 1.69 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.622 1.169 . . . . 0.0 109.459 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.09 179.83 45.19 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -54.39 -28.41 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.366 1.466 . . . . 0.0 111.387 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.06 170.61 16.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.966 1.307 . . . . 0.0 108.632 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.0 134.09 18.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -135.92 19.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.363 1.065 . . . . 0.0 109.81 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.09 163.15 29.73 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -83.97 146.21 28.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 110.696 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -70.66 134.13 86.38 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.036 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.23 -35.67 44.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.795 2.33 . . . . 0.0 114.259 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -72.75 -26.64 61.64 Favored 'General case' 0 C--O 1.227 -0.111 0 O-C-N 121.491 -0.756 . . . . 0.0 111.094 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -46.62 78.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.77 -47.98 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -57.16 -46.34 82.85 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.858 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.56 86.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -69.26 -37.69 78.04 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 110.852 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.01 -25.72 67.97 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.879 -1.138 . . . . 0.0 111.778 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -71.43 -12.35 61.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.453 1.101 . . . . 0.0 110.424 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.28 -1.66 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 112.735 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.23 33.13 10.94 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.24 162.89 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.5 146.37 50.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.2 pt -128.95 3.97 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.824 1.25 . . . . 0.0 110.589 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.32 -28.38 66.75 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.136 -1.603 . . . . 0.0 111.003 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -64.73 -5.58 6.11 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.291 1.836 . . . . 0.0 115.188 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -135.67 50.35 2.11 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.512 1.505 . . . . 0.0 110.426 -169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -46.21 133.28 9.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.493 1.117 . . . . 0.0 110.683 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 m -57.8 154.75 11.41 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -154.0 155.38 35.44 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.094 1.357 . . . . 0.0 109.522 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.42 166.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.354 1.062 . . . . 0.0 109.56 172.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.04 145.92 5.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.717 1.207 . . . . 0.0 109.898 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.07 135.97 33.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.391 1.076 . . . . 0.0 109.884 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -54.49 -28.35 44.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.426 1.49 . . . . 0.0 113.067 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.04 -11.98 61.28 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mt -114.52 -42.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.27 -57.5 6.69 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.928 1.24 . . . . 0.0 111.661 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -1.8 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -116.37 -32.58 5.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.214 1.405 . . . . 0.0 111.591 -168.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.46 128.25 35.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.32 1.448 . . . . 0.0 109.619 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.34 -29.85 71.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.863 0.865 . . . . 0.0 110.182 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.9 tp -147.3 140.43 25.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 108.647 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.84 154.72 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 t -140.09 136.43 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.06 135.65 47.14 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.39 10.46 37.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 110.613 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.2 p -64.21 116.98 6.52 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.643 1.177 . . . . 0.0 111.18 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.317 0 C-N-CA 124.909 1.242 . . . . 0.0 111.051 169.671 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 N--CA 1.459 -0.534 0 N-CA-C 114.089 0.765 . . . . 0.0 114.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -72.31 146.36 47.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.405 1.082 . . . . 0.0 110.098 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 p -129.46 160.22 65.45 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.607 1.963 . . . . 0.0 109.906 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.46 145.21 64.13 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.034 1.823 . . . . 0.0 109.895 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.5 -23.31 20.25 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.915 2.41 . . . . 0.0 112.185 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -85.01 6.58 24.66 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.067 0.947 . . . . 0.0 112.367 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.16 135.9 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.28 145.35 55.85 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -123.67 169.53 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.266 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -136.51 164.32 28.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.611 2.364 . . . . 0.0 106.794 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -134.02 113.25 11.93 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -121.63 61.82 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.06 131.3 11.66 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.304 -0.873 . . . . 0.0 112.885 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.28 160.46 40.81 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.396 2.278 . . . . 0.0 106.159 169.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -65.86 148.97 50.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.838 -0.539 . . . . 0.0 110.324 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -74.4 128.32 86.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.33 -21.23 54.6 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.063 1.175 . . . . 0.0 113.403 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.38 -18.3 65.07 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.399 1.0 . . . . 0.0 112.372 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -86.46 -8.67 57.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.457 1.026 . . . . 0.0 112.516 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 52.91 0.55 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 112.369 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.78 150.78 27.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.008 2.123 . . . . 0.0 112.063 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.62 -52.81 0.42 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -165.97 165.47 18.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.97 1.708 . . . . 0.0 107.263 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -28.54 67.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 0.0 111.223 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.78 -37.36 73.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.3 0.5 . . . . 0.0 110.903 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.9 -45.91 73.09 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.42 -49.37 74.72 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.923 0.489 . . . . 0.0 110.352 173.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.98 -39.71 86.62 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.631 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.232 -0.917 . . . . 0.0 110.838 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -67.41 -32.73 73.83 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.767 -0.583 . . . . 0.0 111.747 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.05 -44.64 91.84 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.693 0.679 . . . . 0.0 110.327 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.08 -38.05 89.65 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.635 0.652 . . . . 0.0 111.423 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -61.92 -51.16 69.26 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.109 0.868 . . . . 0.0 110.258 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.96 -38.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.332 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -63.91 -39.79 95.0 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.025 1.738 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.42 -45.37 80.13 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.239 0.472 . . . . 0.0 111.109 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.75 -41.81 95.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.002 -0.436 . . . . 0.0 110.874 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.05 -51.28 74.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.37 -46.31 57.81 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.566 -0.575 . . . . 0.0 111.786 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.89 -48.16 83.1 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.813 0.806 . . . . 0.0 110.826 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -35.11 76.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -41.45 93.71 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.821 -0.549 . . . . 0.0 110.079 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.89 -50.39 72.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.74 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.55 -45.33 94.61 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.57 -33.58 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.664 -1.273 . . . . 0.0 112.334 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.36 -32.89 20.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.414 0.686 . . . . 0.0 112.304 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.32 -53.68 3.53 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 -169.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.3 p -99.57 -15.54 18.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.49 1.516 . . . . 0.0 110.495 -170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.85 78.49 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.169 0.89 . . . . 0.0 111.815 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 117.868 0.834 . . . . 0.0 109.811 -179.228 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 C--O 1.234 0.248 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 10.7 mmpt? -97.19 170.13 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.021 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.24 142.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 tt -141.05 146.56 23.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.91 120.85 15.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -171.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -104.09 127.85 51.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.871 0.868 . . . . 0.0 108.936 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.08 140.81 51.45 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.768 1.227 . . . . 0.0 109.184 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 m -140.52 168.86 18.82 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.49 1.116 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.14 -25.15 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.009 0.924 . . . . 0.0 111.377 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.49 136.25 5.0 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 169.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.79 55.88 2.16 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.296 1.038 . . . . 0.0 110.724 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -122.18 -25.95 4.79 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.7 m -133.02 -94.67 0.33 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.319 0.963 . . . . 0.0 110.32 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.75 80.03 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -169.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -58.72 -49.7 76.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.348 0.659 . . . . 0.0 110.703 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -63.72 -43.9 95.16 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.562 0.745 . . . . 0.0 110.802 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.81 -44.94 95.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.679 0.391 . . . . 0.0 111.036 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.0 99.72 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.525 0.602 . . . . 0.0 111.091 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.2 tt0 -57.59 -43.64 84.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.252 173.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.19 -53.37 43.22 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.823 0.725 . . . . 0.0 112.076 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -62.38 -44.31 96.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.194 0.497 . . . . 0.0 110.947 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.667 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -54.82 -35.19 63.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.425 1.011 . . . . 0.0 111.59 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -72.31 -62.82 1.3 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.122 0.419 . . . . 0.0 110.798 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -67.44 -37.51 83.12 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.0 -2.22 26.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.349 0.66 . . . . 0.0 112.364 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.55 57.49 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.559 1.552 . . . . 0.0 115.127 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 58.88 11.6 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.585 1.954 . . . . 0.0 113.363 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.39 -12.68 61.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.786 -1.196 . . . . 0.0 110.191 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -125.3 126.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.529 1.931 . . . . 0.0 106.513 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.2 mmpt? -70.3 108.86 4.4 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -96.79 137.59 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.79 165.3 27.76 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.584 1.154 . . . . 0.0 109.805 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.4 p -147.4 159.43 43.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.329 0.652 . . . . 0.0 109.831 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.96 -169.38 2.02 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.36 1.464 . . . . 0.0 109.635 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.42 -177.86 43.88 Favored Glycine 0 CA--C 1.52 0.386 0 O-C-N 121.47 -0.768 . . . . 0.0 112.055 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.89 -28.22 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.542 1.537 . . . . 0.0 111.292 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.4 170.08 17.56 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.835 1.254 . . . . 0.0 108.715 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.74 136.15 21.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -137.52 21.09 2.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.319 1.048 . . . . 0.0 109.846 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.09 153.35 29.33 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.51 150.66 47.8 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.41 0.624 . . . . 0.0 111.369 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -77.45 133.43 67.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.865 1.266 . . . . 0.0 109.123 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.5 -34.54 42.52 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.933 2.422 . . . . 0.0 114.592 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -72.28 -28.76 63.31 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.25 -0.906 . . . . 0.0 110.769 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -47.03 84.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.71 -48.86 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -60.73 -41.32 95.1 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.651 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.33 95.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.8 0.727 . . . . 0.0 109.845 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 77.2 mmm -69.47 -35.54 75.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.822 0.283 . . . . 0.0 111.402 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -28.15 69.31 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.848 -1.157 . . . . 0.0 111.7 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -66.21 -17.27 64.63 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.201 0.91 . . . . 0.0 110.81 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.15 0.4 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.95 0.9 . . . . 0.0 112.021 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.92 32.0 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.35 155.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.62 145.83 47.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.48 -1.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.796 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -58.21 -31.98 67.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.859 0.864 . . . . 0.0 110.958 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -64.49 7.26 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.443 1.897 . . . . 0.0 114.948 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -131.41 29.44 4.57 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.301 1.41 . . . . 0.0 112.527 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -41.48 127.43 3.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.25 1.02 . . . . 0.0 113.434 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 m -54.52 155.2 4.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.229 1.812 . . . . 0.0 115.49 -168.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -154.22 156.6 37.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.175 1.39 . . . . 0.0 109.376 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.41 163.3 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.946 0.898 . . . . 0.0 109.322 170.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.95 145.53 7.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.784 1.234 . . . . 0.0 109.834 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -136.36 133.84 37.21 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.629 1.172 . . . . 0.0 110.035 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.13 -27.99 56.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.625 1.57 . . . . 0.0 113.593 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.82 -0.04 49.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.631 0.651 . . . . 0.0 111.897 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -112.26 -41.79 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.4 mt -47.82 -56.8 6.64 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.351 0.978 . . . . 0.0 111.873 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -83.45 4.18 28.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.702 0.801 . . . . 0.0 112.659 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.88 -27.45 3.61 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.175 . . . . 0.0 112.043 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.83 135.15 56.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.914 1.286 . . . . 0.0 108.678 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.02 -34.23 77.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.4 137.3 25.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.623 1.169 . . . . 0.0 109.175 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.37 147.39 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.1 118.95 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -93.47 133.36 36.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.35 25.54 11.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.203 1.001 . . . . 0.0 108.884 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -72.35 103.87 3.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.765 -1.209 . . . . 0.0 111.263 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.554 0 C-N-CA 125.196 1.379 . . . . 0.0 109.768 169.372 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 CA--C 1.535 0.556 0 N-CA-C 112.633 0.205 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.08 149.2 43.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 p -131.22 158.58 74.84 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.957 2.103 . . . . 0.0 109.258 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.98 159.33 41.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.214 1.943 . . . . 0.0 110.352 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.09 -15.95 25.61 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.078 2.519 . . . . 0.0 111.126 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.31 -12.47 61.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.406 1.482 . . . . 0.0 112.908 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.72 148.26 27.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.223 0.92 . . . . 0.0 112.113 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -68.09 141.45 56.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -135.54 151.04 49.94 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.109 0.564 . . . . 0.0 110.683 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -127.81 161.14 29.71 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.226 2.21 . . . . 0.0 108.031 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -133.07 112.77 12.07 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.3 m0 -124.7 52.09 1.57 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.312 1.845 . . . . 0.0 107.282 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.43 135.07 31.09 Favored Glycine 0 CA--C 1.526 0.723 0 O-C-N 120.809 -1.182 . . . . 0.0 112.241 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.95 158.72 38.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.889 1.676 . . . . 0.0 107.515 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.02 133.42 56.08 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.043 1.737 . . . . 0.0 110.601 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.7 125.95 92.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.39 -24.92 56.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.229 1.286 . . . . 0.0 113.2 -174.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.36 -3.62 41.03 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.135 0.88 . . . . 0.0 112.506 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -123.86 7.0 8.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.221 1.408 . . . . 0.0 109.307 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 99.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.636 1.174 . . . . 0.0 108.472 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -57.27 122.85 13.47 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.977 0.911 . . . . 0.0 108.88 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.82 -105.83 0.25 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 10.6 p -140.56 171.68 13.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.38 1.872 . . . . 0.0 107.523 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.59 -29.25 70.46 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.235 -0.915 . . . . 0.0 111.216 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.23 -40.56 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.024 0.53 . . . . 0.0 109.896 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.504 ' HB3' ' H ' ' A' ' 112' ' ' THR . 9.3 tp10 -63.98 -43.24 96.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -59.71 -47.32 86.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.432 0.693 . . . . 0.0 110.595 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -59.65 -36.59 76.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.984 0.811 . . . . 0.0 111.662 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.94 76.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 110.465 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -64.77 -31.09 72.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.268 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.73 -49.25 78.31 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.657 1.117 . . . . 0.0 109.406 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -56.38 -47.41 78.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.892 0.769 . . . . 0.0 111.819 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -60.68 -47.76 84.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.972 0.806 . . . . 0.0 110.695 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.14 -39.41 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -57.11 -53.98 51.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.073 0.851 . . . . 0.0 109.03 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.61 -39.17 80.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.35 0.406 . . . . 0.0 110.857 -170.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -60.04 -48.15 82.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.482 0.713 . . . . 0.0 111.055 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.98 -48.94 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.73 -48.66 49.82 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.663 -0.521 . . . . 0.0 111.992 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.08 -47.29 87.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 117.816 0.808 . . . . 0.0 111.007 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -28.29 57.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.256 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -38.83 84.39 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.373 0.988 . . . . 0.0 109.799 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -56.77 -49.85 74.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.457 0.571 . . . . 0.0 109.561 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.662 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.5 -35.54 79.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.044 0.838 . . . . 0.0 111.223 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.69 -38.82 32.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.465 0.306 . . . . 0.0 111.19 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.7 -45.73 9.11 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.089 0.955 . . . . 0.0 111.11 -170.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.6 p -111.28 -19.14 12.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.43 1.092 . . . . 0.0 112.071 -169.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.24 18.06 80.1 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 119.047 1.423 . . . . 0.0 109.475 177.863 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 . . . . . 0 C--O 1.234 0.274 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.32 176.9 6.27 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.49 0.586 . . . . 0.0 110.407 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.23 141.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -145.09 149.1 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.246 0.93 . . . . 0.0 109.065 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.88 137.69 43.45 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.88 0.872 . . . . 0.0 109.017 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -119.83 130.54 54.95 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.62 141.75 51.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.544 0.737 . . . . 0.0 110.438 -169.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 95.4 m -140.63 169.98 16.63 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.015 0.926 . . . . 0.0 110.73 172.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 m -56.99 -25.25 58.12 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.36 1.464 . . . . 0.0 111.61 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.77 136.67 5.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.58 56.7 2.68 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.022 0.929 . . . . 0.0 110.51 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -120.43 -31.95 4.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -128.72 -87.59 0.54 Allowed 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.844 0.747 . . . . 0.0 110.248 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -58.92 -50.45 73.98 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 11.7 p -65.67 -36.36 83.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.346 0.521 . . . . 0.0 111.176 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -62.43 -55.24 29.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.559 1.144 . . . . 0.0 111.001 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -56.74 -44.74 81.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.757 0.823 . . . . 0.0 111.029 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.63 98.48 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.454 0.57 . . . . 0.0 111.635 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -56.51 -43.36 79.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.586 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.1 -49.54 77.39 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.713 0.688 . . . . 0.0 112.068 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.72 -45.32 93.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.952 0.876 . . . . 0.0 111.121 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.23 99.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.019 0.527 . . . . 0.0 110.522 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -54.22 -34.93 61.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.7 0.682 . . . . 0.0 111.81 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -71.33 -62.86 1.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.056 0.389 . . . . 0.0 110.554 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -67.54 -40.92 85.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.0 mt -75.88 -4.13 39.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.634 0.774 . . . . 0.0 112.472 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.84 56.34 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.637 1.113 . . . . 0.0 113.948 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.78 9.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.306 2.243 . . . . 0.0 114.098 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.3 -3.65 8.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.941 -1.1 . . . . 0.0 111.153 169.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -132.92 122.07 23.79 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -67.79 97.54 0.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 172.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.01 140.71 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.05 166.45 26.82 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.411 1.484 . . . . 0.0 109.348 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 90.0 p -143.99 157.43 44.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.766 0.827 . . . . 0.0 109.236 169.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.57 -167.45 1.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.79 -179.0 44.15 Favored Glycine 0 N--CA 1.447 -0.582 0 O-C-N 121.685 -0.634 . . . . 0.0 111.873 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.15 -31.06 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.031 1.332 . . . . 0.0 110.841 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.89 168.58 21.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.257 1.423 . . . . 0.0 108.75 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.0 138.14 25.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -130.02 12.15 5.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 109.641 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 162.49 29.95 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.54 152.77 35.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -77.58 133.05 67.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.63 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.96 -36.45 64.4 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.722 2.281 . . . . 0.0 114.207 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -71.94 -31.98 66.87 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.581 -0.699 . . . . 0.0 110.241 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.29 -44.53 94.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.78 -50.96 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -58.88 -40.78 85.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.642 0.656 . . . . 0.0 111.695 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.48 88.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.583 0.629 . . . . 0.0 109.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.8 mmm -66.51 -38.75 87.89 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.381 0.537 . . . . 0.0 110.857 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.6 -21.02 66.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.541 -1.349 . . . . 0.0 112.084 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.88 -30.44 68.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.927 0.785 . . . . 0.0 109.093 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.81 -33.87 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.9 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.147 0.879 . . . . 0.0 111.239 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.34 157.82 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.24 144.96 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -125.13 -0.52 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.958 1.303 . . . . 0.0 110.325 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -58.56 -30.99 67.56 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.212 -1.555 . . . . 0.0 111.432 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.61 -2.32 6.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 114.756 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.7 52.14 1.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.261 1.391 . . . . 0.0 110.085 -171.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -50.43 142.47 10.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 m -61.49 160.86 10.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.059 1.744 . . . . 0.0 114.915 -169.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -156.22 158.6 37.85 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.191 1.397 . . . . 0.0 109.712 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.49 166.69 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.214 1.006 . . . . 0.0 109.224 169.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.9 143.66 10.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.625 0.77 . . . . 0.0 108.977 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.78 140.71 42.72 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 109.855 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.57 -30.66 61.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.081 1.352 . . . . 0.0 113.166 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.78 -11.01 60.53 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.289 1.036 . . . . 0.0 112.094 -173.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.32 -43.86 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -56.97 -40.31 76.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.093 1.315 . . . . 0.0 112.289 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 4.69 51.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.886 0.875 . . . . 0.0 112.589 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -125.1 -26.99 3.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.815 1.246 . . . . 0.0 112.741 -168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 131.79 52.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.738 1.215 . . . . 0.0 109.26 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.3 -25.09 65.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.356 0.662 . . . . 0.0 110.741 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 tp -147.91 140.29 24.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.866 1.267 . . . . 0.0 108.34 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.49 147.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.91 127.73 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.66 132.02 44.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.88 10.3 38.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.944 0.498 . . . . 0.0 110.236 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.5 p -63.79 126.7 28.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.308 1.043 . . . . 0.0 110.954 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.285 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.007 171.333 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo . . . . . 0 CA--C 1.534 0.517 0 CA-C-O 120.701 0.209 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.04 153.21 38.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.665 0.786 . . . . 0.0 109.488 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 p -133.71 159.14 73.65 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.164 1.785 . . . . 0.0 109.746 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.56 139.81 38.29 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.793 1.662 . . . . 0.0 109.62 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.23 -20.34 24.78 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.887 2.391 . . . . 0.0 112.046 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -67.67 -20.04 65.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.561 1.144 . . . . 0.0 112.258 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.75 143.39 18.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 118.677 0.671 . . . . 0.0 109.226 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -61.69 137.09 58.22 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.83 150.37 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.68 0.792 . . . . 0.0 109.582 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.03 163.13 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 108.274 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -132.58 112.73 12.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -120.97 58.22 0.96 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 106.862 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.06 132.48 17.01 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 121.065 -1.022 . . . . 0.0 113.089 -171.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.8 156.6 31.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.919 2.088 . . . . 0.0 106.388 169.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -60.21 148.19 37.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 110.836 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.39 128.54 82.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.501 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.26 -24.61 72.12 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.48 1.453 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.68 -17.4 64.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.173 0.897 . . . . 0.0 112.434 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -105.02 2.37 29.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.567 1.147 . . . . 0.0 111.266 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 45.66 0.33 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.507 1.523 . . . . 0.0 111.579 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.38 153.19 12.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.847 1.259 . . . . 0.0 112.228 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.61 -53.71 0.39 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -167.01 165.41 15.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.54 1.936 . . . . 0.0 107.044 169.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.54 -28.02 66.72 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.487 0.715 . . . . 0.0 111.242 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -69.91 -39.52 76.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.282 0.492 . . . . 0.0 110.694 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.13 -44.33 76.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -55.81 -52.58 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.199 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -58.2 -40.33 81.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.722 0.809 . . . . 0.0 111.675 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.93 83.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.833 -0.542 . . . . 0.0 111.015 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.2 -34.97 73.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.666 -0.646 . . . . 0.0 111.468 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -59.45 -54.41 46.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.968 0.804 . . . . 0.0 109.973 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.9 -29.51 69.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.623 0.647 . . . . 0.0 111.755 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.27 -54.83 31.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.533 1.06 . . . . 0.0 111.259 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.66 -38.25 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -52.82 -57.3 10.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.135 0.974 . . . . 0.0 109.935 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.92 -41.21 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.279 0.232 . . . . 0.0 111.234 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.96 -39.94 87.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mt -58.74 -51.09 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.36 71.08 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.563 0.602 . . . . 0.0 111.777 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.91 -51.38 69.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 117.587 0.694 . . . . 0.0 110.34 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -70.74 -29.35 65.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.954 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -41.44 90.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.638 1.108 . . . . 0.0 110.199 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -57.15 -52.5 65.06 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.57 -35.25 80.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.059 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.93 -37.32 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.13 -36.18 30.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.633 0.373 . . . . 0.0 111.501 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.71 -40.16 10.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.701 1.201 . . . . 0.0 111.896 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -116.53 -19.16 10.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.338 1.055 . . . . 0.0 111.522 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.78 13.22 81.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.362 0.982 . . . . 0.0 112.76 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.248 0.974 0 CA-C-N 118.625 1.213 . . . . 0.0 110.037 -175.771 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t30 . . . . . 0 C--O 1.234 0.267 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -83.09 -175.33 5.78 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 110.269 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -146.42 144.9 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -149.18 152.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.175 0.898 . . . . 0.0 109.182 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 137.5 39.44 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.919 0.888 . . . . 0.0 109.151 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.58 125.09 45.92 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.81 1.244 . . . . 0.0 107.699 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.45 140.97 51.47 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.91 170.41 15.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.318 1.056 . . . . 0.0 112.042 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 p -76.08 35.23 0.13 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.707 2.003 . . . . 0.0 110.607 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.68 110.59 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.721 2.105 . . . . 0.0 108.601 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -75.67 56.33 0.91 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.574 1.15 . . . . 0.0 111.685 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.3 m -129.91 -18.02 3.46 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.2 m -137.1 -87.78 0.29 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.993 0.815 . . . . 0.0 109.187 -170.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -57.16 -53.88 53.04 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.799 0.84 . . . . 0.0 111.137 -170.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 12.2 p -67.2 -35.4 79.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.447 0.567 . . . . 0.0 111.536 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -60.53 -55.72 30.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.161 0.985 . . . . 0.0 110.345 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -57.66 -43.98 85.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.505 0.722 . . . . 0.0 111.253 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.02 96.22 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.569 0.622 . . . . 0.0 111.45 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -57.09 -40.55 77.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.565 0.346 . . . . 0.0 110.663 174.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.22 -50.39 67.63 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.738 0.685 . . . . 0.0 112.084 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.22 -45.07 95.01 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.504 0.652 . . . . 0.0 110.579 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.63 97.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.474 0.71 . . . . 0.0 110.474 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.68 -36.11 64.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.798 0.726 . . . . 0.0 111.45 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -70.72 -62.21 1.47 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.052 0.387 . . . . 0.0 110.789 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.11 -38.74 86.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 71.6 mt -75.65 0.88 16.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.082 0.953 . . . . 0.0 112.232 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.19 22.07 64.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.245 1.403 . . . . 0.0 113.567 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 55.47 13.73 1.0 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.758 2.023 . . . . 0.0 113.39 -169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.42 1.95 14.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.244 1.418 . . . . 0.0 111.284 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 14.8 m95 -129.49 128.89 43.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -67.44 89.35 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 143.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -146.96 163.08 37.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.918 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 79.9 p -141.17 156.07 45.99 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.619 0.768 . . . . 0.0 109.047 169.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.91 -169.3 2.48 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 110.281 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.41 -178.49 46.22 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.47 -27.62 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.765 1.226 . . . . 0.0 110.899 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -147.04 166.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.803 1.241 . . . . 0.0 108.124 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.75 134.08 21.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -134.96 24.48 3.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.308 1.043 . . . . 0.0 109.151 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.05 168.34 39.16 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.97 148.1 27.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.026 0.53 . . . . 0.0 110.53 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -74.37 133.67 77.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 118.117 -0.944 . . . . 0.0 109.129 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.94 -33.61 42.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.868 2.379 . . . . 0.0 114.589 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -72.46 -28.92 63.22 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.254 -0.903 . . . . 0.0 110.853 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.39 85.43 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.17 -49.37 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -43.47 90.31 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.113 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.19 93.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.06 0.846 . . . . 0.0 110.033 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -70.99 -38.21 72.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.717 0.235 . . . . 0.0 111.469 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -63.79 -24.99 67.98 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.794 -1.191 . . . . 0.0 111.393 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -69.55 -14.6 62.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.778 0.831 . . . . 0.0 110.866 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.4 -2.1 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.237 1.015 . . . . 0.0 112.091 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.89 32.36 10.05 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.81 161.07 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.94 146.12 51.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -127.14 -0.7 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.114 1.366 . . . . 0.0 110.447 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -57.95 -31.12 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.388 -1.445 . . . . 0.0 111.267 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -67.7 -4.28 11.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.006 1.723 . . . . 0.0 114.728 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -137.13 53.73 1.88 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.311 1.414 . . . . 0.0 109.678 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -50.16 144.2 7.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.274 1.03 . . . . 0.0 112.345 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 m -64.21 161.36 16.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 114.533 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -156.9 157.67 35.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.471 1.508 . . . . 0.0 109.7 170.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.18 165.35 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.756 0.822 . . . . 0.0 109.492 170.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.86 145.98 6.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.804 1.242 . . . . 0.0 110.128 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.4 134.61 32.66 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.661 1.184 . . . . 0.0 109.944 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.41 -28.42 53.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.396 1.478 . . . . 0.0 113.323 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.92 -11.42 60.86 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.782 1.233 . . . . 0.0 112.201 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.62 -41.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 mt -47.95 -59.08 3.62 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.703 1.138 . . . . 0.0 111.645 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -0.26 30.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.76 -30.74 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.061 1.344 . . . . 0.0 112.066 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.71 131.58 51.17 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 109.858 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.36 -26.06 67.85 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.778 0.431 . . . . 0.0 110.791 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 tp -148.49 142.04 25.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.522 1.129 . . . . 0.0 108.443 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.58 144.14 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.35 126.46 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 p -100.3 135.18 42.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.42 20.68 17.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.474 0.71 . . . . 0.0 109.54 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.1 p -68.1 112.93 5.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.928 1.291 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.157 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo . . . . . 0 CA--C 1.538 0.71 0 N-CA-C 114.647 0.979 . . . . 0.0 114.647 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -63.4 138.45 58.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.551 1.54 . . . . 0.0 110.333 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 p -131.6 154.46 81.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.146 1.779 . . . . 0.0 109.442 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.81 145.21 56.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.203 1.936 . . . . 0.0 110.053 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.87 -21.88 13.87 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.107 2.538 . . . . 0.0 112.073 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -85.8 7.7 22.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.497 1.119 . . . . 0.0 112.38 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.73 144.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.18 138.48 58.42 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -133.12 150.48 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.702 0.801 . . . . 0.0 109.767 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -125.44 159.34 32.14 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.557 1.943 . . . . 0.0 107.914 171.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -133.84 111.88 10.85 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.423 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 32.5 m0 -120.93 57.38 0.98 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.146 1.778 . . . . 0.0 106.741 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.55 132.61 29.78 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 120.915 -1.116 . . . . 0.0 111.998 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.09 160.18 35.41 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.62 1.968 . . . . 0.0 106.106 169.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.12 141.85 55.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.373 0.606 . . . . 0.0 110.785 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.36 127.28 93.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 -22.66 44.06 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.082 1.188 . . . . 0.0 113.329 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.21 -9.95 59.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.495 1.043 . . . . 0.0 112.228 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -111.39 0.69 16.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.051 1.34 . . . . 0.0 110.749 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.72 54.0 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.496 2.319 . . . . 0.0 111.174 170.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.59 144.97 46.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.659 1.983 . . . . 0.0 112.003 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.08 -54.97 0.28 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -165.66 167.0 17.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.939 1.696 . . . . 0.0 107.45 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.18 -29.98 70.13 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.104 0.562 . . . . 0.0 111.201 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.13 -37.43 75.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.878 0.471 . . . . 0.0 110.574 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.23 -46.58 73.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -56.56 -48.86 76.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.098 0.559 . . . . 0.0 110.359 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -61.23 -37.93 84.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.584 0.754 . . . . 0.0 112.001 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.61 80.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.242 -0.912 . . . . 0.0 109.909 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.97 -33.22 75.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.803 0.441 . . . . 0.0 111.153 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.88 -50.31 73.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.721 0.809 . . . . 0.0 110.155 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -64.77 -35.0 79.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.39 0.541 . . . . 0.0 111.584 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -66.29 -51.03 61.46 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.337 0.517 . . . . 0.0 110.662 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.36 -39.96 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -53.29 -54.06 41.92 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.321 1.049 . . . . 0.0 109.393 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.53 -44.4 90.97 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 123.206 0.316 . . . . 0.0 111.008 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.58 -39.79 88.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.647 -0.658 . . . . 0.0 111.216 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.08 -51.05 77.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.28 -45.42 64.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -60.69 -50.4 73.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 117.639 0.719 . . . . 0.0 111.105 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.423 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.4 tpt180 -70.18 -33.18 71.43 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.113 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -40.13 96.26 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.407 1.003 . . . . 0.0 109.976 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -57.77 -51.45 69.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.65 -35.74 82.01 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.267 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -63.67 -36.65 84.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.908 -0.495 . . . . 0.0 111.014 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.3 -37.96 27.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.568 0.347 . . . . 0.0 111.409 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.3 -46.83 8.14 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 110.857 -169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 p -108.49 -17.21 14.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -169.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.36 11.5 80.36 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.238 0.923 . . . . 0.0 112.291 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.472 1.136 . . . . 0.0 108.482 -174.646 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 t30 . . . . . 0 C--O 1.234 0.288 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.65 168.86 18.48 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -144.29 139.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -144.71 150.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 109.084 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 137.14 37.93 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.002 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -119.51 130.97 55.46 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.02 137.56 51.4 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 111.028 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.5 174.32 10.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.245 1.018 . . . . 0.0 112.221 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -56.3 -27.51 55.79 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.991 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.4 142.01 8.27 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.6 58.45 2.73 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.752 0.821 . . . . 0.0 111.083 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -130.6 -18.63 3.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.3 m -133.01 -96.99 0.3 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.071 0.85 . . . . 0.0 108.901 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -54.28 -50.69 66.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.149 0.98 . . . . 0.0 111.952 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p -67.54 -38.57 84.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.738 0.699 . . . . 0.0 111.246 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -58.45 -54.81 42.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.072 0.949 . . . . 0.0 109.989 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.2 mtm -57.57 -44.83 85.6 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.43 0.692 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.27 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.165 0.586 . . . . 0.0 111.59 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.0 tt0 -57.39 -40.64 78.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.214 0.461 . . . . 0.0 110.88 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.09 -53.47 45.31 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -60.97 -44.4 97.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.956 0.378 . . . . 0.0 111.166 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.38 -43.82 97.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.81 -172.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -59.0 -34.67 72.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.404 1.002 . . . . 0.0 111.576 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -65.42 -54.89 22.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.199 0.454 . . . . 0.0 110.809 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -78.17 -45.43 23.19 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -170.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 94.9 mt -72.07 -32.92 67.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.352 0.661 . . . . 0.0 111.542 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.02 175.31 44.26 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.95 -1.93 8.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.176 0.99 . . . . 0.0 111.22 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -61.63 -10.18 7.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.863 0.865 . . . . 0.0 110.723 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 18.7 m95 -127.39 124.89 39.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.655 1.982 . . . . 0.0 105.906 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -75.57 88.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -77.89 140.04 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.09 167.29 23.07 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.215 1.406 . . . . 0.0 109.314 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -142.79 155.64 44.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.03 0.932 . . . . 0.0 109.2 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.55 1.73 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.432 1.093 . . . . 0.0 109.257 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.78 -178.52 44.72 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -56.75 -28.63 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.028 1.331 . . . . 0.0 111.017 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.52 171.02 16.2 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.435 1.494 . . . . 0.0 108.784 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.29 22.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -129.71 10.78 5.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.765 1.226 . . . . 0.0 109.919 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.0 27.8 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -84.51 148.55 26.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -72.18 136.86 81.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 124.246 1.018 . . . . 0.0 108.752 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.51 -29.09 84.22 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.82 1.68 . . . . 0.0 112.891 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.83 -26.05 61.34 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.097 -1.002 . . . . 0.0 111.013 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -44.07 84.68 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.303 0.956 . . . . 0.0 109.084 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.25 -50.23 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -58.3 -41.8 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.97 89.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.541 0.736 . . . . 0.0 110.346 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 76.9 mmm -74.25 -34.2 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.698 0.227 . . . . 0.0 111.111 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.37 -23.18 66.91 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.66 -1.275 . . . . 0.0 111.553 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.39 -17.84 64.84 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.127 0.971 . . . . 0.0 110.634 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.33 -2.45 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.011 0.924 . . . . 0.0 112.6 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.86 32.65 9.76 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.95 155.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -140.28 82.18 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.153 0.978 . . . . 0.0 109.856 -169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.73 0.19 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.921 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -20.04 39.82 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 119.938 -1.726 . . . . 0.0 112.18 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -84.18 1.85 42.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.237 1.415 . . . . 0.0 112.659 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -133.86 49.92 2.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.488 1.04 . . . . 0.0 109.937 -172.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 p -46.98 134.09 10.66 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.909 1.284 . . . . 0.0 111.193 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -58.27 157.38 8.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.71 157.88 38.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.227 1.411 . . . . 0.0 109.398 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.35 168.59 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.573 1.149 . . . . 0.0 109.622 170.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.66 142.83 11.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.26 140.79 43.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.395 1.078 . . . . 0.0 109.723 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.73 -30.66 61.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.984 1.314 . . . . 0.0 113.135 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.69 -12.5 61.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.254 1.021 . . . . 0.0 111.884 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 mt -119.77 -43.22 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.61 -39.14 76.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.171 1.351 . . . . 0.0 112.193 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 6.49 48.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.864 0.866 . . . . 0.0 112.577 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -126.9 -29.39 2.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.717 1.207 . . . . 0.0 112.499 -168.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.64 125.48 23.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.88 1.272 . . . . 0.0 109.49 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.48 -26.53 67.23 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -141.61 137.25 31.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.957 1.303 . . . . 0.0 107.784 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.19 146.13 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.34 129.63 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -101.04 131.68 46.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.62 16.22 26.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.297 0.639 . . . . 0.0 109.99 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.5 p -69.24 109.39 4.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 111.022 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 169.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo . . . . . 0 CA--C 1.538 0.675 0 N-CA-C 115.01 1.119 . . . . 0.0 115.01 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -62.26 139.17 58.51 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.626 1.57 . . . . 0.0 110.248 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -129.55 153.27 80.66 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 126.382 1.873 . . . . 0.0 108.677 171.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.95 162.86 39.94 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.408 1.405 . . . . 0.0 109.821 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.62 -22.76 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.523 2.149 . . . . 0.0 112.724 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -87.01 -21.43 26.13 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.61 154.46 5.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 119.439 1.018 . . . . 0.0 109.649 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -71.07 140.44 50.69 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -123.83 154.53 39.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.3 164.56 28.28 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.784 1.634 . . . . 0.0 107.568 169.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -131.68 113.78 13.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -120.74 53.64 1.11 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.667 1.587 . . . . 0.0 106.771 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 128.1 29.42 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 111.823 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.7 161.43 40.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.77 142.01 49.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.0 124.46 88.84 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.84 -22.29 56.6 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.193 1.262 . . . . 0.0 113.163 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.81 60.33 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.388 0.995 . . . . 0.0 112.5 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -115.22 12.38 16.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.85 1.26 . . . . 0.0 111.537 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.34 66.34 0.93 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.12 1.368 . . . . 0.0 109.694 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -57.1 138.01 55.04 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.063 0.945 . . . . 0.0 110.766 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.08 -61.44 0.2 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -166.67 168.87 14.05 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.764 1.625 . . . . 0.0 107.433 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -30.21 70.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.018 0.527 . . . . 0.0 111.416 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.39 -37.78 74.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.797 0.439 . . . . 0.0 110.651 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 -45.89 77.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -59.0 -45.86 89.61 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.01 0.524 . . . . 0.0 110.601 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -60.84 -39.48 89.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.868 0.758 . . . . 0.0 111.628 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.03 85.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -65.98 -34.76 78.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.795 0.438 . . . . 0.0 111.192 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -58.41 -46.84 85.64 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.015 0.926 . . . . 0.0 110.2 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -65.73 -36.25 83.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.4 0.546 . . . . 0.0 111.284 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -68.14 -45.09 74.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.231 . . . . 0.0 111.453 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.52 -42.87 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.971 0.805 . . . . 0.0 109.449 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -39.46 94.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.021 1.282 . . . . 0.0 110.13 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.47 -42.39 78.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.405 0.282 . . . . 0.0 111.611 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.81 -41.12 83.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.04 -0.413 . . . . 0.0 110.745 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.77 -52.75 56.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.77 55.36 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.577 0.626 . . . . 0.0 111.757 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -61.16 -49.69 76.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.561 0.681 . . . . 0.0 110.966 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -69.8 -30.92 68.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.784 -0.573 . . . . 0.0 110.438 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -41.9 82.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.343 0.974 . . . . 0.0 109.855 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.95 -52.27 65.87 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -69.33 -31.28 69.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.455 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -63.01 -37.9 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.4 1.0 . . . . 0.0 111.016 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.28 51.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.788 0.435 . . . . 0.0 111.084 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.38 -40.84 11.83 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.788 0.835 . . . . 0.0 111.736 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.2 p -117.61 -19.06 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.965 0.906 . . . . 0.0 111.929 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.82 10.02 83.69 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.841 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 119.058 1.429 . . . . 0.0 108.889 -175.088 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 t30 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.34 175.66 6.7 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.5 144.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.91 151.59 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.511 1.05 . . . . 0.0 109.024 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -138.15 129.51 27.63 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 123.568 0.747 . . . . 0.0 109.466 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.15 130.63 55.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.495 1.118 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -131.91 136.58 47.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.491 0.716 . . . . 0.0 111.023 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -146.51 -175.39 4.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.948 0.34 . . . . 0.0 111.155 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -62.76 -19.11 63.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.194 0.998 . . . . 0.0 112.462 -170.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.93 143.01 9.16 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.48 51.19 1.21 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.312 1.056 . . . . 0.0 111.843 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -128.2 -9.98 5.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -168.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.4 p -140.23 -101.98 0.15 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.79 0.723 . . . . 0.0 110.207 -169.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -51.43 -47.63 62.95 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.821 1.648 . . . . 0.0 110.689 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.7 p -66.95 -43.07 84.11 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.133 0.271 . . . . 0.0 110.674 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.641 1.176 . . . . 0.0 110.814 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.5 mtm -61.42 -42.53 98.89 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 110.65 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.34 -44.73 94.06 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 118.646 -0.693 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.54 -44.73 73.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.454 0.57 . . . . 0.0 110.506 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.83 -51.85 55.64 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 119.339 -0.701 . . . . 0.0 111.526 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -62.95 -46.0 89.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.447 0.623 . . . . 0.0 111.023 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.49 94.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.564 0.745 . . . . 0.0 110.657 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -57.23 -35.42 69.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.937 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -68.81 -61.88 1.62 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.169 0.441 . . . . 0.0 110.723 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -64.53 -41.02 96.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.409 0.283 . . . . 0.0 111.426 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.14 -1.82 37.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.286 1.035 . . . . 0.0 112.123 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.6 24.5 53.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.149 1.357 . . . . 0.0 113.998 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 55.8 9.44 0.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.412 2.285 . . . . 0.0 113.972 -170.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -66.05 -5.99 11.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 110.515 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -130.41 115.6 17.09 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -68.7 88.55 0.36 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.171 1.388 . . . . 0.0 107.466 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.04 154.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -150.62 164.69 35.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.705 2.002 . . . . 0.0 107.438 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.9 p -141.21 154.29 45.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 169.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.48 -169.45 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 110.365 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.76 -179.5 42.79 Favored Glycine 0 N--CA 1.447 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.9 -27.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.33 1.452 . . . . 0.0 111.416 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -145.72 170.85 15.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 108.43 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.94 136.36 16.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.12 19.1 2.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.611 1.164 . . . . 0.0 110.093 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.54 -176.8 20.35 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -110.42 144.23 39.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.049 0.94 . . . . 0.0 109.797 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -70.51 134.5 86.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.024 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.2 -33.55 44.92 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.06 2.507 . . . . 0.0 114.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -78.09 -28.55 48.75 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 119.151 0.887 . . . . 0.0 110.504 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.66 75.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.39 -52.13 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.98 -38.77 87.15 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.908 0.776 . . . . 0.0 111.397 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.7 87.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.918 0.487 . . . . 0.0 109.825 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.22 -36.57 79.72 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.209 0.459 . . . . 0.0 111.028 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -63.57 -26.37 68.67 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 120.673 -1.267 . . . . 0.0 111.188 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.55 -16.57 63.45 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.69 0.677 . . . . 0.0 111.095 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.16 -1.07 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.715 0.806 . . . . 0.0 112.07 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.46 31.75 11.2 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -123.34 154.92 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -142.64 76.04 1.51 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.596 1.189 . . . . 0.0 110.371 -169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.4 pt -58.65 -15.12 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.28 1.032 . . . . 0.0 113.339 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.74 -24.84 24.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.62 1.1 . . . . 0.0 111.967 172.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.37 -21.03 33.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.79 -21.86 9.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.875 1.216 . . . . 0.0 114.005 -169.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.0 p 49.01 -164.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.359 1.064 . . . . 0.0 111.553 -169.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 m -129.69 156.19 44.66 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.138 -0.976 . . . . 0.0 111.579 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -155.91 156.11 34.03 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.788 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.87 164.54 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 171.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 147.38 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.084 1.354 . . . . 0.0 110.198 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.39 136.76 33.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.441 1.097 . . . . 0.0 110.051 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -53.86 -29.67 42.29 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.553 1.541 . . . . 0.0 113.074 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.78 -8.74 50.71 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.192 1.397 . . . . 0.0 112.257 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.4 mt -117.29 -42.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.5 mt -47.53 -56.9 6.14 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.693 1.133 . . . . 0.0 112.195 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.87 0.88 51.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.649 0.78 . . . . 0.0 112.813 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -117.89 -31.22 5.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.06 1.344 . . . . 0.0 111.745 -169.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.81 131.31 49.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.206 1.402 . . . . 0.0 109.02 173.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 26.4 t70 -60.43 -32.15 71.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.668 0.387 . . . . 0.0 109.969 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.34 139.58 28.59 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.323 1.049 . . . . 0.0 109.141 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.61 146.05 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.36 121.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -98.58 135.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.85 18.67 19.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.269 1.027 . . . . 0.0 109.844 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.2 p -70.33 117.23 11.62 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.798 1.239 . . . . 0.0 110.006 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.358 0 C-N-CA 124.861 1.219 . . . . 0.0 111.047 170.459 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.535 0.572 0 N-CA-C 113.877 0.683 . . . . 0.0 113.877 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 138.45 58.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 110.235 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.0 p -125.96 153.37 73.73 Favored Pre-proline 0 N--CA 1.448 -0.533 0 C-N-CA 126.206 1.802 . . . . 0.0 108.768 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.67 153.59 77.44 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.776 1.651 . . . . 0.0 109.301 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.8 -23.51 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.407 2.071 . . . . 0.0 111.937 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -76.81 -25.96 53.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.737 0.815 . . . . 0.0 112.65 -172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.27 144.39 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.855 0.752 . . . . 0.0 109.437 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 76' ' ' ASP . 38.3 ttpt -65.31 136.24 56.32 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -135.94 151.31 49.82 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.145 0.578 . . . . 0.0 110.455 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -126.55 159.42 33.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.028 2.131 . . . . 0.0 107.809 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -135.98 111.32 9.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -121.47 62.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.199 1.8 . . . . 0.0 106.661 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.99 134.06 21.31 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.252 -0.905 . . . . 0.0 112.224 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.21 161.05 39.26 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.966 2.107 . . . . 0.0 106.168 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.89 148.53 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.759 0.79 . . . . 0.0 110.667 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -71.76 120.88 82.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.811 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.13 -27.22 73.06 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.328 1.352 . . . . 0.0 112.868 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -6.4 41.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.742 0.701 . . . . 0.0 112.589 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -119.35 0.44 11.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.885 1.674 . . . . 0.0 109.846 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.21 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.279 1.432 . . . . 0.0 109.957 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -57.19 124.93 20.51 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.301 1.04 . . . . 0.0 109.6 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.46 -74.93 0.12 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -167.36 168.89 12.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.602 1.561 . . . . 0.0 107.52 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.59 -30.47 69.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.881 -0.512 . . . . 0.0 111.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.27 -38.63 78.47 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.647 0.379 . . . . 0.0 110.453 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -70.96 -38.52 72.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.683 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -59.51 -47.73 84.4 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 119.34 0.973 . . . . 0.0 110.45 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -58.64 -39.72 81.38 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.254 0.622 . . . . 0.0 111.189 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.64 78.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.639 -0.663 . . . . 0.0 111.03 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.76 -35.15 79.91 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.78 -52.93 63.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.701 0.8 . . . . 0.0 110.722 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.51 -30.61 70.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.728 0.695 . . . . 0.0 112.02 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -63.41 -53.92 44.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.431 1.014 . . . . 0.0 110.346 171.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.88 -37.59 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.528 0.603 . . . . 0.0 109.501 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -55.17 -54.15 46.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 123.786 0.834 . . . . 0.0 109.423 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.25 -43.05 99.1 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 123.256 0.347 . . . . 0.0 110.806 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.27 -40.45 90.11 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.766 -0.584 . . . . 0.0 111.314 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.54 -50.93 78.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.23 -46.23 57.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.02 -50.08 75.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 111.003 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -69.83 -30.29 67.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.496 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -39.7 81.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.588 1.085 . . . . 0.0 110.178 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -56.36 -50.08 72.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.31 -37.79 88.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 111.496 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -61.37 -35.71 78.21 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.11 -0.994 . . . . 0.0 111.753 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.11 -35.99 28.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.702 0.401 . . . . 0.0 111.358 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.72 -41.9 10.44 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.014 1.326 . . . . 0.0 111.682 -169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -115.15 -20.33 10.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.621 1.168 . . . . 0.0 111.579 -169.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.83 81.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.395 0.998 . . . . 0.0 112.768 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.407 1.103 . . . . 0.0 109.573 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -82.79 -176.63 6.39 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 122.683 0.393 . . . . 0.0 110.019 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.19 143.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.85 151.07 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.934 0.894 . . . . 0.0 109.087 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.91 138.02 38.61 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.877 0.871 . . . . 0.0 108.974 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.6 127.58 53.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -123.38 143.81 49.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.857 1.263 . . . . 0.0 109.976 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.1 m -142.12 176.53 8.89 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.374 1.07 . . . . 0.0 112.11 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -65.26 -18.24 65.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.623 1.169 . . . . 0.0 111.891 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.1 136.08 4.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -80.54 55.85 2.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.08 0.952 . . . . 0.0 111.684 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 m -125.74 -18.43 5.17 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.7 m -137.85 -88.39 0.26 Allowed 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 119.152 0.887 . . . . 0.0 109.563 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -56.62 -53.93 51.91 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.711 0.805 . . . . 0.0 111.18 -169.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -67.23 -35.45 79.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.083 0.401 . . . . 0.0 111.248 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.03 -54.7 41.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.177 0.991 . . . . 0.0 110.103 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.0 mtm -57.81 -41.88 83.11 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.465 0.706 . . . . 0.0 111.366 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.01 95.21 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.444 0.565 . . . . 0.0 111.735 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.7 tt0 -55.37 -41.37 72.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.639 0.375 . . . . 0.0 110.784 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -49.89 73.62 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.337 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -62.64 -43.79 97.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.737 0.769 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.62 -42.68 99.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.521 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -51.79 -38.54 56.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -69.52 -62.2 1.48 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.206 0.316 . . . . 0.0 110.419 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -68.9 -40.32 79.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.99 -6.47 54.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.23 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.06 24.36 58.34 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.822 1.201 . . . . 0.0 114.157 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.8 t70 57.87 9.93 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.307 2.243 . . . . 0.0 113.953 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -66.26 -5.67 11.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.021 1.328 . . . . 0.0 110.737 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -128.99 124.53 35.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 173.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.2 mmpt? -66.33 100.94 0.68 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 t -85.4 139.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -146.39 165.83 28.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.194 1.398 . . . . 0.0 109.294 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.8 p -144.02 157.44 44.33 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.593 0.757 . . . . 0.0 110.064 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.68 -167.31 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.93 -174.45 45.82 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.93 -30.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.998 1.319 . . . . 0.0 111.009 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 168.86 21.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 108.569 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.54 138.68 26.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.73 11.21 5.66 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.64 1.176 . . . . 0.0 110.056 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.4 163.84 33.17 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.74 148.55 30.05 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.371 0.605 . . . . 0.0 110.824 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.16 136.24 79.28 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.003 0.921 . . . . 0.0 109.761 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.99 -36.03 63.2 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.705 2.27 . . . . 0.0 113.893 174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -72.44 -30.3 64.48 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.621 -0.675 . . . . 0.0 110.547 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.55 90.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -59.05 -49.04 84.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -38.98 81.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.274 0.943 . . . . 0.0 111.009 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.92 -46.48 84.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.369 0.668 . . . . 0.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.6 mmm -68.5 -36.53 79.03 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 118.372 0.533 . . . . 0.0 111.021 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -65.81 -25.14 67.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.905 -1.122 . . . . 0.0 111.18 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -68.83 -17.37 63.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.265 0.626 . . . . 0.0 110.969 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.92 0.33 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.646 0.778 . . . . 0.0 111.921 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.98 32.28 18.14 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 174.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.4 159.74 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -124.66 144.42 50.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -128.6 3.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.856 1.262 . . . . 0.0 110.226 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.04 -28.76 68.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.129 -1.607 . . . . 0.0 111.119 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -64.63 -4.61 4.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.586 1.955 . . . . 0.0 115.17 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -137.92 49.7 1.95 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.294 1.406 . . . . 0.0 110.815 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -46.05 131.85 9.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.271 1.029 . . . . 0.0 110.723 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -55.71 155.88 5.41 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.185 1.794 . . . . 0.0 115.698 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -153.92 158.04 40.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.319 1.448 . . . . 0.0 109.211 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 168.7 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 169.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.7 mt -56.39 142.86 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.627 0.771 . . . . 0.0 109.141 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.23 135.71 47.6 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.091 1.356 . . . . 0.0 109.454 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -56.39 -31.27 63.7 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.022 1.329 . . . . 0.0 113.267 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -81.36 -5.15 57.55 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.853 -0.529 . . . . 0.0 111.749 -170.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.5 mt -111.39 -44.0 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.77 -39.88 86.37 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.846 1.203 . . . . 0.0 111.523 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.52 3.14 41.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -126.62 -27.0 3.17 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.999 0.92 . . . . 0.0 112.997 -168.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.91 20.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.513 1.125 . . . . 0.0 109.757 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.68 -28.43 69.9 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.907 0.483 . . . . 0.0 110.775 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.22 140.35 33.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.75 144.04 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 124.28 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.94 127.4 48.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.54 22.89 12.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.667 0.746 . . . . 0.0 109.343 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.94 107.26 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.468 1.507 . . . . 0.0 110.482 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.35 0 C-N-CA 125.066 1.317 . . . . 0.0 109.992 170.491 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 CA--C 1.535 0.551 0 CA-C-O 120.938 0.308 . . . . 0.0 111.781 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.7 mtm -72.94 157.6 37.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.379 0.672 . . . . 0.0 109.494 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -129.98 162.31 54.5 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.893 2.077 . . . . 0.0 108.363 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.32 161.46 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.047 1.165 . . . . 0.0 109.503 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.13 -23.38 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.453 2.102 . . . . 0.0 111.985 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -75.48 -31.01 60.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.54 0.736 . . . . 0.0 112.63 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -81.21 152.04 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.753 0.787 . . . . 0.0 110.757 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.36 143.52 50.18 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -135.98 149.4 48.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.746 0.418 . . . . 0.0 110.541 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.69 157.82 38.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.816 2.047 . . . . 0.0 107.728 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -133.98 112.75 11.49 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -122.17 56.45 1.1 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.121 1.769 . . . . 0.0 107.216 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.09 125.2 21.33 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.707 -1.245 . . . . 0.0 111.93 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.89 162.21 41.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.697 1.999 . . . . 0.0 106.447 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -68.75 147.42 51.82 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.36 0.6 . . . . 0.0 111.17 -172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.91 126.37 91.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.524 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.17 -24.57 65.82 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.661 1.574 . . . . 0.0 113.663 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.83 -15.12 63.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.42 1.009 . . . . 0.0 112.34 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -108.61 2.45 22.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.432 1.093 . . . . 0.0 111.482 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 53.05 0.29 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.717 2.007 . . . . 0.0 111.508 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 147.84 37.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.828 2.051 . . . . 0.0 112.082 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.9 -53.29 0.36 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.94 165.79 17.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 107.386 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.06 -29.37 68.5 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.351 0.66 . . . . 0.0 111.132 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.13 -41.44 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.41 0.684 . . . . 0.0 110.206 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.49 -46.77 71.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.912 0.885 . . . . 0.0 108.849 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.53 -52.17 64.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 122.872 0.469 . . . . 0.0 110.185 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -58.45 -39.71 80.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.578 0.751 . . . . 0.0 111.609 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.0 93.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.542 -0.724 . . . . 0.0 110.428 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.39 -34.48 78.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.875 0.47 . . . . 0.0 111.64 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -58.82 -48.51 81.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.908 0.776 . . . . 0.0 109.929 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -64.16 -38.25 90.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.612 0.642 . . . . 0.0 111.254 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.7 mmm-85 -61.97 -51.65 67.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.983 0.811 . . . . 0.0 111.156 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.86 -39.34 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -53.81 -55.29 27.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.066 0.946 . . . . 0.0 109.467 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.51 -42.39 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.146 0.279 . . . . 0.0 110.858 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.5 -39.01 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.078 0.551 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.15 -50.65 79.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.38 73.47 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.68 0.657 . . . . 0.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -60.17 -51.98 67.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.599 0.7 . . . . 0.0 110.992 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -69.2 -29.08 66.98 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.87 -1.062 . . . . 0.0 111.405 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -42.02 87.89 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.798 1.181 . . . . 0.0 109.868 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.43 -51.54 69.0 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.61 -34.46 77.93 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.521 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.18 -38.71 90.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.591 0.632 . . . . 0.0 111.001 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.36 36.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.391 0.276 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -90.43 -48.15 7.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.609 1.163 . . . . 0.0 110.908 -169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.8 p -106.69 -18.91 13.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.209 1.004 . . . . 0.0 111.273 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.26 15.81 75.73 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.82 -0.989 . . . . 0.0 112.503 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-N 118.717 1.258 . . . . 0.0 108.644 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 174.52 8.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.63 142.44 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.01 148.63 21.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.903 0.774 . . . . 0.0 109.007 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.33 132.99 36.38 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -115.78 133.11 56.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.78 141.43 51.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.69 0.796 . . . . 0.0 110.009 -169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.54 169.29 17.88 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 122.103 0.954 . . . . 0.0 112.131 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -76.03 35.81 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.23 2.212 . . . . 0.0 110.857 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.45 112.51 0.86 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.49 54.45 0.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.656 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -128.46 -18.68 3.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.4 m -136.32 -89.61 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.176 0.898 . . . . 0.0 109.688 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -55.24 -52.46 63.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.197 0.999 . . . . 0.0 111.028 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 p -58.03 -47.57 82.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.531 1.133 . . . . 0.0 110.874 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.45 -56.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.89 1.276 . . . . 0.0 110.16 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.1 mtm -57.33 -45.52 84.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.732 . . . . 0.0 111.228 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.03 97.6 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.671 0.669 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' HG12 ' A' ' 34' ' ' VAL . 23.9 tt0 -60.99 -34.57 75.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.832 0.453 . . . . 0.0 110.98 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.72 43.26 Favored Glycine 0 C--N 1.341 0.858 0 C-N-CA 123.706 0.669 . . . . 0.0 111.655 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.67 -43.27 94.04 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 117.533 0.666 . . . . 0.0 110.592 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.73 -43.59 98.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.771 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -53.86 -37.62 63.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.907 1.231 . . . . 0.0 111.954 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -66.76 -57.28 7.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.008 0.367 . . . . 0.0 110.411 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.94 -42.1 61.05 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.094 0.158 . . . . 0.0 111.381 -171.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 -11.43 59.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 112.257 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 26.85 60.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.377 0.989 . . . . 0.0 114.168 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 60.89 6.03 1.11 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.626 2.37 . . . . 0.0 114.134 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.82 -9.68 22.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.56 100.33 0.86 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.456 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.1 t -83.12 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -143.27 166.61 24.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.584 1.553 . . . . 0.0 109.421 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -149.74 161.28 42.54 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.614 -0.679 . . . . 0.0 110.133 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.53 -166.64 1.39 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.998 1.319 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.58 -179.97 44.58 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 111.715 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mt -53.52 -29.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.352 1.461 . . . . 0.0 111.356 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.49 167.14 24.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.602 1.161 . . . . 0.0 108.307 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.49 21.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -135.37 24.96 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.38 1.072 . . . . 0.0 109.255 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.84 167.68 39.18 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -84.78 147.54 26.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.959 0.504 . . . . 0.0 110.508 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -73.7 133.75 79.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.089 -0.957 . . . . 0.0 109.303 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.02 -33.8 44.1 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.897 2.398 . . . . 0.0 114.584 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.68 -29.23 63.24 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 121.35 -0.844 . . . . 0.0 110.87 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.37 85.06 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.22 -49.21 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -44.21 91.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.18 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.07 92.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.927 0.785 . . . . 0.0 110.152 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.1 mmm -71.81 -37.4 70.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.81 0.277 . . . . 0.0 111.525 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -27.36 69.06 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.87 -1.144 . . . . 0.0 111.31 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.98 -13.07 62.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.715 0.806 . . . . 0.0 110.852 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.3 -2.42 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.528 1.131 . . . . 0.0 112.228 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.97 33.41 9.73 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.16 160.87 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -128.33 145.15 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.32 -1.04 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.367 1.467 . . . . 0.0 110.284 173.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -57.8 -29.9 65.26 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.602 -1.311 . . . . 0.0 110.97 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -60.79 -16.2 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.697 1.999 . . . . 0.0 114.537 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' A' ' 21' ' ' GLU . 8.4 pt20 -131.1 54.92 1.88 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.713 1.142 . . . . 0.0 110.452 -169.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 p -49.78 140.94 10.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.93 0.892 . . . . 0.0 111.85 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 m -62.36 160.4 13.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.041 1.736 . . . . 0.0 114.517 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -155.98 156.46 34.53 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.963 1.305 . . . . 0.0 109.689 169.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.12 164.32 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.857 0.863 . . . . 0.0 109.331 170.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.43 146.92 5.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 110.308 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.54 136.01 32.44 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.392 1.077 . . . . 0.0 109.938 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.53 -28.65 46.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.454 1.502 . . . . 0.0 113.138 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.4 -10.83 59.69 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.966 1.306 . . . . 0.0 112.21 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.1 -42.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 mt -48.66 -58.41 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -1.31 36.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -116.38 -31.5 5.58 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.126 1.37 . . . . 0.0 111.7 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.03 44.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.153 1.381 . . . . 0.0 109.543 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.9 -26.22 67.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.443 0.697 . . . . 0.0 110.656 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -148.03 140.43 24.39 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.641 1.177 . . . . 0.0 108.803 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.69 148.13 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.53 130.76 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.29 132.09 45.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 170.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -102.96 23.21 12.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.904 0.882 . . . . 0.0 109.164 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.55 107.66 4.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.979 1.712 . . . . 0.0 110.45 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.066 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 171.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo . . . . . 0 CA--C 1.537 0.644 0 N-CA-C 114.275 0.837 . . . . 0.0 114.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.8 ttm -75.19 149.24 39.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.895 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -132.65 161.23 64.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.744 2.017 . . . . 0.0 110.05 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.98 133.31 24.86 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.029 1.819 . . . . 0.0 109.278 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.03 -19.3 30.28 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.817 2.345 . . . . 0.0 112.318 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -68.15 -20.18 64.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 111.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.73 142.23 16.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -61.39 136.23 57.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -129.97 158.83 38.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.974 0.91 . . . . 0.0 109.298 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -137.92 166.47 23.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.988 1.715 . . . . 0.0 107.914 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -132.87 117.5 17.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -125.43 52.89 1.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.153 1.781 . . . . 0.0 107.314 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.12 132.17 33.45 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.73 -1.231 . . . . 0.0 112.367 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.23 159.65 36.28 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.501 1.92 . . . . 0.0 106.132 169.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -68.71 142.17 55.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.845 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.05 126.95 93.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.112 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.16 -23.53 45.54 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.115 1.21 . . . . 0.0 113.297 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.69 -9.13 58.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.399 1.0 . . . . 0.0 112.225 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -113.0 4.38 16.69 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.236 1.414 . . . . 0.0 110.667 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.38 63.28 0.37 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.725 2.01 . . . . 0.0 110.442 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -59.44 138.97 57.49 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.669 1.588 . . . . 0.0 110.718 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.1 -59.73 0.2 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -166.17 169.27 14.53 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.054 1.742 . . . . 0.0 107.398 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.98 -29.61 68.56 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.369 0.668 . . . . 0.0 111.416 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.79 -37.8 73.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.788 0.435 . . . . 0.0 110.654 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.6 -43.85 75.58 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -57.4 -48.42 79.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.778 0.431 . . . . 0.0 110.141 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -60.99 -38.06 84.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.4 0.68 . . . . 0.0 111.925 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.44 81.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.46 -33.42 75.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.018 0.527 . . . . 0.0 111.13 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.25 -50.04 74.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.957 0.903 . . . . 0.0 110.278 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -64.88 -34.36 78.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.347 0.522 . . . . 0.0 111.656 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.51 -49.72 62.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.623 0.647 . . . . 0.0 110.821 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.93 -39.86 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -53.72 -54.14 42.22 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.458 1.103 . . . . 0.0 109.601 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.87 -43.23 93.64 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.056 0.222 . . . . 0.0 110.911 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.65 -41.08 88.79 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.999 -0.438 . . . . 0.0 110.77 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.7 mt -59.59 -50.33 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.72 -46.67 66.61 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.763 0.71 . . . . 0.0 111.476 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -62.19 -46.36 89.26 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.404 0.602 . . . . 0.0 110.78 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -72.25 -30.58 65.0 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 -174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -42.19 82.44 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.734 0.814 . . . . 0.0 109.62 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.17 -48.78 75.67 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -37.64 86.24 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.451 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -60.32 -37.29 80.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.643 -0.661 . . . . 0.0 111.496 175.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.87 33.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.518 0.327 . . . . 0.0 111.661 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.96 -45.69 7.83 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.465 1.106 . . . . 0.0 111.128 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.5 p -106.88 -19.49 13.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.055 . . . . 0.0 110.902 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.93 79.1 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.215 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.6 mttt . . . . . 0 C--O 1.248 1.003 0 CA-C-N 118.562 1.181 . . . . 0.0 108.703 176.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 173.95 3.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.3 142.24 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.54 146.06 22.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 119.043 0.838 . . . . 0.0 108.824 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.55 124.02 22.13 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -107.6 128.39 54.49 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.62 145.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.158 0.583 . . . . 0.0 110.935 -169.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.7 m -141.42 178.83 7.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.755 1.622 . . . . 0.0 109.374 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -75.85 -19.15 59.11 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.654 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.34 131.65 4.15 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.31 54.33 2.27 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.769 0.828 . . . . 0.0 111.748 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -126.1 -16.88 5.42 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -131.84 -106.33 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -170.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -35.44 75.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -60.71 -47.77 84.8 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.18 0.9 . . . . 0.0 110.377 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -60.01 -49.71 76.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.237 1.015 . . . . 0.0 110.221 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.39 -44.74 89.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.16 0.584 . . . . 0.0 111.841 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.79 99.61 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.234 0.614 . . . . 0.0 111.015 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG12 ' A' ' 34' ' ' VAL . 61.0 tt0 -56.13 -41.2 74.94 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.112 173.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.07 60.97 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.782 0.719 . . . . 0.0 112.309 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.54 -45.78 92.6 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.34 0.57 . . . . 0.0 110.812 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.33 -42.57 99.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.846 -175.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -52.77 -44.35 66.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.395 0.998 . . . . 0.0 111.568 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -74.8 -43.88 52.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.164 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -73.72 -44.58 55.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.494 0.588 . . . . 0.0 110.921 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.01 -9.64 59.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.161 0.984 . . . . 0.0 112.253 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.41 26.48 64.29 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.534 1.064 . . . . 0.0 113.956 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 60.72 5.82 1.01 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.625 2.37 . . . . 0.0 113.986 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.79 -9.32 19.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.641 1.176 . . . . 0.0 110.544 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.52 118.53 23.21 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 172.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -67.87 101.43 1.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -85.1 137.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.19 166.19 25.74 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.62 1.568 . . . . 0.0 109.529 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -147.88 157.06 43.34 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.482 0.713 . . . . 0.0 110.007 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.16 -168.03 1.62 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.546 1.139 . . . . 0.0 110.357 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.54 -175.45 42.09 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.442 -0.787 . . . . 0.0 112.598 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -55.09 -30.28 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.531 1.532 . . . . 0.0 110.681 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 169.6 17.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.776 1.23 . . . . 0.0 109.142 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.53 137.05 20.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -136.49 19.45 3.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.205 1.002 . . . . 0.0 109.777 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.71 29.09 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -94.42 146.95 23.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.342 0.657 . . . . 0.0 110.583 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.33 138.77 78.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.826 1.25 . . . . 0.0 109.455 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.15 -30.34 82.04 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.849 1.699 . . . . 0.0 113.255 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.92 -27.21 62.66 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.626 1.103 . . . . 0.0 110.483 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.31 -48.4 73.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.54 1.063 . . . . 0.0 108.941 171.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.68 -48.13 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -57.92 -47.08 83.88 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.933 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -43.68 81.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 0.0 109.389 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.8 mmm -71.25 -39.64 71.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.276 0.231 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.88 -27.09 69.11 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 120.888 -1.133 . . . . 0.0 111.259 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.2 -9.56 58.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.073 0.949 . . . . 0.0 109.957 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.55 -1.12 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.254 1.022 . . . . 0.0 112.591 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.65 33.52 11.28 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.1 161.54 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -125.58 143.35 51.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.58 3.63 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.03 1.332 . . . . 0.0 110.365 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -60.93 -28.06 68.66 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.2 -1.563 . . . . 0.0 110.965 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -65.5 -4.36 5.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.412 1.885 . . . . 0.0 115.322 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.82 47.87 2.03 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.274 1.397 . . . . 0.0 111.273 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 131.28 8.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.42 1.088 . . . . 0.0 110.789 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -54.82 154.42 5.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.448 1.899 . . . . 0.0 115.455 -169.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -152.22 156.0 38.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.206 1.403 . . . . 0.0 109.311 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.7 164.79 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.263 1.025 . . . . 0.0 109.346 171.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.1 mt -56.4 145.85 6.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.608 1.163 . . . . 0.0 109.671 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -136.93 134.42 36.74 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.404 1.082 . . . . 0.0 109.928 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.17 -27.64 55.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.635 1.574 . . . . 0.0 113.522 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.87 -4.18 57.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.527 0.603 . . . . 0.0 111.797 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -107.96 -42.24 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.6 mt -48.37 -60.45 2.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.388 0.995 . . . . 0.0 111.269 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -75.81 -1.94 27.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.371 0.668 . . . . 0.0 112.736 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -115.85 -31.51 5.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.932 1.293 . . . . 0.0 111.34 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.05 124.12 19.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.127 1.371 . . . . 0.0 109.848 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.7 -31.75 71.92 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.816 0.846 . . . . 0.0 110.184 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 tp -142.06 139.17 32.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.389 1.076 . . . . 0.0 108.547 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.41 147.08 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.95 126.83 51.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.29 118.39 36.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.342 0.519 . . . . 0.0 109.766 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.26 12.63 36.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.848 1.259 . . . . 0.0 110.749 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -65.53 119.18 10.61 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.328 171.667 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 N-CA-C 110.037 -0.793 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.8 tpp -130.23 159.07 37.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.472 1.109 . . . . 0.0 109.586 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 166.58 18.23 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.224 1.81 . . . . 0.0 110.457 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.97 161.34 33.55 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.558 1.505 . . . . 0.0 110.011 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.03 -9.12 17.94 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.096 2.531 . . . . 0.0 114.027 -169.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -115.0 -12.72 11.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.27 146.58 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.764 1.165 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.23 136.95 52.74 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -138.61 151.89 47.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.307 0.643 . . . . 0.0 109.987 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.34 161.71 29.66 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.137 2.175 . . . . 0.0 107.387 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -139.48 112.53 8.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 30.9 m0 -122.43 51.45 1.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.641 1.577 . . . . 0.0 107.062 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.88 132.18 31.32 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 120.885 -1.134 . . . . 0.0 111.88 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.97 35.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.028 1.731 . . . . 0.0 107.411 169.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.27 134.35 56.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.913 1.285 . . . . 0.0 109.842 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.42 124.7 91.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -23.91 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.432 1.421 . . . . 0.0 113.604 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.53 49.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.167 0.894 . . . . 0.0 112.273 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -110.33 8.51 23.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.615 1.166 . . . . 0.0 111.071 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.87 68.7 0.66 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.879 1.272 . . . . 0.0 109.777 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.13 136.34 57.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.792 0.837 . . . . 0.0 110.277 -171.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.55 -61.72 0.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -165.44 167.04 17.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.432 1.493 . . . . 0.0 107.72 171.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.49 -28.05 66.69 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.612 0.765 . . . . 0.0 111.431 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.7 -37.35 70.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.047 0.539 . . . . 0.0 110.941 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -69.39 -44.48 71.38 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.2 -45.96 83.29 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.776 0.431 . . . . 0.0 110.293 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -60.37 -40.47 90.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.47 0.708 . . . . 0.0 111.756 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.08 87.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.487 -0.758 . . . . 0.0 110.513 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -62.8 -37.47 86.85 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.007 0.523 . . . . 0.0 111.274 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.12 -48.95 77.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.364 0.665 . . . . 0.0 110.345 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.53 -36.34 83.46 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.438 0.563 . . . . 0.0 111.824 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -68.43 -47.44 67.22 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.995 0.816 . . . . 0.0 111.085 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.21 -41.41 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.82 -53.17 58.74 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.141 0.976 . . . . 0.0 109.758 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.59 -42.44 98.28 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.781 0.264 . . . . 0.0 110.954 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.6 -41.64 92.56 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.984 -0.447 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.51 -50.78 79.01 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.71 -45.63 60.25 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -61.13 -50.35 73.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 117.446 0.623 . . . . 0.0 111.1 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.436 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.9 tpt180 -68.69 -34.25 75.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.228 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -40.66 98.41 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.687 1.13 . . . . 0.0 109.695 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.79 -51.87 68.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.24 -36.08 83.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.908 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.65 -36.55 83.2 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.709 -0.619 . . . . 0.0 111.2 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.4 -37.85 31.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.652 0.381 . . . . 0.0 111.257 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.35 -46.92 8.07 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.393 1.077 . . . . 0.0 110.868 -170.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -109.41 -18.86 13.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.432 1.093 . . . . 0.0 111.638 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.46 13.16 82.13 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.586 -1.119 . . . . 0.0 112.942 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 119.225 1.512 . . . . 0.0 108.428 179.242 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 . . . . . 0 C--O 1.235 0.307 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -71.86 172.75 9.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.12 143.62 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -146.58 149.7 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 119.211 0.914 . . . . 0.0 109.233 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.23 131.55 32.55 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.586 0.754 . . . . 0.0 109.286 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.25 128.3 56.29 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.3 mt -125.03 141.35 52.18 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.072 0.949 . . . . 0.0 110.319 -169.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.3 m -141.12 168.85 18.79 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 122.223 1.011 . . . . 0.0 112.557 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -76.82 34.21 0.15 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.737 2.015 . . . . 0.0 110.479 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.65 109.15 0.67 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 126.351 1.929 . . . . 0.0 108.605 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.46 51.46 0.72 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.201 1.0 . . . . 0.0 111.746 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -120.99 -20.38 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 m -136.32 -92.85 0.25 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.254 0.933 . . . . 0.0 110.66 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -36.71 85.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -61.04 -47.33 86.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.336 0.654 . . . . 0.0 110.616 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -60.69 -49.98 75.34 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.177 0.991 . . . . 0.0 109.679 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 mtm -58.21 -44.46 88.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.061 0.544 . . . . 0.0 111.623 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.45 -44.21 97.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.794 0.725 . . . . 0.0 111.346 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.6 tt0 -56.94 -41.84 78.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.449 0.3 . . . . 0.0 110.725 173.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.92 -52.86 50.83 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.763 0.697 . . . . 0.0 112.119 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -61.32 -43.05 99.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.394 0.597 . . . . 0.0 110.82 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.07 99.74 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.923 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -55.08 -36.69 65.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.439 1.018 . . . . 0.0 111.553 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -68.4 -57.67 5.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.238 0.472 . . . . 0.0 110.921 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -76.19 -43.87 40.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.1 mt -72.56 -34.49 67.53 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.947 0.499 . . . . 0.0 111.46 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 173.57 42.13 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -1.48 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 111.607 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.83 -10.23 5.26 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.428 -0.795 . . . . 0.0 110.991 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.3 m95 -128.99 119.63 24.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -70.16 92.19 0.75 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -78.95 138.44 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.49 166.81 24.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.219 1.407 . . . . 0.0 109.46 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -147.71 159.89 43.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.429 0.692 . . . . 0.0 109.721 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.41 -166.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 109.304 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.06 43.61 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 121.311 -0.868 . . . . 0.0 111.776 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.45 -29.56 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.991 1.316 . . . . 0.0 110.734 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.8 166.48 29.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.325 1.45 . . . . 0.0 108.247 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.85 140.08 26.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.16 9.33 5.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.65 149.55 24.89 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.0 144.96 56.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.497 0.665 . . . . 0.0 111.413 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -73.21 133.31 81.28 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.575 1.15 . . . . 0.0 108.61 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.01 -34.37 37.7 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.872 2.381 . . . . 0.0 114.282 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.78 -28.47 63.65 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.498 -0.751 . . . . 0.0 110.896 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.01 77.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.34 -48.07 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -39.75 94.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.673 -0.68 . . . . 0.0 111.041 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.01 -44.53 97.28 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.304 0.956 . . . . 0.0 110.3 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 74.3 mmm -68.91 -36.27 77.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.642 0.655 . . . . 0.0 111.469 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.484 -1.385 . . . . 0.0 111.396 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -66.43 -17.35 64.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.93 0.786 . . . . 0.0 111.038 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.66 -0.64 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.08 0.952 . . . . 0.0 112.114 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.43 32.85 12.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.03 158.55 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.3 144.6 49.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.412 1.085 . . . . 0.0 108.153 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.99 4.14 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.977 1.311 . . . . 0.0 110.404 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.09 -27.57 67.11 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.113 -1.617 . . . . 0.0 111.153 172.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.38 -3.19 3.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.468 1.907 . . . . 0.0 115.295 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -139.9 47.65 1.82 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.302 1.41 . . . . 0.0 111.645 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 133.21 7.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.599 1.16 . . . . 0.0 111.356 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -57.51 156.61 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.069 1.748 . . . . 0.0 115.153 -169.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -155.95 158.51 38.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.079 1.352 . . . . 0.0 109.301 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.414 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.31 164.37 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 170.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.61 149.19 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.829 1.652 . . . . 0.0 110.991 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.53 136.06 32.51 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.705 1.202 . . . . 0.0 110.181 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.01 -29.39 57.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.576 1.551 . . . . 0.0 113.319 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.77 -9.01 52.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.912 1.285 . . . . 0.0 112.27 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.51 -42.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.1 mt -46.98 -57.5 4.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.586 1.085 . . . . 0.0 112.186 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.71 -0.06 52.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 112.801 -173.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.94 -31.92 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.135 1.374 . . . . 0.0 111.527 -169.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.83 130.39 45.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.426 1.491 . . . . 0.0 109.887 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -63.07 -28.12 69.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.712 0.805 . . . . 0.0 110.477 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -147.62 139.95 24.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.891 1.276 . . . . 0.0 108.671 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.66 147.76 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.75 124.29 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -99.44 132.86 44.48 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.65 22.9 15.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.682 0.793 . . . . 0.0 109.362 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.0 111.81 6.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.785 -1.197 . . . . 0.0 110.305 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.273 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 169.886 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 CA--C 1.535 0.538 0 N-CA-C 113.224 0.432 . . . . 0.0 113.224 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.1 ttt -69.53 145.23 52.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.035 0.934 . . . . 0.0 109.663 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.9 p -126.01 160.23 57.95 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 126.432 1.893 . . . . 0.0 109.288 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.28 153.92 75.67 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 121.692 1.595 . . . . 0.0 109.226 169.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.45 -24.22 19.43 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.442 2.095 . . . . 0.0 112.004 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -78.45 -25.3 45.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.522 0.729 . . . . 0.0 112.732 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -78.47 147.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 118.822 0.737 . . . . 0.0 109.676 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -67.94 137.36 55.12 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -135.44 150.4 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.971 0.509 . . . . 0.0 110.401 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -126.91 159.85 32.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.127 2.171 . . . . 0.0 107.946 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -132.92 114.94 14.62 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.46 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 24.8 m0 -123.2 53.85 1.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.338 1.855 . . . . 0.0 107.055 -174.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.51 131.12 34.85 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 120.717 -1.24 . . . . 0.0 111.803 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 161.78 37.81 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.795 2.038 . . . . 0.0 106.056 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -68.55 141.61 55.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.227 0.537 . . . . 0.0 110.596 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.24 128.49 93.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.96 -24.38 45.78 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.116 1.077 . . . . 0.0 113.411 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.05 56.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.228 0.922 . . . . 0.0 112.221 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -111.9 3.28 17.46 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.26 . . . . 0.0 110.62 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 62.95 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.892 2.077 . . . . 0.0 110.427 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -60.03 138.96 57.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.722 1.609 . . . . 0.0 110.573 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.55 -59.09 0.21 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 175.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -166.36 168.95 14.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.985 1.714 . . . . 0.0 107.497 169.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.61 -29.36 67.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 111.314 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.9 -38.35 76.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.93 -43.74 74.5 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.04 -47.2 83.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.852 0.461 . . . . 0.0 110.346 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -61.63 -38.65 88.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.75 0.704 . . . . 0.0 111.722 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.08 82.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.168 -0.957 . . . . 0.0 110.334 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.13 -32.11 73.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.976 -0.453 . . . . 0.0 111.197 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.27 -50.37 73.11 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.492 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -45.41 80.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.827 0.74 . . . . 0.0 111.665 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -59.92 -49.73 76.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.866 0.757 . . . . 0.0 110.734 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.0 t -70.77 -39.12 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.78 -56.16 23.83 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 124.342 1.057 . . . . 0.0 108.75 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.57 -38.66 77.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 123.406 0.441 . . . . 0.0 110.7 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.42 -42.46 87.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.898 0.479 . . . . 0.0 111.025 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.79 -50.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.77 -47.58 46.38 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -60.93 -49.37 77.71 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 117.567 0.684 . . . . 0.0 111.479 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -69.55 -34.3 74.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.126 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.77 88.74 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.596 1.089 . . . . 0.0 109.744 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -55.21 -52.36 63.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.62 -34.83 78.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.56 -36.36 82.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.893 0.77 . . . . 0.0 111.071 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.73 28.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.147 0.579 . . . . 0.0 111.494 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.15 -41.45 11.01 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 111.952 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.2 p -115.05 -19.33 10.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.206 1.002 . . . . 0.0 111.17 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.61 76.92 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.837 -0.98 . . . . 0.0 112.869 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.6 mttt . . . . . 0 C--O 1.247 0.923 0 CA-C-N 118.879 1.339 . . . . 0.0 108.754 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 171.99 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -142.97 142.12 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.74 149.08 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 119.489 1.04 . . . . 0.0 109.039 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.72 134.87 41.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -118.4 130.62 56.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -125.74 138.93 53.89 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 110.088 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t -137.78 169.15 18.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.807 1.243 . . . . 0.0 109.875 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -58.49 -24.78 61.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.292 1.037 . . . . 0.0 111.737 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.25 139.51 6.49 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -77.98 51.91 1.01 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.154 0.982 . . . . 0.0 111.549 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.1 m -127.01 -15.91 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.312 -169.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.6 m -138.38 -95.6 0.19 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -54.8 -52.06 63.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.556 0.742 . . . . 0.0 111.661 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 17.5 p -68.9 -36.32 77.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.552 0.16 . . . . 0.0 111.312 -172.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.15 -53.95 51.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.114 0.966 . . . . 0.0 110.469 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.8 mtm -57.88 -44.37 86.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.133 0.573 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.21 99.07 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.384 0.538 . . . . 0.0 111.517 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.41 -32.35 70.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.098 0.559 . . . . 0.0 111.878 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.71 29.71 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -60.16 -41.24 92.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 117.338 0.569 . . . . 0.0 110.647 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.51 99.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.287 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -55.09 -40.17 70.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.824 1.193 . . . . 0.0 111.22 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -64.29 -51.8 61.72 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.396 0.435 . . . . 0.0 110.872 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -82.6 -44.6 15.63 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -171.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 92.4 mt -73.48 -33.81 65.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.816 0.446 . . . . 0.0 111.939 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.72 175.95 46.95 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.96 -2.65 10.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.768 0.827 . . . . 0.0 111.399 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.51 -12.35 6.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.776 1.231 . . . . 0.0 111.299 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 17.2 m95 -129.35 117.84 21.27 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -69.2 97.29 0.91 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.23 136.87 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.77 164.23 31.08 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.54 1.536 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 89.8 p -146.59 159.19 43.76 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.533 0.733 . . . . 0.0 109.729 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.5 -166.97 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.521 1.128 . . . . 0.0 109.621 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.47 -178.96 44.76 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -55.53 -27.93 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.259 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.85 172.12 14.66 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.537 1.535 . . . . 0.0 108.367 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.94 137.66 25.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.85 7.72 5.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.553 1.141 . . . . 0.0 110.452 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 145.86 17.98 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.08 142.35 54.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.742 0.782 . . . . 0.0 112.034 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -69.41 138.88 89.11 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 108.963 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.75 -28.71 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.735 1.623 . . . . 0.0 112.983 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -72.3 -29.16 63.6 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 120.985 -1.072 . . . . 0.0 110.478 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -45.91 87.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.19 -52.65 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -59.96 -41.2 91.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.974 0.807 . . . . 0.0 111.478 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.25 91.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.605 0.639 . . . . 0.0 109.853 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.71 -35.15 72.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.174 -0.329 . . . . 0.0 111.035 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -31.65 70.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.059 -1.026 . . . . 0.0 110.966 174.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.45 -15.64 63.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.211 1.004 . . . . 0.0 110.94 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.59 1.16 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.262 1.025 . . . . 0.0 111.859 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.38 30.92 17.85 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.0 mt -120.75 153.59 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -137.51 80.56 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.5 1.12 . . . . 0.0 111.043 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.32 1.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.0 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 96.8 p -61.26 -19.84 62.17 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.208 1.822 . . . . 0.0 112.212 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -81.33 0.3 37.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 112.956 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.29 50.31 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.431 1.014 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -47.58 137.1 9.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.191 1.396 . . . . 0.0 111.547 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -60.07 157.74 12.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -156.35 157.7 36.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.246 1.418 . . . . 0.0 109.743 170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.416 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.5 166.49 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.742 1.217 . . . . 0.0 109.927 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.56 146.2 7.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.477 1.111 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.77 136.42 32.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.478 1.111 . . . . 0.0 109.908 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.75 -28.45 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.44 1.496 . . . . 0.0 113.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.38 -11.19 60.61 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.993 1.317 . . . . 0.0 112.231 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.2 mt -114.73 -42.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.4 mt -48.93 -58.79 4.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.814 1.188 . . . . 0.0 111.557 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -1.85 34.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -115.47 -31.92 5.75 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.083 1.353 . . . . 0.0 111.699 -169.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.2 130.62 47.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.286 1.434 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.61 -31.58 71.66 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.695 1.198 . . . . 0.0 109.857 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.87 141.61 24.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.135 1.374 . . . . 0.0 108.557 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.62 144.69 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.55 136.59 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 109.08 14.56 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.68 7.43 39.46 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.885 -0.51 . . . . 0.0 112.318 -168.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.93 120.4 11.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.566 1.147 . . . . 0.0 110.968 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.248 0 C-N-CA 125.327 1.441 . . . . 0.0 110.668 170.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 CA--C 1.536 0.589 0 N-CA-C 113.629 0.588 . . . . 0.0 113.629 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.8 ttp -70.45 140.17 51.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.242 1.017 . . . . 0.0 110.261 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.8 p -134.29 159.33 72.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.532 1.933 . . . . 0.0 110.04 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.66 143.6 46.92 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.115 1.877 . . . . 0.0 109.938 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.54 -20.23 20.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.935 2.423 . . . . 0.0 111.668 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -73.49 -7.71 52.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.117 1.367 . . . . 0.0 112.727 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.1 141.55 34.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.12 136.81 58.19 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -133.67 155.06 50.4 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.111 0.565 . . . . 0.0 110.236 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.92 158.76 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.149 173.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -131.49 115.51 16.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.1 m0 -122.48 59.84 1.02 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -174.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.5 133.18 23.36 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 121.408 -0.807 . . . . 0.0 112.119 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -162.21 161.56 27.93 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.628 1.971 . . . . 0.0 106.439 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -65.23 140.31 58.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.462 0.705 . . . . 0.0 110.692 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.27 128.44 91.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.29 -21.95 34.94 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 120.354 1.162 . . . . 0.0 113.338 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.89 -11.96 60.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.628 1.104 . . . . 0.0 111.855 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -107.79 -1.2 21.12 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.665 1.586 . . . . 0.0 110.677 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.84 52.8 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.781 2.432 . . . . 0.0 111.859 173.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -54.26 137.83 40.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.726 2.01 . . . . 0.0 111.796 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.37 -60.59 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -162.94 164.31 25.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.477 1.511 . . . . 0.0 107.585 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.14 -30.46 71.05 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.841 -0.537 . . . . 0.0 111.492 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.31 -37.04 77.58 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.858 0.463 . . . . 0.0 110.378 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.7 -43.34 69.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -55.64 -49.69 72.19 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.89 -0.506 . . . . 0.0 110.213 171.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -60.38 -36.13 77.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.769 0.713 . . . . 0.0 111.923 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.72 77.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.359 -0.838 . . . . 0.0 109.482 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -63.52 -31.47 72.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.094 -0.955 . . . . 0.0 112.532 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.35 -48.43 80.58 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 120.044 1.293 . . . . 0.0 109.862 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.27 -36.58 83.35 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.8 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -65.12 -50.43 66.07 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.778 0.717 . . . . 0.0 110.293 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.15 -38.27 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.92 -52.93 58.99 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 109.331 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.22 -44.52 91.65 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.112 0.258 . . . . 0.0 111.167 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.27 -39.73 89.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.61 -0.681 . . . . 0.0 111.283 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.6 mt -58.16 -52.77 54.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 172.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.86 61.51 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.35 -50.76 71.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 117.703 0.751 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.931 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.542 1.065 . . . . 0.0 109.737 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -57.01 -53.71 55.0 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.33 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.639 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -62.04 -36.8 82.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.575 -0.703 . . . . 0.0 111.157 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.84 28.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.122 0.569 . . . . 0.0 111.714 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.17 -41.52 10.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.611 1.164 . . . . 0.0 111.996 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.0 p -114.62 -19.1 11.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.154 0.981 . . . . 0.0 110.969 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.59 76.33 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.783 -1.01 . . . . 0.0 112.688 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.5 mttt . . . . . 0 C--O 1.246 0.876 0 CA-C-N 118.781 1.291 . . . . 0.0 108.504 179.317 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.482 1.146 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -127.8 1.1 6.05 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.92 0.888 . . . . 0.0 111.1 177.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -69.5 135.23 49.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.88 174.07 3.97 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -141.42 142.59 28.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 tt -145.25 149.7 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 119.308 0.958 . . . . 0.0 109.189 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -135.7 138.3 42.62 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.842 0.857 . . . . 0.0 109.185 -173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -120.23 131.06 54.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.6 mt -127.94 140.08 52.21 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.785 0.834 . . . . 0.0 110.547 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 68.8 m -139.26 175.26 9.71 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.176 0.99 . . . . 0.0 111.887 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.6 p -55.36 -32.1 62.3 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.789 1.236 . . . . 0.0 111.142 172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 143.27 9.9 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 169.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.12 57.83 2.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.094 0.958 . . . . 0.0 111.424 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.6 m -127.92 -20.22 3.89 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 114.325 1.232 . . . . 0.0 114.325 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 76.0 m -134.33 -93.81 0.3 Allowed 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.229 0.922 . . . . 0.0 109.052 -172.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.6 mtm180 -55.36 -50.9 68.49 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.969 0.907 . . . . 0.0 111.518 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.7 p -67.58 -37.85 83.2 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.748 0.703 . . . . 0.0 111.501 -175.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.1 mm-40 -60.5 -52.8 63.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.147 0.979 . . . . 0.0 110.347 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.1 mtm -59.9 -42.07 93.04 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.54 0.736 . . . . 0.0 111.358 177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.91 -43.66 98.2 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 118.457 0.571 . . . . 0.0 111.329 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG3' HG12 ' A' ' 34' ' ' VAL . 79.7 tt0 -55.96 -43.28 77.35 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.959 0.345 . . . . 0.0 110.332 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.434 ' HA2' ' HE2' ' A' ' 25' ' ' LYS . . . -54.5 -52.26 46.21 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-O 119.34 -0.7 . . . . 0.0 112.754 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -65.05 -42.97 93.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 117.525 0.662 . . . . 0.0 111.275 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.69 98.98 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.806 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.434 ' HE2' ' HA2' ' A' ' 22' ' ' GLY . 46.1 mtmt -51.09 -41.2 59.82 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.238 0.926 . . . . 0.0 111.325 172.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -67.32 -61.97 1.65 Allowed 'General case' 0 C--O 1.232 0.164 0 O-C-N 123.329 0.393 . . . . 0.0 110.566 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -69.48 -39.15 77.85 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.3 mt -77.84 -5.37 50.66 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.507 0.723 . . . . 0.0 112.542 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.06 26.57 55.96 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.559 1.076 . . . . 0.0 114.006 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.5 t70 58.69 8.45 0.92 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.427 2.291 . . . . 0.0 114.292 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -66.82 -3.88 7.89 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.89 -1.131 . . . . 0.0 111.093 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 8.6 m95 -132.4 121.59 23.68 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 103.457 -2.794 . . . . 0.0 103.457 177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.9 mmpt? -67.62 97.3 0.6 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 172.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.414 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -80.39 139.86 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -174.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -146.93 165.23 30.43 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.408 1.483 . . . . 0.0 109.501 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.0 p -144.5 157.48 44.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.734 0.814 . . . . 0.0 109.624 169.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.89 -166.31 1.57 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.87 1.268 . . . . 0.0 109.552 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.66 -179.46 46.18 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.0 mt -56.14 -27.66 23.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 124.997 1.319 . . . . 0.0 111.448 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -145.63 171.94 13.98 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.74 1.216 . . . . 0.0 108.968 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.65 135.36 17.36 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -137.03 17.46 3.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.24 1.016 . . . . 0.0 109.896 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.97 167.61 25.1 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -91.31 149.79 21.59 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.224 0.61 . . . . 0.0 110.721 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -74.47 134.14 76.65 Favored Pre-proline 0 CA--C 1.535 0.398 0 CA-C-O 118.126 -0.94 . . . . 0.0 109.872 -171.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -51.87 -34.84 57.34 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.778 2.318 . . . . 0.0 114.115 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -72.98 -32.74 65.38 Favored 'General case' 0 C--O 1.225 -0.196 0 O-C-N 121.447 -0.783 . . . . 0.0 110.297 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.11 -44.72 91.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -57.37 -51.22 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -58.07 -44.49 87.54 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.921 0.782 . . . . 0.0 111.511 177.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.1 -46.0 86.26 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -176.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.1 mmm -69.39 -37.58 77.58 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.984 0.356 . . . . 0.0 111.333 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 58' ' ' ASP . 0.5 OUTLIER -63.69 -27.58 69.31 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.927 -1.108 . . . . 0.0 111.309 174.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.35 -16.27 63.49 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.018 0.826 . . . . 0.0 110.769 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.27 0.55 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.908 0.883 . . . . 0.0 112.052 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.64 32.45 18.75 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -118.35 160.22 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 53' ' ' LYS . 28.5 t70 -125.05 141.88 51.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.67 0.788 . . . . 0.0 109.596 172.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.6 pt -129.76 -0.54 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 125.406 1.482 . . . . 0.0 109.826 169.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -58.62 -33.01 69.54 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 120.344 -1.473 . . . . 0.0 111.116 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -63.28 -17.75 62.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.254 1.821 . . . . 0.0 114.763 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -120.86 52.53 1.18 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 119.664 1.12 . . . . 0.0 110.569 -168.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.2 p -48.18 136.07 12.43 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.979 0.911 . . . . 0.0 110.984 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.8 m -57.11 155.57 8.28 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 -168.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -153.72 156.31 37.58 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.359 1.464 . . . . 0.0 109.395 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.55 168.78 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 124.544 1.138 . . . . 0.0 109.447 170.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -56.51 142.99 11.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 123.673 0.789 . . . . 0.0 108.935 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -136.61 140.88 43.15 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.513 1.125 . . . . 0.0 109.876 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.67 -30.56 61.25 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.066 1.346 . . . . 0.0 113.166 -175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -70.01 -11.12 60.65 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.278 1.031 . . . . 0.0 112.069 -173.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.0 mt -121.06 -43.84 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.9 pp -56.93 -40.66 76.79 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 120.078 1.308 . . . . 0.0 112.341 -173.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.2 4.84 52.13 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.901 0.881 . . . . 0.0 112.542 -177.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -125.59 -26.42 3.54 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.813 1.245 . . . . 0.0 112.851 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.39 132.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.617 1.167 . . . . 0.0 109.384 175.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -67.03 -25.48 66.3 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.705 174.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.6 tp -147.77 141.97 26.14 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.672 1.189 . . . . 0.0 108.655 175.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -118.63 147.04 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 169.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.1 t -132.64 127.27 55.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -100.89 134.39 43.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 169.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.25 18.22 21.33 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.212 0.605 . . . . 0.0 109.971 -173.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 12.6 p -67.98 116.04 8.18 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.198 1.399 . . . . 0.0 110.442 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -163.25 29.4 0.25 Allowed Glycine 0 CA--C 1.532 1.145 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 170.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -110.71 -177.1 3.14 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 128.995 2.918 . . . . 0.0 112.907 -169.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.84 -20.01 65.47 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 -175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.14 -39.72 6.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.497 1.044 . . . . 0.0 111.032 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 50.16 37.21 14.09 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.864 1.666 . . . . 0.0 114.081 169.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -63.87 -24.36 67.71 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.776 -1.202 . . . . 0.0 113.135 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.9 m 44.87 87.71 0.11 Allowed Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 127.054 2.142 . . . . 0.0 113.314 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -45.37 135.92 11.73 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.269 3.312 . . . . 0.0 113.357 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -68.61 145.69 53.72 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.373 1.069 . . . . 0.0 109.57 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -130.2 158.23 74.79 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 126.095 1.758 . . . . 0.0 109.868 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.46 138.18 35.05 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 121.907 1.738 . . . . 0.0 109.291 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.63 -21.19 25.86 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.802 2.335 . . . . 0.0 112.306 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -67.89 -23.13 65.08 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.132 0.973 . . . . 0.0 112.083 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.7 t -99.98 142.21 15.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -170.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.05 139.24 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.984 0.914 . . . . 0.0 108.589 175.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -133.64 151.64 51.71 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.598 0.759 . . . . 0.0 110.123 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -126.92 159.23 34.61 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.781 2.033 . . . . 0.0 107.723 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.8 t60 -135.05 111.15 9.53 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -121.42 62.03 0.91 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.968 1.707 . . . . 0.0 106.847 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.37 133.4 23.81 Favored Glycine 0 CA--C 1.525 0.669 0 O-C-N 121.198 -0.939 . . . . 0.0 112.177 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.55 161.16 35.19 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 126.561 1.944 . . . . 0.0 106.126 169.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -68.23 143.2 55.4 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.237 0.542 . . . . 0.0 110.903 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -69.24 127.15 93.06 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -64.81 -23.73 62.23 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.176 1.251 . . . . 0.0 113.378 -177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.67 -14.66 63.17 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.334 0.97 . . . . 0.0 112.337 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -110.02 3.84 20.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.121 1.368 . . . . 0.0 111.294 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.22 61.66 0.46 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.406 1.882 . . . . 0.0 111.225 175.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -59.13 138.68 57.47 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.805 1.642 . . . . 0.0 110.701 -171.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.09 -59.36 0.2 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.1 t -165.06 167.58 18.19 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.81 1.644 . . . . 0.0 107.402 169.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.28 -30.77 70.68 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.115 0.566 . . . . 0.0 111.283 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.63 -38.54 80.59 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.831 0.452 . . . . 0.0 110.379 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.27 -42.3 72.3 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -56.35 -52.21 65.43 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-O 118.928 -0.558 . . . . 0.0 110.114 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.8 t-105 -56.99 -40.34 76.36 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.89 0.768 . . . . 0.0 111.287 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.22 -40.98 97.16 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.511 0.596 . . . . 0.0 110.16 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -67.31 -29.86 69.55 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.634 -1.174 . . . . 0.0 113.139 173.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -60.55 -50.79 72.15 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 120.853 1.66 . . . . 0.0 109.813 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -65.9 -33.45 75.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.94 0.791 . . . . 0.0 112.035 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 62.7 mtt180 -65.58 -51.81 56.93 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.359 0.982 . . . . 0.0 110.893 174.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 73.3 t -66.08 -37.9 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -54.65 -53.57 53.0 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 123.571 0.749 . . . . 0.0 109.581 173.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -63.06 -43.47 98.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 117.763 0.256 . . . . 0.0 110.963 -174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -40.45 91.21 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.737 -0.602 . . . . 0.0 111.184 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.2 mt -59.32 -50.26 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.26 -46.02 63.79 Favored Glycine 0 C--N 1.337 0.635 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -59.64 -50.0 75.58 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 117.558 0.679 . . . . 0.0 110.895 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -70.32 -30.13 67.02 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 117.321 -1.323 . . . . 0.0 111.554 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -39.95 84.98 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 119.654 1.115 . . . . 0.0 110.104 174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -56.4 -50.92 70.2 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.02 -36.17 83.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.201 0.455 . . . . 0.0 111.662 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -62.7 -36.63 83.57 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.357 -0.84 . . . . 0.0 111.539 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.37 -36.93 33.29 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.481 0.312 . . . . 0.0 111.173 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.4 -42.78 10.71 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.047 1.339 . . . . 0.0 111.797 -169.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.4 p -115.05 -20.29 10.54 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.464 1.106 . . . . 0.0 111.475 -169.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.35 82.31 Favored Glycine 0 CA--C 1.532 1.145 0 CA-C-O 118.856 -0.969 . . . . 0.0 112.939 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt . . . . . 0 C--O 1.247 0.924 0 CA-C-N 119.12 1.46 . . . . 0.0 109.059 178.244 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -162.08 177.14 9.99 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.157 1.383 . . . . 0.0 108.826 -169.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -139.36 136.68 35.02 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 172.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -77.45 178.25 7.35 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.9 140.41 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.0 tt -143.27 152.1 16.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 123.778 0.831 . . . . 0.0 109.325 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.62 136.45 29.15 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.095 0.958 . . . . 0.0 109.088 -169.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -123.64 125.37 44.69 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.654 1.182 . . . . 0.0 108.261 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.3 142.41 49.98 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.755 1.222 . . . . 0.0 109.477 -169.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -139.95 171.44 14.2 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.158 0.983 . . . . 0.0 111.833 176.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.6 p -60.04 -23.0 63.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.941 0.897 . . . . 0.0 111.795 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.96 134.88 4.18 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 169.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -79.82 55.01 1.96 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.289 1.036 . . . . 0.0 111.528 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.5 m -126.55 -16.86 5.22 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.92 1.081 . . . . 0.0 113.92 -169.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.4 m -137.88 -87.12 0.27 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.073 0.851 . . . . 0.0 109.478 -172.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -57.99 -54.36 47.86 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.754 0.822 . . . . 0.0 111.192 -170.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 10.8 p -67.01 -34.57 78.04 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.975 0.352 . . . . 0.0 111.238 -174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -62.16 -55.5 28.08 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.958 0.903 . . . . 0.0 109.998 176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.5 mtm -58.06 -42.71 86.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.274 0.63 . . . . 0.0 111.484 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.6 -43.92 97.96 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 118.621 0.646 . . . . 0.0 111.353 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.6 tt0 -56.88 -41.68 78.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 117.933 0.333 . . . . 0.0 110.611 174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.7 -50.35 68.63 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 118.484 0.584 . . . . 0.0 112.41 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -63.53 -42.97 98.4 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 117.596 0.698 . . . . 0.0 111.089 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.35 99.53 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.564 -176.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -52.0 -38.6 57.33 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 118.954 0.797 . . . . 0.0 111.643 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -70.51 -62.59 1.33 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.204 0.315 . . . . 0.0 110.675 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -68.81 -36.87 78.75 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -169.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 79.2 mt -78.44 -2.11 36.88 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.353 0.661 . . . . 0.0 112.197 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.5 24.05 58.96 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.979 1.276 . . . . 0.0 113.961 171.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 57.14 14.32 1.97 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.031 2.132 . . . . 0.0 113.633 -172.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -73.15 -0.86 15.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.928 1.291 . . . . 0.0 110.91 170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.7 m95 -133.46 122.52 23.8 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 104.391 -2.448 . . . . 0.0 104.391 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.54 97.42 0.59 Allowed 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 171.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG11 ' HB3' ' A' ' 24' ' ' ALA . 1.9 t -82.1 140.88 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -144.76 166.13 26.1 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.166 1.387 . . . . 0.0 109.533 174.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 87.8 p -145.68 158.44 43.85 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.689 0.796 . . . . 0.0 109.888 169.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.34 -168.17 1.95 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.708 1.203 . . . . 0.0 110.205 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.0 179.96 46.82 Favored Glycine 0 CA--C 1.522 0.502 0 O-C-N 121.534 -0.729 . . . . 0.0 111.325 173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -56.38 -27.68 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.049 1.34 . . . . 0.0 111.304 173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.11 168.94 21.1 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.915 1.286 . . . . 0.0 108.563 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.48 138.44 26.15 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -128.74 12.97 6.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.757 1.223 . . . . 0.0 109.826 172.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.45 163.77 34.43 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -170.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.53 146.21 38.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.217 0.532 . . . . 0.0 110.375 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -70.52 134.33 86.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-O 118.137 -0.935 . . . . 0.0 108.671 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -50.15 -35.62 43.11 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.657 2.238 . . . . 0.0 114.095 173.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -71.42 -27.26 63.18 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.451 -0.78 . . . . 0.0 111.011 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.9 85.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.36 -49.91 81.81 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -57.81 -40.24 79.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.395 0.998 . . . . 0.0 111.642 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.52 -46.84 84.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 118.598 0.636 . . . . 0.0 109.618 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.2 mmm -68.1 -35.3 77.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.423 0.556 . . . . 0.0 111.123 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp -68.07 -23.72 64.98 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.669 -1.269 . . . . 0.0 111.308 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -67.13 -21.16 65.85 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 119.091 0.859 . . . . 0.0 110.398 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.7 m -110.59 -1.47 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 123.24 0.616 . . . . 0.0 112.133 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.0 33.28 15.46 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 174.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.64 159.28 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -123.94 144.39 49.82 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 171.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -128.82 3.53 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.984 1.314 . . . . 0.0 110.261 170.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.98 -28.66 67.87 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 120.102 -1.624 . . . . 0.0 111.061 171.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.49 -4.65 4.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.421 1.888 . . . . 0.0 115.192 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -138.16 49.23 1.94 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 120.425 1.466 . . . . 0.0 110.879 -169.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 p -46.61 131.56 11.25 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.307 1.043 . . . . 0.0 110.747 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -56.85 156.73 6.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 126.134 1.773 . . . . 0.0 115.179 -169.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -153.38 157.04 39.39 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.069 1.348 . . . . 0.0 109.132 171.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.456 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.77 164.89 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.867 0.867 . . . . 0.0 109.402 169.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.49 139.89 14.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.684 1.194 . . . . 0.0 109.546 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -130.64 138.39 50.06 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 125.435 1.494 . . . . 0.0 109.671 172.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -57.56 -27.63 62.83 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.598 1.559 . . . . 0.0 113.29 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.05 -12.72 61.94 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.828 1.251 . . . . 0.0 112.075 -174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.6 mt -112.73 -41.21 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.9 mt -48.47 -58.56 4.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.836 1.198 . . . . 0.0 111.499 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.79 0.36 27.28 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -118.66 -31.75 4.76 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.984 1.314 . . . . 0.0 111.783 -168.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 128.36 35.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.143 1.377 . . . . 0.0 109.755 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.65 -25.41 64.81 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.174 0.59 . . . . 0.0 110.781 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.8 tp -145.53 141.08 27.95 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.44 1.096 . . . . 0.0 108.171 173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -119.86 153.06 22.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.88 136.15 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -109.17 122.3 47.01 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.3 25.28 5.06 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.054 0.941 . . . . 0.0 109.52 -172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 18.1 p -75.42 68.34 2.08 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 127.019 2.127 . . . . 0.0 113.606 -169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.74 12.54 25.09 Favored Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.122 -0.987 . . . . 0.0 111.203 170.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -72.51 171.63 12.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 127.546 2.338 . . . . 0.0 111.992 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.02 -16.35 64.3 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.88 -37.46 9.81 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.644 1.111 . . . . 0.0 110.886 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.263 3.8 p-10 37.53 44.23 0.49 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 128.207 2.603 . . . . 0.0 114.684 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -66.23 -14.01 61.26 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.586 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 83.0 m 42.86 86.07 0.15 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 127.924 2.49 . . . . 0.0 113.245 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.52 139.29 9.96 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 124.418 3.412 . . . . 0.0 114.011 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.16 147.08 52.77 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.866 1.266 . . . . 0.0 111.254 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -133.39 159.38 72.8 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.967 2.107 . . . . 0.0 108.964 172.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.1 138.61 40.35 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 121.77 1.647 . . . . 0.0 109.429 173.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.23 -18.48 39.48 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.902 2.402 . . . . 0.0 112.129 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -64.45 -19.93 65.85 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.493 1.117 . . . . 0.0 112.019 174.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.5 t -110.99 136.66 46.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 118.937 0.79 . . . . 0.0 109.105 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -63.2 132.13 50.71 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.132 0.973 . . . . 0.0 108.746 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -122.99 159.55 28.11 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 123.598 0.759 . . . . 0.0 109.475 171.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -128.7 169.78 14.08 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 126.73 2.012 . . . . 0.0 107.188 169.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -136.11 122.49 20.63 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.3 m0 -125.61 58.6 1.3 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.86 1.664 . . . . 0.0 107.107 -174.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.19 125.07 14.59 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.939 -1.101 . . . . 0.0 112.07 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -152.26 158.72 43.21 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 127.569 2.347 . . . . 0.0 105.806 168.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -69.27 149.5 48.43 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.198 0.523 . . . . 0.0 110.832 -172.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -74.89 125.69 89.13 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -67.52 -25.11 41.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.378 1.385 . . . . 0.0 113.471 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.14 -7.54 52.97 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.351 0.978 . . . . 0.0 112.115 173.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -114.57 3.74 14.94 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.951 1.3 . . . . 0.0 110.842 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.94 64.41 0.32 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.851 2.06 . . . . 0.0 110.308 169.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -59.51 139.67 56.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.495 1.518 . . . . 0.0 110.658 -171.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.67 -57.59 0.21 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -166.64 169.43 13.58 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.019 1.728 . . . . 0.0 107.378 170.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.97 -30.5 70.29 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.902 -0.499 . . . . 0.0 111.349 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -70.75 -36.93 73.37 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.762 0.425 . . . . 0.0 110.676 176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.89 -46.34 75.23 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -57.04 -48.46 78.48 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.294 0.637 . . . . 0.0 110.17 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -61.24 -37.86 84.58 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.5 0.72 . . . . 0.0 111.972 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -43.47 82.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.478 -0.764 . . . . 0.0 109.758 176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.43 -33.26 75.45 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.861 0.465 . . . . 0.0 110.931 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.85 -48.57 79.41 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.81 0.844 . . . . 0.0 110.459 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -62.27 -41.49 98.5 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.474 0.579 . . . . 0.0 110.752 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -62.89 -48.61 78.24 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.117 0.871 . . . . 0.0 111.172 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 76.0 t -66.84 -40.27 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.13 0 CA-C-N 118.613 0.642 . . . . 0.0 109.301 -178.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 16.8 ttp180 -55.23 -53.81 51.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 119.029 0.831 . . . . 0.0 109.235 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -66.07 -40.89 91.24 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.319 0.387 . . . . 0.0 111.236 -172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.91 -45.89 87.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.38 0.672 . . . . 0.0 110.428 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.1 mt -58.13 -50.14 79.22 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.68 -47.87 51.4 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 118.573 0.624 . . . . 0.0 111.842 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -59.48 -48.6 81.01 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 117.751 0.776 . . . . 0.0 110.998 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mmt180 -76.87 -25.83 53.54 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.656 -175.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.67 -38.54 83.89 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 120.057 1.299 . . . . 0.0 109.673 170.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -58.61 -50.42 73.88 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.43 -42.32 98.57 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 121.014 0.435 . . . . 0.0 110.503 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -58.78 -33.26 70.11 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 120.274 -1.516 . . . . 0.0 111.854 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.56 -35.4 24.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 122.702 0.401 . . . . 0.0 111.958 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.31 -45.47 8.19 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.774 1.23 . . . . 0.0 112.034 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 36.7 p -113.86 -20.14 11.21 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.869 1.668 . . . . 0.0 110.835 -169.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.21 11.01 81.6 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.585 1.088 . . . . 0.0 112.952 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt . . . . . 0 C--O 1.246 0.907 0 CA-C-N 118.916 1.358 . . . . 0.0 110.379 -177.384 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -151.43 161.81 42.03 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.133 1.373 . . . . 0.0 107.566 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -137.94 140.62 40.37 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -72.71 172.9 9.86 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -144.15 142.37 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.58 151.5 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 124.083 0.953 . . . . 0.0 109.546 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.83 139.04 39.74 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.965 0.906 . . . . 0.0 109.321 -174.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -122.54 128.59 50.95 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.406 1.082 . . . . 0.0 108.653 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.64 139.85 53.49 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.34 1.056 . . . . 0.0 110.015 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.5 m -139.93 175.03 9.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.184 1.793 . . . . 0.0 108.407 170.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -52.78 63.93 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 120.941 -1.099 . . . . 0.0 109.537 170.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -115.88 126.92 7.31 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 107.111 -2.396 . . . . 0.0 107.111 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.91 60.05 0.72 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.378 0.671 . . . . 0.0 110.35 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.7 m -134.75 -20.67 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 -168.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.0 m -126.49 -99.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.44 -47.98 83.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.718 0.69 . . . . 0.0 112.31 -169.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 18.8 p -62.95 -38.41 90.95 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 118.425 0.557 . . . . 0.0 111.485 -175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -62.38 -55.21 30.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.193 0.997 . . . . 0.0 110.546 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 49.7 mtm -55.91 -43.78 77.65 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.263 0.625 . . . . 0.0 111.316 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.42 -42.3 99.34 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 123.362 0.665 . . . . 0.0 111.553 -178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG3' HG12 ' A' ' 34' ' ' VAL . 57.3 tt0 -57.27 -41.19 79.22 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.918 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.72 -49.48 78.19 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 118.707 0.685 . . . . 0.0 112.493 177.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -61.32 -46.25 91.05 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 117.579 0.69 . . . . 0.0 110.833 177.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -64.07 -40.78 97.01 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.327 -0.844 . . . . 0.0 111.315 -172.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -51.31 -43.68 61.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.297 0.953 . . . . 0.0 111.006 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -71.15 -58.3 3.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 123.699 0.625 . . . . 0.0 111.206 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -64.37 -39.43 93.85 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 117.967 0.348 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 73.9 mt -82.51 -2.86 54.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.178 0.991 . . . . 0.0 112.274 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.66 25.95 59.31 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.208 1.385 . . . . 0.0 114.629 170.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 57.56 5.8 0.35 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.13 2.172 . . . . 0.0 113.97 -170.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -66.27 -7.55 19.28 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.837 -1.164 . . . . 0.0 110.343 169.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -128.08 121.02 28.63 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 171.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -68.92 97.86 0.89 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.478 HG11 ' HB3' ' A' ' 24' ' ' ALA . 2.5 t -83.01 140.69 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.35 167.06 23.8 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.337 1.455 . . . . 0.0 109.175 173.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 85.3 p -144.72 157.47 44.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.82 0.848 . . . . 0.0 109.692 170.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.9 -170.28 2.67 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.263 1.025 . . . . 0.0 110.894 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.75 -177.55 42.18 Favored Glycine 0 N--CA 1.447 -0.605 0 O-C-N 122.052 -0.405 . . . . 0.0 113.069 174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -56.48 -32.6 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.11 1.364 . . . . 0.0 109.637 169.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.07 169.07 19.42 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.867 1.667 . . . . 0.0 109.634 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.46 24.53 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 170.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -130.28 8.92 5.13 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.737 1.215 . . . . 0.0 110.087 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 102.96 165.58 25.92 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -170.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -85.27 150.08 25.03 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.047 0.539 . . . . 0.0 111.098 -175.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -73.33 133.25 80.97 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.098 -0.953 . . . . 0.0 109.507 -173.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.72 -36.29 61.29 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.732 2.288 . . . . 0.0 113.994 176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 -70.94 -32.97 70.03 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 121.723 -0.611 . . . . 0.0 110.194 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.5 90.88 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 29.8 t -58.67 -47.6 88.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.62 -40.09 93.62 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.441 0.564 . . . . 0.0 111.184 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.75 -43.27 99.23 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.626 0.771 . . . . 0.0 109.914 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.1 mmm -68.49 -38.0 80.61 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.23 0.468 . . . . 0.0 110.974 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.69 -27.5 68.74 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 121.063 -1.023 . . . . 0.0 111.923 173.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -66.95 -16.77 64.56 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 118.869 0.758 . . . . 0.0 110.929 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 m -116.63 1.47 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.157 0.983 . . . . 0.0 112.054 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.45 30.73 21.1 Favored Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 79.3 mt -117.8 158.89 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -123.77 146.08 48.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.492 1.117 . . . . 0.0 108.506 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.7 pt -128.27 3.31 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 125.045 1.338 . . . . 0.0 110.431 170.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.06 -28.19 67.59 Favored 'General case' 0 CA--C 1.542 0.641 0 O-C-N 119.885 -1.76 . . . . 0.0 111.276 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -64.1 -5.45 4.78 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.483 1.913 . . . . 0.0 115.091 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.48 50.83 1.95 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.993 1.269 . . . . 0.0 110.397 -169.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.1 p -47.09 134.37 10.74 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.958 0.903 . . . . 0.0 110.724 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.2 m -56.79 156.23 6.81 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 126.033 1.733 . . . . 0.0 115.653 -168.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -153.91 157.4 39.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.213 1.405 . . . . 0.0 109.465 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 169.04 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 124.681 1.193 . . . . 0.0 109.441 170.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -56.38 141.76 12.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 175.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -137.39 141.4 41.73 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.475 1.11 . . . . 0.0 109.844 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.3 m -55.4 -30.24 60.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 125.088 1.355 . . . . 0.0 113.299 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.21 -13.67 62.53 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.006 0.922 . . . . 0.0 111.984 -173.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -121.06 -42.46 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 124.383 1.073 . . . . 0.0 108.299 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.37 -39.05 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.329 1.422 . . . . 0.0 112.118 -173.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.5 4.87 51.8 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.792 0.837 . . . . 0.0 112.705 -178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -125.32 -28.8 3.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.886 1.274 . . . . 0.0 112.435 -169.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 128.71 38.4 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 125.043 1.337 . . . . 0.0 108.983 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -68.77 -23.25 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.946 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.85 139.89 26.66 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.746 1.218 . . . . 0.0 108.067 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.9 t -118.7 146.51 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 t -135.43 129.37 49.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.07 129.98 41.95 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 169.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -101.47 23.18 11.46 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.627 0.771 . . . . 0.0 109.379 -174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.2 p -76.56 104.26 6.98 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 120.379 -1.451 . . . . 0.0 112.317 -175.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -123.76 -21.86 2.33 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 121.682 -0.636 . . . . 0.0 111.892 169.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -55.67 128.16 33.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.799 1.24 . . . . 0.0 107.826 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.41 -19.41 35.81 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.886 0.874 . . . . 0.0 113.282 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.19 -6.21 22.38 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.154 0.888 . . . . 0.0 112.722 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.28 108.33 3.16 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 169.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -54.42 -14.22 1.17 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.8 m 60.51 95.58 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 127.023 2.129 . . . . 0.0 110.63 -169.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.31 140.51 20.35 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.901 3.067 . . . . 0.0 113.115 176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 26.4 mmt -73.84 152.82 40.14 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.565 0.746 . . . . 0.0 109.582 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.6 p -133.2 165.29 37.82 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 126.528 1.931 . . . . 0.0 109.393 -175.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -64.81 155.21 68.72 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.828 1.685 . . . . 0.0 110.576 172.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -80.03 -9.29 14.22 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.229 2.619 . . . . 0.0 114.56 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -129.77 0.04 4.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.515 1.052 . . . . 0.0 113.492 -169.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 55.6 t -85.93 145.5 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -61.17 133.11 55.63 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -130.24 149.54 51.89 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.879 0.872 . . . . 0.0 109.003 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -132.89 169.75 16.32 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.085 1.354 . . . . 0.0 108.6 170.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -134.78 115.76 14.07 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 23.3 m0 -121.63 61.43 0.93 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.486 1.515 . . . . 0.0 107.243 -176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -75.82 128.84 9.86 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 121.172 -0.955 . . . . 0.0 112.367 -172.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.85 159.5 44.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.177 2.191 . . . . 0.0 106.401 168.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -69.0 153.8 43.17 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 123.573 0.749 . . . . 0.0 110.612 -175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.05 125.01 73.73 Favored Pre-proline 0 C--O 1.237 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 110.124 -176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.51 -26.34 62.35 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.691 1.594 . . . . 0.0 113.864 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.27 -13.12 62.02 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 119.022 0.828 . . . . 0.0 112.264 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.4 mtm105 -114.39 13.9 17.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 119.264 0.938 . . . . 0.0 111.476 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.83 67.29 0.81 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.465 1.106 . . . . 0.0 109.975 171.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -58.6 138.71 56.72 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.793 0.837 . . . . 0.0 110.383 -170.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.24 -60.02 0.23 Allowed Glycine 0 CA--C 1.522 0.485 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 172.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.8 t -167.32 167.48 13.97 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.671 1.589 . . . . 0.0 107.522 173.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.12 -29.21 68.46 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.093 0.557 . . . . 0.0 111.291 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.97 -39.66 75.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 122.964 0.506 . . . . 0.0 110.681 176.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -65.58 -44.63 86.1 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -59.83 -50.33 74.23 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 118.711 -0.662 . . . . 0.0 110.503 175.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -57.39 -40.28 77.86 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.242 0.928 . . . . 0.0 111.153 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.54 -33.08 74.32 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.627 -0.671 . . . . 0.0 110.892 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -73.93 -34.92 64.51 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.703 -1.248 . . . . 0.0 111.26 176.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -58.26 -52.54 65.16 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 118.962 0.801 . . . . 0.0 109.881 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -65.81 -30.97 71.68 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.513 0.597 . . . . 0.0 112.115 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 -65.11 -49.68 69.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.631 1.105 . . . . 0.0 111.117 173.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.2 t -66.4 -39.61 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.708 0.686 . . . . 0.0 109.187 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.1 ttp180 -53.04 -52.85 57.15 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.26 1.024 . . . . 0.0 109.727 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -66.41 -41.06 89.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 123.145 0.278 . . . . 0.0 111.331 -172.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -64.15 -43.29 95.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.995 0.518 . . . . 0.0 110.421 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 55.9 mt -60.36 -49.35 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 176.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.66 -47.35 64.52 Favored Glycine 0 C--N 1.337 0.601 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -59.74 -49.71 76.66 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 117.31 0.555 . . . . 0.0 110.391 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.95 -31.14 69.79 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 111.312 -175.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.37 -42.04 79.73 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 119.029 0.831 . . . . 0.0 110.069 174.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -57.07 -49.65 75.21 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -66.46 -36.35 82.54 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 119.743 -0.17 . . . . 0.0 111.237 -177.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -61.51 -37.67 84.55 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.249 -0.907 . . . . 0.0 111.238 174.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.89 -37.0 41.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 122.451 0.3 . . . . 0.0 111.183 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.42 -48.32 6.71 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.727 1.211 . . . . 0.0 111.011 -170.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.7 p -105.73 -20.49 13.44 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.749 1.22 . . . . 0.0 111.41 -169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 77.33 18.35 78.21 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.538 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.2 mttt . . . . . 0 C--O 1.248 1.021 0 CA-C-N 118.507 1.154 . . . . 0.0 109.51 176.696 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -126.69 1.01 6.79 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.847 0.859 . . . . 0.0 111.026 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -69.69 134.61 48.86 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 169.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.71 175.53 2.9 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -141.11 142.04 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.3 tt -143.36 151.05 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -137.8 135.8 36.62 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.901 0.881 . . . . 0.0 108.795 -172.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -117.88 137.74 52.59 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.3 mt -133.65 145.63 50.15 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.222 0.609 . . . . 0.0 111.509 -169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.4 m -147.02 173.51 12.39 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.504 1.122 . . . . 0.0 112.359 176.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.8 m -57.79 -29.65 65.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.165 1.786 . . . . 0.0 111.433 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.32 141.36 8.29 Favored Glycine 0 C--N 1.337 0.62 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 169.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -83.78 55.8 3.4 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 117.508 0.654 . . . . 0.0 112.087 -169.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 m -132.6 -12.05 3.06 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.7 m -131.68 -105.81 0.26 Allowed 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.1 mtm180 -50.89 -47.17 60.71 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.587 1.155 . . . . 0.0 111.688 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 p -61.9 -42.12 98.71 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.134 0.574 . . . . 0.0 111.016 -176.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -69.37 -45.03 70.31 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.504 0.722 . . . . 0.0 110.898 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.6 mtm -61.5 -43.23 99.24 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.978 0.511 . . . . 0.0 110.221 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.4 98.49 Favored 'General case' 0 CA--C 1.52 -0.173 0 C-N-CA 123.377 0.671 . . . . 0.0 111.255 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.474 ' HG3' HG12 ' A' ' 34' ' ' VAL . 17.1 tt0 -57.37 -40.94 79.18 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.068 0.395 . . . . 0.0 110.075 174.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.86 -53.51 45.73 Favored Glycine 0 C--N 1.339 0.714 0 C-N-CA 124.062 0.839 . . . . 0.0 111.532 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -61.52 -45.88 92.31 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.141 0.47 . . . . 0.0 110.686 177.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.39 93.83 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.316 0.646 . . . . 0.0 110.321 -175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -57.72 -33.58 68.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.869 0.759 . . . . 0.0 111.353 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -69.31 -62.28 1.45 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.16 0.437 . . . . 0.0 110.664 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -65.7 -43.06 90.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 122.337 0.255 . . . . 0.0 111.397 -169.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.6 mt -76.78 -6.55 52.73 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.599 1.16 . . . . 0.0 112.112 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.84 23.56 51.18 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.972 1.272 . . . . 0.0 114.136 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.3 t70 56.35 11.44 0.82 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.488 2.315 . . . . 0.0 114.081 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -64.89 -7.5 11.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.979 1.312 . . . . 0.0 110.484 169.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -126.65 118.78 25.48 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 102.069 -3.308 . . . . 0.0 102.069 172.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -67.67 98.78 0.72 Allowed 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.474 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.8 t -80.08 138.77 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -174.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -140.11 166.06 25.69 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.772 1.629 . . . . 0.0 109.22 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.2 t -151.6 145.0 24.8 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.024 0.929 . . . . 0.0 108.711 -178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.39 -170.38 2.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.698 1.199 . . . . 0.0 112.02 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.06 -176.59 45.31 Favored Glycine 0 CA--C 1.524 0.652 0 O-C-N 121.155 -0.966 . . . . 0.0 112.117 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.29 -30.38 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.862 1.265 . . . . 0.0 111.23 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.92 167.6 24.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.688 1.195 . . . . 0.0 109.193 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.82 141.9 20.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 170.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -132.16 1.59 3.87 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.574 1.15 . . . . 0.0 110.263 170.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 131.12 -166.25 22.81 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 108.08 -2.008 . . . . 0.0 108.08 -169.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.2 pt? -119.04 149.85 40.97 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.288 1.035 . . . . 0.0 110.322 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -72.0 134.2 83.43 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.087 -0.959 . . . . 0.0 109.759 -169.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -51.38 -36.14 56.95 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.691 2.26 . . . . 0.0 113.895 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -72.46 -32.49 66.29 Favored 'General case' 0 C--O 1.225 -0.19 0 O-C-N 121.538 -0.726 . . . . 0.0 110.387 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.71 -47.24 84.49 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 65.2 t -57.04 -52.04 61.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -58.91 -40.07 83.41 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.604 0.638 . . . . 0.0 111.633 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.89 -44.89 94.89 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 118.512 0.596 . . . . 0.0 109.596 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.2 mmm -68.65 -36.83 79.1 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.28 0.491 . . . . 0.0 111.184 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.35 -25.21 67.93 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 120.886 -1.134 . . . . 0.0 111.524 174.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -68.32 -17.14 64.19 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.9 0.773 . . . . 0.0 110.885 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -114.52 -0.34 9.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.705 0.802 . . . . 0.0 112.108 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 31.68 13.9 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.21 159.74 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -129.77 145.54 51.55 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.7 pt -123.96 -6.51 7.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 124.833 1.253 . . . . 0.0 110.625 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.1 m -57.59 -38.5 74.99 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.866 0.867 . . . . 0.0 110.894 176.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -59.13 -18.59 37.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.845 1.258 . . . . 0.0 113.984 174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -84.03 -40.73 18.01 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 119.639 1.109 . . . . 0.0 110.395 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 p 56.07 176.76 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.162 1.785 . . . . 0.0 111.069 -168.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 m -128.27 153.68 46.7 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.259 -0.901 . . . . 0.0 110.057 -170.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -157.79 158.52 35.39 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.045 0.938 . . . . 0.0 109.467 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.37 163.48 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.647 0.779 . . . . 0.0 108.992 169.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 83.3 mt -58.61 149.0 5.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.771 1.228 . . . . 0.0 110.209 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.54 136.6 33.03 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 124.354 1.062 . . . . 0.0 110.113 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.86 -28.64 51.54 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.392 1.477 . . . . 0.0 113.161 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.25 -11.15 60.55 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.034 1.333 . . . . 0.0 112.188 -176.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.3 mt -114.12 -42.76 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.23 -58.42 5.07 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.852 1.206 . . . . 0.0 111.504 178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.23 -0.93 30.52 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.45 -31.54 5.21 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.945 1.298 . . . . 0.0 111.928 -168.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.8 32.92 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.959 1.304 . . . . 0.0 109.705 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.3 -26.24 67.98 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.533 0.733 . . . . 0.0 110.75 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.6 tp -147.28 142.65 27.4 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.534 1.134 . . . . 0.0 108.669 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.0 t -118.41 151.38 20.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.6 t -140.03 128.26 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.46 136.16 37.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 169.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mp -108.9 7.74 26.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.563 0.745 . . . . 0.0 111.054 -176.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.95 126.7 28.57 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.898 1.279 . . . . 0.0 110.638 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -151.38 -3.12 0.21 Allowed Glycine 0 CA--C 1.529 0.929 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.226 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -77.81 150.95 34.2 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 119.278 1.539 . . . . 0.0 109.35 169.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.39 -17.02 41.02 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.938 1.295 . . . . 0.0 114.362 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.94 11.82 13.55 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.428 1.091 . . . . 0.0 111.897 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -65.52 107.51 1.72 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -52.98 -37.03 60.92 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.047 174.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.56 122.62 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 128.455 2.702 . . . . 0.0 115.24 -177.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.95 173.6 4.7 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.897 2.398 . . . . 0.0 112.431 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 48.3 tpp -124.73 156.35 37.79 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.71 1.604 . . . . 0.0 108.843 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.6 p -128.43 161.17 58.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.622 1.569 . . . . 0.0 110.459 -169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.21 139.25 54.55 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.965 1.777 . . . . 0.0 109.576 173.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.01 -22.45 26.34 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.803 2.335 . . . . 0.0 112.25 -173.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -81.07 3.13 24.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.717 0.807 . . . . 0.0 112.48 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.1 t -115.37 134.55 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 175.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.9 tptt -64.39 132.05 48.96 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -123.34 159.07 29.63 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 123.663 0.785 . . . . 0.0 109.125 170.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -126.58 166.2 17.74 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.144 1.778 . . . . 0.0 107.337 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -133.56 113.17 12.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 31.2 m0 -119.9 58.1 0.91 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.847 1.659 . . . . 0.0 106.702 -176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -72.15 134.24 21.23 Favored Glycine 0 CA--C 1.525 0.714 0 O-C-N 121.335 -0.853 . . . . 0.0 112.364 -174.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.2 161.26 33.51 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.935 2.094 . . . . 0.0 106.118 169.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -56.71 146.95 24.11 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.663 1.185 . . . . 0.0 111.68 -176.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -80.87 117.89 70.0 Favored Pre-proline 0 C--N 1.328 -0.33 0 C-N-CA 124.819 1.248 . . . . 0.0 108.937 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.38 -22.96 71.78 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.535 1.49 . . . . 0.0 113.628 -176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.07 -13.41 61.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.427 1.012 . . . . 0.0 113.036 174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -120.95 13.28 11.37 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.563 1.074 . . . . 0.0 112.094 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.22 55.65 0.21 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.306 1.842 . . . . 0.0 110.378 169.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -61.93 148.61 43.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.81 2.044 . . . . 0.0 112.201 -169.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.56 -54.05 0.34 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.502 -2.239 . . . . 0.0 107.502 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.0 t -166.42 166.93 16.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.106 1.763 . . . . 0.0 107.322 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.55 -29.66 69.29 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.177 0.591 . . . . 0.0 111.158 177.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.22 -37.07 74.93 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 122.896 0.479 . . . . 0.0 110.717 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -67.66 -47.33 69.83 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -54.54 -50.96 66.68 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.935 0.494 . . . . 0.0 110.086 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -58.84 -39.09 80.23 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.872 0.869 . . . . 0.0 112.027 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.92 -44.07 86.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 O-C-N 121.496 -0.752 . . . . 0.0 110.114 176.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -62.58 -36.37 82.48 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.797 175.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -58.25 -47.37 83.77 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.411 1.005 . . . . 0.0 110.157 174.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -64.64 -39.18 93.24 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.645 0.657 . . . . 0.0 111.518 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.2 mmt85 -64.49 -49.09 72.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 119.242 0.928 . . . . 0.0 110.684 177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.18 -39.2 83.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -54.05 -53.78 48.33 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 124.003 0.921 . . . . 0.0 109.442 173.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -63.2 -44.04 96.46 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 123.27 0.356 . . . . 0.0 111.29 -174.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -65.12 -40.88 95.1 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.852 -0.53 . . . . 0.0 111.108 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 54.2 mt -59.48 -49.68 82.73 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.18 -46.06 71.82 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -60.77 -46.95 88.48 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 117.564 0.682 . . . . 0.0 110.465 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 43.9 tpt85 -72.7 -31.19 64.82 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.9 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.03 -40.9 87.3 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 123.263 0.625 . . . . 0.0 110.017 172.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.42 -49.16 75.34 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -61.8 -43.82 98.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.095 0.474 . . . . 0.0 110.408 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.93 -33.82 69.21 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.804 -1.185 . . . . 0.0 112.334 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -85.15 -34.43 22.13 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.019 0.528 . . . . 0.0 112.217 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -94.14 -52.39 4.4 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.001 1.321 . . . . 0.0 110.625 -169.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.8 p -102.06 -14.69 17.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.344 1.457 . . . . 0.0 110.37 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.05 13.59 83.19 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.845 1.212 . . . . 0.0 112.052 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--O 1.245 0.862 0 CA-C-N 118.038 0.919 . . . . 0.0 109.572 -175.297 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.483 1.2 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.15 168.7 20.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.013 1.325 . . . . 0.0 108.373 171.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -147.48 141.09 25.53 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -75.06 176.17 7.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.619 0.645 . . . . 0.0 109.349 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -142.51 143.13 26.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.24 149.71 17.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 123.611 0.765 . . . . 0.0 109.151 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -137.49 132.78 33.78 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 123.959 0.904 . . . . 0.0 108.733 -173.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -115.9 129.99 56.64 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 66.7 mt -129.08 139.38 52.02 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 123.59 0.756 . . . . 0.0 109.562 -169.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 22.7 p -150.16 -174.25 4.67 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.995 169.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -67.6 -9.46 43.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.252 1.021 . . . . 0.0 113.158 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -170.8 126.63 1.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 108.577 -1.809 . . . . 0.0 108.577 169.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -73.13 52.07 0.33 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.282 1.433 . . . . 0.0 113.293 -169.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.4 m -125.75 -18.63 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.5 m -136.3 -90.57 0.28 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 118.741 0.701 . . . . 0.0 109.379 -170.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.5 mtm180 -55.21 -53.2 58.98 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.748 0.819 . . . . 0.0 111.437 -170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 33.4 p -68.01 -35.73 78.8 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.231 0.212 . . . . 0.0 110.894 -173.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.63 -51.59 64.54 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.944 0.898 . . . . 0.0 110.836 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.5 mtm -60.66 -43.06 98.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.249 0.62 . . . . 0.0 110.69 178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.5 97.22 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.455 0.57 . . . . 0.0 111.032 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' HG12 ' A' ' 34' ' ' VAL . 68.7 tt0 -57.98 -41.32 82.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.969 -0.538 . . . . 0.0 110.695 173.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.34 -51.85 56.18 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 118.889 0.768 . . . . 0.0 111.973 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -62.9 -45.69 91.32 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 117.577 0.689 . . . . 0.0 110.711 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.61 -42.53 99.63 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.235 0.614 . . . . 0.0 110.595 -175.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -52.69 -36.29 56.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.866 0.757 . . . . 0.0 111.598 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -72.28 -62.79 1.31 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.368 0.531 . . . . 0.0 110.733 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -65.41 -41.26 93.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.521 0.328 . . . . 0.0 111.822 -169.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.53 -5.85 53.83 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.819 0.848 . . . . 0.0 112.444 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.21 28.74 50.67 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.942 1.258 . . . . 0.0 114.601 170.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.3 t70 59.21 6.24 0.69 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 127.211 2.205 . . . . 0.0 114.197 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -66.33 -7.42 18.76 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.929 -1.107 . . . . 0.0 110.358 169.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -130.93 121.75 25.72 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 103.604 -2.739 . . . . 0.0 103.604 174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -69.46 97.62 1.02 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 173.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.457 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -85.08 134.73 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -141.53 168.3 20.1 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.24 1.416 . . . . 0.0 109.616 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.418 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 95.5 p -145.5 160.43 41.62 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 123.581 0.752 . . . . 0.0 110.12 169.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.51 -166.85 1.59 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.632 1.173 . . . . 0.0 109.842 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.27 -179.39 43.91 Favored Glycine 0 N--CA 1.449 -0.461 0 O-C-N 121.399 -0.813 . . . . 0.0 111.514 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.7 mt -55.65 -27.65 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.349 1.46 . . . . 0.0 111.298 172.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -146.26 169.79 18.07 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.813 1.245 . . . . 0.0 108.405 171.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 136.33 18.89 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 169.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -136.79 26.26 3.05 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.716 1.206 . . . . 0.0 109.428 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 90.09 168.43 42.8 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 60' ' ' SER . 1.3 pt? -86.41 147.68 25.91 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 121.303 0.573 . . . . 0.0 110.779 -178.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -73.97 133.74 78.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 118.108 -0.949 . . . . 0.0 109.081 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.51 -34.47 42.38 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.775 2.317 . . . . 0.0 114.438 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -73.23 -28.21 62.03 Favored 'General case' 0 C--N 1.338 0.09 0 O-C-N 121.189 -0.944 . . . . 0.0 110.921 178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -47.44 81.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 170.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.09 -49.59 80.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -59.92 -41.89 92.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.75 0.705 . . . . 0.0 111.592 178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.43 -45.78 92.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.448 0.567 . . . . 0.0 109.752 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.8 mmm -68.11 -36.22 79.4 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.401 0.546 . . . . 0.0 111.313 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -28.26 69.79 Favored 'General case' 0 C--N 1.334 -0.104 0 O-C-N 120.985 -1.072 . . . . 0.0 111.52 174.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -66.73 -17.54 64.91 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.036 0.835 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.2 m -114.72 -0.41 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 123.89 0.876 . . . . 0.0 112.167 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 32.59 13.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.3 160.83 20.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -131.22 145.97 52.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.2 pt -128.05 -9.93 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.811 1.644 . . . . 0.0 109.923 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' HD11 ' A' ' 44' ' ' LEU . 92.4 p -60.97 -25.84 67.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.844 1.202 . . . . 0.0 111.549 177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.44 -27.39 69.08 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.431 1.493 . . . . 0.0 113.638 172.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -96.17 -29.24 14.17 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 119.47 1.032 . . . . 0.0 112.437 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.0 p 52.04 -173.24 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.882 1.673 . . . . 0.0 112.946 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.5 m -123.81 156.41 36.18 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.241 1.017 . . . . 0.0 111.234 -169.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -156.56 157.24 35.0 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.125 0.97 . . . . 0.0 109.638 174.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.446 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.52 163.71 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.599 0.76 . . . . 0.0 109.033 169.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.0 mt -56.56 146.71 5.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.905 1.282 . . . . 0.0 110.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -140.14 136.18 33.26 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.376 1.07 . . . . 0.0 110.067 174.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.71 -28.75 50.23 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.479 1.512 . . . . 0.0 113.188 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.61 -11.58 60.95 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.88 1.272 . . . . 0.0 112.177 -175.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.1 mt -114.47 -42.36 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 mt -48.52 -58.69 4.3 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.7 1.136 . . . . 0.0 111.775 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -1.12 34.71 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -116.14 -32.37 5.37 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.142 1.377 . . . . 0.0 111.614 -168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.53 126.77 28.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.291 1.436 . . . . 0.0 109.586 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -66.26 -24.55 66.6 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.22 0.608 . . . . 0.0 111.037 175.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.12 139.65 27.46 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.41 1.084 . . . . 0.0 108.554 173.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -117.88 145.26 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 169.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 11.0 t -133.32 129.06 56.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -97.55 132.7 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.34 19.13 20.72 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.593 1.157 . . . . 0.0 109.51 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.1 p -67.89 114.46 6.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.857 1.263 . . . . 0.0 110.008 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.37 24.31 0.27 Allowed Glycine 0 CA--C 1.535 1.286 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 170.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -104.83 -177.57 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 128.501 2.721 . . . . 0.0 111.784 -171.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.78 -25.62 68.32 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -86.95 -46.74 9.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.025 0.829 . . . . 0.0 110.379 177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.5 t70 48.79 33.13 4.1 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.189 1.795 . . . . 0.0 114.082 176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.7 mtpt -69.3 -14.23 62.83 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 120.689 -1.257 . . . . 0.0 113.365 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 93.3 m 43.37 90.27 0.07 OUTLIER Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 127.603 2.361 . . . . 0.0 113.945 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -47.41 136.48 19.92 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.884 3.056 . . . . 0.0 113.495 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -71.25 145.83 49.34 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.518 1.127 . . . . 0.0 110.007 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.3 p -131.22 158.84 74.07 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.328 1.851 . . . . 0.0 110.133 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.1 136.68 38.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.228 1.952 . . . . 0.0 109.327 170.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.25 -23.95 20.4 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.528 2.152 . . . . 0.0 112.641 -171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -79.11 -9.59 59.6 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.214 0.606 . . . . 0.0 112.532 -178.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 78.7 t -94.96 138.48 20.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -62.04 132.25 52.28 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -130.46 156.91 43.99 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.485 1.114 . . . . 0.0 109.572 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -134.44 167.86 19.98 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.241 1.817 . . . . 0.0 108.341 169.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.4 t60 -135.86 118.15 15.63 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -125.34 57.66 1.31 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.377 1.871 . . . . 0.0 106.967 -176.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.52 134.92 28.64 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.784 -1.198 . . . . 0.0 112.311 -175.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.47 160.75 35.08 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 126.523 1.929 . . . . 0.0 106.089 169.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -67.71 143.83 55.74 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.213 0.53 . . . . 0.0 110.73 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.92 126.25 92.1 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 -26.2 55.33 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.139 1.226 . . . . 0.0 112.921 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.48 -4.3 41.87 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.034 0.833 . . . . 0.0 112.538 174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -120.43 0.44 10.54 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.992 1.717 . . . . 0.0 109.385 -173.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.71 95.67 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.9 1.68 . . . . 0.0 109.192 169.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -58.16 123.27 15.42 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.33 -91.33 0.1 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.9 t -158.04 167.89 28.63 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.97 1.308 . . . . 0.0 108.023 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 -31.02 70.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.121 0.568 . . . . 0.0 111.874 -176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.72 -39.48 84.3 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 122.64 0.376 . . . . 0.0 110.164 175.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.6 -38.5 70.85 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -58.72 -49.12 78.77 Favored 'General case' 0 C--O 1.227 -0.097 0 CA-C-N 118.568 0.622 . . . . 0.0 110.186 172.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.23 -37.61 77.94 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.759 0.708 . . . . 0.0 111.207 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.65 84.29 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 121.576 -0.703 . . . . 0.0 109.846 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -63.32 -31.65 72.85 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 117.978 -1.011 . . . . 0.0 112.176 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.31 -52.06 66.89 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 120.251 1.387 . . . . 0.0 110.091 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -65.4 -34.63 78.75 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.869 0.759 . . . . 0.0 111.587 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -63.18 -52.6 61.72 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.836 1.198 . . . . 0.0 110.942 175.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.73 -37.5 78.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttp180 -54.32 -53.85 48.34 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 118.777 0.717 . . . . 0.0 109.409 173.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.34 -42.65 92.67 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 123.367 0.417 . . . . 0.0 110.58 -171.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -65.48 -41.1 93.67 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.959 -0.463 . . . . 0.0 111.195 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.5 mt -59.38 -49.97 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 174.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.03 -46.57 61.29 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 118.589 0.631 . . . . 0.0 111.661 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.33 -48.8 80.2 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 117.618 0.709 . . . . 0.0 110.602 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -70.69 -30.0 66.46 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 117.297 -1.335 . . . . 0.0 111.611 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -39.82 82.24 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.93 1.241 . . . . 0.0 110.068 175.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.21 -49.41 74.18 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.93 -35.95 82.02 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.445 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -61.67 -37.32 83.65 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.23 -0.919 . . . . 0.0 111.415 175.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.23 -35.84 35.55 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.496 0.318 . . . . 0.0 111.041 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -91.73 -42.18 10.28 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.513 1.125 . . . . 0.0 111.664 -171.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 25.2 p -114.41 -20.81 10.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 0.0 111.817 -169.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.59 78.36 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.359 0.98 . . . . 0.0 112.836 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt . . . . . 0 C--O 1.245 0.853 0 CA-C-N 118.817 1.308 . . . . 0.0 109.958 -176.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tmt? . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.14 162.68 37.44 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.819 1.248 . . . . 0.0 107.975 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -68.49 139.51 55.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -71.26 170.27 13.43 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -145.16 143.12 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -147.62 152.67 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.598 0.759 . . . . 0.0 109.526 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -139.49 133.03 30.32 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.805 0.842 . . . . 0.0 109.248 -173.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -115.89 127.81 55.29 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 57.8 mt -124.1 141.54 51.97 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.647 0.779 . . . . 0.0 110.623 -169.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.9 t -144.19 172.12 13.34 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.993 0.917 . . . . 0.0 110.633 -170.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.3 p -59.37 -28.61 67.02 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.337 1.455 . . . . 0.0 110.824 169.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.5 147.98 16.87 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 170.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.8 45.72 1.02 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.853 -0.792 . . . . 0.0 111.886 -174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.4 m -128.12 -3.13 5.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -168.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.0 p -145.91 -106.22 0.1 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.964 1.256 . . . . 0.0 110.982 -169.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -55.31 -36.94 66.74 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.941 0.896 . . . . 0.0 112.163 -177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.2 p -57.5 -52.72 64.24 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.337 1.055 . . . . 0.0 111.169 174.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 54.0 mm-40 -60.06 -50.34 74.08 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.501 1.121 . . . . 0.0 110.363 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.3 mtm -58.41 -44.53 89.06 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.92 0.488 . . . . 0.0 111.03 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.88 -44.57 96.9 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 118.626 0.648 . . . . 0.0 111.437 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.9 tt0 -59.57 -42.74 93.13 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.38 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.86 -53.1 46.75 Favored Glycine 0 C--N 1.341 0.816 0 C-N-CA 123.852 0.739 . . . . 0.0 112.073 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -61.55 -43.8 98.19 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 117.299 0.55 . . . . 0.0 110.838 177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.98 -42.29 99.8 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 117.618 -1.182 . . . . 0.0 111.193 -174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -55.92 -37.58 69.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 120.381 1.446 . . . . 0.0 111.102 175.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -67.52 -56.43 9.56 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.285 0.493 . . . . 0.0 110.887 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -73.09 -45.59 56.34 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 122.068 0.147 . . . . 0.0 111.189 -171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.9 mt -72.15 -32.84 67.27 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 123.131 0.572 . . . . 0.0 111.367 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.4 176.51 51.03 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -64.02 -8.86 13.0 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.182 1.393 . . . . 0.0 111.565 172.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -64.14 -6.79 7.19 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.2 . . . . 0.0 111.398 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.489 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 24.2 m95 -129.18 128.8 44.12 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 126.109 1.764 . . . . 0.0 107.02 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -76.48 88.64 3.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 169.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.5 t -80.54 133.72 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -176.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -141.41 167.33 22.43 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.863 1.265 . . . . 0.0 109.527 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 89.7 p -146.9 159.51 43.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.801 0.84 . . . . 0.0 109.093 169.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.09 -168.04 1.96 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.911 1.284 . . . . 0.0 109.189 177.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.3 -175.78 43.02 Favored Glycine 0 N--CA 1.449 -0.444 0 O-C-N 121.427 -0.795 . . . . 0.0 111.517 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.8 mt -55.96 -28.6 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.716 1.606 . . . . 0.0 111.059 175.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -146.29 173.0 12.63 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.686 1.194 . . . . 0.0 109.455 174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.2 134.26 18.12 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -139.13 10.7 2.58 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.788 0.835 . . . . 0.0 111.259 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.01 136.09 9.2 Favored Glycine 0 C--N 1.341 0.812 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -62.2 145.41 53.61 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.823 0.849 . . . . 0.0 112.686 -172.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -72.26 133.62 83.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.685 1.194 . . . . 0.0 108.86 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.29 -34.63 41.07 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.823 2.349 . . . . 0.0 114.353 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -73.06 -29.33 62.88 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 118.751 0.705 . . . . 0.0 110.606 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.13 -49.3 74.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 172.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.7 -49.87 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -61.37 -39.88 92.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 119.038 -0.506 . . . . 0.0 110.964 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.16 -44.9 96.57 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.713 0.688 . . . . 0.0 110.228 178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 73.5 mmm -68.6 -36.39 78.64 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.807 -0.558 . . . . 0.0 111.28 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.25 -24.76 67.41 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.712 -1.243 . . . . 0.0 111.485 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -66.65 -17.46 64.85 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.003 0.819 . . . . 0.0 110.935 177.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.57 -0.43 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 123.894 0.877 . . . . 0.0 112.125 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.15 32.45 14.13 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.53 159.65 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -127.31 146.3 50.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 169.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.25 0.65 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.182 1.393 . . . . 0.0 110.391 173.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -58.58 -28.74 65.84 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 120.285 -1.509 . . . . 0.0 111.15 171.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -67.42 -4.38 11.02 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.972 1.709 . . . . 0.0 115.001 176.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.82 49.81 2.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 120.577 1.535 . . . . 0.0 110.256 -170.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.2 p -48.18 144.5 3.77 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.112 1.365 . . . . 0.0 112.647 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.8 m -56.78 148.71 19.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.929 1.691 . . . . 0.0 113.936 -169.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -154.44 153.52 31.67 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.281 1.433 . . . . 0.0 109.911 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.413 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.99 165.72 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 C-N-CA 124.448 1.099 . . . . 0.0 109.68 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 63.9 mt -56.37 145.87 6.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.552 1.141 . . . . 0.0 110.047 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -140.04 134.99 32.18 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.452 1.101 . . . . 0.0 109.872 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -55.0 -28.11 49.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.379 1.472 . . . . 0.0 113.168 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.12 -11.87 61.18 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.923 1.289 . . . . 0.0 112.104 -175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -114.42 -41.54 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.8 mt -48.77 -57.62 6.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.035 1.288 . . . . 0.0 111.557 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.25 1.29 29.08 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -174.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -119.83 -32.14 4.32 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.007 1.323 . . . . 0.0 111.862 -168.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.65 128.41 36.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.237 1.415 . . . . 0.0 109.44 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -67.59 -23.48 65.4 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.944 0.498 . . . . 0.0 110.983 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.3 tp -146.47 142.07 27.73 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.67 1.188 . . . . 0.0 107.993 172.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.02 152.86 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 169.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.3 t -139.46 129.0 29.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -93.9 134.72 35.97 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 169.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.7 mp -105.12 3.57 30.46 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.883 0.873 . . . . 0.0 111.485 -174.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.3 p -65.9 110.31 2.83 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.912 1.285 . . . . 0.0 111.688 -175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.11 21.05 0.86 Allowed Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.353 0.978 . . . . 0.0 111.746 169.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -81.49 -177.78 6.66 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.409 2.283 . . . . 0.0 110.624 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.16 -19.45 61.12 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -175.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.01 -33.87 10.32 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.542 1.064 . . . . 0.0 111.218 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 33.17 56.77 0.48 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 128.17 2.588 . . . . 0.0 114.134 173.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -62.96 -22.21 66.64 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.966 -1.016 . . . . 0.0 113.04 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.425 ' HA ' ' HD2' ' A' ' 90' ' ' PRO . 70.8 m 44.05 94.63 0.04 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.811 2.444 . . . . 0.0 114.792 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 89' ' ' CYS . 9.7 Cg_endo -50.93 138.74 42.4 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.574 2.182 . . . . 0.0 112.099 172.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.6 mtm -79.39 156.31 27.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.781 0.833 . . . . 0.0 109.962 175.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.8 p -131.38 161.94 58.99 Favored Pre-proline 0 CA--C 1.541 0.623 0 C-N-CA 126.291 1.836 . . . . 0.0 110.263 -177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.5 140.52 52.57 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.904 1.736 . . . . 0.0 109.948 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.98 -22.01 20.14 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.917 2.412 . . . . 0.0 112.044 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -81.76 6.15 16.35 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.195 0.998 . . . . 0.0 112.461 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 41.1 t -121.01 140.71 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.97 136.42 57.31 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -128.31 156.22 43.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -124.3 164.51 19.45 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.714 1.606 . . . . 0.0 107.497 169.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -131.33 109.92 10.7 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -116.4 55.54 0.81 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.83 126.99 32.95 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 -177.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.68 166.0 33.53 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.506 1.922 . . . . 0.0 106.628 169.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -64.24 149.76 47.31 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.665 0.745 . . . . 0.0 110.772 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -80.95 118.03 70.62 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -64.72 -23.13 63.44 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.617 1.544 . . . . 0.0 112.949 -178.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.99 -14.4 63.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.35 0.977 . . . . 0.0 112.214 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -111.27 4.79 19.41 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.47 1.508 . . . . 0.0 111.497 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.01 60.91 0.79 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.231 1.812 . . . . 0.0 111.55 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -59.16 141.67 53.59 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.016 1.726 . . . . 0.0 110.983 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.86 -58.41 0.23 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.761 -2.135 . . . . 0.0 107.761 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.7 t -165.94 167.29 16.78 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.033 1.733 . . . . 0.0 107.13 169.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -61.19 -30.16 70.24 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.86 -0.525 . . . . 0.0 111.416 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -68.92 -37.29 78.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.912 0.485 . . . . 0.0 110.491 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.45 -43.25 67.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.323 0.649 . . . . 0.0 109.315 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.62 -48.32 75.11 Favored 'General case' 0 C--N 1.34 0.159 0 O-C-N 121.85 -0.531 . . . . 0.0 110.394 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 43.5 t-105 -60.76 -37.45 81.88 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.788 0.722 . . . . 0.0 111.704 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.19 -40.93 77.77 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 121.296 -0.877 . . . . 0.0 110.5 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 118.418 -0.801 . . . . 0.0 112.211 173.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -58.35 -48.77 79.49 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 119.437 1.017 . . . . 0.0 109.3 171.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.84 -47.61 79.98 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.571 1.078 . . . . 0.0 112.0 172.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -60.34 -47.91 84.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.663 0.665 . . . . 0.0 110.383 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 94.1 t -73.59 -37.18 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -177.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -56.02 -54.8 40.47 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 119.487 1.04 . . . . 0.0 108.693 176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -65.9 -43.39 88.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 123.506 0.504 . . . . 0.0 110.436 -172.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -70.04 -34.48 73.3 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 118.858 -0.591 . . . . 0.0 112.256 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.3 mt -59.14 -52.22 63.32 Favored 'Isoleucine or valine' 0 C--O 1.231 0.083 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 169.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.09 -46.79 61.57 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 177.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -65.75 -37.29 85.95 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-N 117.603 0.702 . . . . 0.0 111.541 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -78.96 -30.85 44.78 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.371 -0.831 . . . . 0.0 111.111 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -40.1 81.22 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.448 0.699 . . . . 0.0 109.86 174.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -51.29 -50.17 59.84 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.874 0.87 . . . . 0.0 109.674 173.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -64.83 -45.08 87.67 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 117.657 0.208 . . . . 0.0 110.82 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -57.32 -33.3 67.57 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.902 -1.124 . . . . 0.0 112.32 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.55 -37.88 24.52 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 122.934 0.493 . . . . 0.0 111.996 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.45 -51.71 5.28 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 124.444 1.097 . . . . 0.0 111.014 -169.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 28.8 p -104.07 -17.15 15.05 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 110.722 -169.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 74.79 17.63 80.09 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.291 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 118.926 1.363 . . . . 0.0 108.864 175.225 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.885 0.374 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.36 168.66 24.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.262 1.425 . . . . 0.0 108.627 177.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -69.59 135.82 50.47 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 169.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.05 170.14 8.9 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 176.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.48 141.57 30.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 103.654 -2.721 . . . . 0.0 103.654 174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.85 149.71 20.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-N 119.021 0.828 . . . . 0.0 108.947 177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.37 134.72 36.29 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -114.87 121.15 42.34 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.68 143.56 45.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 110.15 -169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.5 p -153.17 -176.16 5.66 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.477 0.711 . . . . 0.0 111.389 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 p -86.4 -0.98 57.14 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.159 1.384 . . . . 0.0 112.808 176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -178.44 114.09 0.44 Allowed Glycine 0 C--N 1.34 0.795 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 176.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.67 50.71 0.25 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.879 1.272 . . . . 0.0 114.332 -169.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 m -124.88 -20.11 5.07 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 121.206 -0.934 . . . . 0.0 113.444 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.0 m -128.86 -106.08 0.3 Allowed 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 119.042 0.837 . . . . 0.0 109.426 -169.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.17 -40.25 46.2 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 125.391 1.476 . . . . 0.0 113.553 -173.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.2 p -65.99 -45.99 79.64 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.706 0.802 . . . . 0.0 110.911 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -61.56 -46.39 90.12 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.841 0.857 . . . . 0.0 110.049 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 56.5 mtm -59.45 -45.38 91.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.043 0.537 . . . . 0.0 111.033 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.78 -45.05 95.87 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.449 0.568 . . . . 0.0 111.334 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.508 ' HG3' HG12 ' A' ' 34' ' ' VAL . 42.8 tt0 -56.73 -42.96 80.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.825 0.45 . . . . 0.0 110.594 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.14 -52.19 53.94 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-O 119.297 -0.724 . . . . 0.0 112.135 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.9 m95 -60.03 -43.92 94.99 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.503 0.651 . . . . 0.0 110.627 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -63.63 -42.85 98.13 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 118.129 -0.938 . . . . 0.0 111.307 -174.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -55.77 -36.2 67.07 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.73 1.15 . . . . 0.0 111.307 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -69.44 -58.03 4.5 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 118.5 0.591 . . . . 0.0 110.792 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -73.08 -46.01 53.96 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 121.995 0.118 . . . . 0.0 111.106 -170.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 87.0 mt -73.08 -36.36 66.8 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 122.762 0.425 . . . . 0.0 111.487 -176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.14 173.28 43.82 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.173 -1.971 . . . . 0.0 108.173 -169.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.33 -2.36 5.99 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.958 0.903 . . . . 0.0 111.666 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -58.89 -13.11 5.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.66 1.184 . . . . 0.0 111.289 169.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.472 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 15.3 m95 -128.45 120.97 27.9 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 173.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -71.15 95.4 1.24 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.508 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.4 t -83.96 133.54 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -173.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -143.28 167.52 21.94 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.212 1.405 . . . . 0.0 109.59 174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 98.0 p -145.0 159.64 42.62 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.768 0.827 . . . . 0.0 109.36 169.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.7 -170.96 2.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.652 1.181 . . . . 0.0 110.155 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -177.02 -172.43 41.61 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.0 mt -57.38 -28.36 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.958 1.303 . . . . 0.0 110.942 173.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -150.32 166.73 29.11 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.627 1.171 . . . . 0.0 109.568 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.65 26.32 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.128 1.371 . . . . 0.0 107.773 173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -133.13 17.46 4.11 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.093 1.357 . . . . 0.0 110.258 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 168.41 44.74 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -85.68 149.41 25.33 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.469 0.652 . . . . 0.0 111.831 -174.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -78.91 138.13 57.45 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 125.299 1.439 . . . . 0.0 109.746 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -63.52 -28.61 70.39 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 121.79 1.66 . . . . 0.0 112.959 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -71.99 -33.56 68.2 Favored 'General case' 0 CA--C 1.52 -0.202 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 175.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.63 -44.97 92.31 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -57.3 -50.1 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 118.648 -0.691 . . . . 0.0 109.333 175.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -57.93 -44.75 87.08 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-N 119.159 0.89 . . . . 0.0 111.493 177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.87 87.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.7 mmm -68.88 -37.86 79.32 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.157 0.183 . . . . 0.0 111.008 177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.95 -32.53 69.7 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.287 -0.883 . . . . 0.0 111.121 174.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -72.51 -11.32 60.62 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.343 1.057 . . . . 0.0 110.477 -174.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 m -115.68 0.45 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.328 1.051 . . . . 0.0 112.031 173.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.27 30.76 13.09 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 173.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -120.55 160.11 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -129.85 145.52 51.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 169.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 pt -125.31 -8.32 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.676 1.591 . . . . 0.0 110.436 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.9 m -55.97 -32.67 64.11 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.87 0.868 . . . . 0.0 111.119 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -65.76 -14.34 61.15 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.381 1.472 . . . . 0.0 114.371 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -107.69 -30.08 8.77 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 120.536 1.516 . . . . 0.0 111.918 -169.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.0 p 51.2 -175.68 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.283 1.833 . . . . 0.0 113.716 -175.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 m -119.88 155.87 31.84 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.68 1.192 . . . . 0.0 111.0 -170.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -158.43 158.9 35.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.051 0.94 . . . . 0.0 109.629 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.14 165.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 75.7 mt -57.26 144.25 9.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 123.921 0.888 . . . . 0.0 109.466 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -136.46 140.18 42.91 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.773 1.229 . . . . 0.0 110.129 177.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.63 -29.91 62.73 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.187 1.395 . . . . 0.0 113.449 -174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -70.33 -12.28 61.48 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.195 0.998 . . . . 0.0 111.95 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.2 mt -118.45 -44.64 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.45 -40.59 78.79 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 120.1 1.318 . . . . 0.0 112.712 -171.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.35 -1.64 55.69 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.412 0.685 . . . . 0.0 112.67 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -117.69 -26.35 6.58 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.126 1.37 . . . . 0.0 112.831 -168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.36 124.65 18.79 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 125.198 1.399 . . . . 0.0 110.08 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -59.75 -32.43 70.56 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.247 1.419 . . . . 0.0 109.817 176.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.9 tp -145.07 144.33 30.91 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.197 1.399 . . . . 0.0 108.106 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -117.66 153.21 19.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 169.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.91 138.61 50.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.2 p -113.46 131.98 55.83 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -110.44 21.69 16.36 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.809 1.244 . . . . 0.0 108.726 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.5 p -82.79 99.37 9.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.019 1.327 . . . . 0.0 109.718 -175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.06 -0.98 1.16 Allowed Glycine 0 CA--C 1.538 1.498 0 C-N-CA 123.929 0.776 . . . . 0.0 111.441 169.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -74.55 -179.67 4.19 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 126.776 2.031 . . . . 0.0 112.9 -172.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.33 -28.9 68.51 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -175.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -77.98 -52.42 8.84 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.436 0.562 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.5 t0 40.84 37.07 0.47 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.682 1.993 . . . . 0.0 114.03 -177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -65.84 -25.7 67.32 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.561 -1.337 . . . . 0.0 111.542 175.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.4 t 37.32 112.19 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 131.634 3.974 . . . . 0.0 116.555 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.41 140.82 96.06 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.029 1.819 . . . . 0.0 110.57 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -72.52 158.25 36.07 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.176 0.512 . . . . 0.0 109.97 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.1 p -123.06 157.02 61.84 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.948 1.699 . . . . 0.0 109.147 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HG2' HG22 ' A' ' 96' ' ' VAL . 80.5 Cg_endo -76.29 162.17 34.13 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 121.567 1.512 . . . . 0.0 110.36 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -73.22 -17.66 24.23 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.949 2.433 . . . . 0.0 111.591 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -65.91 -22.63 66.52 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.252 1.021 . . . . 0.0 112.352 -177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.402 HG22 ' HG2' ' A' ' 93' ' ' PRO . 26.2 m -113.98 150.5 16.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 118.637 0.653 . . . . 0.0 111.11 -172.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -72.6 149.56 43.85 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.298 -1.742 . . . . 0.0 106.298 169.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -132.55 156.69 46.38 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.69 0.281 . . . . 0.0 111.363 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -126.74 162.14 26.52 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 128.009 2.523 . . . . 0.0 106.822 169.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -144.86 114.76 7.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 39.7 m0 -122.38 10.67 9.9 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.517 1.527 . . . . 0.0 111.49 -169.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -44.7 138.22 5.32 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.938 1.256 . . . . 0.0 114.844 -169.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.69 -100.37 0.21 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.868 1.667 . . . . 0.0 107.177 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -154.86 152.69 30.09 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -76.62 126.41 86.08 Favored Pre-proline 0 C--O 1.234 0.242 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.04 -25.58 66.24 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.34 1.36 . . . . 0.0 113.939 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.89 -13.09 62.21 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.346 0.975 . . . . 0.0 112.368 172.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.1 mtm-85 -111.96 6.24 19.3 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.259 . . . . 0.0 111.378 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.66 60.9 0.5 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.335 1.854 . . . . 0.0 110.737 171.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.56 141.76 54.18 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.919 1.688 . . . . 0.0 111.137 -169.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.66 -59.29 0.22 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -166.38 169.61 13.84 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 126.194 1.798 . . . . 0.0 107.108 169.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -30.12 68.81 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.279 0.631 . . . . 0.0 111.292 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.84 -37.8 73.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.832 0.453 . . . . 0.0 110.766 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -68.64 -43.56 76.02 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -57.01 -51.35 69.62 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.166 -0.445 . . . . 0.0 109.81 173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.2 t-105 -58.06 -38.4 76.24 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.792 0.837 . . . . 0.0 111.903 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.69 87.77 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 121.443 -0.785 . . . . 0.0 109.863 175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -63.95 -34.92 79.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.988 0.515 . . . . 0.0 111.85 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -57.76 -49.96 74.83 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 119.172 0.896 . . . . 0.0 109.798 173.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -63.91 -36.06 82.69 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.293 0.497 . . . . 0.0 111.76 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -67.52 -48.05 68.16 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.637 0.653 . . . . 0.0 111.014 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.09 -41.85 92.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -54.29 -53.61 51.38 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.02 0.928 . . . . 0.0 109.537 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -64.54 -42.91 95.42 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 117.787 0.267 . . . . 0.0 111.072 -174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -67.17 -42.16 84.76 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.982 -0.449 . . . . 0.0 110.848 -177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 60.4 mt -59.32 -49.91 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.61 -43.18 78.71 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 111.427 -0.669 . . . . 0.0 111.427 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.02 -51.64 68.37 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-N 117.484 0.642 . . . . 0.0 111.131 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 19.5 mmm-85 -68.54 -29.58 68.18 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 118.137 -0.935 . . . . 0.0 111.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.85 -40.86 88.05 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 120.123 1.328 . . . . 0.0 109.74 175.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -56.73 -53.16 60.91 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.36 -34.4 78.23 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.605 -176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -63.33 -37.9 89.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.798 -0.564 . . . . 0.0 110.726 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.63 -35.55 29.92 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.193 0.597 . . . . 0.0 111.548 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.07 -42.46 9.4 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.746 1.219 . . . . 0.0 111.72 -169.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.1 p -113.48 -18.18 12.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.044 0.938 . . . . 0.0 111.056 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 86.18 14.82 65.85 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.036 -0.869 . . . . 0.0 111.981 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.245 0.866 0 C-N-CA 124.564 1.146 . . . . 0.0 108.137 -175.694 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -151.08 159.95 44.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.043 1.337 . . . . 0.0 107.558 177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -141.52 134.3 28.73 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.44 173.26 9.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 118.553 0.615 . . . . 0.0 110.138 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -142.33 141.03 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.3 tt -145.53 149.76 16.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.091 0.956 . . . . 0.0 108.995 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.28 131.69 32.65 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.523 0.729 . . . . 0.0 109.065 -174.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -111.33 128.17 55.87 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 70.7 mt -127.3 143.85 51.15 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.401 0.68 . . . . 0.0 110.585 -169.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.5 m -142.51 174.68 10.41 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 122.367 1.079 . . . . 0.0 112.674 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.8 p -77.97 32.69 0.18 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.444 2.298 . . . . 0.0 110.616 169.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.01 113.73 0.83 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -173.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -76.31 53.98 0.87 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.264 1.026 . . . . 0.0 111.611 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.8 m -125.15 -19.67 5.08 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -169.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 58.1 m -138.81 -90.4 0.21 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-N 118.798 0.726 . . . . 0.0 109.1 -173.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -52.37 -53.25 47.18 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 124.041 0.936 . . . . 0.0 112.34 -169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 p -68.14 -38.35 82.07 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 118.658 0.663 . . . . 0.0 111.097 -175.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.2 mm-40 -58.66 -54.86 42.26 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.962 0.905 . . . . 0.0 109.903 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 58.6 mtp -54.73 -46.05 74.19 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.57 1.548 . . . . 0.0 110.576 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.78 -46.28 88.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.881 -178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.431 ' HG3' HG22 ' A' ' 34' ' ' VAL . 23.6 tt0 -57.05 -37.8 72.31 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.445 0.566 . . . . 0.0 110.851 175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.51 -54.03 41.13 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 123.829 0.728 . . . . 0.0 111.498 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -61.75 -41.81 98.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.313 0.557 . . . . 0.0 110.777 177.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.37 -41.8 88.92 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.297 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 mtmt -55.15 -36.33 65.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.873 1.215 . . . . 0.0 111.358 173.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 43.7 mm-40 -67.3 -56.96 7.61 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 123.363 0.414 . . . . 0.0 110.783 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -77.36 -44.47 29.28 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -169.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.447 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 84.4 mt -74.51 -37.07 63.21 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 123.062 0.545 . . . . 0.0 111.071 -176.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.92 173.03 42.95 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -168.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.41 -1.93 5.53 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.677 0.791 . . . . 0.0 111.634 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -57.89 -13.2 4.01 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.034 1.333 . . . . 0.0 111.325 169.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 13.7 m95 -129.13 115.49 17.78 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 104.246 -2.502 . . . . 0.0 104.246 173.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -66.34 100.79 0.67 Allowed 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 21' ' ' GLU . 2.8 p -107.68 133.37 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 123.602 0.761 . . . . 0.0 109.831 -168.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -143.06 167.38 22.21 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.162 1.385 . . . . 0.0 109.459 -172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 p -140.41 151.33 44.84 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.983 0.913 . . . . 0.0 109.92 173.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.02 -166.66 1.9 Allowed 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.584 1.154 . . . . 0.0 109.812 176.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.52 -176.31 46.32 Favored Glycine 0 N--CA 1.451 -0.351 0 O-C-N 121.342 -0.849 . . . . 0.0 111.387 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 45.4 mt -54.95 -31.92 25.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 125.723 1.609 . . . . 0.0 110.806 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.11 167.06 25.05 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.027 1.331 . . . . 0.0 108.087 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.83 133.0 20.43 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 171.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -134.42 21.82 3.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.179 0.992 . . . . 0.0 109.347 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.12 165.25 33.89 Favored Glycine 0 C--N 1.339 0.747 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -87.02 147.88 25.53 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.07 0.548 . . . . 0.0 110.442 -178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -73.43 133.52 80.45 Favored Pre-proline 0 CA--C 1.536 0.412 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.365 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.88 -34.38 45.23 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.884 2.389 . . . . 0.0 114.495 174.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -73.97 -27.85 61.19 Favored 'General case' 0 C--O 1.225 -0.187 0 O-C-N 121.385 -0.822 . . . . 0.0 110.929 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.01 -48.56 75.88 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 171.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.1 -49.18 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -59.8 -43.61 94.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.052 0.541 . . . . 0.0 111.039 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.15 94.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.209 0.604 . . . . 0.0 110.255 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.2 mmm -69.72 -36.66 76.08 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.282 0.492 . . . . 0.0 111.318 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.34 -27.34 69.25 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 120.797 -1.19 . . . . 0.0 111.446 173.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -67.17 -15.17 63.55 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.914 0.779 . . . . 0.0 110.825 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.3 m -117.79 -0.0 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.17 0.988 . . . . 0.0 112.079 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.93 32.59 17.44 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 174.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.64 160.51 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -125.85 145.31 50.29 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 170.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.0 pt -128.56 2.98 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.859 1.264 . . . . 0.0 110.41 170.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 m -58.7 -29.52 66.71 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 120.214 -1.554 . . . . 0.0 111.086 170.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -65.64 -4.73 6.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.425 1.89 . . . . 0.0 115.334 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -135.45 48.47 2.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 120.444 1.474 . . . . 0.0 110.829 -169.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -44.86 132.62 6.59 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.843 1.257 . . . . 0.0 111.111 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -57.29 154.81 9.85 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -168.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -154.15 155.7 35.83 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.108 1.363 . . . . 0.0 109.581 173.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.411 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.23 165.26 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 124.497 1.119 . . . . 0.0 109.784 172.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -57.77 153.16 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.058 1.343 . . . . 0.0 110.067 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -149.98 139.11 21.18 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.688 1.595 . . . . 0.0 108.643 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.34 -28.11 57.98 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.31 1.444 . . . . 0.0 113.464 -177.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.04 -13.51 62.01 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.573 1.149 . . . . 0.0 112.286 -171.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.9 mt -113.36 -40.54 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 175.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 30.8 mt -48.09 -61.33 2.03 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 119.834 1.197 . . . . 0.0 111.603 176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 -3.27 35.78 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -173.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -111.94 -33.11 6.38 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.331 1.452 . . . . 0.0 110.941 -169.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.94 122.65 15.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.48 1.512 . . . . 0.0 110.092 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.23 -23.38 66.41 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.833 1.253 . . . . 0.0 111.197 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 tp -143.82 138.65 28.83 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.747 1.219 . . . . 0.0 107.936 170.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -115.6 145.4 21.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.2 t -132.14 124.85 53.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.29 127.11 50.72 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -102.41 24.57 10.14 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.896 0.855 . . . . 0.0 109.081 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 28.0 p -75.96 107.98 8.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.589 1.556 . . . . 0.0 110.029 -173.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.7 26.91 0.46 Allowed Glycine 0 CA--C 1.532 1.147 0 N-CA-C 110.204 -1.159 . . . . 0.0 110.204 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 104' ' ' ASP . 3.8 p-10 -106.84 -177.02 3.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 127.479 2.312 . . . . 0.0 113.43 -169.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.09 66.32 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.014 0.925 . . . . 0.0 113.388 -176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.19 -52.57 6.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 118.502 0.592 . . . . 0.0 110.224 177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 t70 46.44 28.83 0.78 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 126.498 1.919 . . . . 0.0 114.249 -177.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.1 mtpt -61.57 -32.33 72.41 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 120.539 -1.351 . . . . 0.0 111.466 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 54.69 109.88 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 129.772 3.229 . . . . 0.0 114.575 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -59.6 146.05 96.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.452 2.101 . . . . 0.0 112.101 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -74.1 155.66 38.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.552 1.141 . . . . 0.0 109.833 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -132.17 161.6 61.91 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.879 2.071 . . . . 0.0 109.149 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -71.6 159.71 50.36 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 121.246 1.297 . . . . 0.0 109.583 173.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -75.72 -26.15 10.09 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.397 2.065 . . . . 0.0 112.422 -176.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -74.9 -34.61 62.21 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.274 0.63 . . . . 0.0 112.45 -170.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 32.7 m -74.73 153.43 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.542 0.687 . . . . 0.0 111.013 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -70.65 141.28 51.68 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -134.03 149.71 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.216 0.607 . . . . 0.0 109.902 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -127.07 157.14 40.43 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 126.702 2.001 . . . . 0.0 107.832 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -131.34 113.44 13.77 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.8 m0 -122.26 52.89 1.26 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.154 1.781 . . . . 0.0 106.797 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.15 128.67 34.07 Favored Glycine 0 CA--C 1.526 0.766 0 O-C-N 120.747 -1.221 . . . . 0.0 111.654 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.98 160.83 39.43 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.522 1.929 . . . . 0.0 105.911 169.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 84' ' ' ASP . 30.0 t0 -68.73 144.05 54.5 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.431 0.634 . . . . 0.0 110.747 -174.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -68.38 127.64 93.21 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.51 -23.07 50.73 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 121.162 1.241 . . . . 0.0 113.506 -176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.93 -11.45 60.35 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.454 1.025 . . . . 0.0 112.347 171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 84.1 mtt180 -111.49 3.23 17.93 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.879 1.272 . . . . 0.0 110.755 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.51 60.61 0.22 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.21 2.204 . . . . 0.0 110.844 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -59.43 138.2 57.74 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.806 1.642 . . . . 0.0 110.587 -170.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.68 -58.35 0.19 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -166.3 168.43 15.09 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.902 1.681 . . . . 0.0 107.339 170.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -30.3 70.15 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.781 -0.574 . . . . 0.0 111.394 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.75 -38.55 76.85 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.928 0.491 . . . . 0.0 110.585 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.57 -46.13 77.02 Favored 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -56.91 -49.95 74.05 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.168 0.587 . . . . 0.0 110.26 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 47.4 t-105 -60.33 -37.16 79.75 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.866 0.757 . . . . 0.0 111.975 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.46 80.24 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 121.147 -0.97 . . . . 0.0 110.258 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.38 -32.69 74.46 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.948 -0.47 . . . . 0.0 111.477 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -57.42 -49.09 77.35 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 118.361 -0.828 . . . . 0.0 109.465 171.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -57.4 -45.55 84.41 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.072 0.851 . . . . 0.0 111.829 174.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 -60.73 -48.78 80.26 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.002 0.819 . . . . 0.0 110.681 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.67 -39.65 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 19.5 ttp180 -55.85 -55.94 26.53 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 124.095 0.958 . . . . 0.0 108.956 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -69.52 -37.63 77.21 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 123.536 0.523 . . . . 0.0 110.502 -170.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.01 -42.61 80.42 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.031 0.532 . . . . 0.0 111.255 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 44.3 mt -58.61 -52.19 62.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.161 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.01 -45.94 56.1 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.655 -0.525 . . . . 0.0 111.909 178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -61.61 -50.06 74.08 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 117.726 0.763 . . . . 0.0 111.066 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.41 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.57 -34.77 74.64 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.113 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.7 -40.3 96.45 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 119.207 0.912 . . . . 0.0 109.742 176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -57.32 -49.77 75.06 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 119.222 -0.418 . . . . 0.0 110.076 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -62.71 -43.63 98.32 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 121.021 0.438 . . . . 0.0 110.131 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -59.18 -31.72 69.26 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.649 -1.282 . . . . 0.0 111.87 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.63 -37.19 23.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.471 0.708 . . . . 0.0 112.212 178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.6 -52.97 4.63 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.819 1.248 . . . . 0.0 110.728 -169.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 35.2 p -103.03 -16.52 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.842 1.657 . . . . 0.0 110.414 -170.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.34 86.53 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 124.486 1.041 . . . . 0.0 112.381 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 C--O 1.246 0.893 0 CA-C-N 118.694 1.247 . . . . 0.0 108.743 -172.533 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.483 1.211 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -68.21 -38.81 82.31 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.927 -0.483 . . . . 0.0 110.869 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -67.19 126.28 28.71 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 169.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -73.08 -179.91 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.232 0.613 . . . . 0.0 109.919 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -140.91 142.49 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.82 150.32 15.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 118.87 0.759 . . . . 0.0 109.251 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -139.49 136.8 34.94 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.715 0.806 . . . . 0.0 109.508 -170.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.49 133.05 54.6 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.564 1.146 . . . . 0.0 108.29 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.15 141.0 52.37 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 123.54 0.736 . . . . 0.0 110.244 -171.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.8 t -136.93 168.97 18.56 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.173 1.389 . . . . 0.0 109.434 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.4 p -55.5 -36.11 66.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.52 1.128 . . . . 0.0 110.939 170.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.2 141.47 9.39 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.071 -2.011 . . . . 0.0 108.071 169.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -77.44 51.22 0.86 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.42 1.088 . . . . 0.0 111.712 -173.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.7 m -126.46 -15.58 5.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 118.645 -0.693 . . . . 0.0 112.771 -169.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.5 m -137.98 -98.56 0.19 Allowed 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -170.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -52.31 -50.29 62.53 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 124.081 0.953 . . . . 0.0 112.311 -169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -70.7 -36.32 73.21 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 117.78 0.264 . . . . 0.0 111.509 -174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -60.92 -53.78 53.09 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.247 1.019 . . . . 0.0 110.214 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.7 mtp -53.94 -46.84 71.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.182 1.393 . . . . 0.0 110.551 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.26 95.6 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.914 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.463 ' HG3' HG12 ' A' ' 34' ' ' VAL . 54.7 tt0 -55.92 -41.44 74.57 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 118.223 0.465 . . . . 0.0 110.728 174.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.27 -48.1 85.0 Favored Glycine 0 C--N 1.338 0.674 0 CA-C-O 119.473 -0.626 . . . . 0.0 112.4 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -63.01 -43.57 98.4 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 117.834 0.817 . . . . 0.0 110.864 176.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.29 99.63 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.563 -0.732 . . . . 0.0 110.787 -175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -51.55 -38.31 53.69 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 119.068 0.849 . . . . 0.0 111.907 174.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -70.21 -62.66 1.3 Allowed 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 123.327 0.392 . . . . 0.0 110.565 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -67.95 -37.78 82.0 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -169.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 78.5 mt -77.03 -1.36 28.49 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.682 0.793 . . . . 0.0 112.489 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.34 24.97 59.76 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.573 1.082 . . . . 0.0 113.738 171.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.2 t70 56.12 16.06 2.09 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.768 2.027 . . . . 0.0 113.611 -174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -76.59 2.2 14.66 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 120.945 -1.097 . . . . 0.0 111.33 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.1 m95 -134.21 124.74 26.49 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -67.64 94.25 0.42 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 171.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.463 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.6 t -79.11 138.46 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -143.5 164.62 29.85 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.075 1.35 . . . . 0.0 109.695 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.3 p -146.42 156.56 43.39 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.783 0.833 . . . . 0.0 109.461 169.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.03 -166.89 2.07 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.224 1.009 . . . . 0.0 109.584 173.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.69 44.03 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 1.7 mt -57.03 -25.57 22.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.927 1.291 . . . . 0.0 111.363 173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.02 169.47 19.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.967 1.307 . . . . 0.0 108.825 174.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.21 135.48 21.64 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 169.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -129.18 11.12 5.91 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.723 1.209 . . . . 0.0 110.042 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 162.4 30.61 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -170.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -81.08 146.67 30.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.321 0.581 . . . . 0.0 111.045 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -72.16 133.68 83.42 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-O 118.147 -0.93 . . . . 0.0 108.945 -175.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.53 -34.62 43.09 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.799 2.333 . . . . 0.0 114.563 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -73.41 -28.18 61.85 Favored 'General case' 0 N--CA 1.462 0.143 0 O-C-N 121.567 -0.708 . . . . 0.0 110.731 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.77 73.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 171.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.7 t -57.68 -48.05 84.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -60.04 -41.76 92.95 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 118.57 0.623 . . . . 0.0 110.764 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.47 94.63 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.14 0.576 . . . . 0.0 109.78 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 69.5 mmm -69.07 -38.52 79.07 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.415 0.15 . . . . 0.0 111.061 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? -64.47 -25.1 67.85 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.85 -1.156 . . . . 0.0 111.483 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.79 -15.62 63.15 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.578 0.751 . . . . 0.0 110.42 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 m -115.25 0.82 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.927 0.891 . . . . 0.0 112.064 176.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.74 32.04 19.56 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.9 mt -116.65 159.98 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 177.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -125.95 145.45 50.27 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 pt -127.97 2.7 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.977 1.311 . . . . 0.0 110.383 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.86 -27.98 67.13 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 119.978 -1.701 . . . . 0.0 111.2 171.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -64.84 -5.23 5.52 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.227 1.811 . . . . 0.0 115.107 175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.18 49.61 2.02 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.253 1.388 . . . . 0.0 110.876 -169.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.5 p -46.72 134.64 9.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.3 1.04 . . . . 0.0 110.967 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 m -57.26 155.51 8.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 -168.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -154.48 156.18 36.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.967 1.307 . . . . 0.0 109.395 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.421 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.0 167.98 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 124.41 1.084 . . . . 0.0 109.777 171.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.6 mt -54.41 146.22 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 125.454 1.501 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -138.65 139.49 38.52 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 125.283 1.433 . . . . 0.0 109.773 170.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.5 m -55.81 -29.12 59.24 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.516 1.526 . . . . 0.0 113.259 178.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.75 -7.06 36.23 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 112.392 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.1 mt -117.94 -44.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.3 mt -45.7 -55.85 5.95 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.092 0.957 . . . . 0.0 112.305 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.66 3.7 51.84 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.75 0.82 . . . . 0.0 112.925 -173.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -120.8 -30.01 4.53 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 112.299 -168.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.97 130.37 46.11 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.778 1.231 . . . . 0.0 109.92 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -68.58 -22.98 64.43 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.223 0.609 . . . . 0.0 110.962 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.0 tp -146.44 142.18 27.89 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.924 0.89 . . . . 0.0 108.829 170.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -119.9 145.74 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 173.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.8 t -135.48 135.48 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -174.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.56 107.67 13.56 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -171.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -90.68 8.32 34.99 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.409 0.683 . . . . 0.0 112.637 -168.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 14.6 p -68.65 72.89 0.24 Allowed 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 127.825 2.45 . . . . 0.0 114.669 -170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.06 18.94 11.2 Favored Glycine 0 N--CA 1.473 1.146 0 O-C-N 120.575 -1.328 . . . . 0.0 112.827 174.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -78.3 175.86 9.83 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.301 1.84 . . . . 0.0 111.219 171.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.9 -18.0 64.05 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.86 -32.66 11.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.297 0.953 . . . . 0.0 111.035 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 34.64 55.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.26 2.624 . . . . 0.0 113.885 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -61.29 -25.05 66.85 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.109 -0.948 . . . . 0.0 112.632 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 70.8 m 42.51 84.8 0.18 Allowed Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 127.324 2.249 . . . . 0.0 112.883 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -45.06 135.2 10.89 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.442 3.428 . . . . 0.0 113.245 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.0 ttt -65.01 138.24 58.23 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.902 0.881 . . . . 0.0 110.245 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.9 p -124.02 158.09 61.53 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 126.471 1.908 . . . . 0.0 109.689 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.5 153.39 76.66 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 121.82 1.68 . . . . 0.0 109.324 169.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.63 -23.97 16.41 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 122.478 2.119 . . . . 0.0 112.103 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -73.05 -32.83 65.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.645 0.778 . . . . 0.0 112.196 -173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -72.94 145.07 12.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.432 0.634 . . . . 0.0 109.799 -172.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.86 130.99 44.97 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 65.0 ttp85 -134.54 150.4 50.76 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.021 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -126.78 160.68 30.15 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 127.317 2.247 . . . . 0.0 107.574 175.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -133.13 115.13 14.69 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 177.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.406 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 33.6 m0 -119.11 59.67 0.83 Allowed 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -69.84 123.85 13.78 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 121.467 -0.771 . . . . 0.0 111.767 -171.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.94 160.13 43.59 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 126.61 1.964 . . . . 0.0 106.528 168.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -69.81 149.66 47.69 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.179 0.514 . . . . 0.0 110.591 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -77.2 128.61 80.34 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -68.49 -24.83 35.86 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.221 1.28 . . . . 0.0 113.515 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.38 -12.45 61.13 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.487 1.04 . . . . 0.0 111.722 172.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.0 ttp85 -101.93 2.0 37.46 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.889 1.275 . . . . 0.0 111.043 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.93 67.2 0.82 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.115 1.366 . . . . 0.0 110.385 175.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -57.49 137.42 56.26 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.928 0.891 . . . . 0.0 110.464 -172.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.42 -63.42 0.19 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.4 t -165.15 168.72 16.9 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 107.6 170.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.93 -29.53 68.44 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.386 0.675 . . . . 0.0 111.424 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -71.64 -37.33 70.86 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.22 0.464 . . . . 0.0 110.836 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -68.23 -44.01 76.69 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -58.22 -48.02 81.67 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 122.856 0.462 . . . . 0.0 110.084 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -58.45 -39.89 81.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.561 0.744 . . . . 0.0 111.702 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.99 -42.68 84.65 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.442 -0.787 . . . . 0.0 110.213 177.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -64.52 -34.12 77.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.07 0.548 . . . . 0.0 111.165 177.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -59.37 -48.14 82.78 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.974 0.909 . . . . 0.0 110.222 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -65.14 -36.36 84.02 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.491 0.587 . . . . 0.0 111.521 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -65.57 -50.36 65.44 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 118.265 0.484 . . . . 0.0 110.64 176.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.54 -39.37 84.89 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.14 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -54.44 -53.33 55.61 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 123.781 0.832 . . . . 0.0 109.352 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -64.56 -41.94 95.99 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.046 0.384 . . . . 0.0 111.035 -174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.18 -41.29 90.48 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.597 -0.689 . . . . 0.0 111.411 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 36.9 mt -57.89 -53.03 50.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.55 -45.72 53.75 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 123.677 0.656 . . . . 0.0 111.754 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -60.46 -50.28 74.19 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 117.918 0.859 . . . . 0.0 111.174 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.406 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -70.79 -33.18 70.47 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.991 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.53 -39.61 94.86 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 119.179 0.9 . . . . 0.0 109.969 175.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.83 -52.63 64.68 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 176.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.0 -35.29 80.72 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.05 -0.26 . . . . 0.0 111.255 -176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -62.56 -36.58 83.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.81 -0.556 . . . . 0.0 111.223 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.91 -37.52 26.7 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 122.818 0.447 . . . . 0.0 111.44 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -89.42 -42.96 11.21 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.611 1.165 . . . . 0.0 111.628 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 26.0 p -113.29 -19.0 11.93 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.224 1.01 . . . . 0.0 111.161 -169.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 85.77 10.54 75.83 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.937 -0.924 . . . . 0.0 112.209 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 118.654 1.227 . . . . 0.0 108.364 -174.677 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -150.82 157.57 43.09 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.954 1.302 . . . . 0.0 107.719 177.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -132.97 133.54 43.3 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 103.933 -2.617 . . . . 0.0 103.933 169.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.2 mmmt -71.85 175.1 6.07 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -141.37 140.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 104.51 -2.404 . . . . 0.0 104.51 173.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.78 148.94 20.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.4 131.66 30.21 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 -173.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -115.71 131.24 56.99 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 62.3 mt -125.91 139.59 53.33 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.639 0.776 . . . . 0.0 109.719 -169.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.2 t -135.74 168.75 18.71 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.442 1.097 . . . . 0.0 109.406 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.8 p -58.77 -26.27 63.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.476 1.111 . . . . 0.0 111.314 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.9 138.04 5.94 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 107.514 -2.235 . . . . 0.0 107.514 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.03 53.45 0.95 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.367 1.067 . . . . 0.0 111.603 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.3 m -126.85 -17.66 4.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.921 -169.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.7 m -139.03 -90.93 0.19 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.876 0.762 . . . . 0.0 109.184 -170.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -56.46 -53.46 57.21 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.38 0.672 . . . . 0.0 111.542 -169.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -67.68 -36.4 80.62 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 117.774 0.261 . . . . 0.0 111.197 -175.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 49.1 mm-40 -59.61 -57.58 12.31 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.147 0.979 . . . . 0.0 110.085 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 47.8 mtm -56.86 -43.4 81.14 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.319 0.648 . . . . 0.0 111.517 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.39 -43.28 99.15 Favored 'General case' 0 C--N 1.339 0.136 0 CA-C-N 118.482 0.583 . . . . 0.0 111.824 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.6 tt0 -57.7 -39.74 77.91 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.237 0.471 . . . . 0.0 110.815 174.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.96 -52.4 53.56 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 123.697 0.665 . . . . 0.0 111.546 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.8 m95 -61.32 -45.29 95.04 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 117.303 0.551 . . . . 0.0 110.98 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.7 -44.25 97.3 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.34 0.656 . . . . 0.0 110.852 -174.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -56.3 -34.21 66.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.055 0.843 . . . . 0.0 111.889 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -67.22 -61.61 1.84 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.131 0.423 . . . . 0.0 110.443 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -68.02 -42.71 80.25 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.35 0.26 . . . . 0.0 111.507 -169.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 76.3 mt -79.38 -7.84 58.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.273 1.029 . . . . 0.0 112.241 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 56.81 27.93 56.64 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.859 1.219 . . . . 0.0 114.621 169.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.1 t70 61.58 4.76 1.08 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.696 2.398 . . . . 0.0 114.107 -174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -65.29 -9.11 21.5 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.714 1.206 . . . . 0.0 110.384 169.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -129.37 118.84 22.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 103.68 -2.711 . . . . 0.0 103.68 172.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.64 99.7 0.81 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -84.1 141.47 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -144.01 165.31 28.12 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.941 1.696 . . . . 0.0 109.077 174.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 78.2 p -143.92 155.89 44.23 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.775 0.83 . . . . 0.0 109.736 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.37 1.69 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.622 1.169 . . . . 0.0 109.459 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.09 179.83 45.19 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -54.39 -28.41 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.366 1.466 . . . . 0.0 111.387 173.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -146.06 170.61 16.32 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.966 1.307 . . . . 0.0 108.632 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.0 134.09 18.19 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 169.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -135.92 19.58 3.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.363 1.065 . . . . 0.0 109.81 175.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 99.09 163.15 29.73 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -83.97 146.21 28.12 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.142 0.496 . . . . 0.0 110.696 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -70.66 134.13 86.38 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.036 -175.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.23 -35.67 44.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.795 2.33 . . . . 0.0 114.259 174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -72.75 -26.64 61.64 Favored 'General case' 0 C--O 1.227 -0.111 0 O-C-N 121.491 -0.756 . . . . 0.0 111.094 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -46.62 78.79 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 171.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.77 -47.98 87.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -57.16 -46.34 82.85 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.858 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.56 86.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -69.26 -37.69 78.04 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 121.78 -0.575 . . . . 0.0 110.852 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -65.01 -25.72 67.97 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 120.879 -1.138 . . . . 0.0 111.778 173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -71.43 -12.35 61.36 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.453 1.101 . . . . 0.0 110.424 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.4 m -118.28 -1.66 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 124.113 0.965 . . . . 0.0 112.735 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.23 33.13 10.94 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.24 162.89 17.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -126.5 146.37 50.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.2 pt -128.95 3.97 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.824 1.25 . . . . 0.0 110.589 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -59.32 -28.38 66.75 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 120.136 -1.603 . . . . 0.0 111.003 170.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -64.73 -5.58 6.11 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.291 1.836 . . . . 0.0 115.188 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -135.67 50.35 2.11 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 120.512 1.505 . . . . 0.0 110.426 -169.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -46.21 133.28 9.46 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.493 1.117 . . . . 0.0 110.683 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.6 m -57.8 154.75 11.41 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -154.0 155.38 35.44 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.094 1.357 . . . . 0.0 109.522 171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.42 166.09 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.354 1.062 . . . . 0.0 109.56 172.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.04 145.92 5.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 124.717 1.207 . . . . 0.0 109.898 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.07 135.97 33.15 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.391 1.076 . . . . 0.0 109.884 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.4 m -54.49 -28.35 44.31 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.426 1.49 . . . . 0.0 113.067 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.04 -11.98 61.28 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.907 1.283 . . . . 0.0 112.155 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mt -114.52 -42.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.1 mt -49.27 -57.5 6.69 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.928 1.24 . . . . 0.0 111.661 177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.31 -1.8 34.92 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -174.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -116.37 -32.58 5.23 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.214 1.405 . . . . 0.0 111.591 -168.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.46 128.25 35.73 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.32 1.448 . . . . 0.0 109.619 178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -63.34 -29.85 71.09 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.863 0.865 . . . . 0.0 110.182 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 66.9 tp -147.3 140.43 25.2 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.706 1.202 . . . . 0.0 108.647 175.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.5 t -113.84 154.72 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.052 -1.832 . . . . 0.0 106.052 169.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.8 t -140.09 136.43 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.06 135.65 47.14 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.39 10.46 37.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.547 0.739 . . . . 0.0 110.613 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 21.2 p -64.21 116.98 6.52 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.643 1.177 . . . . 0.0 111.18 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.3 15.17 0.48 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.909 1.242 . . . . 0.0 111.051 169.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -78.51 176.0 9.81 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.806 2.442 . . . . 0.0 109.546 169.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.55 -16.98 59.47 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -85.19 -35.48 21.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.511 1.051 . . . . 0.0 110.265 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.277 1.2 p-10 37.65 48.45 0.94 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 128.817 2.847 . . . . 0.0 114.253 173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -66.78 -14.02 62.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.537 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 84.5 m 34.49 85.39 0.16 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 128.569 2.748 . . . . 0.0 113.971 172.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -44.78 133.21 10.48 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 124.685 3.59 . . . . 0.0 114.089 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -72.31 146.36 47.2 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.405 1.082 . . . . 0.0 110.098 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.4 p -129.46 160.22 65.45 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.607 1.963 . . . . 0.0 109.906 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -68.46 145.21 64.13 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.034 1.823 . . . . 0.0 109.895 174.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.5 -23.31 20.25 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.915 2.41 . . . . 0.0 112.185 -175.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -85.01 6.58 24.66 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.067 0.947 . . . . 0.0 112.367 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -122.16 135.9 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.28 145.35 55.85 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.8 ttm180 -123.67 169.53 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.266 169.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -136.51 164.32 28.44 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 127.611 2.364 . . . . 0.0 106.794 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -134.02 113.25 11.93 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 25.7 m0 -121.63 61.82 0.93 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.06 131.3 11.66 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 121.304 -0.873 . . . . 0.0 112.885 -169.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -155.28 160.46 40.81 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.396 2.278 . . . . 0.0 106.159 169.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -65.86 148.97 50.94 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.838 -0.539 . . . . 0.0 110.324 -177.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -74.4 128.32 86.1 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.33 -21.23 54.6 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.063 1.175 . . . . 0.0 113.403 -174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.38 -18.3 65.07 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.399 1.0 . . . . 0.0 112.372 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.1 mtp-105 -86.46 -8.67 57.41 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.457 1.026 . . . . 0.0 112.516 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -74.78 52.91 0.55 Allowed 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.827 1.651 . . . . 0.0 112.369 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -59.78 150.78 27.08 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.008 2.123 . . . . 0.0 112.063 -175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.62 -52.81 0.42 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 -178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.9 t -165.97 165.47 18.03 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.97 1.708 . . . . 0.0 107.263 169.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.48 -28.54 67.11 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.477 0.711 . . . . 0.0 111.223 176.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.78 -37.36 73.34 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.3 0.5 . . . . 0.0 110.903 176.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.9 -45.91 73.09 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -56.42 -49.37 74.72 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.923 0.489 . . . . 0.0 110.352 173.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.6 t-105 -59.98 -39.71 86.62 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.52 0.728 . . . . 0.0 111.631 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.18 -41.55 94.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.232 -0.917 . . . . 0.0 110.838 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -67.41 -32.73 73.83 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.767 -0.583 . . . . 0.0 111.747 177.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -59.05 -44.64 91.84 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 118.693 0.679 . . . . 0.0 110.327 171.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.08 -38.05 89.65 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 118.635 0.652 . . . . 0.0 111.423 175.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -61.92 -51.16 69.26 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.109 0.868 . . . . 0.0 110.258 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 87.4 t -67.96 -38.44 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-O 117.754 -1.117 . . . . 0.0 110.332 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -63.91 -39.79 95.0 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 121.025 1.738 . . . . 0.0 109.992 178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -66.42 -45.37 80.13 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 118.239 0.472 . . . . 0.0 111.109 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -64.75 -41.81 95.63 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 122.002 -0.436 . . . . 0.0 110.874 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 40.7 mt -60.05 -51.28 74.74 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 175.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.37 -46.31 57.81 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.566 -0.575 . . . . 0.0 111.786 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -60.89 -48.16 83.1 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 117.813 0.806 . . . . 0.0 110.826 177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -35.11 76.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.38 -41.45 93.71 Favored 'General case' 0 C--N 1.339 0.136 0 O-C-N 121.821 -0.549 . . . . 0.0 110.079 175.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.89 -50.39 72.64 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 119.071 -0.49 . . . . 0.0 109.74 177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -61.55 -45.33 94.61 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.57 -33.58 66.31 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 120.664 -1.273 . . . . 0.0 112.334 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -86.36 -32.89 20.73 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.414 0.686 . . . . 0.0 112.304 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -96.32 -53.68 3.53 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.232 1.413 . . . . 0.0 110.567 -169.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 58.3 p -99.57 -15.54 18.58 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.49 1.516 . . . . 0.0 110.495 -170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 71.21 21.85 78.49 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.169 0.89 . . . . 0.0 111.815 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt . . . . . 0 C--O 1.248 0.987 0 CA-C-N 117.868 0.834 . . . . 0.0 109.811 -179.228 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.567 0.223 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -77.39 -16.51 58.81 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.125 0.57 . . . . 0.0 112.109 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -52.79 133.64 37.1 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 123.517 0.727 . . . . 0.0 109.498 175.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 10.7 mmpt? -97.19 170.13 9.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.021 174.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 mp -137.24 142.69 36.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.7 tt -141.05 146.56 23.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -138.91 120.85 15.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -171.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -104.09 127.85 51.7 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.871 0.868 . . . . 0.0 108.936 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.2 mp -121.08 140.81 51.45 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.768 1.227 . . . . 0.0 109.184 -169.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 m -140.52 168.86 18.82 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.49 1.116 . . . . 0.0 111.64 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.2 p -61.14 -25.15 66.8 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.009 0.924 . . . . 0.0 111.377 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -155.49 136.25 5.0 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 169.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.79 55.88 2.16 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.296 1.038 . . . . 0.0 110.724 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -122.18 -25.95 4.79 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -168.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 56.7 m -133.02 -94.67 0.33 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.319 0.963 . . . . 0.0 110.32 -169.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -35.75 80.03 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -169.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.0 p -58.72 -49.7 76.62 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.348 0.659 . . . . 0.0 110.703 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -63.72 -43.9 95.16 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 123.562 0.745 . . . . 0.0 110.802 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.5 mtm -61.81 -44.94 95.86 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.679 0.391 . . . . 0.0 111.036 175.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.84 -43.0 99.72 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.525 0.602 . . . . 0.0 111.091 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.2 tt0 -57.59 -43.64 84.78 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.252 173.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.19 -53.37 43.22 Favored Glycine 0 C--N 1.34 0.775 0 C-N-CA 123.823 0.725 . . . . 0.0 112.076 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -62.38 -44.31 96.76 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 117.194 0.497 . . . . 0.0 110.947 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.74 -42.66 99.78 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 118.608 -0.711 . . . . 0.0 110.667 -176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -54.82 -35.19 63.66 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.425 1.011 . . . . 0.0 111.59 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.3 mm-40 -72.31 -62.82 1.3 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.122 0.419 . . . . 0.0 110.798 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -67.44 -37.51 83.12 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -169.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.0 -2.22 26.22 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.349 0.66 . . . . 0.0 112.364 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.11 27.55 57.49 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.559 1.552 . . . . 0.0 115.127 169.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.7 t70 58.88 11.6 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.585 1.954 . . . . 0.0 113.363 -174.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -72.39 -12.68 61.22 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.786 -1.196 . . . . 0.0 110.191 169.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -125.3 126.25 44.81 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.529 1.931 . . . . 0.0 106.513 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 9.2 mmpt? -70.3 108.86 4.4 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -96.79 137.59 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 -173.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -142.79 165.3 27.76 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.584 1.154 . . . . 0.0 109.805 175.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.4 p -147.4 159.43 43.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 123.329 0.652 . . . . 0.0 109.831 169.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.96 -169.38 2.02 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.36 1.464 . . . . 0.0 109.635 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.42 -177.86 43.88 Favored Glycine 0 CA--C 1.52 0.386 0 O-C-N 121.47 -0.768 . . . . 0.0 112.055 173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -54.89 -28.22 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.542 1.537 . . . . 0.0 111.292 172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.4 170.08 17.56 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.835 1.254 . . . . 0.0 108.715 171.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.74 136.15 21.59 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 169.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -137.52 21.09 2.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.319 1.048 . . . . 0.0 109.846 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 91.09 153.35 29.33 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -68.51 150.66 47.8 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.41 0.624 . . . . 0.0 111.369 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -77.45 133.43 67.57 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.865 1.266 . . . . 0.0 109.123 -175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.5 -34.54 42.52 Favored 'Trans proline' 0 CA--C 1.535 0.525 0 C-N-CA 122.933 2.422 . . . . 0.0 114.592 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -72.28 -28.76 63.31 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.25 -0.906 . . . . 0.0 110.769 178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.25 -47.03 84.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 170.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 49.5 t -58.71 -48.86 84.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -60.73 -41.32 95.1 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-O 118.739 -0.648 . . . . 0.0 111.651 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.33 95.0 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.8 0.727 . . . . 0.0 109.845 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 77.2 mmm -69.47 -35.54 75.71 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 117.822 0.283 . . . . 0.0 111.402 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.89 -28.15 69.31 Favored 'General case' 0 N--CA 1.457 -0.121 0 O-C-N 120.848 -1.157 . . . . 0.0 111.7 172.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -66.21 -17.27 64.63 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.201 0.91 . . . . 0.0 110.81 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -115.15 0.4 8.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.95 0.9 . . . . 0.0 112.021 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.92 32.0 19.09 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 173.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.35 155.38 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.62 145.83 47.6 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 169.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.48 -1.52 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.113 1.365 . . . . 0.0 110.796 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -58.21 -31.98 67.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.859 0.864 . . . . 0.0 110.958 173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -64.49 7.26 0.15 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.443 1.897 . . . . 0.0 114.948 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -131.41 29.44 4.57 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 120.301 1.41 . . . . 0.0 112.527 -169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.6 p -41.48 127.43 3.02 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.25 1.02 . . . . 0.0 113.434 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.0 m -54.52 155.2 4.16 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.229 1.812 . . . . 0.0 115.49 -168.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -154.22 156.6 37.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.175 1.39 . . . . 0.0 109.376 172.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.449 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.41 163.3 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.946 0.898 . . . . 0.0 109.322 170.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 70.9 mt -56.95 145.53 7.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 C-N-CA 124.784 1.234 . . . . 0.0 109.834 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -136.36 133.84 37.21 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.629 1.172 . . . . 0.0 110.035 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.0 m -56.13 -27.99 56.15 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.625 1.57 . . . . 0.0 113.593 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -83.82 -0.04 49.43 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.631 0.651 . . . . 0.0 111.897 -172.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.2 mt -112.26 -41.79 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 169.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.4 mt -47.82 -56.8 6.64 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.351 0.978 . . . . 0.0 111.873 174.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -83.45 4.18 28.84 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.702 0.801 . . . . 0.0 112.659 -174.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -124.88 -27.45 3.61 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.636 1.175 . . . . 0.0 112.043 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.83 135.15 56.8 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 124.914 1.286 . . . . 0.0 108.678 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -63.02 -34.23 77.13 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 169.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 55.3 tp -145.4 137.3 25.48 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.623 1.169 . . . . 0.0 109.175 -179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.37 147.39 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 169.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.1 118.95 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -93.47 133.36 36.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 171.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.35 25.54 11.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.203 1.001 . . . . 0.0 108.884 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 7.9 p -72.35 103.87 3.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 120.765 -1.209 . . . . 0.0 111.263 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.37 15.99 0.76 Allowed Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.196 1.379 . . . . 0.0 109.768 169.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -71.57 173.35 8.14 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 127.583 2.353 . . . . 0.0 111.126 176.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.18 -34.34 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.342 -0.848 . . . . 0.0 111.855 169.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -72.89 -47.1 48.8 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.242 0.617 . . . . 0.0 111.555 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 43.59 43.26 4.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.92 2.088 . . . . 0.0 113.915 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -73.65 -21.54 60.25 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.981 -1.075 . . . . 0.0 112.442 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 96.0 m 46.54 95.79 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 127.679 2.391 . . . . 0.0 113.631 -173.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.84 139.16 19.81 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.593 2.862 . . . . 0.0 112.633 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.08 149.2 43.31 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 110.514 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.3 p -131.22 158.58 74.84 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 126.957 2.103 . . . . 0.0 109.258 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.98 159.33 41.56 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.214 1.943 . . . . 0.0 110.352 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -73.09 -15.95 25.61 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.078 2.519 . . . . 0.0 111.126 170.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.31 -12.47 61.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.406 1.482 . . . . 0.0 112.908 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.5 p -123.72 148.26 27.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 119.223 0.92 . . . . 0.0 112.113 -169.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -68.09 141.45 56.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 169.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -135.54 151.04 49.94 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.109 0.564 . . . . 0.0 110.683 -177.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -127.81 161.14 29.71 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 127.226 2.21 . . . . 0.0 108.031 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -133.07 112.77 12.07 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.3 m0 -124.7 52.09 1.57 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.312 1.845 . . . . 0.0 107.282 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.43 135.07 31.09 Favored Glycine 0 CA--C 1.526 0.723 0 O-C-N 120.809 -1.182 . . . . 0.0 112.241 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.95 158.72 38.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.889 1.676 . . . . 0.0 107.515 169.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -59.02 133.42 56.08 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.043 1.737 . . . . 0.0 110.601 -179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -68.7 125.95 92.29 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -65.39 -24.92 56.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 121.229 1.286 . . . . 0.0 113.2 -174.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.36 -3.62 41.03 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.135 0.88 . . . . 0.0 112.506 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -123.86 7.0 8.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.221 1.408 . . . . 0.0 109.307 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.35 99.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.636 1.174 . . . . 0.0 108.472 169.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -57.27 122.85 13.47 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 123.977 0.911 . . . . 0.0 108.88 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 165.82 -105.83 0.25 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.504 ' H ' ' HB3' ' A' ' 115' ' ' GLU . 10.6 p -140.56 171.68 13.78 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 126.38 1.872 . . . . 0.0 107.523 -176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.59 -29.25 70.46 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.235 -0.915 . . . . 0.0 111.216 170.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -74.23 -40.56 62.33 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.024 0.53 . . . . 0.0 109.896 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.504 ' HB3' ' H ' ' A' ' 112' ' ' THR . 9.3 tp10 -63.98 -43.24 96.32 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -59.71 -47.32 86.1 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.432 0.693 . . . . 0.0 110.595 174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 45.8 t-105 -59.65 -36.59 76.7 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.984 0.811 . . . . 0.0 111.662 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.5 -40.94 76.71 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 121.121 -0.987 . . . . 0.0 110.465 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -64.77 -31.09 72.15 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 118.269 -0.872 . . . . 0.0 112.268 173.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -58.73 -49.25 78.31 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.657 1.117 . . . . 0.0 109.406 172.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -56.38 -47.41 78.97 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.892 0.769 . . . . 0.0 111.819 172.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -60.68 -47.76 84.8 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 118.972 0.806 . . . . 0.0 110.695 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 82.4 t -71.14 -39.41 73.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -57.11 -53.98 51.96 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 119.073 0.851 . . . . 0.0 109.03 178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.61 -39.17 80.97 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 123.35 0.406 . . . . 0.0 110.857 -170.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -60.04 -48.15 82.89 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.482 0.713 . . . . 0.0 111.055 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 58.0 mt -59.98 -48.94 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.73 -48.66 49.82 Favored Glycine 0 CA--C 1.524 0.632 0 CA-C-O 119.663 -0.521 . . . . 0.0 111.992 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -61.08 -47.29 87.01 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 117.816 0.808 . . . . 0.0 111.007 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.08 -28.29 57.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.555 -0.736 . . . . 0.0 111.256 -173.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.64 -38.83 84.39 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 119.373 0.988 . . . . 0.0 109.799 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -56.77 -49.85 74.07 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.457 0.571 . . . . 0.0 109.561 173.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -65.89 -36.58 83.8 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.662 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -62.5 -35.54 79.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 119.044 0.838 . . . . 0.0 111.223 177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.69 -38.82 32.64 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 122.465 0.306 . . . . 0.0 111.19 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.7 -45.73 9.11 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.089 0.955 . . . . 0.0 111.11 -170.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 22.6 p -111.28 -19.14 12.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.43 1.092 . . . . 0.0 112.071 -169.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 75.24 18.06 80.1 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-O 118.849 -0.973 . . . . 0.0 112.912 -176.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.247 0.957 0 CA-C-N 119.047 1.423 . . . . 0.0 109.475 177.863 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? . . . . . 0 N--CA 1.482 1.152 0 CA-C-O 120.867 0.365 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.92 174.02 13.6 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.214 1.405 . . . . 0.0 108.712 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -144.55 139.18 28.01 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 173.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -74.32 176.9 6.27 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 118.49 0.586 . . . . 0.0 110.407 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -143.23 141.01 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 104.775 -2.305 . . . . 0.0 104.775 174.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.9 tt -145.09 149.1 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 119.246 0.93 . . . . 0.0 109.065 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -134.88 137.69 43.45 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.88 0.872 . . . . 0.0 109.017 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -119.83 130.54 54.95 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 61.8 mt -127.62 141.75 51.54 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.544 0.737 . . . . 0.0 110.438 -169.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 95.4 m -140.63 169.98 16.63 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.015 0.926 . . . . 0.0 110.73 172.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 m -56.99 -25.25 58.12 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.36 1.464 . . . . 0.0 111.61 173.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -150.77 136.67 5.7 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -80.58 56.7 2.68 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.022 0.929 . . . . 0.0 110.51 -175.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.7 p -120.43 -31.95 4.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -169.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.9 m -128.72 -87.59 0.54 Allowed 'General case' 0 CA--C 1.527 0.063 0 CA-C-N 118.844 0.747 . . . . 0.0 110.248 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -58.92 -50.45 73.98 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 11.7 p -65.67 -36.36 83.42 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.346 0.521 . . . . 0.0 111.176 -176.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -62.43 -55.24 29.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.559 1.144 . . . . 0.0 111.001 176.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -56.74 -44.74 81.97 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.757 0.823 . . . . 0.0 111.029 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.63 98.48 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 118.454 0.57 . . . . 0.0 111.635 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.0 tt0 -56.51 -43.36 79.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 119.175 -0.44 . . . . 0.0 110.586 173.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.1 -49.54 77.39 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 118.713 0.688 . . . . 0.0 112.068 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -62.72 -45.32 93.29 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.952 0.876 . . . . 0.0 111.121 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.23 99.0 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.019 0.527 . . . . 0.0 110.522 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -54.22 -34.93 61.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 118.7 0.682 . . . . 0.0 111.81 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.0 mm-40 -71.33 -62.86 1.25 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.056 0.389 . . . . 0.0 110.554 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -67.54 -40.92 85.03 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -169.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 78.0 mt -75.88 -4.13 39.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.634 0.774 . . . . 0.0 112.472 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.68 25.84 56.34 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.637 1.113 . . . . 0.0 113.948 171.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.0 t70 57.78 9.61 0.91 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.306 2.243 . . . . 0.0 114.098 -173.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -67.3 -3.65 8.61 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 120.941 -1.1 . . . . 0.0 111.153 169.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -132.92 122.07 23.79 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 103.436 -2.801 . . . . 0.0 103.436 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.3 mmpt? -67.79 97.54 0.65 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.078 -1.452 . . . . 0.0 107.078 172.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.01 140.71 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.05 166.45 26.82 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.411 1.484 . . . . 0.0 109.348 174.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 90.0 p -143.99 157.43 44.34 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.766 0.827 . . . . 0.0 109.236 169.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.57 -167.45 1.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.233 1.013 . . . . 0.0 109.968 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.79 -179.0 44.15 Favored Glycine 0 N--CA 1.447 -0.582 0 O-C-N 121.685 -0.634 . . . . 0.0 111.873 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.2 mt -55.15 -31.06 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.031 1.332 . . . . 0.0 110.841 171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.89 168.58 21.85 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.257 1.423 . . . . 0.0 108.75 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.0 138.14 25.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 171.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -130.02 12.15 5.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.767 1.227 . . . . 0.0 109.641 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 162.49 29.95 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -170.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -76.54 152.77 35.89 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.27 0.628 . . . . 0.0 111.026 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -77.58 133.05 67.52 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.63 -174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -51.96 -36.45 64.4 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.722 2.281 . . . . 0.0 114.207 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -71.94 -31.98 66.87 Favored 'General case' 0 CA--C 1.522 -0.133 0 O-C-N 121.581 -0.699 . . . . 0.0 110.241 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.29 -44.53 94.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.78 -50.96 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 174.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -58.88 -40.78 85.41 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 118.642 0.656 . . . . 0.0 111.695 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.48 88.68 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.583 0.629 . . . . 0.0 109.801 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 70.8 mmm -66.51 -38.75 87.89 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 118.381 0.537 . . . . 0.0 110.857 178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.2 mmpt? -65.6 -21.02 66.54 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 120.541 -1.349 . . . . 0.0 112.084 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -68.88 -30.44 68.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 118.927 0.785 . . . . 0.0 109.093 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.81 -33.87 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.12 29.9 2.24 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.147 0.879 . . . . 0.0 111.239 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 86.8 mt -110.34 157.82 10.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -124.24 144.96 49.66 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 169.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 pt -125.13 -0.52 5.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.958 1.303 . . . . 0.0 110.325 173.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.3 m -58.56 -30.99 67.56 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.212 -1.555 . . . . 0.0 111.432 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -67.61 -2.32 6.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.877 1.671 . . . . 0.0 114.756 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -138.7 52.14 1.81 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 120.261 1.391 . . . . 0.0 110.085 -171.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.9 p -50.43 142.47 10.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.897 0.879 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.5 m -61.49 160.86 10.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.059 1.744 . . . . 0.0 114.915 -169.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -156.22 158.6 37.85 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.191 1.397 . . . . 0.0 109.712 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.49 166.69 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 124.214 1.006 . . . . 0.0 109.224 169.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.1 mt -56.9 143.66 10.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.625 0.77 . . . . 0.0 108.977 178.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.78 140.71 42.72 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.482 1.113 . . . . 0.0 109.855 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.57 -30.66 61.21 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.081 1.352 . . . . 0.0 113.166 -175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.78 -11.01 60.53 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 124.289 1.036 . . . . 0.0 112.094 -173.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.4 mt -121.32 -43.86 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -56.97 -40.31 76.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 120.093 1.315 . . . . 0.0 112.289 -173.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 4.69 51.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.886 0.875 . . . . 0.0 112.589 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -125.1 -26.99 3.59 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.815 1.246 . . . . 0.0 112.741 -168.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 131.79 52.0 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.738 1.215 . . . . 0.0 109.26 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -67.3 -25.09 65.86 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.356 0.662 . . . . 0.0 110.741 174.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.5 tp -147.91 140.29 24.41 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.866 1.267 . . . . 0.0 108.34 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -117.49 147.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 169.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.4 t -134.91 127.73 49.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.2 p -98.66 132.02 44.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -102.88 10.3 38.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 122.944 0.498 . . . . 0.0 110.236 -176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 87' ' ' ASP . 10.5 p -63.79 126.7 28.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.308 1.043 . . . . 0.0 110.954 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.39 -3.78 0.14 Allowed Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.007 171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -74.76 153.74 38.66 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.51 1.655 . . . . 0.0 109.595 169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.1 -20.31 62.48 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.971 1.308 . . . . 0.0 113.801 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.72 8.63 19.01 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.155 0.889 . . . . 0.0 112.489 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 82' ' ' CYS . 39.4 m-20 -67.94 110.48 3.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 169.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mppt? -60.23 -22.67 63.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.959 -1.02 . . . . 0.0 112.045 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 99.6 m 61.23 106.48 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 127.306 2.243 . . . . 0.0 111.201 -169.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -51.92 139.61 50.34 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.996 2.464 . . . . 0.0 112.227 173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.5 mtt -75.04 153.21 38.54 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.665 0.786 . . . . 0.0 109.488 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 p -133.71 159.14 73.65 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.164 1.785 . . . . 0.0 109.746 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.56 139.81 38.29 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 121.793 1.662 . . . . 0.0 109.62 172.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -72.23 -20.34 24.78 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.887 2.391 . . . . 0.0 112.046 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -67.67 -20.04 65.26 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.561 1.144 . . . . 0.0 112.258 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 51.0 t -107.75 143.39 18.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 CA-C-N 118.677 0.671 . . . . 0.0 109.226 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -61.69 137.09 58.22 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -131.83 150.37 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.68 0.792 . . . . 0.0 109.582 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -129.03 163.13 26.06 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.385 1.474 . . . . 0.0 108.274 169.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.4 t60 -132.58 112.73 12.31 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -120.97 58.22 0.96 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.777 1.631 . . . . 0.0 106.862 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -73.06 132.48 17.01 Favored Glycine 0 CA--C 1.524 0.655 0 O-C-N 121.065 -1.022 . . . . 0.0 113.089 -171.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.8 156.6 31.79 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.919 2.088 . . . . 0.0 106.388 169.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -60.21 148.19 37.31 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.816 1.246 . . . . 0.0 110.836 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -76.39 128.54 82.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.501 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.26 -24.61 72.12 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.48 1.453 . . . . 0.0 113.693 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.68 -17.4 64.58 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 119.173 0.897 . . . . 0.0 112.434 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -105.02 2.37 29.5 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.567 1.147 . . . . 0.0 111.266 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 45.66 0.33 Allowed 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.507 1.523 . . . . 0.0 111.579 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.38 153.19 12.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.847 1.259 . . . . 0.0 112.228 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 157.61 -53.71 0.39 Allowed Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.72 -2.552 . . . . 0.0 106.72 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.0 t -167.01 165.41 15.81 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.54 1.936 . . . . 0.0 107.044 169.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.54 -28.02 66.72 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.487 0.715 . . . . 0.0 111.242 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -69.91 -39.52 76.14 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.282 0.492 . . . . 0.0 110.694 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -68.13 -44.33 76.33 Favored 'General case' 0 N--CA 1.457 -0.118 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -55.81 -52.58 63.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.199 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.7 t-105 -58.2 -40.33 81.31 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.722 0.809 . . . . 0.0 111.675 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.88 -36.93 83.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.833 -0.542 . . . . 0.0 111.015 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -70.2 -34.97 73.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.666 -0.646 . . . . 0.0 111.468 175.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -59.45 -54.41 46.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.968 0.804 . . . . 0.0 109.973 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.9 -29.51 69.41 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.623 0.647 . . . . 0.0 111.755 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 36.8 mtp180 -63.27 -54.83 31.04 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.533 1.06 . . . . 0.0 111.259 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 60.9 t -63.66 -38.25 81.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.2 ttp180 -52.82 -57.3 10.64 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.135 0.974 . . . . 0.0 109.935 172.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -65.92 -41.21 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.279 0.232 . . . . 0.0 111.234 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -66.96 -39.94 87.37 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.307 0.643 . . . . 0.0 110.74 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.9 mt -58.74 -51.09 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 170.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.36 71.08 Favored Glycine 0 C--N 1.337 0.613 0 C-N-CA 123.563 0.602 . . . . 0.0 111.777 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -59.91 -51.38 69.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 117.587 0.694 . . . . 0.0 110.34 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.7 tpp85 -70.74 -29.35 65.57 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.954 -175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.12 -41.44 90.54 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 119.638 1.108 . . . . 0.0 110.199 172.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -57.15 -52.5 65.06 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.57 -35.25 80.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.059 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -61.93 -37.32 84.25 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.211 -0.93 . . . . 0.0 111.179 175.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.13 -36.18 30.63 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 122.633 0.373 . . . . 0.0 111.501 -177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.71 -40.16 10.38 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.701 1.201 . . . . 0.0 111.896 -169.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 29.8 p -116.53 -19.16 10.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.338 1.055 . . . . 0.0 111.522 -169.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.78 13.22 81.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.362 0.982 . . . . 0.0 112.76 -179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.248 0.974 0 CA-C-N 118.625 1.213 . . . . 0.0 110.037 -175.771 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.4 mmm . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -151.52 173.72 14.26 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.146 1.378 . . . . 0.0 108.638 176.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -142.2 134.94 28.39 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -83.09 -175.33 5.78 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.073 0.549 . . . . 0.0 110.269 -176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -146.42 144.9 20.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 tt -149.18 152.87 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 119.175 0.898 . . . . 0.0 109.182 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.04 137.5 39.44 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.919 0.888 . . . . 0.0 109.151 -174.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.58 125.09 45.92 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.81 1.244 . . . . 0.0 107.699 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.2 mp -121.45 140.97 51.47 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.923 1.289 . . . . 0.0 109.721 -169.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 60.6 m -140.91 170.41 15.79 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 122.318 1.056 . . . . 0.0 112.042 178.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.6 p -76.08 35.23 0.13 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.707 2.003 . . . . 0.0 110.607 169.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.68 110.59 0.74 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 126.721 2.105 . . . . 0.0 108.601 -173.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -75.67 56.33 0.91 Allowed 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.574 1.15 . . . . 0.0 111.685 -177.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.3 m -129.91 -18.02 3.46 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.2 m -137.1 -87.78 0.29 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 118.993 0.815 . . . . 0.0 109.187 -170.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -57.16 -53.88 53.04 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.799 0.84 . . . . 0.0 111.137 -170.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 12.2 p -67.2 -35.4 79.55 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.447 0.567 . . . . 0.0 111.536 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -60.53 -55.72 30.01 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.161 0.985 . . . . 0.0 110.345 176.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.6 mtm -57.66 -43.98 85.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.505 0.722 . . . . 0.0 111.253 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.29 -45.02 96.22 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.569 0.622 . . . . 0.0 111.45 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -57.09 -40.55 77.19 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 122.565 0.346 . . . . 0.0 110.663 174.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.22 -50.39 67.63 Favored Glycine 0 C--N 1.339 0.732 0 C-N-CA 123.738 0.685 . . . . 0.0 112.084 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -62.22 -45.07 95.01 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 117.504 0.652 . . . . 0.0 110.579 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.63 97.09 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.474 0.71 . . . . 0.0 110.474 -176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -54.68 -36.11 64.3 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 118.798 0.726 . . . . 0.0 111.45 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -70.72 -62.21 1.47 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.052 0.387 . . . . 0.0 110.789 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -67.11 -38.74 86.17 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -169.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 71.6 mt -75.65 0.88 16.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.082 0.953 . . . . 0.0 112.232 177.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.19 22.07 64.73 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.245 1.403 . . . . 0.0 113.567 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.4 t70 55.47 13.73 1.0 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.758 2.023 . . . . 0.0 113.39 -169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -76.42 1.95 14.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.244 1.418 . . . . 0.0 111.284 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 14.8 m95 -129.49 128.89 43.79 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -67.44 89.35 0.22 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.65 143.17 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -146.96 163.08 37.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.074 1.35 . . . . 0.0 108.918 172.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.429 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 79.9 p -141.17 156.07 45.99 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 123.619 0.768 . . . . 0.0 109.047 169.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.91 -169.3 2.48 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.325 1.05 . . . . 0.0 110.281 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -176.41 -178.49 46.22 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.9 mt -57.47 -27.62 29.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.765 1.226 . . . . 0.0 110.899 172.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -147.04 166.89 25.48 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.803 1.241 . . . . 0.0 108.124 173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.75 134.08 21.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -134.96 24.48 3.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.308 1.043 . . . . 0.0 109.151 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.05 168.34 39.16 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -175.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.97 148.1 27.09 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.026 0.53 . . . . 0.0 110.53 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 -74.37 133.67 77.42 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 118.117 -0.944 . . . . 0.0 109.129 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.94 -33.61 42.66 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.868 2.379 . . . . 0.0 114.589 173.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -72.46 -28.92 63.22 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.254 -0.903 . . . . 0.0 110.853 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.78 -46.39 85.43 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 171.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -58.17 -49.37 81.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.75 -43.47 90.31 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-O 118.235 -0.888 . . . . 0.0 111.113 177.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.62 -44.19 93.53 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 119.06 0.846 . . . . 0.0 110.033 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 71.8 mmm -70.99 -38.21 72.7 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 117.717 0.235 . . . . 0.0 111.469 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -63.79 -24.99 67.98 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 120.794 -1.191 . . . . 0.0 111.393 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -69.55 -14.6 62.94 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.778 0.831 . . . . 0.0 110.866 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 m -117.4 -2.1 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.237 1.015 . . . . 0.0 112.091 177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.89 32.36 10.05 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.81 161.07 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -129.94 146.12 51.63 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 169.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 pt -127.14 -0.7 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.114 1.366 . . . . 0.0 110.447 174.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -57.95 -31.12 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.388 -1.445 . . . . 0.0 111.267 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -67.7 -4.28 11.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.006 1.723 . . . . 0.0 114.728 176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -137.13 53.73 1.88 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 120.311 1.414 . . . . 0.0 109.678 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.9 p -50.16 144.2 7.37 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.274 1.03 . . . . 0.0 112.345 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.4 m -64.21 161.36 16.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.132 1.773 . . . . 0.0 114.533 -169.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -156.9 157.67 35.29 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.471 1.508 . . . . 0.0 109.7 170.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.434 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.18 165.35 2.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 123.756 0.822 . . . . 0.0 109.492 170.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 74.4 mt -56.86 145.98 6.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.804 1.242 . . . . 0.0 110.128 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -139.4 134.61 32.66 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.661 1.184 . . . . 0.0 109.944 174.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.41 -28.42 53.99 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.396 1.478 . . . . 0.0 113.323 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.92 -11.42 60.86 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.782 1.233 . . . . 0.0 112.201 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.7 mt -113.62 -41.88 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 175.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.7 mt -47.95 -59.08 3.62 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.703 1.138 . . . . 0.0 111.645 177.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.08 -0.26 30.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -174.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -117.76 -30.74 5.35 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.061 1.344 . . . . 0.0 112.066 -168.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.71 131.58 51.17 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.294 1.438 . . . . 0.0 109.858 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -65.36 -26.06 67.85 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.778 0.431 . . . . 0.0 110.791 174.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.9 tp -148.49 142.04 25.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.522 1.129 . . . . 0.0 108.443 174.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.58 144.14 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.1 t -131.35 126.46 58.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 p -100.3 135.18 42.12 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 169.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.42 20.68 17.5 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.474 0.71 . . . . 0.0 109.54 -174.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.1 p -68.1 112.93 5.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.928 1.291 . . . . 0.0 110.234 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -160.55 27.06 0.31 Allowed Glycine 0 CA--C 1.533 1.157 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -111.06 -175.58 2.74 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 128.101 2.56 . . . . 0.0 112.525 -169.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -57.07 -32.0 65.8 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.43 -49.24 10.18 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.316 0.646 . . . . 0.0 110.839 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.6 t70 45.57 30.87 0.83 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.571 1.948 . . . . 0.0 114.67 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.28 -21.18 66.27 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 120.436 -1.415 . . . . 0.0 113.045 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 78.2 m 45.41 92.59 0.05 OUTLIER Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.383 2.273 . . . . 0.0 113.549 -175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.14 148.38 9.96 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.9 3.066 . . . . 0.0 114.647 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -63.4 138.45 58.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.551 1.54 . . . . 0.0 110.333 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.0 p -131.6 154.46 81.85 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.146 1.779 . . . . 0.0 109.442 173.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.81 145.21 56.18 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.203 1.936 . . . . 0.0 110.053 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.87 -21.88 13.87 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.107 2.538 . . . . 0.0 112.073 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -85.8 7.7 22.8 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.497 1.119 . . . . 0.0 112.38 -176.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -120.73 144.2 30.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.18 138.48 58.42 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -133.12 150.48 52.05 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.702 0.801 . . . . 0.0 109.767 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -125.44 159.34 32.14 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.557 1.943 . . . . 0.0 107.914 171.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -133.84 111.88 10.85 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.423 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 32.5 m0 -120.93 57.38 0.98 Allowed 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.146 1.778 . . . . 0.0 106.741 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.55 132.61 29.78 Favored Glycine 0 CA--C 1.526 0.721 0 O-C-N 120.915 -1.116 . . . . 0.0 111.998 -175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -159.09 160.18 35.41 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 126.62 1.968 . . . . 0.0 106.106 169.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -68.12 141.85 55.95 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.373 0.606 . . . . 0.0 110.785 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.36 127.28 93.26 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.58 -22.66 44.06 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.082 1.188 . . . . 0.0 113.329 -176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.21 -9.95 59.12 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.495 1.043 . . . . 0.0 112.228 171.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 78.4 mtt180 -111.39 0.69 16.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.051 1.34 . . . . 0.0 110.749 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.72 54.0 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.496 2.319 . . . . 0.0 111.174 170.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.59 144.97 46.12 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.659 1.983 . . . . 0.0 112.003 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.08 -54.97 0.28 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.5 t -165.66 167.0 17.6 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.939 1.696 . . . . 0.0 107.45 169.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.18 -29.98 70.13 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.104 0.562 . . . . 0.0 111.201 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -70.13 -37.43 75.29 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.878 0.471 . . . . 0.0 110.574 176.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -67.23 -46.58 73.35 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -56.56 -48.86 76.42 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.098 0.559 . . . . 0.0 110.359 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 31.3 t-105 -61.23 -37.93 84.8 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.584 0.754 . . . . 0.0 112.001 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.61 80.23 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.242 -0.912 . . . . 0.0 109.909 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -64.97 -33.22 75.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.803 0.441 . . . . 0.0 111.153 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -57.88 -50.31 73.74 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.721 0.809 . . . . 0.0 110.155 173.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -64.77 -35.0 79.67 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.39 0.541 . . . . 0.0 111.584 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -66.29 -51.03 61.46 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.337 0.517 . . . . 0.0 110.662 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.36 -39.96 86.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -53.29 -54.06 41.92 Favored 'General case' 0 C--O 1.227 -0.095 0 C-N-CA 124.321 1.049 . . . . 0.0 109.393 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.53 -44.4 90.97 Favored 'General case' 0 CA--C 1.529 0.145 0 O-C-N 123.206 0.316 . . . . 0.0 111.008 -174.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -66.58 -39.79 88.6 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.647 -0.658 . . . . 0.0 111.216 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 41.0 mt -59.08 -51.05 77.19 Favored 'Isoleucine or valine' 0 C--N 1.338 0.081 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.28 -45.42 64.72 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -60.69 -50.4 73.64 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 117.639 0.719 . . . . 0.0 111.105 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.423 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.4 tpt180 -70.18 -33.18 71.43 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.113 -176.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.51 -40.13 96.26 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.407 1.003 . . . . 0.0 109.976 175.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -57.77 -51.45 69.51 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -64.65 -35.74 82.01 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.267 -177.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -63.67 -36.65 84.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.908 -0.495 . . . . 0.0 111.014 177.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.3 -37.96 27.55 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.568 0.347 . . . . 0.0 111.409 -178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.3 -46.83 8.14 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 110.857 -169.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 21.3 p -108.49 -17.21 14.04 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.164 0.985 . . . . 0.0 111.55 -169.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.36 11.5 80.36 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.238 0.923 . . . . 0.0 112.291 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.472 1.136 . . . . 0.0 108.482 -174.646 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -160.47 173.89 14.9 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.188 1.395 . . . . 0.0 108.892 -170.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -144.43 145.87 32.16 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -73.65 168.86 18.48 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -144.29 139.68 24.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -144.71 150.58 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 123.663 0.785 . . . . 0.0 109.084 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -137.78 137.14 37.93 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.952 0.901 . . . . 0.0 109.002 -173.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -119.51 130.97 55.46 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 72.8 mt -129.02 137.56 51.4 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.468 0.707 . . . . 0.0 111.028 -169.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.5 174.32 10.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.245 1.018 . . . . 0.0 112.221 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.7 p -56.3 -27.51 55.79 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.181 1.392 . . . . 0.0 111.991 172.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.4 142.01 8.27 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 169.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -79.6 58.45 2.73 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.752 0.821 . . . . 0.0 111.083 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -130.6 -18.63 3.11 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -169.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 60.3 m -133.01 -96.99 0.3 Allowed 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 119.071 0.85 . . . . 0.0 108.901 -173.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -54.28 -50.69 66.71 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.149 0.98 . . . . 0.0 111.952 -170.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 p -67.54 -38.57 84.38 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.738 0.699 . . . . 0.0 111.246 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 45.3 mm-40 -58.45 -54.81 42.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.072 0.949 . . . . 0.0 109.989 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.2 mtm -57.57 -44.83 85.6 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.43 0.692 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.92 -43.72 98.27 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 123.165 0.586 . . . . 0.0 111.59 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 29.0 tt0 -57.39 -40.64 78.65 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 118.214 0.461 . . . . 0.0 110.88 174.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.09 -53.47 45.31 Favored Glycine 0 C--N 1.338 0.68 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -60.97 -44.4 97.41 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.956 0.378 . . . . 0.0 111.166 177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.38 -43.82 97.91 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.81 -172.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -59.0 -34.67 72.12 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 119.404 1.002 . . . . 0.0 111.576 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -65.42 -54.89 22.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.199 0.454 . . . . 0.0 110.809 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.3 m-85 -78.17 -45.43 23.19 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -170.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 94.9 mt -72.07 -32.92 67.5 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 123.352 0.661 . . . . 0.0 111.542 -177.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.02 175.31 44.26 Favored Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 -169.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -68.95 -1.93 8.58 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.176 0.99 . . . . 0.0 111.22 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -61.63 -10.18 7.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.863 0.865 . . . . 0.0 110.723 170.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.468 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 18.7 m95 -127.39 124.89 39.63 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.655 1.982 . . . . 0.0 105.906 171.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -75.57 88.15 2.7 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.6 t -77.89 140.04 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -145.09 167.29 23.07 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.215 1.406 . . . . 0.0 109.314 174.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 77.7 p -142.79 155.64 44.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.03 0.932 . . . . 0.0 109.2 169.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.05 -166.55 1.73 Allowed 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.432 1.093 . . . . 0.0 109.257 176.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.78 -178.52 44.72 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -56.75 -28.63 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.028 1.331 . . . . 0.0 111.017 173.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.52 171.02 16.2 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.435 1.494 . . . . 0.0 108.784 175.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.95 137.29 22.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -129.71 10.78 5.62 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.765 1.226 . . . . 0.0 109.919 172.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.37 168.0 27.8 Favored Glycine 0 C--N 1.339 0.705 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 -169.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.7 pt? -84.51 148.55 26.46 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.209 0.528 . . . . 0.0 111.097 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -72.18 136.86 81.66 Favored Pre-proline 0 CA--C 1.534 0.352 0 C-N-CA 124.246 1.018 . . . . 0.0 108.752 -176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.51 -29.09 84.22 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 121.82 1.68 . . . . 0.0 112.891 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -72.83 -26.05 61.34 Favored 'General case' 0 C--O 1.227 -0.089 0 O-C-N 121.097 -1.002 . . . . 0.0 111.013 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.26 -44.07 84.68 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.303 0.956 . . . . 0.0 109.084 170.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.3 t -58.25 -50.23 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -58.3 -41.8 85.26 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 119.117 0.871 . . . . 0.0 111.308 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.39 -45.97 89.99 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.541 0.736 . . . . 0.0 110.346 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 76.9 mmm -74.25 -34.2 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 117.698 0.227 . . . . 0.0 111.111 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.37 -23.18 66.91 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 120.66 -1.275 . . . . 0.0 111.553 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.39 -17.84 64.84 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.127 0.971 . . . . 0.0 110.634 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -120.33 -2.45 8.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.011 0.924 . . . . 0.0 112.6 -178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.86 32.65 9.76 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.95 155.44 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -140.28 82.18 1.85 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 122.153 0.978 . . . . 0.0 109.856 -169.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.9 pt -70.73 0.19 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.921 178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.6 m -58.31 -20.04 39.82 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 119.938 -1.726 . . . . 0.0 112.18 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 -84.18 1.85 42.5 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.237 1.415 . . . . 0.0 112.659 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -133.86 49.92 2.24 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.488 1.04 . . . . 0.0 109.937 -172.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.3 p -46.98 134.09 10.66 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.909 1.284 . . . . 0.0 111.193 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -58.27 157.38 8.55 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 -168.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.71 157.88 38.74 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.227 1.411 . . . . 0.0 109.398 171.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.447 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.35 168.59 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.573 1.149 . . . . 0.0 109.622 170.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.66 142.83 11.58 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -136.26 140.79 43.72 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.395 1.078 . . . . 0.0 109.723 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 m -55.73 -30.66 61.55 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.984 1.314 . . . . 0.0 113.135 -174.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.69 -12.5 61.68 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.254 1.021 . . . . 0.0 111.884 -173.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.7 mt -119.77 -43.22 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.8 pp -57.61 -39.14 76.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.171 1.351 . . . . 0.0 112.193 -173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.87 6.49 48.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.864 0.866 . . . . 0.0 112.577 -177.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -126.9 -29.39 2.83 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.717 1.207 . . . . 0.0 112.499 -168.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.64 125.48 23.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.88 1.272 . . . . 0.0 109.49 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.48 -26.53 67.23 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.594 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.5 tp -141.61 137.25 31.75 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.957 1.303 . . . . 0.0 107.784 174.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.19 146.13 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.34 129.63 56.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -101.04 131.68 46.82 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 170.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.2 mp -103.62 16.22 26.95 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.297 0.639 . . . . 0.0 109.99 -172.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 15.5 p -69.24 109.39 4.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.675 1.59 . . . . 0.0 111.022 -176.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -156.4 31.36 0.58 Allowed Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -111.7 -177.64 3.24 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 128.704 2.801 . . . . 0.0 113.414 -169.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.04 -11.61 30.93 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -175.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -121.64 -37.92 2.83 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 119.638 1.108 . . . . 0.0 111.447 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . 0.261 2.3 p-10 36.76 47.66 0.58 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 128.385 2.674 . . . . 0.0 114.789 170.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.57 -13.71 62.3 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 118.269 -0.872 . . . . 0.0 113.121 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.9 m 44.63 88.56 0.1 Allowed Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.896 2.479 . . . . 0.0 113.687 177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -47.9 148.41 6.48 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 124.611 3.541 . . . . 0.0 115.01 -178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 16.3 tmm? -62.26 139.17 58.51 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.626 1.57 . . . . 0.0 110.248 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -129.55 153.27 80.66 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 126.382 1.873 . . . . 0.0 108.677 171.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.95 162.86 39.94 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 121.408 1.405 . . . . 0.0 109.821 172.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.62 -22.76 10.32 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.523 2.149 . . . . 0.0 112.724 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -87.01 -21.43 26.13 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.0 m -77.61 154.46 5.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 119.439 1.018 . . . . 0.0 109.649 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -71.07 140.44 50.69 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -123.83 154.53 39.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 173.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -137.3 164.56 28.28 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.784 1.634 . . . . 0.0 107.568 169.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -131.68 113.78 13.99 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 -174.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 19.4 m0 -120.74 53.64 1.11 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.667 1.587 . . . . 0.0 106.771 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.59 128.1 29.42 Favored Glycine 0 CA--C 1.527 0.816 0 O-C-N 121.149 -0.969 . . . . 0.0 111.823 -176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -155.7 161.43 40.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 169.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.77 142.01 49.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.111 0.482 . . . . 0.0 110.895 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -67.0 124.46 88.84 Favored Pre-proline 0 C--O 1.236 0.357 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -65.84 -22.29 56.6 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.193 1.262 . . . . 0.0 113.163 -175.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.81 60.33 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.388 0.995 . . . . 0.0 112.5 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.5 mtm-85 -115.22 12.38 16.49 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.85 1.26 . . . . 0.0 111.537 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.34 66.34 0.93 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.12 1.368 . . . . 0.0 109.694 169.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -57.1 138.01 55.04 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.063 0.945 . . . . 0.0 110.766 -169.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.08 -61.44 0.2 Allowed Glycine 0 CA--C 1.524 0.606 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 172.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.6 t -166.67 168.87 14.05 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.764 1.625 . . . . 0.0 107.433 173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.88 -30.21 70.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.018 0.527 . . . . 0.0 111.416 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -70.39 -37.78 74.56 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.797 0.439 . . . . 0.0 110.651 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.7 -45.89 77.31 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 176.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -59.0 -45.86 89.61 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 123.01 0.524 . . . . 0.0 110.601 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 28.9 t-105 -60.84 -39.48 89.22 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 118.868 0.758 . . . . 0.0 111.628 177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.03 85.99 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 121.213 -0.929 . . . . 0.0 110.393 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -65.98 -34.76 78.83 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.795 0.438 . . . . 0.0 111.192 176.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -58.41 -46.84 85.64 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.015 0.926 . . . . 0.0 110.2 172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -65.73 -36.25 83.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.4 0.546 . . . . 0.0 111.284 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.4 mmp_? -68.14 -45.09 74.54 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 119.908 1.231 . . . . 0.0 111.453 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.52 -42.87 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 118.971 0.805 . . . . 0.0 109.449 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.82 -39.46 94.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 120.021 1.282 . . . . 0.0 110.13 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -68.47 -42.39 78.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.405 0.282 . . . . 0.0 111.611 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -67.81 -41.12 83.6 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 122.04 -0.413 . . . . 0.0 110.745 178.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.77 -52.75 56.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.123 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -51.98 -46.77 55.36 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.577 0.626 . . . . 0.0 111.757 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -61.16 -49.69 76.2 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.561 0.681 . . . . 0.0 110.966 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -69.8 -30.92 68.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 121.784 -0.573 . . . . 0.0 110.438 -176.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -41.9 82.49 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.343 0.974 . . . . 0.0 109.855 175.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -56.95 -52.27 65.87 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -69.33 -31.28 69.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 119.165 -0.445 . . . . 0.0 111.455 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -63.01 -37.9 89.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.4 1.0 . . . . 0.0 111.016 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.96 -39.28 51.12 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.788 0.435 . . . . 0.0 111.084 -178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -90.38 -40.84 11.83 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.788 0.835 . . . . 0.0 111.736 -169.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 19.2 p -117.61 -19.06 9.54 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.965 0.906 . . . . 0.0 111.929 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.82 10.02 83.69 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 118.774 -1.014 . . . . 0.0 112.841 -175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 119.058 1.429 . . . . 0.0 108.889 -175.088 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.256 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 118.946 -0.549 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -152.79 157.65 41.1 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -144.1 137.08 27.28 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 176.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.34 175.66 6.7 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.5 144.57 24.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 174.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.91 151.59 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 119.511 1.05 . . . . 0.0 109.024 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -138.15 129.51 27.63 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 123.568 0.747 . . . . 0.0 109.466 -171.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -112.15 130.63 55.84 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.495 1.118 . . . . 0.0 108.877 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.3 mt -131.91 136.58 47.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.491 0.716 . . . . 0.0 111.023 -169.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.7 p -146.51 -175.39 4.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 117.948 0.34 . . . . 0.0 111.155 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.9 p -62.76 -19.11 63.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.194 0.998 . . . . 0.0 112.462 -170.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -156.93 143.01 9.16 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.378 -2.289 . . . . 0.0 107.378 169.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.48 51.19 1.21 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 118.312 1.056 . . . . 0.0 111.843 -173.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -128.2 -9.98 5.29 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -168.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.4 p -140.23 -101.98 0.15 Allowed 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.79 0.723 . . . . 0.0 110.207 -169.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -51.43 -47.63 62.95 Favored 'General case' 0 N--CA 1.461 0.115 0 C-N-CA 125.821 1.648 . . . . 0.0 110.689 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 40.7 p -66.95 -43.07 84.11 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 123.133 0.271 . . . . 0.0 110.674 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -62.15 -49.28 76.49 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.641 1.176 . . . . 0.0 110.814 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.5 mtm -61.42 -42.53 98.89 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.089 0.556 . . . . 0.0 110.65 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.34 -44.73 94.06 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-O 118.646 -0.693 . . . . 0.0 111.164 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.54 -44.73 73.09 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.454 0.57 . . . . 0.0 110.506 171.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.83 -51.85 55.64 Favored Glycine 0 C--N 1.334 0.455 0 CA-C-O 119.339 -0.701 . . . . 0.0 111.526 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -62.95 -46.0 89.81 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.447 0.623 . . . . 0.0 111.023 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.75 -45.49 94.09 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.564 0.745 . . . . 0.0 110.657 -173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -57.23 -35.42 69.66 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 118.857 -0.592 . . . . 0.0 110.937 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.6 mm-40 -68.81 -61.88 1.62 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.169 0.441 . . . . 0.0 110.723 175.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -64.53 -41.02 96.64 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.409 0.283 . . . . 0.0 111.426 -169.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 85.8 mt -79.14 -1.82 37.85 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.286 1.035 . . . . 0.0 112.123 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 57.6 24.5 53.04 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.149 1.357 . . . . 0.0 113.998 173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.3 t70 55.8 9.44 0.44 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.412 2.285 . . . . 0.0 113.972 -170.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -66.05 -5.99 11.53 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.69 1.196 . . . . 0.0 110.515 169.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -130.41 115.6 17.09 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 102.613 -3.106 . . . . 0.0 102.613 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -68.7 88.55 0.36 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.171 1.388 . . . . 0.0 107.466 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -74.04 154.82 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -150.62 164.69 35.45 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 126.705 2.002 . . . . 0.0 107.438 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.9 p -141.21 154.29 45.73 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 169.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.48 -169.45 2.75 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 110.365 175.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -171.76 -179.5 42.79 Favored Glycine 0 N--CA 1.447 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.393 175.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.9 -27.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.33 1.452 . . . . 0.0 111.416 174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -145.72 170.85 15.68 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.912 1.285 . . . . 0.0 108.43 172.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.94 136.36 16.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -139.12 19.1 2.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.611 1.164 . . . . 0.0 110.093 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.54 -176.8 20.35 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.4 pt? -110.42 144.23 39.52 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.049 0.94 . . . . 0.0 109.797 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 -70.51 134.5 86.56 Favored Pre-proline 0 CA--C 1.536 0.411 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.024 -169.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.2 -33.55 44.92 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.06 2.507 . . . . 0.0 114.83 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -78.09 -28.55 48.75 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 119.151 0.887 . . . . 0.0 110.504 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.99 -49.66 75.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -56.39 -52.13 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -60.98 -38.77 87.15 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 118.908 0.776 . . . . 0.0 111.397 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.57 -46.7 87.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.918 0.487 . . . . 0.0 109.825 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.4 mmm -68.22 -36.57 79.72 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.209 0.459 . . . . 0.0 111.028 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -63.57 -26.37 68.67 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 120.673 -1.267 . . . . 0.0 111.188 175.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -69.55 -16.57 63.45 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.69 0.677 . . . . 0.0 111.095 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.16 -1.07 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 123.715 0.806 . . . . 0.0 112.07 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.46 31.75 11.2 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 174.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.8 mt -123.34 154.92 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -142.64 76.04 1.51 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.596 1.189 . . . . 0.0 110.371 -169.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.4 pt -58.65 -15.12 5.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.28 1.032 . . . . 0.0 113.339 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.74 -24.84 24.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.62 1.1 . . . . 0.0 111.967 172.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -57.37 -21.03 33.05 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.114 1.153 . . . . 0.0 114.114 176.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.79 -21.86 9.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 119.875 1.216 . . . . 0.0 114.005 -169.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.0 p 49.01 -164.71 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.359 1.064 . . . . 0.0 111.553 -169.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 m -129.69 156.19 44.66 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.138 -0.976 . . . . 0.0 111.579 -169.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -155.91 156.11 34.03 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.574 1.15 . . . . 0.0 109.788 177.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.445 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.87 164.54 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 171.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 67.7 mt -57.35 147.38 5.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 125.084 1.354 . . . . 0.0 110.198 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -140.39 136.76 33.45 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 124.441 1.097 . . . . 0.0 110.051 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -53.86 -29.67 42.29 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.553 1.541 . . . . 0.0 113.074 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -69.78 -8.74 50.71 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.192 1.397 . . . . 0.0 112.257 -175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 11.4 mt -117.29 -42.49 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 41.5 mt -47.53 -56.9 6.14 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.693 1.133 . . . . 0.0 112.195 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.87 0.88 51.91 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.649 0.78 . . . . 0.0 112.813 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -117.89 -31.22 5.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.06 1.344 . . . . 0.0 111.745 -169.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.81 131.31 49.97 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.206 1.402 . . . . 0.0 109.02 173.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 26.4 t70 -60.43 -32.15 71.08 Favored 'General case' 0 C--N 1.333 -0.115 0 C-N-CA 122.668 0.387 . . . . 0.0 109.969 170.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.6 tp -144.34 139.58 28.59 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.323 1.049 . . . . 0.0 109.141 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.61 146.05 19.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 169.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.8 t -133.36 121.65 42.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -98.58 135.19 40.46 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.85 18.67 19.33 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.269 1.027 . . . . 0.0 109.844 -173.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 10.2 p -70.33 117.23 11.62 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.798 1.239 . . . . 0.0 110.006 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -161.7 19.68 0.19 Allowed Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.861 1.219 . . . . 0.0 111.047 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -88.83 -176.47 5.23 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 129.718 3.207 . . . . 0.0 110.672 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.77 -23.14 59.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.1 -41.75 13.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.217 0.917 . . . . 0.0 109.741 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.8 t70 47.99 40.51 13.3 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.009 2.124 . . . . 0.0 113.406 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -68.69 -12.38 61.34 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.806 -1.092 . . . . 0.0 113.21 -173.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 89.8 m 35.96 88.51 0.09 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 128.202 2.601 . . . . 0.0 113.821 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -46.96 140.39 13.43 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.959 3.106 . . . . 0.0 113.877 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -61.82 138.45 58.34 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 110.235 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 45.0 p -125.96 153.37 73.73 Favored Pre-proline 0 N--CA 1.448 -0.533 0 C-N-CA 126.206 1.802 . . . . 0.0 108.768 169.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -66.67 153.59 77.44 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 121.776 1.651 . . . . 0.0 109.301 170.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.8 -23.51 22.37 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.407 2.071 . . . . 0.0 111.937 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -76.81 -25.96 53.88 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.737 0.815 . . . . 0.0 112.65 -172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -80.27 144.39 10.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 CA-C-N 118.855 0.752 . . . . 0.0 109.437 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 76' ' ' ASP . 38.3 ttpt -65.31 136.24 56.32 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 169.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -135.94 151.31 49.82 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.145 0.578 . . . . 0.0 110.455 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -126.55 159.42 33.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.028 2.131 . . . . 0.0 107.809 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -135.98 111.32 9.1 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 36.6 m0 -121.47 62.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.199 1.8 . . . . 0.0 106.661 -174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -71.99 134.06 21.31 Favored Glycine 0 CA--C 1.525 0.667 0 O-C-N 121.252 -0.905 . . . . 0.0 112.224 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.21 161.05 39.26 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 126.966 2.107 . . . . 0.0 106.168 169.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -66.89 148.53 51.82 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 121.759 0.79 . . . . 0.0 110.667 -175.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -71.76 120.88 82.56 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.811 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -63.13 -27.22 73.06 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.328 1.352 . . . . 0.0 112.868 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -6.4 41.9 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.742 0.701 . . . . 0.0 112.589 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.0 ttp85 -119.35 0.44 11.12 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.885 1.674 . . . . 0.0 109.846 -174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.21 93.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.279 1.432 . . . . 0.0 109.957 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -57.19 124.93 20.51 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.301 1.04 . . . . 0.0 109.6 -177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.46 -74.93 0.12 Allowed Glycine 0 CA--C 1.523 0.584 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.9 t -167.36 168.89 12.8 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.602 1.561 . . . . 0.0 107.52 178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.59 -30.47 69.84 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.881 -0.512 . . . . 0.0 111.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.27 -38.63 78.47 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.647 0.379 . . . . 0.0 110.453 175.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -70.96 -38.52 72.8 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.683 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -59.51 -47.73 84.4 Favored 'General case' 0 C--O 1.227 -0.098 0 CA-C-N 119.34 0.973 . . . . 0.0 110.45 172.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 18.0 t-105 -58.64 -39.72 81.38 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.254 0.622 . . . . 0.0 111.189 176.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -38.64 78.27 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.639 -0.663 . . . . 0.0 111.03 177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.76 -35.15 79.91 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 175.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -59.78 -52.93 63.34 Favored 'General case' 0 CA--C 1.52 -0.18 0 C-N-CA 123.701 0.8 . . . . 0.0 110.722 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -66.51 -30.61 70.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.728 0.695 . . . . 0.0 112.02 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -63.41 -53.92 44.78 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 119.431 1.014 . . . . 0.0 110.346 171.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.88 -37.59 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.528 0.603 . . . . 0.0 109.501 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 17.4 ttp180 -55.17 -54.15 46.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 123.786 0.834 . . . . 0.0 109.423 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -63.25 -43.05 99.1 Favored 'General case' 0 CA--C 1.529 0.15 0 O-C-N 123.256 0.347 . . . . 0.0 110.806 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.27 -40.45 90.11 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.766 -0.584 . . . . 0.0 111.314 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 46.3 mt -59.54 -50.93 78.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 173.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.23 -46.23 57.12 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 111.546 -0.621 . . . . 0.0 111.546 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -60.02 -50.08 75.14 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 117.724 0.762 . . . . 0.0 111.003 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -69.83 -30.29 67.76 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 117.427 -1.273 . . . . 0.0 111.496 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -39.7 81.35 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 119.588 1.085 . . . . 0.0 110.178 175.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -56.36 -50.08 72.55 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -64.31 -37.79 88.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 118.24 0.473 . . . . 0.0 111.496 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -61.37 -35.71 78.21 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.11 -0.994 . . . . 0.0 111.753 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -82.11 -35.99 28.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 122.702 0.401 . . . . 0.0 111.358 -178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -91.72 -41.9 10.44 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.014 1.326 . . . . 0.0 111.682 -169.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 30.9 p -115.15 -20.33 10.46 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.621 1.168 . . . . 0.0 111.579 -169.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 84.32 9.83 81.18 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.395 0.998 . . . . 0.0 112.768 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt . . . . . 0 C--O 1.247 0.939 0 CA-C-N 118.407 1.103 . . . . 0.0 109.573 -176.198 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.5 mtp . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -149.9 154.02 37.63 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 125.276 1.43 . . . . 0.0 107.396 178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -145.1 134.37 22.9 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 170.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -82.79 -176.63 6.39 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 122.683 0.393 . . . . 0.0 110.019 -177.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -144.19 143.04 23.83 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 tt -145.85 151.07 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.934 0.894 . . . . 0.0 109.087 178.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.91 138.02 38.61 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 123.877 0.871 . . . . 0.0 108.974 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -119.6 127.58 53.09 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 mp -123.38 143.81 49.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.857 1.263 . . . . 0.0 109.976 -169.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 62.1 m -142.12 176.53 8.89 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.374 1.07 . . . . 0.0 112.11 175.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.7 p -65.26 -18.24 65.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.623 1.169 . . . . 0.0 111.891 169.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -162.1 136.08 4.2 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 169.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -80.54 55.85 2.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.08 0.952 . . . . 0.0 111.684 -173.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 67.3 m -125.74 -18.43 5.17 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -169.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.7 m -137.85 -88.39 0.26 Allowed 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 119.152 0.887 . . . . 0.0 109.563 -172.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -56.62 -53.93 51.91 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.711 0.805 . . . . 0.0 111.18 -169.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.4 p -67.23 -35.45 79.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.083 0.401 . . . . 0.0 111.248 -174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -61.03 -54.7 41.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.177 0.991 . . . . 0.0 110.103 175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 59.0 mtm -57.81 -41.88 83.11 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.465 0.706 . . . . 0.0 111.366 177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.25 -45.01 95.21 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.444 0.565 . . . . 0.0 111.735 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.497 ' HG3' HG12 ' A' ' 34' ' ' VAL . 58.7 tt0 -55.37 -41.37 72.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.639 0.375 . . . . 0.0 110.784 173.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -49.89 73.62 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 119.507 -0.607 . . . . 0.0 112.337 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -62.64 -43.79 97.91 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 117.737 0.769 . . . . 0.0 110.93 177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.62 -42.68 99.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.521 -174.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -51.79 -38.54 56.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.824 0.738 . . . . 0.0 111.807 174.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -69.52 -62.2 1.48 Allowed 'General case' 0 C--O 1.232 0.161 0 O-C-N 123.206 0.316 . . . . 0.0 110.419 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -68.9 -40.32 79.24 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -169.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.99 -6.47 54.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.759 0.824 . . . . 0.0 112.23 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.06 24.36 58.34 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.822 1.201 . . . . 0.0 114.157 172.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.8 t70 57.87 9.93 1.01 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 127.307 2.243 . . . . 0.0 113.953 -171.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -66.26 -5.67 11.22 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.021 1.328 . . . . 0.0 110.737 169.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -128.99 124.53 35.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 103.511 -2.774 . . . . 0.0 103.511 173.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HA ' ' HE2' ' A' ' 33' ' ' LYS . 10.2 mmpt? -66.33 100.94 0.68 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 172.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.0 t -85.4 139.29 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -174.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -146.39 165.83 28.17 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.194 1.398 . . . . 0.0 109.294 175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 85.8 p -144.02 157.44 44.33 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.593 0.757 . . . . 0.0 110.064 169.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.68 -167.31 1.67 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.85 1.26 . . . . 0.0 110.291 -178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.93 -174.45 45.82 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 174.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.93 -30.4 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 124.998 1.319 . . . . 0.0 111.009 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -148.32 168.86 21.46 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.157 1.383 . . . . 0.0 108.569 178.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.54 138.68 26.22 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.73 11.21 5.66 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.64 1.176 . . . . 0.0 110.056 174.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.4 163.84 33.17 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -170.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.74 148.55 30.05 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 121.371 0.605 . . . . 0.0 110.824 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.16 136.24 79.28 Favored Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.003 0.921 . . . . 0.0 109.761 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -51.99 -36.03 63.2 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 122.705 2.27 . . . . 0.0 113.893 174.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -72.44 -30.3 64.48 Favored 'General case' 0 C--O 1.225 -0.208 0 O-C-N 121.621 -0.675 . . . . 0.0 110.547 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.41 -45.55 90.48 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 25.6 t -59.05 -49.04 84.71 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 173.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 -38.98 81.42 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.274 0.943 . . . . 0.0 111.009 -178.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.92 -46.48 84.61 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.369 0.668 . . . . 0.0 109.934 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.6 mmm -68.5 -36.53 79.03 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 118.372 0.533 . . . . 0.0 111.021 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.1 mmtp -65.81 -25.14 67.1 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.905 -1.122 . . . . 0.0 111.18 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -68.83 -17.37 63.99 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.265 0.626 . . . . 0.0 110.969 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.7 m -113.92 0.33 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.646 0.778 . . . . 0.0 111.921 177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.98 32.28 18.14 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 174.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.4 159.74 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -124.66 144.42 50.21 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.3 pt -128.6 3.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.856 1.262 . . . . 0.0 110.226 170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.04 -28.76 68.03 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.129 -1.607 . . . . 0.0 111.119 171.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -64.63 -4.61 4.33 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.586 1.955 . . . . 0.0 115.17 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -137.92 49.7 1.95 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 120.294 1.406 . . . . 0.0 110.815 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.6 p -46.05 131.85 9.73 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.271 1.029 . . . . 0.0 110.723 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.1 m -55.71 155.88 5.41 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 126.185 1.794 . . . . 0.0 115.698 -168.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -153.92 158.04 40.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.319 1.448 . . . . 0.0 109.211 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.448 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -71.5 168.7 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 169.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 76.7 mt -56.39 142.86 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 123.627 0.771 . . . . 0.0 109.141 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.23 135.71 47.6 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.091 1.356 . . . . 0.0 109.454 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -56.39 -31.27 63.7 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.022 1.329 . . . . 0.0 113.267 -173.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -81.36 -5.15 57.55 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 121.853 -0.529 . . . . 0.0 111.749 -170.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 26.5 mt -111.39 -44.0 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 173.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.77 -39.88 86.37 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.846 1.203 . . . . 0.0 111.523 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.52 3.14 41.78 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.91 0.708 . . . . 0.0 112.91 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -126.62 -27.0 3.17 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.999 0.92 . . . . 0.0 112.997 -168.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -64.88 123.91 20.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.513 1.125 . . . . 0.0 109.757 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.68 -28.43 69.9 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 122.907 0.483 . . . . 0.0 110.775 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.9 tp -141.22 140.35 33.95 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -118.75 144.04 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 124.28 55.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.94 127.4 48.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -102.54 22.89 12.76 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.667 0.746 . . . . 0.0 109.343 -174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 26.6 p -75.94 107.26 8.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.468 1.507 . . . . 0.0 110.482 -172.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -153.82 20.25 0.68 Allowed Glycine 0 CA--C 1.536 1.35 0 C-N-CA 125.066 1.317 . . . . 0.0 109.992 170.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -86.05 175.32 8.63 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 129.52 3.128 . . . . 0.0 112.083 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.84 65.35 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 -175.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.82 -50.2 8.33 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.181 0.901 . . . . 0.0 109.258 176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.9 t70 44.73 34.33 1.15 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.808 2.043 . . . . 0.0 113.377 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.0 mtpt -62.73 -27.34 69.2 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 120.702 -1.248 . . . . 0.0 111.392 174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 2.7 t 41.53 110.65 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 131.279 3.832 . . . . 0.0 115.725 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -57.58 143.79 93.94 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.531 2.154 . . . . 0.0 111.781 -178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 77.7 mtm -72.94 157.6 37.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.379 0.672 . . . . 0.0 109.494 170.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -129.98 162.31 54.5 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 126.893 2.077 . . . . 0.0 108.363 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.32 161.46 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 121.047 1.165 . . . . 0.0 109.503 174.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.13 -23.38 13.64 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.453 2.102 . . . . 0.0 111.985 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -75.48 -31.01 60.07 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 123.54 0.736 . . . . 0.0 112.63 -169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.0 m -81.21 152.04 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.753 0.787 . . . . 0.0 110.757 -173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -71.36 143.52 50.18 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -135.98 149.4 48.85 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.746 0.418 . . . . 0.0 110.541 -178.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.69 157.82 38.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.816 2.047 . . . . 0.0 107.728 171.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -133.98 112.75 11.49 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -122.17 56.45 1.1 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.121 1.769 . . . . 0.0 107.216 -173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -68.09 125.2 21.33 Favored Glycine 0 CA--C 1.527 0.794 0 O-C-N 120.707 -1.245 . . . . 0.0 111.93 -174.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -153.89 162.21 41.4 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.697 1.999 . . . . 0.0 106.447 169.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -68.75 147.42 51.82 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.36 0.6 . . . . 0.0 111.17 -172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -71.91 126.37 91.38 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.524 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.17 -24.57 65.82 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 121.661 1.574 . . . . 0.0 113.663 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.83 -15.12 63.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.42 1.009 . . . . 0.0 112.34 173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -108.61 2.45 22.04 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.432 1.093 . . . . 0.0 111.482 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.42 53.05 0.29 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.717 2.007 . . . . 0.0 111.508 174.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -59.89 147.84 37.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 126.828 2.051 . . . . 0.0 112.082 -171.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.9 -53.29 0.36 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -165.94 165.79 17.86 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.0 1.72 . . . . 0.0 107.386 169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.06 -29.37 68.5 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.351 0.66 . . . . 0.0 111.132 176.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -67.13 -41.44 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.41 0.684 . . . . 0.0 110.206 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -67.49 -46.77 71.97 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.912 0.885 . . . . 0.0 108.849 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.53 -52.17 64.58 Favored 'General case' 0 C--N 1.339 0.148 0 C-N-CA 122.872 0.469 . . . . 0.0 110.185 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 24.5 t-105 -58.45 -39.71 80.61 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.578 0.751 . . . . 0.0 111.609 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.0 93.16 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.542 -0.724 . . . . 0.0 110.428 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -65.39 -34.48 78.41 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.875 0.47 . . . . 0.0 111.64 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -58.82 -48.51 81.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 118.908 0.776 . . . . 0.0 109.929 173.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -64.16 -38.25 90.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.612 0.642 . . . . 0.0 111.254 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 40.7 mmm-85 -61.97 -51.65 67.23 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 118.983 0.811 . . . . 0.0 111.156 175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.86 -39.34 84.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -53.81 -55.29 27.85 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.066 0.946 . . . . 0.0 109.467 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -65.51 -42.39 92.14 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 123.146 0.279 . . . . 0.0 110.858 -172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -68.5 -39.01 81.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.078 0.551 . . . . 0.0 111.249 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.15 -50.65 79.01 Favored 'Isoleucine or valine' 0 C--N 1.34 0.16 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -54.11 -43.38 73.47 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 123.68 0.657 . . . . 0.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -60.17 -51.98 67.28 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 117.599 0.7 . . . . 0.0 110.992 178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -69.2 -29.08 66.98 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 117.87 -1.062 . . . . 0.0 111.405 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -42.02 87.89 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 119.798 1.181 . . . . 0.0 109.868 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -57.43 -51.54 69.0 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -66.61 -34.46 77.93 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.521 -176.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -62.18 -38.71 90.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.591 0.632 . . . . 0.0 111.001 175.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.61 -37.36 36.32 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 122.391 0.276 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -90.43 -48.15 7.29 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.609 1.163 . . . . 0.0 110.908 -169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.8 p -106.69 -18.91 13.82 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.209 1.004 . . . . 0.0 111.273 -169.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.26 15.81 75.73 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.82 -0.989 . . . . 0.0 112.503 -179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 81.0 mttt . . . . . 0 C--O 1.25 1.088 0 CA-C-N 118.717 1.258 . . . . 0.0 108.644 178.906 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 120.84 0.352 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.66 171.77 17.12 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.201 1.4 . . . . 0.0 108.652 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -145.52 140.41 27.47 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.44 174.52 8.07 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.63 142.44 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 104.65 -2.352 . . . . 0.0 104.65 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.01 148.63 21.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 118.903 0.774 . . . . 0.0 109.007 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -136.33 132.99 36.38 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -174.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -115.78 133.11 56.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.78 141.43 51.58 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.69 0.796 . . . . 0.0 110.009 -169.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.54 169.29 17.88 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 122.103 0.954 . . . . 0.0 112.131 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 22.1 p -76.03 35.81 0.14 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.23 2.212 . . . . 0.0 110.857 169.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.45 112.51 0.86 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -76.49 54.45 0.93 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.953 0.901 . . . . 0.0 111.656 -177.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -128.46 -18.68 3.94 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -169.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 31.4 m -136.32 -89.61 0.29 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 119.176 0.898 . . . . 0.0 109.688 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 69.8 mtm180 -55.24 -52.46 63.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.197 0.999 . . . . 0.0 111.028 -173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 p -58.03 -47.57 82.68 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.531 1.133 . . . . 0.0 110.874 -178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.45 -56.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.89 1.276 . . . . 0.0 110.16 -178.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.1 mtm -57.33 -45.52 84.19 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.732 . . . . 0.0 111.228 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.87 -44.03 97.6 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 118.671 0.669 . . . . 0.0 111.283 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' HG3' HG12 ' A' ' 34' ' ' VAL . 23.9 tt0 -60.99 -34.57 75.0 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.832 0.453 . . . . 0.0 110.98 176.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.72 43.26 Favored Glycine 0 C--N 1.341 0.858 0 C-N-CA 123.706 0.669 . . . . 0.0 111.655 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -59.67 -43.27 94.04 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 117.533 0.666 . . . . 0.0 110.592 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -61.73 -43.59 98.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.771 -176.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -53.86 -37.62 63.85 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.907 1.231 . . . . 0.0 111.954 174.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 46.2 mm-40 -66.76 -57.28 7.39 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 118.008 0.367 . . . . 0.0 110.411 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -73.94 -42.1 61.05 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 122.094 0.158 . . . . 0.0 111.381 -171.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 71.7 mt -77.81 -11.43 59.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.813 0.845 . . . . 0.0 112.257 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 58.7 26.85 60.7 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 124.377 0.989 . . . . 0.0 114.168 169.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.8 t70 60.89 6.03 1.11 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.626 2.37 . . . . 0.0 114.134 -173.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -64.82 -9.68 22.42 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.65 1.18 . . . . 0.0 110.374 169.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -128.54 119.26 24.49 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 102.99 -2.967 . . . . 0.0 102.99 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -67.56 100.33 0.86 Allowed 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 174.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.456 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.1 t -83.12 135.82 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -172.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -143.27 166.61 24.25 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.584 1.553 . . . . 0.0 109.421 173.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 76.5 p -149.74 161.28 42.54 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.614 -0.679 . . . . 0.0 110.133 169.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.53 -166.64 1.39 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.998 1.319 . . . . 0.0 109.508 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.58 -179.97 44.58 Favored Glycine 0 CA--C 1.521 0.422 0 O-C-N 121.3 -0.875 . . . . 0.0 111.715 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 2.4 mt -53.52 -29.48 16.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 125.352 1.461 . . . . 0.0 111.356 171.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.49 167.14 24.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.602 1.161 . . . . 0.0 108.307 172.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.45 134.49 21.5 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 169.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -135.37 24.96 3.49 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.38 1.072 . . . . 0.0 109.255 175.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.84 167.68 39.18 Favored Glycine 0 C--N 1.34 0.759 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 -175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.411 ' H ' HD23 ' A' ' 44' ' ' LEU . 1.5 pt? -84.78 147.54 26.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.959 0.504 . . . . 0.0 110.508 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -73.7 133.75 79.39 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.089 -0.957 . . . . 0.0 109.303 -174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -51.02 -33.8 44.1 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.897 2.398 . . . . 0.0 114.584 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -72.68 -29.23 63.24 Favored 'General case' 0 C--O 1.227 -0.121 0 O-C-N 121.35 -0.844 . . . . 0.0 110.87 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.37 85.06 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 171.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.22 -49.21 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -44.21 91.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.18 176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.07 92.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.927 0.785 . . . . 0.0 110.152 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 72.1 mmm -71.81 -37.4 70.38 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 117.81 0.277 . . . . 0.0 111.525 178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.46 -27.36 69.06 Favored 'General case' 0 N--CA 1.462 0.129 0 O-C-N 120.87 -1.144 . . . . 0.0 111.31 173.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -68.98 -13.07 62.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.715 0.806 . . . . 0.0 110.852 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -119.3 -2.42 9.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.528 1.131 . . . . 0.0 112.228 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.97 33.41 9.73 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.16 160.87 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -128.33 145.15 51.15 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.3 pt -128.32 -1.04 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 125.367 1.467 . . . . 0.0 110.284 173.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -57.8 -29.9 65.26 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 120.602 -1.311 . . . . 0.0 110.97 171.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -60.79 -16.2 38.02 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.697 1.999 . . . . 0.0 114.537 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' A' ' 21' ' ' GLU . 8.4 pt20 -131.1 54.92 1.88 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.713 1.142 . . . . 0.0 110.452 -169.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 p -49.78 140.94 10.82 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.93 0.892 . . . . 0.0 111.85 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 m -62.36 160.4 13.42 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.041 1.736 . . . . 0.0 114.517 -169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -155.98 156.46 34.53 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.963 1.305 . . . . 0.0 109.689 169.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -70.12 164.32 3.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.857 0.863 . . . . 0.0 109.331 170.142 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.43 146.92 5.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.879 1.272 . . . . 0.0 110.308 -178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.54 136.01 32.44 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.392 1.077 . . . . 0.0 109.938 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.53 -28.65 46.91 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.454 1.502 . . . . 0.0 113.138 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -69.4 -10.83 59.69 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.966 1.306 . . . . 0.0 112.21 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.0 mt -115.1 -42.5 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 59.8 mt -48.66 -58.41 4.78 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.877 1.217 . . . . 0.0 111.686 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -79.34 -1.31 36.31 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -174.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -116.38 -31.5 5.58 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.126 1.37 . . . . 0.0 111.7 -168.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.9 130.03 44.42 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.153 1.381 . . . . 0.0 109.543 178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -65.9 -26.22 67.51 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.443 0.697 . . . . 0.0 110.656 173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.1 tp -148.03 140.43 24.39 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.641 1.177 . . . . 0.0 108.803 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.6 t -116.69 148.13 19.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 169.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.8 t -136.53 130.76 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.29 132.09 45.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 170.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.0 mp -102.96 23.21 12.59 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.904 0.882 . . . . 0.0 109.164 -176.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.5 p -71.55 107.66 4.55 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.979 1.712 . . . . 0.0 110.45 -174.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -157.97 26.69 0.44 Allowed Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 171.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -109.29 -177.45 3.3 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.429 2.291 . . . . 0.0 113.169 -169.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.31 -31.42 69.13 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -81.75 -52.12 7.46 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.533 0.606 . . . . 0.0 110.117 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.4 t70 45.31 32.91 1.09 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.482 1.913 . . . . 0.0 113.994 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -63.93 -21.65 66.57 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.562 -1.336 . . . . 0.0 112.1 175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.8 t 44.18 96.7 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 129.568 3.147 . . . . 0.0 114.661 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -49.09 139.77 25.96 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.91 3.073 . . . . 0.0 114.275 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 58.8 ttm -75.19 149.24 39.0 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.732 1.213 . . . . 0.0 109.895 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -132.65 161.23 64.66 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.744 2.017 . . . . 0.0 110.05 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.98 133.31 24.86 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.029 1.819 . . . . 0.0 109.278 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.03 -19.3 30.28 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.817 2.345 . . . . 0.0 112.318 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -68.15 -20.18 64.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.173 0.989 . . . . 0.0 111.536 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.73 142.23 16.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -61.39 136.23 57.97 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -129.97 158.83 38.47 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 123.974 0.91 . . . . 0.0 109.298 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -137.92 166.47 23.96 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.988 1.715 . . . . 0.0 107.914 169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -132.87 117.5 17.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 21.8 m0 -125.43 52.89 1.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.153 1.781 . . . . 0.0 107.314 -176.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.12 132.17 33.45 Favored Glycine 0 CA--C 1.525 0.678 0 O-C-N 120.73 -1.231 . . . . 0.0 112.367 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.23 159.65 36.28 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 126.501 1.92 . . . . 0.0 106.132 169.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -68.71 142.17 55.08 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.412 0.625 . . . . 0.0 110.845 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.05 126.95 93.19 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.112 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.16 -23.53 45.54 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.115 1.21 . . . . 0.0 113.297 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.69 -9.13 58.35 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.399 1.0 . . . . 0.0 112.225 171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -113.0 4.38 16.69 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.236 1.414 . . . . 0.0 110.667 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.38 63.28 0.37 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.725 2.01 . . . . 0.0 110.442 170.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -59.44 138.97 57.49 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.669 1.588 . . . . 0.0 110.718 -170.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.1 -59.73 0.2 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 175.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.3 t -166.17 169.27 14.53 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 126.054 1.742 . . . . 0.0 107.398 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.98 -29.61 68.56 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.369 0.668 . . . . 0.0 111.416 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.79 -37.8 73.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.788 0.435 . . . . 0.0 110.654 176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -68.6 -43.85 75.58 Favored 'General case' 0 N--CA 1.458 -0.037 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -57.4 -48.42 79.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.778 0.431 . . . . 0.0 110.141 174.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -60.99 -38.06 84.7 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 123.4 0.68 . . . . 0.0 111.925 178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.44 81.66 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.339 -0.851 . . . . 0.0 109.861 176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -64.46 -33.42 75.84 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.018 0.527 . . . . 0.0 111.13 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.25 -50.04 74.15 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.957 0.903 . . . . 0.0 110.278 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -64.88 -34.36 78.21 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 118.347 0.522 . . . . 0.0 111.656 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.51 -49.72 62.11 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.623 0.647 . . . . 0.0 110.821 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.4 t -65.93 -39.86 85.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttp180 -53.72 -54.14 42.22 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 124.458 1.103 . . . . 0.0 109.601 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -64.87 -43.23 93.64 Favored 'General case' 0 C--N 1.333 -0.129 0 O-C-N 123.056 0.222 . . . . 0.0 110.911 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -66.65 -41.08 88.79 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.999 -0.438 . . . . 0.0 110.77 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 39.7 mt -59.59 -50.33 80.37 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.072 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -53.72 -46.67 66.61 Favored Glycine 0 C--N 1.338 0.645 0 CA-C-N 118.763 0.71 . . . . 0.0 111.476 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 -62.19 -46.36 89.26 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 117.404 0.602 . . . . 0.0 110.78 178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.0 tpt85 -72.25 -30.58 65.0 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 121.563 -0.711 . . . . 0.0 110.928 -174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.69 -42.19 82.44 Favored 'General case' 0 C--N 1.338 0.078 0 C-N-CA 123.734 0.814 . . . . 0.0 109.62 173.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -56.17 -48.78 75.67 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -66.11 -37.64 86.24 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.451 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -60.32 -37.29 80.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.643 -0.661 . . . . 0.0 111.496 175.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.36 -36.87 33.41 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.518 0.327 . . . . 0.0 111.661 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -92.96 -45.69 7.83 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 124.465 1.106 . . . . 0.0 111.128 -169.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.5 p -106.88 -19.49 13.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.336 1.055 . . . . 0.0 110.902 -169.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 78.09 16.93 79.1 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.215 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 82.6 mttt . . . . . 0 C--O 1.248 1.003 0 CA-C-N 118.562 1.181 . . . . 0.0 108.703 176.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.3 tpp . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -141.89 10.17 1.97 Allowed 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.289 0.95 . . . . 0.0 111.83 -172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -68.63 129.98 41.51 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 169.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.62 173.95 3.85 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -140.3 142.24 31.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 104.34 -2.466 . . . . 0.0 104.34 172.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.54 146.06 22.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-N 119.043 0.838 . . . . 0.0 108.824 -178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -136.55 124.02 22.13 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -107.6 128.39 54.49 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 59.0 mt -127.62 145.45 50.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.158 0.583 . . . . 0.0 110.935 -169.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.7 m -141.42 178.83 7.17 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 125.755 1.622 . . . . 0.0 109.374 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.7 m -75.85 -19.15 59.11 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.654 171.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -146.34 131.65 4.15 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -81.31 54.33 2.27 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.769 0.828 . . . . 0.0 111.748 -174.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -126.1 -16.88 5.42 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -169.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 59.1 m -131.84 -106.33 0.26 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -170.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 -35.44 75.21 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -171.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.1 p -60.71 -47.77 84.8 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.18 0.9 . . . . 0.0 110.377 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -60.01 -49.71 76.6 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.237 1.015 . . . . 0.0 110.221 177.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 54.1 mtm -58.39 -44.74 89.05 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.16 0.584 . . . . 0.0 111.841 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.18 -42.79 99.61 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.234 0.614 . . . . 0.0 111.015 -178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG12 ' A' ' 34' ' ' VAL . 61.0 tt0 -56.13 -41.2 74.94 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.112 173.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.57 -51.07 60.97 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 118.782 0.719 . . . . 0.0 112.309 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.54 -45.78 92.6 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 117.34 0.57 . . . . 0.0 110.812 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 34' ' ' VAL . . . -62.33 -42.57 99.48 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.846 -175.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -52.77 -44.35 66.46 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.395 0.998 . . . . 0.0 111.568 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -74.8 -43.88 52.35 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 120.348 -0.541 . . . . 0.0 112.164 -175.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -73.72 -44.58 55.98 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.494 0.588 . . . . 0.0 110.921 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 77.0 mt -78.01 -9.64 59.21 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.161 0.984 . . . . 0.0 112.253 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.41 26.48 64.29 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.534 1.064 . . . . 0.0 113.956 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.1 t70 60.72 5.82 1.01 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 127.625 2.37 . . . . 0.0 113.986 -173.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -64.79 -9.32 19.62 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.641 1.176 . . . . 0.0 110.544 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -128.52 118.53 23.21 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 103.158 -2.904 . . . . 0.0 103.158 172.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -67.87 101.43 1.08 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.496 HG12 ' HG3' ' A' ' 21' ' ' GLU . 2.2 t -85.1 137.67 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -172.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -144.19 166.19 25.74 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.62 1.568 . . . . 0.0 109.529 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 95.1 p -147.88 157.06 43.34 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.482 0.713 . . . . 0.0 110.007 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.16 -168.03 1.62 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.546 1.139 . . . . 0.0 110.357 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.54 -175.45 42.09 Favored Glycine 0 CA--C 1.523 0.582 0 O-C-N 121.442 -0.787 . . . . 0.0 112.598 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -55.09 -30.28 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.531 1.532 . . . . 0.0 110.681 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.18 169.6 17.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.776 1.23 . . . . 0.0 109.142 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.53 137.05 20.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -136.49 19.45 3.12 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.205 1.002 . . . . 0.0 109.777 174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.59 170.71 29.09 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 44' ' ' LEU . 1.6 pt? -94.42 146.95 23.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.342 0.657 . . . . 0.0 110.583 -176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -73.33 138.77 78.28 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.826 1.25 . . . . 0.0 109.455 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.15 -30.34 82.04 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 121.849 1.699 . . . . 0.0 113.255 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -71.92 -27.21 62.66 Favored 'General case' 0 C--O 1.226 -0.182 0 CA-C-N 119.626 1.103 . . . . 0.0 110.483 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.31 -48.4 73.2 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.54 1.063 . . . . 0.0 108.941 171.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 60.5 t -57.68 -48.13 84.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -57.92 -47.08 83.88 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.43 -0.795 . . . . 0.0 110.933 175.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -56.9 -43.68 81.57 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.6 0.636 . . . . 0.0 109.389 -173.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 63.8 mmm -71.25 -39.64 71.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.276 0.231 . . . . 0.0 111.375 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.88 -27.09 69.11 Favored 'General case' 0 CA--C 1.528 0.126 0 O-C-N 120.888 -1.133 . . . . 0.0 111.259 173.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -73.2 -9.56 58.85 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.073 0.949 . . . . 0.0 109.957 -178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 m -119.55 -1.12 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.254 1.022 . . . . 0.0 112.591 173.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.65 33.52 11.28 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -118.1 161.54 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 177.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -125.58 143.35 51.06 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.8 pt -128.58 3.63 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 125.03 1.332 . . . . 0.0 110.365 170.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -60.93 -28.06 68.66 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 120.2 -1.563 . . . . 0.0 110.965 172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -65.5 -4.36 5.76 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.412 1.885 . . . . 0.0 115.322 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -137.82 47.87 2.03 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 120.274 1.397 . . . . 0.0 111.273 -169.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 131.28 8.49 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.42 1.088 . . . . 0.0 110.789 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 m -54.82 154.42 5.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 126.448 1.899 . . . . 0.0 115.455 -169.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -152.22 156.0 38.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.206 1.403 . . . . 0.0 109.311 172.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.455 HD13 ' H ' ' A' ' 66' ' ' ILE . 0.0 OUTLIER -69.7 164.79 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 124.263 1.025 . . . . 0.0 109.346 171.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.1 mt -56.4 145.85 6.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.608 1.163 . . . . 0.0 109.671 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -136.93 134.42 36.74 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.404 1.082 . . . . 0.0 109.928 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -56.17 -27.64 55.15 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.635 1.574 . . . . 0.0 113.522 -175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -82.87 -4.18 57.79 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.527 0.603 . . . . 0.0 111.797 -173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 20.4 mt -107.96 -42.24 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 35.6 mt -48.37 -60.45 2.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.388 0.995 . . . . 0.0 111.269 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -75.81 -1.94 27.55 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.371 0.668 . . . . 0.0 112.736 -173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -115.85 -31.51 5.75 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.932 1.293 . . . . 0.0 111.34 -168.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.05 124.12 19.6 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.127 1.371 . . . . 0.0 109.848 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.7 -31.75 71.92 Favored 'General case' 0 C--O 1.227 -0.106 0 C-N-CA 123.816 0.846 . . . . 0.0 110.184 173.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 tp -142.06 139.17 32.21 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.389 1.076 . . . . 0.0 108.547 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -116.41 147.08 20.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.4 t -133.95 126.83 51.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.29 118.39 36.65 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.342 0.519 . . . . 0.0 109.766 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.26 12.63 36.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.848 1.259 . . . . 0.0 110.749 -169.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.0 p -65.53 119.18 10.61 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 177.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -145.27 -12.97 0.23 Allowed Glycine 0 CA--C 1.533 1.199 0 CA-C-O 118.966 -0.908 . . . . 0.0 113.328 171.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -70.37 148.92 47.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.174 1.487 . . . . 0.0 108.722 169.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.97 -16.94 48.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.134 1.374 . . . . 0.0 114.377 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -116.76 10.12 14.17 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 119.349 0.977 . . . . 0.0 111.684 177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.51 90.26 6.23 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 170.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -52.25 -27.43 14.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.857 1.263 . . . . 0.0 113.584 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 78.7 m 76.5 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 128.424 2.689 . . . . 0.0 111.02 -175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -67.23 178.15 3.25 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.335 2.024 . . . . 0.0 110.037 168.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 39.8 tpp -130.23 159.07 37.99 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.472 1.109 . . . . 0.0 109.586 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.75 166.58 18.23 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.224 1.81 . . . . 0.0 110.457 -169.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -63.97 161.34 33.55 Favored 'Trans proline' 0 CA--C 1.545 1.043 0 C-N-CA 121.558 1.505 . . . . 0.0 110.011 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -77.03 -9.12 17.94 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.096 2.531 . . . . 0.0 114.027 -169.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -115.0 -12.72 11.96 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.68 0.992 . . . . 0.0 113.68 -169.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.5 m -73.27 146.58 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 119.764 1.165 . . . . 0.0 110.333 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -69.23 136.95 52.74 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -138.61 151.89 47.64 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.307 0.643 . . . . 0.0 109.987 -174.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -129.34 161.71 29.66 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 127.137 2.175 . . . . 0.0 107.387 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -139.48 112.53 8.08 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 30.9 m0 -122.43 51.45 1.38 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.641 1.577 . . . . 0.0 107.062 -171.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -66.88 132.18 31.32 Favored Glycine 0 CA--C 1.525 0.704 0 O-C-N 120.885 -1.134 . . . . 0.0 111.88 -174.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -151.68 164.97 35.79 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 126.028 1.731 . . . . 0.0 107.411 169.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -58.27 134.35 56.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.913 1.285 . . . . 0.0 109.842 176.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -69.42 124.7 91.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.69 -23.91 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.432 1.421 . . . . 0.0 113.604 -171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.17 -7.53 49.64 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.167 0.894 . . . . 0.0 112.273 174.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -110.33 8.51 23.43 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.615 1.166 . . . . 0.0 111.071 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.87 68.7 0.66 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.879 1.272 . . . . 0.0 109.777 170.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -58.13 136.34 57.2 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.792 0.837 . . . . 0.0 110.277 -171.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.55 -61.72 0.21 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.4 t -165.44 167.04 17.98 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.432 1.493 . . . . 0.0 107.72 171.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.49 -28.05 66.69 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.612 0.765 . . . . 0.0 111.431 178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -71.7 -37.35 70.69 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.047 0.539 . . . . 0.0 110.941 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -69.39 -44.48 71.38 Favored 'General case' 0 CA--C 1.527 0.072 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.2 -45.96 83.29 Favored 'General case' 0 CA--C 1.522 -0.101 0 C-N-CA 122.776 0.431 . . . . 0.0 110.293 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 23.5 t-105 -60.37 -40.47 90.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 123.47 0.708 . . . . 0.0 111.756 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.71 -44.08 87.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 O-C-N 121.487 -0.758 . . . . 0.0 110.513 177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -62.8 -37.47 86.85 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 123.007 0.523 . . . . 0.0 111.274 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -57.12 -48.95 77.39 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.364 0.665 . . . . 0.0 110.345 175.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -63.53 -36.34 83.46 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.438 0.563 . . . . 0.0 111.824 178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 28.4 mmt85 -68.43 -47.44 67.22 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 118.995 0.816 . . . . 0.0 111.085 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.21 -41.41 91.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -54.82 -53.17 58.74 Favored 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.141 0.976 . . . . 0.0 109.758 174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.59 -42.44 98.28 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.781 0.264 . . . . 0.0 110.954 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -65.6 -41.64 92.56 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.984 -0.447 . . . . 0.0 110.843 -179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.51 -50.78 79.01 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.71 -45.63 60.25 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 111.583 -0.607 . . . . 0.0 111.583 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -61.13 -50.35 73.58 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 117.446 0.623 . . . . 0.0 111.1 179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.436 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.9 tpt180 -68.69 -34.25 75.34 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 118.356 -0.83 . . . . 0.0 110.228 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -40.66 98.41 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 119.687 1.13 . . . . 0.0 109.695 176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -58.79 -51.87 68.14 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 176.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.24 -36.08 83.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.908 -177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.65 -36.55 83.2 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.709 -0.619 . . . . 0.0 111.2 176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.4 -37.85 31.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 122.652 0.381 . . . . 0.0 111.257 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.35 -46.92 8.07 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.393 1.077 . . . . 0.0 110.868 -170.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 20.3 p -109.41 -18.86 13.45 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.432 1.093 . . . . 0.0 111.638 -169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 80.46 13.16 82.13 Favored Glycine 0 CA--C 1.531 1.079 0 CA-C-O 118.586 -1.119 . . . . 0.0 112.942 -177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 C--O 1.247 0.942 0 CA-C-N 119.225 1.512 . . . . 0.0 108.428 179.242 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -152.15 157.26 41.3 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.148 1.379 . . . . 0.0 107.609 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -130.94 133.61 45.98 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 103.945 -2.613 . . . . 0.0 103.945 169.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -71.86 172.75 9.33 Favored 'General case' 0 C--O 1.233 0.191 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -144.12 143.62 23.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 tt -146.58 149.7 15.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 119.211 0.914 . . . . 0.0 109.233 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -137.23 131.55 32.55 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.586 0.754 . . . . 0.0 109.286 -172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.25 128.3 56.29 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.3 mt -125.03 141.35 52.18 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.072 0.949 . . . . 0.0 110.319 -169.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.3 m -141.12 168.85 18.79 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 122.223 1.011 . . . . 0.0 112.557 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 33.7 p -76.82 34.21 0.15 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.737 2.015 . . . . 0.0 110.479 169.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.65 109.15 0.67 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 126.351 1.929 . . . . 0.0 108.605 -170.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -76.46 51.46 0.72 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.201 1.0 . . . . 0.0 111.746 -178.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.3 m -120.99 -20.38 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.5 m -136.32 -92.85 0.25 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.254 0.933 . . . . 0.0 110.66 -169.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.36 -36.71 85.01 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -169.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 p -61.04 -47.33 86.91 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.336 0.654 . . . . 0.0 110.616 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -60.69 -49.98 75.34 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.177 0.991 . . . . 0.0 109.679 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.9 mtm -58.21 -44.46 88.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.061 0.544 . . . . 0.0 111.623 176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.45 -44.21 97.51 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.794 0.725 . . . . 0.0 111.346 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.476 ' HG3' HG12 ' A' ' 34' ' ' VAL . 53.6 tt0 -56.94 -41.84 78.98 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.449 0.3 . . . . 0.0 110.725 173.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.92 -52.86 50.83 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 123.763 0.697 . . . . 0.0 112.119 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -61.32 -43.05 99.52 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 117.394 0.597 . . . . 0.0 110.82 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.65 -43.07 99.74 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.923 -175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -55.08 -36.69 65.91 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 119.439 1.018 . . . . 0.0 111.553 175.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -68.4 -57.67 5.52 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.238 0.472 . . . . 0.0 110.921 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -76.19 -43.87 40.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 111.444 0.165 . . . . 0.0 111.444 -169.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.486 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 88.1 mt -72.56 -34.49 67.53 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 122.947 0.499 . . . . 0.0 111.46 -178.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.29 173.57 42.13 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -169.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -67.39 -1.48 4.81 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.843 0.857 . . . . 0.0 111.607 173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.83 -10.23 5.26 Favored 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.428 -0.795 . . . . 0.0 110.991 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 16.3 m95 -128.99 119.63 24.63 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 173.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmmt -70.16 92.19 0.75 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 171.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.476 HG12 ' HG3' ' A' ' 21' ' ' GLU . 1.9 t -78.95 138.44 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -176.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -145.49 166.81 24.6 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.219 1.407 . . . . 0.0 109.46 174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 88.6 p -147.71 159.89 43.31 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.429 0.692 . . . . 0.0 109.721 169.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -163.41 -166.62 1.26 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.952 1.301 . . . . 0.0 109.304 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.18 -179.06 43.61 Favored Glycine 0 N--CA 1.45 -0.402 0 O-C-N 121.311 -0.868 . . . . 0.0 111.776 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -55.45 -29.56 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.991 1.316 . . . . 0.0 110.734 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.8 166.48 29.34 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.325 1.45 . . . . 0.0 108.247 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.85 140.08 26.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.16 9.33 5.68 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.547 1.139 . . . . 0.0 110.356 174.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.65 149.55 24.89 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -172.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.0 144.96 56.41 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.497 0.665 . . . . 0.0 111.413 -175.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -73.21 133.31 81.28 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.575 1.15 . . . . 0.0 108.61 -176.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.01 -34.37 37.7 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.872 2.381 . . . . 0.0 114.282 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -71.78 -28.47 63.65 Favored 'General case' 0 C--O 1.226 -0.159 0 O-C-N 121.498 -0.751 . . . . 0.0 110.896 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.18 -48.01 77.59 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 171.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 17.6 t -59.34 -48.07 88.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -39.75 94.28 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 118.673 -0.68 . . . . 0.0 111.041 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.01 -44.53 97.28 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 119.304 0.956 . . . . 0.0 110.3 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 74.3 mmm -68.91 -36.27 77.81 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.642 0.655 . . . . 0.0 111.469 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.332 -0.173 0 O-C-N 120.484 -1.385 . . . . 0.0 111.396 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -66.43 -17.35 64.74 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.93 0.786 . . . . 0.0 111.038 177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.66 -0.64 8.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.08 0.952 . . . . 0.0 112.114 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.43 32.85 12.55 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -119.03 158.55 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -123.3 144.6 49.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.412 1.085 . . . . 0.0 108.153 171.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.99 4.14 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.977 1.311 . . . . 0.0 110.404 171.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.5 m -60.09 -27.57 67.11 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.113 -1.617 . . . . 0.0 111.153 172.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -65.38 -3.19 3.88 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.468 1.907 . . . . 0.0 115.295 176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -139.9 47.65 1.82 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.302 1.41 . . . . 0.0 111.645 -169.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 p -45.45 133.21 7.64 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.599 1.16 . . . . 0.0 111.356 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.0 m -57.51 156.61 7.87 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.069 1.748 . . . . 0.0 115.153 -169.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -155.95 158.51 38.04 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.079 1.352 . . . . 0.0 109.301 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.414 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.31 164.37 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.159 0.984 . . . . 0.0 110.014 170.255 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.61 149.19 3.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 125.829 1.652 . . . . 0.0 110.991 -176.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -140.53 136.06 32.51 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.705 1.202 . . . . 0.0 110.181 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -55.01 -29.39 57.26 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.576 1.551 . . . . 0.0 113.319 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -69.77 -9.01 52.98 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.912 1.285 . . . . 0.0 112.27 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.4 mt -116.51 -42.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 38.1 mt -46.98 -57.5 4.93 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.586 1.085 . . . . 0.0 112.186 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.71 -0.06 52.25 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.522 0.729 . . . . 0.0 112.801 -173.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -115.94 -31.92 5.59 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.135 1.374 . . . . 0.0 111.527 -169.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.83 130.39 45.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.426 1.491 . . . . 0.0 109.887 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -63.07 -28.12 69.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.712 0.805 . . . . 0.0 110.477 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.7 tp -147.62 139.95 24.47 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.891 1.276 . . . . 0.0 108.671 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.66 147.76 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 169.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 t -134.75 124.29 43.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -177.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.1 p -99.44 132.86 44.48 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.65 22.9 15.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.682 0.793 . . . . 0.0 109.362 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 8.5 p -71.0 111.81 6.67 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 120.785 -1.197 . . . . 0.0 110.305 -178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -159.53 26.03 0.34 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 169.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -110.14 -175.19 2.67 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 127.906 2.482 . . . . 0.0 112.549 -169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.34 -32.43 64.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -82.07 -49.58 10.05 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.342 0.657 . . . . 0.0 110.89 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 34.2 t70 45.57 30.98 0.85 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.554 1.941 . . . . 0.0 114.662 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -66.06 -22.15 66.41 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 120.476 -1.39 . . . . 0.0 113.075 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 86.2 m 47.32 94.36 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 127.324 2.25 . . . . 0.0 113.73 -176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -47.17 134.4 19.18 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.67 2.914 . . . . 0.0 113.224 177.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 28.1 ttt -69.53 145.23 52.8 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.035 0.934 . . . . 0.0 109.663 179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.9 p -126.01 160.23 57.95 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 126.432 1.893 . . . . 0.0 109.288 176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.28 153.92 75.67 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 121.692 1.595 . . . . 0.0 109.226 169.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.45 -24.22 19.43 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.442 2.095 . . . . 0.0 112.004 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -78.45 -25.3 45.86 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.522 0.729 . . . . 0.0 112.732 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.0 p -78.47 147.16 7.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 118.822 0.737 . . . . 0.0 109.676 -175.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -67.94 137.36 55.12 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 169.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -135.44 150.4 49.84 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 122.971 0.509 . . . . 0.0 110.401 -177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -126.91 159.85 32.74 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 127.127 2.171 . . . . 0.0 107.946 172.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -132.92 114.94 14.62 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.46 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 24.8 m0 -123.2 53.85 1.29 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.338 1.855 . . . . 0.0 107.055 -174.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -65.51 131.12 34.85 Favored Glycine 0 CA--C 1.525 0.708 0 O-C-N 120.717 -1.24 . . . . 0.0 111.803 -176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -158.22 161.78 37.81 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 126.795 2.038 . . . . 0.0 106.056 169.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -68.55 141.61 55.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.227 0.537 . . . . 0.0 110.596 -177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -67.24 128.49 93.76 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -66.96 -24.38 45.78 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 CA-C-N 120.116 1.077 . . . . 0.0 113.411 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.05 56.03 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.228 0.922 . . . . 0.0 112.221 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 87.6 mtt180 -111.9 3.28 17.46 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.849 1.26 . . . . 0.0 110.62 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.86 62.95 0.29 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.892 2.077 . . . . 0.0 110.427 170.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -60.03 138.96 57.74 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.722 1.609 . . . . 0.0 110.573 -170.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.55 -59.09 0.21 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 175.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.5 t -166.36 168.95 14.53 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.985 1.714 . . . . 0.0 107.497 169.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.61 -29.36 67.94 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.386 0.674 . . . . 0.0 111.314 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -69.9 -38.35 76.27 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.848 0.459 . . . . 0.0 110.655 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -68.93 -43.74 74.5 Favored 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -58.04 -47.2 83.83 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 122.852 0.461 . . . . 0.0 110.346 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -61.63 -38.65 88.48 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.75 0.704 . . . . 0.0 111.722 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.03 -41.08 82.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.168 -0.957 . . . . 0.0 110.334 177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -66.13 -32.11 73.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.976 -0.453 . . . . 0.0 111.197 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -57.27 -50.37 73.11 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.492 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -56.43 -45.41 80.77 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.827 0.74 . . . . 0.0 111.665 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -59.92 -49.73 76.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.866 0.757 . . . . 0.0 110.734 -179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 80.0 t -70.77 -39.12 75.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -55.78 -56.16 23.83 Favored 'General case' 0 CA--C 1.519 -0.213 0 C-N-CA 124.342 1.057 . . . . 0.0 108.75 177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -69.57 -38.66 77.49 Favored 'General case' 0 N--CA 1.451 -0.377 0 O-C-N 123.406 0.441 . . . . 0.0 110.7 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.42 -42.46 87.69 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.898 0.479 . . . . 0.0 111.025 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 51.5 mt -59.79 -50.95 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -50.77 -47.58 46.38 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -60.93 -49.37 77.71 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 117.567 0.684 . . . . 0.0 111.479 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 11.2 tpt180 -69.55 -34.3 74.0 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.568 -0.729 . . . . 0.0 110.126 -177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -38.77 88.74 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 119.596 1.089 . . . . 0.0 109.744 178.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -55.21 -52.36 63.62 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -66.62 -34.83 78.75 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -62.56 -36.36 82.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 118.893 0.77 . . . . 0.0 111.071 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.14 -37.73 28.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.147 0.579 . . . . 0.0 111.494 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -91.15 -41.45 11.01 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.448 1.099 . . . . 0.0 111.952 -169.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 23.2 p -115.05 -19.33 10.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.206 1.002 . . . . 0.0 111.17 -169.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 83.06 13.61 76.92 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.837 -0.98 . . . . 0.0 112.869 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.6 mttt . . . . . 0 C--O 1.247 0.923 0 CA-C-N 118.879 1.339 . . . . 0.0 108.754 179.919 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -77.11 -28.57 54.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.124 0.569 . . . . 0.0 111.404 -177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.77 133.07 51.25 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 171.99 8.31 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 174.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.6 mp -142.97 142.12 26.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 103.854 -2.647 . . . . 0.0 103.854 175.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.9 tt -141.74 149.08 20.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 119.489 1.04 . . . . 0.0 109.039 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -134.72 134.87 41.5 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -118.4 130.62 56.09 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 64.8 mt -125.74 138.93 53.89 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 110.088 -169.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 42.6 t -137.78 169.15 18.28 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.807 1.243 . . . . 0.0 109.875 -177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.4 p -58.49 -24.78 61.31 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.292 1.037 . . . . 0.0 111.737 171.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -157.25 139.51 6.49 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 107.251 -2.339 . . . . 0.0 107.251 169.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -77.98 51.91 1.01 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.154 0.982 . . . . 0.0 111.549 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.1 m -127.01 -15.91 5.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.312 -169.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.6 m -138.38 -95.6 0.19 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -169.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -54.8 -52.06 63.86 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.556 0.742 . . . . 0.0 111.661 -169.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 17.5 p -68.9 -36.32 77.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.552 0.16 . . . . 0.0 111.312 -172.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -60.15 -53.95 51.67 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.114 0.966 . . . . 0.0 110.469 175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 52.8 mtm -57.88 -44.37 86.63 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.133 0.573 . . . . 0.0 111.027 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.96 -43.21 99.07 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.384 0.538 . . . . 0.0 111.517 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -59.41 -32.35 70.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.098 0.559 . . . . 0.0 111.878 176.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.57 -50.71 29.71 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.641 -0.584 . . . . 0.0 111.641 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -60.16 -41.24 92.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 117.338 0.569 . . . . 0.0 110.647 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.9 -42.51 99.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 117.864 -1.065 . . . . 0.0 111.287 -174.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -55.09 -40.17 70.1 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.824 1.193 . . . . 0.0 111.22 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -64.29 -51.8 61.72 Favored 'General case' 0 C--O 1.232 0.143 0 O-C-N 123.396 0.435 . . . . 0.0 110.872 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -82.6 -44.6 15.63 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 -171.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 32' ' ' TRP . 92.4 mt -73.48 -33.81 65.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 122.816 0.446 . . . . 0.0 111.939 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.72 175.95 46.95 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -169.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -68.96 -2.65 10.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.768 0.827 . . . . 0.0 111.399 174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -59.51 -12.35 6.2 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.776 1.231 . . . . 0.0 111.299 172.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 28' ' ' LEU . 17.2 m95 -129.35 117.84 21.27 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 174.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -69.2 97.29 0.91 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.7 t -80.23 136.87 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -173.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -143.77 164.23 31.08 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 125.54 1.536 . . . . 0.0 109.458 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 17' ' ' SER . 89.8 p -146.59 159.19 43.76 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.533 0.733 . . . . 0.0 109.729 169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.5 -166.97 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.521 1.128 . . . . 0.0 109.621 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.47 -178.96 44.76 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 175.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -55.53 -27.93 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 125.31 1.444 . . . . 0.0 111.259 173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -147.85 172.12 14.66 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.537 1.535 . . . . 0.0 108.367 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -145.94 137.66 25.05 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 169.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -129.85 7.72 5.2 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.553 1.141 . . . . 0.0 110.452 174.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.97 145.86 17.98 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 -172.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.08 142.35 54.27 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.742 0.782 . . . . 0.0 112.034 -176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -69.41 138.88 89.11 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 125.297 1.439 . . . . 0.0 108.963 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -60.75 -28.71 86.92 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 121.735 1.623 . . . . 0.0 112.983 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -72.3 -29.16 63.6 Favored 'General case' 0 C--O 1.227 -0.126 0 O-C-N 120.985 -1.072 . . . . 0.0 110.478 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.96 -45.91 87.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 48.0 t -57.19 -52.65 53.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -59.96 -41.2 91.41 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.974 0.807 . . . . 0.0 111.478 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.94 -46.25 91.46 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.605 0.639 . . . . 0.0 109.853 -179.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 75.8 mmm -70.71 -35.15 72.6 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.174 -0.329 . . . . 0.0 111.035 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.42 -31.65 70.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 121.059 -1.026 . . . . 0.0 110.966 174.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.45 -15.64 63.78 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.211 1.004 . . . . 0.0 110.94 -177.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.59 1.16 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.262 1.025 . . . . 0.0 111.859 177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.38 30.92 17.85 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.0 mt -120.75 153.59 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -137.51 80.56 1.81 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.5 1.12 . . . . 0.0 111.043 -169.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 pt -72.32 1.55 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.506 -0.77 . . . . 0.0 113.0 177.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 96.8 p -61.26 -19.84 62.17 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 121.208 1.822 . . . . 0.0 112.212 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -81.33 0.3 37.8 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.459 1.503 . . . . 0.0 112.956 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -133.29 50.31 2.23 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.431 1.014 . . . . 0.0 109.871 -169.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.4 p -47.58 137.1 9.43 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.191 1.396 . . . . 0.0 111.547 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.9 m -60.07 157.74 12.42 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -169.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -156.35 157.7 36.11 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.246 1.418 . . . . 0.0 109.743 170.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.416 ' H ' HD13 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -72.5 166.49 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.742 1.217 . . . . 0.0 109.927 171.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.2 mt -57.56 146.2 7.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.477 1.111 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -140.77 136.42 32.48 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.478 1.111 . . . . 0.0 109.908 174.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 m -54.75 -28.45 48.61 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.44 1.496 . . . . 0.0 113.096 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.38 -11.19 60.61 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.993 1.317 . . . . 0.0 112.231 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.2 mt -114.73 -42.24 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 64.4 mt -48.93 -58.79 4.29 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 119.814 1.188 . . . . 0.0 111.557 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -1.85 34.96 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -115.47 -31.92 5.75 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.083 1.353 . . . . 0.0 111.699 -169.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.2 130.62 47.86 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.286 1.434 . . . . 0.0 110.215 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.61 -31.58 71.66 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.695 1.198 . . . . 0.0 109.857 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 62.1 tp -148.87 141.61 24.55 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.135 1.374 . . . . 0.0 108.557 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.62 144.69 21.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.7 t -130.55 136.59 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -174.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.16 109.08 14.56 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 -170.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.0 mp -90.68 7.43 39.46 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.885 -0.51 . . . . 0.0 112.318 -168.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.0 p -62.93 120.4 11.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.566 1.147 . . . . 0.0 110.968 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -166.26 30.72 0.2 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.327 1.441 . . . . 0.0 110.668 170.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -109.79 -174.11 2.42 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.704 2.802 . . . . 0.0 112.311 -170.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.94 -21.73 65.09 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.15 -40.2 7.7 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 119.466 1.03 . . . . 0.0 110.561 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.2 t70 49.78 39.31 17.68 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.441 1.896 . . . . 0.0 114.014 169.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.42 -10.54 58.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 117.856 -1.069 . . . . 0.0 113.883 -171.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 75.1 m 34.93 88.05 0.1 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 128.161 2.585 . . . . 0.0 114.17 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -47.25 139.07 16.61 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.248 3.298 . . . . 0.0 113.629 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 62.8 ttp -70.45 140.17 51.92 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.242 1.017 . . . . 0.0 110.261 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.8 p -134.29 159.33 72.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.532 1.933 . . . . 0.0 110.04 -178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.66 143.6 46.92 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.115 1.877 . . . . 0.0 109.938 174.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.54 -20.23 20.81 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.935 2.423 . . . . 0.0 111.668 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -73.49 -7.71 52.92 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.117 1.367 . . . . 0.0 112.727 -177.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.8 t -117.1 141.55 34.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -174.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -61.12 136.81 58.19 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -133.67 155.06 50.4 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.111 0.565 . . . . 0.0 110.236 -179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -127.92 158.76 36.95 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 126.757 2.023 . . . . 0.0 108.149 173.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -131.49 115.51 16.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.415 ' CH2' ' HG3' ' A' ' 130' ' ' ARG . 28.1 m0 -122.48 59.84 1.02 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -174.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -70.5 133.18 23.36 Favored Glycine 0 CA--C 1.523 0.547 0 O-C-N 121.408 -0.807 . . . . 0.0 112.119 -171.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -162.21 161.56 27.93 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.628 1.971 . . . . 0.0 106.439 169.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -65.23 140.31 58.72 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.462 0.705 . . . . 0.0 110.692 -175.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.27 128.44 91.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 175.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.29 -21.95 34.94 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 CA-C-N 120.354 1.162 . . . . 0.0 113.338 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.89 -11.96 60.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.628 1.104 . . . . 0.0 111.855 170.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -107.79 -1.2 21.12 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.665 1.586 . . . . 0.0 110.677 -177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.84 52.8 0.15 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.781 2.432 . . . . 0.0 111.859 173.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -54.26 137.83 40.31 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.726 2.01 . . . . 0.0 111.796 -175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 169.37 -60.59 0.19 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.0 t -162.94 164.31 25.86 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.477 1.511 . . . . 0.0 107.585 169.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.14 -30.46 71.05 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.841 -0.537 . . . . 0.0 111.492 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.31 -37.04 77.58 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.858 0.463 . . . . 0.0 110.378 175.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -70.7 -43.34 69.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -55.64 -49.69 72.19 Favored 'General case' 0 C--N 1.34 0.162 0 O-C-N 121.89 -0.506 . . . . 0.0 110.213 171.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -60.38 -36.13 77.35 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.769 0.713 . . . . 0.0 111.923 178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.64 -44.72 77.27 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.359 -0.838 . . . . 0.0 109.482 176.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -63.52 -31.47 72.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 118.094 -0.955 . . . . 0.0 112.532 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -58.35 -48.43 80.58 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 120.044 1.293 . . . . 0.0 109.862 172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -66.27 -36.58 83.35 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 118.901 -0.571 . . . . 0.0 111.8 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -65.12 -50.43 66.07 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.778 0.717 . . . . 0.0 110.293 176.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.15 -38.27 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -53.92 -52.93 58.99 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.992 0.917 . . . . 0.0 109.331 172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -64.22 -44.52 91.65 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 123.112 0.258 . . . . 0.0 111.167 -175.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -66.27 -39.73 89.63 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.61 -0.681 . . . . 0.0 111.283 -178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.6 mt -58.16 -52.77 54.63 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 172.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -52.86 -44.86 61.51 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.605 -0.598 . . . . 0.0 111.605 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -61.35 -50.76 71.61 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 117.703 0.751 . . . . 0.0 111.201 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG3' ' CH2' ' A' ' 101' ' ' TRP . 10.8 tpt180 -69.83 -32.31 70.66 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 118.437 -0.792 . . . . 0.0 109.931 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -41.5 96.75 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 119.542 1.065 . . . . 0.0 109.737 176.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -57.01 -53.71 55.0 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -66.33 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.639 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -62.04 -36.8 82.68 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 121.575 -0.703 . . . . 0.0 111.157 175.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -81.69 -36.84 28.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.122 0.569 . . . . 0.0 111.714 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.17 -41.52 10.41 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.611 1.164 . . . . 0.0 111.996 -169.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 24.0 p -114.62 -19.1 11.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.154 0.981 . . . . 0.0 110.969 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 82.25 14.59 76.33 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.783 -1.01 . . . . 0.0 112.688 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 80.5 mttt . . . . . 0 C--O 1.246 0.876 0 CA-C-N 118.781 1.291 . . . . 0.0 108.504 179.317 . . . . . . . . 0 0 . 1 stop_ save_